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Thursday, 7 May, 2015
T1:PL
Mammalian circadian clock and metabolism: The epigenetic link
Sassone-Corsi P.1
1Center for Epigenetics and Metabolism, University of California, Irvine
Circadian rhythms govern a number of fundamental physiological functions 
in almost all organisms, from prokaryotes to humans. The circadian clocks 
are intrinsic time-tracking systems with which organisms can anticipate en-
vironmental changes and adapt to the appropriate time of day. Disruption of 
these rhythms can have a profound influence on human health and has been 
linked to depression, insomnia, coronary heart disease, metabolic disorders 
and cancer. At the heart of circadian regulatory pathways is the clock machin-
ery, a remarkably coordinated transcription-translation system that utilizes 
dynamic changes in chromatin transitions and epigenetic control. Recent 
findings show that regulation goes also the other way: specific elements of the 
clock are able to sense changes in cellular metabolism. Importantly, dynamic 
transitions in the epigenome have been associated with regulated patterns of 
nuclear organization. The accumulating evidence that chromatin remodeling 
is implicated in circadian function prompted us to explore whether the clock 
may control nuclear architecture. We applied the 3C-derived 4C technology 
(Chromosome Conformation Capture on Chip) to demonstrate the presence 
of circadian long-range interactions using the clock-controlled dbp gene as 
bait. The circadian genomic interactions with dbp are highly specific and are 
absent in cells whose clock is disrupted by ablation of the Bmal1 gene. We 
establish that the dbp circadian interactome contains a wide variety of genes 
and clock-related DNA elements. While revealing a previously unappreciated 
role of the circadian clock, these findings pave the way towards the elucida-
tion of how nutrition may impact the shaping of the nuclear landscape. 
T3:PL
Modulation of inflammation and metabolism by dietary fatty acids
Calder P.C.1
1Faculty of Medicine, University of Southampton, Southampton SO16 6YD, 
United Kingdom and NIHR Southampton Biomedical Research Centre, University 
Hospital Southampton NHS Foundation Trust and University of Southampton, 
Southampton General Hospital, Southampton SO16 6YD, United Kingdom 
Both inflammation and dysmetabolism contribute to a range of human dis-
eases. These two processes are linked since inflammation alters metabolism, 
while metabolism can produce compounds that induce or modulate inflam-
matory processes. Lipids and their fatty acid components play key roles in 
regulation of inflammatory and metabolic processes. Different fatty acid 
classes, and within the classes, different individual fatty acids have different 
effects. This is because they act through both general and specific molecular 
and cellular mechanisms. Consequently one fatty acid, or class of fatty ac-
ids, may oppose the action(s) of another. Within metabolism, saturated and 
polyunsaturated fatty acids often oppose one another’s actions, while within 
inflammation omega-3 fatty acids (O3FA) often oppose different actions of 
saturated and omega-6 polyunsaturated fatty acids. Among the O3FA, the 
most biologically active are eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA). EPA and DHA are found in oily fish, fish oil supplements 
and a small number of pharmaceutical grade preparations. They are able to 
reduce inflammatory responses and modify metabolism. Key effects of EPA 
and DHA include reduced production of eicosanoids from the omega-6 
fatty acid arachidonic acid; increased production of anti-inflammatory and 
inflammation resolving mediators (resolvins, protectins and maresins); al-
tered activity of several transcription factors (NFkB, AP-1, PPARa, PPARg) 
so acting to reduce production of pro-inflammatory chemicals and to pro-
mote fatty acid b-oxidation, insulin sensitivity and reduction in circulating 
and hepatic triglycerides; and signalling through GPR120 in inflammatory 
cells and adipocytes. Through these molecular and cellular actions, O3FA 
counter several effects of saturated and omega-6 polyunsaturated fatty ac-
ids. The resulting improvements in cell and tissue function are associated 
with improved health and well-being.
Friday, 8 May, 2015
T2:PL
Molecular mechanisms linking inflammation and adipocyte 
de novo lipogenesis to insulin resistance in obesity
Czech M.P.1, Aouadi M.1, Tencerova M.1, Cohen J.L.1, Shen Y.1, 
Pedersen D.J.1, Danai L.V.1, Guilherme A.1
1Program in Molecular Medicine, University of Massachusetts Medical School, 
Worcester, MA, USA
Regulatory mechanisms that control fatty acid synthesis and oxidization 
under various physiological conditions contribute to overall body weight 
changes during nutrient overload. Insulin stimulates synthesis of fatty acids 
(de novo lipogenesis) and their esterification into triglycerides in liver and 
white adipocytes, which can secondarily modulate systemic glucose toler-
ance. Paradoxically, hepatic de novo lipogenesis is greatly increased in obe-
sity while in white adipocytes it is markedly decreased, even though both 
tissues exhibit insulin resistance. Parallel to these effects of obesity on lipo-
genesis and insulin resistance, expansion of immune cells and inflammation 
of these tissues occurs. Although it is clear that inflammation contributes to 
insulin resistance, it has not however been technically possible to determine 
whether immune cells within a given tissue cause insulin resistance within 
that specific tissue. Using newly developed siRNA gene silencing technology 
selectively directed to either resident liver macrophages, denoted as Kupffer 
cells, or selectively to adipose tissue macrophages, we show these tissue im-
mune cells do directly and locally contribute to the insulin resistance in both 
hepatocytes and adipocytes, respectively, in obese mice. The downregulation 
of lipogenic genes in adipocytes caused by obesity is also mediated in part by 
adipose macrophage cytokines. New data on questions that remain open will 
be presented: Do the cytokines that adipocytes release contribute to meta-
bolic regulation in vivo, as do macrophage-derived cytokines? How do rates 
of adipocyte lipogenesis appatently modulate whole body glucose tolerance? 
Acknowledgement: We gratefully acknowledge funding for our studies from NIH 
grant DK030898 and from the International Research Alliance at Novo Nordisk 
Foundation Center for Metabolic Research. 
T5:PL
It is a Parental Responsibility
Marcus C.1
1Karolinska Institutet, Division of Pediatrics, Department of Clinical Science, 
Intervention and Technology, Stockholm, Sweden
Although changes in society are important for the obesity epidemic, pa-
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– especially for younger children. Before 10 years of age parents decide 
almost everything regarding their children’s type of food, meal patterns 
physical activity and snacking. Already during pregnancy parental behav-
ior is of importance. Maternal weight gain is associated with children’s 
long-term weight development at least until 6–12 years of age. Genetic 
factors are of importance for obesity development but obesity genes do 
not make anyone obese without overeating. The temporal pattern for how 
and when parental obesity affects childhood obesity is not the same as 
that for the obesity genes. Parental education is associated with children’s 
weight already at one year of age. Taken together, all these facts clearly 
indicate that the mechanisms behind the strong association between pa-
rental and offspring obesity primarily is of social and/or epigenetic ori-
gin, i.e., factors parents should have the capacity to modify in an obesi-
ty-preventive direction. Thus, the most important measures to be taken 
are to increase the awareness of the parents regarding their importance 
and support the parents as role-models and decision-makers for their 
children. If the parents shoulder these responsibilities, their children will 
have optimal chances to handle both a potential genetic vulnerability and 
the obesogenic society! 
Acknowledgement: Swedish Research Council
T5:PL
Obesity: A societal responsibility
Perry Ivan J.1
1Department of Epidemiology & Public Health, University College Cork, Ireland, 
2HRB Centre for Health & Diet Research
The debate on the relative importance of genes and environment in obe-
sity is now largely redundant. It is accepted that obesity like all conditions 
reflects a complex interplay of both genetic and environmental factors 
and that efforts to partition the origins of this condition between genes 
and environment are futile. This issue will be briefly reviewed. The relative 
contributions of personal agency versus societal conditioning will also be 
addressed. It will be argued that although efforts to empower individuals 
and families are not futile they are likely to play a relatively small part in 
tacking the epidemic of overweigh and obesity in children and adults. Ru-
dolf Virchow in his Report on the 1848 typhus epidemic in Upper Silesia 
stated “If disease is an expression of individual life under favorable con-
ditions, then epidemics must be indicative of mass disturbances of mass 
life.” The global epidemic of overweight and obesity is undoubtedly “in-
dicative of mass disturbances of mass life” – a societal issue that requires 
a societal level response. All of us who work in the area of overweight 
and obesity face difficult challenges in addressing societal level issues, 
in particular the need to confront powerful commercial interests on the 
over-supply of cheap calories and inappropriate/unethical marketing of 
processed, calorie dense foods. 
Acknowledgement: Irish Health Research Board (HRB) 
Saturday, 9 May, 2015
T6:PL
Ecological Public Health: A new approach to 21st century 
public health dilemmas
Rayner G.C.1
1City University London 
The main lines of the modern public health approach were established in 
Europe’s major cities from the mid-19th century. Sanitary measures fo-
cused on unhealthy urban environments, health education applied new 
behavioural rules to personal hygiene, and mass immunisation spread the 
first of many bio-medical measures, with bio-medicine later coming to 
dominate the public health field. Only from the mid- 20th century was 
attention given to the importance of economic factors in driving health 
improvement. In the 1960s, the epidemiologist Thomas McKeown contro-
versially claimed that rising living standards and nutritional improvement 
mattered far more than medicine as an explanation for rising health trends, 
an assessment extended by Nobel Laureate Robert Fogel in his proposi-
tion of ‘techno-physio’ evolution. Rather than improving health, aspects of 
technological and economic advance in the 21st century – the revolution 
in farming production and food systems, private motor transport and a 
burgeoning culture industry – seem only to have confounded it, contrib-
uting to population weight gain and also, via links to climate change and 
biodiversity loss, threatening the ecological platform of human existence. 
In an age of complex and increasingly conjoint public health and envi-
ronmental dilemmas once successful models of public health no appear 
either adequate or able to command public support. Our proposition of 
Ecological Public Health is hardly new. Its past supporters ranged from 
French biologist Rene Dubos to US public health official John Hanlon. 
In my presentation I will argue that in the 21st century public health ad-
vocates must embrace the Ecological Public Health perspective. I further 
demonstrate how such thinking might contribute to the establishment of 
a ‘healthy weight’ society.
Acknowledgement: The presentation is drawn from the book, Ecological Public 
Health: Reshaping the Conditions for Good Health, Routledge 2012, with Tim Lang. 
T8:PL
Long term outcomes of bariatric and metabolic surgery.  
What can bariatric / metabolic surgery offer ?
Suter M.1
1Department of Surgery, Hôpital Riviera-Chablais, Aigle-Monthey, Switzerland, 
Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois 
(CHUV), Lausanne, Switzerland 
Bariatric / Metabolic surgery (BMS) is the only form of treatment for se-
vere obesity that provides significant long-term weight loss and mainte-
nance. With current technology and a laparoscopic approach, BMS can be 
performed safely with low early morbidity and very low mortality. BMS 
results in significant long-term weight loss of between 10 and 30% of total 
body weight. Results depend on the procedure, and generally are superior 
with procedures that alter the enteral route and/or result in malabsorp-
tion. Along with weight loss, BMS induces remission/improvement of 
many obesity-related comorbidities, improves quality of life, and prevents 
the development of obesity-related complications. These effects result in 
improved survival, especially in relation to a reduction in cardiovascular 
risk factors and in the incidence of malignant tumors. Whatever the sur-
gical option, but depending on the patients’ discipline, some weight regain 
occurs over time. According to its magnitude, and together with aging, it 
can result in progressive recurrence of comorbidities. Due to its remark-
able effects on Type 2 diabetes (T2D) in the severely obese patients, BMS 
is also considered for the treatment of poorly controlled T2D in less obese 
patients who would not qualify for surgery based on their weight, with 
promising early and mid-term results. The main long-term side effects of 
BMS are nutritional deficiencies requiring mineral/vitamin supplementa-
tions. Depending on the procedure, other long-term complications, usu-
ally benign but occasionally severe, may develop. While absolutely nec-
essary, BMS is only part of the treatment for severe obesity. Long-lasting 
dietary and behavioral modifications are essential, usually facilitated by 
the surgical procedure. A specialized multidisciplinary approach is key to 
success, and long-term patient follow-up by the bariatric team is essential, 
not only to help achieving good results, but also to prevent and treat com-
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REVIEW SESSIONS / WORKSHOP
Wednesday, 6 May, 2015
T1:RS1 – Secretory Factors in Non-Adipose 
Tissues 
T1:RS1.1 
Ectopic fat and organ steatosis
Perseghin G.1
1Department of Bomedical Sciences for Health, Universitŕ degli Studi di Milano 
& Metabolic, Medicine, Policlinico di Monza, Monza, Italy
Insulin resistance may be detected up to 20 years before the development 
of actual hyperglycemia and it represents a pivotal event into the patho-
genesis of type 2 diabetes. Insulin resistance is also widely present into 
the population and mechanistically it may represent a defensive mecha-
nism against the sedentary life style and overfeeding. In fact, insulin re-
sistance is also largely prevalent in overweight and obese individuals. In 
this context, there is the hypothesis that insulin resistance at the level of 
the skeletal muscle, liver and the heart may be secondary to the excessive 
amount of fatty acids released by the adipocytes because of a dysfunction-
al adipose tissue or simply because of an excessive amount of calories in 
the diet which may push the ri-esterification of these fatty acids also in 
ectopic sites and not only in the subcutaneous and visceral adipose tissue 
with metabolic and functional deleterious effects on this sites of ectopic 
accumulation. On the opposite view accumulation of fat in ectopic sites 
may mediate deleterious effects in remote organs and tissue. For exam-
ple NAFLD/NASH has been consistently associated with increased risk 
of future development of diabetes and cardiovascular disease. Whether 
this association is simply a simultaneous manifestation of the features 
of the metabolic syndrome or whether ectopic fat accumulation is truly 
causative of metabolic and cardiovascular diseases potentially mediated 





1Department of Biochemistry and Molecular Biology, University of Barcelona, 
2CIBER, Fisiopatologia de la Obesidad y Nutrición
The capacity of skeletal muscle to release regulatory factors with endocrine 
and autocrine action in response to physio-pathological stimuli has been 
recognized for long, and has led to the “myokine” concept. Possibly inter-
leukin-6 (IL-6) is a paradigmatic example of myokine, highlighting the 
complexities of myokines action. IL-6 is released by muscle in response 
to exercise and contributes to the insulin-sensitizing effects of exercise, 
whereas IL-6 is also considered a pro-inflammatory cytokine increased as 
consequence of obesity. Recently, multiple novel regulatory factors acting 
as myokines have been identified. Irisin, a cleaved product of the FNDC5 
protein, is produced by muscle under exercise and has a major biologi-
cal action by promoting the browning of fat. Fibroblast growth factor-21 
(FGF21), another endocrine factor capable of inducing brown fat activity, 
white adipose tissue browning and a metabolic health profile, has been 
also recognized as a myokine. FGF21 is released in response to muscle mi-
tochondrial activity and, in fact, it is considered a circulating biomarker of 
muscle mitochondrial disease. Molecules acting as myokines are also of-
ten adipokines, and it is specially remarkable that many of them (i.e. IL-6, 
FGF21) are released by muscle in conditions of enhanced muscular activ-
ity (i.e. exercise) and also by brown adipose tissue in conditions of brown 
fat activation (i.e. cold), which raises the point about similarities between 
the muscle and brown fat signalling secretome. Identification of myokines 
and their biological action provide tools to be influenced by nutritional or 
pharmacological means in order to promote healthy metabolism.
Acknowledgement: Support by MINECO, Spain and Generalitat de Catalunya is 
acknowledged
T1:RS1.3
Beyond intestinal soap – role of bile acids in control of 
adipose tissue function and development of obesity
Kuipers F.1
1Departments of Pediatrics and Laboratory Medicine, University Medical Center 
Groningen, Groningen, The Netherlands
Over the past decade, it has become apparent that bile acids are involved 
in a host of activities beyond their classic functions in bile formation and 
fat absorption. The identification of the farnesoid X receptor (FXR, encod-
ed by Nr1h4) as a nuclear receptor directly activated by bile acids and the 
discovery that bile acids are also ligands for the membrane-bound, G-pro-
tein coupled bile acid receptor 1 (also known as TGR5) have opened new 
avenues of research. Both FXR and TGR5 are expressed in various tissues 
and organs and have been found to regulate various elements of glucose, 
lipid and energy metabolism. Consequently, a picture has emerged of bile 
acids acting as modulators of (postprandial) metabolism. Therefore, strat-
egies that interfere with either bile acid metabolism or signaling cascades 
mediated by bile acids may represent novel therapeutic approaches for 
metabolic diseases. Synthetic modulators of FXR have been designed and 
tested, primarily in animal models, and have revealed that organ-selective 
FXR agonism may provide new approaches in the treatment of obesity 
and certain components of the metabolic syndrome. Furthermore, the use 
of bile acid sequestrants to reduce plasma cholesterol levels has unexpect-
ed benefits. For example, treatment of patients with type 2 diabetes mel-
litus (T2DM) with sequestrants causes substantial reductions in plasma 
levels of glucose and HbA1c. An overview of the molecular mechanisms 
by which bile acids through FXR and/or TGR5 modulate glucose and 
energy metabolism, particularly focusing on adipose tissue biology and 
development of obesity.
T3:RS1 – Changing Behaviors 
T3:RS1.1
Developing theory- and evidence-based interventions.  
Logic modelling for behaviour modification
Kahlert D.1
1University of Stuttgart, Chair Exercise and Health Science, Stuttgart, Germany
Health behaviours, such as physical activity or dieting, are associated with 
body weight. Being physically active and following a healthy diet have 
been shown to reduce the risk of premature death or morbidity. Despite 
those positive outcomes, prevalence studies report that only a small num-
ber of people follow a healthy lifestyle. People’s behaviour is multi-deter-
mined, often guided by routines and habits and is therefore difficult to 
change. Theory-driven and evidence-based interventions aim to support 
people in their lifestyle changes. The development of a theory-driven and 
evidence-based intervention contains several steps that relate tailored 
(or targeted) intervention inputs with intended outputs: the interven-
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intervention would lead to the intended outcome by specifying, for in-
stance, modifiable behavioural predictors and ‘active ingredients’ (Michie 
& Johnston, 2012) that are linked to the behaviour and which should be 
changed within the intervention program by applying behaviour change 
techniques and tools. Systematic reviews and meta-analyses help to iden-
tify evidence-based predictors and intervention components. The imple-
mentation of the intervention as well as a concept of evaluation is also part 
of the development process.
T3:RS1.2
What behaviour changetechniques and theory work best for 
population-based nutrition & physicalactivity interventions?
Michie S.1
1Centre for Behaviour Change, University College London, UK
Interventions to change nutrition and physical activity have had mod-
est and variable success. To some extent, this reflects limitations in the 
scientific methods we use to study and change behaviour. Interventions 
are complex in that they are usually made up of several interacting com-
ponent behaviour change techniques (BCTs). In order to improve inter-
ventions, we need to be able to identify the effective BCTs within com-
plex interventions and understand their mechanisms of action. This talk 
will present BCT Taxonomy v1, a method for specifying interventions in 
terms of their BCTs using standardised terms and definitions developed 
by cross-disciplinary and international consensus. The talk will also report 
results of applying this to identifying effective BCTs within interventions 
aimed at increasing physical activity and healthy eating and illustrate the 
power of using theory to guide such analyses. It will also present a method 
for designing effective interventions, starting with a model of behaviour 
(COM-B) which allows an analysis of the target behaviour in context. This 
model forms the “hub” of the Behaviour Change Wheel, which integrates 
19 frameworks of behaviour change into 9 intervention functions and 7 
policy categories. The talk will show how this can be used to develop pop-
ulation- based interventions, selecting intervention functions, relevant 
BCTs and policies to support their implementation.
T3:RS1.3
Public acceptability in the UK and USA of nudging to reduce 
obesity: The example of reducing sugar-sweetened beverages 
consumption
Petrescu D.C.1, Hollands G.J.1, Ng Y.1, Marteau T.M.1
1Behaviour and Health Research Unit, University of Cambridge
Introduction: The consumption of sugar-sweetened beverages is a major 
contributor to obesity particularly in children. Recent systematic reviews 
provide good evidence that reducing portion size reduces consumption. 
The public acceptability of such an intervention is unknown. Here we 
compare the acceptability in UK and USA samples of government in-
terventions to reduce consumption of sugar-sweetened beverages: three 
nudge interventions (limiting portion size, changing container shape, 
and changing shelf location) and two traditional interventions (increased 
taxation and an education campaign). We also tested the hypothesis that 
informing participants that interventions affect behaviour via non-con-
scious processes decreases acceptability.  
Methods: 1093 UK and 1082 USA participants rated their support for all 
interventions. The information they received was varied across three ex-
perimental conditions. Each intervention was said to affect behaviour: (a) 
via conscious processes; (b) via non-conscious processes; (c) no process 
stated.  
Results: For the majority of both samples, the education campaign and 
the three nudge interventions were acceptable, with education attract-
ing most support. By contrast, only a minority of participants supported 
taxation. There was no support for the study hypothesis: stating that the 
interventions worked via non-conscious processes did not decrease ac-
ceptability for nudge interventions.  
Conclusion: Nudge interventions to reduce consumption of sugary drinks 
appear to be acceptable to the public. Contrary to expectation, highlight-
ing the non-conscious mechanisms via which nudge interventions work 
does not decrease their acceptability.
T3:RS1.4
TV Junkie or PC Freak? – Associations of screen-time with 
eating and drinking habits
Milder I.E.1, Geurts M.1, Dekkers A.L.1, Temme E.H.1, Proper K.I.1,  
Wendel-Vos G.C.1, van den Berg M.1
1Centre for Nutrition, Prevention and Health Services, National Institute for 
Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Background: Screen-time is associated with higher weight and adverse 
health outcomes. This might be due to an influence of TV/PC use on phys-
ical activity and dietary habits, e.g. due to (mindless) snacking and ex-
posure to food advertisements. Indeed some studies (mainly in children) 
have found associations between screen-time, particularly TV, and higher 
consumption of snacks and drinks and energy intake. Aim: To assess the 
associations between TV and PC screen-time and diet in adults  
Methods: Dietary data of 2100 adults were collected in the Dutch Na-
tional Food Consumption Survey 2007–2010 with a repeated 24-h recall. 
Data on leisure screen-time were self-reported. Habitual intakes of several 
food groups and nutrients were estimated and compared between people 
with low, intermediate and high screen-time using confidence intervals 
obtained by bootstrapping. All analyses were carried out with the SPADE 
statistical program (www.spade.nl); adjusting for potential confounders.  
Results: Both PC and TV use tended to be associated with lower intake 
of fruit, vegetables and vitamin C. For PC differences were larger than for 
TV; but still small. Median intakes in the highest (≥ 3 hours/day), vs the 
lowest (≤1 h/d) category of PC time were 66 vs 102 g/day for fruit, 110 vs 
124 g/d for vegetables, and 84 vs 94 mg/d for vitamin C. With high PC 
use, intake of sugar-sweetened beverages was higher (233 vs 145 g/d). On 
the contrary, in the highest category of TV viewing (≥3h/d) intakes of 
sugar-sweetened beverages (151 vs 216 g/d) and mono- and disaccharides 
(90 vs 100 g/d) were lower than for people viewing less than 3 h/d.  
Conclusion: Both TV and PC time were associated with some elements of 
an unhealthy dietary pattern. However, overall our study does not support 
the link between screen-time and diet.
T5:RS1 – Screening and Intervening Early for 
Healthy Growth 
T5:RS1.1
Screening and intervening early for healthy growth: 
Interventions in high risk children
Heitmann B.L.1
1Research Unit for Dietary Studies at Institute of Preventive Medicine, 
Bispebjerg and Frederiskberg Hospital, The Capital REgion, Denmark
Previous interventions have generally not been effective in preventing de-
velopment of overweight, and at the same time studies suggest that some 
subgroups are more predisposed to future obesity. Obesity runs in fami-
lies and the subgroup of children with obese parents is at a much higher 
risk of becoming obese than children of normal weight parents. Likewise, 
there is a several fold higher risk of obesity among children from lower 
than higher socioeconomic status familes, and among those children born 
with a higher birth weight, those born to mothers who smoked during 
pregnancy, or those of Hispanic or African American orgin. Generally, 
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preventing obesity than the studies targeting general populations. How-
ever, most previous studies on high risk groups focused on ethnicity or 
socioeconomic status, only, and hence, there is a need for more studies. 
The Danish Healthy Start Primary Intervention Study included a total of 
963 2–6 year old high risk children, all normal weight at baseline. The 
intervention, which focused on healthy diet, activity, sleep and stress man-
agement, included individual as well as group counselling and teaching 
in practical skills. The study was recently completed and the preliminary 
results, which suggest that the intervention was effective in preventing ex-
cessive weight development over the 18 months intervention period, will 
be presented.
T5:RS1.2
The World Health Organization’s global target for ending the 
increase in childhood overweight by 2025 
de Onis M.1
1Department of Nutrition, World Health Organization, Geneva, Switzerland 
In 2012, the World Health Organization adopted a comprehensive plan 
for maternal, infant and young child nutrition which specified six global 
nutrition targets (1). One of the targets aims to achieve no increase in 
childhood overweight by 2025.This target implies that the global prev-
alence of 7% in 2012 should not rise to 11% in 2025 as current trends 
would predict (2). In addition, the number of overweight children un-
der 5 years of age should not increase from the estimated 44 million in 
2012 to 70 million in 2025 as forecasted. Achievement of the target to 
halt the increase in overweight in children under 5 years of age would 
be possible through the right mix of policies and actions. This presen-
tation will review examples of evidence-based actions that have a strong 
potential for preventing childhood overweight. The policies and actions 
will require considerable political commitment, along with investment of 
resources and participation of a wide variety of sectors and stakeholders. 
In addition, childhood overweight is interlinked with the five other global 
nutrition targets of increasing the rate of exclusive breastfeeding and re-
ducing stunting, anaemia in women of reproductive age, wasting and low 
birth weight. This presents opportunities for synergistic policy and pro-
grammatic approaches to address multiple targets simultaneously, using 
multisectoral platforms that are being established in a growing number of 
countries to improve maternal, infant and young child nutrition.
References
1.  World Health Organization. Global targets 2025. To improve maternal, infant 
and young child nutrition (www.who.int/nutrition/topics/nutrition_globaltar-
gets2025/en/, accessed 12 March 2015).
2.  de Onis M, Blössner M, Borghi B.: Global prevalence and trends of overweight 
and obesity among preschool children. Am J Clin Nutr 2010;92:1257-1264.
T5:RS1.3
The Early Prevention of Obesity in Children (EPOCH) 
Collaboration – results of an Individual Participant Data 
Prospective Meta-Analysis
Baur L.A.1, Askie L.M.1, Rissel C.1, Espinoza D.1, Martin A.1, Wen L.1, 
Magarey A.2, Daniels L.A.3, Campbell K.4, Hesketh K.4, Taylor R.5, Taylor B.5
1University of Sydney, Sydney, Australia,  
2Flinders University, Adelaide, Australia,  
3Queensland University of Technology, Queensland Australia,  
4Deakin University, Geelong, Victoria, Australia,  
5University of Otago, Otago, New Zealand
Introduction: Obesity prevention efforts have increasingly focused early 
in life. RCTs of interventions are more powerful when they are synthesised 
into an individual participant data (IPD) prospective meta-analysis. 
Methods: EPOCH comprises 4 RCTs of obesity prevention strategies 
commencing before age 6 mths. Its main objective was to determine if 
early intervention to prevent childhood obesity influences BMI z-scores at 
age 18–24 mths. There are a range of secondary endpoints. Data from the 
studies were prospectively planned to be combined. Data across the trials 
were aggregated using a one-step linear modelling approach that included 
treatment effect as a fixed effect and accommodated clustering in one trial. 
Multiple-imputation was used to evaluate the impact of missing data. 
Results: The 4 trials comprised 2196 women/infants. Primary outcome 
data were available for 78% of infants. Mean BMI-z score at 18–24 mths 
was 0.67 (95% CI: 0.60 to 0.74) for intervention group, 0.80 (95% CI: 
0.73 to 0.87) for control group (estimated diff –0.13 [95% CI: –0.23 to 
–0.03; p = 0.012]). Multiple-imputation analysis estimated the difference 
at –0.10 (95% CI: –0.20 to 0.00; p = 0.04). Median breastfeeding duration 
was significantly longer in intervention arm (35 wks [95% CI: 30 to 37] 
vs 28 wks [95% CI: 26 to 30]; HR=0.89 [95% CI: 0.8 to 0.98]; p = 0.022). 
Children viewing TV for >1 hr/day was significantly lower in interven-
tion arm (24% vs 35%; OR=0.63 [95% CI: 0.49 to 0.81; p < .001]). There 
were no significant differences in overweight/obesity, sleeping patterns or 
physical activity. 
Conclusion: Early interventions for preventing childhood obesity appear 
effective in reducing BMI z-scores at 18–24 mths to a moderate degree, as 
well as prolonging breast feeding and reducing TV viewing time. 
Acknowledgement: Australian National Health & Medical Research Council
T5:RS1.4
The role of early nutrition in programming of the adult body 
composition – The Helsinki Study of Very Low Birth Weight 
Adults
Matinolli H.M.1, Hovi P.1,2, Männistö S.1, Sipola-Leppänen M.1,3,4,  
Eriksson J.G.1,5,6,7, Mäkitie O.2,5, Järvenpää A.L.2, Andersson S.2,  
Kajantie E.1,2,8
1National Institute for Health and Welfare, Helsinki and Oulu, Finland,  
2Children’s Hospital, University of Helsinki and Helsinki University Central 
Hospital, Helsinki, Finland,  
3Institute of Health Sciences, University of Oulu, Finland,  
4Department of Pediatrics and Adolescence, Oulu University Hospital, Finland,  
5Department of General Practice and Primary Health Care, Institute of Clinical 
Medicine, University of Helsinki, Helsinki, Finland, 
6Unit of General Practice, Helsinki University Central Hospital, Helsinki, Finland, 
7Folkhälsan Research Centre, Helsinki, Finland,  
8Department of Obstetrics and Gynaecology, Oulu University Central Hospital 
and University of Oulu, Oulu, Finland
Introduction: Animal studies have shown that early nutrition plays an 
important role in programming long-term health. Direct human evidence 
is however scarce. We tested the hypothesis that higher early intake of 
protein and other macronutrients predicts adult adiposity in our natural 
experiment of adults born preterm with very low birth weight (VLBW, 
<1500g). 
Methods: Mean gestational age (GA) of the 127 VLBW participants was 
29.0 (SD 2.1) weeks and mean birth weight (BWT) 1105 (SD 218) g. We 
collected detailed information on their nutritional intake during initial 
hospital stay from the hospital records. Mean intakes of energy (94.1 kcal/
kg/day, SD 15.5), protein (1.4 g/kg/d, SD 0.4) and fat (4.3 g/kg/d, SD 1.1) 
during the first three weeks of life were calculated. At the mean age of 22.5 
(SD 2.1) years the subjects underwent a clinical examination including 
measurements of weight, height, body composition (dual x-ray absorpti-
ometry) and resting energy expenditure (indirect calorimetry).  
Results: We found that neonatal energy, protein and fat intakes predict-
ed adult body composition. When adjusted for sex, age, BWT SD score 
and GA, a one g/kg/d higher protein intake predicted 11.1% higher lean 
body mass (LBM) (95% CI 3.7 to 18.9) and 8.5% higher resting energy 
expenditure (0.2 to 17.0)(Figure 1). Similar associations were seen with 
higher early intake of fat but not of carbohydrate. Adjustments for highest 
parental education or preand postnatal medical complications had little 
effect on our results. 
Conclusions: At relatively low neonatal protein intake levels, additional 
protein intake is reflected by healthier body composition, accompanied 
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Fig. 1. Results from linear regression analyses with measurements of body 
composition as dependent variables and early nutritional intakes as independent 
variables. Each line represents the unadjusted regression coefficient with 95% CI. 
All models were adjusted for sex, age, birthweight SD score and gestational age.
T8:RS1 – Ethics of Medico-Surgical Management 
T8:RS1.2
Novel mechanisms of metabolic improvements after bariatric 
surgery
Di Lorenzo N.1, Camperchioli I.1, Carrano F.M.1 
1Dept. Of Experimental Medicine and Surgery, Universitŕ di Roma Tor Vergata 
V.le Oxford 81, 00133 Roma Italy
Overweight and obesity in European adults are responsible for about 
80% of cases of T2DM, 35% of ischaemic heart disease and 55% of hy-
pertension. Additionally osteoarthritis, respiratory difficulties, infertility, 
psychosocial problems and other factors which reduce life expectancy, 
quality of life and disability, are extremely costly in terms of both absence 
from work and use of health resources. Bariatric surgery has proven to 
be the most effective treatment for morbidly obese patients, with long-
term studies providing evidence of a substantial reduction of mortality 
and a decreased risk of developing new health-related comorbidities. A 
BMI reduction of 5 points leads to T2DM reduction of 33%, 27% for hy-
pertension, 20% for hyperlipidemia. Obesity is accompanied by increased 
arterial stiffness, left ventricular hypertrophy, and diastolic dysfunction, 
all associated with a marked improvement even as early as 6 months after 
bariatric surgery. In addition to its significant benefits on weight, surgery 
has tremendous effects on glucose homeostasis and may lead to complete 
remission of T2D, due to the significant improvement in hepatic and mus-
cular insulin sensitivity. Although lifestyle and pharmacological interven-
tions can control glucidic metabolism, they do not reduce the incidence 
of cardiovascular events in obese individuals with diabetes or in other 
high-risk groups with increased body weight. Apart from its malabsorp-
tive effects, bariatric surgery reduces the long-term incidence of diabetes 
by about 80% (Swedish Obese Subjects study) by modifying some gut hor-
mones pattern (GLP-1, GIP, PYY and ghrelin) and their metabolic effects. 
Experimental studies suggest that changes in gut microbiota are associat-
ed to body weight gain and fat accumulation by the mucosal production 
of RELMß, a key factor in glucose homeostasis. At last, the increasing level 
of inflammatory factors (IL-1, IL-6 and TNF) in obese people represents a 
future promising field of research.
T8:RS1.3
Targeted therapy in obesity
Svacina S.1
13rd Medical Department, 1st Medical Faculty, Charles University, Prague, Czech 
Republic
Introduction: The term targeted therapy is used for the use of antibodies 
against different humoral factors or receptors. This therapy is successful 
in oncology, rheumatology, dermatology, ophtalmology and gastroenter-
ology. Many experimental and clinical studies were performed in diabetes 
with controversial results. A review was prepared concerning possible ef-
fects of targeted therapy on obesity. As in diabetes there are three possible 
ways how targeted therapy can be analysed : 1. Discussion about factors 
which can be targeted in obesity therapy. 2. The effect on body weight in 
clinical trials and clinical use of targeted therapy in medicine. 3. Experi-
ments with targeted therapy in obesity treatment.  
Results: 1. There are many possible targets for antibody treatment in obe-
sitology- e.g. proinflammatory factors or some adipokines. The elevation 
of these factors was described in obesity and related diseases. Only few 
of this factors were targeted by antibodies in animal or clinical studies. 2. 
Only few studies of use of targeted therapy in different fields of medicine 
include data about weight or BMI. The use of targeted therapy in rheu-
matology can decrease the risk of type 2 diabetes to 0.5. It is independent 
of BMI. 3. Very few studies in experimental animals use targeted therapy 
in obesity treatment with promising results. The use of antibodies against 
FGFR1 (receptor for growth factor FGF21) decreased weight in animals 
by 10%, decreassed insulin resistence, decreassed hepatic lipid content 
and serum lipid levels. The energy expenditure was increased. Promising 
are also experiments with blocking of soluble activin type II receptors- 
protecting against diet induced obesity.  
Conclusion: Limited data are available on antibody based of obesity and 
its complication except diabetes. The use of targeted therapy in type 2 di-
abetes treatment has a long history with limited results.The history of ex-
periments in obesity is shorter but it also starts to be promising.
T8:RS1.4
Fecal transplantation in obesity and metabolic syndrome
Nieuwdorp M.1
1AMC-VUmc
Alterations in (small) intestinal microbiota are associated with obesity 
and insulin resistance, with the latter usually characterized by low grade 
endotoxemia. We recently showed that fecal transplantation (infusing in-
testinal microbiota from lean donors) in male recipients with metabolic 
syndrome has beneficial effects on the recipients’ microbiota composition 
and glucose metabolism via lowering plasma endotoxin levels (Vrieze, 
Gastroenterology 2012). Moreover, preliminary data suggest that 4 weeks 
daily oral gavage with one of the identified small intestinal bacterial 
strains (butyrate producer Eubacterium hallii) has dose dependent ben-
eficial effects on insulin sensitivity and liversteatosis in male db/db mice. 
Moreover, we found that intestinal bacterial strains are involved in viscer-
al adipose tissue inflammation. Combined our data suggest that specific 
intestinal bacterial strains might be developed as therapeutic targets to 
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T2:RS1 – Remodelling, Fibrosis and 
Inflammation 
T2:RS1.1
Weight loss and changes in the inflammatory cells in adipose 
tissue
Mraz M.1
13rd Department of Medicine – Department of Endocrinology and Metabolism, 
General University Hospital, Charles University in Prague 1st Faculty of Medicine
Adipose tissue lies at the crossroad of nutrition, metabolism and immu-
nity and adipose tissue inflammation was proposed as one of the central 
mechanisms connecting obesity with its metabolic and vascular compli-
cations. Resident immune cells constitute the second largest adipose tis-
sue cellular component after adipocytes and as such play important roles 
in maintaining adipose tissue homeostasis. Obesity-induced changes in 
their number and function result in activation of local and later system-
ic inflammatory response marking the transition from simple adiposity 
to diseases like type 2 diabetes mellitus, arterial hypertension and isch-
emic heart disease. Although the exact mechanisms responsible for the 
initiation of adipose tissue inflammation are still only poorly understood, 
accumulation of body fat leads to increased recruitment of several types 
of proinflammatory immune cells into the adipose tissue, including mac-
rophages, lymphocytes, dendritic and mast cells and neutrophils. Con-
versely, other immune cell subtypes involved in anti-inflammatory reac-
tions as eosinophils or M2 macrophages are decreased. Weight reduction 
is associated with profound changes in the amount and characteristics of 
adipose tissue immune cells; however, the exact roles of diverse subtypes 
of immune cells in the beneficial effects of different weight reducing pro-
cedures remain to be elucidated. Even though we only begin to unravel 
the complex and dynamic network of immune cells in the adipose tissue, 
the study of their phenotypes and interactions under different conditions 
might help discover new immunometabolic pathways and regulatory re-
actions potentially enabling the development of novel strategies in the 
treatment of obesity and its complications.
Acknowledgement: RVO-VFN64165 and IGA NT13299-4
T2:RS1.2
Human adipocyte function is impacted by mechanical cues
Pellegrinelli V.1,2, Heuvingh J.5, du Roure O.5, Rouault C.1,2,3,4, Devulder A.5, 
Klein C.1,2,3, Lacasa M.2,6, Clément E.5, Lacasa D.1,2,3,4, Clément K.1,2,3,4
1INSERM, UMRS U1166, Nutriomics team, F-75013,  
2Sorbonne Universités, UPMC Univ Paris 06, UMRS 1166 I, ICAN, Nutriomics 
team, F-75005,  
3Université Paris Descartes, UMR S 872, Paris, F-75006,  
4Institute of Cardiometabolism and Nutrition, ICAN, AP-HP, Pitié-Salpętričre 
hospital, F-75013,  
5PMMH UMR 7636 CNRS/ESPCI/UPMC/Paris,  
6INSERM, UMRS U1138team 4, Paris, F-75006
In obesity, adipose tissue undergoes chronic inflammation with deposi-
tion of fibrotic depots organized in rigid collagen fibers around adipocytes 
which could impact on adipocyte metabolism through both mechanical 
constraints and biochemical stimuli. To reproduce the fibrotic environ-
ment of obese adipose tissue, we developed an experimental 3D model 
where human mature adipocytes are included in a peptidic hydrogel with 
decellularized material of adipose tissue (dMAT) from obese subjects. 
Functional consequences on adipocyte metabolism and inflammatory 
profile were followed during one week and transcriptional profile of these 
“fibrotic” adipocytes was screened to determine putative mechanotrans-
duction pathways implicated. The Incorporation of dMAT induced alter-
ation of adipocyte metabolism through a decrease in adipokine secretions 
(-60% for leptin and –40% for adiponectin), insulin response and lipolytic 
activity (-30% of glycerol and FFA release). In addition, dMAT increased 
expression/production of cytokines (IL-6, G-CSF) and fibrotic mediators 
(LOXL2 and the matricellular proteins THSB2 and CTGF) in adipocytes. 
CTGF expression levels correlated with the amount of peri-adipocyte fi-
brosis in WAT from obese individuals. Moreover, dMAT-dependent CTGF 
promoter activity, which depends on β1-integrin/cytoskeleton pathways, 
was enhanced in the presence of YAP, a mechanosensitive co-activator of 
TEAD transcription factors. Mutation of TEAD binding sites abolished 
the dMAT-induced promoter activity. By reproducing a fibrotic microen-
vironment, we showed that adipocytes appear as mechanosensitive cells 
with an inflammatory and metabolic altered phenotype. Fibrosis may neg-
atively affect human adipocyte function via mechanosensitive molecules, 
in part stimulated by cell deformation. Identification of the molecular ac-
tors could give novel insights into adipocyte mechano-transduction and 
possible link with adipose tissue dysfunctions.
Acknowledgement: Emergence program 2010 UPMC, National Agency of Re-
search (ANR Adipofib), Fondation pour la Recherche Medicale (FRM team), Eu-
ropean Community seventh framework program ADAPT(grant agreement no. 
201100) and Assistance Publique des Hôpitaux de Paris (APHP; Programs of Clini-
cal Investigation [PHRC] no. 0702) for human data collection.
T2:RS1.3
Impaired mitochondrial biogenesis in adipose tissue in 
acquired obesity
Heinonen S.1, Buzkova J.2, Muniandy M.1, Kaksonen R.1, Hakkarainen A.3, 
Lundbom J.3, Lundbom N.3, Vuolteenaho K.4, Moilanen E.4, Kaprio J.5,6, 
Rissanen A.1,7, Suomalainen A.2, Pietiläinen K.H.1,8
1Obesity Research Unit, Research Programs Unit, Diabetes and Obesity, 
University of Helsinki, Helsinki, Finland,  
2Research Programs Unit, Molecular Neurology, Biomedicum-Helsinki, 
University of Helsinki, Helsinki, Finland,  
3Helsinki Medical Imaging Center, University of Helsinki, Helsinki, Finland,  
4The Immunopharmacology Research Group, University of Tampere School of 
Medicine and Tampere University Hospital, Tampere, Finland,  
5Finnish Twin Cohort Study, Department of Public Health, Hjelt Institute, 
University of Helsinki, Helsinki Finland,  
6National Institute for Health and Welfare, Department of Mental Health and 
Substance Abuse Services, Helsinki, Finland,  
7Department of Psychiatry, Helsinki University Central Hospital, Helsinki, 
Finland,  
8Department of Medicine, Division of Endocrinology, Helsinki University Central 
Hospital, Helsinki, Finland
Introduction: Low mitochondrial number and activity have been sug-
gested as underlying factors in obesity, type 2 diabetes, and metabol-
ic syndrome. However, the stage at which mitochondrial dysfunction 
manifests in adipose tissue after the onset of obesity remains unknown. 
Methods : Here we examined subcutaneous adipose tissue samples from 
healthy monozygotic twin pairs who were discordant (n = 26, ΔBMI >3 
kg/m2) and concordant (n = 14, ΔBMI <3 kg/m2) for body weight and as-
sessed their detailed mitochondrial metabolic characteristics: mitochon-
drial-related transcriptomes with dysregulated pathways, mitochondrial 
DNA (mtDNA) amount, mtDNA-encoded transcripts, and mitochondrial 
oxidative phosphorylation protein levels.  
Results: We report global expressional downregulation of mitochondrial 
oxidative pathways, with concomitant downregulation of mitochondrial 
amount, mtDNA-dependent translation system, and protein levels of the 
oxidative phosphorylation machinery in the obese compared with the 
lean co-twins. Pathway analysis indicated downshifting of fatty acid ox-
idation, ketone body production and breakdown, and the tricarboxylic 
acid cycle, which inversely correlated with adiposity, insulin resistance, 
and C-reactive protein levels.  
Conclusion: Our results suggest that increased caloric intake downreg-
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cutaneous adipose tissue, promoting metabolic glucose dependence and 
causing mild signs of systemic inflammation even at the early stages of 
acquired obesity.
T2:RS1.4
Bone Marrow is an Important Contributor to Human 
Adipogenesis
Rydén M.1, Uzunel M.2, Hĺrd J.L.3, Borgström E.4, Mold J.E.3, Arner E.1, 
Mejhert N.1, Andersson D.P.1, Widlund Y.1, Hassan M.5, Spalding K.L.3, 
Svahn B.2, Ahmadian A.4, Frisén J.3, Bernard S.6, Mattsson J.2, Arner P.1
1Department of Medicine (H7) Karolinska Institutet, Stockholm, Sweden, 
2Department of Clinical Immunology Karolinska Institutet, Stockholm, Sweden,  
3Department of Cell and Molecular Biology (C5) Karolinska Institutet, 
Stockholm, Sweden,  
4Science for Life Laboratory, Division of Gene Technology, Royal Institute of 
Technology (KTH), School of Biotechnology,  
5Department of Laboratory Medicine (H5) Karolinska Institutet, Stockholm, 
Sweden,  
6Institut Camille Jordan, CNRS UMR 5208, University of Lyon, F-69622 
Villeurbanne, France
Introduction: Human white adipocytes display a high turnover through-
out adulthood. This implies that a continuous supply of precursor cells 
is required to maintain adipogenesis. Adipose progenitor cells reside in 
the stroma of white adipose tissue (WAT), but their origins are unclear. 
As adipocytes can differentiate from bone marrow (BM)-derived mesen-
chymal stem cells (MSCs) in vitro, it has been proposed that BM may 
contribute to mammalian adipogenesis but results in animal models have 
been conflicting.  
Methods: Subcutaneous abdominal WAT biopsies were obtained from 65 
subjects that had undergone allogeneic BM or peripheral blood stem cell 
(PBSC) transplantation 3–31 years ago. Donor cell contribution was de-
termined at the bulk and single cell level. Results Over the entire life span, 
BM/PBSC-derived progenitor cells contribute with ~10% to the subcu-
taneous adipocyte population. While this is independent of gender, age 
and different transplantation-related parameters, body fat mass exerts a 
strong influence with up to 2.5-fold increased donor cell contribution in 
obese individuals. Exome-sequencing of single adipocytes suggests that 
BM/PBSC-derived progenitor cells contribute to WAT via either differen-
tiation or cell fusion. This and the continuous, time-dependent, increase 
in donor cell incorporation in recipients without on-going immunosup-
pressive treatment, demonstrate that BM/PBSC-infiltration into WAT is 
not transient, and indicate that BM may contribute to WAT plasticity also 
under physiological conditions.  
Conclusion: Our findings highlight the role of BM as a reservoir for ad-
ipocyte progenitors, particularly in conditions of excess WAT mass and 
suggest that BM/PBSC transplantation could be explored to treat condi-
tions with severe adipose dysfunction.
T3:RS2 – Physical Fitness 
T3:RS2.1
Epidemiology of Physical Fitness – Badge of Sports Versatility 
of Olympic Champions (OVOV) – one of possible effective 
tools for improving the recent situation
Koukal, J.1
1Czech Olympic Academy
Problem to be solved: A survey of obesity prevalence, complications and 
obese patient habits was performed 5 times during 2000–2013 in stan-
dardized random sample of population of the CzechRepublic with more 
then 2000 subjects from all regions and ages. Physical inactivity was found 
as an important risk marker of obesity and its complications. According 
to our data more than two thirds obese have no intensive physical activ-
ity. All 3 metabolic diseases – obesity, hypertension and type 2 diabetes 
are strongly related to the reported low physical activity in childhood. 
Sportsmen in all age are less obese. There are less patient with diabetes 
and hypertension among those who are active in sport. Moreover physical 
activity in childhood determines the low incidence of diabetes and hyper-
tension for the rest of life. Suggested solution: Olympic gold medalists 
in the decathlon Robert Změlík (1992 in Barcelona) and Roman Šebrle 
(2004 in Athens) initiated the creation of an attractive motoric program 
called Badge of Sports Versatility of Olympic Champions – (Czech abbre-
viation – OVOV). They set a very ambitious goal – to increase a personal 
physical activity of girls and boys aged 10 to 15 years to improve their 
physical fitness and motivate them to begin their possible sports career in 
a similar way, what has proven themselves. After the successful launch of 
the project in 2010, the program was expanded. Recently rules, instruc-
tions and an evaluation of performances are adapted for the all people in 
the age span from 7 to 66 plus. Exercise programme OVOV consists of 
60 m run, long jump, ball throw,1000 m run, shuttle basketball dribbling, 
swimming, rope-skipping, medicine ball throw, two-legs triple jump, pull 
ups on sloped bench, push-ups and sit-ups.  
Results: Comparison and analysis of data from the period 2010 – 2014 
will be presented.
T3:RS2.2
Musculoskeletal Health and Function: Effect of obesity
Thivel D.1
1Laboratory of the Metabolic Adaptations to Exercise under Physiological and 
Pathological
Conditions: Clermont University.,2Regional Center for Human Nutri-
tion (CRNH Auvergne) For years researched have been focused on the 
link between obesity and physical activity level. Although this remains 
an important area that definitely needs deeper explorations, physical fit-
ness appears as one of the most important health indicator in our patients 
(more than physical activity itself). Yet aerobic fitness has long been con-
sidered as the primary factor supporting good health, musculoskeletal 
fitness is now recognized as a crucial parameter in maintaining overall 
health and fitness (Armstrong & Welsma, 1997). Basically, musculoskel-
etal fitness may represent the individual overall capacity to conduct daily 
tasks that rely on muscle strength, gait, flexibility, balance or posture. Is 
obese patients’ musculoskeletal fitness impaired? How does obesity exact-
ly impact musculoskeletal health and function? What about weight loss? 
Does it favor improved musculoskeletal fitness parameters? This talk will 
first try to identify the exact link between MSK function and obesity and 
how it affects overall health in adults and kids with obesity. We will then 
try to question the impact of different weight loss strategies (dietary inter-
vention, physical activity programs or bariatric surgery) on MSK fitness 
in obese adults and youth
T7:RS2 – Lifecourse Perspective 
T7:RS2.1
Overweight and obesity: Life course and multigenerational 
studies
Koupil I.1,2
1Centre for Health Equity Studies (CHESS), Stockholm University/Karolinska 
Institutet, Stockholm, Sweden,  
2Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Introduction: Optimal birth size and good health in early life is an im-
portant health outcome in its own right and is also one predictor of sub-
sequent health and education. Current methodological developments in 
life course epidemiology create unique opportunities to investigate how 
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and grandparental characteristics influence health and social outcomes of 
descendant generations.  
Methods: We attempt to model continuities in birth outcome and body 
size across generations together with social mobility patterns in a dynamic 
way that allows for bidirectional and time changing effects. In this way, we 
aim to examine the scope for breaking the "chains of risk" between gener-
ations, and to highlight new potential ways to reduce long term inequali-
ties. We mainly use data from the Uppsala Birth Cohort Multigenerational 
Study (www.chess.su.se/ubcosmg/) and other linked register data where 
we can apply a life course and intergenerational approach to analysis.  
Results: Multiple sub-studies demonstrate associations between social 
and health characteristics across more than two generations. Examples 
include social patterning of pre-pregnancy body mass index, weight gain 
in pregnancy, size at birth, childhood overweight and obesity as well as 
incidence of diagnosed eating disorders.  
Conclusion: When mechanisms by which poor health and adverse pa-
rental (and grandparental) socioeconomic position translate into social 
and health disadvantage in the offspring and following generations (and 
which thus lead to re-emergence and reproduction of health inequalities 
in subsequent generations) are better understood, new opportunities for 
more effective health equity interventions and policies will emerge.
Acknowledgement: The Uppsala Birth Cohort Multigenerational Study is currently 
supported by grants from the Swedish Research Council and the Swedish Research 
Council for Health, Working Life and Welfare.
T7:RS2.2
Lifecourse Epidemiology and Obesity
Kelleher C.C.1
1National Nutrition Surveillance Centre, School of Public Health, Physiotherapy 
and Population Science, University College Dublin, Belfield, Dublin 4, Republic 
of Ireland
There has been mounting interest in the developmental and lifecourse ori-
gins of adult chronic disease, including the role played in the current global 
burden of overweight and obesity. Body weight may be influenced during 
critical periods such as pregnancy, growth and adolescence and in healthy 
ageing. There may be latent, cumulative or trajectory factors at play at dif-
ferent time points and the interplay between social, environmental and 
constitutional factors has to be understood, not just from a mechanistic 
perspective, but also to identify most effective interventions. Maternal and 
child health provides an important context with two separate potentially 
pathological processes; factors leading to microsomia may later be associ-
ated with central adiposity and insulin resistance, whereas those associat-
ed with macrosomia lead to adiposity, and beta-cell dysfunction1. There is 
increasing interest in how environmental stressors may modify genetically 
inherited traits through epigenetic processes across the lifecourse, neces-
sitating increasingly sophisticated cohort study designs with appropriate 
biopsychosocial data to evaluate these pathways. Data from the Lifeways 
cross-generation cohort study in Ireland for instance show consistently 
stronger influences in the maternal than the paternal family lines on child-
hood growth and development, followed from pregnancy until 9 years of 
age2. This presentation will review current relevant International literature.
Acknowledgement: The Lifeways cross-generation cohort study is funded by the 
Health Research Board in the Republic of Ireland. The National Nutrition surveil-
lance Centre is funded by the Health Service Executive.
References:
1.  Gillman MW, Davey-Smith G, Hanson MA et al.: Developmental Origins of 
Health and Disease across Generations-Theory, Observation, Experiment. In: 
Early Life origins of Health and Disease. Newnham JP, Ross MG (eds); Basel, 
Karger, 2009. pp 52–64.
2.  Kelleher CC, Viljoen, K, Khalil H et al.: Longitudinal follow-up of the relation-
ship between dietary intake and growth and development in the Lifeways 
cross-generation cohort study 2001–2013. Proceedings of the Nutrition 
Society 2014 Feb;73(1):118–31.
T7:RS2.3
Specific associations of maternal and paternal obesity risk-
allele scores with offspring early growth
Heude B.1, Koudou Y.1, Clément K.2, Ong K.K.3, Charles M.A.1
1Institut National de la Santé et de la Recherche Médicale, Center for Research 
in Epidemiology and Population Health, Early origin of the child’s health and 
development team, Villejuif; Paris Descartes University, France, 
2Institut de Cardiometabolism and Nutrition, Centre de Recherche en Nutrition 
Humaine lle de France, Pitié-Salpętričre Hospital, Paris; Institut National de la 
Santé et de la Recherche Médicale U872 team Nutriomique, Paris, France,  
3Medical Research Council Epidemiology Unit, University of Cambridge, 
Addenbrooke’s Hospital, Cambridge; Department of Paediatrics, University of 
Cambridge, Addenbrooke's Hospital, Cambridge, England
Introduction: Early postnatal growth has been suggested to be influenced 
by paternal corpulence. We aimed to investigate the respective role of ma-
ternal and paternal genetic susceptibility to obesity in offspring body size 
and fat mass from birth to 5 years.  
Methods: 833 mother-father-offspring trios from the EDEN mother-child 
cohort were genotyped for a set of 16 polymorphisms previously identi-
fied by genome-wide-association studies of adult BMI. A genetic suscepti-
bility score was built by summing the number of alleles carried. Outcomes 
were age- and sex-adjusted SD scores (SDS) for weight, length, BMI and 
skinfolds at birth, 1, 3 and 5 years, and fat mass percent (FM% obtained 
from bioelectric impedance) at 5 years. Maternal and paternal scores were 
investigated in association with these outcomes in repeated cross-section-
al analyses using linear regression models allowing adjustment for sex, 
maternal height and breastfeeding.  
Results: There was no association between maternal genetic score 
and any anthropometric outcome (p > 0.13), whereas paternal genet-
ic score was significantly associated with weight (ß = 0.053 ± 0.014 SDS 
per allele; p < 0.0001), height (ß = 0.035 ± 0.014; p < 0.016) and BMI 
(ß = 0.047 ± 0.014; p < 0.001) as early as 3 years. Patterns of associations 
were similar at 5 years, when paternal score was also significantly asso-
ciated with skinfolds SD-scores (ß = 0.041 ± 0.015; p = 0.007), and FM% 
(ß = 0.032 ± 0.016; p = 0.043).  
Conclusion: Paternal and maternal genetic susceptibilities to obesity 
seem to play distinct roles in offspring early postnatal growth. Further 
investigations are needed to explain these differences, and especially to 
find out whether environmental constraints during fetal life could be re-
sponsible for the absence of genetic effect from the maternal side.
Acknowledgement: Research reating to this abstract was funded by the Collabora-
tive Research Grant from the European Society for Paediatric Endocrinology and by 
the Medical Research Council (MC_UU_12015/2 and MCU106179472)
T7:RS2.4
Does education influence the overweight tracking from 
adolescence to early adulthood?
Araújo J.1,2, Barros H.1,2, Torres A.3, Ramos E.1,2
1EPIUnit – Institute of Public Health, University of Porto, Porto, Portugal,  
2Department of Clinical Epidemiology, Predictive Medicine and Public Health, 
University of Porto Medical School, Porto, Portugal,  
3School of Social and Political Sciences (ISCSP), University of Lisbon (UL), Lisbon, 
Portugal
We aimed to study how social factors, such as participants’ and paren-
tal education, influences overweight tracking from adolescence to ear-
ly adulthood. We analysed data from 1236 adolescents evaluated at 13, 
17 and 21 years under the EPITeen cohort (Porto, Portugal). Education 
was evaluated as complete years of schooling, and parental education 
was defined according to the parent with highest education. Weight and 
height were measured at each moment and overweight was defined as 
BMI>+1SD from WHO growth reference (at 13y) or BMI≥25.0 kg/m2 (at 
21y). The tracking of overweight was summarized in 4 categories: ‘stable 
normal’-normal BMI at both moments; ‘decreasing’-overweight at 13y/
normal at 21y; ‘increasing’-normal at 13y/overweight at 21y; ‘stable over-
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by odds ratio (OR; 95%CI) adjusted for sex and physical activity at 13y, 
through multinomial regression (reference ‘stable normal’). From 13 to 
21y, 16.3% of participants remained overweight; 7.8% were classified in 
the category ‘increasing’ and 10.8% in the ‘decreasing’. In comparison to 
highly educated (>12y), participants with 10–12y of education were more 
likely to increase their BMI (OR = 2.37; 95% CI:1.44–3.88) or to remain 
overweight (1.70; 1.17–2.47). The same trend was observed for parental 
education; participants whose parents completed≤6y of schooling were 
2.3 times (95%CI: 1.23–4.24) more likely to be in the ‘increasing’ and 
2.0 times (95%CI: 1.21–3.33) more likely to be in the ‘stable overweight’. 
Similar trends were observed in those participants more deprived using 
perceived social class and income adequacy. Besides the effect on over-
weight at 13y, education and unfavourable social conditions also impacts 
on overweight tracking to adulthood.
T4:RS1 – Addiction 
T4:RS1.1
Brain imaging and phenotyping
Pagotto U.1
1Dept. of Medical and Surgical Sciences Endocrine Unit, S.Orsola-Malpighi, 
Hospital Alma Mater, University of Bologna, Bologna, Italy
Human food intake is not only under the control of the hypothalamus but, 
mainly by hedonic mechanisms, also influenced by cortical and subcor-
tical areas related to cognition and reward. The activation of the brain in 
response to food or food cues in animals and in humans is under intense 
scrutiny by using neuroimaging methods as positron emission tomography 
(PET) and functional magnetic resonance imaging (fMRI). Neuroimaging 
studies conformed and highlighted the involvement of multiple brain areas 
as prefrontal, orbitofrontal, somatosensory cortices, insula, thalamus, hypo-
thalamus, amygdala and others in the reward properties of food. However, 
important phenotypic differences in the interaction between external food 
related stimuli and brain regions activated have been found when lean/nor-
mal subjects were compared to overweight/obese patients. Somatosensory 
response to food cues seems to be hyper-responsive in obese individuals; 
moreover brain areas controlling executive drive seem to over-react to the 
anticipation of pleasure during cue exposure in obese compared to lean sub-
jects, furthermore the areas of the brain in obese individuals involved in 
cognitive control and inhibitory behaviour seem to be more resistant to the 
perception of reward after food exposure in comparison to what observed 
in the brain of lean subjects. All these alterations in the neuronal response to 
food cues may stimulate the ingestion of energy rich foods and the propen-
sity to become obese.However, functional imaging studies are still limited 
by a number of still unsolved methodological issues that determine different 
and very often contrasting results. In particular, differences in the stimu-
li used and the conditions of presentation during functional imaging and 
even more importantly, differences in the population sampling may explain 
the large fragmentation of the results obtained.
Acknowledgement: This research was supported by a grant from the European 
Union (NEUROFAST FPVII-KBBE-2009-3-245009) to UP
T4:RS1.2
Eating disorders and obesity: Shared comorbidities, risk 
factors and therapy response
Fernandez-Aranda F.1,2
1Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, 
Spain, 
2CIBEROBN Research Network, ISCIII, Spain
Eating disorders (ED) and obesity share some biological and environmen-
tal risk factors, behaviors and intermediate neurocognitive phenotypes. A 
controversial theory postulates that ED and obesity form part of a broad 
spectrum of eating-related and weight-related disorders. Nevertheless, 
contradictory findings in the literature do not allow differentiating ED 
according to weight-related phenotypes. Obese patients with a comorbid 
ED [mainly binge-eating disorder (BED)] have higher eating, general and 
personality psychopathology and a poorer prognosis. The estimated rate 
of lifetime obesity in ED is nearly 30%, particularly in BED/BN, and it 
seems to become more and more prevalent among ED patients (as preced-
ing, coexisting or consequent condition). Patients with lifetime obesity are 
characterized by later age of onset, higher ED severity and greater general 
psychopathology when compared with patients without lifetime obesity. 
Furthermore, a number of clinical and personality differences between 
obese patients with and without a comorbid ED have been observed. As 
in the case of obesity, in ED findings from neuroimaging studies suggest 
that similar neuronal circuits, modulated by dopamine, are activated in 
addiction and ED by either drugs or hyperpalatable food. These studies 
have postulated a Food/Eating addiction model. In ED patients, higher 
food addiction is associated with the bingeing ED subtype (namely AN-
BP, BN and BED), with more severe eating pathology and overall psy-
chopathology and a greater BMI, but also with specific personality vul-
nerabilities. The presence of ED in obese patients, and mainly binge and/
or purge symptomatology, must be taken into account in clinical practice 
and research. Although the ‘Food Addiction’ construct is able to differ-
entiate between ED/Obese subjects and Healthy Eating/Weight controls, 
it needs to be further explored and tested to understand its implication.
Acknowledgement: Financial support was received from Fondo de Investigación 
Sanitaria (PI11/210; PI14/290). Centro de Investigación Biomédica en Red (CIBER) 
Fisiopatología de la Obesidad y Nutrición, is an initiative of Instituto de Salud Car-
los III.
Friday, 8 May, 2015
T1:RS2 – Lipid Metabolism 
T1:RS2.2
Anatomy of adipose organ: News and views
Cinti S. 
1Department of Experimental and Clinical Medicine, University of Ancona, Italy
Gross anatomy dissections of adult mice revealed that subcutaneous and 
visceral fat depots are joined together to form a unique structure. The 
anterior subcutaneous part of the organ is quite complex and composed 
by interconnected depots located in the interscapular, subscapular, deep 
dorsal cervical, deep ventral cervical and axillo-thoracic areas. The axil-
lo-thoracic area is joined with mediastinic depot by projections following 
aortic arch arterial branches. Mediastinic fat surrounds aorta and its main 
branches and, by passing the aortic hiatus, forms a continuum with the 
inter-renal, perirenal and retroperitoneal areas surrounding the abdomi-
nal aorta. Inter-renal fat is continuous with mesenteric fat and periovar-
ian, parametrial and perivesical fat in females and with periureteral and 
perivesical fat in males. Perivesical fat is connected with the gluteal area 
of the posterior subcutaneous depot. This last depot is composed also by 
inguinal and dorso-lumbar areas. Anterior and posterior subcutaneous 
depots are joined by a thin fat bridge along the lateral parts of the body. 
Omental depot is separated by the rest of the abdominal fat by the perito-
neal ligaments including the spleen. White and brown adipocytes are the 
main parenchymal cell type of this organ and their prevalence at different 
sites depend mainly on age, genetic background, nutritional state and en-
vironmental conditions. These new anatomical observations, reinforce the 
concept of adipose organ and open new perspectives on the plasticity of 
this organ with particular reference to the browning phenomenon and its 
therapeutic implications.
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T1:RS2.3
Inducibility of triglyceride turnover in white fat– a marker of 
lean phenotype
Flachs P.1, Zouhar P.1, Svobodova M.1, Janovska P.1, Bardova K.1, 
Madsen L.2,3, Kristiansen K.2, Jones J.G.4, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic, 
2Department of Biology, University of Copenhagen, Denmark,  
3National Institute of Nutrition and Seafood Research, Bergen, Norway, 
4Biocant, Centre for Neuroscience and Cell Biology, University of Coimbra, 
Cantanhede, Portugal
Introduction: White adipose tissue (WAT) is essential for energy storage, 
while energy expenditure in this tissue normally contributes relatively lit-
tle to total energy balance. Nevertheless, UCP1-independent activation of 
lipolysis of triglycerides (TG) and fatty acids (FA) re-esterification (futile 
TG/FA cycle) in adipocytes in abdominal fat could be involved in preven-
tion of dietary obesity by calorie restriction combined with n-3 FA intake 
(Flachs et al, Diabetologia 2011), as well as in activation of whole-body 
lipid catabolism in response to β3-adrenergic agonist (Motillo et al, J. Lip. 
Res. 2014) in mice.  
Methods: To further characterize the role of TG/FA cycle in WAT, we 
studied its possible activation in response to cold-exposure using obesi-
ty-resistant A/J and obesity-prone C57BL/6J mice. Male mice were main-
tained and killed at 30oC, or after 2 days or 7 days of exposure to 6oC. 
TG turnover in WAT was assessed using 2H-NMR (see Zouhar et al at 
this meeting).  
Results: Cold-exposure resulted in lower weight of both subcutaneous 
and gonadal (g) WAT and in decreased TG and NEFA plasma levels at 
day 2, which normalized at day 7. qRT-PCR analysis of gWAT indicated 
induction of genes involved in lipolysis, glyceroneogenesis, FA oxidation, 
and mitochondrial biogenesis at day 2, and increased incorporation of 2H 
(from 2H2O administered for 40 hrs before killing) into tissue TG at day 
7. All these changes were more pronounced in A/J mice, in the absence of 
detectable induction of UCP1 at the protein level.  
Conclusion: Our results support the view that regulated TG/FA cycle 
activity in gWAT is essential for adrenergically-activated non-shivering 
thermogenesis and could contribute to genetically-determined differences 
in propensity to obesity in mice.
T1:RS2.4
ATGL and HSL deficiency contribute to mitochondrial 
dysfunction and insulin resistance in human adipocytes
Jocken J.1, Goossens G.1, Essers Y.1, Hoebers N.1, Blaak E.1
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Center+, The 
Netherlands
Introduction: The mobilization of fat stored in adipose tissue is medi-
ated by adipose triglyceride lipase (ATGL) and hormone-sensitive lipase 
(HSL). We have previously shown that adipose tissue lipase expression is 
reduced in obese insulin resistant versus obese insulin sensitive subjects. 
Subsequently, we hypothesized that reduced adipose tissue lipase expres-
sion may provide less lipid ligands for peroxisome proliferator-activated 
receptor (PPAR) activation, which in turn disrupts mitochondrial oxida-
tion, contributes to lipid accumulation and insulin resistance in human 
adipocytes.  
Methods: Cell culture experiments were performed, using siRNA-medi-
ated knock-down and pharmacological inhibition, to investigate the role 
of ATGL and HSL in mitochondrial substrate oxidation, lipid accumula-
tion and insulin sensitivity in human primary adipocytes.  
Results: In human adipocytes, ATGL and HSL knock-down decreased 
mitochondrial respiration and oxidative phosphorylation (OXPHOS) 
protein content and attenuated palmitate oxidation, which was accompa-
nied by reduced expression of the PPAR target CPT1a. Interestingly, HSL 
and ATGL gene silencing increased lipid accumulation and reduced insu-
lin-stimulated glucose uptake, which was attributable to disrupted insulin 
signalling at Ser1101 of the insulin receptor substrate-1 and downstream 
Akt activation at Ser473. PPAR agonist treatment partly restored these 
defects.  
Conclusion: We demonstrated that reduced ATGL and HSL expression 
and activity in human adipocytes results in mitochondrial dysfunction 
and insulin resistance in human adipocytes, which is at least partly me-
diated by impaired PPAR signalling. Targeting adipocyte lipases may be 
a promising strategy to improve insulin sensitivity in obesity and type 2 
diabetes.
T3:RS3 – Nutrients and Diet Patterns 
T3:RS3.1
The impact of food reformulation
Klepp K.I.1
1Department of Nutrition, University of Oslo, Norway
This presentation will offer a public health perspective on the importance 
of and potential effects of food reformulation with respect to the overall 
diet of a population. In particular, its potential impact on overweight and 
obesity rates will be addressed. Review of available research and experi-
ences and policy measures from three different areas with implications for 
food reformulation will be presented: food symbol labelling, nutrient pro-
filing guiding policies designed to reduce marketing of unhealthy foods 
and drinks to children, and efforts to mobilize the private sector to take 
a leading role in health promoting food reformulation. Specifically, this 
presentation will draw on the experiences from the Nordic Keyhole food 
symbol designed to make it easier for the public to select healthy products. 
The symbol, which recently had its criteria revised, identifies food items 
within given food categories that meet specific criteria with respect to the 
content of added sugar, salt, fiber and the quality of the fat. In Europe, the 
WHO Euro Action Network on reducing marketing pressure on children 
consists of countries having a joint interest in reducing the marketing 
pressure of high salt, energy-dense, micronutrient-poor foods and bever-
ages towards children. Nutrient profiling systems have been developed in 
a number of countries in order to assist national policies to identify foods 
and drinks that should be subject to reduced marketing. The feasibility 
and potential impact of such schemes will be addressed. An increasing 
number of countries have introduced initiatives with industry to reduce 
the use of salt in processed foods. A number of lessons can be learned 
from these efforts, also with respect to overweight and obesity prevention. 
In particular, the current experience from Norway where the Minster of 
Health and Care has established a high level group of business leaders to 
spearhead the efforts will be presented.
T3:RS3.2
Diets, obesity and metabolic health: Gene-environment 
interactions
Pietiläinen K.H.1
1Obesity Research Unit, University of Helsinki
Gene–environment interaction means that each genotype is respond-
ing to environmental variation in a different way. This implies that some 
people are more susceptible to weight gain than others with similar diets 
because of genetic differences. It is also possible, that caloric restriction 
produces a larger weight-loss to a certain group of people. Data pointing 
to this direction are available from overfeeding and energy deficit exper-
iments in monozygotic twin pairs. However, the subject is still under de-
bate and the molecular mechanisms of it are incompletely understood. 
We have recently studied a rare sample of obesity-discordant monozygotic 
twins and observed that development of metabolic disorders due to obe-
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metabolic health in obesity are due to lifestyle. For example, physical ac-
tivity can contribute to a better metabolic state despite obesity. However, 
it is not excluded that the differences arise because of genetic reasons. The 
gene-environment interaction can also be intertwined with epigenetics. 
This review discusses the gene-environment interactions and touches on 
epigenetics in the context of diet, obesity and metabolic health. The main 
focus is on twin studies.
T3:RS3.3
Meal frequency and type 2 diabetes
Kahleova H.1, Belinova L.1, Malinska H.1, Kazdova L.1, Dezortova M.1, 
Hajek M.1, Tura A.2, Hill M.3, Pelikanova T.1
1Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 
2Institute of Biomedical Engineering, National Research Council, Padua, Italy,  
3Institute of Endocrinology, Prague, Czech Republic
Large prospective studies demonstrated that frequent snacking may lead 
to weight gain and increased risk of type 2 diabetes. The aim of our study 
was to compare the effect of six (A6) vs. two meals a day, breakfast and 
lunch (B2) on body weight, hepatic fat content, insulin resistance and beta 
cell function. 
Methods: In a randomized, open, crossover, single-centre study (conduct-
ed in Prague, the Czech Republic), we assigned 54 patients with type 2 
diabetes treated by oral hypoglycaemic agents (mean diabetes duration 
8.1 ± 5.8 years) to follow two regimens of a hypocaloric diet, each for 12 
weeks: A6, and B2. Randomization and allocation to trial groups (n=27 
and n=27) were carried out by a central computer system. Individual cal-
culations of energy requirements for both regimens were based on the 
formula: [resting energy expenditure (REE) x 1.5] – 500 kcal. The diet in 
both regimens had the same macronutrient and energy content. Hepatic 
fat content (HFC) was measured by proton magnetic resonance spectros-
copy. For statistical analysis, 2×2 crossover ANOVA was used.
Results: The intention-to-treat analysis included all participants (n=54). 
Body weight decreased in both regimens (p < 0.001), more in B2 (-2.3; 
95% CI: –2.7, –2.0 kg in A6 vs. –3.7; 95% CI: –4.1, –3.4 kg in B2; p < 0.001). 
HFC decreased in response to both regimens (p < 0.001), more in B2 
(-0.03; 95% CI: –0.033, –0.027% in A6 vs. –0.04; 95% CI: –0.041, –0.035% 
in B2; p = 0.009). Fasting plasma glucose and C-peptide decreased in both 
regimens (p < 0.001), more in B2 (p = 0.004 and p = 0.04, respectively). 
Fasting plasma glucagon decreased in B2 (p < 0.001), while it increased 
(p = 0.04) in A6 (p < 0.001). 
Conclusions: Our results suggest that for type 2 diabetic patients on a 
hypocaloric diet eating larger breakfast and lunch may be more beneficial 
than six smaller meals during the day.
T4:RS2 – Extreme Weight Loss and 
Psychological Support 
T4:RS2.1
Large weight loss and psychological support
Herlesova J.1,2
1OB klinika, Prague, Czech Republic, 2Faculty of Arts, Charles University, Prague, 
Czech Republic
Significant weight loss and comorbidity improvement after bariatric sur-
gery has unquestionable, positive and substantial effect on several psycho-
logical, social and psychopathological issues. However there are certain 
side effects which may emerge after surgery. Complex psychosocial mat-
ters, such as trauma survivorship; severe distress; dissatisfaction with own 
body after weight loss; blaming obesity for negative life events; problems 
persistence after surgery in spite of weight loss; social prejudice towards 
bariatric patients; regime adherence “saboteurs” in social environment. 
These bothersome events may result into increase or new onset of sub-
stance abuse, psychiatric hospitalization, antidepressant use, suicidal at-
tempt, maladaptive eating and emotional eating. The risk period is about 2 
years after surgery, during weight loss plateau and regain or after excessive 
and rapid weight loss. The suitable prevention of mental health worsening 
after surgery is to submit every patient to psychological assessment before 
operation. Therefore every candidate has an opportunity to easily reach 
the psychological or psychiatric support pre- and post- surgery.
T4:RS2.3
Bariatric surgery and hiv
Chevallier J.M.1
1Department of Bariatric surgery, Hôpital Européen Georges Pompidou, Paris, 
France
Background: Performance of bariatric surgery in patients with human 
immunodeficiency virus (HIV) infection is not well known. The advent of 
Antiretroviral treatment (ART) has dramatically reduced the progression 
of HIV/AIDS, so that these patients live longer, with nearly undetectable 
viral loads , and thus may develop obesity and obesity-related comorbidi-
ties. However few data are available regarding HIV-related outcomes after 
bariatric surgery and its impact in ART tolerability.  
Methods: we present here a retrospective of all subjects with HIV infec-
tion who underwent the different kinds of bariatric surgery that were usu-
ally performed in our University Public Hospital since twenty years. We 
compared these data to the few reported in the literature.  
Results: Between 1996 and 2014 5018 bariatric procedures have been 
performed in our University Hospital. 12 were performed on HIV-infect-
ed patients (0.2%). Among 2905 band placements (LAGB) six have been 
implanted in HIV patients( 3 men, 3 women, mean age 43 years, mean 
preop weight 119 kg , mean BMI 44 kg/m2 ). 5 HIV-infected patients (3 
women, one man, mean age 48, mean weight 125 kg, mean BMI 43.25 kg/
m2) underwent Omega loop or Mini -gastric bypass (MGB) among 1779 
bypasses. Finally one HIV –infected man had a sleeve in 2014 among 123. 
Preoperative comorbidities included type 2 diabetes (N=3), hypertension 
(N=6), dyslipidemia (N=2), sleep apnea (N=5), joint pain (N=3). There 
were no death but 4 out of the six bands had to be removed for infection, 
which is much higher rate of band infection than the overall population 
(1%). At 5 years mean percent EBMIL was 46% after LAGB, 66% after 
MGB.  
Conclusion: On HIV-infected patients Adjustable gastric banding is not 
advisable. MGB can be safely performed. Results appear to be comparable 
to those of noninfected patients. Well-controlled HIV infection should 
not be a contraindication to bariatric surgery. Larger studies will need 
multicentric trials to have sufficient numbers of HIV- infected patients.
T5:RS2 – Genetics. Epigenetics and Early 
Feeding Practices 
T5:RS2.1
From monogenic to polygenic obesities
Aldhoon Hainerova I.1,2
1Department of Paediatrics, Third Faculty of Medicine, Charles University, 
Prague, Czech Republic,  
2Institute of Endocrinology, Prague, Czech Republic
Body weight is a highly heritable trait and genetics of obesity has inten-
sively been studied for decades. A discovery of leptin in 1994 and subse-
quent molecular genetic studies led to identification of mutations in a few 
genes with profound effect on body weight. Analyses of these genes have 
helped to unravel important system maintaining homeostatic control of 
energy balance. An overview of molecular-genetic and clinical research in 
the field of rare cases of monogenic obesities will be presented. However, 
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individual susceptibility or resistance to environmental factors which 
influence energy intake and expenditure. Molecular genetic research has 
focused on the identification of common gene variants affecting body 
weight. Genome-wide association studies of body mass index using large 
sample sets have found numerous susceptibility genetic variants and loci. 
The cumulative effect of these variants is relatively small and could only 
explain up to 5% of obesity heritability. Rare gene variants, copy number 
variants, and epigenetic changes have also been suggested as other mech-
anisms contributing to the heritability of obesity. Fat mass and obesity 
associated gene is still the strongest known genetic susceptibility locus 
for obesity. The role of polygenic effects in the mechanism of obesity has 
been investigated in relation to different possible aspects (e.g. dietary in-
take, food preferences, eating behaviour, weight changes in response to 
altered energy balance) but mostly remains unclear. Discovering under-
lying mechanisms and insights into the biology of polygenic effects on 
body weight is further needed as it would help target novel preventive and 
therapeutic strategies.
T5:RS2.2




Pregnancy presents a unique époque in life with considerable potential to 
influence not only maternal health but also the health of the next genera-
tion. Maternal nutrition is essential to ensure normal fetal development. 
Glucose is the main energy substrate for fetal growth and it is now ap-
parent that there is a strong, continuous association between maternal 
glucose levels below those diagnostic of diabetes and the incidence of 
macrosomia and its inherent complications. Maternal diet, and particu-
larly its carbohydrate type and content, influences maternal blood glucose 
concentrations. However, different carbohydrate foods produce different 
glycaemic responses. The glycaemic index is a method for assessing the 
glycaemic responses of different carbohydrates. It has been shown that a 
low glycaemic diet blunts the mid and late pregnancy increase in insulin 
resistance typically seen in westernized societies. It is postulated that eat-
ing primarily high glycaemic carbohydrate foods results in feto-placental 
overgrowth, excessive maternal weight gain and leads to a predisposition 
to fetal macrosomia, while intake of low-glycaemic carbohydrates predis-
poses to normal infant birth weight and normal maternal weight gain. 
In addition maternal behaviour, lifestyle such as exercise and nutritional 
supplements can be modified to promote an optimal in utero environ-
ment for the fetus. The ROLO study, which was a large RCT of low glycae-
mic index diet in pregnancy, did not impact birthweight but significant 
maternal benefits in terms of gestational weight gain and glucose toler-
ance were observed. The PROPS RCT examined the impact of a probiotic 
supplement in women with gestational diabetes and found that probiotics 
attenuated the normal third trimester rise in lipids. These types of preg-
nancy interventions hold potential to improve pregnancy outcome for the 
fetus and infant and may even have beneficial effects on childhood health.
T5:RS2.3
Protective and obesogenic early feeding practices
Hunsberger M.1
1Section for Epidemiology and Social Medicine, University of Gothenburg, 
Gothenburg, Sweden
Objective: To review the protective and obesogenic early feeding practices 
in the literature and present finding from the Identification and preven-
tion of Dietary- and lifestyle-induced health EFfects In Children and in-
fantS (IDEFICS) study.  
Methods: Findings from IDEFICS study, including exclusive breastfeed-
ing and introduction of complementary foods will be presented along 
with a current review of the literature on early feeding practices. IDEFICS 
is a multi-centre study in eight countries examining risks for overweight/
obesity in over 16,000 children. In the IDEFICS cohort, exclusive breast-
feeding across the eight countries was examined in relation to overweight. 
In the Swedish IDEFICS cohort (n=1837) we examined introduction to 
välling, a uniquely Swedish milk cereal drink (MCD). In both studies, 
children for whom early feeding practices were described at baseline and 
weight and height were recorded are included. In the välling study, we 
included children who had both baseline and two year follow-up anthro-
pometric measures. The children were 2–9 years old at the 2007–2008 
baseline and 4–11 years old at follow-up.  
Results: Exclusively breastfeeding for 4–6 months was protective against 
future overweight. Combination feeding was not protective. In Sweden, 
MCD was consumed by the majority (68.7%) of Swedish children, espe-
cially those born to native Swedish parents. MCD consumption was as-
sociated with an increased mean BMI-z-score over two years and over-
weight at follow-up survey. 
Conclusions: Early feeding practices contribute to future overweight. 
Both the type of food and the timing of introduction are important fac-
tors. 
Acknowledgement: On behalf of the IDEFICS study consortium. For more infor-
mation visit http://www.ideficsstudy.eu/Idefics/. We gratefully acknowledge the fi-
nancial support of the European Community Sixth RTD Framework Programme 
Contract No. 016181 (FOOD).
T2:RS2 – Adipose Tissue Oxygen Tension and 
Angiogenesis
T2:RS2.1
Adipose tissue oxygenation in obesity
Hodson L.1
1Oxford Centre for Diabetes, Endocrinology and Metabolism, University of 
Oxford, Oxford, UK
Subcutaneous white adipose tissue is a complex metabolic organ that re-
sponds rapidly and dynamically to alterations in nutritional state. With 
an increasing degree of obesity there is a concomitant increase in white 
adipose tissue dysfunction, moving the tissue toward a proinflammatory 
phenotype. Low oxygenation (also referred to as hypoxia) of subcutane-
ous white adipose tissue has been proposed as a key underlying mecha-
nism triggering tissue dysfunction; evidence for this to exist is more com-
pelling in rodent, than human models. Factors that may play a pivotal role 
in this transition include an increase in cell size (diffusion distance) and a 
decrease in blood flow per unit tissue mass. Subcutaneous white adipose 
tissue blood flow is markedly lower in obese than non-obese subjects in 
both the fasted and fed states. Tissue oxygen partial pressure (pO2) re-
flects the balance between oxygen delivery and consumption, therefore 
the supply of oxygen to the tissue plays an integral role in tissue oxygen-
ation. It would be reasonable to anticipate that oxygen delivery to the tis-
sue is compromised in obesity. In humans, subcutaneous adipose tissue 
oxygenation has been assessed by expression of hypoxia-sensitive genes/
protein or direct assessment of oxygen tension and the effects on interme-
diary metabolism, in lean and obese subjects; findings are inconsistent. 
Here, I will discuss the different approaches used and the importance of 
integrative physiological techniques to try and elucidate what defines sub-
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T2:RS2.2
Adipose tissue angiogenesis and metabolic disorders
Bouloumié A. 1,2
1Inserm, UMR1048, Team 1, Institute of Metabolic and Cardiovascular Diseases, 
Toulouse France,  
2Paul Sabatier University, Toulouse, France
The adipose tissue endothelium plays a major role as an active surface of 
exchange of cells, hormones, nutrients and oxygen between blood and ad-
ipocytes. The adipose tissue (AT) produces a large number of adipokines 
exhibiting angiogenic activity. With obesity, the global angiogenic state of 
AT rises, an effect to be related to potential hypoxic modulation and/or ac-
cumulation of proangiogenic macrophages. This capacity certainly plays 
an important role to maintain adipose tissue buffering capacity against 
lipids. It will allow adequate metabolic responses as well as accurate ex-
traction of lipids from the blood but also might be linked to adipogenesis 
and the formation of new adipocytes. The adipose micro-environment ex-
hibits distinct angiogenic states depending on the anatomic location of the 
fat mass. An elevated and chronic pro-angiogenic pressure in the visceral 
adipose tissue could trigger an accelerated aging process or senescence of 
endothelial cells leading to a pro-inflammatory phenotype together with 
endothelial dysfunction. Therefore, angiogenesis in adipose tissue may be 
considered as a beneficial event which in long term could drive metabolic 
disorders.
Acknowledgement: Some research related to this abstract was funded by Fondation 
pour la recherche médicale and by AstraZeneca.
T2:RS2.3
Moderate normobaric hypoxia, a new paradigm for metabolic 
flexibility
Keijer J.1, Duivenvoorde L.1, Schothorst E.1
1Human and Animal Physiology, Wageningen University, Wageningen, The 
Netherlands
Tools to quantify health status are required for substantiation of health 
improvement by nutrition. Health can be defined as being metabolic flex-
ible. Metabolic flexibility can be assessed by challenging homeostasis. This 
can be done invasively, as is done in the oral glucose tolerance test. It can 
also be done non-invasively, using indirect calorimetry. We used indirect 
calorimetry to examine the fasting-refeeding response of mice as a tool 
to assess the health effect of interventions with diets with varying lipid 
composition. We also developed a mild oxygen restriction (OxR) chal-
lenge to assess metabolic health. In the OxR challenge oxygen availability 
is reduced from 21% O2 (normoxia) to 12% O2 for a limited period of 
time and the metabolic effects are examined. OxR was able to reveal a 
difference in response between adult and old mice that were otherwise 
healthy. OxR was also applied after short term (5 day) feeding of high fat 
and low fat diets to mice and showed diet dependent differences in OxR 
response in liver and white adipose tissue and in serum. While 90% of 
body oxygen is used in mitochondria and adipose tissue is an important 
metabolic organ, little is known about the response of white adipose tissue 
mitochondria to decreased body oxygen availability. This was examined 
using the OxR challenge and our results will be presented.
Acknowledgement: Several parts of the research presented has been published: 
Horakova et al (2012) PLoS One. 7:e43764; Duivenvoorde et al (2014) Journal of 
Gerontology Biological Sciences. DOI: 10.1093/gerona/glu027; Duivenvoorde et al 
(2014) Pflügers Archiv – European Journal of Physiology, DOI 10.1007/s00424-014-
1553-8. This work was supported by EU FP-7 grant agreement no. 244995 (BIO-
CLAIMS Project).
T8:RS2 – Multidisciplinary Clinical 
Management 
T8:RS2.1
Diabetes management in obesity
Roden M.3
1Department of Endocrinology and Diabetology, Medical Faculty, Heinrich-
Heine University,  
2German Diabetes Center, Leibniz Center of Diabetes Research,  
3German Center for Diabetes Research, Düsseldorf
Obesity is tightly linked to type 2 and type 4, but increasingly also to type 
1 diabetes, and generally worsens the course of disease by favoring in-
sulin resistance and vascular complications. This requires simultaneous 
management of diabetes and obesity in most cases. Lifestyle modification 
aiming at prolonged weight loss and does not only prevents or delays, but 
can even cause remission of diabetes. Despite ongoing debates on the op-
timal dietary intervention, overall caloric restriction seems more import-
ant than specific nutrient modulation. In overweight and obese patients, 
glucose lowering treatment should therefore also aim at avoiding weight 
gain. Metformin, the first-line drug for type 2 diabetes treatment, induc-
es some weight loss, which is more pronounced with GLP-1 analogs and 
SGLT-2 inhibitors. Novel drugs such as 11ß-hydroxysteroid dehydroge-
nase inhibitors can specifically reduce nonalcoholic fatty liver along with 
minor weight loss in patients at high risk of diabetes. Finally, bariatric 
surgery not only markedly improves obesity, but also proves successful in 
reversing type 2 diabetes.
T8:RS2.2
Management of obesity-associated arterial hypertension
Jordan J.1
1Institute of Clinical Pharmacology, Hannover Medical School, Germany
Obesity and arterial hypertension are additive in terms or cardiovascular 
risk. There is hope that new vascular biomarkers may prove useful in indi-
vidual risk prediction in these patients. Obese patients require more med-
ications to have their blood pressure controlled and are prone to treatment 
resistant arterial hypertension. Data from good quality clinical trials on 
the utility of weight loss in the management of hypertension is surprising-
ly scarce and the available data is rarely translated into clinical practice. 
Information on how to combine weight loss interventions with antihy-
pertensive medications, which are ultimately required in many patients, is 
virtually non-existent. Antihypertensive treatment recommendations for 
lean hypertensives may not be simply extrapolated to obese hypertensives 
and have to take into account the metabolic comorbidities, particularly 
insulin resistance and dyslipidemia. Given their positive metabolic profile, 
renin angiotensin system inhibitors are a good choice for the treatment of 
obese hypertensive patients. Yet, most patients will require antihyperten-
sive combination therapy. Dihydropyridine calcium channel blockers are 
a good choice as combination partner. From an antihypertensive point 
of view, low dose thiazide diuretics are an excellent combination partner 
for renin angiotensin system inhibitors while potential metabolic side ef-
fects may occur. Beta-blockers while efficiently lowering blood pressure 
can lead to significant weight gain. In obese patients not achieving target 
blood pressure with first line drugs, mineralocorticoid receptor antago-
nists may be particularly useful. However, there is a substantial risk for 



















   
   
   
   
   
   
   
   
   























1Center of Preventive Cardiology, 3rd Dept. Internal Med., 1st Faculty of 
Medicine, Charles
University and University General Hospital, Prague, Czech Republic Hy-
perlipoproteinemias and dyslipidemias (HLP and DLP), representing one 
from the most important risk factors for cardiovascular diseases (CVD), 
occur very often in patients with obesity. However, there is no equation 
between HLP and DLP and obesity. Many patients with severe HLP (be-
fore all patients with familial hypercholesterolemia) are even slim. (The 
hypercholesterolemia in patients with anorexia is a different story). The 
lipid disorder in patients with obesity is characterized by hypertriglycer-
idemia, low HDL-C and increased concentration of small dense LDL 
particles. It is named atherogenic dyslipidemia (ADLP), lipid triad or 
atherogenic lipid phenotype. ADLP occurs very often in combination not 
only with obesity, but also with hypertension and diabetes mellitus type 2. 
This combination of several risk factors is often described as a “Metabolic 
Syndrome” which is connected with elevated cardiometabolic risk. The 
treatment of the patient with obesity and ADLP has to be complex, it is 
necessary to influence all risk factors. The non-pharmacological treatment 
represents the first step in the therapy of ADLP. Pharmacological treat-
ment is based on statins and it is supported by evidence based medicine. 
The combination of statins with fibrates is also recommended in patients 
with ADLP. Niacin is no more available in Europe and the data for ome-
ga-3 fatty acids are not very convincing. Despite the fact, that ADLP rep-
resents a very important risk factor for CVD, the first and main target for 
the HLP/DLP treatment is LDL-C. For the treatment of elevated LDL-C 
levels high dose statins are drugs of choice. The future of the lipid lowering 
therapy is closely connected with very promising group of PCSK-9 inhib-
itors. Mipomersen and lomitapide are already approved for the treatment 
of homozygotes of familial hypercholesterolemia. CETP inhibitors and 
also alfa/delta PPAR agonists have to be evaluated in clinical trials.
T8:RS2.6
Obstructive sleep apnea and obesity
Šonka K.1
1Department of Neurology, First Faculty of Medicine, Charles University and 
General University Hospital, Prague, Czech Republic
Obstructive sleep apnea (OSA) is characterized by load snoring and re-
petitive closure of the upper airway during sleep with increased respi-
ratory efforts to overcome airway closure, leading to arousals and sleep 
fragmentation. Risk factors for OSA include male sex, age, genetic pre-
disposition, cranio-facial anatomical differences, menopause and namely 
obesity. In the Wisconsin Sleep Cohort, one standard deviation increase 
in BMI was associated with a four-fold increase in OSA prevalence. Lon-
gitudinal observations have confirmed both that weight gain predisposes 
to a worsening apnea/hypopnea index and that weight loss works in the 
opposite direction. Obesity is thought to cause OSA through a number of 
mechanisms: a) Increased parapharyngeal fat can change airway anato-
my, b) changes in neural compensation and the stability of the respiratory 
control centers can reduce airway patency and increase collapsibility, c) 
reduction of lung volume caused by abdominal obesity can reduce upper 
airway traction and increase collapsibility, d) obesity may be involved in 
chemoreflex regulation through mediators such as leptin. On the other 
hand, there are several reasons why subjects suffering from OSA have 
more difficulties losing excess weight. The current treatment of OSA fo-
cuses on alleviation of symptoms by increasing airway patency during 
sleep through positive airway pressure, oral appliances, surgery of the 
throat and maxillo-mandibular bones, changes in sleep position and re-
duction of the overweight. Intensive dietary and lifestyle intervention is 
effective in both weight loss and improving OSA. Data supporting bariat-
ric surgery is less methodologically robust but indicates substantial weight 
loss usually followed by improvement in OSA. There is no doubt that obe-
sity is the major modifiable risk for OSA and offers an excellent target 
intervention from both a clinical and public health point of view.
Acknowledgement: Supported by Charles University grant PRVOUK P26/LF1/4
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1University of Copenhagen, Department of Food and Ressource Economics 
Recently, in 2011, Denmark introduced a tax on saturated fat, abandoned again 
in late 2012.
The fat tax distinguished itself from health promoting taxes in general by 
targeting a nutrient which occurs naturally in foods. In this presentation 
we cast light on some important aspects that have to be considered when 
food taxation is used as a health promoting tool; substitution, price-set-
ting structures and in-equality. Substitution: Based on household scanner 
data we estimate the impact of the tax on consumption of saturated fat 
and other non-targeted dietary measures (e.g. salt intake, fruit and vege-
table consumption). The resultant changes in dietary quality are then used 
as inputs into a comparative risk assessment model to estimate the effect 
of these changes on Non-Communicable Disease and mortality in Den-
mark. We also consider the substitution patterns between different types 
of foods and supermarkets and discount stores. Price-setting structures: 
The retail sector might use the tax as a tool to improve their competitive-
ness or to increase revenue, which might either increase or decrease the 
effect of the instrument. We consider patterns in the price-setting struc-
tures for selected foods within different types of stores. In-equality: Due to 
higher prevalence of NCD’s, lower social classes will gain the most health 
benefits if they change behaviour and reduce their intake of detrimental 
nutrients. But despite higher price-sensitivity in this group, the resources 
and/or knowledge to change behaviour might be lacking, which would 
imply a higher tax-burden. We use the above mentioned household scan-
ner data to assess whether the fat tax was regressive/progressive in health 
and economically for different social classes, genders and age groups. In 
conclusion we consider the main reasons for the abolishment of the Dan-
ish fat tax in late 2012 despite clear evidence of positive health effects.
T6:RS1.3
Price policy for healthy diet-lessons from hungary
Martos É.1, Bakacs M.1
1National Institute for Food and Nutrition Science, Budapest, Hungary
Dietary habits and the general health status of the Hungarian population 
are among the worst in Europe. Public health product tax (PHPT) was 
introduced in 2011 taxing non-staple food products that carry proven 
health risks when consumed. The objectives of PHPT were to promote 
healthier nutrition, encourage food reformulation and to increase rev-
enues for public health. The first impact assessment referred to the one 
year period after the introduction of taxation, it included a representative 
survey of 1000 people, an on-line manufacturers’ survey and analysis of 
economic statistical data. 26–32% of the consumers decreased the intake 
of the products subject to PHPT. The price increase was the major driving 
force behind the intake reduction although high percentage of the con-
sumers (22–38%) reduced the intake because increased health conscious-
ness. People with bad self-perceived health status were on average twice 
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people with good health. 40% of the responding food producers carried 
out reformulation, 30% of them totally removed the unfavourable com-
ponents. In conclusion PHPT has achieved its public health aims as the 
population reduced the consumption of product subject to PHPT, food 
manufacturers started reformulation, and the estimated tax revenue was 
almost fully realized. Several questions remained unanswered regarding 
the consumption changes after the first impact assessment. As part of the 
National Nutrition and Nutrition Status Survey, 2014, the second impact 
assessment seeks to answer whether the consumption changes are main-
tained long term and influenced by nutritional and socioeconomic status 
and obtains information on the substitution of some products affected by 
PHPT.
Acknowledgement: Research related to this abstract was funded by the WHO Re-
gional Office for Europe
T8:WS1 – Multidisciplinary Treatment in 
Children and Adults
T8:WS1.2
Multidisciplinary treatment in adults
Roman G.1
1“Iuliu Hatieganu” University of Medicine and Pharmacy, Clinical Center of 
Diabetes, Nutrition, Metabolic diseases, Cluj-Napoca, Romania
Obesity is a chronic disease with multifactorial etiology and complex 
mechanisms, associated with a high rate of morbidity and mortality. The 
main principle of the clinical management is the long-term patient-cen-
tered intervention, aiming to reduce the global health risk through weight 
loss and its maintenance over time, lifestyle optimization and the con-
trol of associated co-morbidity. The success of the intervention implies a 
multifactorial and thus a multidisciplinary approach represented by struc-
tured programs that include optimal hypocaloric diet, sustained physical 
activity, cognitive-behavioural psychotherapy, specific pharmacotherapy 
(where available) and bariatric surgery. Existing data supports the effec-
tiveness and clinical utility of using the multidisciplinary approach. A 
trained medical team, a functional obesity treatment network, common 
protocol and financial support, are important requirements for a succes-
ful intervention. Besides the medical treatment individualized to each 
patient, any intervention aiming to reduce the social and environmental 
determinants of obesity, including factors related to the physical environ-
ment, social values, technology and the economy, is beneficial. Therefore, 
health care providers should colaborate with political and social depart-
ments in order to ensure an optimal multidisciplinary treatment of people 
with obesity. 
Keywords: obesity, multidisciplinary treatment
T8:WS1.3
Pregnancy and obesity: The experiences of obese women 
receiving antenatal care
Williams L. T.1,2, Knight-Agarwal C. R.2, Davis D.2, Davey R.2
1Griffith Health Institute, Griffith University, Australia,  
2Faculty of Health, University of Canberra, Australia
Introduction: Maternal obesity has implications for both mother and 
baby including increased health risks from gestational hypertensive dis-
orders, caesarean section and stillbirth. Despite the increasing prevalence 
of maternal obesity, little is known of the experiences of these women 
within the health care system. The aim of this research was to investigate 
the views and attitudes of obese pregnant women receiving antenatal care.
Methods: A qualitative study using individual interviews was undertak-
en at a large teaching hospital in South-eastern Australia after obtaining 
approval from the relevant Human Research Ethics Committees. Women 
were recruited through the antenatal clinic at the major public hospital, 
and sixteen pregnant women with a BMI of 30 kg/m2 or above agreed to 
participate. The semi-structured interview protocol was developed after a 
review of the literature and after conducting focus group interviews with 
obstetricians and midwives. Questions explored the lived experiences 
of the women around being pregnant at their body size, and their per-
ceptions of how this affected their antenatal care. Interviews were audio 
recorded, transcribed verbatim and data analysed for recurrent themes 
using Interpretative Phenomenological Analysis.
Results: While the experiences of each participant differed, four themes 
emerged: Judgemental attitudes of staff; Poor communication exists; More 
resources required; Maternal motivation is the key.
Conclusion: Obese pregnant women lack knowledge of the health risks 
associated with their pregnancy, and there was no consistent approach to 
the issue by health professionals. Consistent but non-judgemental support 
is required to assist obese pregnant women achieve recommended nutri-
tion and weight gain goals.
Acknowledgement: Rebecca Shepherd, Alice Downing and Kathryn Lawson assist-
ed with recruitment and conducted some of the interviews as part requirement of 
the research component of the Master of Nutrition and Dietetics at the University 
of Canberra.
T8:WS1.4
Bariatric surgeon´s qualification – how important is it
Dolezalova K. 1,2
1OB klinika – Center for Treatment of Obesity and Metabolic Disorders, Prague, 
Czech Republic,  
21st Faculty of Medicine, Charles University, Prague, Czech Republic
Introduction: Differences in requirements for bariatric surgeon qualifica-
tion may be noted among countries & different obesity/bariatric scientific 
societies. Clinical outcomes after bariatric procedures vary widely across 
hospitals and surgeons and proficiency of the operating surgeon may be 
an important factor underlying such variation.  
Methods: Overview of qualification requirements of the American /
ASMBS/ society, and the International Federation /IFSO/ are confronted 
with „real life“ results reported from large centres.  
Results: The ASMBS requirements vary due to individual US State policy. 
There´s a treshold of min.100 stapled procedures.The IFSO requires min.
of 200 procedures to warrant surgeon´s qualification. In our high volume 
bariatric center >600 ops./year, close correlation between surgeon´s qual-
ification/years of experience/volume and re-admission/complication rates 
was found. Surgeons with >10 years bariatric experience and with >50 
complex operations/year exhibit significantly lower /1.1 +- 0.2% vs 11.2 
+-7.8% P < 0.001) re-admissinon/complication rates. Similar data were 
reported by the Michigan group ( Birkmeyer et al.).The bottom quartile 
of surgical skill, as compared with the top quartile, was associated with 
higher complication rates (14.5%vs.5.2%, P < 0.001) and higher mortality 
(0.26%vs.0.05%, P = 0.01).  
Conclusion: The official bariatric qualification requirements, as well as 
the practical skills vary widely. The findings suggest that greater surgi-
cal skills are associated with fewer postoperative complications and lower 
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SPECIAL SESSIONS
Wednesday, 6 May, 2015
EASO OMTF Teaching Course:  
Multidisciplinary Treatment in Adults
Anti-obesity drugs today
Micic D.D.1
1Center for Obesity, Clinic for Endocrinology, Diabetes and Diseases of 
Metabolism, Clinical Center of Serbia, School of Medicine, University of 
Belgrade, Belgrade, Serbia
There are five anti-obesity drugs for long-term use that are approved by 
FDA in USA: orlistat; lorcaserin; phentermine/topiramate; bupropion/
naltrexone and liraglutide while in Europe EMEA approved orlistat and 
recommended use of bupropion/naltrexone. Orlistat is a potent and selec-
tive inhibitor of pancreatic lipase that reduces the intestinal digestion of fat. 
Lorcaserin is a selective 5-HT 2C receptor agonist that specifically activates 
5-HT 2C receptors relative to other 5-HT receptor subtypes. Activation of 
the serotonin-2C receptors in the hypothalamus reduces the food intake. 
Phentermine and extended–release topiramate was approved in Septem-
ber 2012. Primary mechanism of phentermine is appetite suppresion while 
topiramate has an effect on energy-balance. Fixed-dose combination of nal-
trexone (opioid receptor antagonist) and bupropion (dopamine and nor-
epinephrine reuptake inhibitor) has a synergistic effect in reducing appetite 
and induction of weight loss. Liraglutide in a dose of 3 mg is a once-daily 
injectable glucagon-like peptide-1 (GLP-1) analogue that regulates appetite 
and food intake by decreasing hunger and increasing feelings of fulness 
and satiety after eating. Liraglutide was approved in USA by FDA at the 
end of December 2014 for treating obese subjects with BMI of 30 or a BMI 
of 27 with weight-related comorbidities, together with exercise and a re-
duced-calorie diet. Recently it was reported a discovery of unimolecular, 
dual incretin coagonist (GIP and GLP-1) with proven efficacy across animal 
and human models of obesity and diabetes. It was suggested that the poly-
therapeutic drug strategy in the future could possibly rival bariatric surgery 
concerning efficacy, safety, achievement and duration of weight loss.
EASO PPHTF and WHO Europe Join Workshop: 
Primary Prevention of Overweight and Obesity
WHO plans for action on primary prevention of obesity
Breda J.1
1Nutrition, Physical Activity and Obesity, Division Noncommunicable Diseases 
and Health
Promotion Through the Life-course, WHO Regional Office for Europe 
Unhealthy diets and excess body weight are leading risk factors for NCDs. 
Of the six WHO regions, the European Region is the most severely af-
fected by NCDs; cardiovascular disease, diabetes, cancer and respiratory 
diseases together account for 77% of the burden of disease and almost 
86% of premature mortality.A new European Food and Nutrition action 
plan has been adopted and a Physical Activity Strategy is being developed 
for the European region; where on average 1 in 3 children are overweight 
or obese. Among adults, more than half of the population is obese in 46 of 
the 53 countries. There is a strong social gradient observed within coun-
tries in overweight, obesity and NCDs, with low socio-economic groups 
most affected. In terms of regional disparities, the challenge is universal 
but more rapid changes (e.g. in obesity prevalence) are now observed in 
eastern European countries. Childhood obesity is also particularly preva-
lent in southern European countries. Priority concerns include an overall 
excess consumption of energy, but also excessive consumption of satu-
rated fat, trans-fats, sugar and salt. The new action plans on diet and PA 
thus aims to provide guidance to Member States on the types of policy 
options available. This is informed by the rapidly expanding evidence base 
to inform policy development. Action has tended to be taken in the area 
of providing information rather than making changes to day-to-day en-
vironments (e.g. nutrition labelling; price of food; marketing to children, 
environment and PA). The overall neede comprehensive approach will be 
discussed togehter, with a core package of policies likely to be most effec-
tive.
WHO Session: Population Trends 
WHO.1
Childhood obesity trends in bulgaria
Petrova S.1, Duleva V.1, Konstantinova M.2, Rangelova L.1, Dimitrov P.1, 
Bojilova D.1
1National Center of Public Health and Analysis, Sofia, Bulgaria,  
2Clinic of Endocrinology, Diabetes and Genetics, University Pediatric Hospital, 
Sofia, Bulgaria
Introduction: Given the high recent prevalence of childhood overweight 
and obesity in Bulgaria we aimed to investigate their trends among chil-
dren aged 0–18 years from 1998 to 2013.  
Methods: Data were analysed from 5 cross-sectional studies conducted 
on nationally representative samples of children in different age: 7–18 
years old (1998 and 2011); of age 7 years (2008 and 2013) and children 
0–5 years (2007). Height and weight were measured in the all surveys, 
in some studies waist circumferences (WC) were measured. BMI-for-age 
were estimated using IOTF cut-offs and WHO definitions. Percentile dis-
tributions of WC in sex-gender groups were calculated.  
Results: Using IOTF cut-offs, the prevalence of overall overweight of chil-
dren 7–18 years old showed an increasing from 11.8% in 1998 to 23.4% in 
2011, as obesity has raised from 3.2% to 8.4%, The highest rising in over-
weight rate was observed in 7–9 years children (overweight 14.1%, incl. 
obesity 3.5% in 1998 vs. overweight 30.2%, incl. 11.8% obesity in 2011). 
It was observed a parallel significant increasing in the median values of 
WC in both genders. The overweight aroused still in early childhood – in 
children aged 1–4 years it was 10.8%, incl. 2.8% obesity. Data for 7 years 
old children recorded a trend for significant increasing of overweight and 
obesity in the 3 survey periods (1998, 2008, 2011) but the study in 2013 
showed a stabilization of the rates in boys and decreasing of those among 
girls (overweight 29% in 2011 vs. 25.3% in 2013, obesity 13.2% vs. 9.7%). 
The medians of WC have decreased in both genders. The rates of over-
weight and obesity defined by WHO references were much higher in all 
age-gender groups but the trends were the same.  
Conclusion: The prevalence of overweight and obesity among children 
of age 7–18 years were more than doubled in the period 1998–2011. The 
findings from a study on 7 years old children in 2013 suggested that child-
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WHO.2
Obesity in the 21st century in czech republic
Matoulek M.1
13rd Internal Clinic, 1st Medical Faculty, Charles University in Prague
Prevalence of obesity is changing in last last years. We have analyzed data 
from five surveys from 2000 to 2014 – using the same methods in repre-
sentative population sample of Czech Republic. We have found the evi-
dence of progression in obese and overweight group from 2000 to 2008 
and later stabilization. . There are more than 34% overweight and 22% of 
obese in Czech population in 2014. No statistically significant difference 
according to place where people live was found. It seems that number of 
obese and overweight is stable during last five years. Number of under-
weight (BMI under 18) increases in 18–20 years old female group. Waist 
circumference increases in male – more than 60% are in high (102 cm) or 
moderate (94 cm) risk of metabolic complications. The average increase of 
weight gain is 0.25 kg per year from the age of 18 years. The most critical 
period for weight gain is in 7th decade of life. Although the weight is sta-
ble at last five year, physical activity decreased more than we expected but 
consistently with increase of waist circumference. Prevalence of diabetes 
is 6 x times more than in lean subjects. (18% vs. 3%). Hypertension 5 times 
(45% vs 8%) but 86% overweight and 27% obese male do not perceive it 
as problem. The most important predictor of low BMI in adults are regu-
larly physical activity in adolescent age, regularly meal and consumption 
of fruits and vegetable. Otherwise most important predictor of high BMI 
are fastfood consumption , car ownership and consumption of sausages. 
Physical activity reduces incidence of diabetes 21% vs 6% and hyperten-
sion 50% vs.33% regardless to BMI.  
Conclusion: There are several explanations of stabilization of population 
BMI respectively incidence obesity and overweight. Obese people die 
sooner than overweight and lean and life expectancy increased about 7–8 
year in Czech republic and old people often increase weight . May be, that 
also our recommendations and actions deliver first results…
Acknowledgement: Supported of project „Live Healthy“ of General Health Insur-
ance Company
WHO.3
Childhood overweight in Norway: A nationally representative 
study
Hovengen R.1, Biehl A.2, Glavin K.3
1Department of Epidemiology, Norwegian Institute of Public Health, Oslo, 
Norway
Introduction: The Norwegian Child Growth Study provides unique op-
portunities for monitoring trends in childhood overweight by social class 
and other demographic characteristics in Norway.  
Methods: Nurses at 125 schools measured height, weight and waist cir-
cumference in 10221 8 year-olds during three waves of data collection 
in 2008/2010/2012. Overweight (incl. obesity) was classified according to 
IOTF cut-offs for children. Abdominal obesity was defined as weight-to-
height ratio ≥0.5. Additionally, the study have a longitudinal dataset with 
13 repeated measurements from birth of children born in 2002 until 2010 
(N=3172).  
Results: For sexes combined, the overall prevalence of overweight (incl. 
obesity) was 16.2% and abdominal obesity was 8.4%. In total, there was no 
increase during the period 2008–2012. However, significant differences in 
childhood overweight were found by geographic areas, maternal educa-
tion and parental marital status. The analysis of the longitudinal dataset 
showed that the risk of being overweight at 8 years starts at a very early 
age. 
Conclusions: The prevalence of overweight among children aged 8 in 
Norway have stabilized in recent years. In order to encourage good child 
health, prevention should start at an early age, and be aware of vulnerable 
groups to prevent social inequality.
WHO.4
WHO projections in adults to 2030
Breda J.1, Jewell J.1, Webber L.2, Galea G.1
1Nutrition, Physical Activity and Obesity Programme Division of 
Noncommunicable Diseases and Health Through the Life-Course World Health 
Organization – Regional Office for Europe,  
2UK Health Forum 
The prevalence of obesity has increased dramatically across Europe over 
the past 3 decades. Because obesity is a major risk factor for prevailing 
NCDs such as coronary heart disease and type 2 diabetes have become one 
of the biggest public health challenges of this century. How this epidemic 
will unfold in the next twenty years is uncertain since surveillance and 
monitoring data are often lacking and future projections in each country 
have not been carried out. Using available data on adult Body Mass Index 
prevalence, normal weight, pre-obese overweight and obesity trends were 
projected to 2030 for all 53 World Health Organization Euro-region. By 
2030, overweight was predicted to increase in 41 of the 53 Euro-region 
countries. For obesity, increases were predicted in 47 and 34 countries for 
males and females respectively by 2030. The initiative also highlights the 
value of statistical modelling of trends and makes the case for good qual-
ity national surveillance data by which to make more accurate estimates, 
since the majority of data were self-reported so obesity rates are likely to 
be underestimated.
Thursday, 7 May, 2015
T8: CS1 – Should Children, Elderly and Adults 
who are Moderately Obese be Offered 
Surgery?
T8:CS1.1
Should children, elderly and adults who are moderately obese 
be offered surgery?
Angrisani L.1
1General and Endoscopic Surgery Unit, S. Giovanni Bosco Hospital, Naples, Italy
The published literature documents the effectiveness of bariatric surgery 
in adult patients with a BMI <35. According to the IFSO Position State-
ment about Bariatric Surgery in Class I obesity the use of surgery should 
not be extended in children/adolescents or elderly with BMI<35 kg/m2. 
Data about efficacy and safety of surgery in class I obese adolescents are 
lacking. As recommended by the ASMBS pediatric committee best prac-
tice guidelines, the selection criteria for adolescents being considered for 
bariatric procedure should include a BMI≥35 kg/m2 with major co-mor-
bidities or with a BMI ≥40 kg/m2 with minor co-morbidities. The optimal 
weight for lowest mortality appear to be in the overweight/class I obesity 
range in the elderly and there is no clear guidance regarding intentional 
weight loss in older adults, as it is unclear that benefits outweigh risks. 
However, the BMI with its failure to account for gender, fitness, age or 
race, is not a reliable and fair approach to the denial of surgery to patients 
for whom this is the only effective treatment. These surgical decisions 
should be guided, as for other diseases, by the patients’ states of health and 
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T8:CS1.2
Bariatric surgery in children, elderly, and moderately obese: 
No
Reinehr T.1
1Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine
The major arguments favoring bariatric surgery against lifestyle inter-
vention are the much greater success rate and the better improvement of 
obesity associated comorbidities. On the other hand bariatric surgery is 
associated with relevant side effects in the short-term (e.g. preoperative 
mortality, necessity of re-surgery) and in the long term (e.g. irreversible 
side effects such as polyneuropathy without supplementation). Therefore 
the pros and cons of bariatric surgery have to be judged in every case 
and the following issues should be considered: a) General The number 
of obese adults is too high to be treated by bariatric surgery. Therefore, 
this cost-intensive intervention should be offered primarily to the high 
risk group of extreme obese humans. Treatment adherence after bariat-
ric surgery is necessary to avoid side-effects. Eating behavior has to be 
changed after bariatric surgery otherwise relevant side effects occur and 
the long-term effect of bariatric surgery is limited. Lifestyle intervention 
has no proven side effects. b) Specific concerns in different age ranges: 1) 
Children The success rate of lifestyle intervention in children is higher 
than in adults. Quality of life improves even without success in lifestyle 
intervention. Children cannot judge the consequences of an irreversible 
bariatric surgery procedure. The responsibility for an irreversible surgery 
procedure has forensic aspects. There is an increased risk of suicide and 
unwanted pregnancy after bariatric surgery in adolescents. Bariatric sur-
gery is not suitable in most extreme obese adolescents due to low treat-
ment adherence. 2) Elderly Obesity in the elderly is not associated with 
a decreased life span. Comorbidities of obesity likely have no life span 
reducing effect.
T1/T2:CS1 – Central or Peripheral Regulation 
in Obesity and Insulin Sensitivity?
T1/T2:CS1.1
Central or Peripheral Regulation in Obesity and Insulin 
Sensitivity: The need to Focus on Central Regulations
Dulloo A.G.1
1Department of Medicine / Physiology, University of Fribourg, Switzerland
In general, research directed at the ‘periphery’ should be considered as 
equally important as that directed at ‘central regulations’. The issue here 
is about relative focus in a time window that represents the forthcoming 
years – say till 2020 at least. It is argued that in order to understand the 
mechanisms leading to obesity, insulin resistance and cardiometabolic 
diseases that will eventually have the greatest therapeutic impact, the ma-
jor focus over the coming years should be directed at ‘central regulations’. 
The case is put forward that cellular and molecular information gathered 
at the ‘periphery’ has been spectacular over the past two decades, but there 
has been no significant advances in the identification of key components 
of the several control systems that regulate body weight, body compo-
sition and insulin sensitivity. Knowledge relative to ‘central regulations’ 
need to catch-up since lessons from the past suggest that major advance-
ments pertaining to our understanding of the pathogenesis of obesity and 
its cardiometabolic risks only occur when research at the periphery has 
been fully integrated with that of ‘central regulations’, rather than focused 
only at the periphery per se.
T1/T2:CS1.2
We need to focus on peripheral mechanisms/insulin 
sensitivity
Vettor R.1
1Department of Medicine DIMED, University of Padua, Italy
Obesity is a complex disease with an abnormal adipose tissue expansion 
because of an alteration of energy balance due either to an impaired CNS 
control of food intake or to a reduction of energy expenditure due to a 
reduction of muscle insulin sensitivity and oxidative capacity with a chan-
nelling of fuel substrates towards adipose tissue. Insulin resistance could 
therefore appear with a different time sequence in the different tissues 
accordingly with the origin of caloric overflow. In both situations the ex-
pansion of adipose tissue due to energy excess could be limited by the 
appearance of insulin resistance. A failure in the capacity to store energy 
efficiently is the major cause of ectopic lipid accumulation, inflammation 
and insulin resistance because of the capacity of muscle and liver to ful-
ly metabolize fatty acids is insufficient to match the excessive fatty acid 
uptake by cells. Adipose cells could be found also within skeletal muscle 
bundles and fibres and this inter-muscular adipose depot (IMAT) is in-
creased in obesity and is strongly related with the appearance of insulin 
resistance. Moreover, in obesity IMAT is infiltrated with macrophages 
which produce pro-inflammatory cytokines that affect skeletal muscle 
insulin sensitivity in a paracrine way. The expanding adipose tissue mass 
and the related metabolic abnormalities linked with insulin resistance 
and inflammation could cause muscle insulin resistance. The majority of 
insulin-stimulated glucose uptake occurs in muscle and therefore factors 
that acutely modulate insulin sensitivity, anticipating weight gain are can-
tered primarily on nutrient sensing mechanisms within muscle and their 
interactions with the insulin-signalling. These sensing mechanisms can 
detect changes in nutrient availability and provide a means of regulating 
mitochondria function and insulin sensitivity. Defects in the sensing of 
energy status, and the ability to respond appropriately, result in metabolic 
diseases such as obesity.
Controversy Session: Should Weight/
Adipose Tissue Loss or General Health be the 
Treatment Goal?
CS.1
Controversy session: We should focus on body composition
Salvador J.1
1Department of Endocrinology and Nutrition, University Clinic of Navarra, 
University of Navarra, Pamplona, Spain
Obesity is a chronic disease defined by body fat excess. BMI is usually 
considered as a measurement of obesity magnitude in clinical practice. 
Nevertheless, BMI is not a good indicator of body fat on an individual ba-
sis. When body composition is compared with BMI values it becomes ev-
ident that up to 80% of overweight patients and 29% of those with normal 
BMI results exhibit body fat excess, and should be considered as obese. 
Patients with non-obese BMI but with high fat mass display a pattern of 
cardiovascular risk factors similar to that of those anthropometrically 
obese, indicating that body composition represents an essential factor to 
diagnose obesity having clinical consequences. Therefore, we are missing 
a significant number of obese patients if we only base the diagnosis in BMI 
calculation. On the other hand, fat distribution also plays an important 
role in mediating not only cardiovascular, but also other complications 
such as sleep apnoea, diabetes, hormonal dysfunction and cancer, empha-
sizing the importance of measuring waist circumference to detect abdom-
inal obesity. According to this, visceral adipose tissue excess is related to 
mortality, indicating that represents a source of many mediators involved 
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thermore, body composition measurement is a very useful tool to evaluate 
the quality of weight loss, and this is especially evident following bariatric 
surgery, when some patients achieve significant reductions in BMI but 
increasing fat percentage at the same time. Discrepancies between body 
weight and body composition also takes place in aging, where sarcopenia 
and fat excess are clinically relevant. These findings prove that evaluating 
body composition and fat distribution should be incorporated to clinical 
practice in order to better diagnose obesity and to improve the assessment 
of risks, treatment indications and therapeutic outcomes.
Acknowledgement: Collaboration of all components of the Obesity Unit is very 
much appreciated.
CS.2
Should weight/adipose tissue loss or general health be the 
goal? We should focus on general health
Tsigos C.1
1School of Health Sciences and Education, Harokopio University, Athens, Greece
Obesity is a global epidemic that is associated with a large spectrum of nega-
tive health outcomes, many of which can be improved by weight loss. Hence 
the current guidelines for weight management recommend weight loss for 
all obese adults. However, there may be subpopulations of obese persons, 
such as the elderly and the metabolically healthy or highly fit, that may not 
be adversely affected by their excess adiposity or may not necessarily benefit 
from weight loss. Also, despite the established association between obesi-
ty and cardiovascular risk, obese individuals with cardiovascular disease 
tend to have better prognosis than normal weight individuals, presenting 
an “obesity paradox”. Furthermore, weight loss in obese elderly or patients 
with established cardiovascular disease and type 2 diabetes appears to in-
crease mortality risk. Also, given the difficulty to maintain weight loss in the 
long-term, it is not clear whether the benefits of weight loss outweigh the 
potential detrimental effects of weight cycling. Thus, obesity is a complex 
condition that is not always associated with adverse health outcomes and 
weight loss by itself may not be the most appropriate recommendation for 
all obese individuals. Therefore, setting the goal of maintaining a healthy 
lifestyle with improved diet quality and high level physical activity and car-
diorespiratory fitness may be more appropriate in some groups of obese in-
dividuals, than focusing on weight loss alone.
EASO/IFSO-EC Young Investigators United 
(YIU) Scientific and Awards Session 
YI.1
Bariatric operations that do not work
Fiennes A.1
1St Anthony’s Hospital, Surrey SM3 9DW, United Kingdom
Over the 50-year lifetime of bariatric surgery operative procedures have 
become obsolete, either because they were ineffective and based on a 
wrong (or absent) disease model, or because they were hazardous, whether 
effective or not. New hopefuls have come and gone. Yet other procedures 
have persisted, despite an initial basis on a wrong model. The paradoxical 
success of these procedures has led to revisions of the disease model and 
to new understandings of their mechanism of action – for example the 
“regulatory” effects of various bypass procedures. Nonetheless there are 
also failures of apparently understood operations. Among them the most 
intriguing paradigm is that of weight regain after regulatory surgery, part-
ly because it implies an adaptive homeostatic response, expressed by some 
individuals more than others. As obesity grows and as bariatric surgery 
enters middle age these failures challenge us to better research into physi-
ological responses, into the perceived role of behavioural factors and into 
the relationship between the two.
YI.2
Prevention and management of obesity united
Visscher T.L.1
1Research centre for the prevention of overweight Zwolle, Windesheim 
University of Applied Sciences Zwolle & VU University Amsterdam, The 
Netherlands
Nearly 400 years after William Harvey discovered the blood circulation, 
we are still discovering the field of prevention. It is only less then 40 years 
ago that Sir. Geoffrey Rose argued that a population-based approach tar-
gets the real, underlying determinants of impaired health. Only less than 
20 years ago, Swinburn and Egger described the obesogenic environ-
ment with their ANGELO-framework, and about 10 years ago, Kremers 
described his EnRG-framework hypothesizing an interaction between 
individual en environmental determinants of energy-balance related be-
haviours. To date there is no doubt regarding the impact of obesity pre-
vention. Evidence is increasing on the successes of community-based 
programs, including EU-programs, counteracting the real underlying 
determinants, supporting professionals and individuals, and leading to 
decreases in obesity. At the same time evidence shows the success of obe-
sity management approaches. But, those successes are hard to maintain, 
especially when attention for health promotion is lacking. To have a real 
impact on the population’s health, the field of prevention and the field 
of management should be united. Hence, obesity management is only 
successful within healthy environments. And, as health behaviour is also 
the key element in obesity management, obesity management approaches 
should benefit from prevention expertise. Whereas our parents are trained 
to treat the disease, our new generation of clinicians is (or should be) 
trained to deal with the individuals’ own responsibility to live healthily. 
Uniting obesity prevention and management is an extremely important 
direction for Young Investigators United.
Friday, 8 May, 2015
Special Session: Stigma, Discrimination and 
Health Related QoL 
SS.1
The psychology of anti-fat bias in an obesogenic environment. 
Is behavioural justice required?
Hill A.J.1
1Academic Unit of Psychiatry & Behavioural Sciences, Leeds University School of 
Medicine, 101 Clarendon Road, Leeds LS2 9LJ, UK
The rise in interest in anti-fat bias parallels the recognition of obesity as a 
public health problem and a general failure to bring about change. Calls 
to ‘wage war’ on obesity and using stigma to change obesity-relevant be-
haviour have been challenged on human rights and social justice grounds. 
This presentation will address a series of questions. Namely, what is an-
ti-fat bias? Who holds anti-fat attitudes? What is the resultant experience 
of those who are obese? What are the consequences of anti-fat bias? What 
is behavioural justice and how could it be applied to obesity? Anti-fat bias 
is apparent in the prevailing attitudes to and beliefs about obesity and the 
people who are obese. The main components are dislike (the aesthetics of 
appearance), judgements of health (weight as a metric of health; weight 
change indicative of health improvement/decline), and morality (blame, 
lack of willpower). The overarching emotion is fear, as the stereotyping of 
fat is a mainly negative portrayal of character, social exclusion, and poor 
health. Such views are widely held, implicitly by all, and explicitly by the 
majority of general public, health professionals and people who are obese. 
Anticipated and actual discrimination and victimization experiences are 
evidenced in questionnaires, diary records and qualitative interviews with 
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tage is evidenced in all areas of life; education, the workplace, health care, 
socially, and in increased psychological distress. Behavioural justice sits 
within a broader social justice view of equality and valuing diversity. Spe-
cifically, it points to inequalities in access to health-promoting resources. 
The obesogenic environment requires attitudinal as well as physical ad-
justment.
SS.3
Familial weight talk and obesity stigma
Nowicka P.1, Eli K.2
1Division of Pediatrics, Department of Clinical Science, Intervention and 
Technology, Stockholm, Sweden,  
2Unit for Biocultural Variation and Obesity, Institute of Social and Cultural 
Anthropology, University of Oxford, Oxford, UK
An important part of interventions in childhood obesity is the engage-
ment of family members and open discussion about children’s weight. 
However, parents are often reluctant to talk about their children’s weight, 
with health care professionals and with children themselves. One poten-
tial reason for parental reluctance to discuss children’s body weights is the 
pervasiveness of stigmatizing attitudes towards obesity, which encompass 
blame directed at the parents of obese children. Stigmatizing attitudes are 
transmitted directly and indirectly through multiple channels, including 
the media, family members, peers, school policies, and even clinicians. The 
aim of this talk is to review the literature on obesity stigma as transmitted 
within the family. The talk centres on adults’ framings of links between 
their childhood experiences of becoming aware of their own weights, and 
their attitudes and practices concerning weight talk as adults. Specifically, 
this presentation examines whether their own childhood experiences of 
weight talk influence parents’ and grandparents’ decisions not to talk to 
their children or grandchildren about weight. The talk concludes with a 
review of recent research on effective childhood obesity prevention and 
intervention messages that protect children’s self-esteem.
SS.4
Is stigmatization getting worse as overweight becomes the 
norm?
Hilbert A.1
1Integrated Research and Treatment Center AdiposityDiseases, University of 
Leipzig Medical Center, Leipzig, Germany
Weight stigma increased over the last decades of the 20th century as prev-
alence rates of obesity rose substantially. However, for the recent years, 
when prevalence rates of obesity showed smaller gains, time trends of 
weight stigma are unclear. Weight stigma includes pervasive negative ste-
reotypes and attitudes about obesity that can extend to actual discrimi-
nation, evidenced in multiple domains of life. Furthermore, stigmatized 
overweight and obese individuals often have the tendency to internalize 
weight stigma, and thus stigmatize themselves. Such a self-stigma has 
been found to be highly psychopathologically relevant and associated 
with lowered quality of life. This study sought to examine time trends of 
stigmatizing attitudes and, for the first time, of self-stigma. Data from four 
representative surveys of the German population (N = 7000) were ana-
lyzed for time trends between 2005 and 2015. The results did not show 
any change in stigmatizing attitudes from 2005 to 2012. A total of 23% of 
the population held definitive stigmatizing attitudes toward obesity, with 
higher proportions in those with less education and higher age. Similarly, 
the extent of self-stigma did not show any variations from 2012 to 2015 
and was found in 13% of overweight and obese individuals, especially in 
women and in those of lower age. These results suggest a temporal stabil-
ity of stigmatization and self-stigma over the recent years, as overweight 
and obesity show only slight increases. Levels of stigmatizing attitudes and 
self-stigma are substantial as overweight remains to be the norm.
Saturday, 9 May, 2015
T2:CS2 – Lipotoxicity and Skeletal Muscle: Are 
Ceramides to Blame? 
T2:CS2.1
Lipotoxicity and Skeletal Muscle: Are Ceramides to Blame? YES
Amati F.1
1Department of Physiology and Institute of Sport Sciences, University of 
Lausanne, Lausanne,
Switzerland Lipotoxicity is one of the hypotheses being explored to ex-
plain the mechanisms by which obesity leads to insulin resistance (IR). 
Also known as the lipid metabolite theory, lipotoxicity occurs when fatty 
acid in excess of the oxidative needs spillover into harmful pathways of 
non-oxidative metabolism. Within the muscle fibers, it has been shown 
that it is not intramyocellular triglicerides that confer IR but particular 
lipids intermediates, among which ceramides and diacylglycerols (DAG). 
Since the 90s, animal models established these relationships and presented 
mechanisms to explain the deleterious effect of these metabolites. Indeed, 
distinct disruptions of the insulin-signaling cascade have been found for 
DAG and for ceramides. Recent human studies are still not agreeing on 
the role of DAG, with controversies and dissimilar results among different 
studies. At the contrary, the negative effect of ceramides and their role in 
the induction of skeletal muscle IR seems to be consistent across human 
studies.
T2:CS2.2
Lipotoxicity and Skeletal Muscle: Are Ceramides to Blame? No
Schrauwen P.1
1Departments of Human Biology and Human Movement Sciences, Maastricht 
University Medical Center, Maastricht, The Netherlands
Fat accumulation in skeletal muscle is an early hallmark in the develop-
ment of type 2 diabetes mellitus. Indeed, type 2 diabetic patients have 
elevated levels of intramyocellular triglycerides (IMTG), which is highly 
correlated with insulin resistance. However, endurance trained athletes 
also have high amounts of IMTG despite being very insulin sensitive. This 
so-called athletes paradox has learned that it is not the triglyceride accu-
mulation in the muscle cell per se that induces insulin resistance. Rather, 
research in the last decade has revealed several mechanisms by which fatty 
acid intermediates can interfere with insulin signaling. These fatty acid 
intermediates include diacylglycerol, fatty acyl-CoA, acylcarnitines and 
ceramides, but so far no uniform mechanism is availalbe that explains 
how fat accumulation in the muscle leads to insulin resistance. More re-
cent data also point towards an important role for lipid droplet dynamics 
in skeletal muscle insulin sensitivity. Thus, in skeletal muscle lipid drop-
lets are coated with PLINs, which are involved in regulating turnover of 
lipid. Overexpression of PLINs in muscle can prevent lipid-induced in-
sulin resistance, and endurance trained athletes have high PLINs levels. 
It can therefore be concluded that not one single fatty acid intermediate 
– including ceramides – is responsible for skeletal muscle lipotoxicity, but 




















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts22
T2:CS2.3
Leptin administration stimulates the myogenic action of irisin 
through nitric oxide-dependent mechanisms, but reduces its 
browning effect on subcutaneous fat in mice
Rodríguez A.1,3,4, Becerril S.1,3,4, Méndez-Giménez L.1,3,4, Ramírez B.1,3,4, 
Sáinz N.3, Catalán C.1,3,4, Gómez-Ambrosi J.1,3,4, Frühbeck G.1,2,3,4
1Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, 
Spain, 
2Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, 
Pamplona, Spain, 
3CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud 
Carlos III, Spain,  
4Obesity and Adipobiology Group. Instituto de Investigación Sanitaria de 
Navarra (IDISNA), Pamplona, Spain
Introduction: Obese leptin-deficient ob/ob mice show high adiposity and 
reduced muscle mass with leptin administration promoting weight loss 
and inducing muscle accretion through PGC-1α-dependent mechanisms. 
Objective: Our goal was to analyze in vivo and in vitro the effect of leptin 
on FNDC5, a novel PGC-1α-dependent myokine that is synthesized and 
cleaved to form irisin that induces white adipose browning.  
Methods: Twelve-week-old male wild type and ob/ob mice were divided 
in three groups as follows: control, leptin-treated (1 mg/kg/d) and pair-
fed.  
Results: Leptin administration was associated with increased gastrocne-
mius weight and cell surface area, higher Pgc1a and Fndc5 transcript lev-
els and a modest increase in serum irisin. Leptin stimulated Fndc5 mRNA 
expression through nitric oxide (NO)-dependent mechanisms in murine 
C2C12 myocytes and activated both basal and irisin-stimulated myogen-
esis, as evidenced by increased myocyte proliferation, higher myogenin 
and myonectin transcript levels together with lower mRNA expression of 
myostatin and dystrophin and the muscle atrophy-related factors MuRF1 
and MAFbx. Interestingly, leptin reduced Fndc5 expression in a NO-inde-
pendent manner in murine differentiated subcutaneous adipocytes. Fur-
thermore, leptin counteracted the irisin-induced up-regulation of both 
brown (Ucp1 and Cidec) and beige (Tmem26) adipocyte-specific genes 
and the increase in UCP1-positive cells.  
Conclusion: Taken together, our results provide evidence for a regulatory 
role of leptin on FNDC5/irisin, favoring muscle accretion but reducing 
fat browning.
T2:CS2.4
Impact of high fructose diet on skeletal muscle metabolism in 
healthy men
Seyssel K.1,2,3, Meugnier E.2,3, Laville M.1,2,3, Vidal H.2,3, Lę K.A.4, Tappy L.5
1Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), Centre 
Hospitalier Lyon Sud, Pierre-Bénite, France,  
2Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France,  
3Université Lyon 1, INSERM UMR1060, Laboratoire CarMeN, Oullins, France,  
4Nestlé S.A, Nestlé Research Center, Lausanne, Suisse,  
5Department of Physiology, Faculty of Biology and Medicine, University of 
Lausanne, Lausanne, Switzerland
Introduction: Changes in lifestyle, characterized by increased consump-
tion of calorie-rich foods and reduced energy expenditure are major de-
terminants of the current epidemic of obesity. Also the increase of fruc-
tose intake representing about 8% of total energy intake in Europe and 
USA seems to reinforce obesity status.  
Methods: Ten healthy normal weight first-degree relatives of type 2 di-
abetic patients were submitted to two different diets during 7 days: (a) 
control diet and (b) high fructose diet (3.5g fructose/kg fat-free mass/
day). Insulin sensitivity was determined after each diet using a euglycemic 
hyperinsulinemic clamp. Energy metabolism and skeletal muscle gene ex-
pression were evaluated after each diet.  
Results: High fructose diet increased significantly body weight (+0.9kg), 
intrahepatocellular lipids content (+79%), intramyocellular lipids content 
(+26%) concomitantly with a shift in the use of substrates as energy fuel 
toward preferential oxidation of carbohydrates instead of lipids. Hepatic 
insulin sensitivity index significantly decreased. Transcriptomic analyses 
on skeletal muscle highlighted profound effects on mitochondria poten-
tially involved in the metabolic shift.  
Conclusion: A short term fructose overfeeding diet leads to deleterious 
metabolic alterations classically observed in metabolic syndrome. Deci-
phering the mechanisms responsible for the rapid metabolic shift and mi-
tochondrial damage is currently under investigation using a combination 
of human hepatocytes and myotubes cell models.
Special Session: EASO/EFAD Roundtable, Dietary 
guidelines for the prevention and treatment of 
Obesity in Europe – What do the dietitians use?
An overview of dietary guidelines used in europe for obesity 
management
Govers E.1
1Amstelring, institution of primary care, Amstelveen, The Netherlands 1; co-
chair of the EFAD specialist dietetic network (ESDN) on obesity 2; chair of the 
Dutch Network of Obesity dietitians 3.
Several European countries have introduced multidisciplinary evidence 
based guidelines for obesity management over the past decade. An im-
portant part of these guidelines concerns dietary guidelines. On the oth-
er hand, general guidelines for healthy nutrition for the population are 
widely used as a treatment tool in obesity management. Our research 
question was: which dietary guidelines are used in obesity management 
in European countries, and how specific are they? We carried out a sur-
vey among the EFAD members and asked them to send in the multidis-
ciplinary guideline that is in use. Guidelines in English, French, German, 
and Dutch/Flemish were studied. For guidelines in different languages we 
asked a summary in English. We studied the guidelines to find: which 
countries have guidelines; do these guidelines contain dietary guidelines; 
are these used by health professionals for obesity management; how spe-
cific are the dietary guidelines; how do these guidelines differ from the 
general guidelines? Finally, conclusions are drawn on the content: do all 
guidelines emphasize the same nutritional aspects, for instance on fat, fi-
bre, alcohol? And, if not are these differences based on evidence?
Acknowledgement: We wish to thank all associations of dietitians and dietitians in 
national obesity networks for their contribution to the collection of data.
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tre for Primary Care (UK): Obesity: the prevention, identification, assessment 
and management of overweight and obesity in adults and children. NICE 
Clinical Guidelines No 43, London, 2006. 
2.  Seidell JC, de Beer JJ, Kuipers T: Guideline ‘Diagnosis and treatment of obesity 
in adults and children’. Netherlands Journal of Medicine 152:2071–6, 2008. 
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ORAL SESSONS
Wednesday, 6 May, 2015
T1/T2:OS1 – Organ Cross Talk
T1/T2:OS1.1
Effects of gut microbiota manipulation by antibiotics on host 
metabolism in obese humans
Reijnders D.1,3, Goossens G.H.1,3, Neis E.P.2,3, Van der Beek C.M.2,3, Most J.1, 
Holst J.J.4, Lenaerts K.2,3, Kootte R.S.3,5, Nieuwdorp M.3,5,6, Dejong C.H.2,3, 
Blaak E.E.1,3
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Center+, Maastricht, The 
Netherlands,  
2Department of Surgery, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Center+, Maastricht, The 
Netherlands,  
3Top Institute Food and Nutrition, Wageningen, The Netherlands,  
4NNF Center for Basic Metabolic Research, Department of Biomedical Sciences, 
The Panum Institute, University of Copenhagen, Denmark,  
5Department of Vascular Medicine, University of Amsterdam, Amsterdam, The 
Netherlands,  
6Department of Internal Medicine, University of Amsterdam, Amsterdam, The 
Netherlands
Background: Recent studies indicate that gut microbiota manipulation 
affect metabolic health but human data are scarce. Here, we investigated 
the effects of gut microbiota knock-down by antibiotics on insulin sensi-
tivity, metabolic parameters and inflammation in obese humans.  
Methods: 57 male subjects (BMI 31.2 ± 2.6kg/m2, age 59 ± 7y, HOMA-IR 
4.5 ± 0.2) with impaired glucose metabolism were allocated randomly to 
amoxicillin (AMOX; broad-spectrum), vancomycin (VANCO; aimed at 
gram positive bacteria) or placebo (PLA) for 7 days, 1500mg/d. Hepatic 
and peripheral insulin sensitivity (hyperinsulinemic-euglycemic clamp, 
[6,6–2H2]-glucose), postprandial energy expenditure and substrate oxi-
dation, gut permeability, systemic inflammation, plasma leptin and GLP-1 
concentrations were measured. Adipose tissue and skeletal muscle biop-
sies were collected for microarrays. Feces was collected for analysis of mi-
crobiota composition and energy excretion.  
Results: AMOX and VANCO had no significant effect on insulin-me-
diated suppression of endogenous glucose production and insulin-stim-
ulated glucose disposal compared to PLA. However, insulin-stimulated 
non-oxidative glucose disposal (glycogen storage) significantly decreased 
after AMOX compared to PLA (-3.2 ± 1.5 vs. 2.6 ± 1.6μmol/kg/min, 
p = 0.017). Antibiotics did not affect energy intake and expenditure, sub-
strate oxidation, gut permeability, plasma LPS-binding protein, IL-6, IL-8, 
TNF-a, leptin and GLP-1 concentrations. Feces and biopsy analyses are 
currently ongoing.  
Conclusion: The present study demonstrates for the first time that robust 
knock-down of intestinal bacteria by antibiotics has no significant effects 
on insulin sensitivity, host energy metabolism and systemic inflammation, 
but decreases insulin-stimulated glycogen storage in obese men.
T1/T2:OS1.2
Dose-dependent effects of thiazolidinediones in dietary 
obese mice
Flachs P.1, Tvrzicka E.2, Svobodova M.1, Zouhar P.1, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic,  
24th Department of Internal Medicine, 1st Faculty of Medicine of Charles 
University and the General Teaching Hospital, Prague, Czech Republic
Introduction: Thiazolidinediones (TZD) are used for treatment of insu-
lin resistance in diabetic patients; however, the therapy is associated with 
unwanted side effects. The insulin-sensitizing action of TZD is thought to 
result from activation of PPARg in white adipose tissue, associated with 
the secretion of adiponectin and consequent stimulation of AMP-activat-
ed protein kinase (AMPK) in other tissues. Our results suggested that the 
effects of TZD, administered at sub-optimal doses with respect to the im-
provement of insulin sensitivity in mice, may involve a change in plasma 
lipid profile resulting from modulation of hepatic lipid metabolism, inde-
pendent of the adiponectin–AMPK axis. The aim of the present study was 
to further characterize the dose-dependent mechanism of TZD action.  
Methods: C57BL/6 mice were assigned to dietary treatment using: (i) a 
high fat diet (HF); (ii) HF diet with “low” dose of rosiglitazone –10 mg/kg 
diet (HF+R10); (iii) HF diet with “high” dose of rosiglitazone – 100 mg/
kg diet (HF+R100).  
Results: Rosiglitazone in a dose-dependent manner induced high molec-
ular weight form of adiponectin in plasma. Only the R100 mice exhibited 
significantly higher activity of the hepatic AMPK a2 isoform. Conversely, 
the R10 mice showed elevated hepatic lipid content, upregulated expression 
of genes associated with de novo lipogenesis, namely FAS and SCD-1. These 
mice also exhibited specific enrichment of palmitoleate in plasma lipids.  
Conclusion: Different mechanisms contribute to the insulin-sensitizing 
effect of TZD, depending on the dose of the drug. New strategies for treat-
ment of diabetic patients may be based on the use of sub-optimal doses of 
TZD in combination with other interventions.
T1/T2:OS1.3
Insulin regulates hepatic triglyceride secretion and lipid 
content via the brain
Scherer T.1,2, Lindtner C.1, O’Hare J.1, Zielinski E.1, Freudenthaler A.2, 
Baumgartner-Parzer S.2, Tödter K.3, Heeren J.3, Krššák M.2,4, Scheja L.3, 
Fürnsinn C.2, Buettner C.1
1Department of Medicine and Department of Neuroscience, Diabetes, Obesity 
and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, 
USA,  
2Department of Medicine III, Division of Endocrinology and Metabolism, 
Medical University of Vienna, Vienna, Austria,  
3Department of Biochemistry and Molecular Cell Biology, University Medical 
Center Hamburg-Eppendorf, Hamburg, Germany,  
4High Field MR Centre, Department of Biomedical Imaging and Image Guided 
Therapy, Medical University of Vienna, Vienna, Austria
Introduction: Hepatic lipogenesis is increased in obesity and insulin resis-
tance. Thus, a key mechanism of the liver to prevent steatosis is its ability 
to increase the export of triglycerides (TG) packaged as very low–density 
lipoproteins (VLDL). Insulin action comprises of direct effects on periph-
eral organs, but also of indirect effects that are mediated via the CNS (1). 
Systemic hyperinsulinemia decreases VLDL production by the liver, yet it is 
unknown whether brain insulin can independently regulate TG flux.  
Methods: To study the role of brain vs. systemic insulin signaling on 
hepatic TG secretion, we performed tyloxapol infusion studies in male 
Sprague Dawley rats during systemic or isolated brain hyperinsulinemia. 
The latter was accomplished by infusing insulin or vehicle for 4 hrs into 
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Results: ICV insulin infusion increased hepatic TG secretion compared 
to controls (2.59 ± 0.28 vs. 1.80 ± 0.2 μmol/kg/min; P = 0.039; n≥11 per 
group). To the contrary, a hyperinsulinemic euglycemic clamp decreased 
TG flux (0.85 ± 0.05 μmol/kg/min; P = 0.020; n=4), which is in agreement 
with prior reports (2). Furthermore, prolonged ICV insulin infusion in 
rats via osmotic minipumps reduced hepatic lipid content as assessed 
by non–invasive 1H–magnetic resonance spectroscopy (1.25 ± 0.15 vs. 
0.75 ± 0.12; % water signal; P = 0.018; n=8 per group) and lipid profiling 
independent of changes in hepatic de novo lipogenesis. Conversely, mice 
that lack the insulin receptor in the whole brain had reduced hepatic TG 
flux compared to littermate controls, which was again assessed by tylox-
apol studies (154 ± 6 vs. 126 ± 12 μmol/kg/h; P = 0.038; n≥9 per group).  
Conclusion: These studies identify brain insulin signaling as an import-
ant permissive factor in hepatic VLDL secretion that may protect against 
hepatic steatosis.
Acknowledgement: This study was supported by Austrian Science Fund (FWF) 
grant P26766 to T.S., NIH grants DK074873, DK083568, DK082724 to C.B and 
DFG grant (SFB 841) to J.H.
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T1/T2:OS1.4
High-fat diet causes early cardiac effects before the onset of 
obesity. Sirt1 is involved in cardiac responsiveness to high-fat 
diet.
Planavila A.1, Villarroya J.1,2, Redondo-Angulo I.1, Iglesias R.1, Giralt M.1, 
Villarroya F.1
1Departament de Bioquímica i Biologia Molecular, Institut de Biomedicina 
(IBUB), Universitat de Barcelona and CIBER Fisiopatología de la Obesidad y 
Nutrición, 08028 Barcelona, Spain.,  
2Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Introduction: High-fat diet-induced obesity leads to development of car-
diac dysfunction through molecular mechanisms poorly known. The aim 
of this study is to elucidate the early events in cardiac dysfunction caused 
by a high-fat diet, before massive alterations due to obesity and indirect 
mechanisms of heart damage take place. Moreover, we analyzed the role 
of Sirt1, a major mediator of gene regulation in response to metabolism, 
in this process.  
Methods: Wild-type (wt) and Sirt1+/- mice were fed a high-fat diet for a 
short (5 weeks) term. Systemic metabolic and hormonal profile and cardi-
ac molecular alterations were determined.  
Results: Short-time high-fat feeding caused a similar mild increase in 
body weight and triglyceridemia in wt and Sirt1+/- mice. The high-fat 
diet suppressed the expression of lipid catabolism (PPARα target) gene 
expression in the hearts of wt mice, but not Sirt1+/- mice. Pro-inflamma-
tory genes were induced and estrogen-related receptor-alpha (ERRα) tar-
get genes were suppressed in the hearts of wt fed the high-fat diet, but not 
in Sirt1+/- mice. We found the formation of a complex between PPARα 
and Sirt1 in wt mice under high-fat diet conditions which might account 
for suppression of the ERRα pathway. Sirt1 reduction impairs the forma-
tion of this complex and potentiates the binding of PPARα to NF-kB p65 
subunit thereby mediating inhibition of pro-inflammatory pathways and 
induction of PPARα target genes.  
Conclusion: Short-term high-fat diet causes metabolic and inflammatory 
alterations in heart, and Sirt1 is critical for mediating these early cardiac 
alterations. The capacity of Sirt1 to interact with transcriptional regulators 
such as NF-kB and PPARα appears to be involved in the early cardiac re-
sponsiveness to a high-fat diet.
Acknowledgement: This work was supported by Grant SAF2011-23636 from the 
Ministerio de Ciencia e Innovación, Spain, funded in part by the European Com-
munity's Seventh Framework Program (FP7 BetaBat). IR-A was supported by a 
pre-doctoral fellowship from Gobierno Vasco (Programa de Formación de Inves-
tigadores del DEUI).
T1/T2:OS1.5
Colonic short-chain fatty acids infusions promote fat 
oxidation and improve metabolic parameters in overweight 
males
Canfora E.E.1,2, van der Beek C.M.1,3, Goossens G.H.1,2, Jocken J.J.1,2, 
Lenaerts K.1,3, Holst J.J.4,5, Dejong C.H.1,3, Blaak E.E.1,2
1Top Institute Food and Nutrition, Wageningen, the Netherlands,  
2Department of Human Biology; NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Center+, the 
Netherlands,  
3Department of Surgery; NUTRIM School of Nutrition and Translational Research 
in Metabolism, Maastricht University Medical Center+, the Netherlands, 
4Novo Nordisk Foundation Center for Basic Metabolic Research, Copenhagen, 
Denmark,  
5University of Copenhagen, Denmark
Short-chain fatty acids (SCFA), formed by microbial fermentation of 
dietary fiber, are believed to be involved in the etiology of obesity and 
diabetes. The aim of this study was to investigate effects of colonic admin-
istration of physiologically relevant mixtures of SCFA on human substrate 
and energy metabolism. In this randomized, double-blind, crossover 
study, twelve overweight males (BMI ≥ 25 kg/m2 ≤ 34.9 kg/m2) were in-
cluded. Subjects underwent four test days, with rectal administration of 
a SCFA mixture high in acetate (HA), high in propionate (HP), high in 
butyrate (HB) and a placebo (PLA). The primary outcomes fat oxidation 
and energy expenditure (EE) were measured via an open-circuit ventilat-
ed hood system. Blood samples were collected during fasting and after a 
75g glucose drink (postprandial), before and 30, 60, 90 and 120 minutes 
after colonic infusions. Distal colonic infusions with all SCFA mixtures 
increased fasting fat oxidation, compared to PLA (p < 0.001). Fasting 
EE increased after HA and HP, compared to PLA (p < 0.05). HP and HB 
enhanced fasting PPY concentrations (p < 0.05); and all SCFA mixtures 
increased postprandial PYY concentrations (p < 0.01). Fasting free glyc-
erol concentrations were reduced after HB, compared to PLA (p < 0.05). 
Fasting plasma IL-1β concentrations decreased after HA, compared to HP 
and PLA (p < 0.05). Colonic infusions did not affect plasma glucose, GLP-
1, TAG and FFA concentrations. This study showed that colonic infusions 
of SCFA mixtures, in concentrations and ratios reached after dietary fi-
ber intake, beneficially modulate whole body substrate metabolism, with 
a pronounced increase in fat oxidation, EE and plasma PYY. Increasing 
colonic SCFA concentrations may yield new mechanisms for treating or 
preventing metabolic disorders.
Acknowledgement: “The research is funded by TI Food and Nutrition, a public-pri-
vate partnership on pre-competitive research in food and nutrition. The funders 
had no role in study design, data collection and analysis, decision to publish, or 
preparation of the manuscript.”
T1/T2:OS1.6
Restoration of insulin sensitivity in obese condition by chronic 
stimulation of the abdominal vagus nerves.
Malbert C.H.1, Coquery N.1, Guérin S.1, Divoux J.L.2, Picq C.2, Henry C.3
1Ani-Scans, Dept of human nutrition, INRA, 35590 Saint-Gilles, France,  
2Axonic, 2720 chemin Saint-Bernard, 06224 Vallauris Cedex, France,  
3Sorin Group, 4 Avenue de Réaumur, 92140 Clamart, France
Introduction: Alternatives therapies to improve insulin resistance in 
obese patients are eagerly investigated because of the relative failure of 
the behavioral approaches and the irreversibility of bariatric surgery. Since 
the vagus regulates the afferent limb of insulin secretion (Blat et al, 2002), 
vagal stimulation represents an attractive tool. Surprisingly, vagal nerve 
stimulation (VNS) has never been investigated for restoration of insulin 
sensitivity in obese.  
Methods: 16 adults mini-pigs were made obese (87 ± 5.3 kg) by 3 months 
obesogenic diet supplied at 200% of the metabolic requirement. Once 
obese, silicon cuff incorporating two electrodes were implanted around 
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animals, these electrodes were connected to a double channel current 
stimulator placed under the skin (stimulated group) while the other half 
received only a sham device (sham). After 6 months of VNS (Val-Laillet 
et al, 2010), the animals were tested for insulin sensitivity using an eug-
lycemic-hyperinsulinemic clamp. Body composition was also investigat-
ed using CT scan. Vagal tone was extracted from heart rate variability in 
conscious animals.  
Results: Insulin sensitivity index was significantly larger in stimulated 
versus sham group (3.8 ± 0.51 vs 2.3 ± 0.24, p < 0.01) as a result of larg-
er glucose infusion rate (1.9 ± 016 vs 1.4 ± 0.16, p < 0.01). The glycemia 
was not different between groups at the onset of the clamp. The increased 
insulin sensitivity was not associated with changes in body composition 
neither for the subcutaneous nor the abdominal fat contents. Similarly, 
the LF/HF ratio indicative for vagal tone was not significantly different be-
tween groups (2.1 ± 0.03 vs 2.0 ± 0.07 for Stimulated vs Sham, p > 0.05). 
Conclusions: Insulin sensitivity was improved in obese animals after 
VNS. This improvement is not associated with changes in body composi-
tion or in vagal tone.
Acknowledgement: We acknowledge the technical support of R Comte (UMR 
Pegase) for the insulin dosage.
T3:OS1 – Eating Behaviour and Patterns
T3:OS1.1
Uncontrolled and emotional eating as behavioural pathways 
in genetic susceptibility to obesity
Konttinen H.1, Llewellyn C.2, Wardle J.2, Silventoinen K.1, Kaprio J.1, 
Joensuu A.3, Perola M.3, Männistö S.3, Salomaa V.3, Jousilahti P.3, 
Haukkala A.1
1University of Helsinki, Helsinki, Finland,  
2University College London, London, United Kingdom, 
3National Institute for Health and Welfare, Helsinki, Finland
Introduction: Appetite has been hypothesized to be one mechanism me-
diating the effects of genes on weight. We examined whether two appeti-
tive traits, uncontrolled and emotional eating, mediated the associations 
between known obesity-related genetic variants and adiposity.  
Methods: Participants were from two population-based Finnish cohorts: 
25–74 year-olds (DILGOM, N=3834) and 21–26 year-old twins (Fin-
nTwin12, N=985). Genotyping was performed using the cardio-metab-
ochip in DILGOM and the Illumina 670 chip in FinnTwin. A weighted 
polygenic risk score (PRS) of 90 BMI-related loci was calculated based on 
a recent meta-analysis of the GIANT consortium. BMI and waist circum-
ference (WC) were measured in a health examination. The TFEQ-R18 was 
used to assess uncontrolled eating (UE) and emotional eating (EE). Age 
and sex adjusted analyses were first conducted separately in each cohort 
and the results were then combined using fixed-effects meta-analysis.  
Results: The combined estimates indicated that the PRS was positively 
associated with BMI (β=0.16, P < 0.001), WC (β=0.13, P < 0.001) and 
appetitive traits (β=0.08 for UE; β=0.06 for EE, P < 0.001). The highest 
PRS quartile was related to 1.40 (95%CI 1.12–1.74) and 1.36 (95%CI 
1.09–1.71) increased odds of reporting high UE and EE compared with 
the lowest quartile. Mediation models indicated that UE and EE partly 
mediated (βindirect=0.023–0.024, P < 0.001) the associations between the 
PRS and BMI, with similar effects for WC.  
Conclusion: Genetic predisposition to obesity may partly exert its effects 
through two appetitive traits reflecting lack of control over eating and eat-
ing in response to negative emotions. Targeting these eating behaviours, 
as well as the food environment, may increase success in obesity preven-
tion and treatment.
Acknowledgement: We thank the Genetic Investigation of ANthropometric Traits 
(GIANT) consortium. Research relating to this abstract was funded by the Academy 
of Finland (# 265796).
T3:OS1.2
Appetite and food intake patterns in children
Syrad H.1, van Jaarsveld C.H.1, Llewellyn C.1, Wardle J.1
1Department of Epidemiology and Public Health, University College London, 
London, England
Introduction: Food responsiveness (FR) and satiety responsiveness (SR) 
are genetically influenced appetitive traits that are implicated in excess 
weight gain. They are hypothesised to act through energy intake, but no 
studies have examined associations with food intake in daily life. We pre-
dicted that higher FR would be associated with more frequent activation 
of the urge to eat and hence higher meal frequency, and lower SR with 
slower meal offset and hence larger meal size.  
Methods: Data were from 1102 families (n=2203 children) from the 
Gemini twin birth cohort. Appetite was assessed with the FR and SR 
scales from Child Eating Behaviour Questionnaire when children were 16 
months. Diet diaries (3 days) were completed by parents when children 
were 21 months. Diary analysis was done using the ‘Diet In Nutrients Out’ 
(DINO) programme by the Medical Research Council Human Nutrition 
Research Unit (Cambridge, UK). Meal size (total kcals per eating occa-
sion) and meal frequency (eating occasions per day) were determined 
from analysis of timed diary data. Associations between appetite and meal 
size/frequency were analysed adjusting for age, gender, gestational age, 
and clustering by family.  
Results: Higher FR was associated with more frequent meals (B=0.13; 
SE=0.04, p = 0.001) but not with meal size (p = 0.42) or total daily energy 
intake (-0.55). Lower SR was associated with larger meal size (B=-11.38; 
SE= 2.10, p < 0.001) but not with meal frequency (p = 0.15). Lower SR was 
associated with higher total energy intake (B=-19.40; SE= 8.52, p < 0.02).  
Conclusion: SR and FR predicted different consumption patterns, both 
of which potentially predispose to overeating. Food-responsive children 
eat more frequently, and less satiety-responsive children eat more on each 
eating occasion. Different strategies may be required for reducing the im-
pact of FR and SR on overconsumption and weight gain.
Acknowledgement: Recruitment and data collection was funded by Cancer Re-
search UK. Food diary analysis was carried out by MRC Human Nutrition Research 
(Cambridge, UK) and funded by Danone, UK
T3:OS1.3
Impact of high plasma acyl ghrelin level on eating behaviour 
in obese women
Julien B.1, Seyssel K.1, Feugier N.1, Lambert-Porcheron S.1, Drai J.2, 
Laville M.1, Disse E.1
1Centre de Recherche en Nutrition Humaine Rhône Alpes, Hospices Civils de 
Lyon, Université Lyon 1,  
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Université Lyon 1
Introduction: Acyl ghrelin, a stomach 28-amino acid peptide, is an orex-
igenic hormone stimulating appetite and food intake. In obesity, circulat-
ing plasma ghrelin levels are lower than in lean population. Surprisingly, 
some of obese subjects exhibit high ghrelin levels (HGL). We hypothe-
sized that HGL in obesity could enhance hunger and induce eating disor-
ders compared to low ghrelin levels (LGL). The aim of that study is to as-
sess the association between ghrelin levels, hunger, and eating behaviour 
in obese women.  
Methods: 55 obese women were selected and divided into 2 groups ac-
cording to their acyl ghrelin levels (7.51 ± 5.85 pg.mL-1 in LGL and 
65.77 ± 45.04 pg.mL-1 in HGL; p < 0.0001). We assessed eating disorders 
using the EDI-2 (Eating Disorders Inventory-2) and TFEQ (Three Factor 
Eating Questionnaire). Anxiety and depression were assessed by HAD 
scale. Biological and anthropometric profiles were also investigated.  
Results: Anthropometric and metabolic parameters were not different 
between groups. Anxiety and depression scores were similar. Cognitive 
restraint, uncontrolled eating and emotional eating scores were no sta-
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vs. 4.51 ± 0.46; p > 0.05; VAS), respectively between LGL and HGL 
groups. Among the 11 subscales of the EDI-2 questionnaire, 10 were 
not different between HGL and LGL groups, notably the impulse reg-
ulation (2.37 ± 0.79 vs. 2.43 ± 0.61, respectively; p > 0.05) and the buli-
mia (2.22 ± 0.53 vs. 1.93 ± 0.61 respectively) subscales. However, HGL 
group scored significantly higher than LGL group on Drive for Thinness 
(9.30 ± 0.99 vs. 6.46 ± 0.83 respectively; p = 0.03).  
Conclusion: A higher plasma ghrelin level in obesity is not associated 
with altered eating behaviour phenotype.
T3:OS1.4
Timeline over which compensatory mechanisms are activated 
during weight loss with a very-low calorie diet
Nymo S.1, Jřrgensen J.1, Kulseng B.1,2, Truby H.3, Martins C.1,2
1Obesity Research Group, Department of Cancer Research and Molecular 
Medicine, Faculty of Medicine, Norwegian University of Science and 
Technology, Trondheim, Norway,  
2Centre for Obesity, Department of Surgery, St. Olav Hospital—Trondheim 
University Hospital, Trondheim, Norway,  
3Nutrition & Dietetics Department, Monash University, Melbourne, Australia
Introduction: Diet-induced weight loss (WL) activates several compensa-
tory mechanisms, such as increased hunger and reduced fullness feelings, 
reduced resting metabolic rate (RMR) and increased exercise efficiency 
(Ef). Little is known regarding when these mechanisms are activated and 
how they respond with progressive WL. The aim of this study was to de-
termine the timeline over which compensatory mechanisms (changes in 
subjective feelings of appetite, RMR, Ef) are activated during WL with a 
very-low calorie diet (VLCD).  
Methods: Twenty-two adult participants (11 men), with an average BMI 
of 38 ± 4.4 kg/m2 underwent 8 weeks of VLCD followed by 4 weeks of 
weight maintenance. Body weight, RMR, Ef (10, 25 and 50W) and sub-
jective feelings of appetite (in fasting and for 2.5h after a meal) were mea-
sured at baseline, day 3, when participants lost 5% and 10% of their base-
line weight, at week 9 and at week 13.  
Results: Significant WL (1.8 ± 1.7kg) was seen by day 3, and progressively 
at each subsequent time point, with an average reduction in body weight 
of 19 ± 4% at week 9, which then stabilized. RMR fell significantly after 
5% WL, but then stabilized. Ef (all intensities) increased significantly for 
the first time at week 9 and then stabilized. A significant increase in fast-
ing hunger and desire to eat was observed by day 3, but not at other time 
points. AUC for prospective food consumption was significantly reduced 
at week 9, but not other time points.  
Conclusion: The magnitude of WL required to activate the different com-
pensatory mechanisms in response to a VLCD seems to differ: 5% WL for 
a reduction in RMR and 19% WL for an increase in Ef. Fasting hunger and 
desire to eat changed only transiently at day 3 and AUC for prospective 
food consumption transiently with 19% WL.
Acknowledgement: Funding: Liaison Committee between the Central Norway 
Regional Health Authority (RHA) and the Norwegian University of Science and 
Technology (NTNU). Regional Center for Morbid Obesity, Department of Surgery, 
St. Olav Hospital (Trondheim, Norway).
T3:OS1.5
Normal weight obesity in adolescents – associations with 
health behaviours and metabolic risk factors
Olafsdottir A.S.1, Torfadottir J.E.2,3, Arngrimsson S.A.1
1Research Center for Sport and Health Sciences, School of Education, University 
of Iceland.,  
2Educational Research Institute, School of Education, University of Iceland.,  
3Unit for Nutrition Research, Faculty for Food Science and Nutrition, University 
of Iceland.
Introduction: Adolescents often focus on physical appearance rather 
than health. This may affect their health behaviours. Normal weigh obe-
sity (NWO) applies to individuals with normal body mass index (BMI), 
but excessive body fat. Our aim was to explore metabolic disorders and 
lifestyle in this group.  
Methods: Randomly selected 18 year old students (n = 191) from three 
highschools in the capital area in Iceland, with BMI within normal range 
(18.5–24.9 kg/m2) participated. Waist circumference was measured 
and bodycomposition assessed with dual energy X-ray absorptiometry 
(DXA). Aerobic fitness was measured with maximum oxygen uptake test 
on treadmill. Dietary habits were evaluated with 24-hour recall and ques-
tionnaires about diet and lifestyle, and blood samples were taken. NWO 
was defined, according to Lohman’s criteria; BMI within normal range 
and percentage body fat above 17.6% in males and above 31.6% in females. 
Results: In total 40% (n=76) were defined as NWO, thereof 60% (n=46) 
were male participants. Fewer participants with NWO ate breakfast on 
a regular basis, consumed vegetables frequently, slept enough, and were 
physically active compared with participants without NWO. No difference 
was detected between the two groups in energy-, macronutrientor micro-
nutrient intake. Mean difference in aerobic fitness was 3.4 ml/kg/min be-
tween the groups in favor of the non-NWO group (P = 0.01). NWO was 
positively associated with having one or more risk factors for metabolic 
syndrome (Odds Ratio OR=2.2; 95% confidence interval CI: 1.2, 3.9) and 
high waist circumference (OR=7.4; 95%CI: 2.1, 25.9).  
Conclusion: High prevalence of NWO was observed in the study group. 
Promoting healthy lifestyle with regard to nutrition, sleep and physical 
activity in early life should be emphasized.
Acknowledgement: Funding: Univeristy of Iceland Research fund, Directorate of 
Health in Iceland and the Sportsfund of The Ministry of Education, Science and 
Culture.
T6/T7:OS1 –  Working with Perception and 
Stigma
T6/T7:OS1.1
Obesity and Discrimination – A Systematic Review
Spahlholz J.1,2, Baer N.2, König H.H.3, Riedel-Heller S.G.2, Sikorski C.1,2
1Leipzig University Medical Center, IFB AdiposityDiseases, Leipzig, Germany, 
2Institute of Social Medicine, Occupational Health and Public Healt (ISAP), 
Leipzig University, Leipzig, Germany, 
3Department of Medical Sociology and Health Economics, University Medical 
Center
Background: Research on obesity has shown that stigma often accompa-
nies obesity on different societal levels. Obese individuals are often faced 
by a variety of prejudice and stereotypes. It has not been systematically 
evaluated, whether and to what extent negative attitudes translate into ob-
jective determinants of inequality, e.g. discrimination.  
Methods: A systematic literature search was conducted, using Medline, 
ISI Web of Knowledge and The Cochrane Library without time limits. 
Studies pertaining to (a) prevalence estimates and (b) forms of weight-
based discrimination towards obese individuals were included.  
Results: 19 studies were included, indicating that weight discrimination 
is common and pervades many aspects of life for individuals with obesi-
ty. Often, no conceptual distinction between attitudes and discrimination 
were made. Experimental findings were in accordance with non-exper-
imental findings, documenting that disparate treatment was visible on 
a behavioural level and not only a subjective perception. Findings from 
community-based studies reported prevalence estimates between 6.1% 
and 60.7%. A female gender and an increased body weight (BMI>35) were 
associated with higher rates of weight-based discrimination. 
Conclusions: The results provide evidence that discrimination in obesity 
and its negative consequences are highly relevant issues within society and 
need to be the focus of potential legislative interventions. 
Acknowledgement: This work was supported by the Federal Ministry of Education 
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T6/T7:OS1.2
The impact of labelling on acceptance of obesity
Oldham M.1, Robinson E.1
1Psychological Sciences, University of Liverpool, Liverpool, England
Introduction: Visual exposure to obese body weights has been shown to 
increase acceptance of heavier forms. However, despite rates of obesity in-
creasing dramatically since 1972, acceptance of heavier body weights has 
not become common, as obesity is still a widely stigmatised condition. The 
way in which obesity is typically portrayed could explain why increased 
exposure to obesity may not have resulted in a greater acceptance of heavi-
er body weights. The aim of the present work was to examine whether 
labelling heavier body weights as ‘obese’ has an effect on whether exposure 
to heavier body weights reduces negative attitudes towards the obese.  
Methods: 276 Participants were visually exposed to obese or healthy 
weight males with either no attached label, a label describing the males’ 
weight status or a condition in which attention was drawn to the males’ 
weight, before being asked to make judgements about the acceptability of 
an obese person’s weight.  
Results: Exposure to obese males in the absence of a label increased 
acceptance of the obese person’s weight, relative to exposure to healthy 
weight males (p < .05). There was also a significant interaction, whereby 
exposure to obese males labelled as obese did not increase acceptance of 
the obese person’s weight. There was little evidence that exposure to obese 
males increased acceptance of an obese person’s weight when attention 
had been drawn to weight during visual exposure.  
Conclusion: Visual exposure to obese body weights reduces negative atti-
tudes towards the obese. However, the context in which exposure occurs 
is of importance. These findings support the theory that the way in which 
obesity is typically portrayed in popular media will not increase accep-
tance of heavier body weights as a result of visual exposure.
T6/T7:OS1.3
The weight of knowing you are overweight: Perceived weight 
status and risk of future weight gain in us and uk adults
Robinson E.1, Hunger J.2, Daly M.3
1University of Liverpool,  
2University of California,  
3University of Stirling
Introduction: Identifying oneself as overweight is presumed to act as a 
prerequisite to successful weight management efforts. However, the psy-
chological burden attached to the label of ‘overweight’ may actually prop-
agate further weight gain. Our objective was to determine the effect that 
perceiving oneself as ‘overweight’ has on risk of future weight gain.
Methods: Three longitudinal cohort studies were used; National longi-
tudinal study of adolescent health (Add Health), Midlife in the United 
States (MIDUS) and the National Child Development Study (UK cohort). 
3,899 US adults (Add Health), 3,372 US adults (MIDUS) and 6,740 UK 
adults participated. Primary measures were body mass index (BMI) and 
perceived weight status.  
Results: Perceiving oneself as being ‘overweight’ at baseline was sig-
nificantly associated (both before and after adjusting for potential con-
founders) with an increased risk of weight gain in the Add Health cohort 
(B = 1.056, SE = .175, p < .0001), the MIDUS sample (B =.376, SE =.134, 
p = .005) and the UK sample (B = .802, SE = .117, p < .001). The asso-
ciation between perceived overweight and weight gain was mediated by 
stress induced over-eating; perceiving oneself as overweight was associat-
ed with a greater likelihood of over-eating in response to stress, which in 
turn predicted weight gain.  
Conclusion: Perceiving oneself as being ‘overweight’ is counter-intuitively 
associated with an increased risk of further weight gain. The stress and 
stigma associated with perceiving oneself as ‘overweight’ may be more 
detrimental than beneficial to weight management in our current social 
climate.
T6/T7:OS1.4
Outcomes of a Health-At-Every-Size intervention in local 
health centers across the province of Quebec
Gagnon-Girouard M.P.1, Bégin C.1, Provencher V.1, Turcotte M.1, 
Paquette M.C.3, Mongeau L.2
1University Laval,  
2Ministčre de la Santé et des Services Sociaux,  
3Université de Montréal Public Health Research Institute
Introduction: Health-At-Every-Size (HAES), a non-dieting approach, 
promotes the regulation of eating based on the decrease of dietary re-
straint, and the appropriation of internal cues of hunger and satiety (in-
tuitive eating), as well as self-acceptance. Controlled studies have demon-
strated that HAES interventions improve physiological and psychological 
functioning of participants. The Québec government recently implement-
ed a HAES intervention called “Choisir de Maigrir?” in local health and 
social services centers (HSSC). In the context of scarce resources devoted 
to public health, the aims of the present study are to document the efficacy 
of this intervention and to verify whether the core dimensions of HAES 
are actually associated with putative benefits. Outcomes were core dimen-
sions of the HAES approach (restraint, intuitive eating, body esteem), eat-
ing behaviors, psychological distress, and body mass index (BMI).  
Methods: Within 33 HSSC, 216 women receiving the HAES interven-
tion and 110 women on a waiting list were tested. Participants completed 
self-reported questionnaires before and after the intervention, as well as 
one year later.  
Results: Linear mixed models analyses computed according to a group 
(HAES vs. control) by time (baseline, post-test, follow-up) design revealed 
significant group by time effects for restraint, intuitive eating, body es-
teem, eating behaviors, and psychological distress but not for BMI. Pos-
itive changes were maintained in the long-term in the HAES group. In-
crease in intuitive eating was associated with generalized improvement 
among HAES participants in the short and the long term, whereas chang-
es in restraint were related only to short-term changes in eating behaviors. 
Conclusion: The HAES intervention showed sustained improvement on 
core HAES dimensions, psychological profile and eating behaviors. Intui-
tive eating seems to play a central role in the beneficial changes that were 
observed among participants.
T6/T7:OS1.5
Changing adolescent health behaviours: Empirical evidence 
and practical ways forward
Tucker F.1 
1Department of Politics, Philosophy and Religion, Lancaster University, 
Lancaster, UK 1
Introduction: Adolescents are a key target for intervention programmes. 
However, adolescents are very difficult to reach. This paper asks what we 
might consider when designing more effective interventions in the future 
and, coming from an ethical and philosophical perspective, suggests that 
interventions ought to focus on adolescent self-understanding and deci-
sion-making rather than focussing on particular health behaviours.  
Methods: The paper draws on empirical studies and meta-analyses to 
identify features of successful interventions, models from developmen-
tal and health psychology, research into positive youth development, and 
philosophical insights into value formation and autonomy development.  
Results: There are many influences on adolescents that mean health con-
siderations are unlikely to weigh heavily in their decisions: the invisibility 
of future health, adolescents’ interactions with others and the environ-
ment, social practices, and their attitudes and values. Adolescents prior-
itise many things over health, for example, worries about fitting in. They 
operate within systems of consumerist norms, in the grip of marketing 
and brand culture. They have heightened body image, self-consciousness 
and a desire to make autonomous choices. Parental influence gives way 
to the influence of peer networks. These factors are often bound up with 
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that requires specific intervention design strategies. The paper argues that 
an ecological approach enables deeper understanding of the challenges 
that intervention designers face, and suggests ways to improve interven-
tion strategies.  Conclusions: Consideration of the complex influences on 
adolescent health behaviours offers a better understanding of why they 
are hard to reach. Indications are that interventions should focus less on 
individual health behaviour outcomes. Instead, successful interventions 
may include those that focus on personal and social skills.
T6/T7:OS1.6
Governing ‘obesities’ – interdisciplinary obesity research in 
practice
Hillersdal L.1, Winther J.1, Jespersen A.P.1
1University of Copenhagen
Background: Obesity is a complex problem demanding complex solutions. 
This proposal stands at the centre of the large interdisciplinary research con-
sortia “Governing Obesity” at the University of Copenhagen. Researchers 
from different parts of biomedicine, the social sciences and the humanities 
seek to develop novel means and methods to treat and prevent obesity and 
its consequences.The expectation is that these interdisciplinary collabora-
tions will lead to effective interventions at the societal and individual level. 
A part of our involvement in this initiative has been to investigate how in-
terdisciplinary obesity research is done in practice and how scientific claims 
and translational aspirations are interpretated and negotiated across disci-
plines.  Method: Through ethnographic fieldwork including focus groups 
and interviews, it is explored how obesity as a research object is operation-
alised in interdisciplinary research collaboration.  
Results: Interdisciplinary collaboration does not necessarily work upon a 
common perception of what obesity is, epistemological openness or data 
integration. Rather, we argue that complexity-oriented interdisciplinary 
collaboration raise questions about where to locate the “interdisciplinari-
ty” and its effects. We find that an qualification of interdisciplinary obesity 
research requires an attendance to of how different “obesities” come to 
co-exist in different and new ways through collaboration. Interdisciplin-
ary obesity research in practice demands: 1. strategic balancing of aca-
demic investments between individual, collective goals. 2. the ability to 
embody and maintain monodisciplinary identities and indexes. 3. a clear 
articulation of what constitutes research practice standards for each par-
ticipant. These points can guide the development of evaluation measures 
for intersdiciplinary research.
Acknowledgement: Governing Obesity is one of the 18 initiatives established in 
2013 based on a grant from the University of Copenhagen Excellence Programme 
for Interdisciplinary Research (2016). We are very grateful for the funding.
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T1/T2:OS2 – Adipose Tissue Plasticity and 
Oxidative Phenotype
T1/T2:OS2.1
Targeting miR-125b-5p to fight obesity via browning of white 
adipose tissue
Giroud M. 1,2,3, Karbiener M.4, Barquissau V.5, Pisani D.1,2,3, Mairal A.5, 
Beranger G.1,2,3, Beuzelin D.5, Ghandour R. 1,2,3, Chambard J.1,2,3, 
Balaguer T.1,2,3, Scheideler M.4, Langin D.5, Amri Z.1,2,3
1Université Nice Sophia Antipolis, iBV, UMR 7277, Nice, France,  
2CNRS, iBV, UMR 7277, Nice, France,  
3Inserm, iBV, U1091, Nice, France,  
4RNA Biology Group, Institute for Molecular Biotechnology, Graz University of 
Technology, Graz, Austria,  
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Cardiovascular Diseases, Toulouse, France
The recent discovery of functional brown adipocytes in adult humans 
has led to the consideration of their use to increase energy expenditure 
in the treatment of obesity. Furthermore, in rodents and humans, is-
lands of brown adipocytes, termed “brite” (brown-in-white) adipocytes, 
emerge within white adipose tissue (WAT) after cold exposure or β3-ad-
renergic receptor stimulation. The identification of factors which trigger 
an increased mass/activity of human brite adipocyte is of great interest 
for the treatment of obesity. One of these factors is microRNA known to 
interfere with the translation of messengers in proteins. Using hMADS 
cells, able to differentiate into human white adipocytes and convert into 
functional brite adipocytes, we identified miR-125b as down regulated 
upon this conversion. In human and rodent, miR-125b expression was 
down regulated in BAT compared to WAT. miR-125b mimic transfection 
in hMADS brite adipocytes decreased basal oxygen consumption and 
maximal mitochondrial respiration (figure 1). We showed that miR-125b 
levels were down regulated in sub-cutaneous (sc) WAT and in BAT upon 
both in vivo β3-adrenergic receptor stimulation and cold exposure, and 
thus associated with BAT activation and brite recruitment. Finally, we 
found that miR-125b mimic injection in scWAT inhibited β3-adrenergi-
cally-induced UCP1 expression and mitochondriogenesis (figure 2). Our 
observations are in favor of an important role of miR-125b in the control 
of white to brite adipocyte conversion via regulation of mitochondriogen-
esis. miR-125b loss of function should allow a better understanding of the 
mechanisms underlying the role of this miRNA in the browning of white 
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Fig. 1. Figure 1: Effect of miR-125b-5p overexpression in differentiated hMADS. 
Oxigen consumption (A) maximal respiration and uncoupling dependent oxygen 
consumption mesurment during the conversion of white to brite hMADS 
adipocytes. * , p < 0.05
Fig. 2. Figure 2: Gene expression in sub-cuteanous WAT miR-125b-5p injected 
mice. Gene expression was analyzed in mice sc-WAT maintained at thermoneutra-
tility and treated with the beta 3 adrenergenic receptor agonist (CL316 243) or 
with NaCL (control) for 7 days. ***, p < 0.0005
T1/T2:OS2.2
Long-term weight loss is associated with increased NAD+ 
biosynthesis and SIRT1 expression but reduced PARP activity 
in human white adipose tissue
Rappou E. 1, Jukarainen S.J.1, Tummers M.1, Kaye S.1, Kaprio J.2, 
Rissanen A.1, Suomalainen A.3, Virtanen K.4, Pirinen E.3, Pietiläinen K.H.1
1Obesity Research Unit, Research Programs Unit, University of Helsinki, Helsinki, 
Finland,  
2Finnish Twin Cohort Study, Hjelt Institute, Helsinki, Finland,  
3Molecular Neurology, Research Programs Unit,  
4Turku University Central Hospital, Turku PET Center, Turku University Central 
Hospital, Turku, Finland
Background and aims: Mitochondrial dysfunction is one of the hallmarks 
of obesity. Sirtuin 1 (SIRT1) and poly(ADP-ribose) polymerases (PARPs) 
are NAD+-dependent enzymes that regulate mitochondria and energy 
metabolism. In animal studies, calorie shortage increases NAD+ biosyn-
thesis and subsequently SIRT1 activity but inhibit PARP activity. We aim 
to study whether long-term weight loss mimics mechanistic responses of 
calorie shortage to boost mitochondria function in human white adipose 
tissue (WAT). Materials and methods: Nineteen obese subjects with body 
mass index (BMI) ranges 29–39 enrolled in a 12-month weight loss pro-
gram. As controls, 19 healthy lean subjects with BMI ranges 21–24 were 
studied. Total RNA was extracted from subcutaneous WAT biopsies, tak-
en at 0, 5 and 12-month time points. The whole genome-scale expression 
profiles of WAT were analyzed using Affymetrix U133 Plus 2.0 chips. To-
tal PARP activity in WAT was measured using PARP Assay kit. Expression 
of nicotinamide phosphoribosyltransferase (NAMPT), was analyzed in 
WAT using quantitative RT-PCR.  
Results: All obese subjects lost weight (11.6 ± 1.3 kg) between 0 and 5 
months. By 12 months, 1/3 of the subjects continued to loose weight 
(17.5 ± 2.6 kg), while 2/3 maintained or slightly regained body weight 
(5.0 ± 1.2 kg). Between 0 and 5 months, WAT NAMPT and SIRT1 ex-
pression levels significantly increased in all subjects. SIRT1 expression 
levels followed inversely BMI trend. Also, WAT PARP activity trended to 
decline in all subjects at 12 months while in the continuous weight loss 
group, PARP activity significantly decreased.  
Conclusion: Here we showed for the first time that long-term weight loss 
is associated with increased WAT NAD+ biosynthesis and SIRT1 expres-
sion but lowered total PARPs activity in humans.
T1/T2:OS2.3
Short chain fatty acid acetate induces browning of white 
adipose tissue
Sahuri Arisoylu M.1,2, Frost G.2, Bell J.D.1
1Department of Life Sciences, Faculty of Science and Technology, University of 
Westminster, 115 New Cavendish Street, London, W1W 6UW, UK,  
2Nutrition and Dietetic Research Group, Division of Diabetes, Endocrinology 
and Metabolism, Department of Investigative Medicine, Imperial College 
London, Hammersmith Hospital, London W12 0NN, UK
Introduction: Acetate is the most abundant short chain fatty acid pro-
duced in the colon from the fermentation of dietary fibres [1] and was 
recently shown to reduce appetite [2]. Acetate has also been shown to re-
duce adiposity [3]. To assess the peripheral mechanism of acetate we have 
developed a novel nanoparticle delivery method which passively targets 
acetate to the periphery. We have investigated the effects of this treatment 
on body adiposity, inflammation and mitochondrial metabolism.  
Methods: Adult C57BL/6 mice were treated with either acetate encapsu-
lated liposomes or control (3/week for 6 weeks). Whole body and liver 
lipid content were assed by magnetic resonance spectroscopy. Blood and 
tissue samples were collected for glucose, insulin, liver enzymes, lipids and 
inflammatory markers and for gene expression analysis.  
Results: Acetate treatment led to a reduction in body adiposity through 
the process of “browning” of white adipose tissue, including significant 
increase in UCP1 expression. Furthermore liver fat was reduced while 
liver function was improved, inflammation was reduced and insulin sen-
sitivity was increased by acetate treatment. Reduced liver fat arose from 
a reduction in lipolysis and de-novo lipogenesis. At cellular level mito-
chondria showed increased protein expression of electron transport chain 
complexes in liver, which was associated with increased ATP production 
in THLE-2 hepatocytes.  
Conclusion: This study provides new insights into the peripheral action 
of acetate on lipid metabolism and shows that acetate has the potential to 
be used in the management of obesity and fatty liver disease.
References
1. Cummings, J.H. et al.: Gut 28:1221;1987.
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T1/T2:OS2.4
Paradoxical dissociation between metabolic improvements 
albeit increased adipose tissue collagens after bariatric 
surgery induced weight loss
Liu Y. 1,2,3, Aron-Wisnewsky J.1,2, Pelloux V.1,2, Marcelin G.1,2, Torcivia A.4, 
Le Naour G.5, Charlotte F.5, Sasso M.3, Miette V.3, Tordjman J. 1,2, 
Clément K.1,2
1Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpętričre Hospital, 
Paris, France,  
2Inserm UMR U1166; UPMC, Nutriomique, France,  
3Echosens, Paris,  
4Department of Surgery, Assistance Publique-Hôpitaux de Paris, Pitié-
Salpętričre hospital,  
5Department of Pathology, Pitié-Salpętričre hospital
Introduction: During metabolic improvements after weight loss induced 
by bariatric surgery (BS) in morbid obesity, the extracellular matrix (ECM) 
of subcutaneous white adipose tissue (scWAT) shows important remodel-
ling. However the latter and its links with metabolic improvements need 
to be further studied. Here we kinetically characterized scWAT changes 
at expression level and collagen accumulation after BS and their relation-
ships with metabolic improvements.  
Methods: 102 obese candidates for BS were recruited. Gene expression lev-
els of scWAT were evaluated by microarray in 42 women before (T0) and 12 
months (T12) after BS. Collagen accumulation was evaluated by histochem-
istry (picrosirius red) in samples collected during BS (T0) and 3 (T3), 12 
(T12) months after. scWAT stiffness was evaluated by the new medical tool 
(Adiposcan). Degraded collagen I was evaluated by immunohistochemistry 
and, procollagens and degraded collagens measured in tissue explants.  
Results: Expression levels of major ECM genes, e.g. COL3A1, COL6A1, 
COL6A2, ELN, CTGF, MMPs and their inhibitors, and cross-linking en-
zyme (LOX) drastically changed at T12, confirming important remodel-
ling. Intriguingly, these changes were accompanied by an increased accu-
mulation in total and pericellular collagen (collagen I and III) at T3, T12. 
Pericellular collagen accumulation remained significant after adjustment 
for adipocyte size variation and was not associated with metabolic im-
provements. At T12, we observed no significant change of scWAT stiff-
ness. We also found more degraded collagen I around adipocytes after BS. 
Conclusion: Major ECM remodelling at expression levels one year after 
BS is accompanied by increased pericellular collagens accumulation in 
scWAT. This feature might be a witness of ECM adaptation after weight 
loss and of an accumulation of degraded collagens. Studies are ongoing 
to confirm whether this accumulation corresponds to degraded or newly 
synthesized collagens.
T1/T2:OS2.5
Lack of mitochondrial endonuclease g enhances brown 
adipocyte recruitment in white adipose tissue and improves 
glucose homeostasis
Pardo R.1, Cańas X.2, Sanchis D.3, Villena J.A.1
1Laboratory of Metabolism and Obesity. Vall d'Hebron, Research Institute. 
Barcelona, Spain.,  
2PRAAL. Scientific Park of Barcelona. Barcelona, Spain.,  
3Cell signaling and Apoptosis Group. University of Lleida. Lleida, Spain.
Introduction: Compelling evidence suggests that mitochondrial function 
in white adipose tissue (WAT) is a determinant of whole body insulin sen-
sitivity. Also, increased energy expenditure and improved insulin sensitivity 
elicited by calorie restriction or thiazolidinediones is associated to an in-
creased recruitment of brown adipocyte-like cells in WAT. Full differentia-
tion and thermogenic activity of brown adipocytes highly depends on the 
PGC-1α/ERRα tandem of transcriptional regulators. Recently, it has been 
reported that endonuclease G (EndoG), a mitochondrial endonuclease, 
regulates cardiac mitochondrial biogenesis in a PGC-1α/ERRα-dependent 
manner. However, the role of EndoG in adipose tissues remains unexplored. 
Methods: To study the function of EndoG in adipose tissues EndoG 
knockout (EndoG KO) mice were used.  
Results: In brown adipose tissue (BAT), lack of EndoG did not result 
in any noticeable reduction in the expression of mitochondrial OxPhos 
genes. However, we found an increase in the expression of thermogenic 
genes (UCP1, DIO2) that was associated to reduced lipid accumulation in 
brown adipocytes. Moreover, EndoG KO mice had a 40% reduction in the 
mass of major WAT depots. The analysis of WAT revealed that, as in BAT, 
expression of mitochondrial genes was not affected by the lack of EndoG. 
Interestingly, we found a noticeable increase (2–4 fold) in the expression 
of UCP1, DIO2 and PGC-1α that correlated with the appearance of brown 
adipocyte-like cells interspersed among white adipocytes. The increased 
browning of WAT elicited by the lack of EndoG was associated to a better 
glucose tolerance.  
Conclusion: We demonstrate that lack of EndoG is associated to an in-
creased browning of WAT that correlates with decreased fat mass and im-
proved glucose tolerance.
T1/T2:OS2.6
Diet-induced weight loss decreases adipose tissue oxygen 
tension and is accompanied by improved insulin sensitivity in 
overweight and obese individuals
Vink R.G.1, Roumans N.1, Blaak E.E.1, Mariman E.C.1, van Baak M.A.1, 
Goossens G.H.1
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The 
Netherlands
Introduction: Recent studies have indicated that adipose tissue (AT) ox-
ygen partial pressure (pO2) may underlie AT dysfunction. Although AT 
hypoxia is present in rodent models of obesity, we have demonstrated that 
AT pO2 was increased in obese insulin resistant compared to lean insulin 
sensitive individuals, and was inversely associated with peripheral insu-
lin sensitivity. Therefore, the objective of this study was to investigate the 
effects of diet-induced weight loss on abdominal subcutaneous AT pO2, 
AT blood flow (ATBF), AT inflammation and oxidative markers, systemic 
inflammation and insulin sensitivity in overweight and obese individuals. 
Methods: Fifteen overweight and obese individuals underwent a 5-week 
very-low-caloric diet (VLCD, 500 kcal/d) and a subsequent 4-week 
weight-stable diet. Body weight, adiposity, AT pO2 (optochemical mea-
surement system), ATBF (133Xe wash-out), plasma insulin and glucose 
concentrations, and HOMA-IR were determined and an AT biopsy was 
collected (fat cell size and micro-array analysis) at baseline and at the end 
of the weight-stable period.  
Results: As expected, the VLCD significantly decreased body weight 
(-9.7%, p < 0.001) and adiposity (-6.0%, p < 0.001). Furthermore, AT pO2 
(-19.7%, p = 0.002, Figure 1 & 2) and HOMA-IR (-36.4%, p = 0.001) were 
markedly decreased after the VLCD. Fasting ATBF did not change signifi-
cantly (p = 0.54). Micro-array and fat cell size analyses are ongoing and 
will be available at the time of the congress.  
Conclusion: The present study demonstrated for the first time that VL-
CD-induced weight loss markedly reduced AT pO2, which was accom-
panied by improved insulin sensitivity. We are currently investigating 
whether the VLCD-induced decrease in AT pO2 is related to alterations 
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Fig. 1. The fasting adipose tissue oxygen partial pressure (AT pO2) decreased in 14 
out of 15 participants due to the dietary intervention.
Fig. 2. The average fasting adipose tissue oxygen partial pressure (AT pO2) decrea-
sed significantly due to the dietary intervention (N= 15). Values are mean ± SEM.
T8:OS1 – Co-Morbidities
T8:OS1.1
Insufficient weight loss after bariatric surgery: Does it presage 
metabolic treatment failure
Fried M.1,2
1OB Klinika – Center for Treatment of Obesity and Metabolic Disorders, Prague, 
Czech Republic, 
21st Faculty of Medicine, Charles University, Prague, Czech Republic
Introduction: Post-bariatric %EWL, BMI changes and other criteria may 
be considered as relative indicators of treatment success/failure: Metabol-
ic outcomes in patients who did not reach surgically defined success ful 
weight loss (50% EW) are rarely reported.  
Methods: 2781 bariatric patients were analysed. Out of them 541 (19.5%) 
did not maintain 50%EWL in 5 year follow-up. 251 (9.02%) required re-
operation. 290 (10.4%) we not reoperated.Both groups were correlated as 
to metabolic and other outcomes.  
Results: Reoperation group: pre-bariatric BMI 42.8 ± 6.7, and mean 
%EWL at re-do 21.5 ± 3.6 were significantly (p < 0.001) reduced at 
3,6,12,18 mths after reop by 10.2% ± 2.1, 23.4% ± 3.5, 8.9% ± 4.1, and 
27.8 ± 3.9% respectively. Overall %EWL was 51.3%. In 32 (77.7%) dia-
betics FPG, Hb1A dropped to (5.1 ± 1.5 mmol/l ) and (4.2 ± 0.7%) re-
spectively (p < 0.001). In 10 (22.7%) patients their diabetes improved, and 
in two (4.5%) no post reop. changes were noted. In the non reoperation 
group: the still existing 16.5 ± 7.5%EWL was associated with maintenance 
of lowered glycaemia, from pre-bariatric (7.6 ± 2.1 to 5.9 ± 1.3 mmol/l, 
p < 0.01), and significant (p < 0.001) decrease in anti-diabetes medication, 
in systolic BP (10.2 ± 20.1 mmHg, p = 0.01) and triglycerides (36.4 ± 51.3 
mg/dL, p = 0.03).  
Conclusion: Bariatric reoperations are effective on WL and T2DM. Pa-
tients with long-term EWL ≤25% after primary bariatric surgery, still ex-
hibited significant improvement in multiple cardiometabolic parameters 
(diabetes, hypertension, hyperlipidemia) compared to pre-surgical values. 
This may further support the weight independent anti-diabetic/metabolic 
effect of bariatric operations.
T8:OS1.2
Randomized, double-blind, placebo controlled 4 week proof 
of concept trial of beloranib resulted in rapid and significant 
weight loss in patients with hypothalamic injury associated 
obesity
Malloy J.L., Haugen T., Taylor K., Hughes T.E., Kim D.D.
Zafgen, Inc. Boston, MA USA
Beloranib is a methionine aminopeptidase 2 inhibitor that potently re-
duces body weight (BW), hunger, and restores balance to the production/
utilization of fat; prior studies have shown ~11 % BW loss over 12 wks in 
exogenously obese patients. Patients with hypothalamic injury associated 
obesity (HIAO) fail to regulate metabolism and food intake, resulting in 
rapid intractable BW gain, treatment resistant severe obesity, and associ-
ated comorbidities. This was a randomized, double-blind, placebo-con-
trolled study in 14 adults with HIAO. Patients were randomized to receive 
twice weekly SC doses of 1.8 mg of beloranib (n = 8) or placebo (n = 6) 
for 4 wks followed by 4 additional wks where all patients received 1.8 mg 
of beloranib twice weekly. Thirteen out of 14 patients (9 females, age 31.9 
yr, BMI 42.8 kg/m2, BW 126.4 kg) completed 8 wks of follow up, with 12 
patients comprising the pre-specified per protocol population. After 4 wks 
of randomized blinded therapy, patients on 1.8 mg of beloranib (n = 8) 
lost an average (±SEM) of 3.40 ± 0.6 kg of BW vs. a reduction of 0.25 ± 0.9 
kg for PBO (n = 4; p = 0.01). After 8 wks of treatment, beloranib group lost 
a total of 6.15 ± 0.9 kg of BW, while placebo group lost 3.0 ± 0.9 kg during 
the 4-wk open label extension. Lipid profile and markers of inflammation 
were improved at 4 and 8 wks with beloranib treatment. There were no 
serious adverse events and 1 adverse event leading to withdrawal (place-
bo; allergic reaction). All safety measures (laboratory, vital signs, ECGs) 
were unremarkable. This Phase 2 study demonstrated beloranib was well 
tolerated and effective in HIAO and supports a novel non-hypothalamic 
mode of action of beloranib to mediate improvements in BW and car-
diometabolic profile.
T8:OS1.3
Improvements in sleep apnoea endpoints and quality of life 
are related to the degree of weight loss: Results from the 
randomized, double-blind scale sleep apnoea trial
Zammit G.1, Aronne L.J.2, Foster G.3, Rosenberg R.4, Wadden T.5, 
Claudius B.6, Donsmark M.6, Blackman A.7
1Clinilabs Sleep Disorders Institute, New York, NY, USA,  
2Weill Cornell Medical College, New York, NY, USA,  
3Department of Medicine, Temple University, Philadelphia, PA, USA,  
4NeuroTrials Research, Atlanta, GA, USA,  
5Perelman School of Medicine, University of Pennsylvania, PA, USA,  
6Novo Nordisk, Sřborg, Denmark,  
7Toronto Sleep Institute, MedSleep, Toronto, ON, Canada
This is a post hoc analysis of the relationship between weight loss (WL) 
and endpoints related to sleep apnoea and quality of life (QoL) in the 
SCALE Sleep Apnoea trial. Clinicaltrials.gov NCT01557166. Obese adults 
(72% male, mean age 49 y, apnoea-hypopnoea index [AHI] 49.2 events/h, 
body weight [BW] 117.6 kg) with moderate or severe obstructive sleep 
apnoea (OSA) and unable/unwilling to use continuous positive airway 
pressure therapy were treated with liraglutide 3.0 mg (n=180) or placebo 
(n=179), both as adjunct to diet & exercise counselling, for 32 weeks. A 
pre-specified ANCOVA model included treatment, country and gender 
as fixed effects and baseline age and BMI parameter values as covariates. 
Post hoc analyses also included % weight change as a covariate and exam-
ined its interactions with other effects. Liraglutide 3.0 mg reduced AHI 
(–12.2 vs –6.1 events/h, p = 0.015) and BW (-5.7 vs –1.6%, p < 0.0001) vs 
placebo after 32 weeks. AHI reduction was significantly associated with 
WL, irrespective of treatment. The reduction in AHI per %WL depended 
on baseline AHI, with reductions of 0.7, 1.4 and 2.8 events/h for base-
line AHI cohorts <30, 30–59 and ≥60 events/h, respectively (all groups, 
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provement in QoL endpoint measures, including the Epworth Sleepiness 
Scale (Fig), oxygen saturation and sleep architecture (change in total sleep 
time) (p < 0.01 for all). In conclusion, greater WL and improvement of 
AHI were more likely with liraglutide 3.0 mg than placebo. Greater im-
provements in sleep apnoea endpoints and QoL were significantly asso-
ciated with greater WL, irrespective of treatment. The safety profile for 
liraglutide 3.0 mg was generally consistent with that seen with liraglutide 
in type 2 diabetes.
Acknowledgement: Supported by Novo Nordisk
Fig. 1. Change in Epworth Sleepiness Scale score by weight change category
T8:OS1.4
High remission rate of prediabetes in patients after bariatric 
surgery
Brix J.M.1, Kopp H.P.1, Sperker C.2, Schernthaner G.H.3, Schernthaner G.1, 
Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria, 
2Department of Surgery, Rudolfstiftung Hospital Vienna, Vienna, Austria, 
3Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Introduction: A long term follow up of the Swedish Obese Subject study 
indicated a relative risk reduction for the development of diabetes by 80%. 
However, no data are available for patients with prediabetes. Therefore 
we investigated the remission of prediabetes after BS in a large cohort of 
patients with morbid obesity (MO).  
Methods: In total 404 patients with MO (mean age 41 ± 11 years, mean 
BMI 40.8 ± 16.1 kg/m˛) were included before and after BS. All patients 
with unknown type 2 diabetes (T2D) underwent an oral glucose tolerance 
test (OGTT; 75g glucose). The thresholds of diagnostic criteria for predi-
abetes were fasting plasma glucose (FPG) ≥100mg/dl and ≤126mg/dl or 2 
hour post-challenge glucose ≥140mg/dl and ≤200mg/dl. HOMA-Insulin 
resistance (IR) was calculated.  
Results: The prevalence of prediabetes was 23.5% (n=95). The prevalence 
of patients with normal glucose tolerance was 60.2% (n= 243) and of pa-
tients with T2D was 16.3% (n=66). Two years after BS the remission rate 
was 94% (89 patients with pre-surgery prediabetes were in remission, 
only 6 patients still had prediabetes). Patients with prediabetes before BS 
were significantly older (43 ± 11 vs 38 ± 10 years; p < 0.001), had higher 
triglyceride levels (173 ± 84 mg/dl vs 139 ± 64 mg/dl; p < 0.001), had a 
higher HOMA-IR (7.6 ± 4.9 vs 4.7 ± 2.8; p < 0.001). There weren’t any dif-
ferences in BMI. Interestingly the only difference in patients with predia-
betes compared to T2D was HOMA-IR (7.6 ± 4.9 vs 10.5 ± 6.8; p = 0.012). 
Conclusion: This is the first study evaluating prediabetes in a large cohort 
of patients before and after BS. Apart from a difference in HOMA-IR, we 
couldn’t find any significant differences in patients with prediabetes com-
pared to T2D, indicating that prediabetes could be important to assess in 
patients with MO.
T8:OS1.5
What is the effect of wine intake in type 2 diabetes and does 
the wine color matter? A 2-year randomized controlled trial
Shai I.1, Gepner Y.1, Golan R.1, Harman-Boehm I.1, Henkin Y.1, 
Schwarzfuchs D.1, Shelef I.1, Durst R.2, Liberty I.1, Ceglarek U.3, Stumvoll M.3, 
Blüher M.3, Thiery J.3, Rudich A.1, Stampfer M.4
1Ben-Gurion University of the Negev, Israel,  
2Hadassah Hebrew University Medical Center, Israel,  
3University of Leipzig, Germany,  
4Harvard School of Public Health, USA
Background: Recommendations for moderate alcohol consumption re-
mains controversial, particularly in type-2-Diabetes (T2D). Long-term 
randomized-controlled-trials (RCT) are lacking. 
Objective: To assess risk/cardiometabolic effects of initiating moderate 
alcohol in T2D, and if wine-type matters.  
Methods: In a 2-year RCT, 224 well-controlled alcohol-abstaining adult 
diabetics patients were randomized to mineral-water, white-wine and red-
wine (150ml/dinner/2-year). Wines and mineral-water were provided. All 
groups followed a non-calorie restricted Mediterranean diet.  
Results: Retention was 94% after one year and 87% after two. Red-wine 
was superior in modestly increasing HDL-c, and apoA1 with an overall 
decrease of cholesterol/HDL-c, triglycerides/HDL-c, and apoB100/apoA1 
ratios (p < 0·05 for all; vs. mineral-water). Both wine groups modestly 
improved glucose metabolism. Slow-ethanol-metabolizers [wild-type 
alcohol-dehydrogenase homozygotes; ADH1B*1] had favorable wine 
effects on glycemic control parameters as compared to fast-ethanol-me-
tabolizers [ADH1B*2(Arg48His; rs1229984) carriers]. Wine did not alter 
medication usage, blood pressure, or liver function biomarkers. Overall, 
decreased metabolic syndrome components were mainly attributed to 
red-wine (p = 0.039 vs. mineral-water]. 
Conclusions: This first long-term large scale alcohol trial suggests that ini-
tiating moderate wine intake, especially red-wine, among well-controlled 
T2D, and as part of healthy diet, is apparently safe and decreases car-
diometabolic risk. While the genetic interaction supports specific causal 
roles for ethanol, the red-wine's superiority suggests further synergy with 
non-alcoholic constituents. Clinical Trial Registration: NCT00784433
T8:OS1.6
Change in adipose fatty acid composition in obese diabetic 
women after bariatric surgery
Kunesova M.1,2, Sedlackova B.1, Bradnova O.1, Tvrzicka E.2, Stankova B.2, 
Sramkova P.3, Dolezalova K.3,4, Kalouskova P.1, Hlavaty P.1,3, Hill M.1, 
Fried M.3,4, Hainer V.1, Vrbikova J.1
1Institute of Endocrinology Obesity Management Centre, Prague, Czech Rep.,  
24th Dept. Internal Medicine, 1st Medical Faculty, Charles University, Prague, 
Czech Rep.,  
3OB clinic, Prague, Czech Rep.,  
41st Medical School, Charles University, Prague, Czech Rep.
Introduction: Bariatric surgery is the most effective method in obesity 
and type 2 diabetes management. Fatty acid composition of adipose tissue 
reflects composition of fat in food but also metabolic processing of fatty 
acids including oxidation and lipogenesis. Effect of different types of bar-
iatric surgery on fatty acid composition in subcutaneous adipose tissue 
was examined.  
Methods: Severely obese women underwent one of the three bariatric 
methods- biliopancreatic diversion (BPD), laparoscopic gastric banding 
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pometric characteristics and fatty acid composition of adipose tissue was 
analysed before the treatment, after 6 months and after 2 year follow up. 
Fatty acid (FA) composition was analysed by gas chromatography. Results 
were evaluated by bidirectional orthogonal projections to latent structures 
(O2PLS).  
Results: Women in BPD group (n=8), LAGB (n=9), LGCP (n=12) were 
not significantly different in age, basal weight and body fat per cent. The 
highest weight loss was found after BPD. Weight loss was predicted by 
higher decrease in alpha linolenic acid (18:3n-3) and n-3 polyunsat-
urated FA (PUFA) after 6 months and by lower decrease in n-6 PUFA 
-dihomogamma-linolenic (20:3n-6) and arachidonic (20:4n-6). In com-
parison with initial levels significant decrease in percentage of n-3 PUFA 
was found after 6 months (p < 0.05). After 2 years increase in percent-
age of monounsaturated FA (MFA), (p < 0.05) and decrease in n-6 PUFA 
(p < 0.05) in comparison with initial levels was found,  
Conclusion: Bariatric surgery lead to significant changes of fatty acid 
composition in adipose tissue in severely obese diabetic women after two 
year follow-up. Lower decrease of n-6 PUFA predicted higher weight loss.
Acknowledgement: Research relating to this abstract was funded by grant IGA NT-
13735-4 and MZ, 00023761 Ministry of Health Czech Rep.
T5:OS1 – Childhood Growth
T5:OS1.1
Pre and post-natal growth canalisation: Does prenatal growth 
predict the pattern of postnatal growth?
Norris T.1, Johnson W.2, Wright J.3, Cameron N.1
1School of Sport, Exercise & Health Sciences, Loughborough University, UK, 
2MRC Human Nutrition Research Unit, Cambridge, UK,  
3Bradford Institute for Health Research, Bradford, UK.
Introduction: Identify any evidence of weight growth tracking between 
intra & extra-uterine life and determine whether patterns of prenatal 
growth predict patterns of postnatal growth.  
Methods: Multilevel models were used to model fetal and postna-
tal growth from the Born in Bradford (BiB) cohort. Fitted values and 
Z-scores were produced at 20, 30, 40 prenatal weeks & 1, 3, 6, 9, 12, 24 
postnatal months. Restricted and rapid growth were defined as a change 
in conditional Z-score in the fetal period of <-0.67 and >0.67, respectively. 
Catch-down and catch-up growth were defined in the same way, except in 
the postnatal period. ANOVAs were used to test for differences in size and 
growth by type of prenatal growth. Log regression and a sensitivity and 
specificity analysis were employed to examine the predictive ability of the 
type of prenatal growth.  
Results: Infants experiencing restricted fetal growth remained signifi-
cantly lighter than those who had not, for the duration of infancy. In 
this group however, there was a pattern of greater growth than expected 
during infancy. This was opposite to the pattern observed in infants who 
had experienced rapid fetal growth, who exhibited less growth than ex-
pected during infancy. However, the ability of the type of prenatal growth 
to predict the pattern of postnatal growth was minimal, with only rapid 
fetal growth being significantly associated with increased odds of catch-
down growth in infancy.  
Conclusion: That neither restricted nor rapid fetal growth predicted 
postnatal catch-up growth may suggest that the timing of canalisation is 
outside of the fetal period. If infant catch-up and down growth are not 
associated with periods of restricted or rapid fetal growth, definitions of 
these growth patterns may need reconsidering.
T5:OS1.2
Growth trajectories of body mass index during childhood: 
Determinants and health outcome at adulthood
Péneau S.1, Gusto G.2, Goxe D.2, Lantieri O.2, Hercberg S.1,3,4, Rolland-
Cachera M.F.1
1Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle, 
Centre de Recherche en Epidémiologie et Statistiques, Inserm (U1153), 
Inra(U1125), Cnam, COMUE Sorbonne Paris Cité, F-93017 Bobigny,  
2Institut inter-Régional pour la Santé (IRSA), F-37520 La Riche, France.,  
3Unité de Surveillance et d’Epidémiologie Nutritionnelle, Institut de Veille 
Sanitaire, Université Paris 13 Sorbonne Paris Cité, F-93017, Bobigny, France,  
4Département de Santé Publique, Hôpital Avicenne, F-93017, Bobigny Cedex, 
France
Evidence is currently lacking concerning the development of BMI during 
childhood, as well as its determinants and health consequences at adult-
hood. Our aims were: to identify BMI trajectories between 0 and10 years 
of age; to assess their determinants; and to elucidate the association be-
tween these trajectories and metabolic risk factors at adulthood. A total of 
1,668 subjects aged 20–60 participated in this retrospective cohort study. 
Height, weight, waist circumference, fasting blood glucose and lipids and 
blood pressure were measured at adulthood. Growth was assessed using 
measured weight and height data from 0–10 years, collected retrospec-
tively from health booklets. Participants reported gestational age, birth 
weight, early nutrition and parental silhouette. Group-based trajectory 
modelling was applied to identify BMI trajectories. Associations were 
assessed using ANOVA and multiple logistic regression. Six distinct pat-
terns of growth trajectory emerged, including three stable (stable-25th, 
stable-50th, stable-75th) and three ascending (ascending-75th, ascend-
ing-overweight, ascending-obesity) trajectories. Determinants of growth 
trajectory were sex, parental silhouette, gestational age and birth weight 
(all P < 0.001). Trajectory groups were associated with adult BMI and 
waist circumference (P < 0.0001). Subjects in the ascending-overweight 
(OR (95%CI): 2.71 (1.50–4.90)) and ascending-obesity (OR (95%CI): 
3.35 (1.16–9.62)) groups were more likely to present metabolic syndrome 
during adulthood. This study enabled us to illustrate heterogeneity in pat-
terns of growth trajectories. Child and parental determinants were iden-
tified that can be used in overweight surveillance. Trajectories were as-
sociated with BMI, waist circumference and metabolic syndrome during 
adulthood.
T5:OS1.3
Higher childhood BMI is associated with less pubertal gain
Holmgren A.1, 2, Niklasson A.1, Nierop A.F.3, Gelander L.1, Aronson A.S.2, 
Sjöberg A.4, Lissner L.5, Albertsson-Wikland K.6
1GPGRC, Dep. of Pediatrics, Inst. of Clinical Sciences, Sahlgrenska Academy, 
Gothenburg, Sweden,  
2Dep. of Pediatrics, Halmstad County Hospital, Halmstad, Sweden,  
3Muvara bv, Leiderdorp, The Netherlands,  
4Dep. of Food & Nutrition, & Sport Science, University of Gothenburg, 
Gothenburg, Sweden,  
5Dep. of Public Health & Community Medicine, Inst. of Medicine, The 
Sahlgrenska Academy, Gothenburg, Sweden,  
6Dep. of Physiology, Div. of Endocrinology, Inst. of Neuroscience & Physiology, 
The Sahlgrenska Academy, Gothenburg, Sweden
Objective: Our objective was to investigate the impact of body mass index 
(BMI) in childhood on the pattern of growth during puberty. 
Methods: The longitudinally followed Grow up 1990 Gothenburg birth 
cohort, with growth data from birth until adult height was analyzed, using 
the QEPS growth model (describing total height as a combination of four 
mathematical functions; Quadratic -Q, Exponential -E, Pubertal -P and 
Stop –S, Fig 1.), for calculation of estimates for pubertal growth (1). Indi-
vidual BMI-SDS values, from 3.5–8 years of age (n = 1908) were calculated 
for linear and subgroup analyses (low/normal- nw, overweight – ow, obese 
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Results: Ow/ob children already at birth were heavier and grew faster in 
height in the pre pubertal period compared to nw, due to an increased Q 
function. Ow/ob children of both genders had 3.4–4.3 months earlier pu-
berty, reduced growth during puberty, boys and girls had 3 cm and 2 cm, 
respectively, less pubertal gain from the specific pubertal growth function 
(P) compared to their nw peers. We saw a negative dose-response effect 
of childhood BMI on pubertal gain, across the whole BMI spectrum (Fig 
2–3.). The adult height was not related to BMI in childhood. 
Conclusion: For the first time, the result of the present study has shown 
that; the higher the BMI is in childhood, the less is the pubertal gain. 
Higher childhood BMI was also associated with increased pre pubertal 
growth due to an increased Q-function and the resulting adult height was 
similar for ow/ob and nw children.
Reference 
1. Holmgren A et al.: Horm. res. in paed. 2013;80(suppl. 1):177.
Fig. 1. The QEPS-model. The total height (T) is the sum of four growth functions: a 
quadratic growth function (Q), a negative exponential growth function (E), a pu-
bertal growth function (P) and a stop function (S). B =birth, C =about 6 weeks after 
conception. Birth, onset and end of pubertal growth are marked with vertical lines.
Fig. 2. Boxplot for Pmax of low/normal, overweight and obese boys. Pubertal gain 
as Pmax (the pubertal part of the total growth during puberty) related to the 
highest individual BMI SDS at 3.5–8 years of age. Showing the distribution for nw, 
ow and ob boys, withmean values of; 17.8, 15.2 and 12.6 cm.
Fig. 3. Boxplot for Pmax of low/normal, overweight and obese girls. Pubertal gain 
as Pmax (the pubertal part of the total growth during puberty) related to the 
highest individual BMI SDS at 3.5–8 years of age. Showing the distribution for nw, 
ow and ob girls, with mean values of; 13.5, 11.8 and 9.9 cm.
T5:OS1.4
Impact of long-chain polyunsaturated fatty acids during 
pregnancy and lactation on infant body composition up to 5 
years of life – results of the infat-study
Brei C.1, Brunner S.1, Pusch K.1, Much D.1,2, Stecher L.1, Amann-Gassner U.1, 
Hauner H.1,3
1Institute for Nutritional Medicine, Klinikum rechts der Isar, Technische 
Universität München, Munich, Germany,  
2Institute of Diabetes Research, Helmholtz Zentrum München, and 
Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität 
München, Munich, Germany,  
3ZIEL – Research Center for Nutrition and Food Science, Nutritional Medicine 
Unit, Technische Universität München, Freising, Germany
Aim: The ratio of long-chain polyunsaturated fatty acids (LCPUFAs) in 
the maternal diet may have an impact on offspring body composition. 
The effect of reducing the n-6/n-3 LCPUFA ratio in maternal diet during 
pregnancy and lactation on offspring growth and body composition up to 
5 years postpartum (pp) was investigated.  
Methods: In an open-label, randomized controlled trial, 208 healthy preg-
nant women received a dietary intervention (supplementation of 1.2g n-3 
LCPUFAs/day and dietary counseling to reduce arachidonic acid intake) 
from the 15th week of gestation until 4 months of lactation (intervention 
group) or follow their habitual diet (control group). We investigated infant 
fat mass with skinfold thickness (SFT) and abdominal sonographic mea-
surements and child growth. For comparison, multiple linear regression 
models adjusting for sex, pregnancy duration, ponderal index at birth and 
breastfeeding status at 4 months were performed.  
Results: At 5 years of age, anthropometric data of n=114 infants were 
available.  
Results: showed no difference between groups, neither for the sum of 4 
SFT [intervention: 23.9 ± 4.7mm; control: 24.5 ± 5.0mm; mean differ-
ence: –0.7mm (95% CI: –2.5; 1.1mm); p = 0.453], nor for other anthropo-
metric measurements. Findings are consistent with results at earlier time-
points except for BMI at 4 years pp. Sonographic data were analyzed up 
to 4 years: area of subcutaneous fat layers differed significantly at 2 and 4 
years pp in the adjusted model, showing slightly higher rates in the control 
group. Preperitoneal fat did not differ significantly between groups at any 
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Conclusion: Results do not provide evidence that a dietary intervention 
to reduce the n-6/n-3 ratio during early life relevantly affects fat mass in 
the offspring.
T5:OS1.5
Early growth patterns in normal weight and overweight 
pre-school children from different socioeconomic and ethnic 
background: Results from the abcd-study
Luykx D.D.1, Oostvogels A.J.1, Vrijkotte T.G.1
1Department of Public Health, Academic Medical Center, University of 
Amsterdam, Amsterdam, the Netherlands
Introduction: Children with a low socioeconomic status (SES) or from 
non-Western origin are at increased risk for overweight. We explored ear-
ly growth patterns of children from different SES and ethnic background, 
who became overweight at age 5.  
Methods: Term born singletons without fetal growth retardation were in-
cluded (n=3387). Weight status at age 5 was determined by international 
guidelines. BMI-SDS growth patterns between birth and 5 years were cre-
ated using LMS method and compared between normal and overweight 
children, stratified by ethnicity (Western/non-Western) and SES (low/
mid/high maternal education level, only Western included, n=2437).  
Results: At age 5 years, 12.1% of the children were overweight. This was 
higher in non-Western (23.5%) and low SES children (16.3%). Growth 
patterns of normal weight and overweight children at age 5 differed from 
birth onwards (p < 0.001). Overweight children had a high birth weight 
and a relative large increase in BMI-SDS during the first 6 months. Differ-
ences in the overall growth pattern of Western and non-Western children 
were both found for normal weight (p < 0.001) and overweight children 
(p < 0.001). BMI-SDS of non-Western normal weight children was signifi-
cantly higher on almost all ages compared to Western normal weight chil-
dren. The overweight non-Western children had only a higher BMI-SDS 
at birth (Δ:0.233, p = 0.044 and 3 months (Δ:0.221, p = 0.021) compared 
to overweight Western children. A difference in the overall growth pat-
terns by SES was only apparent in overweight children (p = 0.003). Over-
weight low SES children had a significantly higher mean BMI-SDS at age 5 
compared to overweight high SES children (ΔBMI-SDS:0.431, p = 0.010). 
Conclusion: Overall BMI growth patterns of normal weight and over-
weight children at age 5 differ from birth onwards. Intervention strategies 
to prevent childhood overweight should focus on children with high birth 
weight and early accelerated growth, especially from non-Western origin.
Fig. 1. Patterns of mean BMI-SDS in normal weight and overweight pre-school chil-
dren by ethnicity.
T5:OS1.6
Concurrent stunting and obesity in children aged 2.0 – 4.9 
Years in indonesia: The double burden of malnutrition
Rachmi C.N.1, Agho K.E.2, Li M.3, Baur L.A.1, 3
1The Children’s Hospital at Westmead Clinical School, University of Sydney, 
Sydney, Australia.,  
2School of Science and Health, University of Western Sydney, Sydney, Australia.,  
3School of Public Health, The University of Sydney, Sydney, Australia.
Introduction: The prevalence of obesity has risen in low and middle-in-
come countries. This study aimed to determine: a) temporal trends in the 
prevalence of underweight, stunting, and at risk of overweight/obesity 
in young Indonesian children; and b) whether those who are stunted are 
at greater risk of being overweight/obese compared to those of healthy 
height.  
Methods: This was a repeated cross sectional study of children aged 2.0–
4.9 years in waves 1 (1993), 2 (1997), 3 (2000), and 4 (2007) of the Indone-
sian Family Life Survey, a nationally representative survey of households 
involving questionnaires and anthropometric measurements. Height/
length, weight and BMI were expressed as z-scores (2006 WHO Child 
Growth Standards). A weight-for-age-z-score <-2 was categorised as un-
derweight, height-for-age-z-score <-2 as stunted, and BMI-z-score >+1, 
>+2, >+3 as at risk, overweight and obese, respectively.  
Results: There were 1385, 1461, 2089, and 2676 separate children aged 
2.0–4.9 years in the four waves, respectively. The prevalence of stunting 
decreased from waves 1 to 4: from 50.1% (95% CI: 47.5–52.7) to 35.7% 
(95% CI: 33.9–37.5) (P <0.01) – as did the prevalence of underweight – 
from 33.8% (95% CI: 31.3–36.3) to 20.9% (95% CI: 19.4–22.5) (P <0.01). 
In contrast, the prevalence of ‘at risk’/overweight/obesity increased from 
10.8% (95% CI: 9.2–12.5) to 17.6% (95% CI: 16.2–19.1) (P <0.01). At all 
time points, those who were stunted were significantly more likely to be ‘at 
risk’ of overweight/obese compared to those of healthy height (odds ratio 
1.35 to 2.28) (P <0.05).  
Conclusion: There is strong evidence that the double burden of malnutri-
tion occurs in Indonesian children. A coordinated approach to overcome 
both chronic under-nutrition and over-nutrition is required.
Friday, 8 May, 2015
T6/T7:OS2 – Drivers of Difference
T6/T7:OS2.1 
Living at higher altitude and incidence of overweight/obesity: 
Prospective analysis of the SUN cohort
Bes-Rastrollo M.1 2, Diaz-Gutierrez J.1, Pons-Izquierdo J.J.3,  
Donat-Vargas C.1, Sayon-Orea C.4, Martinez-Gonzalez M.A.1 2
1Dept. Preventive Medicine and Public Health, University of Navarra, Pamplona, 
Spain, 
2CIBERobn, Instituto de Salud Carlos III, Madrid, Spain, ‘ 
3Dept. History, Art History, and Geography, University of Navarra, Pamplona, 
Spain,  
4Dept. Preventive Medicine, Complejo Hospitalario de Navarra, Pamplona, Spain
Introduction: Residence at high altitude has been associated with lower 
obesity rates due to hypoxia conditions. However, there is no evidence of 
this association in a free-living population. Therefore, our objective was to 
assess the association between the altitude where each participant of the 
SUN Project is living and the incidence of overweight/obesity.  
Methods: The SUN Project is a dynamic, prospective, multipurpose co-
hort of Spanish university graduates with a retention rate of 90%. We 
included in the analysis 9,302 participants free of overweight/obesity at 
baseline. At the baseline questionnaire participants report their postal 
code and the time they are been living in their city/village. We imputed 
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tional Cartographic Institute and categorized participants in tertiles. We 
used Cox regression models to adjust for potential confounding variables. 
Results: During a median follow-up of 8.5 years, we identified 2,099 in-
cident cases of overweight/obesity. After adjusting for age, sex, baseline 
body mass index, time of residence, physical activity (quartiles), sedentary 
behaviours (quartiles), smoking (non-smokers, current smokers, former 
smokers), snacking, follow a special diet, total energy intake, and adher-
ence to the Mediterranean dietary pattern, those participants in the third 
tertile (>456 m) exhibited a statistically significant 13% reduction risk for 
the development of overweight/obesity in comparison to those in the first 
tertile (<124 m) (adjusted HR: 0.87; 95% CI: 0.77–0.98).  
Conclusion: Living in cities of higher altitude was associated with a lower 
risk of developing overweight/obesity in a cohort of Spanish university 
graduates.
Acknowledgement: The SUN Project is funded by the Spanish Government and the 
Regional Government of Navarra.
T6/T7:OS2.2
Does the importance of dietary costs for fruit and vegetable 
intake vary by socioeconomic position?
Mackenbach J.D.1, Monsivais P.2
1Department of Epidemiology and Biostatistics, EMGO Institute for Health and 
Care Research, VU University Medical Center, Amsterdam, the Netherlands,  
2Centre for Diet and Activity Research, University of Cambridge School of 
Clinical Medicine, Institute of Metabolic Science, Cambridge Biomedical 
Campus, Medical Research Council Epidemiology Unit, Cambridge, UK
Introduction: Lower intake of fruit and vegetables (F&V) among popu-
lations of low socioeconomic position (SEP) has been attributed to lower 
psychological, behavioural, social and material resources. Dietary cost 
may be a stronger determinant of F&V intake in low-SEP groups than in 
higher-SEP groups. The aim of this study was to examine the association 
between F&V intake and dietary costs, testing for effect modification by 
SEP.  
Methods: We used data from the Fenland Study, a population based, 
cross-sectional study of 10,020 British adults. F&V intake was derived 
from a semi-quantitative 130 item Food Frequency Questionnaire (FFQ). 
Retail food prices for each of the foods in the FFQ were combined with 
intake to estimate dietary costs (GBP/day). General linear models were 
used to assess associations between SEP, quartiles of dietary costs, and 
F&V intake. Effect modification of SEP gradients (based on education and 
income) by dietary costs was examined with interaction terms.  
Results: Individuals in the lowest quartile of dietary costs, with low in-
come and low education consumed less F&V than individuals with higher 
dietary costs, high income or education. There was significant interac-
tion between SEP and dietary costs, such that socioeconomic differences 
in F&V intake were magnified among individuals who consumed low-
est-cost diets.  
Conclusion: Amplification of socioeconomic inequalities in diet among 
those consuming low-cost diets indicates the need to address food costs in 
strategies to promote healthy diets. The lack of socioeconomic inequalities 
for individuals on high dietary costs suggests that high dietary costs may 
compensate for lack of other resources such as nutrition knowledge or 
attitudes towards healthy eating.
T6/T7:OS2.3
Neighbourhood built environment typologies and adiposity 
in school age children
Barnett T.A.1,2, Van Hulst A.2,3, Kestens Y.3, Chaix B.4,5, Henderson M.2,3
1Epidemiology and Biostatistics Unit, INRS-Institut Armand-Frappier, Université 
du Québec, Laval, QC, Canada 1,  
2Centre de recherche du CHU Sainte-Justine, Montreal, Canada,  
3École de santé publique de l’Université de Montréal, Montreal, Canada, 
4Inserm, Paris, France,  
5Université Pierre et Marie Curie-Paris6, UMR-S 707, Paris, France, 6Department 
of Pediatrics, Université de Montréal, Montreal, Canada
Background: Neighborhoods are complex multidimensional systems. 
However, the interrelation between multiple neighborhood dimensions is 
seldom taken into account in relation to childhood adiposity. We created 
a neighborhood typology using a wide range of built environment features 
and examined associations with adiposity in children aged 8–10 years.  
Methods: Data include 512 Montreal-area youth from the first wave of 
QUALITY, an ongoing study on the natural history of obesity in 630 
Quebec youth (8–10 years at baseline) with a history of parental obesi-
ty. Anthropometrics and body composition based on dual energy x-ray 
absorptiometry were obtained. Multiple neighborhood features obtained 
through in-person neighborhood assessments and geocoded adminis-
trative data were summarized using principal components analysis, and 
contrasting neighborhood types were identified using cluster analysis. We 
examined associations between specific neighborhood typologies and in-
dicators of total (body mass index z-score and fat mass index) and central 
(waist circumference and central fat mass %) adiposity using multivari-
able linear regressions.  
Results: Cluster analysis resulted in a 5 distinct neighborhood types char-
acterized by high, moderate or low levels of walkability and safety from 
vehicular traffic. Children living in neighborhoods characterized by lower 
levels of safety from vehicular traffic had significantly higher levels of both 
overall and central adiposity. 
Conclusions: Neighborhoods characterized by heavy road traffic with 
fewer traffic calming measures appear to be the most obesogenic to chil-
dren, regardless of other features that are associated with walkability. Pol-
icies targeting the improved walkability of neighborhoods for children 
may need to prioritize safety from vehicular traffic. 
Acknowledgement: The QUALITY cohort is funded by the Canadian Institutes of 
Health Research, the Heart and Stroke Foundation of Canada and the Fonds de la 
recherche en santé du Québec. The QUALITY Residential study was funded by the 
Heart and Stroke Foundation of Canada.
T6/T7:OS2.4
Obesity as a predictor of impaired physical performance in 
the elderly: Results of a longitudinal epidemiological study.
De Stefano F.1, Zambon, S.1, Giacometti L.1, Benvegnů, L.1, Pigozzo, S.1, 
Marin R.1, Manzato E.1, Busetto L.1
1Medical department- DIMED University of Padova, Italy
Aim: To evaluate the influence of obesity on muscle strength and physical 
performance, in a follow-up of 6 years.  
Methods: 2911 Italian subjects aged ≥65 years from the Progetto Veneto 
Anziani (ProVA), were analyzed. Physical performance, and leg muscu-
lar strength were measured both at baseline and at the end of follow-up. 
Study population was stratified by six BMI classes in according with who 
classification of obesity. Associations between BMI physical performance 
and muscular strength were evaluated.  
Results: At baseline the normal weight subjects had the best results in tests 
of physical performance (8:29 ± 0.03), with significant differences com-
pared with underweight (7:50 ± 0:15, P <0.001), overweight (8:12 ± 0.02, 
p <0.001), obese I level (7.72 ± 0:04, P <0.001), obese II level (6.67 ± 0:09, 
P <0.001) and obese III level (5.88 ± 0:24, P <0.001). This association 
was not modified by further adjustment for leg muscular strength, age, 
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At the end of follow-up, a statistically significant reduction in physical 
performance and muscle strength was observed in underweight, normal 
weight, overweight, I and II obese subjects, while in obese III level there 
was a statistically significant reduction only in physical performance and 
not in muscle strength. In a multiple logistic analysis, adjusting for age, 
sex, smoking, income, education, physical activity and chronic disease, 
a significant increased risk of a statistically significant reduction in SPPB 
test was observed for overweight and obese subjects.  
Conclusion: In our elderly population, high BMI values affect negatively 
physical performance and expose the elderly to a risk of a further decline 
in physical performance with consequent disability
T6/T7:OS2.5
Effect modification by obesity on the association between 
serum 25(OH)D and blood pressure: Results from NHANES 
2001–2006
Vogt S.1, Baumert J.1, Thorand B.1, Scragg R.2
1Institute of Epidemiology II, Helmholtz Zentrum München, German Research 
Center for Environmental Health, Neuherberg, Germany,  
2Section of Epidemiology and Biostatistics, School of Population Health, 
University of Auckland, Auckland, New Zealand
Introduction: The joint effect of low 25(OH)D levels and obesity on hy-
pertension has rarely been examined. We explored a possible effect mod-
ification by obesity on the association between 25(OH)D and blood pres-
sure in participants of the US National Health and Nutrition Examination 
Surveys (NHANES) 2001–2006.  
Methods: The present study included 10 313 participants aged ≥ 20 years. 
The association of serum 25(OH)D [ng/mL] with systolic and diastolic 
blood pressure was examined with linear regression. All models were 
adjusted for age, sex, ethnicity, physical activity, alcohol consumption, 
smoking status, education, diabetes and kidney disease and prescribed 
medication for hypertension. Additive interaction was assessed through 
a cross-product interaction term between 25(OH)D and body mass index 
[BMI] as well as waist circumference [WC] category (overweight: BMI of 
25 – 30 kg/m˛ / WC of 80 – 88 cm in females or 94 – 102 cm in males; 
obesity: BMI ≥ 30 kg/m˛ / WC ≥ 88 cm in females or ≥ 102 cm in males). 
Results: 25(OH)D was significantly inversely associated with both systolic 
and diastolic blood pressure in obese but not in non-obese participants. 
While the interaction between 25(OH)D and overweight was not signifi-
cant in any of the models, a significant interaction between 25(OH)D and 
obesity was found in the systolic blood pressure models (BMI: β = -0.15, 
p-value = 0.006; WC: β = -0.14, p-value = 0.004) as well as a smaller, 
non-significant interaction in the diastolic blood pressure models (BMI: 
β = -0.09, p-value = 0.03; WC: β = -0.03, p-value = 0.42).  
Conclusion: Results from this large, cross-sectional sample indicate that 
obesity modifies the association between 25(OH)D and blood pressure, 
suggesting a stronger association with 25(OH)D in obese participants.
T6/T7:OS2.6
Are aga-born obese adults more metabolically healhty than 
sga-born obese individuals?
Matta J.1, Carette C.2, Comte B.3,4, Levy-Marchal C.5, Pujos-Guillot E.3,4, 
Zins M.1, Czernichow S.1
1Inserm UMS 011 Villejuif, France,  
2Department of Nutrition Ambroise Pare University Hospital, Boulogne, France,  
3UMR 1019 Human Nutrition Unit, CRNH Auvergne, Clairmont-Ferrand, France,  
4Universite d'Auvergne, Clairmont Universite, 63122 Saint-Genes, Champanelle, 
France, 5INSERM Institute of Public Health, Paris, France
Introduction: Recently it has been shown that not all obese individuals 
display cardiometabolic abnormalities and a “metabolically healthy obese 
(MHO)” phenotype has been sought. No data on the inverse favorable risk 
of MHO in adults born appropriate for gestational age (AGA) compared 
to adults born small for gestational age (SGA) exist. Objective: Assess the 
risk of metabolically healthy obesity in AGA versus SGA.  
Methods: Individuals were derived from a registry in the city of Haguenau, 
France. 132 out of 1,308 participants aged 29.5 ± 4.1 years were identified 
as obese (BMI≥30 kg/m˛) and were divided into two groups: SGA (n=74) 
and AGA (n=58). Metabolic variables such as total cholesterol, HDL-cho-
lesterol, triglycerides, fasting glucose, insulin and blood pressure were ob-
tained and compared by t-test. MHO phenotype was determined using 
the HOMA-IR index which requires determination of fasting plasma glu-
cose and insulin concentrations. Relative risk (RR) and 95% CI was com-
puted for the probability of metabolically healthy obesity in AGA versus 
SGA after correction for age, sex and socioeconomic status.  
Results: SGA obese subjects had higher total cholesterol levels (4.9 ± 1.5 
vs. 4.2 ± 1.5, p = 0.03) and fasting insulin levels (11.0 ± 4.5 vs. 9.4 ± 3.8, 
p = 0.04) compared to AGA obese subjects. AGA obese group had a high-
er favorable risk of metabolic healthy obesity versus SGA obese group 
RR=1.95 (95% CI 1.06–3.58) independently of age, sex and socioeconom-
ic status.  
Conclusion: Appropriateness for gestational age confers a higher favor-
able risk of metabolically healthy obesity compared to smallness for ges-
tational age.
Acknowledgement: Funding: Fondation Francophone pour la Recherche sur le 
Diabčte
T3:OS2 – Macro and Micro Nutrients
T3:OS2.1
Association of high dietary protein intake with the risk 
of weight gain and total death in subjects at high risk of 
cardiovascular disease
Hernández-Alonso P.1, Salas-Salvadó J.1,2, Ruiz-Canela M.2, Corella D.2, 
Estruch R.2, Fitó M.2, Arós F.2, Gómez-Gracia E.2, Fiol M.3, Lapetra J.4, 
Basora J.2, Serra-Majem L.5, Muńoz M.Á.6, Buil-Cosiales P.2, Saiz C.2, 
Bulló M.1,2
1Human Nutrition Unit-URV-IISPV, Spain,  
2CIBERobn-ISCIII, Spain,  
3Institute of Health Sciences-UIB, Spain,  
4Department of Family Medicine-San Pablo Health Center, Spain,  
5Department of Clinical Sciences-ULPGC, Spain,  
6Primary Health Care Division and Research-IDIBAPS-Jordi Gol, Spain
Introduction: Although diets high in dietary protein are widely used to 
manage overweight and obesity, there is a lack of consensus about their 
long-term efficacy and safety. The aim of this study was to simultaneous-
ly assess the association of long-term high-protein consumption on body 
weight changes and death outcomes in subjects at high cardiovascular 
risk.  
Methods: A secondary analysis of the PREDIMED (PREvención con DIe-
ta MEDiterránea) trial was conducted. Dietary protein was assessed using 
a food-frequency questionnaire during the follow-up. Cox proportional 
hazard models, including macronutrient substitution models, were used 
to calculate the multivariate relative risk of protein intake in body weight 
and waist circumference changes, and the incidence of cardiovascular out-
comes, total, cardiovascular and cancer death.  
Results: Higher total protein intake was significantly associated with a 
greater risk of weight gain when protein replaced carbohydrates (HR: 
1.90; 95%CI: 1.05, 3.46) but not when replaced fat (HR: 1.69; 95%CI: 0.94, 
3.03). However, no association was found between protein intake and 
waist circumference. Contrary, higher total protein intake was associated 
with a greater risk of all-cause death in both carbohydrate and fat substitu-
tion models (HR: 1.59; 95%CI: 1.08, 2.35; and HR: 1.66; 95%CI: 1.13, 2.43, 
respectively). Animal protein was associated with an increased risk of fatal 
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Conclusion: Higher dietary protein intake is associated with long-term 
increased risk of body weight gain and overall death in a Mediterranean 
population at high cardiovascular risk.
Acknowledgement: The authors thank the participants for their enthusiastic collab-
oration and the PREDIMED personnel.
T3:OS2.2
Micronutrient and protein deficiencies after gastric bypass 
and sleeve gastrectomy: A one year follow-up
Aron-Wisnewsky J.1,2,3, Verger E.1,3, Dao M.1,3, Kayser B.1,3, Oppert J.1, 
Bouillot J.4, Torciva A.5, Clement K.1, 2, 3
11Institute of Cardiometabolism and Nutrition, ICAN, Assistance Publique-
Hôpitaux de Paris, Pitié-Salpętričre hospital, Nutrition department, F-75013, 
Paris, France,  
2Sorbonne Universités, UPMC University Paris 06, UMRS 1166 I, ICAN, Nutriomics 
team, F-75005, Paris, France,  
3INSERM, UMRS U1166, Nutriomics team, F-75013, Paris, France,  
4Assistance Publique-Hôpitaux de Paris, Visceral surgery Department, Ambroise 
Paré Hospital, 92100 Boulogne-Billancourt, France,  
5Assistance Publique-Hôpitaux de Paris, Visceral surgery Department, Pitié-
Salpętričre hospital, F-75013, Paris, France
Background: Roux-en-Y gastric bypass (GBP) and sleeve gastrectomy 
(SG) have increased dramatically, potentially increasing nutritional de-
ficiencies prevalence even in purely restrictive procedures. Objective: 
analyze the effect of food restriction through bariatric surgery (BS) on 
nutritional parameters. Design: 23 and 29 obese patients undergoing GBP 
and SG were prospectively followed at baseline and3, 6 and 12 months 
after BS (N=14 and N=19 at T12). We evaluated food intake both using 
both a self-administered web-based 24h dietary record, and the PANDiet 
score (T0, T3, T12), as well as measured serum vitamins and minerals 
concentration (T0, T3, T6, T12).  
Results: We observed suboptimal food intakes with low probabilities of 
adequacy for protein, fiber, vitamin D and magnesium at T0. The drastic 
energy and food reduction lead to very low and similar probabilities of 
adequacy for nutrients at T3 and T12 in both procedures. Serum analyses 
demonstrated a continuous decrease in prealbumin along the follow-up 
indicating moderate protein malnutrition in 30% and 35% of GBP pa-
tients and 48% and 75% of SG patients, respectively at T3 and T12. Con-
versely, despite the low probabilities of adequacy observed at T3 and T12, 
systematic vitamin and mineral supplementation after GBP and SG pre-
vented most nutritional deficiencies except for iron, where 5% of patients 
displayed iron deficiency at T12 in both procedures.  
Conclusion: GBP and SG have comparable effects in terms of energy and 
food restriction, and risk of micronutrient and protein deficiencies in the 
first year post BS. Such results suggest that (i) cautious monitoring of pro-
tein intake after GPB and SG is mandatory and (ii) systematic vitamin 
and mineral supplementation in the first year after SG may be beneficial.
Acknowledgement: CRC fibrota valetine lemoine for technical help and agathe ar-
loti as project manager
T3:OS2.3
Serum vitamin d levels in middle-aged women predict lasting 
stable differences in BMI and waist-hip ratio: Follow-up over 
three decades
Lehtinen-Jacks S.1,2, Leu M.2, Hunsberger M.2, Zetterberg H.3,4, Lissner L.2
1School of Health Sciences, University of Tampere, Tampere, Finland,  
2Department of Public Health and Community Medicine, Institute of Medicine, 
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,  
3Department of Psychiatry and Neurochemistry, Institute of Neuroscience a 
Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 
Sweden,  
4UCL Institute of Neurology, Queen Square, London, United Kingdom
Introduction: The chronology of the association between low serum 
vitamin D (25(OH)D) and obesity is unclear. We assessed 25(OH)D in 
relation to longitudinal development of BMI, waist-hip ratio (WHR) and 
height in 38–60 year old women for up to 35 years.  
Methods: The Population Study of Women in Gothenburg started in 
1968/69 in Gothenburg, Sweden. Anthropometric measures were tak-
en at baseline and at 4 follow-up visits; the latest in 2000/03. Levels of 
25(OH)D were analyzed in serum drawn and stored since the baseline 
in 1227 (84%) women. Linear regression and repeated measures models 
(SAS PROC MIXED), respectively, were used to model the baseline and 
the longitudinal associations between 25(OH)D (dichotomized, cutpoint 
51.45 nmol/L) and BMI, WHR and height, adjusting for covariates.  
Results: At baseline, mean BMI was 25.2 kg/m2 in women with low 
25(OH)D and 23.8 kg/m2 in the other women (p < 0.001). The respec-
tive figures for WHR were 0.75 and 0.74 (p < 0.001). Adjusted for covari-
ates, low 25(OH)D was associated with higher BMI at baseline (β=1.45, 
95%CI 0.97;1.92) and in the longitudinal analyses at all visits (β=1.47, 
95%CI 0.99;1.94). When considering only the follow-up visits adjusted for 
baseline BMI, the association was negligible (β=0.01, 95%CI –0.27;0.24). 
Similarly, low 25(OH)D was associated with higher WHR at baseline 
(β=0.012, 95%CI 0.006;0.019) and longitudinally when all visits were in-
cluded (β=0.011, 95%CI 0.005;0.018), but not when baseline WHR was 
taken into account in the repeated measures model (β=-0.001, 95%CI 
–0.007;0.005). No differences in height were observed at baseline or lon-
gitudinally.  
Conclusion: Lower 25(OH)D was associated with higher BMI and WHR 
at baseline and this difference was maintained (but not increased) over the 
35-year follow-up.
T3:OS2.4
Carbohydrate quantity and quality in relation to body 
composition among children and adolescents in South China
Liu Y.1, Luo J.1, Tian G.1, Duan R.1, Yang M.1, Xue H.1, Cheng G.1
1Department of nutrition, food safety and toxicology, West China School of 
Public Health, Sichuan University, Chengdu, P.R. China
Introduction: It has been suggested that both quantity and quality of car-
bohydrate have profound effects on long-term health. We aimed to inves-
tigate the relation of dietary carbohydrate quantity and quality to body 
composition among Chinese children and adolescents, who habitually 
have high carbohydrate consumption, along with an increasing preva-
lence of obesity.  
Methods: Cross-sectional data on 1721 Chinese children (52.7% girls) 
aged 7–15 years were analyzed. Using 3-day 24 hour dietary recalls, total 
carbohydrate intake and carbohydrate quality characterized with dietary 
fiber, the glycemic index (GI) and the glycemic load (GL) were consid-
ered. Body weight, height as well as skin-fold thicknesses were measured 
to obtain body mass index standard deviation score (BMI SDS), percent-
age body fat (%BF), fat mass index (FMI) and fat-free mass index (FFMI), 
as measures of body composition in the present study. Multivariate lin-
ear regression models were used to explore the relevance of carbohydrate 
quantity and quality to body composition.  
Results: Among girls, fiber intake and dietary GI were related to %BF 
and FMI (p≤0.04): girls with lower fiber intake or higher dietary GI had 
8.9% or 15.2% higher %BF and 9.5% or 12.7% higher FMI than girls with 
higher fiber intake or lower dietary GI (adjusted for birth weight, ma-
ternal overweight and physical activity). Furthermore, these associations 
were more pronounced in girls aged 10–12 years. Among boys, higher 
carbohydrate intake and higher dietary GL were positively related to BMI 
SDS (p≤0.03; adjusted for birth weight, maternal educational level, and 
physical activity).  
Conclusion: Our data suggest that high carbohydrate quality is positively 
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T3:OS2.5
No differences in appetite sensations after animal protein 
(pork/veal, eggs) vs vegetable protein (beans/peas) when 
adjusting for dietary fibre
Klingenberg L.1, Kristensen M.D.1, Belza A.2, Bendsen N.2, Astrup A.1, 
Raben A.1
1Department of Nutrition, Exercise and Sports, University of Copenhagen, 
Denmark,  
2Novo Nordisk A/S, Denmark
Introduction: There is no consensus yet on whether appetite sensations 
differ between animal and vegetable protein.The aim of this study was to 
investigate if meals with vegetable protein affect appetite sensations and 
ad libitum energy intake differently compared to isocaloric meals with an-
imal protein and similar amounts of macronutrients.  
Methods: In a randomized, controlled, single-blinded, 4-way crossover 
study on 33 healthy males (mean±SD age: 25.8 ± 5.1 y; BMI: 23.2 ± 1.9 kg/
m2) appetite sensations and spontaneous energy intake were studied on 
separate occasions using four different tests meals (3.5 MJ, 18.5 E% from 
protein). Meals consisted of pork/veal, fava beans/split peas, eggs adjusted 
for dietary fibres (28.5 g), or eggs without adjustment for dietary fibres 
(6.0 g). Appetite sensations were recorded at baseline and every half hour 
using visual analogue scales until the ad libitum meal.  
Results: There were no significant differences in subjective appetite sensa-
tions or ad libitum intake after vegetable or animal protein sources. How-
ever, spontaneous energy intake was lower after egg with fibre compared 
to egg alone (247 ± 175 kJ, P < 0.05). Further, tendencies were observed 
towards higher satiety following egg with fibre compared to egg alone and 
decreased hunger sensations after egg with fibre compared to pork/veal 
(p < 0.1).  
Conclusion: Vegetable and animal protein did not affect appetite sensa-
tions or spontaneous energy intake differently, when adjusting for dietary 
fibre content.
Acknowledgement: We thank the kitchen staff at NEXS and the volunteers for their 
participation
T3:OS2.6
No effect of glycemic index (low vs. High) on ghrelin and 
leptin in obesity
Boyadjieva N.1, Handjieva-Darlenska T.1, Karamfilova V.2, Kamenov Z.2
1Department of pharmacology and toxicology, Medical Faculty, Medical 
University, Sofia, Bulgaria,  
2Clinic of Endocrinology, Alexandrovska hospital, Medical Faculty, Medical 
University – Sofia, Bulgaria
Introduction: Ghrelin and leptin are major players in the regulation of 
appetite and metabolism. However, there are not enough data in the lit-
erature on the effect of different exogenous factors (drugs, diet, glycemic 
index) on the ghrelin and leptin secretion in obesity. Aim: Thereafter, the 
purpose of our study was to determine the effect of glycemic index (low 
vs. high) on plasma levels of ghrelin and leptin, and on the anthropo-
metric parameters in obese subjects. Materials and methods: A 16-week 
randomised, controlled, dietary intervention was performed in obese 
adult subjects (n= 30, men and women) with the following mean baseline 
characteristics: age 46 years, body mass index (BMI) of 32.8 кг/-, waist 
circumference 110 cm, hip circumference 125 cm, etc. At the begining and 
at the end of the study the anthropometric and body tissue parameters 
were measured. Blood samples were taken for biochemical analyses. Plas-
ma levels of ghrelin and leptin were determined by ELISA methodology. 
Result:. The rеsults showed higher reduction in body weight in the group 
on a low glycemic index (LGI) diet in comparison with the group on a 
high glycemic index (HGI) diet. No effect of the GI on the plasma levels 
of ghrelin and leptin was determined. However, in the group on LGI diet 
a slight decrease in leptin concentrations was detected.  
Conclusion: The LGI diet has a beneficial effect on the parameters of obe-
sity. More studies are needed to demonstrate the long-term effect of these 
diets in the regulation of appetite and metabolism.
T5:OS2 – Childhood Obesity
T5:OS2.1
Multidisciplinary treatment of children with leptin receptor 
deficiency
Morinder G.1, Etminan Malek M.1, Janson A.1
1National Childhood Obesity Centre, Karolinska Institutet and Karolinska 
University Hospital Huddinge, Stockholm, Sweden
Introduction: Two brothers, born to normal-weight parents of Turkish 
origin who were first cousins, presented with severe obesity at early age. 
They were referred to the National Childhood Obesity Centre (NCOC) 
at age 2 years and were diagnosed with leptin receptor (LEPR) mutations 
(c.1226C>A) at age 5 and 4 years. This diagnosis is known to be associated 
with hyperphagia, severe obesity and hypogonadism. Unlike for children 
with leptin deficiency, there are currently no treatment options other than 
lifestyle intervention for children with LEPR mutations.  
Methods: The children were investigated for hormonal deficiencies. The 
NCOC used a multidisciplinary approach to support the parents and per-
sonnel at daycare and school in making lifestyle adjustments.  
Results: Growth hormone (GH) was analyzed overnight in the younger 
brother and levels were very low with acceptable linear growth. Both chil-
dren were given thyroxine, and the older underwent surgery for retractile 
testes. Leptin levels were 22 and 31 μg/L (ref <7,5 μg/L). Caloric intake 
was markedly reduced by a dietician and at least one hour of physical ac-
tivity daily was encouraged in collaboration with a physiotherapist. Ad-
ditional support was given to the parents by a psychologist. The NCOC 
staff visited day-care and school facilities to reinforce recommendations 
on food and physical activity. The family visited the NCOC 6–8 times/
year. Body Mass Index (BMI) decreased from 31.2 kg·m-2 at age 1 years 
11 mo to 21.5 kg·m-2 at age 7 years 9 mo, and from 27.9 kg·m-2 at age 2 
years 10 mo to 22.3 kg·m-2 at age 6 years 3 mo (Fig 1). 
Discussion: Lifestyle adjustments by a multidisciplinary team can de-
crease the degree of obesity in children with LEPR mutations. In these 
children, the intervention was started before the diagnosis of LEPR muta-
tion was set. Successful treatment was accomplished by a strong therapeu-
tic alliance with the parents and networking with persons and personnel 
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Fig. 1. BMI-charts of two brothers with leptin receptor mutations.
T5:OS2.2
“What happens at Grandma’s stays at Grandma’s”: Explaining 
differences between parental and grandparental feeding of 
preschool aged children.
Eli K.1, Howell K.2, Fisher P.A.2, Nowicka P.1,3
1Unit for Biocultural Variation and Obesity, Institute of Social and Cultural 
Anthropology, University of Oxford, Oxford, UK,  
2Department of Psychology, University of Oregon, Eugene, USA,  
3Unit of Pediatrics, Department of Clinical Sciences, Intervention and 
Technology, Karolinska Institute, Stockholm, Sweden
Introduction: While extensive evidence shows that family involvement is 
important in the prevention and treatment of childhood obesity, grand-
parental feeding of young children remains understudied. This is notable 
since nearly one quarter of UK and US families rely on grandparents as 
the main providers of informal childcare. Informal care has been linked to 
increased risk of overweight in preschoolers.  
Methods: 22 parents and 27 grandparents (60% overweight/obese) from 
16 families of children aged 3–5 years (56% overweight/obese) were in-
terviewed. The interviews were transcribed and analyzed qualitatively to 
assess differences between parental and grandparental feeding, and how 
such differences are negotiated in families.  
Results: Parents and grandparents consistently identified sugary foods/
beverages and fast foods as problematic. However, in most families, re-
gardless of child weight, grandparents engaged in indulgent feeding prac-
tices despite the parents’ stated wishes. The analysis yielded 3 thematic 
categories: (1) disagreements about feeding stem from parents’ and grand-
parents’ differing definitions of healthy feeding; (2) differences between 
parents’ and grandparents’ feeding practices reflect differences in per-
ceived caretaking roles; (3) parents and grandparents negotiate differenc-
es in feeding practices through grandparental compliance and parental 
compromise.  
Conclusion: Differences between parents’ and grandparents’ feeding 
practices are related to concepts of healthy feeding, perceptions of care-
taking roles, and extent of time spent with the child. Specifically, the find-
ings suggest that in childhood obesity interventions, clinicians should 
evaluate to what extent grandparents provide childcare, and ask to involve 
them in treatment-related discussions.
T5:OS2.3
Is obesity in early childhood associated with impaired 
cognition? – Findings form the uk millennium cohort study
Martin A.1, Booth J.N.2, Young D.1, Revie M.1, Boyter A.C.1, Johnston B.1, 
Tomporowski P.D.3, Reilly J.J.1
1University of Strathclyde, Glasgow, Scotland,  
2University of Dundee, Dundee, Scotland,  
3University of Georgia, Athens, USA
Introduction: Obesity is associated with marked deficits in educational 
attainment in adolescence. The issue of when these obesity-related deficits 
appear is unclear. The present study tested the hypothesis that obesity is 
associated with impaired cognitive outcomes in early childhood.  
Methods: Associations between weight status in early childhood 
(3–5years) and cognitive performance assessed by British Ability Scale II 
tests of Pattern Construction (visuo-spatial skills), Naming Vocabulary 
(expressive language skills), and Picture Similarity (reasoning skills) at age 
5years were examined in the UK Millennium Cohort Study (MCS). Data 
from 12,349 participants with objectively measured weight status were 
examined: 76.5% were healthy weight, 18% overweight and 5.5% obese, 
relative to UK 1990 reference data.  
Results: Obese children at 3years had significantly lower performance 
in Pattern Construction at age 5years compared to those of a healthy 
weight, even after controlling for a wide range of confounders (β= –0.026, 
p = 0.03). Controlling for confounders, boys who became obese between 
the age of 3 and 5years had lower scores in Pattern Construction (β= 
–0.029, p = 0.03). However, becoming non-obese had a beneficial impact 
on Picture Similarity performance in girls (β= 0.028, p = 0.04).
Conclusions: Obesity in early childhood showed adverse relationships for 
some cognitive outcomes but it is unclear if the magnitude of the relation-
ship is of practical importance. Stronger relationships may emerge later 
in childhood. Study findings might provide education and public health 
stakeholders with greater motivation to engage with initiatives to both 
treat and prevent pediatric obesity in future.
Acknowledgement: We are grateful to The Centre for Longitudinal Studies, Insti-
tute of Education for the use of these data and to the UK Data Archive and Eco-
nomic and Social Data Service for making them available. However, they bear no 
responsibility for the analysis or interpretation of these data.
T5:OS2.4
Circulating mirnas are deregulated in overweight/obese 
children: Preliminary results of the ifamily study
Iacomino G.1, Russo P.1, Stillitano I.1, Lauria F.1, Marena P.1, Ahrens W.2,3, 
Siani A.1
1Institute of Food Sciences, CNR, Avellino, Italy,  
2Leibniz Institute for Prevention Research and Epidemiology—BIPS, Bremen, 
Germany,  
3Institute of Statistics, Faculty of Mathematics and Computer Science, University 
Bremen, Bremen, Germany
MicroRNAs (miRNA) are small non-coding RNAs involved in the modu-
lation of gene expression and in the control of cell functions. Alterations of 
miRNA patterns often occur in cancer and metabolic disorders, including 
obesity. Recent studies showed remarkable stability of miRNAs in both 
plasma and serum making miRNAs potential circulating biomarkers for 
a variety of diseases. The aim of this pilot study is to evaluate whether cir-
culating miRNAs were differentially expressed in plasma samples of over-
weight/obese and normal weight children belonging to the Italian cohort 
of the IFamily project (www.ifamilystudy.eu). The IFamily project builds 
on the IDEFICS cohort (www.ideficsstudy.eu), established in 2006. It aims 
to assess the determinants of eating behaviour in children and adolescents 
from eight European countries Ten overweight/obese (age 11.2 ± 1.5 
years, BMI 28.2 ± 1.5 kg/m2) and ten normal weight (age 11.9 ± 1.7 years, 
BMI 16.4 ± 1.7 kg/m2) children were selected for the pilot study from the 
Italian participants. MiScript miRNA PCR Array Human Serum/Plasma 
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NAs in pooled plasma samples from the two groups. Validation of selected 
miRNAs was carried out using RT-qPCR. The validation study showed 
that five specific circulating miRNAs were significantly deregulated in 
overweight/obese children. Our preliminary results indicate that circulat-
ing miRNAs are significantly deregulated in overweight/obese children. 
The planned completion of the miRNA analyses in selected samples of the 
eight European countries participating to the IFamily project will allow to 
assess whether miRNA profiling is a promising strategy to identify chil-
dren who may suffer from metabolic abnormalities during growth.
T5:OS2.5
The alterations in advanced glycation end products, 
their receptors and adipokines in centrally obese vs. lean 
adolescents
Gurecká R.1, Koborová I.1, Csongová M.1, Šebeková K.1
1Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in 
Bratislava, Bratislava, Slovak Republic
Introduction: In adults, central obesity associates with altered levels of 
adipokines and dysregulated AGE/RAGE pathway (advanced glycation 
end products/receptor for AGE), which contribute to complications of 
obesity, such as insulin resistance. We asked whether these alterations are 
manifested in centrally obese (CO) aparently healthy adolescents.  
Methods: Plasma samples from 669 adolescents aged 14–21 years, ob-
tained in the cross-sectional study „Respect for Health“ were analyzed for 
adiponectin, leptin, CML (carboxymethyl lysine, most abundant AGE), 
RAGE, esRAGE (endogenuos secretory RAGE) and sVAP-1 (soluble vas-
cular adhesion protein-1) levels using commercial ELISA kits. CO was 
defined as waist-to-height ratio ≥0.50. To compare groups of lean and CO, 
we used Mann-Whitney test, p < 0.05 was considered significant.  
Results: In both genders, levels of leptin were significantly higher, and 
those of adiponectin and both forms of RAGE lower in CO subjects. 
Concentration of CML was lower in CO girls, with same trend in boys. 
sVAP-1 levels did not differ between the groups. Data are given in table 
(mean±SD).  
Conclusion: Alterations in AGE/RAGE pathway and adipokine levels are 
manifested already in centrally obese adolescents, and thus may potential-
ly play a role in development of central obesity-associated cardiometabol-
ic complications in later life.
Fig. 1. Data are given as mean±SD. NS – not significant, p≥0.05.
T5:OS2.6
Birth weight as a predictor of blood pressure in children aged 
5 to 6 years
Lancashire E.R.1, Gill P.2, Knowles G.1, Pallan M.1, Adab P.1
1Public Health, Epidemiology and Biostatistics, School of Health and Population 
Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK,  
2Primary Care Clinical Sciences, University of Birmingham, Edgbaston, 
Birmingham, B15 2TT, UK
Introduction: Previous research on the relationship between birth weight 
(BW) and children’s blood pressure (BP) shows conflicting outcomes. 
Studies have been criticised for failing to account for potential confound-
ing factors and/or use of unstandardised BP values. This study considers 
the relationship between BW and a standardized measure of BP in British 
children aged 5–6 years having adjusted for potential confounding factors. 
The relationship is considered overall and also by sex/ethnicity using data 
from the WAVES study.  
Methods: Measured BP and parent reported BW together with age, sex 
and objectively measured height data were available for 767 children. 
Based on age, sex and height-standardised US definitions of high BP chil-
dren were classified as having normal or elevated (pre, stage 1 and stage 2 
hypertensive) BP. Multilevel logistic regression (adjusted for weight status, 
socioeconomic status, sex, ethnicity and age) was used to explore the rela-
tionship between BW (in 100g units) and BP.  
Results: Overall there was an inverse relationship between BW and cur-
rent BP. For every 100g increase in BW the odds of having an elevated 
BP were reduced by 4.2% for SBP (OR=0.958, 95% CIs 0.922–0.994) and 
4.7% for DBP (OR=0.953, 95%CIs 0.925–0.982). The outcome for SBP was 
more evident in girls (OR=0.946, 95%CIs 0.896–0.999) and South Asian 
(SA) children (OR=0.885, 95%CIs, 0.786–0.996). The outcome for DBP 
was more evident in boys (OR=0.949, 95%CIs 0.909–0.989) and SA chil-
dren (OR=0.929, 95%CIs 0.857–0.987). 
Conclusion: After adjusting for weight status and other potential demo-
graphic confounding factors, higher BW was associated with reduced 
odds of having elevated systolic or diastolic BP. The association varied by 
subgroup with both relationships more marked among SA children.
T8:OS2 – Multidisciplinary Treatment
T8:OS2.1
Liraglutide 3.0 Mg: Weight-loss dependent and independent 
effects
Van Gaal L.1, Pi-Sunyer X.2, Uddén Hemmingsson J.3, Claudius B.4, 
Svendsen C.B.4, Bays H.5
1Diabetology & Metabolism, Antwerp University Hospital, Antwerp, Belgium,  
2Columbia University, New York, NY, USA,  
3Capio St Goran's Hospital / Karolinska Institutet, Stockholm, Sweden,  
4Novo Nordisk, Sřborg, Denmark, 5L-MARC Research Center, Louisville, KY, USA
The SCALE trials examined the efficacy and safety of liraglutide 3.0 mg 
in overweight or obese adults (n=5,358) with or without prediabetes 
(NCT01272219); with type 2 diabetes (NCT01272232); or with obstruc-
tive sleep apnoea (NCT01557166). Liraglutide 3.0 mg resulted in greater 
reductions in mean body weight (BW) (5.7–8.0% vs 0.2–2.6%) and waist 
circumference (WC) (4.7–8.2 cm vs 1.2–4.0 cm) compared with placebo 
(both p < 0.0001) and also significantly improved secondary endpoints 
such as HbA1c, fasting plasma glucose (FPG), blood pressure (BP), lipid 
profile and use of oral antidiabetic drugs (OADs). Impact of weight on 
Quality of Life-Lite© (IWQoL-Lite©) scores and the apnoea-hypopnea 
index (AHI) also improved. This post hoc analysis examined the rela-
tive contribution of weight loss (WL) to the treatment effect of liraglu-
tide 3.0 mg on key secondary efficacy endpoints. A mediation model was 
applied to explain the dependent and independent relationship between 
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mg-induced WL mediated its effects on secondary efficacy endpoints was 
ranked from 0–100%, where 100% indicated the highest likelihood of a 
WL-dependent effect. Endpoints predominantly driven by WL with lira-
glutide included WC, diastolic BP, triglycerides, high density lipoprotein 
cholesterol levels, AHI and IWQoL-Lite© scores (all ranked 88–100%). 
Endpoints mainly independent of WL included glycaemic outcomes and 
use of OADs (ranked 18–32%) (Figure). Importantly, for each endpoint, 
including those largely independent of WL, lowered BW was a significant 
contributor to the treatment effect. In conclusion, in individuals that are 
overweight or have obesity, liraglutide 3.0 mg mediates its effects via both 
WL-dependent and -independent mechanisms.
Acknowledgement: Supported by Novo Nordisk
Fig. 1: Relative contribution of weight loss on secondary efficacy endpoints with 
liraglutide 3.0 mg
T8:OS2.2
Efficacy and safety of liraglutide 3.0 Mg in adult overweight 
and obese weight loss responders without diabetes: Results 
of the 56-week randomised, controlled, scale obesity and 
prediabetes trial
Astrup A.1, Fujioka K.2, Violante Ortiz R.3, Jensen C.B.4, Lilleřre S.K.4, 
O'Neil P.5
1University of Copenhagen, Copenhagen, Denmark,  
2Scripps Clinic, La Jolla, CA, USA,  
3Medical Research Unit in Clinical Epidemiology, Mexican Institute of Social 
Security, Mexico,  
4Novo Nordisk, Sřborg, Denmark,  
5Department of Surgery, Medical University of South Carolina, Charleston, SC, 
USA
The SCALE Obesity and Prediabetes trial evaluated the efficacy and safe-
ty of liraglutide 3.0 mg for weight management in patients without T2D 
(NCT01272219). This subgroup analysis compared key efficacy and safety 
outcomes of responders (≥5% weight loss [WL] from baseline) vs non-re-
sponders (<5% WL from baseline) for liraglutide 3.0 mg and placebo 
(PBO) at 56 wks. Overweight/obese individuals (BMI ≥27 kg/m˛ with ≥1 
comorbidity or BMI ≥30 kg/m˛) were randomized 2:1 to liraglutide 3.0 
mg (n=2487) or PBO (n=1244) as adjuncts to diet and exercise. Mean 
baseline characteristics were age 45 years, 79% female, body weight 106 
kg, BMI 38 kg/m2, 61% prediabetes. Change from baseline data are LS 
means with LOCF. At wk 56, more individuals on liraglutide vs PBO were 
WL responders (63.2% vs 27.1%; p < 0.0001). WL was greater in respond-
ers vs non-responders for both liraglutide and PBO (Table). Responders 
on liraglutide had greater improvements than non-responders across 
a range of efficacy outcomes. Reductions in FPG and SBP were greater 
with liraglutide vs PBO for responders and non-responders (Table). Of 
reported adverse events (AEs), GI AEs were most common and occurred 
with similar frequency in responders (liraglutide 69.2%; PBO 44.4%) and 
non-responders (liraglutide 67.2%; PBO 39.6%). Except for gallbladder 
AEs, AE profiles were similar for responders and non-responders (Ta-
ble). Mean change in pulse rate from baseline was similar for liraglutide 
responders and non-responders (Table). In conclusion, more patients 
on liraglutide 3.0 mg achieved WL ≥5%, with a greater WL seen in the 
responder population. In both groups, responders had greater improve-
ments in glycaemic, cardiometabolic and health-related QoL outcomes. 
AE rates were largely equivalent in responders and non-responders.
Acknowledgement: Supported by Novo Nordisk
Fig. 1. Selected efficacy and safety endpoints for responders and non-responders 
in the SCALE Obesity and Prediabetes trial.
T8:OS2.3
Adipose tissue morphology predicts improved insulin 
sensitivity following moderate or pronounced weight loss
Eriksson Hogling D.1, Andersson D.P.1, Bäckdahl J.1, Hoffstedt J.1, 
Rössner S.1, Thorell A.2, Arner E.1, Arner P.1, Rydén M.1
1Department of Medicine (H7), Karolinska Institutet, Karolinska University 
Hospital, Huddinge, Stockholm, Sweden,  
2Department of Surgery, Karolinska Institutet, Ersta Hospital, Stockholm, 
Sweden
Introduction: Subcutaneous adipocyte size and adipose tissue morpholo-
gy (adipocyte size in relation to fat mass) associate with insulin resistance. 
Subjects with adipose tissue morphology characterized by few but large 
adipocytes (hypertrophy) display reduced insulin sensitivity. We investi-
gated if baseline subcutaneous adipocyte size or adipose tissue morpholo-
gy predicts improved insulin sensitivity after weight loss.  
Methods: Subcutaneous abdominal adipose tissue biopsies were exam-
ined in 100 overweight or obese individuals before and ten weeks after a 
hypo caloric diet (resulting in 7 ± 3% weight loss), and in 61 obese sub-
jects before and two years after gastric by-pass surgery (33 ± 9% weight 
loss). Adipocyte size was measured by light microscopy and degree of 
adipose tissue hypertrophy or hyperplasia was calculated in each subject 
based on the relationship between adipocyte volume and total fat mass. 
Insulin sensitivity was determined by homeostasis model assessment of 
insulin resistance (HOMAIR).  
Results: At baseline, subjects with hypertrophy had higher HOMAIR val-
ues than those with hyperplasia (p < 0.0001). HOMAIR were normalized 
in both cohorts following weight loss. However, the improvement was 
more pronounced in subjects with baseline hypertrophy (p = 0.0002–
0.027). Adipocyte size predicted HOMAIR improvement only in the sur-
gery cohort. Baseline anthropometric measures such as fat mass, body 
mass index, waist-to-hip ratio or waist circumference showed no signif-
icant association with improved HOMAIR.  
Conclusion: Subcutaneous adipose tissue morphology, but not anthropo-
metric measures, predicts improved insulin sensitivity following moder-
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T8:OS2.4
Rate of weight loss does not affect long-term weight regain
Vink R.G.1, Roumans N.1, Mariman E.C.1, van Baak M.A.1
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Centre+, Maastricht, The 
Netherlands.
Introduction: Dietary guidelines recommend ‘slow’- over ‘rapid’-weight 
loss for the management of obesity. This is based on the belief that slow 
weight loss is preferential for long-term weight management. However, 
this notion has not been confirmed by scientific studies in which weight 
loss in the slow- and rapid-weight loss group was similar. Therefore, the 
objective of this study was to investigate the effect of rate of weight loss, 
with similar total weight loss, on long-term weight regain in overweight 
and obese individuals.  
Methods: Fifty-seven participants (BMI: 28–35 kg/m2) were randomized 
to a low-calorie-diet (LCD; 1250 kcal/d) for 12 weeks or a very-low-cal-
orie-diet (VLCD; 500 kcal/d) for 5 weeks. Both groups subsequently un-
derwent a 4-week weight-stable period followed by a 9-month follow-up. 
Weight and body composition (BodPod) were determined at 4 time points 
(Figure 1).  
Results: Diet-induced weight loss was similar in both groups (LCD: 
–9.1% and VLCD: –10.0%, p = 0.26, Figure 2). Interestingly, regain of 
lost weight after follow-up was not significantly different between groups 
(LCD: +58.6% and VLCD: +54.7%, p = 0.78). Fat-free mass (FFM) loss 
induced by the diet was higher in the VLCD-group compared to the LCD- 
group (p < 0.05) and was associated with weight regain during follow-up 
(whole group: r=0.325, p = 0.018). However, the difference in mean FFM 
loss between the groups was too small to translate into differences in mean 
weight regain.  
Conclusion: The present study showed that, with similar total weight loss 
of approximately 10% of initial weight, the rate of weight loss did not af-
fect long-term weight regain. Dietary recommendations concerning the 
rapidity of weight loss should be critically reviewed in light of recent sci-
entific evidence.
Fig. 1. Study overview. Body weight and body composition were determined before 
and after the diet (T1 and T2 respectively), after the weight-stable period (T3) and 
after 9-month follow-up (T4). LCD: low-calorie-diet, VLCD: very-low-calorie-diet.
Fig. 2. Body weight at time points T1, T2, T3 and T4 (same as indicated in Figure 
1) in the LCD-group and VLCD-group. LCD: low-calorie-diet, VLCD: very-low-
calorie-diet.
T8:OS2.5
Weight loss under treatment of hypogonadal men with 
testosterone undecanoate injections (TU): Long-term 
experience of 21.678 patient-months from a single urologist’s 
office registry
Saad F.1,2, Haider K.S.3, Haider A.3, Doros G.4, Traish A.5
1Bayer Pharma AG, Global Medical Affairs, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Private Urology Practice, Bremerhaven, Germany,  
4Boston University School of Public Health, Boston, USA,  
5Boston University School of Medicine, Boston, USA
Introduction: This registry assesses long-term effectiveness and safety of 
TU in a urological setting. Material and 
Methods: Observational, prospective, cumulative registry study: 347 men 
(age: 57.32 ± 7.12 years) with total testosterone (T) levels ≤12.1 nmol/L 
and hypogonadal symptoms received TU 1000 mg/12 weeks following an 
initial 6-week interval for up to 7 years. Anthropometric parameters were 
measured every 3 months.  
Results: This cohort represented a mixed population with a variety of 
comorbidities: type 2 diabetes mellitus (n=126, 36.3%), cardiovascular 
disease (n=68, 19.6%), inflammatory bowel diseases (IBD; n=61, 17.6%), 
osteoporosis (n=61, 17.6%), Klinefelter’s syndrome (n=36, 10.4%), psori-
asis (n=15, 4.3%). 4.3% had normal waist circumference (WC; <94 cm), 
30.8% elevated (94 to 102), and 64.8% substantially elevated (≥102 cm). 
7.5% had normal weight, 22.8% were overweight, and 69.7% obese. WC 
decreased progressively from 105.77 ± 8.6 to 97.74 ± 7.05 cm, weight 
from 103.87 ± 16.38 to 87.82 ± 8.99 kg, and BMI from 33.18 ± 5.35 
to 28.42 ± 2.95 kg/m2 with statistical significance vs previous year for 
all three measures over the entire observation period. Weight loss was 
16.67 ± 7.7% at 7 years. During the first treatment year and before join-
ing the registry, approximately 5% of patients decided against continuing 
TRT. Once in the registry, no further dropouts were recorded. During the 
entire observation time, no major adverse cardiovascular event occurred.
Conclusions: Long-term TRT with TU in an unselected cohort of hypo-
gonadal men resulted in improvements in a variety of anthropometric and 
metabolic parameters. Long-term TU was well tolerated and excellent ad-
herence suggested a high level of patient satisfaction.
T8:OS2.6
The utility of obesity staging classification systems in 
selecting persons for bariatric surgery
Valderhaug T.G.1, 2, Hjelmesćth J.1, 3, Sandbu R.4, Aasheim E.T.5, Hertel J.K.1
1Morbid Obesity Centre, Vestfold Hospital Trust, Třnsberg, Norway,  
2Department of Endocrinology, Akershus University Hospital, Nordbyhagen, 
Norway.,  
3Department of Endocrinology, Morbid Obesity and Preventive Medicine, 
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.,  
4Department of Surgery, Vestfold Hospital Trust, Třnsberg, Norway.,  
5Imperial Weight Centre, Imperial College London, London, UK
Introduction: Increasing numbers of obese people calls for development 
of evidence based criteria to prioritize the right type of treatment to those 
that can benefit most. The King’s Obesity Staging Criteria (KOSC) com-
prises a set of health related domains graded into stage 0, 1, 2, or 3. We 
aimed to examine whether patients undergoing bariatric surgery differed 
from those opting for conservative treatment, according to KOSC.  
Methods: 2188 consecutive morbidly obese patients who attended our 
tertiary care center from 2005–10 were graded in the following KOSC 
domains; airway/apnoea, BMI, CVD-risk, diabetes, economic complica-
tions, functional and gonadal axis, perceived health status, body image 
and eating behavior. Stages 0–1 represent minor health risk, while stag-
es 2–3 represent established clinical, metabolic, and socio-psychological 
states linked to obesity.  
Results: Out of 2188 patients, a total of 1213 (55%) patients received life-
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patients received lifestyle intervention and subsequent bariatric surgery. 
Compared to those who received lifestyle intervention, the patients treat-
ed with bariatric surgery were younger (42 vs. 44 years, p < 0.001), had 
a higher BMI (45.3 vs. 43.3 kg/m2, p < 0.001) and had a lower 10 year 
estimated CVD-risk (10 vs. 12%, p = 0.01). The treatment groups were 
not statistically different in the obesity staging categories (Figure). Com-
pared to those with the reference BMI of 35–50 kg/m2, participants with 
BMI 50–60 kg/m2 had higher odds (OR 1.64, 95% CI 1.26–2.10) of being 
selected for bariatric surgery.  
Conclusion: Our data indicate that increasing BMI, rather than an indi-
vidual patient’s health risks and manifest morbidity, predicted treatment 
choice in morbidly obese patients.
Fig. 1. Obesity treatment by the King’s Obesity Staging Criteria. None of the study 
participants were categorized in stage 0.
Saturday, 9 May, 2015
T1/T2:OS3 – Adipose Tissue Mass and Function
T1/T2:OS3.1
Effects of 5-year growth hormone supplementation therapy 
on subcutaneous adipose tissue phenotype and adipokine 
profile in adult growth hormone deficiency
Ukropcova B.1,4, Janakova Z.1, Kurdiova T.1, Balaz M.1, Surova M.1, 
Maderova D.1, Belan V.2, Payer J.3, Klimes I.1, Gasperikova D.1, Ukropec J.1
1Institute of Experimental Endocrinology Slovak Academy of Sciences, 
Bratislava, Slovakia,  
2Dr. MAGNET, Bratislava, Slovakia,  
35th Department of Internal Medicine, University Hospital, Comenius University, 
Bratislava, Slovakia,  
4Institute of Pathophysiology, Faculty of Medicine, Comenius University, 
Bratislava, Slovakia
Introduction: Adult growth hormone deficiency (GHD) is associated 
with central adiposity, enlarged adipocytes and shifts in adipose tissue 
adipokine profile that might contribute to the whole body metabolic de-
rangements (dyslipidemia, glucose intolerance, insulin resistance). We in-
vestigated effects of 5-year GH supplementation on subcutaneous adipose 
tissue (SAT) phenotype (n=17) and adipokine profile (n=11) in GHD 
adults in comparison to age, BMI & gender-matched controls (n=17/11).  
Methods: Metabolic phenotyping included euglycemic hyperinsulinemic 
clamp (EHC), oral glucose tolerance test (oGTT) & MRI (abdominal fat 
distribution). Samples of subcutaneous abdominal adipose tissue (SAT) 
were obtained by needle biopsy and adipokine profile was determined by 
protein cytokine arrays (RayBio). Fat cell size was measured morphomet-
rically.  
Results: GH supplementation decreased fat cell size by 13,3% (114,0 vs 
98,8μM) and improved adipose tissue insulin sensitivity (EHC: insu-
lin-induced suppression of FFA; 0,35 vs 0,04mM) and whole body glucose 
tolerance (oGTT: 2h glycemia; 7,94 vs 6,02mM) by 88,6 and 24,2% , resp., 
without affecting whole body insulin sensitivity or adiposity. Over two-
fold changes in SAT adipokine proteins expression included proteins in-
volved in adipocyte proliferation and differentiation (BMP4, EGF, M-CSF, 
SCF), angiogenesis (BDNF, angiogenin, SDF1, GCP2), neurogenesis 
(BDNF, CNTF, GDNF, SDF1), browning (BMP4), metabolism (IGF1) and 
inflammation (MCP1, MCP4, IL2, IL3, IL5, IL10, IL13, M-CSF, MDC, eo-
taxin, IFNγ).  
Conclusion: Five-year growth hormone supplementation to GHD adults 
modulated subcutaneous adipose tissue adipokine profile, with beneficial 
effects for adipose tissue growth, differentiation and metabolism.
Acknowledgement: Pfizer Investigator Initiated Research Grant, EFSD New Hori-
zons
T1/T2:OS3.2
A role for Wnt signaling in the reversal of metabolic 
disturbances after gastric bypass in obese mice
Maris M.1, Vangoitsenhoven R.1, Monteiro Carvalho Mori Cunha J.P.1, 
Lannoo M.2, Overbergh L.1, Mathieu C.1,3, Van der Schueren B.1,3
1Laboratory for Clinical and Experimental Medicine and Endocrinology, KU 
Leuven, Leuven, Belgium,  
2Department of Abdominal Surgery, University Hospitals Leuven, Leuven, 
Belgium,  
3Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium
Introduction: Gastric bypass surgery has beneficial effects on obesity-in-
duced metabolic disturbances, but the underlying mechanisms remain 
unclear. As Wnt genes are positively and negatively correlated with obesi-
ty, diabetes, insulin resistance and beta cell dysfunction, our main aim is 
to reveal a potential role for Wnt signaling in the reversal of these meta-
bolic consequences after gastric bypass surgery in mice.  
Methods: 8-weeks old male C57Bl/6 mice were fed a high fat diet (60 
kcal% fat) for 14 weeks, followed by either Roux-en-Y gastric bypass 
(RYGB; n=13) or Sham surgery (Sham; n=10). After surgery, mice were 
maintained on a high fat diet for another 8 weeks (Sham group was pair 
fed with the RYGB group). Using RNA-Seq and qRT-PCR, the mRNA 
expression profile of Wnt ligands and its antagonists (i.e. secreted Friz-
zled-related proteins (sFRP)) was determined in pancreatic islets and epi-
didymal white adipose tissue of RYGB and Sham mice.  
Results: 8 weeks post-surgery, Sham mice returned to their pre-surgery 
weight (43.4 g ± 6.9), whereas RYGB mice showed a 43% reduction in 
body weight, accompanied by improved metabolic parameters, as com-
pared to Sham mice (P < 0.01). Despite a 3-fold reduction in fasting in-
sulin levels in RYGB as compared to Sham mice (P < 0.05), the mRNA 
expression level of Wnt ligands and sFRP was similar in pancreatic islets. 
In contrast, epididymal adipose tissue of RYGB mice showed a 75% and 
94% decrease in sFRP4 and sFRP5 mRNA expression levels respective-
ly as compared to Sham mice (P < 0.01). Additionally, a trend towards 
decreased mRNA expression of Wnt5a and Wnt5b could be detected in 
RYGB as compared to Sham mice (P = 0.1).  
Conclusion: RYGB surgery strongly reduced the expression level of the 
secreted Wnt antagonists sFRP4 and sFRP5 in white adipocyte tissue. As 
secreted proteins are interesting drug targets, a potential role for these 
secreted proteins in the reversal of metabolic disturbances after RYGB 
surgery will be studied more in depth.
Acknowledgement: Research relating to this abstract was funded by the Flemish 
Research Foundation (FWO G085713N). M.M. is a postdoctoral fellow supported 
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T1/T2:OS3.3
Dysregulation of lipid droplet-associated rab proteins 
in adipocytes as a novel pathogenic component in the 
development of insulin resistance in obesity
Rabanal Y.1,2, Guzmán-Ruiz R.1,2, Trávez A.1,2, Moreno N.R.1,2, Garcia-
Navarro S.1,2, López-Miranda J.2,3, Tinahones F.2,4, Vázquez-Martínez R.1,2, 
Malagón M.M.1,2
1Dept. of Cell Biology, Physiology and Immunology, IMIBIC/Reina Sofia 
University Hospital/University of Córdoba, Córdoba, Spain,  
2CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud 
Carlos III, Spain,  
3Lipids and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/
University of Córdoba, Córdoba, Spain,  
4Biomedical Research Laboratory, Endocrinology Department, Hospital Virgen 
de la Victoria, Málaga, Spain
Introduction: Lipid droplets (LDs) are essential subcellular organelles 
responsible for lipid storage in adipocytes. LDs are surrounded by a phos-
pholipid monolayer that harbors a variety of proteins, including several 
members of the Rab family of GTPases such as Rab18, which regulates 
lipid traffic to and from LDs. Investigating how LD-associated Rabs are 
regulated is pivotal to the understanding of the regulation of lipid storage 
and mobilization in adipocytes and their contribution to lipotoxicity and 
metabolic disease.  
Methods: Data from two comparative proteomic studies [LDs isolated 
from control vs. insulin-stimulated 3T3-L1 cells; omental adipose tissue 
of lean subjects vs. normoglycemic (NIR) or insulin resistant (IR) obese 
subjects] were screened to identify potential regulators of Rab proteins. 
One protein was selected (Rab-GDP dissociation inhibitor 2, GDI2) and 
further characterized.  
Results: GDIs inhibit the dissociation of GDP from Rabs, thus preventing 
their activation and recruitment to target membranes. Accordingly, over-
expression of GDI2 in 3T3-L1 cells reduced both lipogenesis and lipolysis 
and concomitanty inhibited the association of Rab18 to the LD surface. 
Notably, the expression of GDI2 and/or the distribution of Rab18 were 
significantly altered in in vitro models of insulin resistance. Finally, GDI2 
was up-regulated in the adipose tissue of IR obese subjects as compared to 
NIR obese or lean subjects. 
Conclusions: Our data suggests that the up-regulation of GDI2 and sub-
sequent impaired recruitment of Rab proteins to the LD surface contrib-
ute to the dysregulation of lipid metabolism observed in obese subjects 
and highlight the relevance of Rab proteins and their regulators as patho-
genic components in the development of insulin resistance. 
Acknowledgement: This work was supported by MINECO/FEDER (BFU2010-
17116; BFU2013-44229-R), J. Andalucía/FEDER (CTS-6606; PI-0200/2013), and 
CIBERobn (Instituto de Salud Carlos III), Spain.
T1/T2:OS3.4
Metabolipidomical profiling of adipose tissue during lipolysis
Kuda 0.1, Cerna M.1, Janovska P.1, Kopecky J.1
1Institute of Physiology Academy of Sciences of the Czech Republic v.v.i.
Introduction: Metabolipidomical analysis of adipose tissue covers mea-
surement of both water-soluble metabolites like Krebs cycle intermedi-
ates, and water-insoluble metabolites – bioactive and storage lipids. Our 
goal is to characterize complex metabolism of adipose tissue – lipolysis 
pathway – and interaction between adipocytes and macrophages.  
Methods: Mature adipocytes were isolated using collagenase from epidid-
ymal adipose tissue of adult C57BL/6J mice. Adipocytes were incubated 
in the presence of RAW 246.7 or bone marrow-derived macrophages (0.2 
mil cells and 50 μl of adipocyte suspension). Aliquots of the original tis-
sue, as well as cells and medium after the incubation were stored in liquid 
nitrogen. Free glycerol and fatty acids were measured in media to estimate 
a rate of re-esterification. Cell, tissue and media samples were extracted 
for metabolipidomical profiling – levels of oxylipins and endocannabi-
noids were measured using RP-LC-MS/MS techniques – profiles of glyc-
erolipids and triacylglycerols, were measured using shotgun lipidomical 
approach – and Krebs cycle intermediates and nucleotides were measure 
with HILIC-LC-MS/MS method.  
Results: Using this metabolipidomical approach, we were able to detect 
changes related to altered lipolytical rate. Eicosanoids released from adi-
pose tissue, adipocytes, macrophages or the co-culture after isoproterenol 
stimulation might serve as adipose tissue-derived signals for other cells 
in vicinity. Changes in glycerolipid / triacylglycerol profiles illustrate re-
modeling of acyl chains. Levels of Krebs cycle intermediates as well as en-
ergetic equivalents demonstrate the flux and demands for energy during 
lipolysis/ fatty acid re-esterification.
T1/T2:OS3.5
Depot differences in adipose tissue oxygen tension are 
associated with metabolic and cardiovascular risk in 
overweight and obese woman
Vogel M.1, Jocken J.1, Sell H.2, Blaak E.1, Goossens G.1
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Centre+, The 
Netherlands,  
2Paul-Langerhans-Group for Integrative Physiology, German Diabetes Center, 
Düsseldorf, Germany
Background: Upper and lower-body fat depots exhibit opposing associa-
tions with obesity-related cardiometabolic diseases. Recent data indicate 
that adipose tissue (AT) oxygen tension (AT PO2) is related to AT dys-
function. We compared in vivo ATPO2 in abdominal and femoral subcu-
taneous (sc) AT in overweight/obese women, and examined depot-specif-
ic effects of oxygen tension on metabolism and inflammation.  
Methods: 8 overweight/obese (BMI 34.2 ± 1.9 kg/m2) post-menopausal 
women with impaired glucose metabolism were included. AT PO2 was 
assessed in abdominal and femoral sc AT using microdialysis-based op-
tochemical measurements. Furthermore, AT blood flow (ATBF) (133Xe 
wash-out), insulin sensitivity (hyperinsulinemic-euglycemic clamp) and 
body composition (DEXA) were measured. AT biopsies were collected 
for gene/protein expression analysis and cell culture experiments to de-
termine effects of AT PO2 (5 vs. 10 vs. 21% O2) on adipogenic differen-
tiation, adipokine expression and secretion, mitochondrial oxygen con-
sumption and glucose uptake.  
Results: AT PO2 was significantly higher in abdominal compared to 
femoral sc AT (62.7 ± 6.6 vs. 50.0 ± 4.5 mmHg, p = 0.017), despite low-
er ATBF in abdominal than femoral AT (1.8 ± 0.3 vs. 2.8 ± 0.5 ml/100g 
tissue/min, p = 0.028). Interestingly, abdominal sc AT PO2 was positive-
ly associated with BMI (r=0.89, p = 0.01), systolic (r=0.86, p = 0.01) and 
diastolic (r=0.79, p = 0.03) blood pressure, and 2h-glucose level (r=0.82, 
p = 0.02). Results of the cell culture experiments will be available at the 
time of the meeting.  
Conclusion: This study demonstrated for the first time that AT PO2 was 
significantly higher in abdominal than femoral subcutaneous AT of over-
weight/obese women, despite slightly lower ATBF, and may contribute to 
increased cardiometabolic disease risk.
T1/T2:OS3.6
Identification and characterization of human adipocyte 
progenitors by expansion of their vascular niche
Corvera S.1, Min S.Y.1, Rojas-Rodriguez R.1
1Program in Molecular Medicine 1, Diabetes Center of Excellence 2, and 
Cardiovascular Center of Excellence 3, University of Massachusetts Medical 
School, Worcester, MA
Adipose tissue expandability has conferred evolutionary advantages that 
are now being undermined by the emergence of obesity and metabolic 
disease. Major gaps in our understanding of normal and pathogenic hu-
man adipose tissue growth are the identity of adipocyte progenitors and 
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we report that human adipocyte progenitors proliferate in conjunction 
with adipose tissue capillaries and describe methods whereby they can 
be clonally isolated from human adipose tissue. These progenitors are 
amenable to expansion, differentiate in response to classic adipogenic 
stimuli and survive as adipocytes when implanted into immunodeficient 
mice. Unexpectedly, adipocytes differentiated from these progenitors 
strongly (>100-fold) induce the brown adipocyte-specific uncoupling 
protein-1 in response to adenylate cyclase activation, resulting in a ther-
mogenic phenotype characterized by uncoupled oxygen consumption. 
These results thus identify human brite/beige progenitor cells associated 
with expanding adipose tissue vasculature, and suggest that browning of 
adipose tissue occurs in response to capillary network growth in response 
to hemodynamic stress.
Acknowledgement: This study was funded by National Institutes of Health grant 
DK089101.
T6/T7:OS3 – Actions for Change
T6/T7:OS3.1
Adressing the obesity epidemic through a novel user-friendly 
approach to menu labelling in the west of ireland
Kerins C.1,2, Gibson I.1,2, Cunningham K.1,2, Jones J.1,2,3, Kelly C.1,2,3
1National Institute for Preventive Cardiology, Moyola Lane, Newcastle, Galway, 
Ireland,  
2Croí, the West of Ireland Cardiac Foundation, Moyola Lane, Newcastle, Galway, 
Ireland,  
3Health Promotion Research Centre, National University of Ireland, Galway, 
University Road, Galway, Ireland
Introduction: With eating out-of-home becoming more common, menu 
labelling has garnered growing public and legislative support as a poten-
tial strategy for addressing the obesity epidemic. The aims of this research 
were to examine the impact of novel and user-friendly heart healthy 
awards on consumers buying behaviour and to explore perceptions of this 
initiative from food establishment’s perspectives.  
Methods: This quasi-experimental study recruited a convenience sample 
of eight food establishments; all with at least one menu item meeting the 
heart healthy award criteria. Sales of all menu items sold over an eight 
week period were tracked; 4 weeks prior to and 4 weeks during display of 
the awards on their menus. In addition, structured interviews were con-
ducted with staff from each food establishment.  
Results: The interviews revealed that consumer demand was the main 
reason for engaging in the programme. Notably, half of the food establish-
ments made changes to their food practices to improve nutritional profile 
as a consequence of the programme. The absolute change in menu item 
sales showed a clear trend towards an increase in heart-healthy menu item 
selections with an increase of 556 of the healthier menu items sold over 
the 4 week period. The study was underpowered to detect a statistically 
significant difference.  
Conclusion: The provision of heart-healthy awards on menus may po-
tentially be an important element of a comprehensive obesity prevention 
strategy. Menu labelling may provide consumers with the information 
they need to make healthier choices and may also encourage food estab-
lishments to improve the nutritional profile of the foods they offer. As the 
current study used a small convenience sample of food establishments, 
larger scale studies are warranted.
 Fig. 1. Heart Healthy Menu Awards
T6/T7:OS3.2
Can front-of-pack nutrition labelling help consumers choose 
foods for a healthful diet?
Green J.H.1, Siwajek P.1, Fern E.B.2
1Department of Nutrition, Health and Wellness and Sustainability, Nestec SA, 
Vevey, Switzerland,  
2Recently retired from Nestec SA, Vevey, Switzerland
Introduction: The aim of this study was to find out whether hypotheti-
cal aliquots of homogenised healthful diets meet the UK’s multiple traffic 
light (MTL) nutrient profile requirements for green lights for total fat, sat-
urated fat, total sugars and salt.  
Methods: The nutrient composition of 7 days’ menus for the US MyPlate 
and DASH Eating Plan were derived using the USDA nutrient database 
(Release 27). The total diet was expressed either per 100g for foods or per 
100ml for beverages. A healthful diet was also developed from packaged 
foods using MTL labels to help guide selection.  
Results: The MyPlate and DASH diets met the WHO guidelines for to-
tal fat, saturated fat and salt, while total sugars provided 22.2 ± 7.5, and 
23.3 ± 4.1% energy, respectively (n=7 days, mean ± SD). For both diets, 
the foods achieved MTL green lights for saturated fat and salt, and bever-
ages for total fat, saturated fat, and salt. All other nutrients achieved only 
amber lights, with the foods in the MyPlate diet providing 4.9 ± 1.6 g total 
fat/100g and 6.3 ± 2.2 g total sugars/100g, and the beverages providing 
4.5 ± 1.8 g total sugars/100ml. The corresponding amber light values in 
the DASH Eating Plan were 4.5 ± 0.4 g total fat /100g and 5.7 ± 1.3 g total 
sugars/100g for foods, and 7.0 ± 0.8 g total sugars/100ml for beverages. A 
“packaged foods” diet with 4 green lights for foods and beverages provid-
ed 21.2% energy from total fat, 8.3% from saturated fat, 23.3% from total 
sugars and 5.4g salt.  
Conclusion: The MTL label is intended to help guide product choice for 
a healthful diet, but in practice this was found to be difficult to achieve 
because of the strict thresholds for total fat and total sugars.
T6/T7:OS3.3
The effect of calorie-labelling of meals on macro- and micro-
nutrients chosen by young-adults over 9-months
Nikolaou C.K.1, Hankey C.1, Lean M.E.1
1Department of Human Nutrition, University of Glasgow, New Lister Building, 
10–16 Alexandra Parade, Glasgow, G31 2ER.
Background: Calorie-labelling has been introduced as a tool to help con-
sumers to control calorie-intake when eating out-of-home. To date, there 
is limited evidence on whether calorie-labelling has an impact on calories 
chosen and no evidence on the effect of it on other macro- and micro-nu-
trients. The aim of this study was to assess the impact of calorie-labelling 
on energy, macro- and micro-nutrients chosen.  
Methods: Young adults were observed when choosing meals over three 
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out calorie-labels (10 weeks), period 3: with calorie-labels and estimated 
energy requirements (10 weeks). Meal-choices were analysed using a nu-
tritional software (WinDiets, 2011). ANOVA was carried out to test for 
differences between macro- and micro-nutrients during the three periods 
(SPSS 21, Chicago inc).  
Results: Energy, four macro- and 19 micro-nutrients levels were derived 
from 4,200 meals. Mean (SE) for key macro- and micro-nutrients were 
for Period 1: energy = 661 (6.9) kcal, fat = 31.5 (0.4) g, saturated fat = 
10.5 (0.2) g, Vit C = 79.8 (2.9) mg, Vit D = 17.1 (2) mg, Ca = 271.5 (29.5) 
mg, Na = 1,242 (51) mg. Period 2: energy = 723 (7) kcal, fat = 34.7 (0.4) 
g, saturated fat = 12 (0.2) g, Vit C = 86.6 (3) mg, Vit D = 26.8 (2.6) mg, Ca 
= 354 (33) mg, Na = 1,351 (50.4) mg. Period 3: energy = 585 (5.9) kcal, 
fat = 27.3 (0.4) g, saturated fat = 8.6 (0.2) g, Vit C = 77.2 (2.9) mg, Vit D 
= 14 (1.7) mg, Ca = 271 (32.9) mg, Na = 1,232 (61.7) mg. All macro- and 
micro-nutrients, except for B1, Vit C, Vit E, Ca and Na, were significantly 
different between the three periods (p < 0.001).
Conclusions: Calorie-labelling resulted in reduced calorie, fat, saturated 
fat contents of the meals chosen, without compromising the provision of 
micronutrients, which were all above recommended daily amounts. 
Acknowledgement: Authors would like to thank the catering staff for posting the 
calorie-labels for a period of nine months.
T6/T7:OS3.4
Diet and physical activity interventions to prevent or treat 
obesity in South Asian children and adults: A systematic 
review and meta-analysis
Brown T.1, Smith S.1, Bhopal R.2, Kasim A.1, Summerbell C.D.1
1School of Medicine, Pharmacy and Health, Durham University, UK.,  
2Centre for Population Health Sciences, University of Edinburgh, UK.
Aim: To assess the effectiveness of interventions to prevent or treat obesity 
in South Asian populations.  
Methods: Systematic review of lifestyle interventions of any duration, in 
South Asian children or adults in any country that reported an anthropo-
metric measure. There was no restriction on type of comparator; RCTs, 
CCTs, and before-after studies were included.  
Results: 29 studies were included, 7 children, 21 adult and one mixed age. 
16 studies were conducted in South Asia, 10 in Europe and 3 in USA. 
Effective trials included physical activity interventions in South Asian 
men in Norway and South Asian school children in the UK. Meta-analy-
ses of interventions in children showed no significant difference between 
intervention and control. Meta-analyses in adults showed improvement 
in weight in data from two trials adjusted for baseline differences (-1.82 
kgs, 95% CI –2.48 to –1.16) and in unadjusted data from three trials fol-
lowing sensitivity analysis (-1.20 kgs, 95% CI –2.23 to –0.17). There was 
no evidence that interventions were more or less effective by country or 
socio-economic status.  Conclusions: Meta-analysis found an unclear pic-
ture of the effects of interventions on BMI for South Asian children, but 
did show an improvement in weight (but not BMI or waist circumference) 
for adults. Evidence of culturally appropriate approaches to and character-
istics of, effective interventions in adults were also identified. The protocol 
for this systematic review was registered with PROSPERO (registration 
no. CRD42014008800).
T6/T7:OS3.5
Are weight management programmes cost-effective?
Retat L.1, Brown M.1, Suhrcke M.2, Webber L.1
1UK Health Forum, London, UK,  
2Centre for Health Economics, University of York, York, UK
Objective: As part of the NICE guidance on adult Lifestyle Weight Man-
agement programmes, the UK Health Forum used a health and econom-
ic model to estimate the potential health and economic consequences of 
running weight management programmes in UK adults.  
Methods: We developed an economic evaluation model capable of con-
sidering the impact of future changes in body mass index on health and 
related healthcare costs for adults. Incremental cost-effectiveness ratios, 
quality-adjusted life year, savings over several different time horizons were 
estimated. Five interventions were modelled, for example, comparing in-
dividual weight loss programmes lasting either 6, 12 or >12 months in 
length, a weight loss programme involving group sessions; an individual 
weight loss programme but with supervision from a health professional 
and finally a weight loss programme that included a combination of dif-
ferent group and supervision sessions. A sensitivity analysis of the critical 
parameters was also carried out.  
Results: Results (Fig. 1) showed that interventions resulted in between 
0.3kg/m2 (<12month programme) and 3kg/m2 weight loss (combination 
programme). Modelling showed that most interventions investigated 
were cost-effective but only if the rate of regain of BMI was low (<5%, 
depending on age and sex categories). The sensitivity analysis shows that 
the critical elements in the likely cost effectiveness are gender, initial BMI, 
age, rate of regain of BMI and the intervention cost.  
Conclusion: Given the impact of ‘yoyo dieting’ and frequent weight re-
gain following trials, the NICE modelling results suggested that continu-
ous weight management interventions over the lifecourse to help prevent 
obesity-related diseases and reduce the total cost to health services are 
necessary.
Fig. 1. The rate of regain of BMI [% per annum] for which the weight management 
programme is no longer cost effective.
T6/T7:OS3.6
Effect of a childhood obesity prevention programme on 
blood pressure in uk south asian primary school children: The 
beaches study
Pallan M.J.1, Adab P.1
1School of Health and Population Sciences, University of Birmingham, 
Birmingham, UK
Introduction: Childhood obesity is associated with increased cardiomet-
abolic risk, including elevated blood pressure (BP). Behavioural interven-
tions in overweight children have been shown to significantly reduce BP, 
and evidence suggests that school-based obesity prevention programmes 
have a favourable effect on BP. This study examines the effect of a school-
based childhood obesity prevention programme on BP in South Asian 
(SA) children aged 6–8 years using data from the Birmingham healthy 
Eating and Active lifestyle for CHildren Study (BEACHeS; a phase II fea-
sibility study). SA are an important target group as they are vulnerable to 
the cardiometabolic effects of obesity.  
Methods: 8 primary schools in Birmingham, UK participated. Children 
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Objectively measured height, weight and BP data were available pre- and 
post-intervention for 230 and 245 children in the intervention and control 
arms respectively (89% SA). Multiple linear regression models were devel-
oped for systolic and diastolic blood pressure (SBP and DBP) to estimate 
differences in the study arms post-intervention.  
Results: In unadjusted analyses, SBP and DBP were significantly lower 
in the intervention arm compared with control (-2.48 mmHg for SBP 
(95%CI: –4.50, –0.45), –1.96 mmHg for DBP (95%CI: –3.72, –0.20)). 
These differences remained after adjustment for sex, age, ethnicity, height, 
baseline BP and post-intervention BMI z-score (-2.08 mmHg for SBP 
(95%CI: –4.00, –0.17), –1.97 mmHg for DBP (95%CI: –3.70, –0.24)). 
Conclusions: The BEACHeS programme lowered SBP and DBP in young 
SA school children by approximately 2 mmHg. This translates into a sig-
nificant reduction in cardiometabolic risk in this vulnerable population.
Acknowledgement: The NPRI funding partners for the study are: British Heart 
Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic 
and Social Research Council; Medical Research Council; Research and Develop-
ment Office for the Northern Ireland Health and Social Services; Chief Scientist 
Office, Scottish Executive Health Department; Welsh Assembly Government and 
World Cancer Research Fund.
T3:OS3 – Genes and Metabolic Function
T3:OS3.1
Fluoxetine induces plasticity in hypothalamic circuits 
controlling leptin sensitivity and food intake
Scabia G.1, Mainardi M.2, Barone I.1, Scali M.2, Ceccarini G.1, Vitti P.1, 
Pizzorusso T.3, Maffei L.2, Santini F.1, Maffei M.4
1Department of Clinical and Experimental Medicine. Obesity Center, University 
Hospital, Pisa, 
2Institute of Neuroscience, CNR, National Research Council, Pisa,  
3Department of Neuroscience, 
Psychology, Drug Res. and Child Hlth. NEUROFARBA, Univ. of Florence, Florence, 
Italy, 
4Institute of Clinical Physiology, CNR, National Research Council, Pisa
Introduction: Leptin (LEP), a satiety hormone secreted by white adipose 
tissue, signals to the brain, namely the arcuate nucleus of the hypothala-
mus (ARC), the status of the energy stores and acts by activating the an-
orectic POMC neurons and by inhibiting the orexigenic NPY neurons. 
LEP discovery represented a promising pharmacological therapy for obe-
sity, but treatment of obese patients has substantially failed. Indeed obese 
patients display high plasmatic LEP levels, suggesting resistance to this 
hormone. Our previous work has shown that hypothalamic LEP sensitiv-
ity can be enhanced in mice via environmental cues, that promote neural 
plasticity. Fluoxetine (FLX), a selective serotonin reuptake inhibitor, is 
widely used for treating major depression and is known to induce neural 
plasticity in the sensory systems of adult rodents. Aim of this study is to 
investigate FLX effects on hypothalamic plasticity and LEP sensitivity in 
adult mice.  
Methods: Adult mice were treated for 3 wks with FLX added to drinking 
water. Body weight and food intake were monitored. LEP sensitivity was 
assessed by monitoring food intake after LEP injection and by calculat-
ing the activation level of STAT3 by immunofluorescence. Hypothalamic 
plasticity was assessed by quantifying the excitatory and the inhibitory 
inputs on POMC and NPY neurons by immunofluorescence.  
Results: We observed a significant reduction in body weight and in-
creased locomotor activity, and a higher sensitivity to LEP anorectic ac-
tion. We looked for molecular correlates of these modifications: in the 
ARC, FLX induced a stronger signaling activation in response to LEP and 
significant rearrangements of synaptic excitation/inhibition ratio on NPY 
and POMC neurons.  
Conclusion: Our results indicate that FLX treatment enhances LEP sen-
sitivity in adulthood by modulating neuronal response and by stimulating 
neural plasticity in the ARC.
T3:OS3.2
Impact of caloric restriction on gut barrier integrity in obese 
women
Ott B.1, Norman K.2, Büttner J.3, Eichhorn C.4, Hastreiter L.1, Skurk T.1, 
Hauner H.1,4
1Center of Life and Food Science Weihenstephan, Technische Universität 
München, Department of Clinical Nutritional Medicine, Freising-
Weihenstephan, Germany, 
2Charité-Universitätsmedizin Berlin, Forschungsgruppe Geriatrie am EGZB, 
Berlin, Germany, 
3Charité-Universitätsmedizin, Medizinische Klinik mit Schwerpunkt Hepatologie 
und Gastroenterologie, Berlin, Germany,  
4Institute of Nutritional Medicine, Klinikum rechts der Isar, Technische 
Universität München, Munich, Germany
Introduction: This study addresses the hypothesis that a disrupted gut 
barrier function contributes to subclinical inflammation in obesity. Spe-
cific aim of the study was to investigate whether caloric restriction affects 
gut permeability and decreases gut-derived inflammatory load in obese 
women.  
Methods: 20 obese women (BMI 34.9 ± 3.8kg/m˛) underwent a caloric 
restriction protocol of 800 kcal/d (formula diet, kindly provided by MOD-
IFAST®, Nutrition & Santé, France) with additional 200g of vegetables for 
28 days. Anthropometric and clinical parameters, gut permeability and 
insulin sensitivity were analysed before and immediately after interven-
tion. To assess gut permeability we used a standardized four-sugar-test 
(mannitol, lactulose, sucrose, sucralose) and measured plasma zonulin 
and lipopolysaccharide binding protein (LBP).  
Results: The dietary intervention induced a mean weight loss of 
6.9 ± 1.9kg. In parallel, total cholesterol, HDL-cholesterol, LDL-choles-
terol, triacylglycerides and fasting blood sugar values showed significant 
reductions. HOMA-IR, chemerin, leptin, hsCRP and LBP decreased, 
whereas RANTES and MCP-1 were unaffected. The intestinal permea-
bility marker zonulin was significantly reduced after weight loss, and the 
sugar absorption test indicated a significant improvement of the intestinal 
barrier.  
Conclusion: Our findings demonstrate that a four-week dietary restric-
tion plus weight loss improves gut barrier integrity in obese women.
T3:OS3.3
Fine mapping of a GWAS-derived obesity candidate region on 
chromosome 16p11.2
Volckmar A.1, Song J.Y.2, Jarick I.3, Pütter C.6, Goebel M.1, Horn L.1, 
Struwe C.1, Haas K.1, Knoll N.1, Grallert H.4, Illig T.5, Reinehr T.7, Wang H.J.2, 
Hebebrand J.1, Hinney A.1
1Department of Child and Adolescent Psychiatry, Universitätsklinikum Essen, 
University of Duisburg-Essen, Essen, Germany,  
2Institute of Child and Adolescent Health, School of Public Health, Peking 
University, China,  
3Institute of Medical Biometry and Epidemiology, University of Marburg, 
Germany,  
4Institute of Epidemiology, Helmholtz-Zentrum Munich, Germany, 
5Hannover Unified Biobank, Hannover Medical School, Hannover, Germany,  
6Institute of Medical Informatics, Biometry and Epidemiology, University of 
Duisburg-Essen, Germany,  
7Vestische Hospital for Clinic of Children and Adolescents Medicine, Datteln, 
University of Witten/Herdecke, Witten, Germany
Large-scale genome-wide association studies (GWASs) have identi-
fied 32 chromosomal loci associated with increased body mass index in 
population-based studies on adults. One of these SNPs, rs7359397, tags 
a large region (approx. 1MB) with high linkage disequilibrium (r˛>0.7), 
which comprises five genes (SH2B1, APOBR, sulfotransferases: SUL-
T1A1 and SULT1A2, TUFM). We had previously described a rare muta-
tion in SH2B1 solely identified in extremely obese individuals but not in 
lean controls. The coding regions of the genes APOBR, SULT1A1, SUL-
T1A2, and TUFM were screened for mutations (dHPLC, SSCP, Sanger 
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non-synonymous variants were genotyped (TaqMan® SNP Genotyping, 
MALDI TOF, PCR-RFLP) in independent large study groups (up to 3,210 
extremely obese/overweight cases, 485 lean controls and 615 obesity tri-
os). In silico tools were used for the prediction of potential functional ef-
fects of detected variants. Except for TUFM we detected non-synonymous 
variants in all screened genes. Two polymorphisms rs180743 (APOBR 
Pro428Ala) and rs3833080 (APOBR Gly369 Asp370del9) showed nomi-
nal association to (extreme) obesity (uncorrected p = 0.003 and p = 0.002, 
respectively). In silico analyses predicted a functional implication for 
rs180743 (APOBR Pro428Ala). Both APOBR variants are located in the 
repetitive region with unknown function. Variants in APOBR contributed 
as strongly as variants in SH2B1 to the association with extreme obesity in 
the chromosomal region chr16p11.2. In silico analyses implied no func-
tional effect of several of the detected variants. Further in vitro or in vivo 
analyses on the functional implications of the obesity associated variants 
are warranted.
T3:OS3.4
Cardiorespiratory fitness, body composition and health 
related quality of life 2 years after Roux-en-Y gastric bypass 
surgery in adolescents
Brissman M.1, Ekbom K.1, Hagman E.1, Mĺrlid S.2, Gronowitz E.2, 
Flodmark C.E.3, Olbers T.2, Marcus C.1
1Karolinska Institutet, Department of Clinical Science, Intervention and 
Technology, Division of Paediatrics, Stockholm, Sweden,  
2Dept of Surgery, Sahlgrenska University of Gothenburg,  
3Childhood Obesity Unit, University Hospital, Malmö
Introduction: Obesity in adolescents is a worldwide health problem. We 
have previously shown promising results two years after Roux-en-Y gas-
tric bypass surgery on weight loss, metabolic risk markers and quality of 
life in adolescents – the AMOS study. The aim of the current study was to 
describe the two-year outcome in cardiorespiratory fitness, body compo-
sition, physical activity and the relationship with health-related quality of 
life for adolescents in a subset of the AMOS study.  
Methods: Forty-one adolescents (10 boys, 31 girls, age 14–18 years, body 
mass index 35–69 kg•m-2) were included and underwent surgery. In ad-
dition to anthropometrical measurements participants performed a sub 
maximal bicycle test, a six minute walk test, dual-energy X-ray absorpti-
ometry and the Short Form-36 Health Survey as well as a short interview 
at baseline, one and two years after surgery.  
Results: Relative VO2max per kg body mass (+51%) and per kg fat-free 
mass (+18%) as well as walking distance (+14%) were significantly in-
creased one year and persisting two years after surgery compared to base-
line. Despite a reduction of fat-free mass (-9.8 ± 5.2 kg) absolute VO2max 
was maintained (+9%, ns) and significantly increased in non-smokers. 
Body mass and fat mass was significantly decreased (-45.4 ± 18.9 kg and 
–33.6 ± 13.4 kg respectively). Self-reported physical activity was signifi-
cantly increased and health-related quality of life was improved or un-
changed.  
Conclusion: Roux-en-Y surgery in obese adolescents significantly im-
proved relative VO2max, functional capacity, physical activity and body 
composition over two years. Absolute VO2max increased in non-smokers 
despite a reduction in fat-free mass indicating an improved metabolism 
and cardiorespiratory function. This has not been observed in adults and 
indicates that it may be better to perform obesity surgery early in life.
T3:OS3.5
What is the role of fat-free mass and resting metabolic rate in 
the control of food intake?
Hopkins M.1, Finlayson G.2, Duarte C.3, Whybrow S.4, Horgan G.W.5, 
Blundell J.E.2, Stubbs R.J.6
1Academy of Sport and Physical Activity, Faculty of Health and Wellbeing, 
Sheffield Hallam University, Sheffield, United Kingdom,  
2Institute of Psychological Sciences, Faculty of Medicine and Health, University 
of Leeds, Leeds, United Kingdom,  
3Cognitive and Behavioural Centre for Research and Intervention, University of 
Coimbra, Coimbra, Portugal,  
4Public Health Nutrition Research Group, Rowett Institute of Nutrition and 
Health, University of Aberdeen, Aberdeen, United Kingdom,  
5Biomathematics and Statistics Scotland, Aberdeen, United Kingdom,  
6College of Life and Natural Sciences, University of Derby, Derby, United 
Kingdom
Background: The relationship between body composition, energy expen-
diture and ad libitum energy intake has rarely been examined under con-
ditions that allow any interplay between these variables to be disclosed. 
Objective: The present study examined the relationships between body 
composition, energy expenditure and energy intake under controlled lab-
oratory conditions in which the energy density and macronutrient content 
of the diet varied freely as a function of food choice. Design: Fifty nine 
subjects (30 males: BMI = 26.7 ± 4.0 kg/m2; 29 females: BMI = 25.4 ± 3.5 
kg/m2) completed a 14 day stay in a residential feeding behaviour suite. 
During days 1 and 2, subjects consumed a fixed diet designed to main-
tain energy balance. On days 3–14, food intake was covertly measured 
in subjects who had ad libitum access to a wide variety of foods typical 
of their normal diets. Resting metabolic rate (indirect calorimetry), total 
daily energy expenditure (doubly labelled water) and body composition 
(deuterium dilution) were measured on days 3–14.  
Results: Hierarchical multiple regression models indicated that after con-
trolling for age and sex, fat-free mass (p < 0.001) and resting metabolic 
rate (p < 0.001) predicted daily energy intake. Importantly however, a me-
diation model using path analysis indicated that the effect of fat-free mass 
(and fat mass) on energy intake was fully mediated by resting metabolic 
rate (p < 0.001).  Conclusions: These data indicate that resting metabolic 
rate is a strong determinant of energy intake under controlled laboratory 
conditions where food choice is allowed to freely vary and subjects are 
close to energy balance. Therefore, the conventional adipocentric mod-
el of appetite control should be revised to reflect the infuence of resting 
metabolic rate.
Acknowledgement: The present study was funded by the Food Standards Agency, 
UK.
T3:OS3.6
Isolation of genomic region involved in nutrigenetic and 
pharmacogenetic interactions affecting adipose tissue depots 
and metabolic profile in a novel congenic rat strain
Školníková E.1, Liška F.1, Šedová L.1, Křenová D.1, Křen V.1, Šeda O.1
1Institute of Biology and Medical Genetics, Charles University, General Teaching 
Hospital, Prague, Czech Republic
In a process of positional cloning of metabolic-syndrome related locus we 
derived new congenic strain by introgressing a limited rat chromosome 4 
(RNO4) region comprising A2m gene from spontaneously hypertensive 
rat (SHR) into BN-Lx (Brown Norway) genomic background.  
Methods: We mapped the differential segment by using >140 microsatel-
lite markers on RNO4. Male rats (n =6/strain/diet) of BN-Lx and BN-Lx.
SHR4(A2m) were fed standard diet for 15 weeks (STD, control groups) 
or STD followed by 10 days of high-sucrose diet (HSD) or dexametha-
sone (DEX) for 3 days. We assessed comprehensively the morphometric 
and metabolic profiles of all groups. Two-way ANOVA with STRAIN and 
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Results: The differential segment of RNO4 spans about 9Mb between 
markers D4Mgh30-D4Mit26. The morphometric analysis showed sig-
nificant nutrigenetic and pharmacogenetic interactions of the differen-
tial segment for relative weights of visceral (p = 0.02) and retroperitone-
al (p = 0.01) fat depots. The congenic strain was more sensitive to both 
HSD-induced increase and dexamethasone-induced decrease of the fat 
mass. Also, the global insulin resistance indices showed more robust de-
terioration in BN-Lx.SHR4(A2m) (e.g. area under the glycemic curve 
rose by 88% compared to 13% in BN-Lx in response to DEX). BN-Lx.
SHR4(A2m) exhibited significantly lower levels of PP and PYY in serum. 
The sequence comparison showed several distinct genes with non-synon-
ymous amino acid changes including Ankrd26, A2m and Pex5.  
Conclusion: We have identified a nutrigenetic and pharmacogenetic in-
teraction involving HSD / DEX and RNO4 segment of spontaneously hy-
pertensive rat origin affecting glucose tolerance and fat deposition.
Acknowledgement: Supported by MSMT LK11217.
T8:OS3 – Bariatric and Metabolic Surgery
T8:OS3.1
Remission rates of diabetes mellitus after gastric bypass 
surgery for obesity
Backman O.1, Jia T.2, Marsk R.1, Naslund E.1, Rasmussen F.2
1Departement of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 
Stockholm, Sweden,  
2Department of Public Health, Karolinska Institutet, Stockholm, Sweden
Background: Bariatric surgery has been suggested to cause remission of 
diabetes mellitus (DM) in up to 80% of patients operated. However, fol-
low-up is often short (2 years) and many patients are treated in specialised 
surgical centres. This study aims to assess the rate of remission of DM 
after Roux-en-Y gastric bypass (RYGB) in a nationwide cohort using the 
Swedish prescription registry with a four-year follow-up.  
Methods: From the nationwide inpatient registry 3099 patients who had 
undergone a RYGB procedure was identified (ICD codes JDF 10, JDF 11). 
A general population reference cohort, matched on age and gender, was 
created with 30990 subjects. Linkage was performed to the nationwide 
Swedish prescription registry with ATC codes A10A, A10B. The percent-
age of subjects who had at least one prescription dispensed the year be-
fore surgery (or pseudosurgery date) and during 4 years after surgery was 
calculated. The number of new cases of DM (no prescription dispensed 
before surgery with a prescription filled after surgery) during follow-up 
was also assessed.  
Results: Mean ±SD age was 41.1 ±10.2 and 76% were females. In the sur-
gical cohort, 15.3% were treated for DM before surgery and 9.0, 6.4, 6.3, 
6.3% at 1, 2, 3 and 4 years after surgery. The corresponding proportions in 
the control cohort were 1.8, 2.0, 2.2, 2.3, 2.5%, before, 1, 2, 3 and 4 years 
after the pseudosurgical date. There were 3.5% new cases in the control 
cohort and 1.0% in the surgical cohort during the 4-year follow-up period. 
Conclusion: In this nationwide cohort study, RYGB results in a significant 
reduction of patients treated for DM during a 4-year follow-up period. 
The number of new cases of DM in patients that have undergone RYGB is 
comparable that of the general population.
T8:OS3.2
5-year follow-up of omentectomy in addition to bariatric 
surgery and potential effects on metabolic risk factors
Andersson D.P.1, Eriksson-Hogling D.1, Rydén M.1, Bäckdahl J.1, Thorell A.2, 
Löfgren P.1, Arner P.1, Hoffstedt J.1
1Department of Medicine, Karolinska University Hospital Huddinge, Karolinska 
Institutet, Stockholm, Sweden,  
2Department of Surgery, Ersta Hospital, Karolinska Institutet, Stockholm, 
Sweden
Background: Visceral obesity is a risk factor for cardiovascular disease. 
However, removal of a large portion of visceral adipose tissue by omen-
tectomy in addition to gastric bypass operation (GBP) has not shown any 
additional positive metabolic effects after up to 2 years follow-up. The aim 
of this study was to investigate the impact of omentectomy on cardio-met-
abolic risk factors at a longer follow-up time.  
Methods: 81 obese women, that had previously been randomized to GBP 
in conjunction with omentectomy or GBP alone in a previous double 
blind controlled trial studying the potential effect of omentectomy, were 
asked to be re-examined with dual-energy X-ray absorptiometry for body 
composition, blood pressure, fasting glucose, insulin sensitivity measured 
by homeostasis model assessment of insulin resistance (HOMA-IR) and 
blood lipids 5 years after surgery.  
Results: There were no significant differences between the omentecto-
my (n=40) and non-omentectomy group (n=41) at baseline in the whole 
group in any of the measured variables (p = 0.09–0.93). Twenty-six 
omentectmized and 26 non-omentectomized women completed the 
examination five years postoperatively. There were no significant differ-
ences between the omentectomy and non-omentectomy group regarding 
HOMA-IR (1.42 ± 0.72 mmol/l x mU/l and 1.15 ± 0.55 mmol/l x mU/l 
respectively), cholesterol (4.28 ± 0.76 mmol/l and 4.20 ± 0.86 mmol/l re-
spectively), HDL-cholesterol (1.64 ± 0.52 mmol/l and 1.56 ± 0.43 mmol/l 
respectively), triglycerides (0.92 ± 0.32 mmol/l and 0.99 ± 0.61 mmol/l 
respectively) or BMI (31.4 ± 6.0 kg/m2 and 30.7 ± 5.2 kg/m2 respectively) 
(p = 0.16–0.73).  
Conclusion: In our cohort, removal of the greater omentum in addition 
to GBP does not result in any enhanced positive effects 5 years post-op-
eratively.
T8:OS3.3
Bariatric surgery increases the risk of osteoporosis and 
fractures in women in the Swedish Obese Subjects study
Ahlin S.1, Peltonen M.2, Anveden Ĺ.1, Jacobson P.1, Sjöholm K.1, 
Svensson P.A.1, Larsson I.3, Näslund I.4, Sjöström L.1, Carlsson L.M.1
1Department of Molecular and Clinical Medicine, Institute of Medicine at 
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden,  
2Department of Chronic Disease Prevention, National Institute of Health and 
Welfare, Helsinki, Finland,  
3Department of Medicine, Unit of Clinical Nutrition, Sahlgrenska University 
Hospital, Gothenburg, Sweden,  
4Department of Surgery, Faculty of Medicine and Health, Örebro University 
Hospital, Örebro, Sweden
Introduction: Bariatric surgery is an effective treatment to achieve long-
term weight loss but less is known about the long-term effects of bariatric 
surgery on bone health. The aim of this study is to report the outcome of 
osteoporosis and fracture risk in the Swedish Obese Subject (SOS) study.  
Methods: The SOS study is a controlled, prospective intervention trial 
including 2010 patients that have undergone bariatric surgery and 2037 
matched controls. Study participants were recruited between 1987 and 
2001. Information on osteoporosis and fractures was obtained by cross 
checking social security numbers from the SOS database with ICD9/
ICD10 codes for osteoporosis and fractures in national health registers. 
Information on smoking, age for menopause and physical activity was re-
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Results: Women in the surgery group had a significantly higher risk of 
osteoporosis compared to controls. The incidence rate of osteoporosis was 
16.5 per 10000 person-years (95% confidence interval; CI: 12.2–22.4) for 
women in the surgery group and 6.5 per 10000 person-years (95% CI: 
4.0–10.6) for women in the control group (hazard ratio [HR] 2.48; 95% 
CI: 1.38–4.44; p = 0.002). Women in the surgery group also had a sig-
nificantly higher risk of fracture. The incidence rate of fracture was 55.1 
per 10000 person-years (95% CI: 46.4–65.3) for women in the surgery 
group and 33.9 per 10000 person-years (95% CI: 27.3–42.1) for women 
in the control group (HR 1.62; 95%: CI 1.23–2.13; p = 0.001). Men in the 
surgery group had no significantly elevated risks of osteoporosis and frac-
tures compared to controls.  
Conclusion: Results from the SOS study indicate that bariatric surgery 
increases the risk of osteoporosis and fractures in women.
T8:OS3.4
Pregnancy after gastric banding:a prospective study on the 
impact of gestation on weight loss and quality of life
Disse E.1, Papastathi C.1, Pasquier A.2, Berthiller J.3, Laville M.1, Gouillat C.2, 
Robert M.2
1Department of Endocrinology & Metabolism, University Hospital Lyon Sud, 
Lyon, France,  
2Department of Digestive Surgery, University Hospital Edouard Herriot, Lyon, 
France, 
3Department of Medical Evaluation and Research, Hospices Civil de Lyon, 
France
Background: longitudinal evidence on weight evolution, optimal con-
ception period to assure optimal weight loss and antenatal quality of life 
(QOL) for pregnancies after Laparoscopic Adjustable Gastric Banding 
(LAGB) is sparse.  
Methods: this is a non-randomised, prospective, multi-center cohort. 
Data from 467 obese women that underwent LAGB and were of child-
bearing age were compared to data from 94 women who became preg-
nant. Excess weight loss (%EBL), weight loss evolution, band related 
complications and QOL scores were monitored at 6-month intervals for 
3 years. Outcomes of:
1) gestating women and women that did not get pregnant
2) women who became pregnant during the first 18 months post-opera-
tively and women that gestated afterwards, were compared.  
Results: pregnant women achieved lesser improvements on weight loss 
compared to their peers (BMI 35.4 kg/m2 vs 31.1 kg/m2, P < 0.0001,%EBL 
43.6% vs 64.7%, P < 0.0001). There was no significant difference between 
them in the physical component summary (PCS), (median value 51.1 vs 
53.0, P:0.59) and mental component summary (MCS)(45.1vs 45.0, P:0.79). 
There was no significant impact of the timing of gestation between wom-
en conceiving in the first 18 months compared to those who conceived 
afterwards(BMI 46.6 kg/m2 vs 41.7 kg/m2, P:0.47,% EBL 35.2% vs 35.5%, 
P:0.67, MCS 47.1 vs 43.8, P:0.72, PCS 50.4 vs 51.5, P:0.41), but the first 
group developed digestion problems significantly more (41.7% vs 10.8%, 
P:0.01). In our longitudinal model utilized to determine the independent 
factors of BMI evolution, pregnancy significantly and independently in-
fluenced weight loss (P < 0.0001) but had no significant impact on QOL. 
Conclusions: LAGB provides a significant and sustainable improvement 
on weight loss and QOL measures. Pregnancy influences the extent of 
weight loss and its evolution, but these effects are independent of the con-
ception timing. QOL after gastric banding and pregnancy is not altered 
and it’s not predictive of the weight loss evolution.
T8:OS3.5
Prevalence and Predictors of Nutritional and Medical 
Complications after Roux-en-Y Gastric Bypass in the 
Treatment for Obesity – a Retrospective Cohort Study
Gribsholt S.B.1,2, Pedersen A.M.1, Svensson E.2, Thomsen R.W.2, Richelsen B.1
1Department of Endocrinology and Internal Medicine, Aarhus University 
Hospital, Denmark,  
2Department of Clinical Epidemiology, Aarhus University Hospital, Denmark
Introduction: Medical and nutritional complications after Roux-en-Y 
gastric bypass (RYGB) are an increasing clinical problem. The prevalence 
of these complications is not fully elucidated and their impact on quality 
of life (QoL) is unknown. In a population-based cohort of RYGB patients, 
we aim to estimate the prevalence and possible predictors of these compli-
cations, and their association with QoL.  
Methods: A questionnaire on medical and nutritional complications and 
QoL (SF-12) was mailed to all RYGB-operated patients in the Central 
Denmark Region 2006–2011. By Poisson regression, we calculated risk 
ratios of complications comparing different predictors. The association 
between number of complications and QoL was investigated by Spearman 
rank coefficient.  
Results: The response-rate was 64% (1429/2242 patients; 80% women, 
median follow-up 5 years). Complications leading to contact with the 
health care system were reported by 68%, most commonly fatigue (34%), 
abdominal pain (34%), and anemia (28%). The risk of complications was 
higher in women than men (Incidence Rate Ratio (IRR):1.2, 95% confi-
dence interval (CI); 1.1, 1.4), for smokers (IRR:1.1, 95% CI: 1.0, 1.2) and 
for patients with symptoms before RYGB (IRR:1.3, 95% CI: 1.5, 1.4), while 
the risk was lower for older patients (>45 years vs <35 years, IRR 0.8, 95% 
CI: 0.7, 0.9). QoL decreased with amount of complications (0 = median 
score 44; 5+ =median score 31; r= 0.30). While 8% answered their wellbe-
ing was worse after RYGB, 85% felt better.  
Conclusion: Overall, 68% experienced one or more medical or nutri-
tional complications. Risk of complications differed by gender, age and 
smoking status. The majority reported improved wellbeing after RYGB, 
but increased number of complications was associated with lower QoL.
The idefics intervention: What can we learn for public policy?
Williams G.1
1Department of Politics, Philosophy & Religion, Lancaster University
Introduction: This presentation considers how far findings from IDEFICS 
and similar interventions are relevant to the policy process and political 
decision-making.  
Methods: The presentation offers theoretical and normative arguments 
concerning the evaluation of evidence and its implications for policy. The 
presentation is divided into three parts. The first considers problems in the 
nature and applicability of evidence gained from school- and communi-
ty-level obesity interventions. The second part considers whether such in-
terventions might represent a model that policy-makers could implement. 
The third part considers how we should think about policy measures giv-
en the limited evidence we can obtain and the many different goals that 
public policy must take account of.  
Results: The presentation argues that: (1) there are clear reasons why we 
are not obtaining very solid evidence for effective school- and communi-
ty-level interventions; (2) public policy is not in a good position to man-
date larger-scale, long-term versions of these interventions; and (3) there 
are clear problems in obtaining ‘evidence’ for most public policy options, 
but this should not deter us from pursuing options which tackle system-
ic problems and hold a good likelihood of delivering benefits on several 
dimensions.  
Conclusion: Research on school- and community-level obesity interven-
tions has not produced much evidence that is directly relevant to policy. 
Instead, it shows how difficult it is to affect obesity rates without changing 
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T1:PO.001
Narciclasine attenuates diet-induced obesity and associated 
dysfunctions by promoting oxidative metabolism in skeletal 
muscle in mice and humans
Julien S.G.1, Sinnakannu J.2, Brunmeir R.3, McFarlane C.4, Xu F.5
1Singapore Institute for Clinical Sciences. Brenner Centre for Molecular 
Medicine. Department of Growth, Development and Metabolism. Agency 
for Science, Technology and Research (A*STAR), 30 Medical drive, Singapore 
117609, Republic of Singapore.
Introduction: Given that only 20% of individuals with dietary restrictions 
are able to maintain long-term weight loss, increasing energy expenditure 
is becoming an attractive approach to combat obesity. Physical exercise is 
the ideal way to expend extra energy, but physical activity unfortunately 
continues to decline in the modern lifestyle and is even prevented in some 
cases. Thus, there is a need for novel pharmacological approaches that en-
hance energy expenditure by introducing the same beneficial metabolic 
effects as exercise in humans. 
Methods: Herein, we employ diet-induced obesity mouse model and hu-
man myotube cells; and various approaches such as Indirect calorimetry, 
RNAseq, Seahorse, quantitative RT-PCR, Digital Infrared Thermal Imag-
ing to decipher the effects of narciclasine on bioenergetics. 
Results: Narciclasine (ncls)-treated mice fed a high-fat diet (HFD) showed 
significantly increased energy expenditure and voluntary physical activi-
ty, along with a marked reduction of fat accumulation in liver, skeletal 
muscle and adipose tissues as compared with vehicle treated control mice. 
In addition, ncls promoted Pgc1a gene expression, oxidative metabolism 
and a shift from glycolytic to oxidative fibers in the skeletal muscle of di-
et-induced obese mice. Intriguingly, ncls also enhanced heat production 
in vivo as well as in vitro in both murine and human primary myotubes, 
suggesting a role for this compound in muscle thermogenesis. 
Conclusion: Here, we report a novel pharmacological strategy that atten-
uates diet-induced obesity in mice by mimicking the beneficial metabolic 
effects of endurance training. Our current study demonstrates that nar-
ciclasine has promising potential for the prevention and the treatment of 
obesity in humans. 
Acknowledgement: We thank Drs. Vincent Mouly, Gillian Butler-Browne and Ravi 
Kambadur for providing the human primary myoblasts (36C15Q).
T1:PO.002
Longitudinal changes of serum levels of angiopoietin-like 
protein 6 and selenoprotein P after gastric bypass surgery
Kim S.H.1, Lim J.S.1, Park H.S.1, Lee S.K.2, Jang Y.J.2, Lee Y.J.3, Heo Y.S.4
1Department of Family Medicine, University of Ulsan College of Medicine, 88, 
Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea.,  
2Department of Physiology, University of Ulsan College of Medicine, 88, 
Olympic-Ro 43-Gil, Songpa-gu, Seoul 138-736, South Korea.,  
3Department of Family Medicine, Inha University, College of Medicine,7-206, 
Sinheung-dong 3-Ga, Jung-gu, Incheon 400-711, South Korea.,  
4Department of General Surgery, Inha University, College of Medicine, 7-206, 
Sinheung-dong 3-Ga, Jung-gu, Incheon 400-711, South Korea.
Background: Bariatric surgery has proven to have benefit for weight loss 
and metabolic profiles. Recent evidences suggest that the liver-derived 
hepatokines play a role in the pathophysiology of metabolic diseases. 
However, there are few studies on longitudinal changes in hepatokines af-
ter gastric bypass. Here, we investigated changes in serum levels of angio-
poetin-like protein 6(Angptl6) and selenoprotein P after gastric bypass. 
Methods: We recruited 10 patients who were preformed gastric bypass 
surgery for weight loss. We measured metabolic parameters and serum 
levels of Angptl6 and selenoprotein P before and after surgery(1 month 
and 9 month). We evaluated changes of two hepatokines after surgery and 
correlation between degree of changes in Angptl6/selenoprotein P level 
and metabolic parameters. 
Results: Body mass index linearly decreased after bariatric surgery. 
HbA1C, AST, ALT, GGT, total cholesterol, triglyceride, LDL-cholesterol, 
and Angptl6 significantly decreased at the point of 1 month after surgery 
and then maintained over 9 months. However, significant reducing ef-
fect of fasting insulin and HOMA-IR which is apparent at 1 month after 
surgery was reversed at 9 months after surgery. Regarding hepatokines, 
selenoprotein P level linearly increased. Angptl6 showed significant cor-
relation with LDL-cholesterol and fasting insulin. Change in Angptl6 was 
significantly correlated with changes in total cholesterol and LDL-choles-
terol. Selenoprotein P was inversely correlated with GGT and change in 
selenoprotein P was also inversely correlated with changes in HOMA-IR. 
Conclusion: Our results suggest that gastric bypass surgery could alter 
serum levels of hepatokines independent of weight loss, and that these 
changes might be related to hepatic metabolic changes.
Fig. 1. Longitudinal changes in BMI, HbA1c, HOMA-IR, GGT, serum levels of 
Angtpl6, and selenoprotein P on 1 moth and 9 month after gastric bypass surgery 
in 10 study subjects.
T1:PO.003
Impact of high-fat diet composition on development of 
obesity in mice with whole-body deletion of ampk α2-subunit
Janovska P.1, Flachs P.1, Cerna M.1, Zouhar P.1, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic 
Introduction: Published data have shown both rise (Villena et al, Diabe-
tes 2004) and reduction (Jelenik et al, Diabetes 2010) in body weight (BW) 
gain in mice fed high-fat (HF) diet in response to whole-body deletion of 
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between studies could be related to the composition of HF diet used in 
different experiments. The aims of the our study were to (i) characterize 
the effect of the AMPK α2-/- in the context of dietary obesity induced by 
either by corn-oil based (cHF) or lard-based (HSD) diet, and (ii) check 
possible role of genetic background of the mice. 
Methods: Adult male AMPK α2-/- mice (Viollet, et al, J Clin Invest 2003) 
on either obesity-prone C57BL/6J (B6) or obesity-resistant A/J back-
ground, and their wild-type littermates, were fed either cHF or HSD (both 
60% energy as fat) for 10 weeks. 
Results: Both cHF and HSD induced BW gain with a stronger effect in B6 
mice and with potent effect of HSD as compared with cHF. In B6 mice, 
BW gain correlated with adiposity and hepatic accumulation of lipids and 
the reduction of BW gain was observed only in AMPK α2-/- mice fed cHF 
diet. In the A/J mice, with a relatively small induction of dietary obesity, 
the stronger effect of HSD on BW was observed again, but without impact 
of AMPK α2-/-. Only in AMPK α2-/- mice on A/J background higher 
accumulation of lipids in skeletal muscle, and lower weight of the muscle 
as compared with the wild-type littermates, independent on the type of 
the diet, was detected. 
Conclusion: Only in the B6 mice fed corn-oil based HF diet but not lard-
based HF diet, the paradoxical anti-obesity effect of whole-body deletion 
of AMPK α2-subunit could be detected.
T1:PO.004
Effects of fat distribution on hypertrophic cardiomyopathy 
phenotype
Guglielmi V.1, Marinoni G.M.1, Maresca L.2, Lanzillo C.3, Coppa S.1, 
D‘Adamo M.1, Colangeli L.1, Preziosi P.2, Calň L.3, Sbraccia P.1
1Department of Systems Medicine, University of Rome “Tor Vergata”, Italy,  
2Department of Diagnostic Imaging, Policlinico Casilino, Rome, Italy,  
3Department of Cardiology, Policlinico Casilino, Rome, Italy 
Introduction: Hypertrophic cardiomyopathy (HCM) is the most com-
mon genetic heart disease, characterized by heterogeneous phenotypic 
expression with extreme diversity in the pattern and extent of left ventric-
ular (LV) hypertrophy. Among extrinsic factors, body mass index (BMI) 
and male sex were found independently associated with LV mass increase 
and progression of heart failure symptoms in HCM. The aim of our study 
was to assess whether adipose tissue distribution may influence cardiac 
morphology and function in HCM patients with respect to gender. 
Methods: We studied 24 overweight/obese subjects (age 59.4 ± 12 yrs, 
9F/14M, BMI 29.3 ± 3.7 kg/m2) with echocardiography- and cardiovas-
cular magnetic resonance-based diagnosis of HCM, confirmed by genetic 
analysis. Dual-energy X-ray absorptiometry was used to evaluate body 
composition and regional (trunk and appendicular) fat distribution. 
Results: Age- and gender-adjusted analysis revealed that maximum in-
terventricular septum thickness but not LV mass index was positively 
associated with trunk adipose tissue percentage (β=0.41, p < 0.05). How-
ever, septum thickness showed a stronger association with male gender 
(β=0.61, p < 0.01) compared to abdominal adiposity. In constrast, total 
and appendicular fat percentages were not related to any measure of LV 
mass, volume and function. Instead, BMI was associated with left atrium 
area (β=0.45, p < 0.05), an indirect measure of LV dysfunction, irrespec-
tive of both age and gender. 
Conclusion: In our cohort of HCM patients, septum hypertrophy extent 
was independently associated with abdominal but not total fat. We also 
confirmed that male gender represents another important feature associ-
ated to the magnitude of hypertrophy.
T1:PO.005
Early differences in metabolic flexibility between obesity-
resistant and obesity-prone mice
Bardova K.1, Horakova O.1, Janovska P.1, Kus V.1, van Schothorst E.2, 
Hoevenaars F.2, Hensler M.1, Keijer J.2, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic,   
2Human and Animal Physiology, Wageningen University, Wageningen, The 
Netherlands 
Introduction: Decreased metabolic flexibility supports development of 
adverse consequences of obesity. Metabolic flexibility to glucose is tradi-
tionally assessed using indirect calorimetry (INCA), which also allows for 
measuring energy expenditure. The aims of this study were to (i) char-
acterize metabolic flexibility of obesity-resistant A/J and obesity-prone 
C57BL/6J mice at weaning, i.e. during the switch from lipid to carbohy-
drate intake and before the dissociation in body weight; (ii) to compare 
INCA with glucose tolerance test (GTT) approach. 
Methods: A/J and C57BL/6J mice were maintained at 20°C and weaned 
to chow diet at 30 days of age. During the first day after weaning, using 
separate subgroups of fasted mice (n=8), either GTT (oral, OGTT; and in-
traperitoneal, IGTT; using 1–3 mg glucose/g body weight, BW) or INCA 
oral gavage with 1–7.5 mg glucose/g BW; or a fasting/refeeding protocol) 
were performed, either at 20°C or 34°C (to exclude interference of ther-
mogenesis), using mice of both genders. 
Results: Comparable results were obtained using (i) both OGTT and 
IGTT with 1 mg glucose/g BW at 20°C; (ii) INCA with 7.5 mg glucose/g 
BW at 34°C; and (iii) INCA during fasted/re-fed transition at 34°C. Re-
sults furthermore indicated lower ability to switch between metabolic 
substrates associated with low glucose tolerance and relative hyperglyce-
mia in C57BL/6J as compared with A/J mice. 
Conclusion: We have found lower glucose tolerance using GTT and lower 
metabolic flexibility using INCA in C57BL/6J versus A/J mice. These dif-
ferences between strains may be linked to the differential genetically-de-
termined propensity to obesity of the mice.
T1:PO.006
Association between nafld severity and body composition in 
obese subjects
Pataky Z.1, Genton L.2, Terraz S.3, Pichard C.2, Golay A.1, Spahr L.4
1 Service of Therapeutic Education for Chronic Diseases, WHO Collaborating 
Centre, University Hospital of Geneva and University of Geneva,  
2Service of Clinical Nutrition, University Hospital of Geneva and University of 
Geneva,  
3Service of Radiology, University Hospital of Geneva and University of Geneva,  
4Service of Gastroenterology and Hepatology, University Hospital of Geneva 
and University of Geneva 
Introduction: Nonalcoholic fatty liver disease (NAFLD) is considered the 
hepatic manifestation of the metabolic syndrome. NAFLD prevalence in 
obese patients increases with the worldwide epidemic of obesity and could 
be higher than 70%. The link between overweight or obesity and liver dis-
ease is well known, however, little evidence exists on the relationship be-
tween body composition and the severity of NAFLD. 
Methods: Fifteen overweight or obese patients (age=51.4 ± 8.0, 
BMI=35.1 ± 5.0 kg/m2) with NAFLD (alcohol consumption < 20 gr/week) 
were investigated. NAFLD activity score (NAS) was used to assess dis-
ease severity based on steatosis (0–3), lobular inflammation (0–3) and 
hepatocyte ballooning (0–2). Subjects with NAS ≥ 2 were included in the 
study (NAS=3.5 ± 1.7). Body fat was assessed by bioelectrical impedance 
analysis (BIA) and liver fat content was measured by magnetic resonance 
imaging (MRI). Linear relationships among variables were computed by 
Spearman’s correlations. Multivariable analysis was performed with the 
linear regression model. 
Results: A positive association between percent fat mass and NAS score 
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ing BMI to the model in multiple regression analysis (β=0.22, p = 0.002). 
There was a positive association between serum CRP levels and liver ste-
atosis as evaluated by MRI (Spearman’s coefficient=0.63, p = 0.01). We 
found no association between body fat evaluated by BIA and liver fat con-
tent measured by MRI. 
Conclusion: NAFLD severity is associated with body composition. In-
creased fat mass is linked to higher NAS in obese patients. Body com-
position assessed by BIA could be a complementary method of NAFLD 
assessment before liver biopsy. This approach should be investigated in 
larger cohorts.
T1:PO.007
Lard vs. Corn-oil feeding in mice: Metabolic effects of 
obesogenic diets with different composition of fatty acids
Pavlisova J.1, Kopecky J.1, Rossmeisl M.1
1Department of Adipose Tissue Biology, Institute of Physiology, Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic 
Introduction: Saturated fatty acids (SFA), mainly palmitic acid, could ag-
gravate insulin resistance by triggering proinflammatory responses and 
endoplasmic reticulum stress. Here we compared long-term metabolic 
effects of two high-fat diets (35% fat; wt/wt); one with a high content of 
SFA in a form of pork lard (HL) and the other with a high content of n-6 
polyunsaturated fatty acids in a form of corn-oil (HO). 
Methods: Subgroups (n = 8) of male C57BL/6N mice were fed the experi-
mental diets for 8 weeks. Tissue and plasma samples were collected for the 
assessment of lipid composition and gene expression analysis by qPCR. 
Insulin sensitivity was assessed by hyperinsulinaemic-euglycaemic clamp 
in a separate experiment. 
Results: No differences in body weight gain and energy intake were ob-
served between the HL and HO group. Neutral lipids accumulated sig-
nificantly less in plasma of HL mice (HO 64 ± 6 mg/dl; HL 53 ± 4 mg/dl), 
which was, however, at the expense of severe hepatic steatosis (liver tri-
glycerides: HO 133 ± 6 mg/g; HL 225 ± 15 mg/g). This was accompanied 
by a substantial increase (1,7-fold) in hepatic expression of stearoyl-CoA 
desaturase-1 (SCD-1) gene in HL group. Hepatic as well as whole-body 
insulin sensitivity were impaired to a similar extent in both groups. 
Conclusion: Our results suggest that high intake of SFA induces adaptive 
increases in hepatic SCD-1 gene expression in order to transform SFA into 
less toxic monounsaturated fatty acids, which are more willingly re-ester-
ified to neutral triglycerides in the liver, thus causing hepatic steatosis. 
Therefore, despite significantly different level of hepatic steatosis, insulin 
sensitivity of HO- and HL-fed animals remaines comparable. 
Acknowledgement: Research relating to this abstract was funded by Czech Science 
Foundation (grants 13-00871S and 14-09347S)
T1:PO.008
Rat intestine urea cycle is geared to produce ornithine and 
citruline in detriment of arginine
Agnelli S.1, Arriarán S.1, Remesar X.1,2,3, Fernández-López J.A.1,2,3, 
Alemany M.1,2,3
1Department of Nutrition and Food Science, Faculty of Biology, University of 
Barcelona, Barcelona, Spain,  
2Institute of Biomedicine of the University of Barcelona, Barcelona, Spain,  
3CIBEROBN, Spain 
Male adult lean Zucker rats fed standard chow or a hyperproteic diet 
for 30 days, were killed, and their small intestine was dissected, cleaned 
and cut in three equal-length segments. They were weighed and frozen. 
Later, the samples were used for the measurement of enzyme activities: 
AMP-deaminase, carbamoyl-P-synthases and Orn transcarbamylase. The 
samples were also used for the analysis of gene expression of these en-
zymes, plus glutaminase, Gln synthase, N-acetyl-Glu synthase, arginase 
2, argininosuccinate synthase and lyase, and nitric oxide synthase. There 
were significant differences in activity (Orn transcarbamylase) and gene 
expression (carbamoyl-p- synthase 1, AMP deaminase, argininosuccinate 
synthase, arginase 2 and endothelial nitric oxide synthase) along the 3 in-
testine segments. The level of gene expression for urea cycle enzymes was 
highest for carbamoyl-P synthases (mainly type 1) and arginase 2. The 
lowest number of transcript copies per mg protein was for argininosuc-
cinate synthase, probably the cycle controlling enzyme. High expression 
of glutaminase (vs. Gln synthase) and AMP deaminase, combined with 
high expression (and total activity) of carbamoyl-P-synthases ensured the 
smooth generation of carbamoyl-P. The high number of transcript copies 
(and enzyme activity) of Orn-transcarbamylase and N-acetyl-Glu syn-
thase ensued a rapid flow of both Orn and Cit. On the other side, an active 
arginase also could, potentially, help increase the levels of Orn (and thus 
Cit). These changes agree with the known production of urea cycle inter-
mediates in the intestine. There were no changes in the overall panorama 
described when the rats were fed a hyperproteic diet.  
Acknowledgement: Grants: PN Biomedicina SAF2012-34895, and PN Ciencia y 
Tecnología de los Alimentos AGL-2011-23635 from the Government of Spain
T1:PO.009
Analysis of npy expression in peripheral blood mononuclear 
cells as a biomarker of recovery of fasting sensitivity 
associated to weight loss
Reynés B.1, Cifre M.1, Díaz-Rúa R.1, Palou A.1, Oliver P.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology (LBNB), 
Universitat de les Illes Balears and CIBER de Fisiopatología de la Obesidad y 
Nutrición (CIBERobn), Palma de Mallorca, Spain 
Introduction: Peripheral blood mononuclear cells (PBMC) are consid-
ered as a good source of biomarkers to define health/disease. We have 
reported that PBMC can reflect, at transcriptomic level, metabolic alter-
ations related to obesity, as fasting insensitivity, even in early stages of 
weight gain. We aimed to evaluate if PBMC were also able to reflect meta-
bolic recovery related to weight loss. 
Methods: Expression of key energy metabolism genes (Fasn, Srebp1, 
Pparg, Cpt1a and Npy) was measured by real-time RT-PCR in PBMC 
samples of normoweight, cafeteria-obese rats and rats fed a control bal-
anced diet after the intake of a cafeteria diet (post-cafeteria model) in fed 
and fasted conditions. Groups with different periods of diet administra-
tion were used. 
Results: Genes analysed in PBMC followed the expected fasting regula-
tion which disappeared in obese rats and, interestingly, was recovered in 
post-cafeteria animals, although results were somehow dependent of time 
of diet administration and age of the animals. The most robust and out-
standing results were obtained for the orexigenic Npy gene. As expected, 
Npy expression increased with fasting; increased expression was of high 
magnitude and independent of the age of the animals. This fasting reg-
ulation was lost in cafeteria-fed animals and recovered in post-cafeteria 
rats regardless of time of administration of the balanced diet. A similar 
regulatory behaviour was observed when analysing Npy expression in hy-
pothalamus. 
Conclusion: Gene expression analysis in PBMC could be useful to deter-
mine effectiveness of body weight loss programs. Particularly, Npy expres-
sion in PBMC appears especially useful as marker of fasting sensitivity 
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T1:PO.010
Fibroblast-like de-differentiation of adipocytes co-cultured 
with pancreatic adenocarcinoma cells
Zoico E.1, Darra E.1, Rizzatti V.1, Franceschetti G.1, Budui S.1, Guerra C.1, 
Buffoli L.1, Menegazzi M.V.2, Cinti S.3, Zamboni M.1
1Department of Medicine, Geriatric Section, University of Verona, Verona, Italy,  
2Biochemistry, Department of Life and Reproduction Sciences, University of 
Verona, Verona, Italy,  
3Institute of Human Morphology, University of Ancona, Ancona, Italy 
Introduction: The epidemiological association between excess adipose 
tissue and pancreatic cancer has been demonstrated. However the role of 
adipose tissue in pancreatic cancer microenvironment has not been stud-
ied. 
Methods: 3T3-L1 adipocytes and pancreatic tumor cells (MiaPaCa2) were 
co-cultured using a transwell culture system. After 5 days from adipocyte 
induction (post-induction day=PID 5, MiaPaCa2 were seeded in the top 
chamber and maintained in co-culture for 6 (PID 11) and 9 (PID 14) days. 
3T3-L1 adipocytes in co-culture or not were stained with Oil Red O and 
observed at photomicroscope; electron microscope images were obtained 
for 3T3-L1 adipocytes in co-culture or not. RT-PCR analyses were per-
formed in 3T3-L1 adipocytes in co-culture and in controls for the main 
genes of interest. EMSA was used on nuclear protein extraction. 
Results: After 6 and 9 days of co-culture we observed the appearance of 
cells with simil-fibroblast aspect, not present in control conditions (Fig-
ure 1). Moreover in co-culture, adipocytes were significantly reduced in 
number, size and lipid droplets content. After 9 days of co-culture, we 
found a decrease in gene expression of GLUT-4, HSL, adiponectin and 
leptin, compared with controls, as well as an increase in the expression of 
MMP11, OCT 3/4, SOX 2, C-MYC, KLF4, suggesting a de-differentiation 
phenomenon (Figure 2). Moreover glycerol release in culture medium sig-
nificantly decreased after co-culture. In MiaPaCa2 the expression of WnT 
5a increased early in co-culture with 3T3-L1. EMSA of c-JUN and AP1 
in 3T3-L1 demonstrated an increased signal in adipocytes in co-culture 
at PID 11 and 14.
Conclusions: These data first showed the de-differentiation of adipocytes 
after co-culture with pancreatic cells toward a fibroblast-like phenotype. 
The cross talk between adipocytes and cancer cells may profoundly influ-
ence tumor microenvironment, growth and invasion.
Fig. 1. Images of red-oil staining of 3T3-L1 in co-culture with MiaPaCa2 and as 
controls, at PID (Post-induction day) 8,  11, 14.
Fig. 2. Real-time PCR gene expression analyses in 3T3-L1 after 9 days of 
co-culture (PID 14) with MiaPaCa2 cells and in controls (PID 14).
T1:PO.011
Seipin is necessary for normal brain development and 
spermatogenesis in addition to adipogenesis
Ebihara C.1, Ebihara K.1,2, Abe M.A.1,2, Mashimo T.3, Tomita T.1, Zhao M.1, 
Gumbilai V.1, Kusakabe T.1,4, Yamamoto Y.1, Aotani D.1,4, Kataoka S.Y.1, 
Sakai T.1, Hosoda K.1,2,5, Serikawa T.3, Nakao K.1,4
1Department of Medicine and Clinical Science, Kyoto University Graduate 
School of Medicine, Kyoto, JAPAN,  
2Institute for Advancement of Clinical and Translational Science, Kyoto 
University Hospital, Kyoto, JAPAN,  
3Institute of Laboratory Animals, Kyoto University Graduate School of Medicine, 
Kyoto, JAPAN,  
4Medical Innovation Center, Kyoto University Graduate School of Medicine, 
Kyoto, JAPAN,  
5Department of Health and Science, Kyoto University Graduate School of 
Medicine, Kyoto, JAPAN
Seipin, encoded by BSCL2 gene, is a protein whose physiological func-
tions remain unclear. Mutations of BSCL2 cause the most-severe form of 
congenital generalized lipodystrophy (CGL). BSCL2 mRNA is highly ex-
pressed in the brain and testis in addition to the adipose tissue in human, 
suggesting physiological roles of seipin in non-adipose tissues. Since we 
found BSCL2 mRNA expression pattern among organs in rat is similar 
to human while BSCL2 mRNA is not highly expressed in mouse brain, 
we generated a Bscl2/seipin knockout (SKO) rat using the method with 
ENU (N-ethyl-N-nitrosourea) mutagenesis. SKO rats showed total lack 
of white adipose tissues including mechanical fat such as bone marrow 
and retro-orbital fats, while physiologically functional brown adipose tis-
sue was preserved. Besides the lipodystrophic phenotypes, SKO rats also 
showed impairment of spatial working memory with brain weight reduc-
tion and infertility with azoospermia. We confirmed reduction of brain 
volume and number of sperm in human patients with BSCL2 mutation. 
This is the first report demonstrating that seipin is necessary for normal 
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T1:PO.012
Cardiotrophin-1 decreases intestinal sugar absorption
López-Yoldi M.1,2, Barber A.1, Prieto J.3,4, Martínez J.A.1,2,5, Bustos M.3, 
Moreno-Aliaga M.J.1,2,5
1Department of Nutrition, Food Science and Physiology, University of Navarra, 
Pamplona, Navarra, Spain,  
2Centre for Nutrition Research. University of Navarra, Pamplona, Navarra, Spain,  
3Department of Gene Therapy and Hepatology, CIMA, University of Navarra, 
Pamplona, Navarra, Spain,  
4CIBERehd. Institute of Health Carlos III, Madrid, Spain,  
5CIBERobn, Physiopathology of Obesity and Nutrition, Institute of Health Carlos 
III, Madrid, Spain 
Introduction: Cardiotrophin-1 (CT-1) is a member of the IL-6 family 
of cytokines with a key role in glucose and lipid metabolism. We have 
previously reported the anti-obesity properties of chronic CT-1 treatment 
in genetic and dietary models of obesity. In the present study, we aim to 
examine the in vitro and in vivo effects of CT-1 on intestinal sugar ab-
sorption in mice. 
Methods: Small intestine everted rings were used to evaluate the in vitro 
effects of different concentrations of CT-1 (1–100 ng/ml) on alpha-meth-
ylglucoside (alpha-MG) uptake. Rings were preincubated during 1 h with 
the cytokine and then alpha-MG (1 mM) uptake was measured for 15 
min. In addition, the effects of acute (single dose) and chronic (6 days) 
CT-1 administration (5 μg/mice, i.v.) on alpha-MG uptake were also eval-
uated in wild type and CT-1 knock-out mice. At the end of the treatment, 
intestinal everted rings were obtained and the uptake of alpha-MG (1 
mM, 15 min) was also measured. 
Results: In vitro CT-1 treatment caused a significant decrease on al-
pha-MG absorption at different doses (1–50 ng/ml). This effect was not 
observed with CNTF, another cytokine of the same family. Interestingly, 
both acute and chronic CT-1 administration to mice also induced a signif-
icant reduction on alpha-MG uptake in intestinal everted rings. 
Conclusion: The present data demonstrate the ability of CT-1 to inhibit intestinal 
sugar absorption both in vivo and in vitro, which could contribute to the hypoglyce-
mic and anti-obesity properties of this cytokine. Acknowledgement: This study was 
supported by grants from the Government of Navarra (Department of Health); Mu-
tua Madrileńa Foundation; FIS (PI10/01516 and PI13/01851); Línea Especial “Nu-
trición, Obesidad y Salud Universidad de Navarra”; and by the agreement between 
FIMA and the “UTE project CIMA”. M.L-Y. was supported by a doctoral grant from 
Asociación de Amigos University of Navarra.
T1 – Genetics, epigenetics and omics
T1:PO.013
New alleys to tackle obesity: Understanding naturally 
occurring weight resistance inconstitutionally thin individuals
Alexandre V.1, Germain N.2, Galusca B.2, Wynn E.3, Hager J.1, Estour B.2
1Nestlé Insitute of Health Sciences SA, Nutrition and Metabolic Health unit,  
2Saint-Etienne Hospital, Endocrinology Department,  
3Nestle Research Center, Clinical Development Unit 
Introduction: Constitutional thinness (CT) is a metabolically normal, 
weight gain resistant phenotype that mirrors obesity. CT individuals 
present low BMI (< 18.5 kg/m˛), with normal metabolic profile and no 
eating disorders. A pilot study on 10 CT versus 10 controls overfed for 
one month showed that CT individuals are resistant to weight gain and 
present an increased basal metabolism, a gap between energy intake and 
expenditure, an increase in anorexigenic hormonal profile and a specific 
change in urine metabolomics. The basis for this is not known but gene 
expression patterns in adipose tissue showed significant differences in 
CTs versus controls at baseline. These preliminary data pointing towards 
a human weight gain resistant phenotype prompted us to design a larger 
intervention trial to study these individuals exhaustively.  
Methods: We designed a clinical study to investigate the molecular and 
physiological differences between 35 CT and 35 controls, before and after 
15 days of overfeeding providing an extra daily 600 kcal with Renutryl 
Booster®. The main outcomes are the changes in transcriptomics, lipid-
omics, proteomics and metabolomics of biopsies (abdominal fat and mus-
cle), plasma and urines before and after the overnutrition period. Changes 
in anthropometric parameters, energy metabolism, muscle and fat histol-
ogy, fecal microbiota and bone quality are also assessed.
Results: Here we will present an introduction to constitutional thinness 
and the design of the clinical study for in-depth characterization of this 
interesting phenotype.
Conclusion: Results will provide an extensive characterization of CT and 
new insights about the pathways and mechanisms involved in resistance 
to weight gain. This may lead to new, more efficient strategies for treating 
obesity.
T1:PO.014
The role of Plzf (Promyelocytic leukemia zinc finger) gene 
in regulation of metabolic and hemodynamic traits in the 
spontaneously hypertensive rat
Pravenec M.1, Silhavy J.1, Landa V.1, Zidek V.1, Mlejnek P.1, Strnad H.2, 
Peterkova R.3, Peterka M.3, Liska F.4, Kazdova L.5, Izsvak Z.6, Mancini M.7
1Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, 
Czech Republic,  
2Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 
Prague, Czech Republic,  
3Institute of Experimental Medicine, Academy of Sciences of the Czech 
Republic, Prague, Czech Republic,  
4Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles 
University in Prague, Czech Republic,  
5Institute for Experimental Medicine, Prague, Czech Republic,  
6Max-Delbrück-Center for Molecular Medicine, Berlin, Germany,  
7Sapienza University of Rome, Rome, Italy 
Introduction: The spontaneously hypertensive rat (SHR) is the most 
widely used model of essential hypertension and is predisposed to left 
ventricular hypertrophy, myocardial fibrosis, and metabolic disturbanc-
es. Recently, a quantitative trait locus (QTL) influencing blood pressure, 
left ventricular mass and heart interstitial fibrosis was genetically isolated 
within 788 kb on chromosome 8 segment of SHR-PD5 congenic strain 
that contains only 7 genes, including mutant Plzf gene. 
Methods: To identify Plzf as a quantitative trait gene (QTG), we target-
ed Plzf in the SHR using the TALEN technique and obtained SHR line 
harboring mutant Plzf gene with a premature stop codon at position of 
amino acid 58. 
Results: The Plzf mutant allele is semi-lethal since approximately 95% 
of newborn homozygous animals die perinatally due to a caudal regres-
sion syndrome. Heterozygous rats were grossly normal and were used for 
metabolic and hemodynamic analyses. SHR-Plzf+/- versus SHR wild type 
controls exhibited reduced body weight and relative weight of epididymal 
fat, lower serum and liver triglycerides, as well as lower serum and liver 
cholesterol. In addition, SHR-Plzf+/- rats exhibited significantly increased 
sensitivity of adipose and muscle tissue to insulin action when compared 
to wild type controls. The SHR-Plzf+/- heterozygous rats vs. wild type 
controls showed significant amelioration of cardiomyocyte hypertrophy 
and fibrosis. Gene expression profiles revealed differential expression of 
genes with the role in cell cycle. 
Conclusion: These results provide evidence for important role of Plzf in 
regulation of metabolic and hemodynamic traits in the rat and suggest 
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T1:PO.015
Biotin (vitamin b7) biology is altered and linked to 
inflammation in obesity – a study of monozygotic twins
Järvinen E.1, Muniandy M.1, Ismail K.2, Bogl L.2, Tummers M.1, Kaprio J.2, 
Rissanen A.1, Ollikainen M.2, Pietiläinen K.1
1Obesity Research Unit, Research Programs Unit, University of Helsinki, Finland,  
2Department of public health, University of Helsinki, Finland 
Introduction: Biotin modifies chromatin structure by biotinylation, and 
functions as a coenzyme for carboxylases regulating fatty acid metabo-
lism, amino acid catabolism and gluconeogenesis. We investigated if these 
biotin-dependent functions are altered in obesity. Subjects: Monozygotic 
(MZ) twins, n= 14–26 weight discordant pairs (deltaBMI>3), depending 
on analysis 
Methods: DNA methylation from blood leukocytes and adipose tissue 
(AT) was analyzed by Infinium Human Methylation 450 Bead Chip Ar-
ray, gene expression from AT and adipocytes (A) by Affymetrix U133 Plus 
2.0 and of leucocytes with RT-qPCR. Serum biotin, CRP and triglycerides 
(TG) were measured by standard methods. Human adipocytes were cul-
tured in low and high biotin concentrations, and analyzed by Affymetrix 
U133 Plus 2.0 and imaging methods. 
Results: In the leucocytes of the obese co-twins the biotin pathway was 
less methylated, biotin-dependent carboxylase PCCB and MCCC1 gene 
expressions were upregulated and correlated positively with CRP (PCCB 
0.91; p = 0.0046 and MCCC1 0.79; p = 0.036). Serum biotin levels were 
lower in the obese (274 ng/l) than the lean co-twin (390 ng/l, p = 0.034), 
and the levels correlated negatively with TG (-0.56, p = 0.045). In AT 
and A gene expression arrays, biotin-dependent carboxylases (ACACA, 
ACACB, PCCB, MCC2) were downregulated (p < 0,05) in the obese co-
twins. In adipocytes cultured in low biotin, normal differentiation and 
lipid accumulation, but altered gene expression in lipid metabolism path-
ways was observed. 
Conclusion: Biotin biology is modified by obesity. Systemic inflammation 
and expansion of adipose tissue may lead to increased need of biotin for 
normal adipose tissue function.
T1:PO.016
Blocking endothelial expression of megalin results in a novel 
model system of obesity
Tavares E.1, Antequera D.2,3, Pascual C.2,3, Maldonado R.1, Dietrich M.4, 
Carro E.2,3
1Clinical and Experimental Pharmacology Research Unit, Valme University 
Hospital, Seville, Spain.,  
2Neuroscience Group, Instituto de Investigacion Hospital 12 de Octubre (i+12), 
Madrid, Spain.,  
3Center for Networked Biomedical Research in Neurodegenerative Diseases 
(CIBERNED), Madrid, Spain.,  
4Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section 
of Comparative Medicine, Department of Neurobiology, Yale University School 
of Medicine, New Haven, USA; Department of Biochemistry, Universidade 
Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Megalin, a low-density lipoprotein receptor-related protein-2, mediates 
blood brain barrier (BBB) transport of multiple ligands, including leptin 
or insulin, which are fundamental for brain development, function and 
protection against injury. We recently generated a mutant mouse strain 
lacking endothelial megalin, named EMD mice, resulting in an Alzhei-
mer´s-like impaired the behavioral model. Next, we tested the hypothesis 
that blocking megalin expression at the BBB confers other metabolic al-
terations associated with BBB-transport. We found that EMD mice result 
in a mouse model of obesity with elevated body mass, mainly due to an 
increase in adipose tissue, and associated with higher blood levels of in-
sulin, leptin and triglycerides. Curiously, these findings were observed in 
male whereas no such difference was observed in female mice. In sum-
mary, EMD mice represent a novel model system to determine molecular 
signaling in inflammatory processes involved in neurodegeneration and 
metabolic syndrome.
Acknowledgement: This work was supported by grants from Instituto de Salud 
Carlos III (FIS2012/00486), Fundación Investigación Médica Mutua Madrileńa 
(2010/0004), Fundación Ramón Areces (CIVP16A1825), and CIBERNED.
T1:PO.017
Association of human adenovirus 36 with common obesity 
gene variants
Dusatkova L.1,2, Zamrazilova H.1, Aldhoon Hainerova I.1,3, Atkinson R.L.4, 
Sedlackova B.1,2, Lee Z.P.4, Vcelak J.1, Hlavaty P.1, Bendlova B.1, 
Kunesova M.1, Hainer V.1
1Institute of Endocrinology, Prague, Czech Republic,  
2Faculty of Science, Charles University, Prague, Czech Republic,  
3Department of Pediatrics and Center for Research of Diabetes, Metabolism and 
Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic, 
4Obetech Obesity Research Center, Richmond, VA, USA
Introduction: Both, obesity candidate genes and human adenovirus 36 
(Adv36) infection are involved in the pathogenesis of obesity. We studied 
potential interaction of these pathogenetic factors and their relation to 
obesity in Czech adolescents. 
Methods: Genotyping of variants in/near genes PCSK1 (rs6232, 
rs6235), BDNF (rs925946, rs4923461), SEC16B (rs10913469), 
TMEM18 (rs7561317), SH2B1 (rs7498665), KCTD15 (rs29941), MC4R 
(rs17782313), FTO (rs9939609) and analysis of Adv36 antibodies by en-
zyme-linked immunosorbent assay was performed in 616 normal weight 
(BMI < 90th percentile for sex and age of the Czech reference) and 628 
overweight adolescents (BMI ≥ 90th percentile) aged 13–18 years. 
Results: In the whole cohort of 1,244 adolescents a significantly higher 
prevalence of Adv36 positivity was observed in the risk allele carriers of 
PCSK1 rs6232 vs. non-carriers (χ2=4.07, p = 0.04). Similar difference was 
observed for BDNF rs925946 in normal weight boys (χ2=5.86, p = 0.02). 
Regardless BMI, the risk allele homozygotes for BDNF rs4923461 had 
increased risk of Adv36 positivity compared to the wild-type homozy-
gotes (OR=2.29, 95%CI 1.06–4.91, p = 0.04). Moreover, overweight girls 
carrying risk BDNF allele rs4923461 exhibited significantly higher levels 
of Adv36 antibodies compared to the non-carriers (p = 0.01). Adv36 anti-
bodies were significantly higher in overweight boys carrying obesity risk 
allele for SEC16B (p = 0.03). Interestingly, MC4R risk allele was related to 
lower levels Adv36 antibodies in overweight adolescents (p = 0.03). 
Conclusion: Some of the investigated obesity gene variants exhibited sig-
nificant associations with Adv36 infection. Based on our results it should 
be considered whether candidate gene variation may have an impact on 
susceptibility to Adv36 infection. 
Acknowledgement: Research related to this abstract was funded by the grants: IGA 
MZCR NT/13792-4 and NT/12342-5, MH CZ-DRO (Institute of Endocrinology 
- EÚ, 00023761), CZ0123 from Norway through the Norwegian Financial Mech-
anisms.
T1:PO.018
The impact of differential alternative splicing in a model of 
adipocyte insulin resistance
Chai X.1, Yan S.1, Lo A.2, Sun L.2, Ghosh S.1,2
1Centre for Computational Biology, Duke-NUS Graduate Medical School, 
Singapore,  
2Program in Cardiovascular & Metabolic Disorders, Duke-NUS Graduate Medical 
School, Singapore 
Differential alternative splicing (DAS) quantifies differences in splice iso-
forms between two conditions, uncovering functional variations and reg-
ulator complexity that are missed by traditional gene expression analysis. 
Insulin resistance is a precursor to adipose tissue dysfunction, but the ex-
tent to which alternative splicing might play a role in this process remains 
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splicing in differentiated 3T3-L1 adipocytes treated with 2.5 nM tumour 
necrosis factor alpha (TNF-α) for 24 hrs. Insulin resistance was verified 
by reduced Akt-Ser473 phosphorylation and reduced 2-deoxyglucose up-
take. RNASeq was performed on triplicate cell samples, before and after 
TNF-α treatment. Reads were mapped by TopHat 2.0 and isoform quan-
tification was performed by Cufflinks 2.2 and WemIQ, using the mouse 
reference genome (mm10 build). Transcript isoforms were classified into 
12 categories based on the nature of differential expression in response to 
TNF-α. Exon skipping and alternative promoter usage were the two most 
common splicing events observed among genes displaying DAS (each at 
27%). The splicing regulators Qk, Mbnl1, Mbnl2 were down-regulated, 
whereas the Hnrnp, Srsf and Rbfox family of regulators were up-regulated 
in TNF-α treated cells (absolute fold-change ≥ 1.5-fold, false discovery 
rate ≤ 10%). Several of the DAS isoforms corresponded to transcripts 
with known effects on cellular functions, including subcellular localiza-
tion (Ing4, Lpin1, Gtf2i), protein-protein interactions (Kif1b, Cxcl12), and 
enzyme activity levels (Fmr1, Agrn, Sat1). Gene-set enrichment analysis 
identified over-representation of DAS genes in several biological pathways 
related to ‘acute phase response signaling’, ‘iNOS signaling’, ‘IL-6 signal-
ing’, etc. (Fisher’s p-value < 1e-06). These results allow us to develop new 
and testable hypotheses on the role of alternative splicing in the develop-
ment of adipocyte insulin resistance.
Acknowledgement: This work was supported by Duke-NUS GMS grant WBS 
R-913-200-076-263 to SG.
T1:PO.019
Genetic susceptibility factor as a predictor of weight loss after 
bariatric surgery
Ciudin A.1, Lecube A.5, Ortiz A.1, Simo-Servat O.1, Guillen K.2, Pich S.2, 
Casagran O.2, Konstantinidou V.3, Salas E.2,3, Hernandez C.1, Fort J.4, 
Simo R.1, Mesa J.1
1Endocrinology Department, Vall d´Hebron University Hospital, Barcelona, 
Spain,  
2Scientific Departament. Gendiag.exe. Esplugues de Llobregat, Spain,  
3Scientific Departament. Ferrer inCode. Barcelona, Spain,  
4Metabolic Surgery Department, Vall d´Hebron University Hospital, Barcelona, 
Spain,  
5Endocrinology Department, Arnau de Vilanova University Hospital, Lleida, 
Spain
Background: Obesity is directly related to an increased risk of diabetes 
mellitus, hypertension, dyslipidemia, cardiovascular disease, and overall 
mortality. Weight loss is effective in decreasing these risks and reducing 
disease severity. Bariatric surgery is an effective therapy for sustained 
weight loss in most of the morbidly obese patients. But there is also a sig-
nificant number of individuals with an inappropriate response to bariatric 
surgery. Two recent retrospective studies assessed the role of genetic load 
as a predictor of this response, but the results are still unelucidated.
Objectives: To assess whether a selection of genetic variants may allow 
us to identify individuals who will have an unsatisfactory response after 
bariatric surgery.
Methods: A retrospective case-control study of 100 women who un-
derwent bariatric surgery (Roux-en-Y laparoscopic gastric bypass): 30 
cases with less than 40% of the excess weight loss and 70 controls who 
showed more than 75% of the excess weight loss after one year. All indi-
viduals were analyzed with a genetic score from Nutri inCode. The rele-
vance of each variant was considered (rs7566605, rs9939609, rs2229616, 
rs17782313, rs6235, rs1801282, rs1800795, rs2241766, rs2867215). The 
predictive ability was analyzed by discrimination (area under the ROC 
curve), sensitivity and specificity and a score was calculated.
Results: The panel of genetic variants Nutri inCode showed a significant 
discrimination ability (0.56, 95% CI 0.46, 0.67) with a good sensitivity 
(88%) in identifying individuals who have a poor response to bariatric 
surgery. The specificity of this panel is 26%.
Conclusions: The panel of genetic variants Nutri inCode has a good sen-
sitivity in identifying individuals who have a poor response to bariatric 
surgery. As the response to surgery is a multifactorial process, the inclu-
sion of other variables in order to improve good sensitivity obtained with 
genetic variables is necessary.
Acknowledgement: Special acknowledgement to Mrs Adoracion Gromaz for her 
contribution to the study.
T1:PO.020
The Zbtb16 gene affects body weight, insulin sensitivity and 
lipid levels in a single-gene congenic rat model
Krupková M.1, Liška F.1, Kazdová L.2, Šedová L.1, Křenová D.1, Křen V.1, 
Šeda O.1
1Institute of Biology and Medical Genetics of the First Faculty of Medicine, 
Charles University, Prague and General University Hospital, Prague, Czech 
Republic,  
2Department of Metabolism and Diabetes, Institute for Clinical and 
Experimental Medicine, Prague, Czech Republic 
We have previously isolated an apparently pleiotropic locus on rat chro-
mosome 8 affecting major features of metabolic syndrome in the congenic 
SHR.PD-(D8Rat42-D8Arb23)/Cub (SHR-Lx) strain carrying only 7 genes 
of polydactylous rat strain (PD/Cub) origin on spontaneously hyperten-
sive rat (SHR) genetic background. In this study, we have derived 2 new 
minimal congenic sublines in order to determine the validate Zbtb16 
gene’s role in pathogenesis of metabolic disturbances observed in the SHR-
Lx strain. Adult male rats of SHR.PD(Zbtb16) and SHR.PD(Htr3) strains 
were fed standard diet (STD) and subsequently treated with dexameth-
asone in drinking water (0.026 mg/ml) for 3 days. We contrasted mor-
phometric and metabolic profiles between the two strains. The differential 
segment of SHR.PD(Zbtb16) minimal congenic subline contains only 
Zbtb16 gene and spans 254kb, while the one in SHR.PD(Htr3) subline 
spans 563kb and contains 6 genes: Htr3a, Htr3b, Usp28, Zw10, Tmprss5, 
and Drd2. SHR.PD(Zbtb16) showed significantly higher fasting levels 
of glucose and triacylglycerols, increased area under the glycemic curve 
during oral glucose tolerance test in comparison to SHR.PD(Htr3). We 
also observed blunted free fatty acid suppression during glucose load in 
SHR.PD(Zbtb16). The insulin sensitivity of skeletal muscle was substan-
tially impaired in SHR.PD(Zbtb16) skeletal muscle (basal glycogenesis: 
173 ± 8 vs. 49 ± 9 nmol glucose/g/120min in SHR.PD(Htr3), p = 0.0007). 
The metabolic disturbances including dyslipidemia, impaired glucose tol-
erance and insulin resistance of skeletal muscle observed in the original 
SHR-Lx strain are present in the single-gene congenic SHR.PD(Zbtb16) 
strain, establishing the Zbtb16 as a pleiotropic hub of metabolic syndrome 
features.
Acknowledgement: Supported by GACR 15-04871S.
T1:PO.021
Genomic and trascriptomic analysis of adipose tissue in rat 
recombinant inbred model of metabolic syndrome
Hodulova M.1, Krupkova M.1, Sedova L.1, Krenova D.1, Kren V.1, Seda O.1
1Institute of Biology and Medical Genetics of the First Faculty of Medicine, 
Charles University, Prague and General University Hospital
Background: Central obesity is one of main features of metabolic syn-
drome. It represents a major risk factor for a number of health problems 
and chronic diseases. We have previously established a model for func-
tional genomic dissection of metabolic syndrome, the recombinant in-
bred rat strain panel PXO. In the current study, we contrasted two strains 
(PXO3-1 and PXO3-2) based on the highest divergence in metabolic syn-
drome features.
Methods: We compared the adult male rats of PXO3-1 and PXO3-2 
strains at the level of genome (>20,000 single nucleotide polymorphisms) 
and visceral adipose tissue transcriptome (Affymetrix® Rat Gene 2.1 ST 
Array Stripusing Affymetrix GeneAtlas system) followed by gene set en-
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Results: In comparison with PXO3-2, the PXO3-1 strain shows increased 
amount of both visceral and retroperitoneal fat, lower level of triacylglyc-
erols and total cholesterol. Genomic comparison of strains PXO3-1 and 
PXO3-2 showed the difference to be limited to distinct areas of chromo-
somes 1, 3, 5, 8, 12, 16 and 19 with only 3.21% polymorphic loci overall. 
Network analysis of transcripts with significantly changed expression in-
cluding up-regulated (e.g. APOLD1, p = 4.39E-05; ADIPOR2, p = 1.27-
E03) and down-regulated (e.g. RETN, p = 2.34E-04; AEBP1, p = 1.43E-
03) transcripts in PXO3-1 compared to PXO3-2, revealed enrichment in 
metabolic pathways associated with obesity and key upstream regulators 
such as PPARD, HGF and VEGF.
Conclusion: Based on combined genomic and transcriptomic analysis, 
we have identified differentially expressed transcripts between genomi-
cally close substrains and dysregulated signaling and metabolic pathways 
associated with obesity.
T1 – Lipid Metabolism
T1:PO.022
Incretins level may reflect disturbed lipid metabolism
Goralska J.1, Malczewska-Malec M.1, Kiec-Wilk B.2, Zabielski P.3, 
Chabowski A.3, Razny U.1, Stancel-Mozwillo J.1, Sliwa A.1, Zdzienicka A.1, 
Malecki M.2, Solnica B.1, Dembinska-Kiec A.1
1Department of Clinical Biochemistry, Jagiellonian University Medical College, 
Krakow, Poland,  
2Department of Metabolic Diseases, Jagiellonian University Medical College, 
Krakow, Poland,  
3Department of Physiology, Medical University of Białystok, Poland
Introduction: Incretins may be associated with not only glucose metab-
olism but also with fat metabolism. The aim was to investigate plasma 
GIP level in relation to plasma concentration of 14 different fatty acids in 
diabetic and non-diabetic subjects.
Methods: A total of 93 subjects, included patients with diabetes type 1 
(n=13), diabetes type 2 (n=33) and non-diabetic subjects (n=45). Fast-
ing plasma GIP level as well as concentrations of fatty acids (LC-MS/MS 
method) were measured.
Results: Fasting GIP plasma level was significantly increased in diabetes 
type 2 compared to diabetes type 1 (44,45 vs 20,19pg/ml). The highest 
saturated to unsaturated (SFA/UFA) ratio was found in diabetes 2 (0,52), 
medium in control (0,49) and lowest in diabetes type 1 (0,45). Diabe-
tes t.2 patients presented lipid profile with increased long chain (C<20) 
SFA, MUFA and decreased PUFA. The n-3/n-6 ratio was significantly de-
creased in diabetes t.1. Relative amount of essential PUFA was decreased 
in diabetes t.2 and increased in diabetes type 1, compared to controls, as 
the effect of changes only in C18:2 n-6. All diabetic groups revealed de-
creased relative n-3 PUFA amount related to decreased DHA, not EPA. 
GIP level positively correlated with (C<20) SFA and MUFA and negatively 
with (C≥20) FA and PUFA.
Conclusion: The detailed plasma lipids study revealed the associations of 
GIP secretion with fatty acids profile and suggest, that this gut hormone 
level may reflect disturbed fatty acids metabolism with ineffective desatu-
rase and elongase action.
T1:PO.023
Development of the uplc-ms/ms method for analysis of 
acylcarnitines and aminoacids
Cerna M.1, Brabcova I.1, Kopecky J.1, Kuda O.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic 
Introduction: Acylcarnitine (AC) and amino acid (AA) profile analysis is 
performed for the biochemical screening of metabolic disorders, mainly 
in newborns. Changes in AC and AA levels in plasma/serum and organs 
can serve as an important marker of various metabolic diseases as well as 
markers of activity of metabolic pathways. AC and AA levels are usually 
analysed by flow injection-tandem mass spectrometry. This approach is 
fast and cheap, but isn’t able to distinguish between isobaric AC species, 
which come from different metabolic pathways. 
Methods: We have developed a method, which allows us to separate and 
quantitate the isobaric species. This method is based on hydrophilic in-
teraction chromatography (HILIC) using high efficiency Kinetex chro-
matographic column coupled to tandem mass spectrometry. Using this 
technique, sample amount could be reduced up to 1 ul of plasma, while 
the panel of detectable AC and AA increased up to 57 AC and 21 AA, 
respectively. We used mouse strain C57Bl/6 and A/J for validation of the 
method. Samples of plasma from both strains were divided into triplicates 
and analyzed separately in three days to assess the inter-assay validation, 
and as a triplicate within one run to assess the intra-assay validation. 
Results: Overall average inter-assay precision was 9.43% for AC in Bl/6 
and A/J strain, whereas inter-assay precision for AA was 10.79%. Intra 
assay precision for AC was 8.65% for both mice strains, while intra assay 
precision for AA was 5.55%. 
Conclusion: In summary, we have developed a method, which is very ef-
ficient, reasonably fast and sensitive for metabolomics analysis of small 
volumes. This method is also validated with good precision and accuracy 
(up to 12%).
T1:PO.024
Combined polyphenols increase fat oxidation and 
mitochondrial oxidative capacity but do not improve 
peripheral and hepatic insulin sensitivity in healthy 
overweight men and women
Most J.1, Timmers S.1, Jocken J.W.1, Schrauwen P.1, Goossens G.H.1, 
Blaak E.E.1
1Maastricht University Medical Center+
Obesity and related cardiometabolic disorders are characterized by insulin 
resistance and reduced mitochondrial capacity. Recent evidence suggests 
that dietary polyphenols might improve these deteriorations. Indeed, we 
have shown that 3-day Epigallocatechin-gallate+Resveratrol supplemen-
tation (E+R) increased energy expenditure (EE)[1]. Moreover, metabolic 
flexibility tended to improve after a high-fat mixed meal (HFMM, 2.6MJ, 
61E%fat) in men. These findings may translate into long-term benefits 
on insulin sensitivity and lipid metabolism. In this double-blind RCT, 42 
healthy overweight subjects (age 38 ± 2y, BMI 29.7 ± 0.5kg/m2, HOMAIR 
2.05 ± 0.2) received either E+R (300+80mg/d, respectively) or placebo 
(PLA) for 12 weeks. Before and after intervention, peripheral and hepatic 
insulin sensitivity was assessed by 2-step-hyperinsulinemic-euglycemic 
clamp. Fasting and postprandial (HFMM) lipid handling was measured 
using indirect calorimetry, blood sampling, microdialysis and adipose 
tissue and skeletal muscle biopsies. Insulin-stimulated glucose rate of dis-
appearance, respectively suppression of endogenous production, were not 
affected by the intervention (P > 0.70). In contrast to PLA, postprandial 
TAG-concentrations did not increase after E+R-supplementation com-
pared with week 0 (p < 0.01). Moreover, E+R increased fasting (p = 0.06) 
and postprandial fat oxidation (p = 0.03) without changes in EE. This was 
accompanied by increased oxidative capacity in permeabilized muscle fi-
bers (p < 0.05). Finally, E+R tended to decrease visceral fat mass, while 
whole-body mass and composition, assessed by DEXA-scan, remained 
unchanged. 12-wk E+R-supplementation improved lipid handling and 
oxidative capacity, but this did not translate into increased insulin sensi-
tivity in healthy obese men and women.
Acknowledgement: The authors would like to thank the study participants, as well 
as Jos Stegen, Wendy Sluijsmans, Yvonne Essers, Kirsten van der Beek, Gabby Hul, 
Hasibe Aydeniz, Nicole Hoebers, Esther Kornips and Gert Schaart for excellent 
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T1:PO.025
Alterations by the association of obesity-hypoestrogenism in 
cardiovascular parameters in female Wistar rats
Mailloux-Salinas P.1, Colado-Velazquez J.1, Medina-Contreras J.1, Meza-
Cuenca F.1, Bravo G.1
1Pharmacobiology department, CINVESTAV-IPN, Mexico City 
Introduction: Obesity is a public health problem occurring mainly in ad-
vanced age individuals1. In females, at the end of reproductive age the lack 
of hormones originates physiological alterations exacerbating problems 
caused by obesity in the cardiovascular system [2].
Methods: Female Wistar rats were randomized in 4 groups (n=6). Intact 
(C: control), intact with obesity (OB: obese), ovariectomized (HE: hy-
poestrogenic) and ovariectomized-obesity (HE-OB). The OB groups were 
given hypercaloric diet (30% sucrose in drinking water) and standard 
chow ad libitum during 32 weeks; at the end of this period, mean arterial 
pressure (MAP) was measured. It was obtain blood and tissue samples to 
perform biochemical assays and oxidative stress.
Results: Weight was increased significantly in groups with hypercaloric 
diet in comparison to C group. MAP was significantly higher in the HE-
OB in comparison to the other groups. Plasma glucose, total cholesterol, 
LDLc, and TGs were significantly higher in the HE-OB in comparison 
with C, OB and HE, while HDLc levels were significantly lower. We found 
significant increases in oxidative stress parameters in the groups receiving 
hypercaloric diet.
Conclusion: The combination of both conditions, hypoestrogenism and 
obesity significantly alter biochemical, cardiovascular parameters, and 
increasing the susceptibility of the animals to develop oxidative stress 
damage.
References
1.  Lapidus L et al. (1984) Distribution of adipose tissue and risk of cardiovascular 
disease and death: a 12 year follow up of participants in the population study 
of women in Gothenburg, Sweden. Br Med J, 289:1257–1261. 
2.  Ley C et al. (1992) Sex-and menopause-associated changes in body-fat distri-
bution. Am J Clin Nutr 55:950–954.
T1:PO.026
Postprandial regulation of skeletal muscle lipid metabolism 
by angiopoietin-like protein 4 in overweight subjects with 
impaired glucose metabolism
van der Kolk B.W.1, Goossens G.H.1, Jocken J.W.1, Kersten S.2, Blaak E.E.1
1Department of Human Biology, NUTRIM School of Nutrition and Translational 
Research in Metabolism, Maastricht University Medical Center+, The 
Netherlands,  
2Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, 
Wageningen University, The Netherlands 
Introduction: Angiopoietin-like protein 4 (ANGPTL4) decreases plas-
ma triglyceride clearance via inhibition of lipoprotein lipase (LPL), and 
may thereby contribute to impairments in lipid metabolism in humans. In 
this study, modulation of circulating ANGPTL4 after high-fat meals with 
varying dietary fat quality was studied in overweight subjects. Secondly, 
we examined whether ANGPTL4 acts as a myokine after a high-saturated 
fat (SFA) meal. 
Methods: The effects of a mixed-meal either high in SFA, mono- (MUFA) 
or polyunsaturated (PUFA) fat on plasma ANGPTL4 levels were studied 
in ten obese insulin resistant men (BMI 33.8 ± 3.8 kg/m2). Skeletal muscle 
fatty acid handling and ANGPTL4 fluxes across muscle (forearm balance 
technique) were examined in 35 middle-aged overweight subjects (BMI 
30.4 ± 0.7 kg/m2) with impaired glucose metabolism before and during a 
4-hour high-SFA mixed-meal test. 
Results: Plasma ANGPTL4 concentrations were decreased after intake 
of the SFA meal (5.2 ± 0.3 vs. 4.2 ± 0.3 ng/ml; P < 0.01; n=35). This de-
crease was evident after the SFA and MUFA meal but not after a PUFA 
meal in the late postprandial phase (P = 0.04, n=10). Under fasting condi-
tions, no release of ANGPTL4 from forearm skeletal muscle was observed 
(-0.1 ± 0.2 ng∙100 ml tissue-1∙min-1 vs. zero; P = 0.53), while after a high-
SFA meal ANGPTL4 was released (-0.3 ± 0.1 ng∙100 ml tissue-1∙min-1 vs. 
zero; P = 0.01). At ECO2015, data on the relationship between ANGPTL4 
and in vivo muscle LPL activity will be available. 
Conclusion: A SFA and MUFA but not a PUFA meal decreased plasma 
ANGPTL4 concentrations, indicating a differential regulation with di-
etary fat quality in overweight subjects. For the first time, we showed a sig-
nificant ANGPTL4 release across forearm muscle after a high-SFA meal.
T1:PO.027
Hypolipidemic effects of polydextrose in mouse
Putaala H.1, Raza G.S.2, Tiihonen K.1, Mäkelä K.A.2, Herzig K.H.2
1DuPont Nutrition and Health, Active Nutrition, Kantvik, Finland,  
2Institute of Biomedicine, Department of Physiology and Biocenter of Oulu, 
University of Oulu, Finland
Introduction: Hyperlipidemia is a risk factor for cardiovascular diseases. 
Polydextrose (PDX, Litesse® Ultra™, DuPont) is a soluble glucose polymer 
with low caloric value, widely used as a sugar and fat replacer in various 
foods. PDX has been suggested to improve hyperlipidemia [1,2,3] and 
have satiety-enhancing effects [4,5]. We investigated the effects of PDX 
on lipid profiles in mice fed with western diet in an attempt to further 
characterize lipid-attenuating mechanisms. 
Methods: Male C57BL/6 (n=36) mice were fed either fiber-deficient 
(<0.5% fibre 10% kcal fat) or western-type diet (5% fiber, 41% kcal fat) for 
2 weeks. Animals were gavaged twice daily either with water or with PDX 
150 mg/day and water. Body weight, food intake and indirect calorimetric 
were performed in a home cage-based monitoring system (LabMaster®). 
Fasting blood samples and feces were collected for lipid measurements. 
Liver gene expression for lipid metabolism genes was performed by real–
time PCR. 
Results: PDX did not change body weight or indirect calorimetric pa-
rameters (heat production, RER and total activity). Plasma cholesterol 
concentration was reduced by PDX (p < 0.05) in fiber-deficient diet. Mice 
fed with western diet with PDX had significantly reduced food intake, 
reduced fasting plasma concentrations of cholesterol (p < 0.05) and tri-
glyceride (p < 0.001). This was reflected by numerically increased fecal 
total lipid content. The liver gene expression analyses indicate that PDX 
upregulates LDLr in western diet fed animals. 
Conclusion: The results suggest that PDX attenuates food intake and plas-
ma cholesterol and triglyceride under western diets. The increase in fecal 
output of lipids as well as upregulation of LDLr in the liver might both 
contribute.
References:
1.  Tiihonen et al.: Manuscript in preparation 
2.  Pronczuk & Hayes (2006) Nutr Res 26:27–31.
3.  Schwab et al.: (2006) Eur J Clin Nutr 60:1073–1080.
4.  Hull et al.: (2012) Appetite 59:706–712.
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T1:PO.028
The role of serum content of cyclopropaneoctanoic acid 
2-hexyl in obese patients.
Mika A.1,2, Stepnowski P.1, Chmielewski M.4, Malgorzewicz S.6, Kaska L.5, 
Proczko M.5, Ratnicki-Sklucki K.5, Sledzinski M.7, Sledzinski T.3
1Department of Environmental Analysis, Faculty of Chemistry, University of 
Gdansk, Poland, 2Department of Lipid Biochemistry, Institute of Biochemistry 
and Biophysics, Polish Academy of Sciences, Poland,  
3Department of Pharmaceutical Biochemistry, Medical University of Gdansk, 
Poland,  
4Department of Nephrology, Transplantology and Internal Medicine, Medical 
University of Gdansk, Poland.,  
5Department of General, Endocrine and Transplant Surgery, Medical University 
of Gdansk, Poland,  
6Department of Clinical Nutrition, Medical University of Gdańsk, Poland.,  
7Departments of Emergency Medicine, Medical University of Gdansk
Introduction: Fatty acids containing cyclopropane group are present in a 
bacteria, protozoa and plants (1). These fatty acids could display some bi-
ological activity (2). Recently we have reported the presence of some of cy-
clopropane fatty acids in adipose tissue of obese women (3), however, the 
source of cyclopropane FA in human is not known. Cyclopropaneoctanoic 
acid 2-hexyl, was also detected in serum of obese women (3). The aim of 
the current study was to verify if the presence of cyclopropaneoctanoic 
acid 2-hexyl in human serum is associated with obesity and to examine 
the potential association of serum content of this fatty acid with markers 
of alterations related to obesity.
Methods: Serum content of cyclopropaneoctanoic acid 2-hexyl were as-
sayed by GCMS in non-obese subjects, morbidly obese patients, morbidly 
obese patients that were on low calorie diet for 3 months and in patients 
with chronic kidney disease, which is associated with some lipid alter-
ations.
Results: Serum content of cyclopropaneoctanoic acid 2-hexyl were elevat-
ed in morbidly obese patients and patients with chronic kidney disease. 
Low calorie diet in obese patients resulted in lowering the level of cyclo-
propaneoctanoic acid 2-hexyl to the level observed in control subjects. 
Serum triglycerides concentrations displayed similar pattern to serum 
cyclopropaneoctanoic acid 2-hexyl, and these variables were significantly 
correlated. There was no correlation between this fatty acid and BMI. The 
strongest predictor of serum content of cyclopropaneoctanoic acid 2-hex-
yl was the age of the test subjects.
Conclusion: The serum cyclopropaneoctanoic acid 2-hexyl content is el-
evated in patients with morbid obesity and chronic kidney disease. Since 
diet caused decrease of cyclopropaneoctanoic acid 2-hexyl in serum of 
obese patients, one can suppose that this fatty acid originate from food. 
Our results suggests that the level of this fatty acid in serum is not associ-
ated with obesity but rather with age.
T1:PO.029
Delayed clearance of Triglyceride rich lipoproteins in Young, 
Healthy Obese Subjects
Larsen M.A.1, Goll R.1,2, Lekhal S.3, Florholmen J.1,2
1Research Group of Gastroenterology and Nutrition Institute of Clinical 
Medicine, University of Tromsř, Norway,  
2Department of gastroenterology, Clinic of Internal Medicine, University 
Hospital of North Norway,  
3Morbid Obesity Center, Helse Sřr-Řst, Childrens department, Třnsberg, Norway 
Introduction: Obesity is strongly associated to the metabolic syndrome. 
Detection of early subclinical signs of metabolic disturbances would 
therefore be of strategic value in the management of obesity. The aims 
were first to study the postprandial triglyceride (TG) clearance in young 
and healthy obese subjects; second to investigate if fasting TG can predict 
delayed postprandial TG clearance. 
Methods: Eighteen healthy, obese subjects (BMI >30 kg/m2), with no 
clinical signs of metabolic disturbances volunteered to participate. In 
addition, age- and sex-matched, healthy, normal weight subjects con-
stituted a control group. Subclinical markers of metabolic disturbances 
were assessed by measuring postprandial TG in serum (SE-TG), and tri-
glycerides in chylomicrons (CM-TG) by oral fat-tolerance-test (OFTT) in 
both groups. Postprandial TG clearance during 8 hr was measured. Insu-
lin resistance (IR) was measured by the homeostasis model assessment of 
insulin resistance (HOMA-IR). 
Results: Twelve (66%) of the healthy obese individuals had insulin resis-
tance measured by HOMA-IR. There was a delayed SE-TG and CM-TG 
at 6 hr when compared to the control group, while at 8hr the differences 
were only detected for the CM-TG clearance. Fasting TG in uppernormal 
level was found to be a predictor for a delayed postprandial TG clearance 
(fasting TG>1.02 mmol/L). 
Conclusion: In young, obese subjects with no clinical signs of metabolic 
disturbances, early metabolic disturbances including IR, delayed post-
prandial TG clearance can be detected. Fasting serum TG in upper- nor-
mal level predicted delayed postprandial TG clearance and IR.
T1:PO.030
Afamin and lysophosphatidylcholine 18:2, potential markers 
of type 2 diabetes risk, are opposingly regulated in obesity.
Kurdiova T.1, Ukropcova B.1, Belan V.2, Berberich R.3, Gasperikova D.1, 
Schmitz G.4, Dieplinger H.3, Ukropec J.1
1Institute of Experimental Endocrinology, Slovak Academy of Sciences,  
2Radiodiagnostic Clinic, University Hospital, Bratislava, Slovakia,  
3Division of Genetic Epidemiology, Medical University of Innsbruck, Austria,  
4University Clinic, Regensburg, Germany 
Introduction: Serum afamin and lysophosphatidylcholine (LPC) 18:2, 
two potential markers of increased type 2 diabetes (T2D) risk, were inves-
tigated in middle-aged lean (BMI: 22.3 ± 0.5 kg.m-2), obese/overweight, 
prediabetic & T2D men (31.7 ± 0.6kg.m-2, n=71). 
Methods: Metabolic phenotyping included euglycemic hyperinsulinemic 
clamp (EHC), oGTT, MRI (abdominal fat distribution) & 1H-MRS (he-
patic lipid content). Physical activity was monitored by accelerometers. 
Serum LPC & afamin were analyzed by mass spectrometry & ELISA. Sub-
cutaneous abdominal adipose tissue (SAT) was obtained by biopsy and 
gene expression was quantified by qPCR. Fat cell size was measured mor-
phometrically. 
Results: Serum afamin was higher in obesity (23%, p < 0.05), increasing 
progressively with prediabetes & T2D (38 & 36% respectively, p < 0.001). 
Circulating LPC18:2 decreased by >30% with obesity, prediabetes & 
T2D (p < 0.001). LPC18:2 negatively correlated with afamin (r=-0.42, 
p < 0.001). Afamin was negatively associated with whole body & adipose 
tissue insulin sensitivity (r=-0.35, p < 0.001; r=0.31, p < 0.01), ambulato-
ry activity (r=-0.29, p = 0.03) and adiponectinemia (r=-0.48, p < 0.001) 
and positively with insulinemia (r=0.35, p < 0.001), glycemia (r=0.29, 
p = 0.01), TAGs (r=0.35, p = 0.001) & hepatic lipids (r=0.35, p = 0.001). 
Afamin was positively associated with fat cell size (r=0.52, p < 0.001), and 
negatively with expression of irisin precursor Fndc5 and lipolysis promot-
ing zinc-α-2-glycoprotein (both r=-0.48, p < 0.001) in SAT. Association 
between afamin and insulin sensitivity was in part independent on obe-
sity. Afamin combined with LPC18:2 explained 49% of variability in the 
whole body insulin sensitivity. 
Conclusion: Changes of serum afamin and LPC 18:2 might predict diabe-
tes risk in obese nondiabetic individuals.
Acknowledgement: 7th FP EC 2007-2.1.1-6. LipidomicNET, EFSD New Horizons. 
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T1:PO.031
Chemerin blood levels are associated with cross-sectional 
areas of different compartments of adipose tissue at l5 level
Vrselja Z.1,2, Salha T.2, Marić A.1,3, Radić R.1
1Department of Anatomy and Neuroscience, Faculty of Medicine, University of 
Osijek, Osijek, Croatia,  
2Department of Radiology, University Hospital Osijek, Osijek, Croatia,  
3Department of Physical Medicine and Rehabilitation, University Hospital 
Osijek, Osijek, Croatia 
Introduction: Increasing obesity prevalence is of great importance since 
it is associated with low-grade chronic inflammation. Adypocytes which 
constitute adipose tissue, among other cells, produce a large number of 
adipocytokines which are responsible for immunometabolic modulation. 
Chemerin is a multifunctional protein which primarily acts as a chemo-
tactic cytokine. Chemerin is associated with early stages of low-grade 
chronic inflammation of adipose tissue possibly through regrutation of 
immune cells to the adipose tissue, angiogenesis, osteoblastogenesis etc. 
We aim to investigate the relationship between chemerin blood levels and 
abdominal region adipose tissues. 
Methods: We included 60 volunteers in the study; all participants under-
went magnetic resonance (MR) of abdominal region using 2D FLSAH 
sequence for optimal detection of adipose tissue. MR data was analyzed 
using open source ImageJ program in order to obtain the adipose tissue 
surface area. Blood samples were taken from all participants, chemerin 
serum levels were determined with commercial ELISA kit. 
Results: Average participant had BMI of 24.5 ± 4.7 and was 20 [20–30.75] 
years old. The average area of adipose tissue at L5 level was 281 ± 119 
cm2, subcutaneous adipose tissue 215 ± 91 cm2 and visceral adipose tissue 
65 ± 38 cm2. Chemerin positively correlated with overall adipose tissue 
(r=0.721, p < 0.001), subcutaneous (r=0.694, p < 0.001) and visceral ad-
ipose tissue (r=0.588, p < 0.001). After age and gender adjustment, over-
all adipose tissue was the most important predictor of chemerin levels 
(R2=0.749, p < 0.001, β=0.27).
Conclusion: Chemerin blood levels had a strong and medium positive 
correlation with different compartments of adipose tissue. Visceral and 
subcutaneous adipose tissue might contribute equally to the chemerim 
blood levels.
T1:PO.032
Mathematical Modelling of Energy Flux with ‘Optimum’ Food 
Micronutrients in Humans
McGill A.T.1
1School of Population Health, Univesriy of Auckland, Auckland, New Zealand 
Introduction: Central obesity related metabolic syndrome (MetS) is as-
sociated with the degenerative diseases of type II diabetes mellitus, car-
diovascular disease and cancer. It is hypothesised that the nuclear fac-
tor-erythroid 2-related factor 2 system (NRF2) uses (phyto)chemicals 
for energy efficient cell metabolism & in humans became an antioxidant 
and antitoxicant amplifying cell protection system allowing human lon-
gevity. Mathematical systems modelling should show that high micronu-
trient:macronutrient ratio food diets in humans involve highly efficient 
energy metabolism and tissue repair via the NRF2 system, and this will 
prevent both excess central fat accumulation and related MetS. 
Aim: To formulate a comprehensive multistep mathematical model of the 
energy-efficient phytochemical-dependant human antioxidant/antitoxi-
cant cell protection NRF2 system.
Methods: Involve 1) Developing an energy compartment-based equation 
of energy flux in humans into which a term for micronutrient action can 
be inserted at a later stage 2) Running metabolomics analysis from tissue/
blood samples of various human models, particularly assessing before and 
after change from westernised (energy dense) to whole food (micronutri-
ent dense) diets 3) Using mathematico-engineering systems modelling of 
the actual flux of energy in the NRF2 system, and calculating the energy 
potentials of (Michael) reactions involving plant chemicals 4) Putting the 
above models of human-specific energy flux equations into the Dynamic 
Energy Budget (DEB) framework at the DEB2015 school (Apr 2015, Mar-
seille, France http://deb2015.mio.univ-amu.fr) 
Results: Progress & the DEB2015 project will be presented. 
Conclusion: The results will be discussed in the light of human dietary 
evolution
Acknowledgement: Professors Tim Coulson and Stanley Ulijaszek, Future fo Food 
Programme, Oxford Martin School, University of Oxford, Oxford UK, and Profos-
ser Bas Kooijman, VU University, Amsterdam, The Netherlands for their encour-
agement and support
T1:PO.033
Selected polymorphisms of fatty acid desaturase in two 
phenotypes of metabolic syndrome
Zak A.1, Jachymova M.2, Vecka M.1, Burda M.3, Stankova B.1, Zeman M.1, 
Tvrzicka E.1
14th Department of Medicine, 1st Medical Faculty, Charles University in Prague, 
Czech Republic,  
2Institute of Clinical Chemistry and Laboratory Diagnostics, 1st Medical Faculty, 
Charles University in Prague, Czech Republic,  
3Institute for Research and Applications of Fuzzy Modeling, University of 
Ostrava, Czech Republic
Fatty acid (FA) composition of plasma lipids depends on their dietary intake 
and FA metabolism. The contents of plasma and tissue polyunsaturated FA 
(PUFA) influences, several components of metabolic syndrome (MS) like 
insulin resistance, and atherogenic dyslipidemia. The key enzymes of PUFA 
metabolism are the fatty acid desaturase1 (FADS1) and FADS2. It is known 
that patients with MS exhibit a heterogeneous phenotype; however, the re-
lationships of individual FA to MS components have not been studied yet. 
Using GC, we examined the plasma phosphatidylcholine FA composition 
of 166 individuals with MS and of 188 controls. Selected polymorphisms 
of FADS1 and FADS2 were determined by PCR-RFLP. By means of clus-
ter analysis of plasma FA, both groups of subjects were divided into two 
clusters. In cluster1, there were 65.7% of MS patients; cluster2 contained 
34.3% of patients. The patients with MS within cluster1 (MS1) differed from 
the individual patients within MS2 by waist circumference (104 vs 101 cm, 
<0.05), glucose (5.99 vs 5.44 mmol/l, P < 0.05), NEFA (0.55 vs 0.43 mmol/l, 
P < 0.01), HOMA-IR (3.05 vs 2.23 ratio, P < 0.05), and conjugated dienes in 
LDL (71.5 vs 60.9 μmol/l, P < 0.01). The FA composition in the MS1 group 
differed from the MS2 group by higher contents of palmitoleic, g-linole-
nic, and dihomo-g-linolenic acids, as well as by a lower content of linoleic 
acid (all P < 0.01). We found the association of some FADS polymorphisms 
[FADS1 (rs174537, chi2=7.45, P < 0.05; rs174537, chi2=7.45, P < 0.05; 
rs174545, chi2=8.36, P < 0.05); FADS2 (rs174570, chi2=8.57, P < 0.05)] 
with the splitting of MS into cluster1 and cluster2. These clusters differ in 
the adipose tissue distribution, insulin resistance, lipolysis, oxidative stress, 
and in the association with some polymorphisms of FADS.
Acknowledgement: The study was supported by the grant NT/13199, IGA, Minis-
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T1 – Myokines
T1:PO.034
Change of circulating irisin concentrations in morbidly obese 
patients after roux-en-y gastric bypass
Lee Y.J.1, Hur Y.2, Choi J.1
1Department of Family Medicine, Obesity center, University Hospital and 
Faculty of Medicine in Inha University in Incheon, Republic of Korea,  
2Department of Surgery, Obesity center, University Hospital and Faculty of 
Medicine in Inha University in Incheon, Republic of Korea
Background: Irisin, a humoral factor secreted from muscle (myokine), 
has been known to stimulate the program of brown fat development in 
adipose tissue (“browning”). Recent animal studies suggested that irisin 
has possibility to enhance energy expenditure in obese patients. However, 
we have limited clinical data to understand biology of irisin in human, 
especially in morbidly obese patients taken bariatric surgery.
Methods: This is a pilot, single center, longitudinal, observational study. 
We recruited twelve morbidly obese subjects (25–56 years, 29.6~45.9 kg/
m2 of BMI) who underwent Roux-en-Y gastric bypass surgery (RYGBP) 
and visited the obesity center postoperatively. Fasting serum samples for 
measuring irisin were collected preoperatively, and one and nine months 
after RYGBP. We analyzed the association between irisin concentrations 
and clinical characteristics.
Results: Serum irisin concentrations, 1.0115 ± 0.2282 μg/ml ranging from 
0.7347 to 1.4928 pre-operatively, altered bidirectionally on one month af-
ter RYGBP. Five out of twelve subjects showed increased irisin levels from 
0.9028 ± 0.7387 (range, 0.8393 – 0.9865) μg/ml to 1.6975 ± 0.6593 (range, 
1.0439 – 2.5102) μg/ml, while seven of them had decreased irisin levels 
from 1.0891 ± 0.2738 (range, 0.7347 – 1.4928) μg/ml to 0.8304 ± 0.1855 
(range, 0.5535 – 1.1560) μg/ml. Serum irisin concentrations on 9 months 
were 1.1108 ± 0.1515 μg/ml (range, 0.9158 – 1.3481), and eight had elevat-
ed irisin levels by 0.1827 ± 0.1400 μg/ml and four had non-elevated levels 
by - 0.0675 ± 0.0538 μg/ml compared with pre-operative values.
Conclusions: The alteration of serum irisin level was associated with 
weight loss effect of Bariatric surgery.
T1 – Gut microbiota
T1:PO.035
Influence of panax ginseng on obesity and gut microbiota in 
obese middle-aged korean women
Song M.1, Kim H.1, Choi H.2, Choi Y.3, Chin Y.3, Wang J.1
1Department of Rehabilitation Medicine of Korean Medicine, Dongguk 
University,  
2Department of Endocrinology, Dongguk University,  
3College of pharmacy, Dongguk University 
Gut microbiota is regarded as one of the major factors involved in control 
of body weight. The anti-obesity effects of ginseng and its main constitu-
ents have been demonstrated, however, the effects on gut microbiota are 
still unknown. To investigate the effect of ginseng on gut microbiota, 10 
obese middle-aged Korean women took Panax ginseng extracts for eight 
weeks and assessment of body composition parameters, metabolic bio-
markers, and gut microbiota composition was performed using 16S rRNA 
gene-based pyrosequencing at baseline and at wk 8. Significant changes 
were observed in body weight and BMI, however, slight changes were ob-
served in gut microbiota. We divided the subjects into two groups, the 
effective weight loss group (EWG) and the ineffective weight loss group 
(IWG), depending on weight loss effect, in order to determine whether 
the anti-obesity effect was influenced by composition of gut microbiota, 
and the composition of gut microbiota was compared between the two 
groups. Before ginseng intake, significant differences of gut microbiota 
were observed between both at phyla and genera and the gut microbiota 
of the EWG and IWG was segregated on a principal coordinate analysis 
plot. Results of this study indicate that ginseng exerted a weight loss ef-
fect and slight effects on gut microbiota in all subjects. In addition, its an-
ti-obesity effects differed depending on the composition of gut microbiota 
before ginseng intake.
Fig. 1. The phylum compositions of fecal bacteria were compared before treatment 
in the EWG and IWG. The relative contribution abundance of dominant phyla 
identified from pyrosequencing data is shown. EWG, effective weight loss group; 
IWG, ineffective weight loss group.
Fig. 2. Principal coordinate analysis (PCoA) plot. The plot showed the clustering 
pattern between the EWG and IWG based on weighted pairwise Fast UniFrac 
analysis.Full line circles indicate grouping of the communities in the before 
ginseng intake and dotted line circles indicate that in the after ginseng intake.
T1:PO.036
High-fat diet-induced obesity rat model: A comparison 
between wistar and sprague-dawley rat
Marques C.1,2, Meireles M.1, Norberto S.1, Leite J.1, Freitas J.1,3, Pestana D.1,2, 
Faria A.1,4,5, Calhau C.1,2
1Departamento de Bioquímica, Faculdade de Medicina, Universidade do Porto, 
Porto, Portugal,  
2CINTESIS, Centro de Investigaçăo em Tecnologias e Sistemas de Informaçăo em 
Saúde, Porto, Portugal,  
3Universidade de Trás-os-Montes e Alto Douro, Vila Real, Portugal,  
4Faculdade de Cięncias da Nutriçăo e da Alimentaçăo, Universidade do Porto, 
Porto, Portugal,  
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Introduction: In the past decades, obesity and associated metabolic com-
plications have reached epidemic proportions. For the study of these pa-
thologies, a number of animal models have been developed. However, a 
direct comparison between Wistar and SD Rat as models of high-fat (HF) 
diet-induced obesity has not been adequately evaluated so far. 
Methods: Wistar and SD rats were both assigned for two experimental 
groups for 17 weeks: standard (St) and high-fat (HF) diet groups. To assess 
some of the features of the metabolic syndrome, oral glucose tolerance 
tests, systolic blood pressure measurements and blood biochemical analy-
sis were performed throughout the study. The gut microbiota composition 
of the animals from each group was evaluated at the end of the study by 
real-time PCR. 
Results: HF diet increased weight gain, body fat mass, mesenteric adipo-
cyte’s size, adiponectin and leptin plasma levels and decreased oral glu-
cose tolerance in both Wistar and SD rats. However, the majority of these 
effects were more pronounced or earlier detected in Wistar rats. The gut 
microbiota of SD rats was less abundant in Bacteroides and Prevotella but 
richer in Bifidobacterium and Lactobacillus comparatively to the gut mi-
crobiota of Wistar rats. Nevertheless, the modulation of the gut microbi-
ota by HF diet was similar in both strains, except for Clostridium leptum 
that was only reduced in Wistar rats fed with HF diet. 
Conclusion: Both Wistar and SD Rat can be used as models of HF diet-in-
duced obesity although the metabolic effects caused by HF diet seemed to 
be more pronounced in Wistar Rat. Differences in the gut microbial ecol-
ogy together with other mechanisms, such as increased gut permeability, 
may account for the worsened metabolic scenario observed in Wistar Rat.
Acknowledgement: This work was supported by Fundaçăo para Cięncia e Tecnolo-
gia (PTDC/AGR-TEC/2227/2012; SFRH/BPD/75294/2010; SFRH/BD/78367/2011 
and SFRH/BD/93073/2013).
T1 – Gut hormones/incretins
T1:PO.037
The relationship between serum amylase and fasting plasma 
ghrelin, peptide yy3–36 in healthy men
Tak Y.J.1, Lee S.Y.2
1Department of Family Medicine, Pusan National University Hospital, Pusan 
National University Hospital, Busan, South Korea,  
2Obesity, Nutrition and Metabolism Clinic, Department of Family Medicine, 
Research Institute of Convergence of Biomedical Science and Technology, 
Pusan National University Yangsan Hospital, Yangsan, South Korea
Objective: Both appetite and carbohydrate metabolism are important in 
development of obesity. Recently serum amylase has been shown to be as-
sociated with obesity as well as metabolic disorder. Here, we investigated 
the relationship between total amylase, ghrelin and peptide YY (PYY) in 
healthy men.
Materials and Methods: In this cross-sectional study, twenty-one men 
were enrolled and all subjects had no symptoms and no any medical his-
tory or diseases. Serum total amylase, fasting serum levels of ghrelin and 
PYY3-36, anthropometry and caloric intake per day were measured. Par-
tial correlation coefficients adjusting for age and linear regression analy-
sis were computed to examine association between serum amylase and 
ghrelin, PYY3-36.
Results: The mean age, body mass index and waist circumference (WC) 
of subjects were 51.5 ± 10.9 years, 24.2 ± 1.7 kg/m2 and 87.0 ± 4.4 cm, re-
spectively. The subjects had no significant difference in serum amylase, 
ghrelin and PYY3-36 according to presence of obesity. Serum amylase 
showed significant correlation with WC (r = -0.438, P = 0.054), ghrelin 
(r = 0.533, P = 0.015) and PYY3-36 (r = -0.511, P = 0.021) after adjust-
ing for age. PYY3-36 showed statistically negatively associated with se-
rum amylase in multivariate linear regression model including age, WC 
(β = -0.428, P = 0.045). In contrast, positive association between ghrelin 
and serum amylase became non-significant in multivariate linear regres-
sion model including age, WC (β = 0.260, P = 0.146).
Conclusion: Serum amylase levels were related with ghrelin and PYY3-
36 in men. Amylase, ghrelin and PYY3-36 together may relate to obesity, 
although further research is required to find the mechanism behind these 
associations.
Fig. 1. Serum amylase (A) and Ghrelin levels (B) between obese and non-obese 
group. Statistical significance test between groups was done by Mann-Whitney 
U-test
Fig. 2. Correlation between waist circumference and serum amylase (A), ghrelin 
(B), peptide YY3-36 (C)
T1:PO.038
Differentially nibbling endogenous cannabinoid cb1 and 
cb2 receptor subtypes in spontaneous and splice variants of 
ghrelin-induced feeding in rats
Chen C.1,2, Ting C.1
1Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, 
Taiwan,  
2Division of Gastroenterology, Department of Medicine, Taipei Veterans General 
Hospital, Taipei, Taiwan
Objective: Dysregulation of endocannabinoid system has been reported 
leading to the development of obesity and metabolic disorders. Endoge-
nous endocannabinoids act on two cannabinoid receptor subtypes, type 1 
(CB1) and type 2 (CB2), to exert their biological actions. However, com-
prehensive information regarding CB1 and CB2 receptors in modulating 
feeding behavior is important, but remains less understood.
Methods: We investigated the differential roles of CB1 and CB2 recep-
tors in spontaneous and centrally-administered splice variants of ghrelin, 
O-n-octanoylated ghrelin and des-Gln14-ghrelin, stimulation of food in-
take in conscious rats.
Results: Intraperitoneal (IP) injection of different doses of selective CB2 
receptor antagonist, AM-630 (0.3, 1.0, and 3.0 mg/kg), enhanced cumu-
lative food intake during the first 12 hours with a dome-shaped dose-re-
sponse relationship in freely-fed rats, with the most effective dose of 1.0 
mg/kg. In contrast, the selective CB1 receptor antagonist, AM-251 (0.3, 
1.0, and 3.0 mg/kg, IP) dose-dependently suppressed the cumulative food 
intake in 16-h food-deprived rats. Centrally-administered O-n-octanoy-
lated ghrelin and des-Gln14-ghrelin-induced hyperphagic effects were 
counteracted dose-dependently by IP AM-251, but not AM-630.
Conclusions: We showed that endogenous CB2 receptor plays a role in 
inhibiting food intake in satiated state, whereas CB1 receptor promotes 
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a CB1 receptor-dependent mechanism. Differentially nibbling CB1 and 
CB2 receptor subtypes may provide a new avenue to treat eating and met-
abolic disorders.
Acknowledgement: The authors thank the help from Chi Chin-Wen, Ph.D., Hung 
Mei-Whey, MS, Miss Lee Chia-Jung, and the Clinical Research Core Laboratory, 
Taipei Veterans General Hospital.
T1:PO.039
A case of anorexia with extreme weight loss after a sleeve 
gastrectomy due to excessive pyy secretion. Improvement of 
symptoms with octreotide therapy.
Pucci A.2, Cheung W.H.2, Jones J.2, Kingett H.1, Doyle J.1, Adamo M.1, 
Jenkinson A.1, Elkalaawy M.1, Finer N.1, Hashemi M.1, Batterham R.L.2
1University College London Hospitals, London, UK,  
2University College London, London, UK
Background: A 22 yr old lady underwent an uneventful sleeve gastrecto-
my (SG) [weight (w) 136 kg, BMI 47 kg/m2]. Her post-operative course 
was normal until 6 months post-surgery when she developed severe nau-
sea, and reduced caloric intake. This resulted in excessive weight loss (2 yr 
post-SG w 56 kg, BMI 19.4 kg/m2). She underwent multiple investigations 
and organic and psychological causes of her weight loss were excluded. A 
random plasma gut hormone assessment revealed high circulating PYY 
levels (1200 pg/ml).  
Methods: A 3-hour oral mixed test meal study after an overnight fast was 
performed to assess circulating PYY levels and subjective appetite at base-
line and after 14 days treatment with octreotide 100 mcg subcutaneously 
three times a day. PYY levels were compared to samples from 10 post-SG 
‘control’ patients.  
Results: The patient had abnormally high fasted and nutrient-stimulated 
(60 min) PYY plasma levels [PYY levels (pg/ml)]: patient fasted =793, 
control SG fasted =
88 ± 11, patient 60 min = 1326, control SG 60 min = 207 ± 28 coupled 
with high subjective nausea scores compared to control SG patients. Oc-
treotide treatment suppressed the patient’s fasted (227 pg/ml) and nutri-
ent-stimulated PYY levels (299 pg/ml) and markedly increased her appe-
tite. She has remained on octreotide treatment with complete resolution of 
her nausea, increased caloric intake and 6 kg weight gain.  
Conclusion: PYY is implicated in mediating appetite changes post-SG. 
Our case highlights that patients may develop an exaggerated PYY re-
sponse following SG leading to nausea, and excessive weight loss More-
over, octreotide therapy offers an effective treatment.
T1:PO.040
Changes in appetite, food intake, and appetite regulating 
hormones during acute weight loss induced by roux-en-y 
gastric bypass and low-calorie diet
Bottin J.H.1, Thomas E.L.1, Balogun B.1, Bech P.R.1, Ghatei M.A.1, 
Moorthy K.1, Leeds A.R.2, Bell J.D.1, Frost G.S.1
1Imperial College London, UK,  
2University of Copenhagen, Denmark 
Introduction: Roux-en-Y gastric bypass (RYGB) reduces appetite by in-
creasing appetite regulating hormones such as PYY and GLP-1 (1). Al-
though previous studies have compared the effects of RYGB on appetite 
with energy restriction alone using low-calorie diets (LCD), few studies 
have been able to match the weight loss induced by RYGB. 
Aim: To compare the effect of comparable weight loss achieved by RYGB 
and LCD on appetite regulation 
Methods: Morbidly obese volunteers (n=20, BMI:40–55kg/m2) awaiting 
RYGB followed a liquid formula 810kcal/day LCD (Cambridge Weight 
Plan®, Northants, UK) for 2 weeks. After, they were randomly assigned to 
RYGB and standard post-operative diet (RYGB) or continuing the LCD 
(LCD) for another 4 weeks. Fasting and post-prandial ratings of appetite 
and blood samples were collected at baseline and at 6 weeks. PYY and 
GLP-1 concentrations were measured by RIA. Food intake was assessed 
during an ad-libitum meal. 
Results: Weight loss at 6 weeks was similar in both groups (RYGB: 
14.7 ± 0.6 kg; LCD: 13.5 ± 0.8 kg; NS; n=15). The RYGB group exhibited 
significant changes in appetite ratings at 6 weeks (table 1, figure 1). This 
was not observed in the LCD group. At 6 weeks, PYY and GLP-1 concen-
trations were significantly increased (figure 2) and food intake significant-
ly decreased in the RYGB group only (RYGB baseline: 353g ± 46; RYGB 
6 weeks: 57g ± 8, p = 0.0002; LCD baseline: 273g ± 48; LCD 6 weeks: 
185g ± 21, p = 0.11).
Conclusion: Despite similar weight loss with LCD and RYGB, only the 
latter led to significant changes in appetite, in part through changes in 
GLP-1 and PYY levels. These changes in circulating gut hormones may 
favour weight loss sustainability in RYGB compared with LCD over the 
long-term.
Acknowledgement: The Section is funded by grants from the MRC, BBSRC, NIHR, 
an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7- 
HEALTH- 2009- 241592 EuroCHIP grant and is supported by the NIHR Imperial 
Biomedical Research Centre Funding Scheme and Cambridge Weight Plan, Ltd.
References
1.  Vincent and le Roux, 2008 
Fig. 1. Appetite ratings and gut hormones concentrations (area under the curve) at 
baseline and at 6 weeks
Fig. 2. Appetite ratings at baseline and at 6 weeks
Fig. 3. GLP-1 and PYY concentrations at baseline and at 6 weeks
T1:PO.041
Steviol glycosides from the sweetener stevia induce glp-1 
secretion in intestinal organoids and stc-1 cells
van der Wielen N.1,2, ten Klooster J.P.3, Boekschoten M.1,2, Witkamp R.F.2, 
Meijerink J.2
1TI Food and Nutrition, Wageningen, The Netherlands,  
2Division of Human Nutrition, Wageningen University, Wageningen, The 
Netherlands,  
3Department of Life Sciences, HU University of Applied Sciences, Utrecht, The 
Netherlands
Introduction: Since their approval by EFSA and FDA, steviol glycosides 
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er, despite extensive use in our food, their effects on gastrointestinal hor-
mone release have not been investigated in much detail. Here, we studied 
the effect of steviol glycosides on GLP-1, a key hormone in food intake 
regulation and insulin secretion. 
Methods: Effects of steviol glycosides on gut hormone secretion were first 
measured in the murine enteroendocrine cell line, STC-1. Next, we used 
epithelial organoids, prepared from mouse stem cells, which give a better 
reflection of the normal cellular environment. To reveal the underlying 
mechanism behind the effect of steviol glycosides on GLP-1 secretion, 
transcriptomic changes and secondary messengers including intracellular 
calcium were measured. 
Results: Steviol glycosides induced GLP-1 secretion in both ileal organ-
oids and STC-1 cells. Data suggested the involvement of signalling path-
ways other than the classical sweet taste receptor signalling pathway as 
rebaudioside A did not increase intracellular calcium levels and G-protein 
alpha gustducin was absent in these cells. Transcriptome analysis may give 
rise to new leads for alternative signalling routes. 
Conclusion: Steviol glycosides induce secretion of the gut hormone GLP-
1 in STC-1 cells and in murine ileum-derived organoids, suggesting that 
stevia products might influence intestinal food intake regulation and glu-
cose homeostasis.
T1 – Bone & Muscle
T1:PO.042
Is undercarboxylated osteocalcin related with obesity 
measurements?
Ertaş Y.1, Gezmen-Karadağ M.1
1Gazi University, Faculty of Health Sciences, Department of Nutrition and 
Dietetics, Ankara, Turkey
Introduction: Undercarboxyleted osteocalcin (ucOC) is one of a bone 
formation measure which found in circulating system higher than its fully 
carboxylated form. In recent years, a few studies found that plasma ucOC 
levels may be related with body mass index and body fat mass in type 2 
diabetes. The aim of this study was investigate the relationship between 
plasma ucOC levels and some obesity measurements in healthy subjects.
Methods: The study was carried out on 80 healthy male and female par-
ticipants aged 25–50 years. Body weight (kg), body fat mass (kg) and body 
fat percentage (%) were taken with a bioelectric impedance analyzer and 
plasma ucOC levels (ng/mL) were determined with ELISA method. Body 
mass index (BMI) scores were divided into two groups as normal and 
overweight according to the WHO classification.
Results: According to BMI, 47.5% of all participants were overweight. 
Plasma ucOC levels were found lower in overweight participants than 
normal BMI participants (p < 0,05). In all participants, a poor negative 
correlation was observed between plasma ucOC levels and BMI, body fat 
mass and body fat percentage (p < 0,05). Whereas poor negative correla-
tion was found between plasma ucOC levels and BMI, body fat percentage 
in female participants (p < 0,05); there was not any significant correlation 
in male participants (p > 0,05).
Conclusion: With this study, relationship between ucOC and BMI, body 
fat mass was shown for the first time in healthy normal and overweight 
people. Current study will be lead to plan further investigations about un-
derlying mechanisms of these relationships and ucOC may be a potential 
therapeutic agent for obesity treatment.
T1:PO.043
Effects of body fat mass on bone in normal weight men and 
women: The Fourth Korean National Health and Nutrition 
Examination Survey (KNHANES IV).
Choi M.1, Kwon Y.1, Roh Y.1
1Department of Family Medicine, Kangnam Sacred Heart Hospital, College of 
Medicine, Hallym University, 948-1 Daerim 1-dong, Yeongdeungpo-gu, Seoul, 
Korea 
Background: Osteoporosis & osteopenia are disorders characterized by 
reduced bone quality and increased fracture risk. In traditional paradigm, 
incidence rates of femoral neck and long-bone fractures in the under-
weight group were higher than the overweight or obese group. But the 
accumulation of fat (sp, abdominal depot) was found to be a risk factor of 
bone loss. This study was aimed to evaluate the association between bone 
health and body fat in normal-weight adult Korean.
Methods: Totally, 5515 adult (mean age 50.3) from the fifth Korean Na-
tional Health and Nutrition Examination Survey (KNHANES V) were 
included in this study. Bone mineral densities (BMD) and body fat were 
measured using dual energy X-ray absorptiometry. Correlation analysis 
and regression analysis was used to evaluate relationship of body fat %, 
BMI and BMD. Cut off points of normal weight obesity is male 20.6, fe-
male 33.4 for body fat (%).
Results: Correlation analysis showed that BMDs of total femur, trochan-
ter, intertrochanter, femoral neck, and lumbar spine were negatively asso-
ciated with fat mass and positively associated with BMI in normal weight 
obesity. There was no statistically significant association between body fat 
% and BMD in normal weight non-obese men in total femur, intertro-
chanter, femoral neck, and lumbar spine. Regression analysis has similar 
results.
Conclusion: Body fat mass have a detrimental effect on BMD in normal 
weight obesity. But in normal weight non obese man, body fat mass is 
unclear effect about BMD.
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Fig. 2. BMDs of total femur, trochanter, intertrochanter, femoral neck, and lumbar 
spine were negatively associated with fat mass and positively associated with BMI 
in normal weight obesity.
Fig. 3. There was no statistically significant association between body fat % and 
BMD in normal weight non-obese men in total femur, intertrochanter, femoral 
neck, and lumbar spine.
T1 – Imaging
T1:PO.044
Uncoupling between striatal dopamine transporter and 
glucose metabolism in diet induced obesity
Malbert C.H.1, Coquery N.1
1Ani-Scans Unit, Dept of Human Nutrition, INRA,  
35590 Saint-Gilles, France 
Introduction: Dopamine receptor was down regulated in obese brain 
(Nummennmaa et al, 2012). Data are conflicting about the density of do-
pamine transporter in obese striatum. Furthermore, while striatal D2R 
availability is negatively associated with frontocortical glucose metabo-
lism in obese patient (Volkow et al, 2004), the impact of obesity on striatal 
metabolism is unknown.
Methods: Fourteen adults mini-pigs were imaged for dopamine trans-
porter and glucose metabolism in lean and obese conditions. Obesity was 
induced by high fat, high glucose diet supplied at 200% metabolic require-
ment (measured by indirect calorimetry) during 3 months. Brain glucose 
metabolism was obtained using PET imaging (HR+ Siemens) after the IV 
injection of 250 MBq FDG (IBA). The density of dopamine transporter 
was evaluated using SPECT imaging (Millenium, GE) after the IV injec-
tion of 180 MBq DatScan (GE). Sinograms were corrected for attenua-
tion using STIR software. The amount of radioactivity was obtained using 
Pmod software adapted to our pig brain atlas.
Results: The animals almost doubled their weight during the three 
months high calorie, high fat/glucose diet (87 ± 4.4 versus 36 ± 3.9 kg). 
Striatal dopamine transporter density expressed as the ratio between stri-
atum vs occipital cortex was significantly less in the obese than in lean 
situation (1.8 ± 0.04 vs 1.6 ± 0.02, p < 0.01). Inversely, the striatal glucose 
metabolism expressed as the ratio between striatum vs cerebellum was 
significantly greater in the obese than in the lean condition (1.4 ± 0.02 vs 
2.3 ± 0.02, p < 0.01). Identical figures were obtained with statistical pa-
rameter mapping analyses.
Conclusions: Our results demonstrated clearly a reduced density of stri-
atal dopamine transporter in morbid obese animal. This was associated 
with an increased striatal metabolism that might compensate for changes 
in synaptic dopamine availability. This uncoupling might a critical mech-
anism to explain overeating in obesity.
T1:PO.045
Associations between biomarkers of subclinical inflammation 
and early deterioration of glycemia before the diagnosis of 
type 2 diabetes are partly independent of obesity: Kora s4/f4 
study
Klüppelholz B.1, Thorand B.2,3, Koenig W.4, de las Heras Gala T.2, 
Meisinger C.2, Huth C.2,3, Giani G.1,5, Franks P.W.6,7,8, Roden M.1,5,9, 
Rathmann W.1, Peters A.2,3, Herder C.1,9
1German Diabetes Center, Düsseldorf, Germany,  
2Helmholtz Zentrum München, Neuherberg, Germany,  
3German Center for Diabetes Research (DZD), Neuherberg, Germany,  
4University of Ulm Medical Center, Ulm, Germany,  
5University Hospital Düsseldorf, Düsseldorf, Germany,  
6Lund University Diabetes Center, Skĺne University Hospital Malmö, Malmö, 
Sweden,  
7Umeĺ University, Umeĺ, Sweden,  
8Harvard School of Public Health, Boston, MA, USA,  
9German Center for Diabetes Research (DZD), Düsseldorf, Germany
Introduction: The role of biomarkers of subclinical inflammation in the 
early deterioration of glycemia before type 2 diabetes is largely unknown. 
Therefore, the aim of this study was to test if increased levels of proin-
flammatory biomarkers and decreased adiponectin in the circulation are 
associated with 7-year increases of HbA1c in non-diabetic individuals. 
The second aim was to investigate if baseline levels in waist circumference 
(WC) and 7-year changes in WC explain these associations.
Methods: This study is based on participants of both the KORA S4 survey 
(1999–2001) and its 7-year follow-up KORA F4 (2006–2008). Individuals 
with diabetes at baseline or with a diagnosis of diabetes between both sur-
veys were excluded, which left a sample of 850 men and women. Linear 
regression analyses were performed to assess associations of baseline val-
ues of biomarkers with 7-year changes in HbA1c.
Results: High leukocyte count, high-sensitivity C-reactive protein 
(hsCRP), serum amyloid A (SAA) and interleukin (IL)-6 were positively 
associated with changes in HbA1c after adjustment for age, sex, lifestyle 
factors and baseline HbA1c, whereas adiponectin was inversely associated 
(P <0.0001 to 0.02). Effect sizes were reduced by 19–56% when baseline 
data for WC, 7-year changes in WC and lipids (LDL-C, HDL-C and tri-
glycerides) were added to the model, but positive associations between 
baseline leukocytes, hsCRP and SAA on the one hand and increase in 
HbA1c during the 7-year follow-up on the other hand remained signif-
icant (P 0.004 to 0.045).
Conclusion: An elevated leukocyte count and elevated hsCRP and SAA 
were associated with early deterioration of glycemia already before the 
diagnosis of type 2 diabetes. These associations were independent of base-
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T1 – Immunometabolism
T1:PO.046
Acute hyperglycemia increases monocyte and t-lymphocyte 
content in subcutaneous adipose tissue of healthy obese 
women
Kračmerová J.1,2, Tencerová M.1,2, Krauzová E.1,2, Mayerová V.1,2, Koc M.1,2, 
Šiklová M.1,2, Štich V.1,2, Rossmeislová L.1,2
1Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of 
Medicine, Charles University in Prague, Prague 10, CZ-100 00 Czech Republic,  
2Department of Sport Medicine, Third Faculty of Medicine, Charles University in 
Prague, Prague, CZ-100 00 Czech Republic
Background/Objectives: Hyperglycemia represents one of possible me-
diators for activation of immune system. It may contribute to worsening 
of inflammatory state of adipose tissue associated with obesity and thus 
accelerate the development of metabolic syndrome. The aim of our study 
was to investigate the effect of a short-term hyperglycemia (HG) on the 
phenotype and relative content of immune cells in subcutaneous abdom-
inal adipose tissue (SAAT) in obese women without metabolic compli-
cations. 
Subjects/Methods: Three-hour HG clamp combined with infusion of 
octreotide (to block insulin secretion) and control investigations with in-
fusion of either octreotide or saline were performed in three groups of 
obese women (n=10 per group). Before and at the end of the interven-
tions, samples of SAAT were obtained by needle biopsy. The relative con-
tent of immune cells in SAAT was determined by flow cytometry. Gene 
expression analysis of immunity-related markers (chemokines/cytokines, 
markers of macrophages and lymphocytes, Toll like receptors) in SAAT 
was performed by quantitative real-time PCR. 
Results: In SAAT, HG induced an increase in the content of CD206 neg-
ative monocytes/macrophages (4.9 ± 0.5% vs.5.6 ± 0.5%. p < 0.05) and 
T lymphocytes (T helper and T cytotoxic lymphocytes; 3.4 ± 0.3% vs. 
5.6 ± 0.5% and 1.9 ± 0.2% vs. 3.1 ± 0.2% respectively, p < 0.01). Further, 
HG promoted an increase of mRNA levels of immune response mark-
ers (CCL2, TLR4, TNFα) and lymphocyte markers (CD3g, CD4, CD8a, 
TBX21, GATA3, FoxP3) in SAAT (p < 0.05). Under both control infu-
sions, none of these changes were observed. 
Conclusions: Acute HG increased the content of monocytes and lympho-
cytes in SAAT of healthy obese women. This result suggests that the short-
term HG can modulate an immune status of AT in obese subjects.
Acknowledgement: This work was supported by grant IGA NT 144 86 of Min-
istry of Health, Collaborative Project ADAPT (www.adapt-eu.net) Contract No. 
HEALTH-F2-2008-2011 00, UNCE 204015 of Charles University and by grant 
GAP301/11/0748 of the Grant Agency of the Czech Republic.
T1:PO.047
Role of interleukin 15 in liver fat accumulation in patients with 
concomitant obesity
Fadieienko G.D.1, Babak O.Y.1, Kolesnikova O.V.1, Solomentseva T.A.1, 
Kurinna O.G.1, Sytnyk K.O.1
1Department of liver and gut diseases, GI
Background: non-alcoholic fatty liver disease (NAFLD) and obesity are 
associated with low grade inflammation. Experimental data suggest cru-
cial role of interleukin 15 (IL-15) in NAFLD development. Y. Cepero-Do-
nates et al. showed that exceeded secretion of IL-15 promotes fat accumu-
lation in mice. The aim was to investigate IL-15 concentration in patients 
with NAFLD associated with obesity depending on steatosis degree. The 
study included 32 patients with NAFLD associated with obesity, 31 nor-
mal weight patients with NAFLD and 26 healthy volunteers.
Methods: NAFLD was diagnosed by abdominal ultrasound examination. 
Steatosis degree was assessed using hepatorenal index (HRI). Obesity was 
measured using body mass index (BMI) and waist circumference (WC). 
Concentration of IL-15 were measured using enzyme-linked immuno-
sorbent assay kit. The results showed that IL-15 concentration was sig-
nificantly increased in patients with NAFLD comparing to control group. 
Concentrations of IL-15 observed in NAFLD patients with concomitant 
obesity were significantly higher than those in NAFLD patients with nor-
mal weight (p < 0,05). In all NAFLD patients IL-15 correlated with HRI 
supporting its role in hepatic fat accumulation. Furthermore, in patients 
with NAFLD there was significant correlations of IL-15 concentration 
with BMI (p < 0,05) and WC (p < 0,05).
Conclusions: patients with NAFLD and concomitant obesity might have 
more significant proinflamatory status that could be caused by adipose 
tissue dysfunction and abnormal adipocytokines synthesis. Exceeded IL-
15 observed in NAFLD patients with obesity supports its role in liver lipid 
accumulation found in experimental studies. Further investigations are 
needed to explore correlations of IL-15 with histological findings in NA-
FLD obese patients.
T1:PO.048
Effect of diet and cd36 deficiency on murine mesenteric lymph 
nodes
Geys L.1, Lijnen H.R.1, Scroyen I.1
1Center of Molecular and Vascular Biology, KU Leuven, Leuven, Belgium 
Introduction: Mesenteric lymph nodes (MLN) of diet-induced obese 
mice are smaller than those of lean mice because of atrophy of lymphoic 
cells. Cluster of differentiation (CD)36 contributes to high fat diet induced 
obesity (DIO) and is expressed on lymphocytes.
Methods: Five weeks old male wild-type (WT) and CD36 deficient 
(CD36-/-) mice were kept on standard fat diet (SFD, lean) or on high fat 
diet (HFD, obese) for 15 weeks. Macrophage content and lymphocyte 
populations of MLN were analyzed by FACS.
Results: DIO, as compared to SFD feeding, was associated with signifi-
cantly smaller MLN in WT mice, but not in CD36-/- mice. MLN of obese 
versus lean mice showed lower prevalence of cytotoxic T cells (TC; CD8+), 
helper T cells (TH; CD4+), activated T cells (Tact; CD4+CD25+) and reg-
ulatory T cells (Treg; CD4+FoxP3+CD25+). These differences were not 
observed between MLN of obese and lean CD36-/- mice. Treg cell content 
in MLN of WT, but not CD36-/-, mice correlated positively with MLN 
size. MLN macrophage content was lower for lean than obese WT mice, 
but was significantly higher for lean as compared to obese CD36-/- mice. 
Overall, MLN of obese CD36-/- mice contained significantly fewer mac-
rophages as compared to obese WT mice. Analysis of apoptotic markers 
in MLN revealed lower expression of annexin V and caspase 3 (pro-apop-
totic) in MLN of obese CD36-/- versus WT mice, and higher expression 
of annexin V and FasL for lean CD36-/- versus lean WT mice. Caspase 8, 
Caspase 9, Bax, AIFm2, Bcl2 and XIAP were not affected by either diet or 
genotype, thus not supporting differences in apoptosis.
Conclusion: DIO in WT mice, as compared to lean mice, is associat-
ed with smaller MLN, lower prevalence of TC, TH, Tact and Treg cells. 
CD36-/- mice appear to be protected against these changes.
Acknowledgement: Skillful technical assistance by J. Creemer (Clinical Immunolo-
gy, KU Leuven, Leuven, Belgium) and C. Vranckx is gratefully acknowledged.
T1:PO.049
Nesfatin-1 levels are significantly increased after weight loss 
induced by bariatric surgery
Krzizek E.C.1, Brix J.M.2, Hoebaus C.1, Kopp H.P.2, Feder A.2, Ludvik B.2, 
Schernthaner G.1, Schernthaner G. H.1
1Department of Medicine II, Medical University of Vienna, Vienna, Austria,  
2Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Background and aims: Nesfatin-1 was recognized as a central novel an-
orexigenic modulator of food intake and body weight.Thus, nesfatin-1 
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of action of nesfatin-1 is less clear, however, it might have an impact on 
glucose homeostasis. Therefore, it was of interest to investigate nesfatin-1 
levels in patients before and after weight loss induced by bariatric surgery 
(BS) and their respective relation to glucose homeostasis.
Materials and methods: We included 63 non-diabeticpatients (mean age: 
42± 11 years, means±SEM; mean BMI: 46.7 ± 7.0 kg/m˛) with morbid 
obesity (MO), who were investigated before and 2 years after BS. Glucose 
tolerance was assessed by an oral glucose tolerance test (75gms). Nesfa-
tin-1 levels were assessed by a commercial ELISA.
Results: BMI was reduced from 46.5 ± 7.7 to 31.9 ± 6.0 (p <0.001). Nesfa-
tin-1 levels increased (3.49 ± 1.26 vs 7.96 ± 2.18 ng/ml; p < 0.001) and 2h 
post challenge blood glucose (BG) levels decreased (110 ± 36 vs 60 ± 19, 
p < 0.001) 2 years after bariatric surgery. Preoperative no correlation 
could be found. Postoperative fasting nesfatin-1 levels correlated signifi-
cantly with 2h post challenge BG(r= –0.289; p = 0.049). The change in 
fasting nesfatin-1 levels correlated with the change in 2h BG levels (r= 
–0.502; p = 0.001).The change in nesfatin-1 levels was not correlated with 
the change in body weight.
Conclusion: This is the first study demonstrating increased nesfatin-1 lev-
els in morbidly obese patients after weight loss induced by BS. The correla-
tion of nesfatin-1 levels with 2h BG, however not with bodyweight, sug-
gests a role of nesfatin-1 in improved glucose tolerance following BS.T2
T3 – Nutrients and diet patterns
T3:PO.001
Systematic Review on the determinants of Fruit and Vegetable 
consumption in young children (aged 0–6)
O‘Malley C.1,2, Mazarello Paes V.3, Hesketh K.3, Moore H.J.1,2, Ong K.5, 
van Sluijs E.4,5, Lakshman R.4,5, Summerbell C.D.1,2
1School of Medicine, Pharmacy and Health, Durham University, UK.,  
2Fuse – UKCRC Centre for Translational Research in Public Health, UK.,  
3Insitute of Child Health, Public, Policy and Practice, University College London, 
UK.,  
4CEDAR- UKCRC Centre for Diet & Activity Research, University of Cambridge, 
UK.,  
5MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, 
Cambridge, UK.
Introduction: A diet rich in fruit and vegetables (F&V) in young children 
can reduce the risk of obesity. Identifying determinants, including barri-
ers and facilitators, of F&V consumption in young children, is needed to 
design effective and sustainable interventions. 
Methods: A systematic review of both quantitative (prospective cohort 
and intervention studies) and qualitative evidence was conducted. Eight 
electronic databases were searched in June 2012. 
Results: 49 papers were included (29 intervention, 7 prospective cohort, 
13 qualitative). Increased parental knowledge, education, higher socioeco-
nomic status (SES), and children’s liking/preference for specific F&V, were 
all positively associated with an increase in F&V consumption. Maternal 
feeding practices, particularly modelling of healthful dietary behaviours, 
were positively associated with a higher F&V consumption. In contrast, 
parental pressure to eating healthy foods, or restricting the consumption 
of unhealthy foods, was found to have a detrimental effect on child F&V 
consumption. A number of barriers and facilitators to F&V consumption 
in young children were identified; accessibility, cost of food, temperament 
behaviours of the child, lack of transport, convenience of unhealthy food, 
and time constraints. 
Conclusion: Interventions for the prevention of obesity in young children 
should include should include a focus on maternal modelling of healthful 
dietary behaviours, and address the barriers and facilitators to F&V con-
sumption identified in this review.The protocol for this systematic review 
has been registered with PROSPERO (registration no. CRD42012002881) 
and published (Lakshman et al. Systematic Reviews 2013, 2:28).
T3:PO.002
Comparing effects of a partial meal replacement diet plan 
with conventional diet on weight loss, fat mass, chemerin, 
insulin and peptide yy levels, and inflammation in obese men
Khoo J.1, Ling P.S.2, Yap S.Y.3, Chen D.D.3, Dhamodaran S.4
1Department of Endocrinology, Changi General Hospital, Singapore,  
2Department of Dietetics and Nutrition, Changi Genreral Hospital, Singapore,  
3Clinical Trials and Research Unit, Changi General Hospital, Singapore, 
4Department of Gastroenterology, Changi General Hospital, Singapore
Background: Meal replacements (MR) reduce energy density (ED). Levels 
of the anorectic gut hormone peptide YY (PYY) increase with high-pro-
tein low-ED diets and facilitate weight loss. The adipokine chemerin, 
which promotes insulin resistance and inflammation, increases in obesity 
and decreases with weight loss. We compared effects of an MR-based diet 
and a reduced-fat (< 30% of calories) conventional diet (CD) on weight 
loss, waist circumference (WC), body fat mass, chemerin, fasting PYY and 
insulin levels, and inflammation in obese men. 
Methods: Obese (mean body mass index 32.9 kg/m2, range 30.5–42.3) 
men (mean age 40.2 years, range 30–61) were randomized to a CD (n= 23) 
or an isocaloric plan including 1–2 MR/day (MR group, n= 23), to reduce 
intake by 500 kilocalories/day for 12 weeks. 
Results: At 12 weeks, weight, WC, fat mass, serum chemerin, insulin 
and high-sensitivity C-reactive protein (marker of systemic inflamma-
tion) reduced more in the MR group (-4.19 ± 3.78 kg; –4.79 ± 3.33 cm; 
–2.47 ± 3.63 kg; –11.2 ± 12.1 ng/ml; –5.6 ± 5.1 mU/L; –2.20 ± 3.86 mg/L) 
than in the CD group (-2.63 ± 1.86 kg; –2.52 ± 2.27 cm; –1.59 ± 2.32 kg; 
–7.6 ± 13.7 ng/ml; –3.4 ± 5.7 mU/L; –1.22 ± 3.60 mg/L). In the MR but 
not the CD group, serum PYY increased (11.4 ± 19.4 versus –4.6 ± 10.3 
pg/ml), and was associated (r = 0.35, p = 0.03) with a significant increase 
in proportion of energy intake from protein (3.2 ± 0.9%) which did not 
occur with CD (0.6 ± 1.0%). 
Conclusions: MR-based diets are more effective for inducing reductions 
in weight, fat mass, chemerin, insulin and systemic inflammation. The use 
of MR was associated with higher proportion of energy intake from pro-
tein, which may increase PYY level and promote weight loss.
Acknowledgement: We thank all the men who participated in the study.
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Assessment of dietary sodium intake by spot urine and by 
a food frequency questionnaire: Validation against 24 hour 
urine collection
Chouccair S.1, Naja F.1, Akl C.1, Helou R.1, Ismaeel H.2,3, Nasreddine L.1,3
1Department of Nutrition and Food Science, Faculty of Agricultural and Food 
Sciences, American University of Beirut, P.O.Box: 11-0236 Riad El Solh 1107-
2020, Beirut, Lebanon, 
2Division of Cardiology, Department of Internal Medicine, American University 
of Beirut, P.O.Box: 11-0236 Riad El Solh 1107-2020, Beirut, Lebanon,  
3Vascular Medicine Program, American University of Beirut Medical Center, 
P.O.Box: 11-0236 Riad El Solh 1107-2020, Beirut, Lebanon
Background: Recent evidence suggests a link between salt intake and in-
creased risk of obesity, but the assessment of dietary salt intake may be 
limited by several methodological factors. This study aims at evaluating 
the validity of spot urine sodium (Kawasaki equation) and a short FFQ 
in assessing sodium intake in Lebanese adults. The 24 hour urine sodium 
excretion is used as the gold standard. 
Methods: A convenience sample of 88 subjects provided a 24 hour urine 
sample and a spot urine sample (second morning void). Urinary sodium 
and creatinine levels were determined. Reliability of the FFQ was assessed 
by its re-administration one month later. Spearman correlation coeffi-
cients and Bland Altman tests were calculated to evaluate the relationship 
between sodium intake as assessed by the FFQ (Na FFQ), spot urine (Na 
spot) and 24 hour urinary excretion (Na 24h). 
Results: The intra class correlation coefficient to evaluate the reliability 
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24h (mean= 3632.29 ± 1765.13 mg/day) and Na FFQ (4131.13 ± 1566.52 
mg/day) (r=0.568), and the mean difference (498.83 ± 1732.06 mg/d) was 
not significantly different from zero. Classification agreement was of 51% 
and the weighted kappa value was of 0.416, indicating moderate agree-
ment. Spearman correlation coefficient between Na spot and Na 24h was 
high and significant (r= 0.647), but the mean difference (736.54 mg/d) 
was significantly different from zero. Classification agreement was of 57%, 
weighted kappa value of 0.481, indicating moderate agreement.
Conclusion: These results suggest that there is moderate agreement be-
tween the FFQ, spot urine and 24 hour urine collection in estimating so-
dium intake, but the results may be limited by the small sample size.
Acknowledgement: The authors would like to aknowledge all study subjects for 
participating in the study. The authors would also like to aknowledge the support 
of Mr. Mohamad El Medawar and Ms. Maya El Mokdad for their help during data 
collection.
T3:PO.004
Paternal occupation: A socioeconomic factor influence the 
association between protein intake and body composition 
among children and adolescents in south china
Yang M.1, Xue H.1, Duan R.1, Liu Y.1, Cheng G.1
1Department of nutrition, food safety and toxicology, West China School of 
Public Health, Sichuan University, Chengdu, China
Introduction: Paternal occupation is a socioeconomic factor both related 
to childhood diet and body composition. Our aim was to examine wheth-
er protein intake is associated with body composition among children 
with different paternal occupation in South China.
Methods: 1716 participants (46% girls) aged 6–16 years were cross-sec-
tionally recruited. Daily intakes of protein were obtained by 3-d 24h di-
etary recalls. Height, weight and skinfold thickness were measured to cal-
culate body mass index SD score (BMI SDS), percentage of body fatness 
(%BF), fat mass index (FMI) and fat-free mass index (FFMI). Information 
on socioeconomic status was collected by questionnaire. The associations 
between total/animal/vegetable protein intake and BMI SDS, %BF, FMI 
and FFMI were investigated using multiple linear regression analysis for 
girls and boys with different paternal occupation, respectively.
Results: Girls with higher total/animal protein intake had higher %BF and 
FMI in paternal occupation group of temperal employment after adjusted 
for breast-feeding, maternal overweight, carbohydrate intake and phys-
ical activity level (p < 0.05). Among girls whose fathers were blue-collar 
workers, animal protein intake was negatively associated with BMI SDS, 
%BF, FMI and FFMI, while girls with higher vegetable protein intake had 
higher FMI and FFMI (p < 0.05). In addition, animal and vegetable pro-
tein intake were positively associated with BMI SDS in girls with pater-
nal occupation of white-collar worker and liberal profession, respectively 
(p < 0.05). There was no relation of protein intake with body composition 
in boys with different paternal occupation.
Conclusion: Protein intake might be related to body composition among 
girls in South China, which is largely dependent on paternal occupation.
Corresponding author: Cheng G.
T3:PO.005
To investigate the relationship between body mass index and 
serum vitamin d levels in healthy adults
Genç F N.1, Gezmen-Karadağ M.2, Ertaş Y.2
1Ankara Kecioren Egitim Arastirma Hastanesi, Ankara, Turkey,  
2Gazi University, Faculty of Health Sciences, Department of Nutrition and 
Dietetics, Ankara, Turkey
Introduction: This study was conducted on 102 female and 40 male par-
ticipants between 19–50 ages. The participants have not any chronic dis-
ease. The aim of the study is to investigate the relationship between body 
mass index and serum vitamin D levels in adults.
Methods: A questionnaire was administered to the participants in order 
to determine the general characteristics and physical activity status of 
them. The energy and nutrient intakes within one day was recorded with 
24-hour dietary intake form in a period of three days. Anthropometric 
measures were taken with a bioelectric impedance analyser. Serum vita-
min D levels (ng/mL) were determined.
Results: According to the study result, none of the participants has suf-
ficient (≥30 ng/mL) serum vitamin D level. There is no statistically sig-
nificant difference (p > 0,05) between the groups of the participants with 
respect to the relationship between serum vitamin D levels and body mass 
index (kg/m2), height (cm), body weight (kg), waist circumference (cm), 
hip circumference (cm), total body water (kg), body muscle mass (kg). 
The only statistically meaningful (p < 0,05) result is that; the ratio of body 
fat decreases with an increase of serum vitamin D level in female partici-
pants. However, this is not the case for male participants (p > 0,05).
Conclusion: Vitamin D deficiency and insufficiency is common in par-
ticipants, especially in females. Due to vitamin D has an important phys-
iological effect for the body, serum vitamin D levels should be within the 
recommended level.
T3:PO.006
Effect of an acute high carbohydrate diet on body 
composition using DXA in young men
David-Riel S.1, Rouillier M.A.1, Brazeau A.S.2, St-Pierre D.H.1, Karelis A.D.1
1Department of kinanthropology, Université du Québec ŕ Montréal, Montreal, 
Canada,  
2Department of Medicine, McGill University, Montreal, Canada 
Introduction: The use of dual-energy X-ray absorptiometry (DXA) for 
the measurement of body composition is common in both clinical prac-
tice and in research protocols. However, a limitation of the DXA is that it 
cannot measure total body water content, which could affect the results of 
lean body mass (LBM) due to a significant change in muscle water content 
(e.g. changes in glycogen levels). To our knowledge, no study has been 
conducted to validate or not the need to standardize a diet before using 
the DXA. 
Objective: To investigate the effect of an acute high carbohydrate diet (≥ 
75% of total calories) on body composition using DXA. 
Methods: Ten young healthy men (age: 23.4 ± 2.8 years; BMI 23.6 ± 2.3 kg 
/ m2) completed the study. Three DXA (day 0, 3 and 6) were performed for 
the measurements of fat mass and LBM. Between day 0 and 3, the subjects 
followed a normal diet. Thereafter, between day 3 and 6, participants were 
prescribed a high carbohydrate diet for 3 days and completed a food diary 
to determine the percentage of carbohydrates consumed. 
Results: Mean percentage of carbohydrate intake over 3 days was 
88.3 ± 13.4%. Mean LBM values for the 3 measurements (day 0 vs. 3 vs. 
6) were: 59.4 ± 7.2 vs. 60.0 ± 8.0 vs. 60.4 ± 7.4 kg. Our results show a sig-
nificant increase in LBM between the first and third DXA measure. In ad-
dition, we observed a significant difference in total body weight between 
the first and third DXA measure. No significant difference was observed 
between the 3 measures for body fat percentage (13.0 ± 5.4 vs. 12.6 ± 5.4 
vs. 12.8 ± 5.5%). 
Conclusion: These preliminary results indicate that the effect of an acute 
high carbohydrate diet seems to affect LBM values using DXA. This study 
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T3:PO.007
Diet quality is associated with obesity risk among adults: A 
cross-sectional study in South China
Duan R.1, Liu Y.1, Xue H.1, Yang M.1, Su X.2, Cheng G.1,3
1Department of nutrition, food safety and toxicology, West China School of 
Public Health, Sichuan University, Chengdu, P.R. China,  
2West China School of Public Health, Sichuan University, Chengdu, P.R. China,  
3State Key Laboratory of Biotherapy and Cancer Center, West China Clinical 
Medical School, Sichuan University, Chengdu, P.R. China.
Introduction: The association of overall diet quality with obesity risk has 
been investigated widely in western countries. However, literature is quite 
limited among adults in China. Our aim was to identify whether diet qual-
ity, characterized by a predefined score, was associated with obesity risk 
in Chinese adults. 
Methods: 572 adults aged 25–65 years were randomly selected in South 
China. Dietary data from 3-d 24h dietary recalls were used to calculate 
Chinese Dietary Index for Preventing Non-communicable Chronic Dis-
eases (CDI-NCD), which was developed based on energy requirement 
level of adults. CDI-NCD comprised 18 components (7 food groups, 7 
nutrients and 4 behaviour indictors), with higher score indicating better 
diet quality. Height, weight, waist and hip circumference were measured 
to calculate body mass index (BMI) and waist-to-hip ratio (WHR). Mul-
tiple linear regression models were used to examine associations between 
diet quality and BMI, WHR. 
Results: Subjects with normal weight had better diet quality than those 
with excess weight (p = 0.004). Higher diet quality was significantly as-
sociated with lower obesity prevalence (3.1% for the highest diet quality 
tertile vs 17.9% for the lowest diet quality tertile, p = 0.03). Subjects whose 
diet quality was in the highest tertile had lower BMI and lower WHR than 
those diet quality was in the lowest tertile [BMI: median (95% CI): 23.11 
(21.42, 24.79) vs 24.61 (22.98, 26.24), respectively; p for trend=0.02; WHR: 
0.85 (0.82, 0.88) vs 0.88 (0.85, 0.91), respectively; p for trend=0.04; adjust-
ed for gender, age, physical activity and income level]. 
Conclusion: A high-quality diet is associated with reduced obesity risk 
among Chinese adults. This relation should be investigated in further data 
with longitudinal study design.
T3:PO.008
Do Mexican Parent Preferences of Foods have any effect on 
their weight status?
De Lira-García C.1, Jiménez-Cruz A.2, Bacardí-Gascón M.2
1Universidad Autónoma de Baja California, Escuela de Enología y Gastronomía,  
2Universidad Autónoma de Baja California, Facultad de Medicina y Psicología
Introduction: Parents food preference (PFP) can determine children food 
preferences and they have been related to childhood overweight and obe-
sity of both parents and children. The aim of the study was to identify PFP 
and to examine their associations with family characteristics, and parents 
overweight (OW) and obesity (OB). 
Methodology: 1103 Mexican parents participated in this study. PFP, lev-
el of education, income and body mass index were assessed. A list of 53 
foods usually consumed by Mexican families was applied at baseline and 
a year later. The association between baseline PFP and a year later, level of 
education, income and BMI was assessed with the Chi-square and Fisher 
correction. 
Results: Most parents were female (87%), their average age was 35 ± 7y, 
and 62% were OW/OB. A year later, people with obesity at baseline were 
more likely to prefer sweetened beverages (p = 0.01) than normal weight 
and were less likely to prefer vegetable soup (p = 0.01). Parents that pre-
ferred pears, cucumbers and yogurt at baseline were less likely to have 
obesity one year later (OR=0.26, IC 95%, 0.12–0.58, p = 0.001), and those 
who preferred coffee were more likely to have obesity (OR=3.72, IC 95%, 
1.25–11.04, p = 0.018). No association with level of income or years of 
education was found. 
Conclusion: Preference of pears, cucumbers and yogurt decrease the 
odds of being obese and preference of coffee increase the odds for obesity 
a year later.
T3:PO.009
Comparison of Diet Quality According to Body Mass Index and 
Conicity Index in Adults
Koksal E.1, Yilmaz H.2, Karacil M.S.3
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey
Introduction: It is known that adequacy and diversity of nutrients and 
food groups are important for promoting health. Prevalence of obesity is 
increasing due to the inadequate and imbalanced or excessive nutrition. 
In this study, it is aim to compare the diet quality of individuals acording 
to BMI classification and conicity index. 
Methods: This study was caarried out with 494 individuals including 183 
female and 311 male adults mean age 32.9 ± 10.80 years. Anthropometric 
measurements (body weight, height, waist circumference) and 24-hour 
dietary recall of the individuals were obtained. Dietary qualities of the 
individuals were evaluated using the Healthy Eating Index 2010 and Mean 
Adequacy Ratio. The dietary qualities were evaluated according to BMI 
classifications and conicity index score. 
Results: It is found that 54.4% of individuals are normal weight, 30.2% are 
overweight and 15.4% are obese. It was not determineted significant dif-
ference mean MAR values of normal and obese people (p > 0.05) while it 
was obtained significant difference mean HEI 2010 values between groups 
(p < 0.05). There was positive correlation between conicity index value 
with MAR value (r: 0.132; p: 0.003) and between BMI with HEI 2010 val-
ues (r: 0.121; p: 0.007). 
Conclusion: Diet quality of individuals are associated with obesity and 
chronic disease risk in several studies.. Evaluating diet by different per-
spective and developing suggestions for personel is provided to prevent 
obesity.
T3:PO.010
Regular consumption of pistachio modulates plasma 
lipoprotein subclasses in pre-diabetic subjects
Hernández-Alonso P.1, Salas-Salvadó J.1,2, Baldrich-Mora M.1,2, Mallol R.3, 
Correig X.3, Bulló M.1,2
1Human Nutrition Unit-URV-IISPV, Reus, Spain,  
2CIBERobn-ISCIII, Spain,  
3Metabolomic Platform, CIBERdem-ISCIII, URV-IISPV, Reus, Spain
Introduction: The beneficial effect of nut consumption on cardiovascu-
lar risk factors is widely known. However, analysis of conventional lipid 
profiles does not completely explain the atherogenic risk associated with 
pre-diabetes. We investigated whether chronic consumption of pistachios 
changes the lipoprotein subclasses to a healthier profile in pre-diabetic 
subjects. 
Methods: A randomized cross-over clinical trial in 54 subjects with 
pre-diabetes was conducted. Subjects consumed a pistachio-supplement-
ed diet (PD, 50% carbohydrates, 33% fat, including 57g of pistachios daily) 
and a control diet (CD, 55% carbohydrates, 30% fat) for 4 months each, 
separated by a 2-week wash-out. Diets were isocaloric and matched for 
protein, fiber and saturated fatty acids. Nuclear magnetic resonance was 
performed to determine changes in particle composition and size of plas-
ma lipoproteins through the intervention periods. 
Results: Small low-density lipoprotein particles (sLDL-P) significantly 
decreased after pistachio consumption compared to the nut-free period 
(P = 0.023). The non-high-density lipoprotein particles (i.e. VLDL-P plus 
LDL-P) significantly decreased under the PD compared to CD (P = 0.041). 
The percentage of sHDL-P increased by 2.23% after the PD compared with 
a reduction of 0.08% after the CD (P = 0.014). Consequently, the overall 
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Conclusion: These data suggest that regular pistachio intake modifies the 
lipoprotein particle size and subclass concentrations independently of 
changes in the total plasma lipid profile. These findings support the need 
of elucidating alternative mechanisms whereby a pistachio-rich diet could 
decrease the risk of cardiovascular disease and mortality.
Acknowledgement: The authors thank the participants for their enthusiastic col-
laboration, and the American Pistachio Growers (USA) and Paramount Farms for 
their funding support.
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Satiety-promoting green-plant membranes promote weight-
loss and decrease risk factors for metabolic diseases
Montelius C.1, Stenblom E.L.1, Egecioglu E.1, Erlanson-Albertsson C.1
1Dep. of Experimental Medical Science, Appetite Regulation Unit, Lund 
University, Sölvegatan 19,  
22184 Lund, Sweden
Current diet and exercise regimes to promote bodyweight loss are not 
enough, as the global obesity epidemic, and the metabolic diseses contin-
ues to increase. Strengthening of inherent satiety signals can be one way 
to succeed with weight-loss programs. Thylakoids from green plants have 
satiety-promoting effects, occurring through retardation of fat digestion 
by interaction of thylakoids with lipid droplets and with lipase/co-lipase 
[Albertsson et al, Biochem J 2007; Emek et al, Prep Biochem Biotechnol 
2010; Köhnke et al, Livestock Science 2010]. Thylakoids also retarded nu-
trient uptake over the intestinal wall [Montelius et al, Br J Nutr 2011], and 
decrease circulating levels of ghrelin and elevate CCK-levels [Köhnke et 
al, Scand J Gastroenterol 2009; Montelius et al, Clin Nutr 2013]. Further-
more, thylakoids prevent postprandial hypoglycaemia and decreased sub-
jective hunger in humans [Stenblom EL et al, Appetite 2013]. Body weight 
gain, food intake and body fat mass is decreased in animals [Emek et al, 
Prep Biochem Biotechnol 2010; Köhnke et al, Phytother Res 2009, Mon-
telius et al, J Nutr Sci 2013]. In humans, thylakoid supplement decrease 
metabolic risk factors and decrease body weight, body-fat mass and waist/
hip circumferences [Montelius C et al, Appetite 2014; Stenblom EL et al, 
Obesity & Weight loss therapy, 2014]. Thylakoids added to food in adjunct 
to lifestyle intervention may therefore be helpful in enabling overweight 
subjects to lose weight and improve metabolic parameters.
T3:PO.012
Specific dietary patterns associated with metabolic syndrome 
in korean adults
Kang Y.1, Kim J.1,2
1Department of Medical Nutrition, Graduate School of East-West Medical 
Science, Kyung Hee University, Yongin 446-701, South Korea,  
2Research Institute of Medical Nutrition, Kyung Hee University, Seoul 130-701, 
South Korea
Introduction: Dietary patterns are found to be associated with metabolic 
risk factors. We explored the association between dietary patterns and the 
risk of metabolic syndrome in the general Korean population using the 
most recent nationally representative survey data. 
Methods: A total of 13,410 Korean adults (aged ≥ 19 years) who partic-
ipated in the fifth Korean National Health and Nutrition Examination 
Survey were studied. Dietary intake was assessed by the 24-hour recall 
method. Food items were categorized into 24 food groups based on com-
mon food groups classified in the Korean Nutrient Database. Metabolic 
syndrome was defined by the joint interim statement of the International 
Diabetes Federation and the American Heart Association/National Heart, 
Lung, and Blood Institute. Data were analysed using SAS software version 
9.3. 
Results: Three dietary patterns were derived using factor analysis: tra-
ditional, westernized, and healthy. The traditional pattern was positively 
associated with hypertriglyceridemia (P = 0.0169), low high-density lipo-
protein-cholesterol (P = 0.0179) and metabolic syndrome (P = 0.0138) 
after adjusting for age, sex, body mass index, income, smoking status, 
physical activity, educational level, alcohol intake and energy intake. The 
westernized pattern was positively associated with fasting plasma glucose 
(P = 0.0348). In contrast, the healthy pattern was inversely associated with 
abdominal obesity (P = 0.0094) and hypertriglyceridemia (P = 0.0003) af-
ter adjustment for potential confounders. 
Conclusions: Specific Korean dietary patterns were associated with the 
risk of metabolic syndrome and its components in Korean adults.
Acknowledgement: This research was supported by the Basic Science Research 
Program of the National Research Foundation of Korea (NRF) founded by the Min-
istry of Education, Science and Technology (NRF2012R1A1A1012317).
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E to the healthy Nordic diet promotes normal body 
composition in Finnish men
Kanerva N.1, Borodulin K.1, Jousilahti P.1, Kaartinen N.E.1, Maukonen M.1, 
Männistö S.1
1Deparment of Health, National Institute for health and Welfare, Helsinki, Finland 
Introduction: It has been shown that a healthy diet can be constructed 
of Nordic foods. We assessed whether the healthy Nordic diet, measured 
using the Baltic Sea Diet Score (BSDS), is associated with obesity mea-
sures (body mass index (BMI), waist circumference (WC) and body fat 
percentage (BFP)). 
Methods: This study included 4812 Finns (25–74 y) from the National 
FINRISK 2012 Study who filled in a validated food frequency question-
naire. Participants’ weight, height, WC, and BFP (TANITA TBF-300MA) 
were measured. The BSDS was calculated giving higher points for high 
consumption of Nordic fruits and berries, vegetables, cereals, ratio of 
polyunsaturated to saturated and trans fatty acids, low-fat milk, and fish, 
and for low consumption of red and processed meat, total fat (E%), and 
alcohol. The BSDS ranged from 0–25, higher points indicating higher 
adherence. Linear regression was used to analyse cross-sectional associ-
ations between the BSDS and obesity measures. Logistic regression was 
used to analyse the risk for having excess BMI (≥25 kg/m2), WC (men 
≥100 cm, women ≥90 cm) or BFP (men >20%, women >30%). 
Results: The BSDS had an inverse linear association with WC and BFP in 
men (P <0.05), but not in women. Furthermore, men and women in the 
top versus lowest BSDS quintile had lower risk of excess BMI, WC and 
BFP when age and energy intake were adjusted for. After adjusting for 
educational level, smoking status, and leisure-time physical activity, only 
the risk of excess BFP remained significantly lower in men (OR 0.80; 95% 
CI 0.54-1.00; P <0.05). 
Conclusion: These results support the earlier findings that the healthy 
Nordic diet is associated with lower obesity measures in men and can be 
promoted as a healthy-weight diet in Finnish population.
T3:PO.014
Effect of meal frequency on glucose levels in women with 
polycystic ovary syndrome: A randomized trial
Papakonstantinou E.1, Kechribari I.2, Mitrou P.3, Trakakis E.4,5, Vassiliadi D.5, 
Georgousopoulou E.2, Zampelas A.1, Kontogianni M.D.2, Dimitriadis G.5
1Department of Food Science and Human Nutrition, Agricultural University of 
Athens, Greece , 
2Department of Nutrition and Dietetics, Harokopio University, Athens, Greece,  
3Hellenic National Center for Research, Prevention and Treatment of Diabetes 
Mellitus and its Complications (H.N.D.C), Athens, Greece,  
43rd Department of Obstetrics and Gynecology, University of Athens, Attikon 
University Hospital, Haidari, Greece,  
52nd Department of Internal Medicine, Research Institute and Diabetes Center, 
Athens University Medical School, Attikon University Hospital, Haidari, Greece
Aims/Hypothesis: The aim of the study was to compare the effect of two 
meal patterns (threevs six- meals per day) on glucose levels in women 
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Methods: In a randomized, crossover, 24 weeks study, 40 women with 
PCOS, aged 27 ± 6 years, body mass index (BMI) 27 ± 6 kg/m2, followed 
a weight maintenance diet (%carbohydrates:protein:fat, 40:25:35), con-
sumed either as a three-or a six-meal pattern, with each intervention 
lasting for 12 weeks. Anthropometric measurements, diet compliance 
and subjective hunger, satiety and desire to eat were assessed biweekly. 
All women underwent an oral glucose tolerance test with 75g glucose for 
measurement of plasma glucose and insulin at the beginning and end of 
each intervention. HaemoglobinA1c(HbA1c), blood lipids and hepatic 
enzymes were measured at the beginning and end of each intervention. 
Results: Body weight remained stable throughout the study. Six- meals 
decreased significantly fasting insulin (p = 0.014), fasting insulin resis-
tance (HOMA-IR, p = 0.026) and post-OGTT insulin sensitivity (Mat-
suda index, p = 0.039) vs three-meals. After incorporation of individual 
changes over time, with adjustment for potential confounders, the only 
variable that remained significant was the Matsuda index, which was 
then used in multivariate analysis and general linear models. Six-meals 
improved post-OGTT insulin sensitivity, independently of age and body 
weight vs. three-meals (p = 0.012). No significant differences were found 
between six- or three-meals for glucose, HbA1c, blood lipids, hepatic en-
zymes, subjective desire to eat and satiety.
Acknowledgement: The authors are grateful to Vasso Fragaki, head nurse of the 
Diabetes Center of Attikon University Hospital, for conducting the participants’ oral 
glucose tolerance test procedure. The authors are also grateful to Maria-Assimina 
Gerama, clinical dietitian, for her valuable help with patient nutrition education and 
for conducting anthropometric measurements.
T3:PO.015
Investigation of Individual Attitudes and Behaviors for 
Controlling Their Body Weight
Bilici S.1, Ayhan B.2, Uyar M.F.3, Gencer F.4, Karaalioglu N.5, Albayrak Z.6
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey.
Background and aims: Recently, the dietary solutions which are claim-
ing faster results for controlling body weight spreaded among individuals 
especially with the influence of the media. This study was conducted to 
determine weight watching methods which are not advised by a specialist, 
neither under control of them. 
Methods: This study held with 400 adults (83% women, 17% men) who 
are living Ankara in Turkey, aged average 24.8 ± 7.23 years. A question-
naire done face to face by specialists to determine individuals dietary hab-
its, recent dieting situation. Anthropometric measurements such as body 
weight (kg) and height (cm) both measured with standard methods. 
Results: Three hundred fourth five (86.25%) individuals were university 
graduates. By the questionnaire it was determined that 57.5% of adults 
skipped at least one meal and 3.5% of these individuals did this for los-
ing weight. According to WHO‘s BMI classification, 11.5% of individu-
als were underweight, 69.9% of them were normal weight and 18.8% of 
them were obese. Even they were underweight or normal weight 43.8% of 
samples identified themselves as overweight or obese. Also we determine 
that samples who were on diet (24.8%) did this at least a year for losing 
weight. For this reason 70% of them “drinking a lot of water”, 65% of them 
“consuming more fruits and vegetables” for controlling their body weight. 
More than 3 quarter of samples (78.5%) stated that they didn’t do regular 
exercise for controlling their body weights.
Conclusion: In order to achieve the normal body weight with the pro-
tection of health risks and ensure conservation of weight in years, the ap-
plication of diet program what based on scientific basis and prepared by 
professionals about nutrition is important.
T3:PO.016
Investigation of the effect of calcium consumption by diet on 
the body composition and blood values in women with and 
without metabolic syndrome
Arıtıcı G.1, Bas M.1, Işıldak M.2
1Health Science Faculty, Department of Nutrition and Dietetics, Acıbadem 
University, İstanbul,  
2Endocrinology Department, Gazi University, Ankara, Turkey 
Introduction: This study is executed by totally premenopausal 146 wom-
en between 19 and 52 years old who have applied to Başkent University 
Ankara Hospital Endocrinology Polyclinics between August and Decem-
ber 2012. 
Methods: In this study; it is intended to investigate the effect of calcium 
consumption by diet on the body composition and blood values in women 
with and without metabolic syndrome. Metabolic syndrome diagnosis is 
made according to ATP III criteria. A questionnaire form is applied in or-
der to specify the general properties, nutrition habits and physical activity 
status of the patients. Calcium consumption is determined by using food 
consumption frequency form. 
Results: 82.5% of the women in the case group has <800 mg calcium 
intake per day and 78.3% in the control group has <800 mg calcium 
intake. A negative correlation is found between the abdominal fat ( r= 
–0.175, p = 0.034), diastolic (r= –0.251, p = 0.002) and systolic (r= –0.279, 
p < 0.001) blood pressures via the calcium intake. The difference is statis-
tically found significant. Case and control groups are compared in terms 
of body fat %, abdominal fat kg, muscle kg, water kg and the differenc-
es are found as statistically significant (p < 0.001). The serum calcium 
(p < 0.001), parathyroid (p = 0.244), phosphor (p = 0.729) and vitamin 
D (p = 0.222) levels of case and control groups are examined. The serum 
calcium level difference between the groups are found statistically signif-
icant (p < 0.001), but on the other hand the differences in parathyroid, 
phosphor and vitamin D are statistically found insignificant (p > 0.05).
Conclusions: As a result of this study; it is observed that there is an in-
verse relationship between abdominal fat, tension and HDL cholesterol 
via calcium intake.
T3:PO.017
Nutritional intervention to improve the quality of lunchboxes 
in school age children in méxico
Díaz Ramírez G.1, Bacardí Gascón M.2, Jiménez Cruz A.2
1CISALUD, UABC. Tijuana, México,  
2Facultad de Medicina y Psicología. UABC. Tijuana, México.
Introduction: In Mexico, it has been shown that most children take un-
healthy lunchbox (LB) to schools. The objective of this study was to evalu-
ate a nutritional intervention addressed to improve the nutritional quality 
of foods contained in the LB of elementary school children. 
Methods: Two schools with 522 children were randomly assigned to the 
intervention group (IG), and two schools with 421 children to the control 
group (CG). The intervention consisted in the displayed at the schools of 
posters with healthy food, handout pamphlets with healthy recipes, and 
letters aimed to parents with nutritional information. In both groups, 
the LBs content were recorded during three nonconsecutive days before 
and after the intervention. An adequate LB (ALB) for elementary school 
children should contained ≤ 270kcal, water and fruit or vegetables and 
a prepared meal (sandwich, taco); in addition, a healthy LB (HLB) must 
not contained any soft drink, high fat, sugar, and salt containing snacks or 
prepared meals. 
Results: After the intervention it was shown less content of fat in the LB 
in the IG (p = 0.003), and 19% of children in the IG meet the criteria of 
ALB compared to 10% from the CG (p = 0.002). There was not difference 
between groups with the HLP criteria. In the IG, the LB of boys and girls 
increased the content of fruit from 25 to 46% (p = 03) and vegetables from 
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of fruit and vegetable from 46% to 45% (p = 0.025). No changes were seen 
in the food content of LB among girls in the CG. 
Conclusion: A short and feasible intervention improved the quality of the 
food content of the LBs.
T3:PO.018
Effects of acute native banana starch ingestion on appetite 
and food intake in healthy subjects.
Ble-Castillo J.L.1, Juarez-Rojop I.E.1, Tovilla-Zarate C.A.2, Garcia-
Vazquez C.1, Servin-Cruz M. Z.1, Boldo-León X.M.1, Aguilar-Mariscal H.1, 
Olvera-Hernandez V.1, Aguilar-Barojas S.1, Diaz-Zagoya J. C.1
1Laboratorio de Bioquimica de Enfermedades Metabolicas, Centro de 
Investigación, DACS, Universidad Juarez Autonoma de Tabasco, Villahermosa, 
Tabasco, Mexico,  
2Division Academica Multidisciplinaria de Comalcalco, Universidad Juarez 
Autónoma de Tabasco, Villahermosa, Tabasco, Mexico
Introduction: Previous studies have shown benefits from native banana 
starch (NBS) supplementation in improving glucose metabolism in ex-
perimental models and diabetic patients. Whether this substance could 
affect appetite regulation is, however, unknown. The aim of this study was 
to examine the effects of NBS, rich in resistant starch on the subjective 
measures of appetite and energy intake in healthy subjects. Postprandial 
glucose and insulin responses were also assessed. 
Methods: In a randomized, single-blind, crossover study, 28 young healthy 
subjects were divided to receive either a beverage containing 40 g of NBS 
or digestible corn starch (DCS). Effects on appetite were estimated, using 
visual analogue scales (VAS) for subjective measures and an ad libitum 
test meal. Blood samples were obtained at 0, 30, 60, 90, 120, 150 and 180 
min after beverages and VAS questionnaire was also applied at these times. 
After a washout period of 6 days subjects received the alternative treat-
ment. 
Results: A reduction on energy intake at the ad libitum test meal was ob-
served after NBS supplement compared to DCS. However, there were no 
significant differences in subjective appetite measures between groups. 
There was a significant reduction in glucose AUC-180 min and insulin 
AUC-180 min following the NBS supplement compared to DCS.
Conclusions: NBS supplementation decreased energy food intake and 
glycemic response in healthy subjects and may have beneficial effects in 
helping to reduce body weight. Further research to elucidate the mecha-
nism behind these changes is required.
Acknowledgement: This study was supported by the „Programa de Fomento a la 
Investigación“ from the „Universidad Juarez Autonoma de Tabasco“ (UJAT-2012-
1A-45)
T3:PO.019
Effect of regular magnesium supplementation on Insulin 
Resistance in obese patients
Wulfsohn R.1, Tisi Bańa M.2, Olkies A.3, Ravenna M.4
1Therapeutic Center Maximo Ravenna MD,  
2Austral University Hospital 
Introduction: Insulin resistance (IR) is one of the most important met-
abolic disorders associated with obesity. Magnesium supplementation is 
frequent in use in very low-calorie diets (VLCD) and has shown to be 
related to the decrease in IR. 
Methods: Retrospective review of medical records. Sixty patients were 
selected (30 female) with BMI > 30, mean age 46 years, with glycemia 
100 - 125 mg/dl, insulinemia > 15 mcU / mL and HOMA > 3, without 
taking antidiabetic drugs, who underwent a VLCD treatment plan alter-
nating with LCD, with multivitamin and potassium. Half of patients re-
ceived regular supplements of magnesium citrate. All attended cognitive 
behavioral therapeutic groups oriented to lose weight with physical activ-
ity and monthly medical- nutritional monitoring which was reassessed at 
6 months. 
Results: Both groups had significant decreases in weight and insulin resis-
tance index at 6 months. Patients who regularly took magnesium showed 
higher statistically decreases than those who did not (weight –21.37 kg 
vs. –8.43kg HOMA –2.58 vs. –0.7). In a multivariate model, the initial 
HOMA, the weight loss and the regular supplementation with Mg ++ 
were independently associated with lower rates of insulin resistance at 6 
months.
Conclusions: Regular magnesium supplementation reduces insulin resis-
tance in obese patients regardless of weight loss and the insulin resistance 
base level
T3:PO.020
A comparison of the nutrient composition of 11 different 
commercially available formula-based very low calorie diet 
(fb-vlcd) foods for use as total dietary replacement during 
weight loss
Clarizio C.A.1, Cox J.1, Hewlett B.1, Johnston K.L.1
1LighterLife, Cavendish House, Parkway, Harlow Business Park, Harlow, Essex, 
CM19 5QF
Very low calorie diets (VLCD) (<800kcal/d) have been available for use 
in the UK for 30 years. Developed to create a near-fasting metabolic re-
sponse without nutrient depletion, there are compositional criteria that 
should be met so neither the nutritional status nor general health of 
those on a VLCD is compromised. There is currently no published data 
comparing the nutritional composition of the different VLCDs available 
within the UK. As such, we obtained data on the compositional make-up 
of 11 different commercial VLCDs from information provided either on 
pack or on individual company websites. A variety of packs from each 
provider was used to reflect a realistic day’s intake and included where 
possible a shake, a textured meal and a soup. The daily nutrient intake for 
each VLCD was then compared with that described in Codex Stan 203-
1995. 3 providers (27%) failed to meet the minimum daily requirements 
(MDR) for protein. 6 providers (55%) failed to meet the MDR for Copper 
and Vitamin B6 with 3 of these additionally failing to meet the MDR for 
magnesium. Detailed nutrition information from several providers was 
neither on the packaging nor easily obtained elsewhere (e.g. company 
website) and was often neither complete nor very clear. Provision of ad-
equate nutrition whilst on a VLCD is vital to ensure good health during 
weight loss. This cross-sectional analysis of nutrition information provid-
ed by commercially produced VLCDs within the UK market shows that 
not all commercial providers meet either the total MDR required whilst 
on a VLCD, nor provide appropriate nutritional information for consum-
ers either on the packaging or on their websites. LighterLife complies fully 
with CODEX Standard 203-1995 and also provides complete transparen-
cy of compositional information. This is an important consideration for 
individuals or Health Care professionals who are considering the use of 
VLCDs for weight loss.
T3:PO.021
Dairy biomarker response to dairy fat overfeeding
Jenkins B.1, Seyssel K.2,3,4, Summerhill K.1, Alligier M.2,3,4, Laville M.2,3,4, 
Koulman A.1
1Medical Research Council Human Nutrition Research, Elsie Widdowson 
Laboratory, Fulbourn Road, Cambridge, United Kingdom,  
2Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA), Centre 
Hospitalier Lyon Sud, Pierre-Bénite, France,  
3Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France,  
4Université Lyon 1, INSERM UMR1060, Laboratoire CarMeN, Oullins, France
Introduction: Tetradecanoic acid (C14:0), pentadecanoic acid (C15:0), 
trans-palmitoleic acid (tC16:1) and heptadecanoic acid (C17:0) are sug-
gested to be biomarkers of dairy consumption. If the four above men-
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should increase significantly during dietary supplementation of diary fat 
the period of the study. 
Methods: 26 subjects were submitted to fifty-six days of overfeeding, 
where they were expected to eat in excess of their usual diet of 760 kcal/
day. The additional energy intake was derived from high fat sources, 
which included 100 grams of Emmental cheese, 20 grams of butter and 40 
grams of almonds representing an increase of 70 grams. Plasma phospho-
lipid fraction was obtained by solid phase extraction (SPE) followed by 
phospholipid fatty acid derivatisation by 14% Boron trifluoride methanol 
solution, with gas chromatography flame ionisation detection. 
Results: The plasma phospholipid fatty acids did not directly correlate 
with the estimated increase of these in fatty acid in the diet. A signifi-
cant increase of 17% was found for the trans-palmitoleic acid (tC16:1 ; 
p = 0.004) and a significant increase of 10% for the pentadecanoic acid 
(C15:0 ; p = 0.02) after overfeeding. Nevertheless no differences were 
found after overfeeding for tetradecanoic acid (C14:0 ; p = 0.48) and hep-
tadecanoic acid (C17:0 ; p = 0.32). 
Conclusions: That trans-palmitoleic acid (tC16:1) and pentadecanoic 
acid (C15:0) have a good correlation with dietary dairy fat intake, whereas 
tetradecanoic acid (C14:0) and heptadecanoic acid (C17:0) do not, there-
fore hinting at either a possible endogenous productions or other dietary 
sources. Therefore odd chain fatty acids do not exclusively come from ru-
minant sources.
T3:PO.022
Effect of isoenergetic and ad libitum meals varying in fat and 
carbohydrate composition on satiation, satiety quotient and 
suppression of food hedonics
Finlayson G.1, Gibbons C.H.1, Caudwell P.1, Hopkins M.2, Blundell J.E.1
1Appetite Control & Energy balance Research, School of Psychology, Faculty of 
Medicine & Health, University of Leeds, Leeds, UK,  
2Academy of Sport and Physical Activity, Sheffield Hallam University, Sheffield, 
UK
Introduction: Dietary fat is often regarded as having a weaker action on 
satiation than carbohydrate. The aim of the present study was to clarify 
the action of ad libitum and isoenergetic meals varying in fat and carbo-
hydrate content (i.e. HFLC or LFHC) on parameters of appetite and food 
hedonics. 
Methods: Forty-five overweight and obese males (n=15) and females 
(n=30) were recruited onto this crossover study. Subjects were studied on 
2 separate probe days in which they were given access to either HFLC 
(50vs38% by energy) or LFHC (3vs84%) meals. Satiety was measured us-
ing appetite ratings adjusted for energy intake from isoenergetic meals to 
calculate the satiety quotient (SQ). Satiation was assessed by intake of ad 
libitum energy meals. Hedonic measures of explicit liking (subjective rat-
ings) and implicit wanting (speed of forced-choice) for an array of HFLC 
and LFHC foods were tested before and after an isoenergetic meal. 
Results: There was a large effect of isoenergetic HFLC/LFHC meals on 
satiety with a greater SQ after LFHC (p < 0.001, η2=0.40). Furthermore 
there was a greater intake from ad libitum meals after HFLC (p < .001, 
η2=0.71). There was an interaction between nutrient content of the test
meal and hunger state on explicit liking (p = 0.049, η2=0.11) and implic-
it wanting (p = 0.029, η2=0.14); with consumption of the LFHC, but not 
HFLC meal effectively reducing the hedonic bias for HFLC foods. 
Conclusion: When consumed ad libitum, these data confirm that HFLC 
meals have a weaker action on satiation than LFHC. When examined cal-
orie for calorie, consumption of LFHC meals induce a greater satiety (SQ) 
compared to isoenergetic HFLC meals. Furthermore, HFLC meals do not 
dampen the subsequent appeal bias for HFLC foods compared to energy, 
weight and palatability matched LFHC meals.
T3:PO.023
Acute effects of intermittent energy restriction on energy 
compensation: A pilot study
Antoni R.1, Johnston K.L.2, Collins A.L.1, Robertson M.D.1
1Nutrition, Metabolism and Diabetes Research Group, Faculty of Health and 
Medical Sciences, University of Surrey, Guildford, UK,  
2LighterLife UK Ltd, Cavendish House, Parkway, Harlow Business Park, Harlow, 
Essex, CM19 5QF
Introduction: The intermittent energy restriction (IER) approach to 
weight loss involves short spells of severe (75–100%) energy restriction 
(ER) alternated with ad libitum (AL) intake. Little is known about the 
acute effects of severe ER on energy compensation; overcompensation 
would limit the long-term efficacy of IER. Aim: To compare the effects 
of 1 day of total (100%) and partial (75%) ER on energy compensation. 
Methods: 6 healthy, overweight males (43 ± 15yrs; 29 ± 3kg/m2) and 2 fe-
males (26 ± 0yrs; 29 ± 3kg/m2) were recruited into this cross-over study. 
Subjects completed 3 dietary interventions in a randomized order with a 
minimum 1 week washout: 1 day of isoenergetic (iso) intake; partial 75% 
ER using LighterLifeTM FoodPacks; and total 100% ER (i.e. a fast). Sub-
jects completed validated food diaries on dietary intervention days and 
for 2 subsequent days of AL intake. 
Results: Findings are presented in Fig 1. Subjects overconsumed by 
28 ± 23% of energy requirements 1 day post total ER and by 14 ± 16% 
after partial ER (both non-significant vs iso). Cumulative 3-day intakes 
were significantly lower on both total and partial ER trials, with subjects 
sustaining comparable energy deficits of –25 ± 16% (p < 0.05 vs iso) and 
–28 ± 10% (p < 0.001 vs iso) respectively. 
Conclusion: Subjects were unable to compensate for energy deficits in-
curred during severe ER. Additionally, this is the first cross-over study 
to show that despite allowing some food intake on ER days, partial ER 
can produce similar energy deficits to total ER in the short-term. Further 
investigations into whether these findings pertain with extended weight-
loss and maintenance periods are warranted.
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T3:PO.024
The estimate of overweight students’ diet: The imbalance lipid 
and fat-soluble vitamins
Valeeva E.1, Korolev A.2, Nikitenko E.2, Stepanova N.1, Makarova V.2
1Kazan Federal University, Russia,  
2I.M. Sechenov First Moscow State Medical University, Russia 
Introduction: The study aimed to assess and analyze the fat component 
(including fat-soluble vitamins) of diet students Kazan Federal University 
with overweight and obese. 
Methods: Participants were 151 students aged 19–23. The method of 24-
hour recall was used and the nutrient content was further estimated using 
standard data base. 
Results: 32 students were estimate as overweight and obese (21,2% of the 
target group): 23 people were overweight and 9 people were estimated as 
obese. In this group the percentage of energy from total fat was higher 
than RDA: 40,7% and 39,9% in men and women respectively. The sum 
of essential fatty acids (linoleic and α-linolenic) composed 7,8% and 
5,6% of total energy. The consumption of n-3 longer chain polyunsatu-
rated fatty acids (EPA and DHA) was extremely low: 32,4 ± 22,3 mg and 
140,2 ± 112,8 mg of respectively for males; 27,7 ± 12,7 mg and 74,9 ± 21,3 
mg for females. Cholesterol and plant sterols intake as well as their ra-
tio have been found as negative 1,97/1. As far as fat-soluble vitamins are 
concerned, the significant deficiency has been shown: an average content 
of vitamin A is 0,68 ± 0,17 mg, vitamin D – 2,7 ± 0,19 μg, vitamin E – 
6,7 ± 4,9 mg and vitamin K – 74 ± 18 μg which is equal to 50–58% of these 
substances’ RDA respectively. 
Conclusion: The results have shown that there is significant imbalance 
within fat component of students’ diet. The imbalance revealed within fat 
component along with deficiency of fat-soluble vitamins may contribute 
to further weight gain and result in metabolic syndrome development in 
the future. It is essential to decrease the proportion of total fat as well as to 
optimize the ratio of different food sources of fatty acids and vitamins by 
taking some measures including functional products use.
Acknowledgement: Research relating to this abstract was funded by the subsidy 
allocated to Kazan Federal University for the project part of the state assignment in 
the sphere of scientific activities
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Gelesis100 significantly decreases carbohydrate intake in 
overweight and obese subjects with high fasting glucose
Astrup A.1, Kristensen M.1, Gnessi L.2, Watanabe M.2, Svacina S.3, 
Matoulek M.3, Hlubik P.4, Stritecka H.5, Contaldo F.6, Pasanisi F.6, 
Heshmati H.M.7, Zohar Y.7, Ron E.S.7, Urban L.E.7, Sannino A.8, Demitri C.8, 
Saponaro C.8
1University of Copenhagen, Frederiksberg C, Denmark,  
2Policlinico Umberto I, Rome, Italy,  
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Introduction: Changes in macronutrient intake induced by Gelesis100 
were assessed in overweight and obese subjects based on fasting glucose 
at baseline (> or ≤ median of all study subjects) in the FLOW (First Loss 
Of Weight) study. 
Methods: Changes in macronutrient intake (24-h recall) were assessed in 
114 overweight and obese adult subjects (38 males, 76 females) includ-
ing 56 with high (> 5.15 mmol/L) and 58 with low (≤ 5.15 mmol/L) fast-
ing glucose, following Gelesis100 administration (2.25 g, n = 41, and 3.75 
g, n = 34, twice daily) vs placebo (n = 39). Gelesis100 was administered 
orally, before lunch and dinner, in a double-blind fashion, over 12 weeks, 
together with an energy-restricted diet (-600 kcal/day). Subjects received 
instructions at baseline, without enforcement thereafter, to optimize ca-
loric intake from macronutrients (carbohydrate 45–50%, fat 30%, protein 
20–25%). Statistical comparisons used analysis of covariance adjusting for 
relevant parameters. 
Results: Unlike subjects with low fasting glucose, subjects with high fast-
ing glucose on Gelesis100 2.25 g and 3.75 g had a significant decrease 
from baseline to the end of treatment in carbohydrate intake compared 
to those on placebo. Changes for percent calories from carbohydrate in-
take (mean ± standard deviation) were –4.6 ± 9.1 (P = 0.003), –2.9 ± 11.6 
(P = 0.043), and 4.7 ± 11.1, with Gelesis100 2.25 g, Gelesis100 3.75 g, and 
placebo, respectively. 
Conclusion: Chronic administration of Gelesis100 to overweight and 
obese subjects induces a significant decrease in carbohydrate intake in 
subjects with high fasting glucose at baseline. This finding may support 
the glucostatic theory of appetite control as an explanation for the dramat-
ic weight loss results observed in prediabetic subjects in the FLOW study.
T3:PO.026
Prevalence of micronutrient deficiency in pateients with 
morbid obesity before bariatric surgery
Krzizek E.C.1, Brix J.M.2, Kopp H.P.2, Schernthaner G.H.1, Schernthaner G.2, 
Ludvik B.2
1Department of Medicine II, Medical University Vienna, Vienna, Austria,  
2Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria
Background and aims: Postoperative micronutrient deficiency is a 
known side effect of bariatric surgery. In this study we examined the prev-
alence of micronutrient deficiency in patients with morbid obesity (M0) 
preoperatively. Materials und methods: 1541 patients with MO wishing 
to undergo bariatric surgery (age: 40 ± 12 years, mean BMI: 44 ± 9 kg/
m˛, means±SEM, 77.3% female) were analyzed in this cross sectional ex-
amination. Iron state, vitamin B12, folic acid, 25hydroxy(OH)-vitamin D, 
vitamin A and vitamin E levels were determined. Subsequently, patients 
underwent nutritional counseling and were substituted accordingly. 
Results: 63.2% (n=974) of the patients had a deficit in folic acid (<5.3ng/
ml), 97.5% (n=1502) in 25OHvitamin D (<75nmol/l), 5.1% (n=80) in vita-
min B12 (<188pg/ml), and 6.2% (n=96) in vitamin A (<1.05μmol/l). 9.6% 
(n=148) exhibited iron deficiency (ferritin<15μg/l). None of the patients 
had a deficit in vitamin E. 
Conclusion: Our data show a high prevalence of micronutrient deficiency 
in patients with morbid obesity preoperatively and emphasize the impor-
tance of exact preoperative evaluation and adaequate substitution as well 
as postoperative surveillance.
T3:PO.027
Evaluation of body fat ratio according to the mediterranean 
diet quality index
Kabaran S.1, Yurt M.1, Öztürk B.1
1Eastern Mediterranean University, Faculty of Health Sciences, Department of 
Nutrition and Dietetics, Famagusta, North Cyprus via Mersin on Turkey
Objective: Mediterranean diet is a sample nutrition model that help to 
prevent risk of obesity. This research was planned to identify the body fat 
ratio according to the Mediterranean diet quality index. 
Method: In this study, a total of 313 univesity students (41.5% of males, 
58.5% of females), between the ages of 18–26 (mean 21.7 ± 1.90) years 
were included. Body fat ratio was determined by Tanita MC-980MA Body 
Composition Analyzer. A questionnaire form was applied to determine 
general nutrition habits. University students’ adherence to the Mediterra-
nean diet was assessed by the 16 item questionnaire Mediterranean Diet 
Quality Index (KIDMED index). KIDMED index (range 0–12) classified 
as ≥8 score as optimal diet (high), 4–7 score as improvement need (inter-
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Results: It was determined that only 48.6% of students took 3 main meals. 
It was found that 34.4% of the student were skipping breakfast and 18.2% 
of them skipping lunch. It was found that 43.1% of the students had low 
KIDMED index, 53.0% of them had intermediate KIDMED index, and 
only 3.8% of them had high KIDMED index. According to the low, in-
termediate and high KIDMED index body fat ratio were found to be 
23.6 ± 7.28%, 24.1 ± 8.93%, 19.3 ± 6.23%, respectively. Difference of body 
fat ratio between low and high KIDMED index and between interme-
diate and high KIDMED index were found to be statistically significant 
(p < 0.05). 
Conclusion: In conclusion, there is a need for national plans to encourage 
university students’ adherence to the Meditarrenean Diet, also reducing 
the risk of high body fat ratio.
T3:PO.028
Trace elements deficiency after gastric bypass surgery: An 
underestimated complication
Ashby H.L.1, Abeysekera A.1, Labib M.H.1
1Department of Clinical Biochemistry, Dudley Group NHS Foundation Trust, 
Russells Hall Hospital, Pensnett Road, Dudley
Introduction: Trace elements deficiency is a recognised complication 
following Roux-en-Y gastric bypass (RYGB) surgery. However, the true 
prevalence of micronutrient deficiencies is not known as these may go 
either unrecognised or underreported. Moreover, micronutrients require-
ments or supplementation following RYGB has not been standardised. 
Methods: We audited serum levels of selenium, zinc and copper at 1-year 
in a cohort of patients who underwent RYGB and who were advised to 
take multivitamins and trace elements supplementation. 
Results: Low serum selenium concentration was detected in 18 out of 33 
patients (54.5%), low serum zinc in 26 of 124 patients (21.0%) and none 
of 28 patients (0%) had low serum copper. In the patients who were defi-
cient in selenium, the mean percentage excess body weight (%EBW) loss 
at 1-year was 70.6% compared to %EBW loss of 59.2% with those who 
were not deficient (p = 0.03). 
Conclusion: Our audit showed that selenium and zinc deficiencies are 
relatively common following RYGB, despite patients being advised to take 
a multivitamins with trace elements preparation. Selenium deficiency has 
been reported in 14 to 22% after RYGB yet no recommendations current-
ly exist for supplementation in these patients Zinc deficiency has been 
reported in 6–37% of patients following RYGB and, apart from a few case 
reports, the prevalence of copper deficiency is unknown in this popula-
tion. Predisposing factors following RYGB may include an imbalanced 
diet, insufficient supplementation and non-compliance with supplements 
as these are not usually prescribed but patients are advised to get them 
over the counter. We conclude that trace elements deficiency is relatively 
common following RYGB and that supplementation is probably underes-
timated and often inadequate.
T3:PO.029
Assessment of the children’s adherence to the mediterranean 
diet who study in primary school at famagusta area
Kabaran S.1, Öztürk B.1
1Eastern Mediterranean University, Faculty of Health Sciences, Department of 
Nutrition and Dietetics, Famagusta, North Cyprus via Mersin 10 Turkey
Objective: Children’s nutritional status can be changed according to re-
gional differences. This research was planned to identify the children’s 
adherence to the Mediterranean diet, anthropometric measurements, 
and nutritional status who study in primary schools at Famagusta area in 
North Cyprus. 
Method: In this study, a total of 843 children (47.3% of males, 52.7% of 
females), between the ages of 8–11 years were included. Dietary intakes of 
children were determined by a 24-hour dietary recall. Body weight, height 
and waist circumferences, body fat ratio were performed and body mass 
index (BMI) was calculated. Children‘s adherence to the Mediterranean 
diet was assessed by the 16 item questionnaire Mediterranean Diet Qual-
ity Index (KIDMED index). 
Results: It was found that mean energy intake of children were 
1598.7 ± 468.08 kcal, and that 49.4 ± 9.39% of this total energy intake were 
from carbohydrates, 15.5 ± 4.17% were from proteins, and 34.9 ± 8.10% 
were from fats. It was determined that, 46.9% of males and 47.5% of fe-
males ware normal weight, 17.3% of males and 17.1% of females were 
overweight, 18.8% of males and 14.0% of females were obese according 
to the BMI for age and gender. It was found that only 34.4% of children 
showed high KIDMED index results, 56.7% had intermediate values and 
8.9% had low index results. Children with high KIDMED index have 
higher calcium intake than those of intermediate and low KIDMED index 
and that difference was statistical significant (p < 0.05). 
Conclusion: There is a need for national plans and politicals to increase 
children’s adherence to the Meditarrenean diet, and daily calcium intake 
in primary schools at Famagusta area.
T3:PO.030
The effect of resistant starch on satiety and weight control
Yassıbaş E., Çelebi F., Bolluk S., Deniz B.
1Department of Nutrition and Dietetics, Faculty of Health Science, Gazi 
University in Ankara, Ankara, Turkey, 
Food intake is determined by internal and external factors creating dif-
ferent saturation effects (hunger, satiety, desire to eat, satisfaction, etc.). 
It has been stated that resistant starch (RS) increases postprandial satiety 
and satisfaction and decreases following food intake and appetite [1, 2, 3, 
4]. Resistant starch affects the satiety condition and body weight control 
through various mechanisms. Upon consuming resistant starch, the first 
mechanism delays the decrease of blood glucose which creates hunger sig-
nals and increase appetite through fixed oscillation of postprandial blood 
glucose. In the second mechanism, short chain fatty acids formed after the 
fermentation of RS in large intestine reduce the storage of fatty acids from 
visceral adipose tissue and increase oscillation of fatty acids from hepatic, 
portal and venous blood. Therefore, satiety increases and and affects food 
intake. Decreasing food intake by increasing RS saturation can take a role 
in body weight control as resistant starch contains less energy than normal 
starch. In addition, the contribution of taken RS to energy can be between 
0–100% and 70% of RS can be metabolized in large intestine depending 
on the type and products of RS and its process in colon [5]. Further studies 
are required so that these effects of RS are supported and specific sugges-
tions about RS supplementation can be determined.
References:
1.  Nutrition Research. 2009;29(2):100–105. 
2.  The American Journal of Clinical Nutrition. 2010;91(4):932–939. 
3. British Journal of Nutrition. 2010;103(6):917. 
4. Journal of the American College of Nutrition. 2008;27(6):711–718. 
5. British Journal of Nutrition. 1996;75(05):733–747.
T3:PO.031
Resistant starch: Can it be used for the treatment of diabetic 
patients?
Şahin G., Bolluk S., Çelebi F., Deniz B.
University in Ankara, Ankara, Turkey
It is important to determine the type of carbohydrate used in medical nu-
trition treatment of diabetes which has increasing prevalence worldwide 
[1]. It is considered that the amount and quality of carbohydrate is related 
with postprandial glycaemia and the modification of carbohydrate type of 
a diet may affect the health of patient in the long run. In addition, glucose 
and insulin levels can be controlled and the progression of disease can 
be halted by consuming resistant starch(RS) and low glycemic indexed 



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247Abstracts 79
ing the inhibition of α-amylase, increasing the viscosity of chyme in small 
intestine, reducing glucose intake rate, linking glucose and preventing it 
from diffusing cells [2]. These effects have been found out in slightly over-
weight, hyperinsulinemic and diabetic adults besides healthy individuals 
[3]. In addition, it is indicated that RS reduces appetite by skipping from 
digestion and being fermented in large intestine, and ensures weight con-
trol and improves intestine health [4]. Additionally, RS can be used in 
many foods because it is a natural origin, sweet and white food stuff which 
contains normal size particles affecting the texture of product at a mini-
mum. RS makes a positive contribution to foods in terms of its appear-
ance, texture and taste in mouth that cannot be found in highly fibrous 
foods. In this respect, using this type of starch in the products produced 
for diabetic individuals can increase the life quality of diabetic people.
References:
1. Journal of Agricultural Faculty. 2011;25(2):147–157. 
2. Diabetologia. 2003;46(5):659–665. 
3. Journal of Food Technology. 2010;8(2):67–73. 
4. British Journal of Nutrition. 2010;103(6):917.
T3:PO.032
Interactions between Vitamin D, Magnesium and adipose 
tissue: A mechanism review and some clinical considerations
Kjeldbjerg C.1, Taylor M.1, Mastrostefano M.2
1Student at CNELM (Centre for Nutrition Education & Lifestyle Management),  
2Research Supervisor at CNELM
Vitamin D deficiency and obesity are growing public health issues. Evi-
dence suggests that vitamin D deficiency - obesity correlation. Literature 
also suggests that level of Magnesium is low in Western diet and this may 
correlate with obesity. Main aims of this mechanism review: • assesses 
the association between plasma 25(OH)D and fat mass and the potential 
effects of vitamin D on energy regulation • investigate possible mecha-
nisms linking subclinical Magnesium deficiency and obesity • consider 
the interaction of vitamin D, Magnesium and adipose tissue. • evaluate 
Magnesium and Vitamin D supplementation as a possible clinical inter-
vention for obesity. 
Methods: Systematic literature review. 
Results: 
• A robust correlation is confirmed between obesity, reduced 25(OH)D 
and Magnesium deficiency, but the existence/direction of a causal link 
is debatable. 
• Research is not conclusive if vitamin D and magnesium supplementa-
tion may reduce body fat mass. 
• The synergistic action hypothesis is supported e.g. via on adipose tissue 
suboptimal methylation of the vitamin D metabolising enzyme CY-
P24A1 which may be associated with differing concentrations of serum 
25(OH)D. 
• Research is partially hampered by the lack accurate of measurements of 
Magnesium and Vitamin D deficiency. A useful human biomarkers for 
the latter may be receptors target gene (DUSP10, CYP24A1). 
Acknowledgement: Our sincere gratitude to those who have made the completion 
of this project possible and in particular to Dr. James Neil, Research Director at the 
CNELM, for his inspiring lectures and research guidance.
Fig. 1. Vitamin D and Obesity mechanism diagram (Source: C. Kjeldbjerg - 
CNELM - BSc Research Project)
Fig. 2. Magnesium and Obesity mechanism diagram (Source: M. Taylor - CNELM 
- BSc Research Project)
T3:PO.033
Differences in peptide response to high fat and high 
carbohydrate foods between obese and lean adults
Gibbons C.1, Caudwell P.1, Finlayson G.1, Blundell J.1
1School of Psychology, University of Leeds 
Introduction: Exogenous administration of appetite-related peptides has 
measurable effects on appetite and food intake. However, the relation-
ship between postprandial peptides at circulating physiological levels and 
short-term appetite control is not well understood. In addition, differenc-
es between obese (OG) and lean (OG) postprandial peptide response is 
not well researched. 
Methods: We have compared postprandial profiles of peptides and me-
tabolites in response to fat and CHO in lean (n=12) and obese (n=16) 
adults (age 45.6 ± 6.2 years). Plasma was collected before and then pe-
riodically for 180 minutes after consuming high fat or high CHO meals 
of equal energy and weight (590kcal; 685g; 50% or 4% energy from fat). 
Simultaneous ratings of hunger and fullness were tracked for 180 minutes. 
Next, ad libitum food intake was measured. 
Results: OG had significantly higher BMI (29.8 vs 21.8 kg/m2), body 
mass, fat mass and waist circum. compared to the LG (p < 0.05). Fast-
ing peptides levels for glucose, insulin, triglycerides and leptin were also 
higher in OG (all p < 0.05), but no difference was seen for GLP-1 or PYY. 
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glucose, triglycerides, GLP-1 and PYY; only insulin response was differ-
ent between the groups. Insulin responded more strongly to carbohydrate 
compared to fat in both groups, and there were no interactions. There was 
however a main effect of group with the OG showing a greater change 
from baseline in insulin after both food types compared to the LG (F(1,26) 
4.597, p < 0.05). No differences in hunger, fullness or ad libitum energy 
intake were revealed (p > 0.05). 
Conclusion: Whilst body composition was associated with a number of 
fasting peptide levels (particularly tonic peptides), the response to food was 
similar in OG and LG; with the exception of insulin. This supports the no-
tion of insulin sensitivity being a main contributor to poor appetite control.
T3:PO.034
Vitamin d status and its association with cardiometabolic risk 
in a random sample of lebanese adults
Nasreddine L.1, Naja F.1, El-Hajj Fuleihan G.2, Hariri D.1, Hwalla N.1
1Department of Nutrition and Food Science, Faculty of Agricultural and Food 
Sciences, American University of Beirut, P.O.Box: 11-0236 Riad El Solh 1107-
2020, Beirut, Lebanon,  
2Department of Internal Medicine, Faculty of Medicine, American University of 
Beirut, P.O.Box: 11-0236 Riad El Solh 1107-2020, Beirut, Lebanon
Background: A link between vitamin D deficiency, obesity and increased 
cardiometabolic risk has been suggested in the literature. This study aims at 
investigating the association between vitamin D, adiposity markers (BMI, 
waist circumference WC, percent body fat %BF) and selected cardiometa-
bolic risk factors including lipid profile (TG, TC, HDL, LDL), fasting plasma 
glucose, hyperinsulinemia, metabolic syndrome (MS) and the inflammato-
ry marker CRP in a random sample of the adult Lebanese population. 
Methods: The study sample included 296 subjects aged 20 years and older 
drawn from the nation-wide Nutrition and Non-Communicable Diseas-
es Risk factors survey. Weight, height, and WC were measured and BMI 
calculated. MS was defined based on IDF criteria. Body fat was estimated 
based on multiple skinfold measurements. 
Results: Vitamin D deficiency (serum 25-OHD<10 ng/ml) was higher in 
women compared to men (35.7% and 7.9% respectively) while vitamin D 
insufficiency (serum 25-OHD between 10–20ng/ml) was higher in men 
compared to women (59.7% and 49% respectively). Correlation analysis 
revealed significant negative associations between serum 25OHD and 
%BF (r= –0.318), BMI (r= –0.217), WC (r= –0.98; p < 0.05), insulin (r= 
–0.202), HOMA (r=-0.200) and MS (r = -0.203) among women. Multi-
variate logistic regression showed that, across vitamin D tertiles, higher 
vitamin D levels were associated with lower odds of adiposity as assessed 
by %BF (p for trend <0.05) and lower odds of the MS (p for trend<0.05) 
among women. 
Conclusion: The high prevalence of low vitamin D status coupled with 
the suggested association between vitamin D, adiposity and MS highlight 
an issue of public health concern. The findings of this study should be 
further investigated in larger population studies.
Acknowledgement: We acknowledge Ms. Nada Adra for her help in statistical anal-
yses and we acknowledge all study subjects for participating in the study.
T3:PO.035
Risk of gaining weight due to eating in the absence of hunger 
among mexican health sciences college students
Santillana-Marín E.1, Bacardí-Gascón M.2, Pérez-Morales M.3,  
Jiménez-Cruz A.2
1Cisalud,  
2Facultad Medicina Psicologia,  
3Facultad Ciencias Químicas e Ingeniería 
Introduction:Eating in absence of hunger (EAH), is defined as eating in 
response to the presence of palatable food in the absence of physiological 
hunger, and is considered a risk factor for overeating during childhood 
and adolescence.
Objective: To assess the risk of increasing BMI, obesity (O), and abdom-
inal obesity (AO) because of EAH, among college students over a year of 
follow-up. 
Methods:A prospective study was conducted from October2013 to Oc-
tober 2014.Participants were second year medical, dentistry, psycholo-
gy and nursing students.A previously validated EAH questionnaire was 
applied at baseline.Factorial analysis was conducted to assess the main 
components of the EAH score.To assess the risk of increasing weight a 
binomial logistic regression was conducted. 
Results:The study population were 697 college students, and after a year 
638 (91.5%) students were assessed.Mean age was 20.3y. At baseline the 
prevalence of O and AO was 12% and 35% respectively. External stimulli 
(8.6%), negative feelings (41%), fatigue (12%), and boredom (7.4%) con-
tributed to 69% of the variability for EAH. Normal weight men had higher 
EAH by external stimulli, fatigue and boredom (p < 0.05) than O. Normal 
weight women had higher EAH by boredom (p = 0.012) than O. After a 
year, the prevalence of O and AO was 15% and 42%, respectvely. Patic-
ipants with an external stimulli score >12 were 1.9 times more likely to 
increase two or more kg (OR=1.9, CI 95% 1.3-2.9; p = 0.004). 
Conclusion: O and AO increased over a year period. Due to external 
stimulli, fatigue and boredom, normal weight men had more EAH than 
O men. Due to boredom normal weight women had more EAH than O. 
High external stimulli score increases the risk for weight gain
T3:PO.036
A retrospective analysis of reported alcohol consumption 
and correlation to BMI in patients attending the Rotherham 
Institute for Obesity (RIO)
Reale S.1, Walker L.1, Capehorn M.1
1Rotherham Institute for Obesity (RIO)
Introduction: Alcohol consumption has been reported to significantly 
increase Body Mass Index (BMI) and waist circumference due to being 
the second most energy dense macronutrient. However, there is a lack of 
evidence to support a clear interaction between alcohol consumption and 
BMI, and this study aimed to establish whether there is a clear correla-
tion between reported alcohol intake and BMI in patients attending the 
Rotherham Institite for Obesity (RIO). 
Methods: A retrospective analysis of self-reported alcohol consumption 
by patients attending RIO during 2012–13 (n=2251, age=50.9 +/- 19.0 yrs, 
BMI=41.4 +/- 9.6 kg/m2) was performed. Descriptive statistics were pro-
duced including normality tests and Spearman‘s Rank-Order Correlation 
was completed. 
Results: 54% of patients (n=1236) reported to consume alcohol weekly 
with the mean female and male drinker consuming 8.0 +/- 10.6 u/wk and 
13.7 +/- 16.6 u/wk respectively, both of which fall below national guide-
lines. However, further analysis demonstrated that 126 (8.1%) female and 
92 (13.3%) male patients were consuming up to 6 times the recommend-
ed levels, increasing their risk of liver disease. No significant correlation 
was established between age and units consumed (r=0.002, one-tailed 
p > 0.05) whereas a negative correlation was observed between BMI and 
units consumed (r=0.84, one tailed p < 0.001).
Conclusions: The results are in aligned with previous research that has 
found an inverse relationship between alcohol consumption and BMI. 
Some findings suggest that frequent heavy „binge“ drinking is more pos-
itively associated with BMI, rather than consumption over multiple days. 
Frequency of alcohol intake was not recorded nor analysed in this study 
and therefore adds to the study limitations. The relationship between alco-
hol consumption and BMI remains unclear due to its complexity and the 
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T3:PO.037
Clinical inertia in following the rules of diabetic diet in 
patients with type 2 diabetes mellitus
Mikolajczyk M.1, Kosmalski M.1
1Department of Internal Medicine, Diabetology and Clinical Pharmacology, 
Medical University of Lodz, Lodz, Poland
Introduction: The aim of the study was to assess the knowledge about 
the principles of a diabetic diet in patients with type 2 diabetes mellitus 
(T2DM) hospitalized for various reasons and to correlate the results with 
the type of medical care, anthropometric measurements and mean A1c 
value (HbA1c). 
Methods: The study included 100 patients (58 women, 42 men) with 
T2DM hospitalized in 2014 in the Department of Internal Medicine, Dia-
betology and Clinical Pharmacology, Medical University of Lodz. Patients 
were asked to fill the questionnaire concerning knowledge about diabetic 
diet and to indicate the type of medical care, under they reside: Diabetic 
Outpatient Clinic and/or GP Clinic. In each patient following data were 
collected: anthropometric measurements ( BMI, waist and hip circumfer-
ence, WHR) and HbA1c test was performed 
Results: Patients were in mean age 63.52 ± 12.64 years, mean duration 
of diabetes 11.89 ± 11.03 years, mean BMI 30.68 ± 6.93 kg / m˛, mean 
HbA1c value 8.87 ± 1.76%. Patients gave 74.6% correct answers in the test 
of knowledge about diabetic diet. In the study group, 53 patients were un-
der the care of Diabetic Outpatient Clinic and GP Clinic(A), 47 patients 
only under GP Clinic (B). Patients in group A had mean BMI 30.57 ± 6.7 
kg / m˛ (vs. group B 30 8 ± 7.26 kg / m˛), mean HbA1c value 8.36 ± 1.75% 
(vs. group B 9.46 ± 1.5%) and gave 76.6% correct answers in the test of 
knowledge about diabetic diet (vs. group B 72.3%). 
Conclusion: 
1.  The majority of patients with T2DM are overweight or obese. 
2.  Despite the good results of the test of knowledge about diabetic diet, 
patients did not follow rules of diabetic lifestyle (clinical inertia). 
3.  Patients under care of GP Clinic and Outpatient Diabetes Clinic had 
higher knowledge of the diabetic diet and achieved better therapeutic 
targets than patients only under care of GP Clinic. 
4.  Patients need permanent education on every medical visit.
Acknowledgement: Research relating to this abstract was funded by the grant of the 
Medical University of Lodz no. 503/0-077-09/503-01.
T3:PO.038
Obesity and health-related lifestyle factors in romania – “oro” 
study
Roman G.1, Bala C.G.1
1“Iuliu Hatieganu” University of Medicine and Pharmacy, Department of 
Diabetes, Nutrition, Metabolic diseases, Cluj-Napoca, Romania
Introduction: Regional studies have shown around 50% prevalence of 
adult overweight/obesity in Romania, with limited data on lifestyle pat-
terns. The cross-sectional ORO-Study aimed to evaluate prevalence of 
obesity and related lifestyle risk factors at national level. 
Methods: The study included 8 regional centers. Collected data were: an-
thropometric, social status, family/personal medical history, lifestyle and 
eating habits. A 24h food recall diary and two questionnaires were used: 
Global Physical Activity (WHO) and food frequency Nurses Health Ques-
tionnaire, translated and validated. 
Results: Representative sample of 2103 individuals were enrolled, mean 
age 41.5 years, mean BMI 29.9 kg/m2, 61.9% women, 72.8% from urban 
area. Prevalence of overweight / obesity was 31.1% / 21.3%; obesity 9.9% 
in 18–39 years, 30.1% in 40–59 years, 41.6% in 60–79 years age groups 
(p <0.001). Overweight / obesity in men was 41.6% / 23.0%, in women 
24.7% / 20.3% (p <0.001) and higher in rural area: 33.0% vs 30.3% and 
25.7% vs 19.7% (p = 0.004). Overweight and obese people had ≥ 3 meals/
day (36.0% and 38.8% vs 29.8% (p = 0.002), most consistent meal after 9 
pm (22.8% vs15.4%), large food quantities eaten less than 2h following 
another meal, less physical activity, less night sleep. Eating while watching 
TV was more frequent in normal BMI (51.8% vs 41.5%, p < 0.001), same 
for drinking water (56.1% vs 40.8%, p < 0.001) and sugar-sweetened car-
bonated drinks (6.6% vs 6.2%, p < 0.006). 
Conclusions: High prevalence of overweight and obesity increasing with 
age was found. Irregular meals, eating while watching TV were the most 
frequent unhealthy eating habits, although not always related to obesity. 
Despite some study limitations, the results suggest the complexity of the 
obesity-related risk factors.
Acknowledgement: Research relating to this abstract was funded through a grant 
received from the Coca-Cola Foundation by Research Consulting Association.
T3:PO.039
The effect of weight loss on body composition and serum lipid 
profiles in obese women
Akbulut G.1, Celebi F.2
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey
Introduction: Obesity is one of the most important health problems 
among the advanced and developing countries in recent years. An im-
balance of energy intake and energy expenditure leads to obesity which is 
associated with increased morbidity and mortality. In contrast, persistent 
weight loss significantly reduces overall mortality. This study was planned 
to investigate the effects of weight loss on body composition and serum 
lipid profiles in obese women. 
Methods: Obese women with body mass index (BMI)>30.0 kg/m2 (n:25) 
and aged 20–43 years were included in this study. According to the needs 
of each individual, dietary program was maintained to provide a weight 
loss 0.5–1 kg/week. The body composition was measured using bioelectri-
cal impedance analyzer (BIA). All of the measurements (BIA, serum lipid 
profiles, and anthropometric measurements) were taken before initial diet 
and after 12 weeks. 
Results: The mean age of women was 31.56 ± 7.3 years. There were sig-
nificant differences in body composition between initial and at the end of 
the diet programme. Body weight (kg), BMI, fat mass (kg), fat percentage 
(%), fat free mass, waist circumference (cm) and waist/hip ratio decrased 
significantly at the end of the diet programme. (p = 0.00). Also, decreasing 
in the level of serum total cholesterol (TC) and low-density lipoprotein 
cholesterol (LCL-C) were found significant (p = 0.001). 
Conclusion: As a result of this study, the diet has positive effects on body 
composition and serum lipid profiles. And this findings help to decrease 
mortality and morbidity.
T3:PO.040
Evaluation of iodine defficiency in kazan city studentsthe 
problem of iodine deficiency in the environment and 
deterioration of health status associated with it is vital for the 
tatarstan.
Stepanova N.V.1, Valeeva E.R.1, Korolev A.A.2
1Kazan Federal University, Russia,  
2I.M. Sechenov First Moscow State Medical University, Russia 
Introduction: The problem of iodine deficiency in the environment and 
deterioration of health status associated with it is vital for the Republic of 
Tatarstan with its geochemical peculiarities of nature and soil structure. 
The incidence of endocrine diseases, eating disorders, metabolic and im-
mune disorders (ED) under 14 years of age increased 1.6 fold for the peri-
od from 1996 to 2012 in the city of Kazan, and the 2,1 – 2,7 fold increase 
was registered for the period from 2007–2009. All these years, iodine de-
ficiency disorders (IDD) made 23.5—28.0% of ED. 
Methods: 220 children aged 12–14 living in Kazan and studying in gym-
nasiums No.3 and No.7 were examined. Prevention of iodine deficiency is 
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examination, ultrasound scan of thyroid gland, determination of ioduria 
and the level of the basal thyroid-stimulating hormone (TSH). 
Results: The thyroid volume is significantly larger in children of gymna-
sium No.3, as well as the higher incidence of structure variations: nodular 
goiter and focal changes of the goiter. The ioduria indices in students of 
gymnasium No.3 correspond to iodine deficiency (ioduria median made 
61 mkg/l), and in gymnasium No.7 – to normal level (ioduria median – 
115.5 mkg/l). The indices of TSH in students were within standard values 
and made 1.4 ± 0,6 mU/l (gymnasium No.7), and 1,6 ± 0,8 mU/l (gymna-
sium No.3), which is indicative of absence of functional thyroid disorders 
in children of both gymnasia. Significant difference in the level of iodine 
supply was directly associated with group prevention of IDD in gymnasia. 
Conclusion: Indices in gymnasium No.3 are indicative of demand for 
prevention of iodine deficiency and existing risk for IDD developing in 
children living in the territory of Kazan. 
Acknowledgement: The work is performed according to the Russian Government 
Program of Competitive Growth of Kazan Federal University
T3:PO.041
Effect of phosphorus supplementation on subjective appetite 
scores
Ayoub J.1, Abou Samra M.1, Hlais S.1, Bassil M.2, Obeid O.1
1Departement of Nutrition and Food Science, American University of Beirut, 
Beirut Lebanon, 
2Natural Sciences, Lebanese American University, Beirut, Lebanon 
Introduction: We have previously reported that phosphorus preload was 
able to reduce energy intake at subsequent meal by about 30%. A study 
was conducted to investigate the effect of 12 week phosphorus supplemen-
tation on subjective appetite scores. 
Methods: A double blind randomised placebo controlled study was con-
ducted on 47 overweight and obese subjects. Subjects were asked to in-
gest 3 tablets [placebo and phosphorus (125mg/tablet)] with each 3 main 
meals (breakfast, lunch and dinner) for 12 weeks. Subjective appetite 
scores were taken at baseline, 6 and 12 weeks. 
Results: Baseline subjective appetite scores were similar between the 
groups. Several parameters of subjective appetite scores were found to 
decrease as the experiment progressed (time) including that of appetite, 
quantity of food to reach fullness, hunger, and number of snacks. How-
ever, changes in appetite, quantity of food to reach fullness (indicator of 
satiation), taste of food and numbers of snacks were significantly reduced 
in the phosphorus group as compared to the placebo. While that of hunger 
(indicator of satiety) was not affected. 
Conclusion: Phosphorus supplementation seems to affect food or energy 
intake through a reduction in satiation rather than satiety.
Acknowledgement: Research relating to this abstract was funded by National 
Council for Scientific Research, Lebanon
T3 – Changing behaviors
T3:PO.042
The effect of food offered by grandparents on eating habits of 
their grandchildren
Papamichael M.M.1, Gavrieli A.1, Chantzialexiou M.1, Panou I.1, Fappa E.1
1Department of Dietetics, IST College, Athens, Greece 
Introduction: Parents and care-takers play an important role in the de-
velopment of childhood obesity. In many cultures, grandparents are also 
involved in child care process. However, studies investigating the effect of 
grandparents, involved in child care, on the dietary habits of grandchil-
dren are limited. Thus, aim of this study was to investigate whether there 
was a relationship between the type of foods offered by grandparents and 
children’s consumption of these foods. 
Methods: Data from 114 children (aged 8–12 years) were included in this 
study. From all available data, those regarding the provision of specific 
foods by grandparents to children and the frequency of consumption of 
these foods by children were used for the present analysis. For analytic 
purposes children were split into two group, different for each analy-
sis based on the type of food grandparents brought: a) group “yes” my 
grandparents offer me “this type of food” and b) group “no” my grandpar-
ents do not offer me “this type of food”. The types of food children were 
asked whether they were offered by their grandparents were: salty snacks, 
sweets, fruits, sodas. 
Results: Using Kolmogorov-Smirnoff, test data were found to be not nor-
mally distributed; therefore non-parametric statistics were used for all the 
analysis. Mann-Whitney test revealed that group a consumed more often 
the food offered by grandparents compared to group b, when the food 
was fruits (p = 0.052), sweets (p = 0.016), or salty snacks (p = 0.015). No 
statistically significant difference was found for the frequency of drinking 
sodas between the two groups (p = 0.346). 
Conclusion: Findings of this study showed that children offered a food 
by their grandparents consumed more frequently this food, compared to 
those not offered this food.
T3:PO.043
Morbid obesity: Study od dietetc and anthropometric profile 
of patients and a strategy in food education
Dias L.D.1, Ferrari F.Z.1, Regis J.M.1, Souza A.P.1, Cintra R.G.1, Oliveira M.R.1
1Center for Studies and Practices in Nutrition, Institute of Biosciences of 
Botucatu, University of Sao Paulo State, Botucatu, Sao Paulo, Brazil
Obesity is a health problem that worsens and surgical treatment is indicat-
ed when nonsurgical treatment is ineffective and there is high risk of life 
to the patient. To be successful is important to have a nutritional moni-
toring in pre and post-surgical as well as awareness of the patient self-care 
education. 
Objective:to formulate nutritional orientation for a group of obese pa-
tients and their caregivers; to assess the dietary habits and anthropometric 
measurements. 
Methodology: workshops conducted each 15 days, during 6 months, 
when were covered: Ideal Menu, Fractionation, Food Variety, Sodium, 
Fats, Fiber and satiety, Nutritional Labeling, Importance of Calcium, Anx-
iety and foods; besides tasting and delivering healthy recipe every meet-
ing. The adults morbid obese was the inclusion criterion. The dietetic data 
were obtained by 24h recall in the beginning of the study. Anthropometric 
measurements were evaluated. A test about quality from Brazilian Health 
Minister to evaluated dietary habits, and the software NUTWIN® to nu-
tritional composition were used. 
Results: the mean energy intake was 1771 ± 787 kcal (n=15). Fiber 
(15.5g±9.8g), calcium (424.5 ± 187.8mg) or iron (11.2 ± 4.7mg) were be-
low the recommended amount. The average of Body Mass Index is 46 ± 4. 
No changes were observed in the patient´s weigh in the end of the study. 
But after strategic to orientation, the score to Health Minister test im-
proved. The initial was 33 and 46 points at the end, characterizing them in 
the group of care to food and subsequently in adequate food. 
Conclusions: the habits were characterized by low fiber and minerals. 
This feed pattern of risk is worsening their nutritional status and need 
educational preparatory actions for surgery. The workshop is a strategy to 
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T3:PO.044
Do social norm based messages increase fruit and vegetable 
intake in children?
Sharps M.1, Halford J.1, Boyland E.1, Field M.1, Robinson E.1
1Institute of Psychology, Health and Society, University of Liverpool, Eleanor 
Rathbone Building, Liverpool, L69 7ZA, UK
Introduction: Children are influenced by the eating behaviour of their 
peers. Social norm messages suggesting that others eat healthily are effec-
tive at increasing fruit and vegetable intake in adults, but this hasn’t been 
tested in children. The present study tested whether exposure to social 
norm messages in a board game increased fruit and vegetable intake, rela-
tive to health or control messages. 
Methods: 164 children (84 males, 80 females) played a game which con-
tained either social norm messages about the fruit and vegetable con-
sumption of their peers, health messages about the benefits of fruit and 
vegetable consumption, control messages related to fruit and vegetables, 
or control messages unrelated to food. After exposure to messages in a 
game, participants consumed snacks from a selection of foods, including 
fruit and vegetables. The choice and amount of snack food consumed was 
examined. We examined whether BMI moderated the effect of message 
type. 
Results: There was no significant effect of message type on the amount 
of fruit and vegetables eaten. There was a significant interaction between 
condition and BMI; normal weight children ate significantly more fruit 
and vegetables after seeing health messages than after seeing control mes-
sages (unrelated to food). There were no significant differences between 
the social norm and other conditions. 
Conclusions: In this study, health-based messages increased fruit and 
vegetable consumption in normal weight children relative to control mes-
sages (unrelated to food). Social norm messages did not result in a statisti-
cally significant increase in fruit and vegetable consumption.
T3:PO.045
Smartphone Usage, Obesity, and Lifestyle Habits of Children 
and Adolescents in South Korea
Han S.1, Choi J.2, Park Y.1, Park J.1
1Department of Family Medicine, College of Medicine, Dong-A University,  
2Department of Family Medicine, College of Medicine, Kosin University
Due to its highly addictive characteristic, smartphone use can reduce 
physical activities and cause unhealthy lifestyle habits, which leads to obe-
sity. This study aimed to investigate the correlation between smartphone 
usage and obesity related factors. We visited four primary schools in south 
korea for the completion of questionnaires for 10 ~ 11 years old students. 
Out of 667 students, 240 underweight students were excluded, while 427 
students were classified into average-weight group and overweight/obese 
group. The hours of smartphone use, relationship between Smartphone 
Addiction Scale and obesity, and correlation with obesity related factors 
were analyzed. T-test was conducted based on the hours of smartphone 
use. The result showed that the students who used smartphones for 2 or 
more hours had significantly higher BMI than the students who did not.
(p < 0.05) The result of the logistic regression analysis showed more stu-
dents who used smartphones for 2 or more hours daily, watched TV for 
120 minutes or more, have taken their last meal later than 7 pm, watched 
TV while eating, and ate fatty foods. Moreover, the students in the poten-
tial risk group among the students who used smartphones tend to have 
their last meal later than 7 pm, eat excessively, and watch TV while they 
consume fatty foods, snacks, or drinks. The smartphone usage time and 
smartphone addiction are significantly related to the obesity factors in 
children and adolescents
T3:PO.046
Effects of a community-based cardiovascular disease 
prevention programme on long term weight loss and lifestyle 
goals in an obese population
Kerins C.1,2,4, Gibson I.1,2,4, Cunningham K.1,2,4, Jones J.1,2,4, Windle J.1,2,4, 
Costello C.1,2,4, Walsh A. M.1,2,4, Connolly S.3, Crowley J.2,5, Flaherty G.1,2,4
1National Institute for Preventive Cardiology, Croí Heart and Stroke Centre, 
Moyola Lane, Newcastle, Galway, Ireland,  
2Croí, the West of Ireland Cardiac Foundation, Moyola Lane, Newcastle, Galway, 
Ireland,  
3Imperial College Healthcare NHS Trust, London, United Kingdom,  
4School of Medicine, National University of Ireland, Galway, University Road, 
Galway, Ireland,  
5University Hospital Galway, Newcastle Road, Galway, Ireland
Introduction: Obesity is one of the primary risk factors for cardiovascular 
disease and type 2 diabetes. We sought to measure the long term changes 
in anthropometric measures and lifestyle habits in an obese cohort after 
participation in a preventive cardiology programme. 
Methods: High risk patients (Heart SCORE ≥ 5%ą) and their family 
members were enrolled on a 16-week intensive lifestyle programme, Croí 
MyAction, delivered by a multidisciplinary team. Body mass index (BMI), 
waist circumference, physical activity levels and dietary habits were as-
sessed at initial assessment (IA) and at 1 year (1-yr). To calculate the Med-
iterranean diet score a food habit questionnaire was administered, with 
the use of a photographic food atlas to estimate portion sizes. Individuals 
also completed a Chester Step Test, a sub-maximal exercise assessment 
which determined an estimate of their maximal aerobic capacity. 
Results: Of 741 patients enrolled, 390 completed the 1-yr assessment. The 
mean age of participants was 58 years, with 52.3% being male. Results 
demonstrated that there was a significant mean improvement in BMI, 
waist circumference, Mediterranean diet score and functional capacity at 
1-yr. 
Conclusion: Obesity is a growing epidemic in Ireland and these results 
demonstrate that long-term weight loss and lifestyle goals can be achieved 
and sustained as part of a comprehensive community-based cardiovascu-
lar disease prevention programme.
Reference:
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM, et al.: 
European Guidelines on cardiovascular disease prevention in clinical practice 
(version 2012). The Fifth Joint Task Force of the European Society of Cardiology 
and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. 
Atherosclerosis. 2012. Type of presentation: Poster
T3:PO.047
An adapted cognitive behavioral approch to addressing 
overweight and obesity among qatari youth
Alneama J.M.1, Ahmedna M.2, Al-Kuwari M.G.2
1Qatar University, Doha, Qatar,  
2Aspetar- Orthopedic and Sports Medicine Hospital, Qatar 
An Adapted Cognitive Behavioral Approach to Addressing Overweight 
and Obesity among Qatari Youth 
Introduction: The levels of overweight and obesity have reached epidem-
ic proportions in Qatar which stress the need for prevention programs. I 
can program is designed to manage the weight of overweight/ obese Qa-
tari school children at the vulnerable age of 9–12 years 
Methods: Integrate behavioral economics and cognitive behavioral thera-
py for 83 overweight/obese Qatari children in a multi-cohort prevention/
intervention study which involves three phases: (1) intensive lifestyle and 
weight loss camp, (2) 12-week after-school clubs as supplement/consol-
idation of knowledge, skills, and habits learned during the camp while 
engaging parents for long term sustainability of lifestyle changes, and (3) 
maintenance for knowledge, skills, habits, and behaviors gained in camp 
and afterschool clubs through web and social/family support 
Results: 100% of participating children lost weight at an average of 2 kg 
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on dietary habit and physical activity revealed that over 60% did not take 
enough to fulfill their daily requirements of fruits, vegetables and milk. 
They predominantly consumed calorie-dense fast foods, soft-drink, and 
sweets. Furthermore, Over half (53%) did not engage in physical activity 
in their spare time. 
Conclusion: the pilot phase succeeded in accomplishing the Adapt and 
pilot a school-based intervention that combines behavioral and cognitive 
approaches to promote healthy lifestyle among 9–12 year old children in 
select Qatari schools in the first year and laying a strong foundation for 
the start of the intervention cohorts in Qatari schools in years 2 through 5.
T3:PO.048
Is self-weighing an effective tool for weight loss: A systematic 
review and meta-analysis
Madigan C.D.1, Daley A.J.1, Lewis A.L.3, Aveyard P.2, Jolly K.1
1Health and Population Sciences, University of Birmingham, Edgbaston, 
Birmingham, UK,  
2Nuffield Department of Primary Care Health Sciences, University of Oxford, 
New Radcliffe House Radcliffe Observatory Quarter Woodstock Road Oxford 
OX2 6GG,  
3School of Social and Community Medicine, University of Bristol Canynge Hall 
39 Whatley Road Bristol, BS8 2PS
Background: Finding simple, yet effective, ways in which individuals can 
be helped to lose weight and sustain weight loss could improve public 
health. One strategy that has shown promise is self-weighing. 
Purpose: To examine the effectiveness of self-weighing for weight man-
agement. 
Methods: A systematic review and meta-analysis of 19 randomised con-
trolled trials that included self-weighing as an isolated intervention or as 
a component within an intervention. We also conducted sub group anal-
ysis of trials to examine whether there were differences between daily and 
weekly weighing frequency and trials that included goal setting and ac-
countability versus those that did not. 
Results: One study examined self-weighing as a single strategy and it was 
ineffective (-0.5 kg 95% CI –1.3 to 0.3). Adding self-weighing/self-reg-
ulation techniques to programmes resulted in a significant difference of 
–1.7 kg (95% CI –2.6 to –0.8). Multi-component interventions including 
self-weighing compared to no/minimal control resulted in significant 
mean differences of –3.7 kg (95% CI –4.6 to –2.9). There were no differ-
ences between trials that asked participants to weigh daily or weekly and 
those that had goal setting or not. Trials with accountability had signifi-
cantly (p = 0.007) greater weight loss than trials that did not include this 
component. 
Conclusions: It is inconclusive whether advising self-weighing without 
other intervention is effective. Adding self-weighing to a behavioural 
weight loss programme may improve weight loss. Behavioural weight 
loss programmes that include self-weighing are more effective than min-
imal interventions. Adding accountability to interventions that include 
self-weighing may improve effectiveness.
T3:PO.049
Nutrition And Eating Behavior 4 Years After Laparoscopic 
Sleeve Gastrectomy (LSG)
Mack I.1, Ölschläger S.1, Lenhard K.1, Sauer H.1, Becker S.1, Meile T.2, 
Kramer M.2, Zipfel S.1, Teufel M.1
1Department of Psychosomatic Medicine and Psychotherapy, University 
Medical Hospital Tübingen, Tübingen, Germany,  
2Department of General, Visceral and Transplant Surgery, University Medical 
Hospital Tübingen, Tübingen, Germany
Introduction: The outcomes of conservative treatment, especially with se-
vere obesity, are rather poor. In contrast, obesity surgery has been shown 
to be an effective treatment. LSG is characterized by its limited risk and 
concomitant substantial weight loss outcome. However, to date, long-term 
follow-up data on eating and nutrition behaviour are lacking. 
Methods: Of 169 patients who had undergone LSG, 148 were contacted. 
82 participated in the study (55.4%). 64 were examined at the study centre 
und 18 by interview via mail and telephone. Symptoms of eating disorders 
were assessed using a structured interview (EDE) and validated question-
naires (SIAB, EDI, FEV). Data on nutrition intake were acquired by two 
24 h recalls and a validated food frequency questionnaire and subsequent-
ly analysed using the multiple source method. 
Results: On average the LSG lay 4 years ahead of the follow-up examina-
tion. The initial BMI prior LSG was 48.6 ± 8.1 kg/m2 and after 4 years LSG 
36.1± 10.8 kg/m2. The excess weight loss was 49.5 ± 33.2%. Prior LSG n=8 
patients had a binge eating disorder, 4 years after LSG only n=1 patient. 
In the follow-up LSG patients report self-induced vomiting 7.4%, loss-of-
control-eating 15.7% und grazing 39.1%. In 10% of the patients the energy 
intake exceeds the energy requirements needed in order to maintain the 
actual body weight. 
Discussion: The excess weight loss after 4 years LSG was 50%. In the long-
term follow-up the whole picture of an eating disorder is seldom. How-
ever, some patients display eating disorder symptoms which may be par-
alleled by an increased energy intake. It is likely that the surgery outcome 
could be positively influenced if patients at risk were identified in time and 
supported by targeted intervention.
T3:PO.050
Eating behaviours are strong determinants of obesity risk, 
independently from socio-economic position
Meirhaeghe A.1, Pigeyre M.2, Rousseaux J.2, Chmielewski A.2, Duhamel A.2, 
Amouyel P.1, Dallongeville J.1, Romon M.2
1Inserm, U744, Institut Pasteur de Lille, Université de Lille, Lille, France,  
2Nutrition Unit, EA2694, University of Lille, Lille University Medical Center, Lille, 
France.
Introduction: Associations between eating behaviours and body weight 
are well known. The aim of this study was to assess the influence of so-
cio-economic position (SEP) on this relation. 
Methods: We conducted a case-control study with 605 obese patients 
consulting for obesity (78% women, age=41 yrs, BMI=42 kg/m˛) and 403 
non-obese controls (77% women, age=40 yrs, BMI=22 kg/m˛) recruit-
ed in a preventive health center. Eating behaviour was assessed both by 
TFEQ-R21 and questionnaire about eating circumstances. SEP was es-
tablished with a score constructed using occupation, education, income 
and divided in three groups (low/medium/high). Obese and non-obese 
subjects were compared using multivariate linear and logistic regression 
analyses. 
Results: Compared with a medium SEP, a low or a high SEP were as-
sociated respectively, with a higher or a lower risk of obesity (OR=2, 
p = 0.0002 and OR=0.7, p = 0.014). Concerning TFEQ, cognitive restraint 
(p = 8×10–9), uncontrolled eating (p = 9×10–20) and emotional eating 
(p = 5×10–35) were positively associated with obesity, with no interaction 
with SEP. For eating circumstances, eating at night (p = 3×10–11), in front 
of TV (p = 1×10–6) or in a large size plate (p = 1×10–108) were associated 
with obesity. Eating in a large plate was more frequent in low SEP, even 
in absence of obesity (p = 0.02). Only the association between the plate 
size and obesity was different according to SEP (inter p = 0.01); the risk 
of obesity associated with this behaviour was more pronounced in high 
SEP than in low SEP (OR=71, p = 1×10–35 vs OR=15, p = 10×10–13, re-
spectively). 
Conclusion: 1) Eating behaviours are strong determinants of the risk of 
obesity, mostly independently of SEP. 2) Some obesogenic behaviours 
such as plate size are more prevalent in low social class.
Acknowledgement: Research relating to this abstract was funded by the Fondation 
pour la Recherche Médicale, Institut Pasteur de Lille, Inserm, Lille University and 
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T3:PO.051
Associations between habit formation and weight loss in the 
10 top tips (10tt) trial: A randomised controlled trial of habit-
based advice for weight control in general practice
Beeken R.J.1, Vickerstaff V.2, Leurent B.2, Omar R.3, Croker H.1, Morris S.1, 
Nazareth I.2, Wardle J.1
1Department of Epidemiology & Public Health, University College London,  
2Department of Primary Care & Population Health, University College London,  
3Department of Statistical Science, University College London
Introduction: According to habit-formation theory, habits are auto-
matically-triggered actions, learned through repetition of the action in 
a consistent context. The 10TT trial tested a novel weight management 
intervention based explicitly on this theory. Previously presented data 
showed that patients allocated to 10TT lost significantly more weight over 
3 months than those allocated to usual care. The present analysis tested 
the hypothesis that change in patient-reported frequency and automatici-
ty of target behaviours would be associated with weight loss. 
Methods: A two-arm, individually-randomised, controlled trial in obese 
adults (n=537) in primary care, compared 10TT with usual care. At baseline 
and 3 months patients were weighed and reported the frequency and auto-
maticity of target behaviours using items from the self-report habit index. 
Results: Frequency and automaticity scores for each target behaviour were 
summed to create total scores. Frequency increased in both groups, but 
more in the 10TT group (10TT mean Δ=25.5; usual care mean Δ=17.7). 
There was also a larger increase in automaticity within the 10TT group 
(10TT mean Δ=26.9; usual care mean Δ=19.5). The amount of change was 
associated with weight loss for both frequency (r=-0.09,95%CI= [-0.11, 
–0.06]) and automaticity (r=-0.08,95%CI= [-0.11, –0.06]). 
Conclusion: As hypothesised, weight loss was related to change in the 
automaticity and frequency of target behaviours. This provides some sup-
port for the theoretical basis of 10TT; although the size of the associa-
tions was small. Formation of targeted habits may not be the only process 
through which weight loss occurred. Longer term outcomes will indicate 
if habit formation has a stronger role to play the effectiveness of 10TT for 
weight loss maintenance.
Acknowledgement: Research relating to this abstract was funded by The National 
Prevention Research Initiative (NPRI) Funding Partners.
T3:PO.052
A longitudinal study of food craving and dieting in adults 
engaged in weight management
Smithson E.F.1, Hill A.J.1
1Academic Unit of Psychiatry & Behavioural Sciences, Leeds University School of 
Medicine, 101 Clarendon Road, Leeds LS2 9LJ, UK
Background: Research evidence on the relationship between dieting and 
food cravings is conflicting, and there is little longitudinal research. The 
present study investigated the frequency and nature of cravings over time 
in adults engaged in weight management. 
Methods: A large national sample of individuals (N=2932; 97% female; 
BMI=31.6) enrolled with a commercial weight loss organisation complet-
ed on-line assessments of craving experiences (Control of Eating Ques-
tionnaire), depression/anxiety, and dietary restraint on 2 occasions, 7 
weeks apart. These data were analysed by dieting status (controlling for 
BMI, sex, age) and related to body weight measured at group meetings. 
Results: Cross-sectional analysis showed those ‘dieting to lose weight’ 
(55% of sample) reported significantly fewer, less intense, more resist-
ible, and more easily controlled food cravings than those ‘watching their 
weight’ (35%). There was no group difference in the types of foods craved, 
daily hunger, or mood. Over time, cravings lessened and weight reduced 
(-2.0kg). Longitudinal analyses showed this reduction was not accounted 
for by change in mood or dietary restraint. Frequency of eating in response 
to food cravings at Time 1 significantly predicted overall weight change; 
those less likely to eat in response to food cravings lost more weight. There 
was also a significant positive relationship between participants’ sense of 
control over their food cravings and weight loss. 
Conclusions: This is one of the first intentional studies of these relation-
ships. Clinically, these findings are important, showing that dieting (and 
increased restraint) does not lead to weight gain via increased food crav-
ings. Psychological strategies are available for dieters who do struggle to 
cope with food cravings.
T3:PO.053
Eating behaviour was associated with prevention of weight 
gain in varenicline treated overweight or obese smokers 
during smoking cessation
Svendsen M.1, Heggen E.1, Klemsdal T.O.1, Tonstad S.1
1Section for Preventive Cardiology, Department of Endocrinology, Obesity and 
Preventive Medicine, Oslo University Hospital, Norway. 1
Aim: To study the relation between eating behaviour (restraint, disinhibi-
tion, hunger, binge eating) and weight change in overweight/obese smok-
ers treated with varenicline for smoking cessation. Subjects and methods: 
In a randomized clinical trial 122 smokers (≥10 cigarettes/day) with BMI 
25–40 kg/m2 were randomized to moderately energy reduced diets re-
duced in carbohydrate or fat. The subjects received dietary and motiva-
tional counselling at 10 visits over 3 months. Treatment with varenicline 
was started one week after randomization. At randomization, 4 and 12 
weeks after target quit day (TQD), the TFEQ and the BES were used to 
assess eating behaviour. Food records were used to assess compliance with 
diet. Subjects with complete assessments of eating behaviour 12 weeks af-
ter TQD were included in the current analysis (N=88). 
Results: Protein intake in the low-carbohydrate vs fat-reduced diets was 
26 E% vs 20 E%, fat was 39 E% vs 31 E% and carbohydrates were 29 E% 
vs 41 E% (all p < 0.0001). No differences in weight changes (-0.1 ± 3.6 kg 
vs 0.04 ± 2.6 kg, p > 0.8) or in eating behaviour scores (all p > 0.2) be-
tween the dietary groups were seen 12 weeks post-TQD. The groups were 
combined and a one-way repeated measures ANOVA showed increased 
restraint (p < 0.0001) and decreased disinhibition, hunger and binge eat-
ing (all p < 0.03) between randomization and 12 weeks. In a general linear 
model, with change in weight as the dependent factor, change in restraint, 
disinhibition, hunger and binge eating as cofactors and dietary interven-
tion groups as the fixed factor, increase in dietary restraint (p = 0.014) and 
decrease in binge eating (p = 0.029) were associated with lower weight 
gain (model R2 = 0.14). 
Conclusion: In the contex of smoking cessation, dietary restraint and de-
creased binge eating may be useful in preventing early weight gain inde-
pendent of the macronutrient composition of the diet.
Acknowledgement: The authors thank Ĺshild M. Lode, Edith B. Hesselberg and 
Thea A.M. Bergvatn for assistance with the dietary counseling and dietary calcula-
tions, Ragnhild Kleve and Lise Bergengen for motivational counseling and admin-
istrative help and Nicole Warmbrodt for dietary counseling, and establishing the 
calorimetric method and database.
T3:PO.054
Association between appetitive traits and weight in adults in 
britain
Hunot C.1, Beeken R.J.1, Croker H.1, Klienman N.1, Wardle J.1
1Health Behaviour Research Centre, Department of Epidemiology and Public 
Health, University College London, London, United Kingdom (UK)
Background: Appetitive traits such as Food Responsiveness (FR), Enjoy-
ment of Food (EF), Satiety Responsiveness (SR) and Slowness in Eating 
(SE) have been shown to be risk factors for excess weight in children, but 
there have been few studies in adults. Using the newly developed Adult 
Eating Behaviour Questionnaire (AEBQ), we assessed FR, EF, SR, and SE, 
as well as Emotional Over and Under-eating (EOE, EUE), Hunger (H) and 
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(BMI) and weight status. Four could be termed food approach traits (FR, 
EF, H, EOE) and four food avoidant traits (SR, SE, EUE, FF). 
Methods: Data were from members of an online survey panel who com-
pleted the AEBQ and provided weights and heights to calculate BMI. Lin-
ear regression was used to examine associations between each appetitive 
trait and BMI, with gender and age as covariates. ANOVA was used to 
examine differences by weight status. 
Results: Data were available for 964 participants (18–79 years; 416 men, 
548 women; 377 normal-weight, 280 overweight, 261 obese). BMI showed 
significant positive linear associations with three food approach traits (FR, 
EF and EOE; β: .100 to .309; all p’s <.01) but no association with H. There 
were significant negative associations with SR, SE, and EUE (β: -.106 to 
-.191; all p’s<.05) but not FF. Obese respondents had significantly higher 
scores than others for FR and EOE and significantly lower scores for SR, 
SE and EUE (p < .05), but did not differ on EF, H or FF. 
Conclusions: Results indicate that overweight and obese adults have stron-
ger responses to food cues and weaker responses to satiety cues than nor-
mal-weight adults; consistent with data on children. Information on appe-
titive traits could be used to tailor weight management recommendations.
T3:PO.055
Exploring the influences of the home food environment on 
primary school children’s diet and weight status
Ong J.1, Ullah S.2, Leslie E.1, Magarey A.1
1Nutrition and Dietetics, Flinders University, Adelaide, South Australia, Australia,  
2Flinders Centre for Epidemiology and Biostatistics, Flinders University, 
Adelaide, South Australia, Australia
A child’s home food environment (HFE) supports or inhibits healthy eating, 
but its influence on childhood obesity is unclear due to poor understanding 
of underlying dimensions and mechanisms. This study aimed to investigate 
the relationship between the HFE and childhood obesity as mediated by 
child diet. Baseline data collected by questionnaire from parents of chil-
dren (9–11 years old) participating in the Obesity Prevention and Lifestyle 
(OPAL) Program were used (n=3323). Exploratory factor analysis using 
polychoric correlation explored 21 underlying components of the HFE. 
These components were used to define the overall HFE and linked to child 
diet (defined as meeting guidelines for fruit, vegetable and non-core food 
intake, based on parent report of child intake of defined food groups the 
previous day) and measured child BMI in structural equation modelling, 
adjusting for confounders. Five components incorporating 10 items were 
retained to describe HFE. After adjusting for age, gender, socioeconomic 
status and physical activity, all associations in the model were significant 
(p < 0.05) and explained 9.3% and 4.5% of variance in child diet and BMI 
respectively. Our model was a good fit and showed that a more positive HFE 
was directly associated, and indirectly associated through child diet, with a 
lower BMI in children. Parents are important facilitators of primary school 
children’s healthy eating at home. The robust statistical methodology used 
provides support for a model of the direct and indirect dynamics between 
the HFE and childhood obesity. The model can be tested in future longitudi-
nal and intervention studies to identify the most effective HFE component 
that should be targeted in childhood obesity prevention efforts.
Acknowledgement: Child and parent participants and all staff involved in data col-
lection
T3:PO.056
A nutrition education programme for saudi adolescents 
involving interactive activities with mothers is more effective 
for improvement of food intake and nutritional knowledge.
Alamri E.S.1, de Looy A.E.1, Collinson A.1
1School of Health Professions, University of Plymouth, Plymouth PL6 8BH UK
Introduction: Poor food choice and obesity in Saudi Arabia are of grow-
ing concern1. This study aims to examine whether interactive activities at 
home between mother and daughter, additional to school based nutrition 
education for daughters, leads to improvement in nutritional knowledge 
and food intake in homes of Saudi adolescent girls (17–18 yrs). 
Methods: Adolescent girls and mothers were recruited from 3 matched 
high schools. Using a 4 week cluster randomised design adolescents in 
school A received nutrition education and interactive activities (cooking/
recipe modifications to reduce fat intake) to complete with their mothers, 
adolescents in school B received education only and school C acted as 
control. Questionnaires on nutrition knowledge and food frequency ques-
tionnaires were administered pre and post intervention 
Results: 207 girls and their mothers were recruited (72, 69 and 66 schools 
A, B and C, respectively). There was no significant difference in pre-in-
tervention nutritional knowledge scores for mothers and adolescents 
between schools. Post intervention adolescents’ scores in A and B were 
significantly higher than school C (p < 0.05). Post intervention moth-
ers’ scores in school A were significantly higher than schools B and C 
(p < 0.05). Fruit, vegetables, milk and wholemeal bread consumption 
were positively correlated with nutritional knowledge scores of mother 
and adolescent in school A only (p < 0.05). 
Conclusion: Interactive activities effectively support nutritional knowl-
edge transfer from school to home resulting in improvement in adolescent 
and mothers’ nutritional knowledge and food intake.
Acknowledgement: We are grateful to Tabouk University (Saudi Arabia) Schools 
and families for support.
References:
1.  Al-Hazzaa, H (2007) Rising trends in BMI of Saudi adolescents: evidence from 
three national cross sectional studies. Asia Pacific J of Clin Nutr 16:462–466.
T3:PO.057
Study on non-communicable disease related lifestyle and 
behavior risk factors in west china
Xu X.1, Wu X.3, Deng Y.3, Ji K.3, Zhang N.3, Yi G.3, Cheng G.2
1Department of Nutrition and Food Safety, West China School of Public Health, 
Sichuan University, Sichuan center for disease control and prevention, Chengdu 
610041, Sichuan, China, 
2Department of Nutrition and Food Safety, West China School of Public Health, 
Sichuan University, Chengdu 610041, Sichuan, China,  
3Sichuan center for disease control and prevention, Chengdu 610041, Sichuan, 
China
Objective: In China, the resident population of Sichuan province, located 
in the west, is in the front rank. The proportion of elderly people, who 
are more likely to suffer from chronic disease, is also very large here.This 
study is to investigate the prevalence of NCDs and the related risk factors 
in west China aged 18 and above, and to provide scientific basis for devel-
oping NCDs-related intervention strategies.
Methods: A cross-sectional survey conducted in 2013–2014 with random 
samples using multi-stage stratified clustering sampling method from 12 
counties (districts) of Sichuan province. Datas on NCDs and lifestyle risk 
factors were collected through interviewer-administered questionnaires 
and physical (biochemical) measurements according to standardized pro-
tocol. 
Results: A total of 7131 adult residents participated in the survey. The 
prevalence of hypertension, diabetes, overweight, obesity, central obesity 
were 28.5%, 10.5%, 32.3%, 9.7%, 38.4% for men and 27.8%, 10.4%, 31.3%, 
12.7%, 48.6% for women respectively. Meanwhile, prevalence rate of alco-
hol drinking (year), current smoking, lower intake of vegetable and fruit, 
excess consumption of red meat, lack of physical activity were 53.5%, 
52.5%, 44.2%, 64.7%, 19.9% for men and 14.9%, 3%, 40.4%, 48.4%, 16.3% 
for women.
Conclusions: The prevalence rate of NCDs and risk factors was still high 
in Sichuan. Innovative and effective strategies are needed to prevent fur-
ther worsening of the situation. The intervention measures should be fo-
cus on emphasizing the significance of good lifestyle and behavior.
Acknowledgement: The present study is funded by the central and local govern-
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per and Cheng Guo gave some very valuable suggestions. Xu Xinyin,Ji Kui,Zhang 
Ningmei, Yi guanghui carried out and administrated the project. Wu Xianping and 
Deng Ying organized the study.The authors thank all researchers and respondents.
T3:PO.058
Characteristics of successful weight loss maintainers after 
very low calorie diet-induced weight loss
Hart K.1, Jones C.1, Johnston K.L.2
1Department of Nutritional Sciences, Faculty of Health and Medical Sciences, 
University of Surrey, Guildford, UK,  
2LighterLife UK Ltd, Cavendish House, Parkway, Harlow Business Park, Harlow, 
Essex, CM19 5QF
Very low calorie diets (VLCD) induce substantial initial weight loss and 
continued use of formula-based products may promote improved weight 
loss maintenance (WLM) thereafter(1). Tackling weight regain remains 
a key issue for obesity treatment. This study aimed to investigate the 
factors associated with successful weight loss maintenance after VLCD 
weight loss, to better support individuals and optimise this crucial stage 
of the weight loss ‘journey’. Individuals registered with Lighterlife (LL) 
(n=1100), a weight-loss programme comprising a VLCD, behavioural 
modification and group support, who had lost at least 10% of their start-
ing weight and had spent at least 6 months on the LL maintenance pro-
gramme, were invited to complete an online questionnaire, assessing diet 
and activity behaviours, along with an optional food frequency question-
naire (FFQ). Data analysis (n=104) is ongoing and although no one par-
ticular approach was associated with greater WLM success, results sug-
gest that participants most commonly employed healthier eating (95%), 
smaller portions (90%), lower energy drinks (87%) and continued use of 
meal replacement products (76%) to assist with WLM. However greater 
WLM was associated with more LL foodpack use and group attendance, 
with a significantly more frequent attendance when corrected for dura-
tion of maintenance (Q1 WLM: 1.03[0.9], Q4 WLM: 1.66[1.2] groups per 
month; p = 0.04). Psychologically, greater WLM was associated with less 
external and emotional eating and greater dietary restraint (see Figure 1). 
Following initial weight loss on a very low calorie programme individu-
als report employing a range of techniques to maintain their weight loss, 
most importantly continued group support. Further analysis will address 
any associations between reported dietary intakes and WLM success. 
Acknowledgement: The authors would like to thank Shangari Raviraj for her help 
with data collection.
References:
1. Johansson K et al.: (2014) Am J Clin Nutr 99 (1):14–23.
2 Van Strien T et al.: (1986) Int J Eat Disorder 5(2):295–315.
Fig. 1. Figure caption: Eating behaviors as assessed by the Dutch Eating Behavior 
Questionnaire(3) in high (Q4) and low (Q1) weight loss maintainers who have 
previously lost weight on a Very Low Calorie Diet. (*p = 0.04, duration corrected)
T3:PO.059
Monitoring of nutritional state and metabolic rate among 
czech military and civilian medical students
Blažek O.1, Fajfrová J.1, Vacková M.1, Pavlík V.1
1Department of Military Internal Medicine and Military Hygiene, Faculty of 
Military Health Science University of Defence Hradec Králové, Hradec Králové, 
Czech Republic
Introduction: Becoming a student of university leads to significant 
change of lifestyle, especially eating habits and physical activity. Students 
of military medicine are supposed to be in good shape in contrast to reg-
ular students of medicine. Aim of the study is to find out, how serious is 
their lifestyle change, how it affects their body composition, mental and 
physical shape. Study also aims to measure how mentioned parameters 
change over time. Another goal is to compare military group to civilian. 
Methods: To each group we enrolled 30 military students and 30 civ-
il students. We performed assessment of body height and weight, BMI, 
waist circumference and body composition by multifrequency impedance 
analyser InBody 720. Resting energy expenditure (REE) was measured by 
indirect calorimetry with Vmax Encore. Physical fitness was assessed by 
W170 test during cycle ergometry. 
Results: Military vs. civilian group; BMI 23.1 kg/m2 ± 2.0 vs. 21.9 ± 2.6 
kg/m2 (p = 0.97); percentage of body fat in normal range was in 70% vs. 
60%; waist circumference 76.0 ± 6,2 cm vs. 73.6 ± 7.4 cm (p = 0.91); rREE 
(percentage of predicted REE) 88.3 ± 6.7% vs. 88.2 ± 6.6% (p = 0.52); 
mean heart rate during W170 test was 138 ± 5 bpm and 141 ± 6 bpm 
(p = 0.029). 
Conclusion: So far, our expectations are being disproved by the fact that 
there are almost no differences between military and civil students. Ex-
cept military group performed better on ergometry and we expect the 
difference to grow bigger. Surprisingly, eating and lifestyle habits were not 
as bad as we thought they will be. These were only entry measurements. 
Changes in nutritional state and physical fitness are still to come.
T3:PO.060
Nutritional state and lifestyle of czech military medical 
students
Vacková M.1, Fajfrová J.1, Blažek O.1, Pavlík V.1
1Department of Military Internal Medicine and Military Hygiene, Faculty of 
Military Health Science University of Defence Hradec Králové, Hradec Králové, 
Czech Republic
Introduction: Becoming a student of university leads to significant 
change of lifestyle, especially eating habits a physical activity. On the con-
trary, students of military medicine are supposed to be in good shape to 
fulfill their military duties. Aim of work was the monitoring of nutritional 
state and lifestyle of military medical students. 
Methods: To evaluation were included 109 (73 men, 36 women) students 
of Faculty of Military Health Science with the mean age 21.9 ± 2.1 years. 
Nutritional state of students was evaluated by BMI, waist circumference, 
skinfold thickness, mid-arm circumference and bioelectrical impedance 
analysis. Muscle strength was evaluated using the hand grip test. Lifestyle 
was evaluated by food frequency and physical activity questionnaire. 
Results: Men vs. women; BMI 25.6 ± 4.7 kg/m-2 vs. 21.7 ± 3.2 kg/m-2, 
percentage of body fat 11.8% vs. 21.4%. Prevalence of normal weight ac-
cording to BMI was 78.8%, of overweight was 18.7% and of obesity was 
only 2.6%. Percentage of body fat in normal range was in 66.6%, below 
lower bound was in 28% and above upper bound was in only 5.4%. Fre-
quency of physical activity was on average 5 times vs. 4 times a week. Fruit 
and vegetables, meat, cereals and dairy products were consumed daily, 
sweets 4 times a week, alcohol 2 times a week, and coffee daily. Smokers 
were only 9 men and 4 women. 
Conclusion: Military student have lower prevalence of overweight and 
obesity in comparison with Czech population. According to all of the re-
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tional state. Mainly thanks to regular physical activity and also to balanced 
diet which is in accordance with WHO recommendation.
T3:PO.061
Ambulatory health information system for obesity prevention 
and treatement (pathmate) tailored for teenagers: A 
preliminary longitudinal study
Durrer D.1, Kowatsch T.2, l‘Allemand-Jander D.3, Büchter D.3, 
Pletikosa Cvijikj l.4, Maass W.5, Schutz Y.1,6
1Eurobesitas Center (COMs), Vevey, Switzerland 
Introduction: Multi-professional programs for the management of obesi-
ty in teenagers, which combine physical activity, nutritional and psycho-
logical components, are well established today. However, due to restricted 
resources available, only limited number of patients can be included in 
these programs, considering the low medical coverage and high needs 
consequent to the generally high prevalence of obesity. The objective was 
to develop a technical platform with a number of innovative tailored ap-
plications allowing an access to interactive interventions via a tablet PC. 
Methods:Six adolescents (13–17 years, BMI Percentile 97 for age & gen-
der) participated in a longitudinal field study. Following a baseline mea-
surement, one month, 3 month and 4 month evaluations were organized. 
The following measurements were made: 1. Well-being, mental health, 
mood, eating disorders, motivational interview all by validated question-
naires; 2. changes in body weight and BMI_SDS, blood pressure, speed 
of eating (by sequential photogrammetry), daily physical activity (PA by 
accelerometer, Fitbit), degree of relaxation (by skin conductance and heart 
rate), all by objective measurements. 
Results: Body weight loss at 4 months averaged as much as 6.2kg (range: 
3.8 to 8.0 kg). Although the applications were developed together with the 
teenagers, a large inter-individual variability of the platform usage (in-
conspicuously measured) was observed. The applications judged the most 
useful were mood test, relaxing exercise and PA tracking. 
Conclusion: For the MD’s, this new tool can provide a useful aid to work 
and communicate with (pre)obese teenagers during the consultation. A 
“Tamagoshy like” approach could stimulate the adherence to Pathmate.
Acknowledgement: National Science Foundation, Project no. 135552
T3:PO.062
Readiness to change body weight and lifestyle factors 
according to the transtheoretical model in an overweight/
obese upper-austrian population
Haider S.1, Luger E.1, Schrotter K.1, Rieder A.1, Dorner T.E.1
1Centre for Public Health, Institute of Social Medicine, Medical University of 
Vienna 
Introduction: Overweight and obesity is a global public health threat. 
The willingness to change body weight, nutritional and physical activity 
behaviour can be assessed with the transtheoretical model (TTM)1. Will-
ingness is divided in 5 stages of change (SOC): precontemplation, con-
templation, preparation, action and maintenance. The aim of this study 
was to assess the readiness for changing lifestyle and body weight in an 
Upper-Austrian population. 
Methods: A computer assisted telephone interview survey was conducted 
in subjects ≥18 years. SOC were asked and analysed dependent on BMI. 
For assessing gender specific differences chi-square test was performed. 
Results: 453 persons [47 (18) years, 51% women (w), BMI: 24.9 (3.9) kg/
m˛] were included in the analysis. According to the WHO criteria 3% 
were underweight, 53% normal weight, 34% overweight and 10% obese. 
In subjects who were overweight/obese, 23% were in the precontempla-
tion, 7% in the contemplation, 47% in the action and 23% in the main-
tenance stage concerning body weight. However, only 6% of overweight/
obese subjects were changing their nutritional and 7% their physical activ-
ity behaviour at the moment (action stage), whereas 72% claimed to main-
tain nutritional and 54% physical activity changes (maintenance stage), 
respectively. Compared to obese women, men were more likely to be in 
the precontemplation stage concerning nutritional (p = 0.000) physical 
activity (p = 0.037) changes. 
Conclusion: A majority of overweight/obese persons indicate that they 
are actively changing their body weight. However, most of them are not in 
the action stage regarding changing nutrition and physical activity habits. 
Obese men are less ready to perform lifestyle modifications.
Reference:
1. Prochaska JO, et al. Br J Addict, 1992. 87(6):825–828.
T3:PO.063
Images help obese women to memorize nutritional guidance
Micali F.G.1, Diez-Garcia R.W.1
1Departament of Internal Medicine, Ribeirăo Preto Medical School, University of 
Săo Paulo 
Introduction: The association of images with written or oral information 
facilitates cognitive processes like attention and memory, favoring compli-
ance with information. This study aimed to compare the memorization of 
eutrophic (n = 18) and obese (n = 15) women about nutritional guidance 
associated with images. 
Methods: Nutritional guidelines were presented during two workshops 
that dealt with the following themes: sugar content in food and drinks, 
food with equivalent energy content but distinct nutritional quality, fat 
content in food and preparations, and healthy food. Five messages were 
conveyed, accompanied by five images; a total of 20 images were em-
ployed. Immediately (T0), 30 days (T30), and 60 days (T60) after the 
workshops, the participants answered a structured questionnaire with 
Likert scales to evaluate the degree at which they recalled the messages. 
The Wilcoxon-Mann-Whitney and McNemar tests were used and the lev-
el of significance was set at 5%. 
Results: Obese women memorized the messages more than eutrophic 
women (all p values < 0.03). Only eutrophic women presented diminished 
recall along time (p = 0.0004 between T0 and T30). Memorization was 
higher than 63.3%, and the average memorization was 86.7% when all the 
themes, groups, and times were taken into account. The best memorized 
themes were about the sugar content of foods and drinks (from 85.6 to 
97.3%) and healthy food (from 81.1 to 100.0%). 
Conclusion: Pictorial instruments can aid obesity treatment and pre-
vention, since it favors memorization that could be accessed before food 
choices.
Acknowledgement: Funding: Research relating to this abstract was funded by 
Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq (protocol 
number 473848/2011-2).
T3:PO.064
Losing weight and maintaining healthy life style with help of 
cbt and internet
Málková I.1, Málková H.1, Fraisová A.1
1STOB, Prague, Czech Republic 1
Introduction: The rate of obesity in population worldwide is rising, there-
fore we must seek and try new methods. Recently, one of new tools used 
is internet due to its ability to reach many users of the web with minimal 
costs. The majority of internet weightloss programs offer only education. 
That impersonal approach is not successful in installing longterm change 
of behaviour. Current research is aimed on combining internet with CBT. 
Methods: STOB (Stop Obesity), established in 1990, has influenced many 
hundreds of thousands of people. Its methods are based on CBT. In order 
to provide longterm support in an individual weight reduction, in 2011 
STOB set up a community website www.stobklub.cz, which has 140,000 
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weightloss program for 4 up to 12 weeks, which has been used by 20,400 
members so far (10% of them were men) with an average BMI of 28. Users 
reduced their weight by 60,000 kgs. STOB prepared a new application, 
STOBkolo (STOBwheel) that works with an individual measure of readi-
ness and motivation of a given user. 
Results: STOBkolo works with patients´ readiness to change their hab-
its. According to the degree of patients´ motivation and other individual 
needs, the individual stages of STOBkolo offer various materials (e-books, 
videocourses, self-coaching consisting of food-coaching, fit-coaching and 
psycho-coaching, the system of „traffic lights“ offering an immediate feed-
back, and other tools). Members of STOBklub form motivational groups 
with longterm personal support. 
Conclusion: STOB combined with its STOBkolo two major approaches: 
proven methods of CBT with newer medium of internet. This model in 
accordance with plans of Patients Organization of EASO works with indi-
viduality of every patient. 
Acknowledgement: This work was supported by the grant N. DOT/
O4/03/004277/2014 of Prague City Hall
T3:PO.065
Loops - lund overweight and obesity preschool study: An 
intervention involving parents of preschool children with 
obesity has a long-term effect on the weight development of 
targeted children.
Önnerfält J.1,2, Erlandsson L.2,3, Orban K.2,3,, Helgason C.4, Thorngren-
Jerneck K.1,2
1Department of Paediatrics, Clinical Sciences Lund, Lund University, Sweden., 
2Vĺrdalinstitutet, Swedish Institute for Health Sciences, Lund University, 
Sweden.,  
3Department of Health Sciences, Faculty of medicine, Lund University, Sweden.,  
4Department of Psychology, Lund University, Sweden
Introduction: There is still lack of evidence of what are the best interven-
tional strategies to combat childhood obesity for preschool children. In-
terventions have shown to be more effective, the younger a child is. There 
is also a positive effect of involving parents of an obese child. Aim To 
evaluate if a family-based intervention involving exclusively the parents 
of obese preschool children, had a long-term positive effect on the weight 
development of targeted children. A secondary aim was to compare two 
different interventional strategies 
Methods: 80 children with obesity (BMI-SD 3.26 ± 0.71) aged 4–6 years 
were included. All parents were offered a 2-hour lecture and got access 
to a website with information about diet and exercise. They were also in-
vited to attend group meetings with the purpose of giving support to ac-
complish lifestyle changes. The parents were randomized into two groups, 
either to one led by a psychologist or by an occupational therapist. The 
interventions had in common that they aimed to support parents to make 
lifestyle changes for healthier eating and more active lifestyle and differed 
in the theoretical frameworks and ways in which they influenced the par-
ents. The interventions lasted one year and the children were followed up 
at end of intervention and one year after. 11 children were lost at the one-
year follow up. 
Results: There was a significant reduction in BMI-SD from the time of 
referral to the intervention project to the end of intervention (p = 0.000) 
and one year after (p = 0.003). There was no significant difference between 
the two different interventions. 
Conclusion: It is important to make interventions in very early life to 
combat childhood obesity. Supporting parents, without involving the 
obese child, is a successful strategy.
T3:PO.066
Evaluation of eating habits and lifestyle in obese patients 
before and after bariatric surgery
De Giuseppe R.1, Biino G.2, Persico F.3, Ciliberto A.3, Giovannelli A.3, Cena H.3
1Institute of Human Nutrition and Dietetics, Department of Public Health, 
Experimental and Forensic Medicine, University of Pavia; Italy,  
2Institute of Molecular Genetics, National Research Council of Italy, Pavia; Italy,  
3Department of General Surgery, Istituto Clinico S. Ambrogio, Milano, Italy
Introduction: The lack of improvement in eating habits and lifestyle in 
bariatric patients might predict the unsuccessful maintenance of body 
weight reduction at long term*. We aimed to evaluate eating habits and 
lifestyle of obese patients who have undergone Gastric Bypass Roux-en-Y 
(RYGB) and Sleeve Gastrectomy (SG). 
Methods: We retrospectively analyzed dietary habits (A), food frequen-
cies (B), physical activity (C) and smoking habits (D) in 50 RYGB (25M; 
aged: 24–64; BMI: 44.8 ± 6.8 kg/m2) and 50 SG patients (25M; aged: 22–
63; BMI: 44.5 ± 7.4 kg/m2) by means of a validated questionnaire, before 
(T0) and after 6 months (T1) from bariatric surgery. A score for each sec-
tion (A, B, C, D) was calculated. The score assigned to each item ranged 
0–3 points; maximum score corresponding to the best response. 
Results: ANOVA analysis, age/gender adjusted: 
• A and B scores improved significantly at T6 (RYGB and SG: p < 0.001), 
• C score did not reach the significance, 
• D score did not change at T6 neither in RYGB nor in SG. Multilevel 
models: 
• A and C scores did not correlate with independent variables (age, gen-
der, weight, BMI, ideal and relative weight) neither in RYGB nor in SG, 
• B score was negatively correlated both with weight (BYPGR: p = 0.002) 
and with BMI (SG: p = 0.003), 
• D score positively correlated with age, only in SG (p = 0.002), being the 
correlation stronger in females than in males (p = 0.004). 
Conclusion: Although dietary habits slightly improved, overall patients 
did not change their physical activity levels and smoking habits at T6. 
This was probably due to an incorrect perception about bariatric surgery 
procedures that reduce drastically weight in the short-term but need to 
be supported by an adequate lifestyle intervention program over the long 
term.
*Soares FL et al. (2014)
T3:PO.067
Development of the ‘adult eating behaviour questionnaire’ for 
appetitive trait measurement.
Hunot C.1, Beeken R.J.1, Croker H.1, Wardle J.1
1Health Behaviour Research Centre, Department of Epidemiology and Public 
Health, University College London, London, United Kingdom (UK)
Introduction: Appetitive traits such as Food Responsiveness (FR) and 
Satiety Responsiveness (SR), are stable predispositions towards food, ge-
netically linked to determined phenotypes, which could contribute to an 
individual’s susceptibility to gain weight in the obesogenic environment. 
In children these traits have been measured using the ‘Child Eating Be-
haviour Questionnaire’ (CEBQ) and low ‘food avoidance’ (SR) and high 
‘food approach’ (FR) traits have been consistently associated with obesity 
and weight gain. Adult appetite questionnaires tend to incorporate re-
straint and disinhibition, but no reliable measure of SR exists for use in 
adult populations. 
Methods: We developed a self-report questionnaire, the ‘Adult Eating 
Behaviour Questionnaire’ (AEBQ) from the parent report CEBQ. Items 
for inclusion were derived from the CEBQ and expanded based on a lit-
erature review to include items on Hunger. Piloting led to the deletion of 
some items, including the Desire to Drink scale, due to difficulties in com-
prehension and an altered response format from ‘often/never’ to ‘agree/
disagree’. Responses to items from 708 adults (18 to 81 years, 336 men, 
372 women) were analysed to determine the final factor structure of the 
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Results: Principal Component Analysis revealed a 35 item scale with eight 
factors similar to the CEBQ. The factors were internally valid and had 
good test-retest reliability (all Cronbach alphas >.7). 
Conclusions: The AEBQ is a robust measure of four ‘food approach’ and 
four ‘food avoidant’ traits, which is internally and externally reliable. This 
instrument will enable us to track associations between appetitive traits 
and weight into adulthood and could potentially identify individuals at 
risk of weight gain.
Fig. 1. Fig 1. Internal and external reliability measures of the ‘Adult Eating 
Behaviour Questionnaire’.
T3:PO.068
Barriers to healthy eating among medical students at 
university hospital and medical school canteens in germany: 
Results from a cross-sectional study
von Philipsborn P.1,2, Küppers D.2,3, Hommes F.2,4, Stratil J.2,5, 
Mühlensiepen F.6, Martin A.7
1Faculty of Medicine, Technische Universität München, München, Germany.,  
2German Medical Students‘ Association, Berlin, Germany.,  
3Faculty of Medicine, Universität Gießen, Gießen, Germany.,  
4Faculty of Medicine, Rheinisch-Westfälische Technische Hochschule Aachen, 
Aachen, Germany.,  
5Faculty of Medicine, Universität Tübingen, Tübingen, Germany.,  
6Berlin School of Public Health, Charité Universitätsmedizin Berlin, Berlin, 
Germany.,  
7Institute for Sport, PE and Health Sciences, University of Edinburgh, Scotland, 
United Kingdom.
Introduction: University, workplace and hospital canteens can play a 
crucial role in influencing long-term dietary habits of students, staff and 
patients, and can thus influence the occurrence of obesity and other di-
et-related conditions. This study aims to identify barriers to healthy eating 
in university hospital and medical school canteens. 
Methods: A cross-sectional survey was conducted among medical stu-
dents eating in university hospital and medical school canteens in Ger-
many on their consumption patterns, the perceived food environment 
and adherence to dietary recommendations published by WHO and the 
German Nutrition Association on six food items (salad, vegetables, fruit, 
whole grain or potatoes, meat and fish). 
Results: 97.3% of respondents (n=1590) indicated non-adherence to at 
least one of six dietary recommendations. The average number of declared 
non-adherences was 2.8 (SD=1.5). Reported reasons for non-adherence 
were lack of variety (49% of respondents), quality (47%), availability 
(43%), stable dietary preferences (40%), price (32%), lack of awareness/
prompting at the point of purchase (31%), non-inclusion in the default 
menue (29%), craving for salty/fatty food (29%), perceived value-for-mon-
ey (24%) and impractical serving and vending arrangements (17%). On 
average, respondents reported eating in a hurry in 51% of cases (SD=26). 
Reported reasons were the length of the lunch break (63%), general stress 
level (59%), noise level (38%), low-quality food (30%) and lack of cosiness 
(27%) in the dining hall. 
Conclusion: There is considerable room for improvement and a clear 
need for action in the product range, food environment and choice ar-
chitecture provided by university hospital and medical school canteens in 
Germany, which should lead by example.
Fig. 1. 1590 students from 38 medical schools across Germany completed a 
questionnaire with 19 closed and open-ended questions with in total 31 question 
items. Questions refered, among others, to the adherence to six standard dietary 
recommendations on salad, vegetable, whole grain and potatoe, and meat und fish 
intake, and to frequency of hurried eating.
Fig. 2. In the perception of most students, the canteen they visit most frequently 
does not offer a food environment supportive of healthy eating. Eating in a 
stressful atmosphere has been linked to unhealthy eating patterns, but only a 
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Fig. 3. Participants whose answers indicated non-adherence to standard dietary 
recommendations were asked to specifiy perceived barriers to the uptake of 
healthier eating patterns. Perceived lack of variety, quality and availability are 
important barriers for most items, whereas the price is particularly important for 
salad and fruit.
T3:PO.069
Dietary guidance given to patients with diabetes in burkina 
faso and mali: Content and impact of professional profile.
Garanet F.1, Besancon S.2, Traoré A.3, Mesenge C.4, Delisle H.5
1Research institute for Health Science,  
2Santé Diabčte (Mali);,  
3Bamako University Hospital,  
4Université Senghor de la Francophonie,  
5University of Montreal, Canada
Objectives: To assess the recommendations provided by health pro-
fessionals to persons with diabetes regarding diet, physical activity and 
weight control, and to examine the relationship between advice given and 
characteristics of the health professionals.
Methodology: The cross-sectional study was conducted over three 
months in 2012 in Ouagadougou and Bamako.Interviews with closed 
and open-ended questions were conducted with a total of 78 health pro-
fessionals (including 60 MDs) involved in the treatment of persons with 
diabetes in public hospitals and health centres. Dietary recommendations 
pertaining to specific food items, meal and snack patterns, cooking meth-
ods and meals away from home were rated. Types of recommendations 
for physical activity and for body weight were rated in a similar fashion.
Results:24% had no specific training in diabetes management, all respon-
dents declared providing some dietetic advice to patients. In general, rec-
ommendations focused on foods to avoid, to restrict or to consume ad 
libitum, and diet sheets were given to patients. Most interviewed practi-
tioners recognized that they did not have enough time or training to pro-
vide adequate dietetic guidance. 44% gave specific advice to patients on 
insulin and 20% talked about cooking methods. Advice given to patients 
was considered ‘acceptable’ in 65% of respondents for diet, in 70% for con-
trol of body weight, and in 95% for physical activity. Dietary and physical 
activity guidance scores were significantly higher in professionals with 
specific training, and in MDs compared with other health professionals.
Conclusion: The study highlights the need to improve dietary counsel-
ing , particularly as regards developing specific dietary plans with indi-
vidual patients for better compliance. Health professionals specialized in 
nutrition are becoming a priority in Africa to address nutrition-related 
non-communicable diseases, to train other health professionals and to 
assist individual patients.
Acknowledgement: The study was supported by Université Senghor and Santé Di-
abčte.
T3 – Physical fitness
T3:PO.070
Metabolic syndrome treatment with an advanced EMS device
Fujimoto T.1, Tabata A.2, Kinugasa Y.2
1Clinic F,  
2Ito Co., Ltd 
Objectives: Our study examines the possibility of boosting basal met-
abolic rates and reducing visceral fat with the AC BODY, an advanced 
electrical muscle stimulation (EMS) device developed by a domestic med-
ical device maker. We evaluated biochemical and physiological findings, 
including abdominal computed tomography (CT) images and measure-
ments of blood hormone levels associated with metabolic syndrome. 
Methods: We measured body weight, body mass index, and basal met-
abolic rate before and after treatment. Treatment was applied through a 
course of 10 weeks using rotation point-energizing EMS. 9 subjects were 
included in this study. Each treatment period was 30 minutes. Treatment 
involved the application of variable electrical stimulation with frequencies 
varying from 200 to 300 Hz to the abdomimal muscles simultaneously 
from 5 stimulating points of the electrode, through clockwise and coun-
terclockwise rotating stimulation each minute. We observed statistically 
significant declines after treatment in the following aspects: body weight 
(60.67 to 58.39 kg), BMI (22.89 to 22.06), body fat percentage (25.94 to 
24.01%), abdominal fat percentage (25.04 to 22.46%), total muscle mass 
(42.23 to 41.80 kg), waist circumference (77.60 to 74.23 cm), and basal 
metabolic rate (1331to 1280kcal). The area of visceral fat as indicated in 
CT images decreased by 43.2% and 31.1%, respectively. No dietary or ex-
ercise therapy was imposed during the treatment period. 
Conclusions: Treatment with the advanced EMS device resulted in sig-
nificant decrease in visceral and subcutaneous fat while maintaining ab-
dominal muscle mass, which points to the potential efficacy of treating 
metabolic syndrome by an approach other than exercise or diet.
T3:PO.071
Gender and age-related differences in athletes’ health status 
in individual and team sports
Šarac J.1, Sindik J.1, Gregurinović T.2, Tomić D.2, Missoni S.1
1Institute for Anthropological Research, Zagreb, Croatia,  
2Polyclinic for Occupational Health and Sport, Zagreb, Croatia
Introduction: Routine medical examinations are important in deter-
mining not only the current health status of athletes, but also potential 
different responses of males and females to certain athletic activities and 
gender-related health status differences. The main goal of this study was 
to determine the differences between athletes who are actively engaged in 
team vs. individual sports, stratified by age groups and gender, in BMI and 
other chosen biochemical health indicators. 
Methods: The data were collected during routine medical examinations 
in 2011 and 2012 from 8482 athletes in Zagreb, Croatia. Collected data in-
cluded height, weight, BMI, blood pressure (diastolic and systolic), pulse 
rate, hemoglobin, hematocrit, leukocyte, thrombocyte, and sedimenta-
tion. 
Results: A number of statistically significant differences in BMI and cho-
sen biochemical indicators have been revealed in female athletes (strati-
fied by age groups) between individual and team sports. On the contrary, 
a minimal number of statistically significant differences in these variables 
related to the sport type have been detected in male athletes. Moreover, 
these differences indicate health status in male and female athletes across 
different age groups. 
Conclusions: Possible explanations for such results could be the specific 
features of different sport types, different gender-related motivation for 
choosing a sport type or greater general importance of physical activity 
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chosen health indicators collected during routine medical examinations, 
according to a sport type, could be a useful proxy for detecting gender and 
age-related differences in athletes’ health status.
T3:PO.072
Body mass index and six-minute step test predict 
cardiorespiratory fitness in lean and obese sedentary young 
women
Carvalho L.P.1, Di Thommazo-Luporini L.1, Luporini R.L.2, Bonjorno J.C.1, 
de Oliveira C.R.3, Pacheco E.P.1, Lopes Zangrando K.L.1, Lanzotti H.1, 
Trimer R.1, Mendes R.G.1, Borghi-Silva A.1
1Cardiopulmonary Physiotherapy Laboratory, Federal University of Sao Carlos, 
Sao Carlos, Brazil,  
2Santa Casa de Misericórdia de Sao Carlos, Sao Carlos, Sao Paulo, Brazil, 
3Department of Medicine, Federal University of Sao Carlos, Sao Carlos, Brazil
Introduction: Physical inactivity leads to impaired cardiorespiratory 
fitness (CRF) as well as it render sedentary people more susceptible to 
reduced functional capacity and higher mortality risk. Obesity is quite 
prevalent in women and it is usually associated to sedentary lifestyle, con-
tributing to increase bad outcomes. The six-minute step test (6MST) has 
been proposed to evaluate functional capacity in this population in clinical 
centers when the maximal cardiopulmonary exercise testing (CPX) is not 
available due to limited space and staff. However, it is not of our knowl-
edge the existence of predictive equations of metabolic responses to CPX 
from demographic and anthropometric variables and from performance 
in the 6MST. Our aims were to assess the number of step cycles (NSC) ob-
tained by 6MST as well as BMI and age ability to predict maximal oxygen 
uptake (VO2) achieved during CPX in sedentary young women. 
Methods: Thirty-three sedentary women (20–45y; 18.5<BMI<24.9 or 
BMI>30 kg.m-2) underwent a clinical evaluation (including body com-
position), a CPX, and a 6MST. To assess the ability to predict peak VO2 
achieved during CPX we applied stepwise multiple linear regression anal-
ysis and to verify relationships between metabolic and body composition 
variables we used the Pearson´s correlation coefficients (p < 0.05). 
Results: BMI, NSC and age were selected and entered the reference equa-
tion explaining 83% of the total variance in peak VO2 obtained during 
CPX. Strong correlations were found between VO2 and both BMI and 
body fat (r= –0.85) as well as VO2 and 6MST performance (r=0.81). 
Conclusion: Concomitantly, BMI, 6MST and age are able to predict max-
imal VO2 in sedentary young lean and obese women, including a simple 
and inexpensive functional evaluation tool.
Acknowledgement: The Fundaçăo de Amparo ŕ Pesquisa do Estado de Săo Paulo 
(FAPESP Process 2009/01842-0 and 2013/15681-3), Sao Paulo, SP, Brazil for fund-
ing this study and the Cardiopulmonar Physiotherapy Laboratory of the Physiother-
apy Department of Universidade Federal de Săo Carlos.
T3:PO.073
Marital status and educational level in greek obese adults
Fotiadou E.1, Kourtoglou N.1, Gounitsioti I.1, Dimitroula C.1, Axiotidou E.1, 
Kouniakis F.1, Bellivani M.1, Tzotzas T.1, Savopoulos C.1, Hassapidou M.N.2, 
Hatzitolios A.I.1
1Obesity & Metabolism Outpatient Clinic, EASO accredited Collaborating COM, 
1st Propedeutic Department of Internal Medicine, AHEPA University Hospital of 
Thessaloniki, Greece,  
2Department of Human Nutrition & Dietetics, Alexander Technological 
Educational Institute of Thessaloniki, Greece
Introduction: A series of studies have stated associations among marital 
status, educational level and obesity. The aim of this study was to assess 
whether these associations were observed in Greek obese adults. 
Methods: Demographic and anthropometric data from a total number 
of 153 obese outpatients were analyzed (mean age 47.3 ± 11.8 years and 
mean BMI 39.6± 7.4 kg/m2, 113 women, 40 men). WHO cut-offs were 
used to define obesity subgroups - Class I, II & III. Marital status and edu-
cational level were obtained using a validated questionnaire. 
Results: Regarding the overall population 25%, 33% and 42% belonged to 
the obesity subgroups I, II & III respectively. More than half outpatients 
(60.5%) were married. Subgroups of obesity and marital status were sig-
nificantly associated in overall (p < 0.01) as well as in female (p < 0.05) 
population. In obesity classes I & II there were more married individuals, 
while in class III the majority was unmarried. According to their educa-
tional level, 11% attended primary school, 49% high school and 40% had 
a university degree. Outpatients, mainly men, who attended only primary 
school had significantly higher BMI than those who attended high school 
(p < 0.01) or/and university (p < 0.05). 
Conclusions: Marital status seems to influence development of obesity 
both in men and women. Furthermore, this study indicates the need for 
higher educational level along with health education programs, especially 
for the early school leavers.
T3:PO.074
The impact of feeding status on the adipose tissue responses 
to exercise in overweight men
Chen Y.C.1, Travers R.L.1, Walhin J.P.1, Betts J.A.1, Thompson D.1
1Department for Health, University of Bath, United Kingdom 
Background: Feeding profoundly affects metabolic responses to exercise 
in various tissues but it is unclear whether feeding status influences the 
way adipose tissue responds to exercise. 
Methods: Ten healthy overweight males aged 26 ± 5 years (mean ± SD) 
with waist circumferences between 105 ± 10 cm completed a walking pro-
tocol at 60% of maximum oxygen uptake under either FASTED or FED 
conditions in a randomised, counterbalanced design separated by a 3–4 
week wash-out period. Blood samples were collected at regular intervals 
to examine changes in metabolic parameters. Adipose tissue samples were 
obtained at baseline and one hour post exercise to examine changes in ad-
ipose tissue gene expression and secretion of selected adipokines ex-vivo. 
Results: Incremental glucose and insulin area under the curves were sig-
nificantly higher in FED than FASTED conditions (156 ± 43 vs. 14 ± 6 
mmol.300 min.l-1, p = 0.015 and 37.8 ± 8.2 vs.0.7 ± 0.3 nmol.300 min.l-1, 
p = 0.002, respectively). Significant trial × time interaction effects were 
found for adipose tissue expression of GLUT4, HSL, PDK4 and IRS2 (all 
p < 0.05) when exercising under diverse dietary conditions; with expres-
sion of HSL (2.09-fold) and PDK4 (1.68-fold) up-regulated under FAST-
ED conditions and expression of PDK4 (0.77-fold) and IRS2 (0.81-fold) 
down-regulated under FED conditions. Feeding did not impact upon se-
rum and ex-vivo adipose secretion of IL-6, leptin and adiponectin.
Conclusions: This study shows that feeding prior to acute exercise affects 
adipose tissue gene expression responses. Given the potential role of ad-
ipose tissue in metabolic health, choosing to exercise whilst in a fed or 
fasted state will potentially impact the long-term responses to an exercise 
programme.
Key words: Gene expression, obesity, walking
T3:PO.075
Structured, supervised physical training after gastric bypass 
has positive impact on weight reduction and aerobic capacity
Stolberg C.R.1, Mundbjerg L.H.1, Juhl C.B.1, Gram B.2
1Department of Endocrinology, Hospital of South West Jutland, Esbjerg,  
2Institute of Regional Health Research, Hospital of South West Jutland, Esbjerg
Introduction: Bariatric surgery is the most efficacious treatment for se-
vere obesity. Evidence regarding effects of physical training post-surgery 
is lacking. The purpose of this study was: 1) to evaluate the effect of gastric 
bypass (GB) on weight loss, VO2max, and muscle strength and 2) to eval-
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Methods: Sixty patients with morbid obesity, qualified for GB, were 6 
months post-surgery randomized 1:1 to 26 weeks intervention (I) or a 
control group (C).The intervention consisted of 2 x 40 min training ses-
sions per week each involving training of aerobic capacity and muscle 
strength, instructed and supervised by physiotherapists. Measurements 
on anthropometry, VO2max, and muscle strength were performed 
pre-surgery, 6, and 12 months post-surgery. 
Results: Preliminary results from 42 of the 60 patients are present-
ed (mean (SD)). At baseline the body weight (kg) was: 126.3(8.9), BMI 
(kg/m2): 43.1(6.0), VO2max (l/min): 2.6(0.7), and muscle strength for 
hip extension (N): 219.0(58.3). GB resulted in reduced body weight (Δ: 
–27.7 (1.0), p < 0.001) and BMI (Δ: - 9.4(0.4), p < 0.001), no changes in 
VO2max, and a significant decrease in muscle strength (Δ: –17.4(30.3), 
p < 0.007). Physical training caused an additional significant reduction in 
bodyweight (Δ:-1.5(1.5), p < 0.03), in BMI (Δ:-0.6(0.4), p < 0.003), and an 
increase in VO2max in I compared to C (Δ:0.5(0.1) p < 0,002).There was 
no significant effect on muscle strength. 
Conclusion: Post-bariatric patients undergoing structured supervised 
physical training loose more weight and increase their aerobic capacity 
compared to control. The reduced muscle strength during the initial phase 
of weight loss emphasizes the need of post-surgery specific strength train-
ing.
T3:PO.076
Effects of aerobic training, resistance training or both in 
obese adolescents with the metabolic syndrome: The hearty 
randomized controlled trial
Frappier A.1, Alberga A.S.2, Sigal R.J.3, Kenny G.P.1, Doucette S.4, 
Prud‘homme D.1,5
1School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, 
Ottawa, Canada, 2Faculty of Education, University of Calgary, Calgary, Canada,  
3Departments of Medicine, Cardiac Sciences and Community Health Sciences, 
Faculties of Medicine and Kinesiology, University of Calgary, Calgary, Canada,  
4Department of Community Health and Epidemiology, Dalhousie University, 
Halifax, Canada,  
5Institut de Recherche de l‘Hôpital Montfort, Ottawa, Canada
Introduction: There is little evidence regarding the effect of exercise 
training in obese adolescents with Metabolic Syndrome (MetS). We aimed 
to determine the effects of Aerobic, Resistance, and Combined training 
on the prevalence of MetS in obese adolescents enrolled in the HEARTY 
(Healthy Eating, Aerobic and Resistance Training in Youth) trial. 
Methods: After a 4 weeks run-in, previously-inactive post-pubertal ad-
olescents (N=304) aged 14–18 years old (Tanner Stage IV-V) with Body 
Mass Index ≥ 85th percentile for age & sex were randomized to 4 groups 
for 22-weeks. Of these, a sub-sample (n=49) was identified as having MetS 
based on the International Diabetes Federation definition. All participants 
[Aerobic training (N=11), Resistance training (N=12), Combined aerobic 
and resistance training (N=10), or non-exercising Control (N=16) re-
ceived dietary counseling with a daily energy deficit of 250 kcal. This is a 
secondary analysis of the HEARTY trial. 
Results: There were no significant changes in the prevalence of MetS be-
tween groups, however, significant improvements in MetS parameters 
were observed within groups; with Aerobic training, there was a decrease 
in waist circumference (-3 cm) and systolic (-11 mmHg) and diastolic (-5 
mmHg) blood pressure from baseline to post-intervention. Resistance 
training decreased body mass index (-1.5 kg/m2), percentage body fat 
(-2%), waist circumference (-5 cm) and systolic (-10 mmHg) and diastolic 
(-6 mmHg) blood pressure from baseline to post-intervention. Combined 
aerobic and resistance training decreased triglyceride concentrations (-0.7 
mmol/L) and increased high density lipoprotein concentration (+0.04 
mmol/L) compared to baseline. The Control-diet group significantly de-
creased systolic blood pressure (-7 mmHg) and fasting insulin (-24.9 μIU/
mL) when comparing pre- and post-intervention. 
Conclusions: Exercise, regardless of modality, did not reduce the prev-
alence of MetS but did improve MetS components in obese adolescents. 
Acknowledgement: Funded by the Canadian Institutes of Health Research (Clini-
calTrials.Gov NCT00195858)
Fig. 1. Prevalence of Metabolic Syndrome at baseline and post-intervention based 
on the International Diabetes Federation
Fig. 2. Number of participants with the metabolic syndrome at baseline and 
post-intervention based on the International Diabetes Federation
Fig. 3. HEARTY Participants’ anthropometric and metabolic parameters at 
baseline and post-intervention Data are medians (IQR)
T3:PO.077
Obese children and adolescents who skip breakfast present 
abnormalities in the lipid profile and blood pressure
Freitas Jr I.F.1, Monteiro P.A.1, Antunes B.M.1, Silveira L.S.1, Brunholi C.C.1, 
Christofaro D.J.1, Fernandes R. A.1
1Pos-Graduation Program in Science of Motricity – Univ. Estadual Paulista – 
UNESP – Săo Paulo-Brasil
Objective: To analyze the effect of weekly breakfast intake frequency on 
metabolic changes in obese children and adolescents. 
Methods: The study included 285 obese children and adolescents, aged 
six to 16 years (10.9 ± 2.7). Body composition (percentage of body fat and 
trunk fat), blood samples (glucose, triglycerides, total cholesterol and its 
fractions HDL-Cholesterol, LDL-Cholesterol e VLDL-Cholesterol), blood 
pressure and food intake were assessed. The subjects were distributed in 
two groups: Breakfast Skippers and Non-Skippers. Non-skippers were just 
those who answered taking breakfast every day. 
Results: In overall sample, 50.9% (n=145) subjects reported daily con-
sumption of breakfast at least once a week. Skippers presented higher 
mean values of systolic blood pressure (117.3 mmHg and 112.7 mmHg 
[p = 0.038]), triglycerides (106 mg/dL and 92.5 mg/dL [p = 0.037]). On 
the other hand, higher mean values of HDL-cholesterol (44.0 mg/dL and 
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Conclusion: Obese children and adolescents who skip breakfast present-
ed abnormalities in plasma lipid concentrations and in systolic blood 
pressure.
Acknowledgement: UNESP, CAPES, CNPq
T3:PO.078
Optimal cutoffs for defining physical fitness in sedentary 
obese women
Di Thommazo-Luporini L.1, Carvalho L.P.1, Luporini R.L.2, Trimer R.1, 
Nogi C.Y.1, Lopes Zangrando K.T.1, Petronilho A.2, Catai A.M.3,  
Borghi-Silva A.1
1Cardiopulmonary Physiotherapy Laboratory, Department of Physiotherapy, 
Federal University of Sao Carlos, Sao Carlos, Brazil,  
2Santa Casa de Misericordia of Sao Carlos, Sao Carlos, Brazil,  
3Nucleus of Research in Physical Exercise, Department of Physiotherapy, Federal 
University of Sao Carlos, Sao Carlos, Brazil
Introduction: Obesity is linked to reduced functional capacity and in-
creased health risk and has been diagnosed using the body mass index 
(BMI) to stratify its severity. Nevertheless, its use is limited once it does 
not reflect body composition either physical fitness. Our aim was to iden-
tify optimal cutoffs for body composition and performance measurements 
that predict functional capacity better than BMI does. We hypothesized 
that a stratification based on oxygen uptake (VO2) and body composition 
data could identify levels of obesity severity. 
Methods: This is a cross-sectional study. Fifty-eight sedentary obese 
women (20–45 y) were assessed and they were allocated in three groups, 
accordingly to BMI (kg.m-2): GI (n = 18), GII (n = 19), and GIII (n = 21). 
Subjects underwent body composition analysis (to obtain body fat (BF%) 
and lean mass (LM%) percent) and cardiopulmonary exercise testing 
(CPX). We applied ANOVA one-way with Tukey post-hoc to verify be-
tween-group differences and receiver operating characteristic (ROC) 
curve analyses to find out optimal cutoffs to identify appropriate physical 
fitness. 
Results: Demographic, anthropometric, and body composition data and 
CPX variables are presented in table 1. The areas under the ROC curve 
determined for BMI, BF%, LM% and CPX distance were 0.9 (0.8–1), 0.9 
(0.7–0.9), 0.9 (0.8–1) and 0.8 (0.7–0.9) as well as the cutoffs points were ≤ 
34.5kg/m2, ≤ 43.6%, ≥ 53.3%, > 546m, respectively.
Conclusions: BMI, BF%, LM% and CPX distance were accurate to deter-
mine cutoffs discriminating obese women with adequate physical fitness 
from those with poor one. Regarding the BMI, the best tradeoff found to 
discriminate the physical fitness in obese women has a superior value than 
the usually accepted value for obesity classification.
Acknowledgement: The Fundaçăo de Amparo ŕ Pesquisa do Estado de Săo Paulo 
(FAPESP 2009/01842-0) Sao Paulo, SP, Brazil and the Conselho Nacional de Desen-
volvimento Científico e Tecnológico (CNPq 141331/2011-9) for funding this study.
Fig. 1. Table of demographic, anthropometric, and body composition characteri-
stics and variables at the peak of maximal treadmill cardiopulmonary exercise test.
T3:PO.079
Relationships between physical function, strength and 
obesity in children: Implications for physical fitness and 
activity
Ecclestone C.1, Mahaffey R.1, Morrison S.1, Ferrari J.1, Drechsler W.1
1School of Health, Sport & Bioscience, University of East London, London, UK
Physical fitness, activity, musculoskeletal function and strength are re-
portedly lower in obese children compared to their healthy weight peers. 
However, little information exists on the relationships between these vari-
ables. This research aims to investigate the relationships between child-
hood obesity with physical function and strength. Nine overweight/obese 
(OWB) and nine sex-, age- and height-matched healthy weight (HW) 
children (mean age 9.69 ± 0.63 years) participated in the study. Dynamic 
medial/lateral (ML) and anterior/posterior (AP) centre of pressure (CoP) 
excursions were assessed using a Tekscan HR Mat pressure measurement 
system. Excursions were measured through the stance phase of gait at; 
first contact (FC), metatarsal contact (MC), foot flat (FF), heel off (HO), 
last contact (LC). Muscle strength was measured by hand held dynamom-
eter. Six minute walk time (6MWT) and chair rise tests were performed. 
Between group differences were determined by independent t-tests. Vari-
ables shown to correlate with BMI z-score (dependent variable) were en-
tered into multivariable linear regression as predictor variables. Figure 
1 presents CoP data during stance, demonstrating significantly great-
er lateral and anterior excursion in the OWB group compared to HW. 
Maximal strength data is presented in Table 1. OWB group demonstrated 
significantly weaker hip and knee flexor strength compared to the HW 
group. Six minute walk distance was significantly greater in the HW group 
(451.33 ± 69.13m) compared to the OWB group (379.11 ± 65.01m). Mul-
tiple regression results presented in Table 2 show BMI z-score was signifi-
cantly associated with; CoP ML displacement between MC and FF, CoP 
AP displacement between FC and MC, and maximal hip flexion force. The 
findings indicate that physical function and strength are reduced in OWB 
children compared to HW peers. This has implications for physical fitness 
and activity programmes to reduce childhood obesity.
Acknowledgement: C. Ecclestone was funded as a research Assistant by the Dr Wil-
liam M. Scholl Podiatric Research and Development Fund.
Fig. 1. Figure 1. Group mean Foot Centre of Pressure (mm) through stance; (a) 
medial/lateral position, (b) anterioposterior position. * significant difference 
between OWB (dash line) and HW (solid line)
Fig. 2. Table 1. Group mean ± standard deviation of maximal force (N•kg.^67). * 
significant deference between OWB and HW groups (p < .05)
Fig. 3. Table 2. Multiple linear regression of Centre of Pressure, strength and 
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T3:PO.080
Weight-supported (anti-gravity) treadmill exercise in 
caribbean-black obese women
Uglialoro A.D.1, Ali A.2, Chang N.1, Sbiroli E.1, Swanenberg I.1, Yearwood L.2, 
Banerji M.A.2, Godwin E.3, Kral J. G.1
1Department of Surgery, SUNY Downstate Medical Center, Brooklyn NY,  
2Department of Medicine, SUNY Downstate Medical Center, Brooklyn NY,  
3Department of Rehabilitation, SUNY Downstate Medical Center, Brooklyn NY
Background: Diabesity is prevalent in Caribbean-Black women in 
US inner-city environments with limited access to physical activity. 
Weight-bearing exercise is time-consuming, painful and difficult for 
obese people. In this pilot study 16 Caribbean-Black women aged 41 ± 11 
y (mean ± SD), mean BMI 35 kg/m2 (range: 28–49.5) performed twice 
weekly 30-minute bouts of moderate exercise on an AlterG Anti-Gravity 
Treadmill™ at 70%, 65%, and 60% weight support and increasing levels of 
incline. 
Methods: Anthropometry, oral glucose tolerance tests with plasma in-
sulin, C-Protein and GLP-1, fasting adiponectin, ghrelin and Il-6, accel-
erometer testing with FitBit™ and socio-economic stress questionnaires. 
Treadmill distance and expended calories were recorded for each exercise 
session. Treadmill speed was the only parameter that was variable and ad-
justed by the participant depending on fatigue. Responders were defined 
as having improved 2-hr plasma glucose levels. 
Results: Mean participation was 11 weeks (range: 8–20) amounting 
to mean 23 bouts (range 18–24). Three subjects had impaired glucose 
tolerance at entry (1 DM, 2 IGT), all of whom improved their area-un-
der-the curve (AUC). 11/16 responders significantly reduced their AUC 
(p = 0.0032). Mean s-triglycerides in the 16 subjects decreased from 
71.0 ± 27 mg/dl to 62.9 ± 22.4 mg/dl ± 22.4 (p = 0.029). There were no 
statistically significant differences in before-after BMI. 
Conclusion: An innovative and convenient moderate weight-supported 
(anti-gravity) treadmill exercise program improving mobility in this pop-
ulation is a feasible approach to improve metabolic fitness.
T3 – Food reformulation
T3:PO.081
Nutriose®, a resistant dextrin, displays low glycemic 
and insulinemic responses: Combining technological, 
organoleptical and nutritional attributes for obesity and 
diabetes prevention
Lefranc-Millot C.1, Rodriguez B.1, Guerin-Deremaux L.1, Thabuis C.1
1Roquette Nutritional Sciences, Roquette, Lestrem, France 
Worldwide obesity has nearly doubled since 1980, with 35% of adults 
overweight and 11% obese in 2008, and 42 million children under 5 
years overweight or obese in 2013. There are also 347 million people with 
diabetes, among which over 60 and 90 millions in India and China, re-
spectively1. In this context, dietary fibers, such as the resistant dextrin 
NUTRIOSE®, offer unmatched advantages to the food balance equation. 
To evaluate the glycemic and insulinemic responses of NUTRIOSE®, 6 
different cross-over trials were conducted in 5 countries. 6 to 24 healthy 
human volunteers randomly consumed either 50g NUTRIOSE® or 50g 
anhydrous dextrose or glucose (controls), during experimental sessions 
of 120 to 240 minutes each. Blood glucose and insulin responses were 
calculated based on regular sampling, either from capillary or venous or-
igin, and expressed as percent (AUC concentrations for NUTRIOSE® / 
mean AUC concentrations for control). Depending on the methodologies 
used, glucose responses for NUTRIOSE® ranged from 25 to 48, insulin 
responses from 13 to 20, both being very low responses. Previously, a 
12-week supplementation with NUTRIOSE® had already demonstrated 
its ability to lower insulin resistance, improve determinants of metabolic 
syndrome2 and induce improvements in body composition and weight, 
energy intake and hunger in overweight men3. Therefore, NUTRIOSE® 
soluble fiber may be a good candidate for sugar and energy substitution 
or reduction, and for fiber content improvement of food, possibly helping 
consumers to reach the dietary recommendations worldwide and contrib-
uting to obesity and diabetes prevention. 1. WHO, 2014, Factsheets 311 
and 312. 2. Applied Physiology, Nutrition and Metabolism, 2010 3. Inter-
national Journal of Food Sciences and Nutrition, 2011
T3 – Genetic susceptibility
T3:PO.082
Genetic variation at three chromosomal loci potentially 
involved in both anorexia nervosa and body mass index
Hinney A.1, Kesselmeier M.2, Volckmar A.L.1, Antel J.1, GCAN3, WTCCC4, 
Heid I.M.5, Winkler T. W.5, GIANT6, Herpertz-Dahlmann B.7, de Zwaan M.8, 
Herzog W.9, Ehrlich S.10, Zipfel S.11, Egberts K. M.12, Adan R.13, Zeggini E.14, 
Bulik C.15, Collier D.16, Scherag A.2, Hebebrand J.1
1Dep of Child and Adolescent Psychiatry, Universitätsklinikum Essen, Essen, 
Germany,  
2Clinical Epidemiology, Jena University Hospital, Jena, Germany,  
3Genetic Consortium for AN,  
4Wellcome Trust Case Control Consortium,  
5Dep of Genetic Epidemiology, University of Regensburg, Regensburg, 
Germany,  
6Genetic Investigation of ANthropometric Traits Consortium,  
7Dep of Child and Adolescent Psychiatry, RWTH Aachen, Aachen, Germany,  
8Dep of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, 
Hannover, Germany,  
9General Internal and Psychosomatic Medicine, University of Heidelberg, 
Heidelberg, Germany,  
10Dep of Child and Adolescent Psychiatry, Technische Universität Dresden, 
Dresden, Germany,  
11Dep of Psychosomatic Medicine and Psychotherapy, University Tuebingen, 
Germany,  
12Dep of Child and Adolescent Psychiatry, University of Würzburg, Würzburg, 
Germany,  
13Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The 
Netherlands,  
14Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK,  
15Dep of Psychiatry, University of North Carolina, Chapel Hill, NC, USA,  
16Institute of Psychiatry, King‘s College London, London, UK
Regulation of body weight is disrupted in patients with anorexia nervosa 
(AN). Prior to the onset of AN body weight covers the whole BMI range. 
Since the genetic contribution to the etiology of AN is high, we hypothe-
sised overlapping genetic loci for AN and BMI. We performed a cross-trait 
analysis of the 1000 SNPs with the lowest p-values from a genome wide 
association study (GWAS) of AN (GCAN, Boraska et al. Mol Psych 2014) 
for evidence of association in the largest published GWAS meta-analysis 
for BMI (GIANT; Speliotes et al. Nat Genet 2010). We detected Bonferroni 
corrected significant associations for 9 SNPs at 3 independent chromosomal 
loci (chr. 2, 10 and 19). None of the nearest genes to these SNPs has previ-
ously been associated with AN or BMI. Information on the function of most 
of these genes is sparse. One gene is biologically plausible as it is involved 
in the BDNF signaling pathway. GWAS did not reveal a genome wide sig-
nificant locus for AN. A cross trait analysis for AN and BMI revealed three 
independent chromosomal loci with potential relevance for both. In depth 
molecular genetic and biological analyses are warranted to unravel the rele-
vance of these loci and the genes they contain for AN and BMI.
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T3:PO.083
Interactive effects of the irx3 and fto polymorphisms on 
obesity in a mediterranean population
Corella D.1, Coltell O.2, Sorli J.V.1, Asensio E.M.1, Barragan R.1,  
Fernandez-Carrion R.1, Gonzalez I.1, Ordovas J.M.3, Frances F.1
1Department of Preventive Medicine and Public Health. University of Valencia 
and CIBER OBN, Valencia, Spain,  
2University Jaume I, Castellon, Spain,  
3JM-Human Nutrition Research Center, Boston, USA
Obesity-associated variants within the FTO gene are functionally con-
nected with regulation of the IRX3 (Iroquois related homeobox 3) gene 
expression. Irx3-knockout male mice have reduced adiposity. Although 
the IRX3 gene has been identified as the target of the FTO SNPs, epi-
demiological studies demonstrating associations between IRX3 SNPs 
and obesity are lacking. Our aim was to analyze the association of IRX3 
variants with obesity-related measurement as well as their interactive ef-
fects with the FTO. We studied participants in the PREDIMED-Valen-
cia Study (n=1094). SNPs in the Chr. 16 (rs3751723 in the UTR 5 IRX3: 
54320197; rs12445085 intergenic IRX3: 54322319 and rs9939609-FTO: 
53820527) were determined. DNA methylation was analyzed by MAL-
DI-TOF mass spectrometry in 195 subjects (CpG sites surrounding the 
rs9939609-FTO SNP: Chr16:53817859-53822719). Multivariate regres-
sion models were used. rs12445085 C>A was associated with body-
weight (77.1+/-0.6 in CC; 79.3+/-0.7 in CA and 80.8+/-1.3 kg in AA; 
P = 0.007) and BMI (30.0+/-0.2 in CC; 30.9+/-0.3 in CA and 31.2+/-0.5 
kg/m2 in AA; P = 0.008). Similar results we found for rs3751723-IRX3. 
Moreover we found a strong interactive effect of the rs9939609-FTO 
SNP and rs12445085 (P-interaction: 0.043 for body-weight). The associ-
ation between IRX3 SNPs and BMI were only significant in carriers of 
the FTO-associated (A) allele (P < 0.001 for rs12445085). No significant 
associations were found for IRX3 SNPs in homozygous subjects for the 
rs9939609-FTO T-allele (P = 0.692). Also significant associations between 
rs12445085-IRX3 and FTO-methylation levels were detected. In conclu-
sion, we found interactive effects of the IRX3 and FTO polymorphisms on 
obesity-related parameters.
Acknowledgement: Study co-financed by CIBERobn, University of Valencia, and 
research grants from FIS (PI11/02505), CNIC (CNIC06) and Generalitat Valenci-
ana (ACOMP/2013/165 and ACOMP/2013/159)
T3:PO.084
TNF-α methylation is positively correlated with waist 
circumference in young and apparently healthy individuals.
Marques-Rocha J.1,2, Mansego M.2,3, Bressan J.1, Milagro F.2,3, Martínez J.2,3
1Department of Nutrition and Health, Universidade Federal de Viçosa, Viçosa, Brazil,  
2Department of Nutrition, Food Science and Physiology, Centre for Nutrition 
Research, University of Navarra, Pamplona, Spain,  
3Spanish Biomedical Research Centre in Physiopathology of Obesity and 
Nutrition, CIBERobn, Carlos III Health Institute, Madrid, Spain
Introduction: The aim of this study was to investigate the associations 
between the methylation and expression of inflammatory genes with an-
thropometric, biochemical, clinical, and dietary measurements in young 
and apparently healthy individuals. 
Methods: We evaluated 156 individuals (91 women and 65 men; ages 
23.1 ± 3.5 y; body mass index 22 ± 2.9 kg/m2) for anthropometrics, bio-
chemical, clinical, dietary, antioxidant and inflammatory markers. DNA 
methylation and mRNA levels of IL-6 and TNF-α were assessed in pe-
ripheral blood mononuclear cells. A statistical analysis was performed to 
detect differences among subjects by the median of methylation of these 
genes. Spearman correlation coefficients were also used. 
Results: Subjects with higher TNF-α methylation levels showed higher 
waist circumference and waist-hip ratio, circulating levels of oxidized 
low-density lipoprotein, and erythrocyte glutathione peroxidase activity 
values, but lower nail concentrations of selenium, and lower dietary in-
take of potassium, magnesium and copper (P < 0.05). The methylation of 
TNF-α was negatively associated with the relative expression of this gene 
in the same cells (r=-0.333; p < 0.001). However, IL-6 methylation levels 
were not statistically associated with IL-6 expression, neither relationships 
were observed between TNF-α and IL-6 plasma levels with the methyla-
tion and expression of these genes. The relative expression of TNF-α sta-
tistically correlated with the expression of other genes related with the 
inflammatory process such as ICAM, IL-6, IL-18 and RIL-1. 
Conclusions: In young and apparently healthy individuals, the methyla-
tion of TNF-α was significantly associated with waist circumference and 
waist-hip ratio and other important biomarkers related with obesity.
Acknowledgement: We wish to thank the CAPES Foundation, Ministry of Edu-
cation of Brazil (process nş 6409-13-0). This work has been funded by the Spanish 
Government (CIBERon and Nutrigenio project, ref. AGL2013-45554-R) and the 
Government of Navarra (Resmena project; ref. 48/2009).
T3:PO.085
Tas1r3 and Ucn2 transcript levels in peripheral blood cells are 
associated with sugary and fatty food consumption and with 
excess of fat accumulation in children
Priego T.1, Sanchez J.1, Pico C.1, Ahrens W.2, De Henauw S.3, Kourides Y.8, 
Lissner L.4, Molnár D.5, Moreno L. A.6, Russo P.7, Siani A.7, Veidebaum T.9, 
Palou A.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology, UIB and CIBER 
Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain,  
2Faculty of Mathematics and Computer Science, University of Bremen; BIPS – 
Institute for Epidemiology and Prevention Research GmbH, Germany,  
3Dept. of Public Health/Dept. of Movement and Sport Sciences, Ghent 
University, Belgium,  
4Dept. of Public Health and Community Medicine, University of Gothenburg, 
Sweden,  
5Dept. of Pediatrics, University of Pécs, Hungary,  
6GENUD Research group, University of Zaragoza, Spain,  
7Institute of Food Sciences, National Research Council, Italy,  
8Research and Education of Child Health Institute, Cyprus,  
9National Institute for Health Development, Tervise Arengu Instituut, Estonia
Introduction: New types of robust biomarkers of dietary exposure and 
function are needed to implement strategies for obesity prevention in 
children. Of special interest are those biomarkers of consumption of food 
rich in simple sugars and fat, as their intake has been associated with obe-
sity development. Peripheral blood cells (PBCs) represent a new promis-
ing tool for identifying novel transcript-based biomarkers. We studied the 
potential associations between the expression levels of Tas1r3 and Ucn2 
genes in PBCs and the frequency of sugary, fatty, and junk food consump-
tion. 
Methods: 463 children aged 2–9 from the IDEFICS cohort were studied. 
Expression levels of Tas1r3 and Ucn2 genes were analyzed by RT-qPCR. 
Results: Children with low frequency of consumption of sugary foods 
displayed higher Tas1r3 expression levels with respect to those with inter-
mediate or high frequency; furthermore, children with high consumption 
frequency of junk food showed lower transcript levels of this gene with 
respect to those with low or intermediate frequency. In turn, children 
with high frequency of consumption of fatty foods showed lower Ucn2 
expression levels with respect to those with low or intermediate frequency. 
Moreover, expression levels of Tas1r3 were related with BMI and fat mass 
changes during a two-year follow-up period, with low expression levels 
being related with increased fat accumulation over time. 
Conclusion: Transcript levels of Tas1r3 and Ucn2 in PBCs may be consid-
ered as potential biomarkers of consumption of sugary, fatty, or junk food, 
to complement data of food intake questionnaires.
Acknowledgement: Research relating to this abstract was funded by the EC within 
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T3 – Taste, hedonics and appetite
T3:PO.086
Food ‘Wanting’ and ‘Liking’ in free-living lean and obese 
participants using a novel smartphone application: 
Mindeating
Alabduljader K.A.1, Cliffe M.L.2, Kubis H.P.1
1School of Sport, Health and Exercise Sciences, Bangor University, Gwynedd, 
LL57 2PZ, U.K.,  
2Department of Nutrition and Dietetics, Betsi Cadwaladr University Health 
Board, Bangor, Gwynedd LL57 2PW, U.K.
Introduction: In laboratory-based measures of food reward, differences 
have been detected between lean and obese individuals. We investigated 
food reward in free-living participants using a new smartphone application 
(Mindeating), which has been developed to allow recording of real time 
food ‘wanting’ (anticipatory reward) and ‘liking’ (consummatory reward). 
Methods: Participants were adult smartphone users recruited via invita-
tions sent to Bangor University and Betsi Cadwaladr University Health 
Board staff, students and patients in North Wales. Following collection of 
baseline characteristics participants were given access to the Mindeating 
mobile phone application and were asked to record food ‘wanting’ on a 
scale of 0 (not at all) –10 (very strongly) each time food ‘wanting’ was 
perceived and ‘liking’ of food immediately after each eating episode using 
the same scale, continuously for 14 days. 
Results: 59 participants were recruited in the required BMI categories. 
22 lean and 19 obese participants (BMI 22.1 ± 1.87 vs 35.3 ± 5.10, age 
37.5 ± 11.05 vs 39.7 ± 8.65 years) provided complete data. Obese partic-
ipants ate less often (lean 4.35 ± 1.32 vs. obese 3.67 ± 0.77 times per day, 
p = 0.05). There was no significant difference in wanting scores between 
groups (lean 7.03 ± 1.08 vs obese 6.88 ± 1.11, p = 0.68). However, obese 
participants recorded significantly lower liking scores (lean 7.76 ± 0.77 vs. 
obese 7.11 ± 1.10, p = 0.03) and the difference between food liking and 
wanting scores (food reward gain) was reduced in obese participants (lean 
+0.73 ± 0.83 vs obese +0.22 ± 0.72, p = 0.045). 
Conclusion: In daily life, obese participants gained a lower reward from 
eating in comparison to lean participants. This finding is in agreement 
with a reward-deficient response to food in obese individuals.
Fig. 1. Example of Mindeating Smartphone Application user interface.
T3:PO.087
Consumption of green-plant membranes suppresses wanting 
and hedonic hunger in emotional eaters
Stenblom E.1, Montelius C.1, Egecioglu E.1, Erlanson-Albertsson C.1
1Department of Experimental Medical Science, Appetite Regulation Unit, 
Faculty of Medicine, Lund University, Sölvegatan 19, S-221 84 Lund, Sweden
Introduction: Membranes from green leaves have previously been found 
to affect appetite-regulating hormones in humans. The aim of this study 
was to investigate how treatment with green-plant membranes affects 
hunger, satiety, liking and wanting for palatable food. 
Methods: 22 female participants were included, receiving either a green-
plant supplement (5 g) or placebo on two separate days, before breakfast. 
VAS-questionnaires about hunger, satiety and cravings were filled out 
hourly, until an ad libitum snack buffet was served at 16:00, and once after, 
including questions about liking. The participants also filled out an eating 
behaviour questionnaire (TFEQR18-V2) with questions regarding emo-
tional eating (EE), cognitive restraint (CR) and uncontrolled eating (UE). 
The study was a randomised, placebo-controlled, double blind, meal in-
tervention study with a cross over design.  
Results: Intake of green-plant membranes increased subjective ratings of 
satiety (p < 0.01, two-way RM ANOVA) and decreased ratings of hunger 
(p < 0.05, two-way RM ANOVA) and cravings for all snacks and sweets 
during the day compared to placebo (Fig. 1). In addition, there was a de-
creased subjective liking for sweet after treatment (Fig. 2). Food intake 
was not affected significantly. When correlated to eating behaviour scores, 
we found that the treatment effect of green-plant membranes on wanting 
for all snacks (Fig. 3), sweet-and-fat snacks in particular (Fig. 4), was pos-
itively correlated to emotional eating. 
Conclusion: Green-plant membranes may be used as a food supplement 
to reduce wanting and hedonic hunger, associated with overeating and 
obesity. Individuals scoring high for emotional eating behaviour may have 
enhanced treatment effect.
Fig. 1. VAS-ratings on wanting palatable foods. Treatment with green-plant 
membranes before breakfast decreased rated feelings of wanting for all categories 
of snacks respectively (salty, sweet and sweet-and-fat), and all snacks combined, 
compared to control during rest of the day (*p < 0.05, **p < 0.01, ***p < 0.001, 
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Fig. 2. VAS-ratings on liking palatable foods. Treatment with green-plant 
membranes before breakfast decreased ratings of liking for sweet snacks after 
consumption from the afternoon snack buffet compared to control (**p < 0.01, 
VAS, Wilcoxon signed rank test). (n=18 for liking salt, n=18 for sweet, n=20 for 
sweet-and-fat, and n=21 for total liking).
Fig. 3. Correlation between treatment effect on wanting all snacks and eating 
behaviour. The difference in tAUC for VAS (control minus treatment conditions) 
showed positive correlation with emotional eating scores (EE). Higher scores for 
EE were correlated to more treatment effect by green-plant membranes on wanting 
all snacks (p < 0.01, Pearson r).
Fig. 4. Correlation between treatment effect on wanting sweet-and-fat and eating 
behaviour. The difference in tAUC for VAS for wanting sweet-and-fat snacks 
(control minus treatment conditions) showed positive correlation with emotional 
eating scores (EE). Higher EE was correlated to more treatment effect by 
green-plant membranes (p < 0.01, Pearson r).
T3:PO.088
Effect of animal and vegetable sources of protein on acute 
appetite sensation and energy intake
Kristensen M.D.1, Bendsen N.T.2, Astrup A.1, Raben A.1
1Department of Nutrition, Exercise and Sports, Faculty of Science, University of 
Copenhagen, Denmark,  
2Novo Nordisk A/S, Denmark 
Introduction: High protein intake is associated with reduced hunger 
and increased satiety when compared to normal or low protein intake. 
However, there is no consensus that one protein source is more satiating 
than others. We examine whether protein from legumes (beans/peas) is 
comparable to protein from animal sources (pork/veal) regarding acute 
meal-induced satiety. 
Methods: 43 healthy men (mean ± SD age: 24.4 ± 4.8 y, BMI: 23.0 ± 2.1 
kg/m2) completed this randomized, double-blind, placebo-controlled, 
three-way cross-over meal test. Meals differed in protein content at the 
expense of carbohydrates and differed in fibre content, but had the same 
fat content. The meals consisted of high-protein meat (HP-Meat, 18 pro-
tein E%, 6 g fibre/100 g), high-protein legumes (HP-Legume, 19 protein 
E%, 25 g fibre/100 g) and low-protein legumes (LP-Legume, 9 protein E%, 
10 g fibre/100 g). Subjective appetite sensations were recorded at baseline 
and every half hour using visual analogue scales (VAS) until the ad libitum 
meal was served 3 h after the test meal. 
Results: Ratings for VAS showed lower hunger, prospective food con-
sumption and composite appetite score, and higher fullness for HP-Le-
gume compared to HP-Meat or LP-Legume (P < 0.05 for all), and higher 
satiety for the HP-Legume meal compared to HP-Meat meal (P < 0.05). A 
12–13% lower energy intake was seen after consumption of HP-Legume 
compared to HP-Meat or LP-Legume (P < 0.01). 
Conclusion: Protein from legumes produces increased satiety and reduced 
hunger and ad libitum energy intake compared to protein from meat. How-
ever, the comparison may be confounded due to higher fibre content of 
legumes. The public health and clinical implication is that high-protein le-
gumes provide high satiety, and may be beneficial for weight control.
Acknowledgement: We are grateful to the kitchen staff at the Department Nutri-
tion, Exercise and Sports for their assistance and to the volunteers who participated 
in this study.
T3:PO.089
Neuroendocrine appetite regulation across the menstrual cycle
Arnoni Y.1,2,3, Bick A.1, Raz N.1, Hershkop K.2, Marko L.2, Levin N.1,3, Weiss R.2,3
1fMRI unit Neurology Department,  
2The Human Metabolism and Nutrition Department,  
3Hadassah the Hebrew University Hospital Jerusalem Israel
Background: The female menstrual cycle is characterized by variable 
eating patterns. We tested brain responses to visual food cues during the 
menstrual cycle and correlated them with sex hormones. 
Methodology: Brain activity was assessed by functional magnetic resonance 
imaging (fMRI) to explore activation of homeostatic and reward brain re-
gions in response to pictures of high calorie foods in 18 healthy normal 
weight females in follicular and luteal phase during fasting and fed states. 
Results: In the hypothalamus and the reward system regions, increased 
activity in response to food images was significantly greater in the luteal 
phase compared to follicular phase regardless of prandial state. Specifical-
ly, in the amygdala- fasting activation in luteal vs. follicular p = 0.006 and 
fed activation in luteal vs. follicular, p = 0.02; with a similar significant 
trend in the arcuate cingulate cortex (ACC) and striatum. Importantly, 
in the reward areas the response in the fed luteal state was greater than 
the response in the fasting of the follicular state (amygdala p = 0.06, ACC 
p = 0.01). The response in reward areas was correlated with progesterone 
concentrations (r=0.40, p = 0.02 for amygdala and r=0.48, p = 0.003 for 
ACC). In visual regions, activation was present in both menstrual phases, 
with greater activation in fast than fed states (follicular p = 0.003, luteal 
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Conclusions: The effect of the menstrual phase on brain activity in reward 
regions is more robust then the fed/fasting condition and correlates with 
progesterone concentrations. Unraveling the hormonal and molecular 
mechanisms driving these phenomena may identify novel interventional 
approaches to female obesity.
T3:PO.090
The effects of food perception on energy compensation 
following exercise in sedentary women
Lafreniere J.1, McNeil J.1, Provencher V.2, Doucet E.1
1Behavioural and Metabolic Research Unit, School of Human Kinetics, University 
of Ottawa, Ottawa, Ontario, Canada,  
2Institute of Nutrition and Functional Foods, Laval University, Québec, Canada
Background: An effect of food labeling on energy intake (EI) has been 
previously reported and may partly explain the large inter-individual re-
sponses in EI previously noted following exercise (Ex). 
Objectives: To assess how labeling and exercise interact to influence food 
perception and EI following physical activity. Design: In this randomized 
cross-over design, 14 inactive women took part in 4 experimental condi-
tions: Ex (300kcal at 70% of their individual VO2peak) and lunch labeled 
as low in fat (LF), Ex and lunch labeled as high in fat (HF), sedentary 
control (Ctl) and LF, and Ctl and HF. The lunch was compose of a pasta 
plate, a yogurt and oatmeal cookies with the same nutritional composition 
throughout sessions. EI at lunch and for the following 34 hours (validated 
food menu), as well as healthiness perception of the meal, appetite ratings 
(visual analogue scales) and level of stress were assessed. 
Results: No significant difference was observed in EI at lunch and for 
the following 34 hours across sessions. However, participants with high 
vs. low scores on a perceived stress scale showed opposite responses to 
the exercise and labeling manipulation. The food items presented as LF 
were perceived as healthier (p < 0.001), but this distinction was more con-
sistently significant across food item when no exercise was performed. 
Healthiness ratings correlated positively with the amount of food con-
sumed (ρ=0.339, p < 0.001). The labeling manipulation showed stronger 
influence on food item associated healthier initial beliefs. 
Conclusion: Despite no effects of exercise and food labeling on acute EI 
(lunch and total 48h), healthiness perception was influenced by labeling 
and initials beliefs and linked with the amount of different food item con-
sumed.
Acknowledgement: The authors would like to thank the participant for their devot-
ed contribution in this project.
T3:PO.091
Disrupted normal ingestion during glucose intake modulate 
glucosekinetics in humans
Tsuji T.1,2, Tanaka S.1, Satoh K.2, Kogo M.1, Yamamoto T.3
11st Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, 
Osaka University,  
2Department of Oral and Maxillofacial Surgery, Saiseikai Matsusaka General 
Hospital,  
3Department of Health and Nutrition, Faculty of Health Science, Kio University
Introduction: Tastes and flavors that are appreciated during ingestion are 
thought to induce various physiological effects on energy homeostasis. 
This study aims to reveal the importance of these chemical senses in glu-
cose kinetics and autonomic nervous activity by imposing interventions 
during glucose intake. 
Methods: The conventional glucose-loading test was applied to seven 
healthy male and females (age, 24 - 32 y) under various experimental con-
ditions together with a self-reporting questionnaire about satisfaction. We 
then assessed blood glucose curves (BGC), serum insulin response curves 
(IRC), and salivary α-amylase (s-AMY) activity. 
Results: Three successive oral glucose-loadings induced a gradual down-
ward shift in the BGC together with increased s-AMY activity, which is 
a stress marker; whereas adding a pleasant flavor to the glucose solution 
given during the third trial increased the BGC to the same level as that 
during the first loading with increased satisfaction. Direct delivery of glu-
cose into the stomach without oral sensory stimulation or clipping the 
nose to interfere with smooth nasal air-flow induced a downward shift 
in both BGC and IRC, resulting in a decrease of the area under the BGC, 
together with an increase in the s-AMY level that negatively correlated 
with satisfaction scores. 
Conclusion: The present study demonstrates that favorable chemical 
senses are important in enhancing glucose absorption from the gastroin-
testinal tract, insulin release and reducing sympathetic nervous activity.
Fig. 1. Time-course changes in bloodglucose levels after successive glucose-loa-
dings.
Fig. 2. Changes in salivary α-amylaseactivities before and after successive glucose 
loadings.
Fig. 3. Correlations among area underblood glucose curves, salivary α-amylase 
activity and satisfaction scores.
Fig. 4. Effects of nose clipping andintragastric glucose loading on blood glucose 
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T3:PO.092
Changes in smell function, satiety quotient and food reward 
in response to a weight loss intervention
McNeil J.1, Prud‘homme D.1,2, Rabasa-Lhoret R.3,4, 5, Finlayson G.6, 
Doucet É.1
1Behavioral and Metabolic Research Unit, School of Human Kinetics, Faculty of 
Health Sciences, University of Ottawa, Ottawa, Ontario, Canada,  
2Montfort Hospital Research Institute, Ottawa, Ontario, Canada,  
3Department of Nutrition, Faculty of medicine, University of Montréal, Montréal, 
Québec, Canada,  
4Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Québec, 
Canada,  
5Service d’endocrinologie, Centre hospitalier de l’Université de Montréal 
(CHUM) Montréal, Québec, Canada,  
6Appetite Control & Energy Balance Research, School of Psychology, University 
of Leeds, Leeds, United Kingdom
Introduction: Acute energy deficits increase smell function. It is un-
known whether long-term energy deficits induce similar changes in smell 
function, and whether these potential changes are related to diet-induced 
changes in body composition, food reward and intake. 
Methods: Sixteen overweight menopausal women (age: 52.9 ± 3.3 y; BMI: 
32.8 ± 4.6 kg/m2) completed a 12-month intervention. Five and 11 women 
formed the control and intervention (700kcal/day energy deficit) groups, 
respectively. Body composition (DEXA), smell function (Sniffin‘ Sticks), 
appetite (visual analogue scales), food reward (Leeds Food Preference 
Questionnaire) and food intake (ad libitum food menu) were measured at 
baseline and 12 months later. Satiety quotient (SQ; mm/100kcal) follow-
ing a meal was also calculated. 
Results: Lower BMI (32.8 ± 4.6, 30.8 ± 5.6 kg/m2; P = 0.01), fat mass 
(39.4 ± 10.4, 34.8 ± 12.5 kg; P = 0.004) and odor discrimination scores 
(13.1 ± 1.0, 11.7 ± 2.0; P = 0.04), and greater SQ (4.9 ± 3.6, 7.6 ± 3.9; 
P = 0.0001), were noted in all participants at 12 months. No differences 
in food reward and intake were noted across time, but lipid intake was 
lower in the control vs. intervention group (603.7 ± 205.7, 314.2.6 ± 200.4; 
P = 0.02). Changes (Δ) in discrimination scores were negatively linked 
with Δimplicit wanting (ρ= –0.63; P = 0.04) and Δpreference (ρ= –0.74; 
P = 0.01) for high-fat vs. low-fat foods between baseline and 12 months 
later. 
Conclusion: Lower BMI, fat mass and smell function, and greater SQ, 
were noted post-intervention. However, changes in these variables were 
not related. Δodor discrimination scores were negatively linked with 
Δhigh-fat food reward, suggesting that women with greater decreases in 
smell function post-intervention saw greater increases in high-fat food 
reward.
T3:PO.093
Investigation of the effects metformin and metformin with 
insuline on food choices and taste changes of the patients 
applied to dietary polyclinic of an hospital in istanbul
Köksal S.1, Beyhan Y.2
1Faculty of Health Sciences, Department of Nutrition and Dietetics, Acıbadem 
University, İstanbul, Turkey,  
2Faculty of Health Sciences, Department of Nutrition and Dietetics, Haliç 
University, İstanbul, Turkey
Introduction: The previous research suggest that using metformine caus-
es increase in sweet taste sensation and decrease in consumption of some 
foods. 
Methods: This study was conducted on 50 individuals started on insu-
lin+metformin for the first time by the endocrinologist and 50 individ-
uals started on just metformin, again for the first time. The individuals 
included in the study were subjected to both questionnaire and taste tests 
before starting on the medication (begining) and one month later (con-
trol). During the study, the individuals were subjected to taste tests on 
four basic tastes to test their perceptions at the start of the research (be-
gining) and one month after they started on antidiabetic agents (control). 
Results: During the research, it has been determined that among the 
individuals using metformin, 50% had diabetes, 44% insulin resistance, 
and 26% obesity, while among the individuals using metformin + insulin, 
100% had diabetes, 8% insulin resistance and 16% obesity. Furthermore, 
18% of the individuals on metformin had hyperlipidemia, 12% hyperten-
sion and 4%, hypothyroidism incidence, while 28% of the individuals on 
metformin + insulin had hyperlipidemia, 20% hypertension and 4%, hy-
pothyroidism incidence. The body weights of the group using only met-
formin recorded at the begining showed an average of 3.8 kg decrease 
in the control (p < 0,05). No significant difference has been observed in 
the begining and control weights of the group using insulin+metformin 
(p > 0,05). 
Conclusions: As a conclusion, results indicate that increase in sensitivity 
in the perception of sweet taste, the sensitivity in the perception of the 
other basic tastes, salty, bitter and sour, has also increased after the use of 
antidiabetic agent/agents.
T3:PO.094
Exploring the relationship between cognitive, sensory and 
nutritional food attributes and the perceived satiety potential 
of food.
Buckland N.J.1, Dalton M.1, Stubbs R.J.2, Hetherington M.M.1, Blundell J.E.1, 
Finlayson G.1
1School of Psychology, University of Leeds, Leeds, UK,  
2Department of Psychology, University of Derby, Derby, UK
Introduction: Identifying and promoting foods that enhance satiety 
may improve appetite control and weight management. However little is 
known about consumers’ perceptions of the cognitive, sensory and nutri-
tional attributes which underpin the satiety enhancing potential of foods. 
Methods: Using online surveys, 887 consumers rated 75 individual foods 
based on cognitive (e.g. satiating capacity), sensory (e.g. taste) and nutri-
tional (e.g. energy content) dimensions. Objective nutrient and cost (£/
kcal) information per food was sourced from manufacturer packaging 
and nutrition databases. 
Results: Bivariate correlations showed foods perceived as satiating were 
associated with lower energy and fat content and with percieved higher 
healthiness, frequency of consumption and with greater perceived con-
trol over eating. More satiating foods were associated with higher cost (£/
kcal), %protein and lower %fat and energy density. %Carbohydrate was 
not associated with satiating capacity. Linear regression models showed 
low energy content (as rated by consumers) (β=-.89, p < .001), low energy 
density (β=-.54, p < .001), low %fat (β=.23, p = .04) and high cost (β=.23, 
p = .01) were the strongest correlates of satiating capacity. 
Conclusion: Consumer cognitive, sensory and nutrient perceptions 
alongside objective nutritional attributes are important factors underpin-
ning the perceived satiety potential of foods. Foods rated as most satiating 
by consumers were low in energy density, low %fat and more expensive 
(per calorie). These findings have implications for the development and 
marketing of satiety enhancing foods.
T3:PO.095
The relationship between binge eating status and 
hormone profiles of obese patients undergoing weight loss 
intervention
Nozaki T.1, Sawamoto R.1, Furukawa T.1, Morita C.1, Hata T.1, Kawai K.1, 
Komaki G.2, Sudo N.1
1Department of Psychosomatic Medicine, Graduate School of Medical Sciences, 
Kyushu University, Fukuoka, Japan,  
2School of Health Sciences Fukuoka, International University of Health and 
Welfare, Fukuoka, Japan
Objective: Some obese patients seeking weight loss treatment have a binge 
eating problem; however, the psychological and biological mechanisms of 
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to determine which hormones are related to the binge eating of female, 
obese patients who participated in a weight loss intervention (WLI) based 
on cognitive behavioral treatment. 
Methods: Ninety female, obese patients completed seven months of WLI. 
Body fat percentage (BFP) was measured using dual energy x-ray absorp-
tiometry and serum levels of the biomarkers ghrelin, leptin, adiponectin, 
interleukin-6 (IL-6), IGF-1, and insulin were assessed before and after 
the treatment. Binge eating status was assessed by the Binge Eating Scale 
(BES). BES scores were classified by tertile value; the group in the highest 
third of the distribution, “high BES”, was compared to that in the lowest 
third of the distribution, “low BES”. 
Results: No significant difference was found in BFP at baseline or after the 
treatment between the high and low BES groups. However, high BES had 
a higher leptin level than low BES at baseline, and the difference became 
significantly stronger after adjusting for confounding factors such as BFP 
and age. IGF-1 was also significantly higher in the high BES group at base-
line, but the difference disappeared after adjustment for confounding fac-
tors. The binge eating symptoms decreased significantly after treatment in 
the high BES compared to the low BES group, independent of the change 
of BFP. Leptin and IL-6 also decreased significantly after treatment, but 
only leptin maintained significance after adjustment for confounding fac-
tors such as the change of BFP. The serum levels of other biomarkers were 
not significantly changed between the groups. 
Conclusion: The present study suggests that binge eating status is related 
to the serum leptin level, regardless of the degree of body fat loss by obese 
patients during WLI.
Acknowledgement: This study was supported by a Research Grant (23-2) for Ner-
vous and Mental Disorders from the Ministry of Health, Labour and Welfare of 
Japan and a Grant-in-Aid for Scientific Research (25460902) from the Japan Society 
for the Promotion of Science, and a Budget for clinical research base development 
project (GAQQ250001) from the Ministry of Health, Labour and Welfare of Japan.
T3:PO.096
Marital stress and food intake: An examination of the 
moderating role of BMI and restraint
Côté M.1, Bégin C.1, Gagnon-Girouard M.2, Provencher V.3
1School of psychology, Laval University, Quebec, Canada,  
2Psychology Department, Université du Québec ŕ Trois-Rivičres, Trois-Rivičres, 
Canada,  
3Institute of Nutrition and Functional Foods, Laval University, Quebec, Canada
Introduction: Stress has been commonly associated with obesity through 
its disinhibiting effect on food intake (Sominsky & Spencer, 2014). 
Ego-threatening stressors, particularly relational ones, have been shown 
to increase food intake among restrained eaters and overweight individ-
uals (Tanofsky et al., 2000).The aim of the present study was to examine 
the impact of a stressful marital discussion on food intake in both spouses, 
while taking into account the effect of BMI and restraint on this relation-
ship. 
Methods: Eighty heterosexual couples were recruited via email. In lab-
oratory, couples discussed for 15 minutes an aspect that they want their 
partner to change, after what they completed individually a bogus taste 
test (to assess food intake). The following variables were also assessed: 
mood states, BMI, and restraint. Using PROCESS macro (Hayes, 2013), a 
three-way interaction between mood change (measured before and after 
the discussion), BMI, and restraint was tested with multiple regression 
analyses among both men and women, controlling for hunger (Fig. 1). 
Results: Among women, the model was significant, F(8, 70)=3.46, 
p = 0.002. The three-way interaction was significant (p = 0.039). Re-
strained women with high BMI ate more when their mood worsened, 
as opposed to unrestrained women with high or average BMI who ate 
significantly less (Fig. 2). Among men, although the overall model was 
significant, F(8, 70)=3.99, p = 0.001, only hunger predicted significantly 
food intake (p < .001). 
Conclusion: These results suggest that the impact of a relational stress 
on food intake is different among genders. For women, higher BMI and 
restraint score are associated with more disinhibited eating, thus support-
ing the importance to address restraint and BMI when studying stress-in-
duced eating.
Fig. 1. Conceptual model of conditional, direct and indirect effects.
Fig. 2. Interaction plot showing associations between mood change and food 
intake in grams for women at different values of restraint (RS) and body mass 
index (BMI). All variables are z-standardized.
T3:PO.097
Visual analogue scales to assess appetite sensation – good 
agreement between 100 mm pen and paper vs tablet-based 
scores
Klingenberg L.1, Nyby S.1, Kristensen M.B.1, Raben A.1
1Department of Nutrition, Exercise and Sports, Faculty of Science, Copenhagen 
University, Denmark
Introduction: Different electronic visual analogue scales (eVAS) using 
handheld devices have already been validated. These devices have, how-
ever, most often not the same scale length as the pen and paper (P&P) 
version. Furthermore, with the introduction of different tablet computers, 
new possibilities for assessing appetite sensations are opening up since 
tablets are found in most homes and work places. The aim of this study 
was to verify whether appetite sensation scores obtained from 100 mm 
visual analogue scales (VAS) using an e VAS (eVAS) can be compared to 
those obtained from the traditional P&P method. 
Methods: On a single occasion, using a within-subject design, 21 healthy 
participants recorded their appetite sensations before lunch, and at five 
additional time points during the postprandial period. At each time point, 
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satiety, and prospective food consumption, but the order of the two meth-
ods was randomized. 
Results: We observed that the immediate, successive completion of ques-
tionnaires from the two methods resulted in no significant difference in 
results on appetite sensations as also indicated by a strong linear relation-
ship between the two (r from 0.71 to 0.98, P < 0.01). A Bland-Altman plot 
of the calculated composite score at baseline revealed good agreement be-
tween the mean value between eVAS and P&P and the difference between 
the methods. 
Conclusion: We conclude that VAS scores obtained from a tablet-based 
electronic VAS and the gold standard P&P method with similar scale 
length are interchangeable, both before and in response to a meal.
T3:PO.098
The control of eating questionnaire is predictive of weight 
loss in an integrated analysis of phase 3, randomized, 
double-blind, placebo-controlled, trials of prolonged-release 
naltrexone/bupropion
Dalton M.1, Finlayson G.1, Blundell J.E.1
1Appetite Control & Energy Balance Research, School of Psychology, Faculty of 
Medicine & Health, University of Leeds, UK
Food cravings are associated with overeating and obesity, and may have 
implications for successful weight loss. Gaining control over food crav-
ing is a component of the management of obesity and the development 
of healthy eating habits. The present analysis evaluated the psychometric 
properties of Control of Eating Questionnaire (CoEQ) and tested its pre-
dictive validity by examining its association with weight loss in four Phase 
3 clinical trials that examined the effect of treatment with a prolonged-re-
lease combination of naltrexone/bupropion (NB) on weight loss in obese 
adults. In an integrated analysis of four Phase 3 trials, subjects completed 
the CoEQ at baseline and Weeks 8, 16, 28, and 56. All analyses were con-
ducted on subjects who had complete weight and CoEQ measurements 
at baseline and Week 56, and had completed 56 weeks of NB (n=1238) 
or Placebo (n=720). Confirmatory Factor Analysis (CFA) was used to 
determine the psychometric properties of the CoEQ. CFA supported a 
four-factor solution of the CoEQ. Factors identified were: Craving Control 
(CRAV), Craving for Sweet (SWT); Craving for Savoury (SAV); and Pos-
itive Mood (MOOD). The CoEQ was important in predicting the weight 
loss response to drug treatment. Improvement in CRAV at each time 
point was associated with Week 56 weight loss. Further, improvement in 
CRAV at Week 8 was associated with a greater fat mass loss at Week 56. 
The CoEQ has good psychometric properties and internal consistency. 
Food craving is closely associated with drug-induced changes in body fat. 
Early improvements in CRAV and SWT were predictive of lower body fat 
and BMI at Week 56. Therefore, the CoEQ is a valid measure for the expe-
rience of food cravings and has applications for research and the clinical 
management of obesity.
T3 – Protective foods
T3:PO.099
Superior metabolic efficiency of phosphatidylcholine-rich 
omega-3 phospholipids compared to soy- or egg yolk-derived 
phosphatidylcholine in dietary obese mice
Rossmeisl M.1, Pavlisova J.1, Bardova K.1, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic
Introduction: Studies in animal models of obesity demonstrated that the 
metabolic effects of dietary omega-3 fatty acids (EPA and DHA) depend 
on their lipid form, with marine phospholipids (PL) showing better effica-
cy than fish oils. However, PL themselves could have beneficial metabolic 
action. We aimed to compare herring-derived omega-3 PL rich in phos-
phatidylcholine with phosphatidylcholine-rich preparations from soy or 
egg yolk in dietary obese mice. 
Methods: Male C57BL/6N mice were fed for 9 weeks a control high-fat 
diet (cHF; lipids ~35 wt%) or cHF-based experimental diets: (i) cHF with 
10% lipids replaced by herring-derived omega-3 PL (PC-M), (ii) cHF with 
10% lipids replaced by phosphatidylcholine-rich concentrate from soy 
(PC-S), or (iii) cHF with 6% lipids replaced by phosphatidylcholine-rich 
concentrate from egg yolk (PC-E). Experimental diets were matched for 
phosphatidylcholine content. 
Results: Feeding mice cHF diet resulted in obesity (increased adiposity), 
glucose intolerance, insulin resistance, hypertriacylglycerolemia, adipo-
cyte hypertrophy and hepatic steatosis. All these abnormalities were ame-
liorated to different extents in mice fed PC-M, while PC-S and PC-E were 
both ineffective except for their marginal effect on hepatic steatosis. In 
the liver, the complex down-regulation of lipogenic and cholesterol bio-
synthesis genes was observed in the PC-M group, while less pronounced 
decreases in the expression of lipogenic genes were also observed in the 
PC-S and PC-E group. 
Conclusion: Dietary intervention with omega-3 PL elicited superior effects 
compared not only to fish oils, but also to other PL-based preparations lack-
ing EPA/DHA. Thus, the combination of both EPA/DHA and the phospha-
tidylcholine molecule seems to confer the highest metabolic effects.
T3:PO.100
Effect of a dietary portfolio on metabolic syndrome in 
patients with morbid obesity
Chávez-Manzanera E.1, Guevara-Cruz M.2, Palomo-Martínez L.1,  
Gómez-Fernández C.1, García-García E.1, R Tovar A.2, Torres y Torres N.2
1Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias 
Médicas y Nutrición Salvador Zubirán, México City. México,  
2Department Physiology of Nutrition, Instituto Nacional de Ciencias Médicas y 
Nutrición Salvador Zubirán, México City. México
Introduction: Obesity and metabolic syndrome are recognized as one of 
the most important health public challenges. Recently, it has been used 
the implementation of dietary strategies using specific dietary portfolios 
(DP; combination 2 or more functional foods) to control circulating levels 
of lipids and glucose. The aim of this study was to assess the effect of a DP 
containing nopal, soy protein, oats, chia seed and inulin in subjects with 
morbid obesity on components of metabolic syndrome and the concen-
tration of total cholesterol, LDL cholesterol, glucose, HOMA-IR and PCR. 
Methods: This was a single center, randomized, placebo-controlled, dou-
ble-blind parallel-arm study. Patients with morbid obesity (BMI ≥40 kg/
m2) and metabolic syndrome received a diet low in saturated fat, accord-
ing to ATPIII program, with a reduction of 500 Kcal to their usual diet 
during two months with a moderate physical activity plan, along with the 
consumption of DP or placebo (control group). 
Results: A total of 53 Mexican subjects with a mean age of 36 ±10.9 years 
and BMI of 43 ± 2.71 kg/m2 were studied. There was a significant decrease 
in serum triglycerides in the DP group (from 184 ± 65.4 to 152 ± 42.6, 
P < 0.011) compared to the control group. In addition, there was a de-
crease in serum total cholesterol (from 191 ± 33.8 to 176 ± 32.0, P < 0.010) 
and LDL cholesterol (126 ±3 1.7 to 113 ± 37.7, P < 0.014). DP and control 
groups had a significant decrease in body weight, waist circumference, 
glucose and HOMA-IR. 
Conclusion: These results indicate that DP consumption produced a fa-
vorable effect on blood lipids in morbid obese with metabolic syndrome 
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T3:PO.101
Effect of probiotic/prebiotic supplements containing 
bifidobacterium lactis and chicory inulin to the body 
composition in obese individuals
Oksuzkaya F., Soylu M., Kaner G., Inanc N.
Department of Nutrition and Dietetics, Faculty of Health Sciences, Erciyes 
University, Kayseri, Turkey, 
This study was conducted to demonstrate the impacts of the probiotic/
prebiotic addition which contains bifidobacterium lactis and chicory inu-
lin on body composition in obese individuals. A total of 66 obese partici-
pants (BMI: 25–40 kg/m2) aged 18–55 years were divided into two groups 
and dietary treatment was applied for 12 weeks. A general questionnaire 
was applied to the participants. In addition to the dietary treatment, study 
group (n = 45) were given 1 sachet probiotic containing live and active 
5 billion CFU Bifidobacterium lactis and prebiotic containing 900 mg 
chicory inulin. Placebo was given to the control group (n = 21). Height, 
waist and hip circumference were measured, height and body composi-
tion were assessed by Inbody 230 BIA. The mean age of participants were 
32,25 ± 9,51 years. 75.5% of individuals were women while 24.5% were 
male. At the end of the study, body weight decreased –4.79% ± 2.46 kg of 
the study group, it was found –9.4% ± 4.79 in the control group (p < 0.001). 
Reduction in BMI of study group (-4.91% ± 2.5) was lower than controls 
(-9.38% ± 4.8) (p < 0.001). No significant decreases were found in muscle 
mass of both groups (p > 0,05). Fat weight loss were more statistically sig-
nificant in the study group (-8.68% ±5.73) compare with the control group 
(-19.26%±9.89) (p < 0.001). Differences in fat content of the study group 
(-4.59% ± 4.55) was statistically significant lower compared with the con-
trol group (-11.16 ± 6.79%). Reduction in waist/hip ratio in the control 
group was determined higher than the study group (p,001). A significant 
decreases were found in body weight and fat, BMI, waist/hip ratio and fat 
ratio in both groups except muscle weight (p < 0,01). At the end of the 
study, there wasn’t found effectiveness of prebiotic/probiotic supplements 
to the dietary treatment. For this reason, it would be useful to conduct 
further research on this topic.
Key words: Obesity, prebiotic, probiotic.
T3 – Energy balance
T3:PO.102
Differential sympathetic nervous system outflow to skeletal 
muscle in lean vs obesity-prone rats.
Gavini C.K.1, Britton S.L.2, Koch L.G.2, Novak C.M.1
1School of Biomedical Sciences and Department of Biological Sciences, Kent 
State University, Kent, Ohio, USA.,  
2Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Rats selectively bred for high intrinsic aerobic capacity (HCR) are lean, re-
sistant to obesity, and consistently more active than low-capacity runners 
(LCR), which are more prone to metabolic syndrome. We have shown that 
HCR have elevated daily energy expenditure (EE), primarily due to activ-
ity-EE rather than to resting EE. This high activity-EE stems from height-
ened daily activity plus low economy of activity in HCR wherein those ex-
cess calories are dissipated by skeletal muscle as heat. We primarily focus 
on the ventromedial hypothalamus (VMH), part of a pathway regulating 
energy balance (EB) through its actions on peripheral glucose and lipid 
allocation, modulating respiratory quotient and thermogenesis. We have 
also shown that activation of receptors for melanocortins (MC), a system 
involved in controlling EB, in the VMH more effectively impacts metab-
olism in HCR compared to LCR. We hypothesize that this difference in 
metabolism is due to differential activation of the sympathetic nervous 
system (SNS), impacting molecular mediators of energy expenditure. 
Norepinephrine turnover was used to asses SNS drive. Rats received in-
tra-VMH microinjections of MC receptor agonist Melanotan-II (MT-II) 
or vehicle (aCSF) to measure MC-induced enhancement of SNS outflow 
to muscle. Compared to vehicle, intra-VMH MT-II induced a significant 
increase in SNS activity in most of the tissues analyzed, including muscle; 
moreover, HCR were significantly more affected than LCR. These results 
support the hypothesis that pathway modulated by MC receptors in the 
VMH more effectively impacts metabolism in HCR compared to LCR; 
this may be due to differences in SNS activation. This likely results in dif-
ferential alterations in mechanisms impacting muscle metabolism.
Fig. 1. Figure1: Norepinephrine turnover (NETO) in skeletal muscle of HCR and 
LCR, A) Soleus, B) EDL. Compared to vehicle, intra-VMH MT-II induced a 
significant increase in NETO in both HCR and LCR. Change in NETO was higher 
for HCR in soleus and for LCR in EDL. (*p < 0.05).
Fig. 2. Figure2: Norepinephrine turnover (NETO) of HCR and LCR in A) BAT, B) 
Heart. Compared to vehicle, intra-VMH MT-II induced a significant increase in 
NETO in both HCR and LCR. Change in NETO was higher for HCR in BAT and 
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Fig. 3. Figure3: Norepinephrine turnover (NETO) of HCR and LCR in different 
white adipose depots (WAT), A) Mesenteric WAT (MWAT), B) Inguinal WAT 
(IWAT) . Compared to vehicle, intra-VMH MT-II induced a significant increase in 
NETO in both HCR and LCR; HCR were more affected than LCR in both WAT. 
(*p < 0.05).
Fig. 4. Figure4: Norepinephrine turnover (NETO) in liver of HCR and LCR. 
Compared to vehicle, intra-VMH MT-II induced a significant increase in NETO in 
both HCR and LCR; HCR were significantly more affected than LCR. (*p < 0.05).
T3:PO.103
Children and adolescents with obesity and with physical 
activities out of school have unbalanced diet risk
Maslova O.1, Napituhina I.1, Tase I.1, Agadzanjana K.1, Vetra A.1,2,  
Dzivite-Krisane I.1,2, Gailite J.1,2
1Children‘s Clinical University Hospital, Riga, Latvia,  
2Riga Stradins University, Latvia 
Introduction: For obesity prevention of children and adolescents is very 
important to keep balanced diet and have regular physical activities. 
Methods: Data about anthropometric parameters (weight, height, body-
mass index (BMI), waist circumference), eating habits and physical activ-
ities was collected and analyzed by a multidisciplinary team in Children’s 
Clinical University Hospital (Riga, Latvia) between August and November 
2014. 
Results: 31 children participated in study, 14 girls and 17 boys. Mean 
age (years± SD) was 13.25 ± 2.45, weight (kg ± SD) 86.93 ± 23.68, height 
(cm ± SD) 165.93 ± 12.40, BMI (kg/m˛ ± SD) 31.06 ± 5.22, waist circum-
ference (cm ± SD) 104.53 ± 14.10. 7.1% (n=1) of girls and 41.2% (n=7) of 
boys admitted regular eating in front of TV and 42.9% (n=6) of girls and 
23.5% (n=4) of boys admitted occasional eating in front of TV (p = 0.04). 
We find also statistically significant difference between children with 
physical activities out of school and without it relation to overeating and 
eating in fast food restaurants. 55.5% (n=5) of children with physical ac-
tivities out of school answered that they have had overeating feeling 1 
time per day or more and only 5.9% (n=1) those children, who do not 
have physical activities out of school have had overeating feeling regularly 
(p = 0.008). 33.3% (n=3) of physically active children mentioned that they 
eat in fast food restaurant at least 1 time per 2 weeks or more and 11.8% 
(n=2) of children who is not physically active (p = 0.043). 
Conclusion: Physically active children and adolescents have to pay more 
attention to balanced diet and regular meal out of school.
T3:PO.104
Differential regulation of metabolic parameters by energy 
deficit and hunger
Kitka T.1, Tuza S.1, Varga B.1, Horváth C.1, Kovács P.1
1Division of Pharmacological and Drug Safety Research, Gedeon Richter Plc., 
Budapest, Hungary
Introduction: Hypocaloric diet is known to decrease both energy expen-
diture (EE) and respiratory exchange rate (RER), affecting the efficacy of 
dieting oppositely. Energy deficit and subjective hunger may be modulat-
ed separately both in human and animal studies by drug treatment (only 
energy deficit) or food restriction (both energy deficit and hunger). Thus 
it would be important to separate the effects of energy deficit and hunger 
on EE and RER. 
Methods: Three parallel and analogous experiments were performed 
using three pharmacologically distinct anorexigenic drugs: rimonabant, 
sibutramine and tramadol. Metabolic parameters of vehicle-, drug-treated 
and pair-fed diet-induced obese mice were recorded. The three experi-
ments underwent common statistical analysis to identify effects indepen-
dent from the mechanisms of action. 
Results: RER was similarly decreased by drug treatments and paired feed-
ing throughout the experiment. Contrarily, EE was decreased by paired 
feeding compared to both vehicle- and drug-treatment in the passive 
phase. In the active phase, EE was influenced by the pharmacological 
mechanisms of action. 
Conclusion: Our results suggest that RER is mainly affected by the actual 
state of energy balance and unaffected by hunger. In contrast, EE is rather 
influenced by subjective feelings of hunger. Therefore, pharmacological 
medications that decrease hunger may enhance the efficacy of a hypoca-
loric diet by maintaining metabolic rate. Furthermore, our results yield 
the proposal that effects of anorexigenic drugs on EE and RER should 
be determined compared to vehicle and pair-fed groups, respectively, in 
animal models.
Acknowledgement: The study was partially supported by a grant from the ERNYŐ 
2013 of the Hungarian Government.
T3:PO.105
The effect of life-style interventions on weight reduction and 
weight maintenance
Halmy E.1, Kovács F.1, Halmy L.1
1Platon Health Advising and Services Ltd.
Aim: To study the effectiveness of life-style interventions in weight man-
agement. 
Method: The life-style interventions were based on calory restricted diet, 
increased physical activity, education, and regular control. The weight re-
duction program (a) duration 3 weeks in hospitalisation n:146, BMI:41.6 
kg/m˛ daily underwater exercise, gymnastic, brisk walking, LCD. The 
weight maintenance (b) was supported in self-helped group during 2 years 
n:129, BMI:30.2 kg/m˛ weekly organised dietetic consultation, gymnastic 
with music, education. 
Results: (a) Body-weight kg 119.4 (SD:25.8)- 112.9 (SD:24.2) body fat kg 
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(SD:37) – 165.4 (SD:49.1) systolic blood pressure Hgmm 147.8 (SD:19.6) 
- 123.5 (SD:11.9) diastolic BP Hgmm 90.4 (SD:12.6) - 76.9 (SD:7.4) cho-
lesterol mmol/l 5.3 (SD:1.1) - 4.34 (SD:1) LDL-cholesterol 3.1 (SD:0.9) 
- 2.6 (SD:0.8) HDL-cholesterol 1.3 (SD:0.3) - 1.1 (SD:0.2) triglyceride 2.4 
(SD:2.7) - 1.6 (SD:1.1) hCRP 8.8 (SD:8.2) - 4.9 (SD:4.4) p < 0.001. Walking 
distance km/day 4.5 (SD:3.2) - 10.2 (SD:5.7) p < 0.001. Mean of energy ex-
penditure by walking 514.1 (SD: 366.9) kcal/day. (b) Body-weight Δ-1.5 kg 
p < 0.001, body fat Δ-1.2 kg p < 0.001, decreased BMI, waist circ p < 0.001, 
hip circ p < 0.05, dyastolic BP p < 0.05, systolic BP NS.
Conclusion: The inpatient program was effective in weight reduction and 
risk factors normalization. The self-helped group program was suitable 
for long term weight maintenance either in prevention of weight gain or 
in post-obese condition. Effectiveness is feasible with compliance and the 
aid of organized follow-up.
T3:PO.106
The relation between the menstrual cycle with food craving 
and eating attitudes
Büyükkaragöz A.H.1, Sağlam D.1, Cengiz E.Ş.1, Karaca E.1, Baş M.1, 
Arıtıcı G.1, Köksal S.1
1Acibadem University, Health Sciences Faculty, Department of Nutrition and 
Dietetics, Istanbul
Introduction:A food craving is a desire “so strong that it will cause a per-
son to go far out of his or her way to satisfy [it]” and leads to the sub-
jective experience of a compulsive urge to eat, and are associated with 
higher Body Mass Index (BMI) as well as eating disorders. In retrospective 
studies, women have commonly experience an increase in food cravings 
during the days prior to menses (i.e., the late luteal phase), with some 
studies also finding elevations in food cravings during menses. 
Methods:The participants in this study consisted of 678 female university 
students in Istanbul. The questionnaire was included asked about the so-
cio-demographic items, including age; weight, height and BMI was based 
on self-report. The participants completed the Dutch Eating Behaviours 
Questionnaire (DEBQ), Daily Symptom Rating Scale (DSR), Eating At-
titudes Test - 26 (EAT-26) and The Attitudes to Chocolate Questionnaire 
(ACQ). 
Results: Participants’ mean age was 20.14 ± 2.04 years. The average BMI 
was 21.29 ± 2.92 kg/m2. Ninety-six participant were in the underweight 
range, 9.0% of participants were in the overweight range, and 1.2% % of 
participants were in the obese range. Disturbed eating behaviours was 
found in 25.2%, and binge eating behaviours was found in 19.2% of the 
total sample. Results indicated that there was significant correlate between 
BMI and DSR (r=0.083; p = 0.030), DEBQ-restraint (r=0.357; p = 0.000), 
DEBQ-emotional (r=0.278; p = 0.000), EAT-26 (r=0.083; p = 0.031) and 
ACQ (r=0.255; p = 0.000). Also, luteal phase was associated with higher 
DSR, ACQ and DEBQ-emotional scores (p < 0.05).
Conclusions: In conclusion, the luteal phase contributed to a higher choc-
olate craving response to food and high-sweet-fat food, and there was sig-
nificant relation between the body mass index and chocolate craving. A 
large body of research has demonstrated that individual factors may have 
specific influences on chocolate craving.
T3:PO.107
Weight cycling and psychological correlates among dieters in 
turkey
Büyükkaragöz A.H.1, Bas M.1, Karaca E.1
1Acibadem University, Health Sciences Faculty, Department of Nutrition and 
Dietetics, Istanbul
Introduction: Weight cycling refers to losses and subsequent regaining of 
body weight that often occurs in association with dieting. Weight cycling 
(WC) is independently associated with adverse health outcomes such as 
increased cardiovascular morbidity/mortality and psychological problems. 
Methods: The sample was composed of patients who had been consulted 
at a private obesity clinic in Ankara between May 2014 and December 
2014 with the intention of losing weight. The participants in this study 
consisted of 116 people (90 women and 26 men). The participants com-
pleted the Dutch Eating Behaviours Questionnaire (DEBQ), Beck De-
pression Scale (BECK), Thinness and Restricting Expectancy Inventory 
(TREI) and the questionnaire to assess weight cycling. 
Results: In the whole study group (n = 116), the prevalence of reported WC 
was 42.2% (46.7% of women, %26.9 of men). Results indicated that there 
was significant correlation between body mass index and TREI (r=0.295; 
p = 0.005), DEBQ-restraint (r=0.374; p = 0.000) and DEBQ-emotional 
(r=0.400; p = 0.000) for women, BECK (r=0.404; p = 0.041) for men. In 
addition, results from indicated that there was significant correlate be-
tween body mass index and TREI (r=0.332; p = 0.032), DEBQ-restraint 
(r=0.503; p = 0.001) and DEBQ-emotional (r=0.447; p = 0.003) for cycler 
women, but no cycler men. There was a significant difference between 
TREI scores of individuals with WC compared to non-WC. There was 
also a significant difference in the BECK and DEBQ-emotional scores of 
women compared to men. 
Conclusion: As a conclusion, weight cycling prevalence is higher in wom-
en than men. Also, weight cycling status is related with thinness and re-
stricting expectancy, emotional eating and depression level among wom-
en, but not among men. More efforts are needed by clinicians to focus on 
better management of weight-loss programs, in order to avoid multiple 
weight fluctuations and to achieve long-term weight maintenance.
T3:PO108
Is dietary restraint deserving of its poor reputation in obesity 
management?
Picone T.J.1, Franklin J.L.1, Manson E.1, Loughnan G.1, Markovic T.1
1Metabolism and Obesity Services, Department of Endocrinology, Royal Prince 
Alfred Hospital, Sydney, Australia
Introduction: Dietary restraint (DR) has been implicated in both the ae-
tiology and treatment of obesity. While DR is necessary for weight loss, 
high DR may lead to disinhibition, disordered eating, binge eating, and 
weight gain. The present study aimed to evaluate the role of DR in a sam-
ple of obese weight loss subjects. It was hypothesised that compared to low 
and high DR, moderate DR would protect against weight gain, poor eating 
pattern and psychopathology. 
Method: Baseline anthropometry, psychological measures (DASS, BDI), 
eating and exercise behaviour (Food habits questionnaire and Modified 
Beacke), medical profiles and weight loss outcomes were assessed ac-
cording to degree of DR as measured by the TFEQ in 2496 patients (1731 
female) who had attended an outpatient obesity management clinic be-
tween 1992 and 2013. 
Results: Subjects with higher DR had lower baseline weight, BMI and 
waist circumference. These subjects did not report increased symptoms 
of depression or anxiety and reported lower fat score and higher better 
habits score. In women, high DR was also associated with higher activ-
ity levels. Although linear regression showed that DR was a predictor of 
baseline weight secondary to self-esteem, it only accounted for 1.9% of 
the variance in baseline weight. DR did not remain predictive in men after 
adjusting for self-esteem. Higher baseline DR did not predict short or long 
term weight loss. 
Conclusion: Contrary to the hypothesis, higher DR is associated with 
lower body weight and healthier eating and physical activity behaviours in 
an obese treatment seeking population with no adverse effect on depres-
sion or anxiety. Although DR is not predictive of weight loss in the short 
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T3:PO.109
Determination of Relationship Between Obesity and Alkaline 
Diet in School Aged Children
Karacil M.S.1, Koksal E.1, Tekcicek M.2
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey,  
2Department of Pediatric Dentisty, Faculty of Dentistry, Hacettepe University 
Introduction: This study was aimed to evaluate relationship between obe-
sity and alkaline diet in school aged children. 
Methods: This study was conducted 96 girls and 92 boys totally 188 chil-
dren. Anthropometric measurements of children were taken and body fat 
percentage (%) was measured by bioelectric impedance analyzer that can 
be used for children and 24-hour dietary recall of children was collected. 
Potential Renal Acid Load (PRAL) value formulated by Remer ile Manz 
was used for evaluating alkalinity of diet. 
Results: According to the children‘s body composition it was not detected 
children who have low body fat percentage while 39.9% of children have 
high body fat percentage. Mean body fat percentage of girls (27.6 ± 4.94) 
were found more than boys (24.3 ± 7.17) and the difference is significant 
between groups (p < 0.05). It was determined that diet alkalinities of chil-
dren are positive associated with fruit and vegetable consumption but 
negative associated with meat and meat products and grain consumption 
(p < 0.01). It was found there is no relationship between dietary PRAL 
values and height, weight, waist circumference, waist / height ratio, body 
mass index but there is a negative correlation with body fat percentage 
which is an indicator of body composition (r = -0.215; p <0.01) 
Conclusion: Increasing of diet alkalinity can be an indicator of a healthy 
diet in the prevention of many diseases. Nowadays increasing of fruit and 
vegetable consumption increase diet alkalinity and it will have an import-
ant role in prevention of childhood obesity and chronic diseases in adult-
hood.
T3:PO.110
Pharmacokinetics of quercetin which reduce body fat 
humans.
Nakamura J.1, Tomimori N.2, Yoshimura M.1, Fukui N.1
1Suntory Global Innovation Center Limited, Tokyo, Japan,  
2Suntory Wellness Limited, Tokyo, Japan
Introduction: Quercetin is one of the most abundant polyphenols in veg-
etables and fruits. It has been reported that quercetin induces lipolysis. 
We demonstrated that the beverage containing quercetin glucoside (QG) 
reduces body fat of obese humans last year. Objective:The objective of this 
study was to investigate the pharmacokinetics of quercetin on healthy hu-
mans and mild obese humans ingesting a beverage containing QG 110mg 
as isoquercitrin (QG1). 
Methods: A total of 20 volunteers composed of 10 healthy humans 
(18.5≦body mass index<25 kg/ m2) and 10 mild obese humans (25≦body 
mass index<30 kg/m2) participated in this study. Test beverage was pack-
aged a bottle of 350 ml containing QG 110mg as QG1. After an overnight 
fast, each study participant ingested a test beverage without breakfast. 
Blood samples were collected at 0.25,0.5,1, 1.5,2, 4,8, 12,24,36,48 and 60 
hr after test beverage ingestion. 
Results: The mean area under the curve of plasma total quercetin from 
baseline to 60 hr [AUC 0-60 hr] was 2.8 μg hr/mL, maximum plasma con-
centration (Cmax) was 997 ng/mL, and time to reach Cmax (Tmax) was 
0.5 hr. There was no difference between healthy humans and mild obese 
humans in the respective pharmacokinetics parameters. 
Conclusions: The beverage containing QG is absorbed promptly within 
an hour and is an excellent way to reduce body fat in humans effectively.
T3:PO.111
Evaluation of Knowledge, Attitude and Behavior on Popular 
Weight-Loss Diets in Adults
Bilici S.1, Yilmaz H.2, Uyar B.3, Gencer F.4, Karaalioglu N.5, Albayrak Z.6
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara,
Turkey Introduction: Recently, unhealthy and popular weight-loss diet 
solutions, which are not personally designed and claiming faster results 
on weight loss, spreaded among individuals especially with the influence 
of the media. The aim of this study to determine knowledge, attitude and 
behavior of popular weight loss diets among adults. 
Methods: Total 400 (332 female, 68 male) adults (mean age of partici-
pance 24.8 ± 23.7 years) participated this study between October 2013- 
May 2014. A questionnaire examined face to face by specialists. 
Results: According to WHO‘s BMI classification, it is determined that 
69.9% of individuals had a normal body weight, 11.5% were underweight, 
18.8% were obese. Also, 58.9% of normal weight individuals, 54.7% of 
obese individuals believed obese themselves (p < 0.05) and 31.8% of the 
participants stated that they had knowledge about the contents of the 
popular diets. It is determined that they had knowledge about popular 
diets from internet (34.1%), newspapers and magazines (25.5%), friends, 
neighbors and relatives (22.2%), books (11.4%) and dieticians (2.5% ). 
Participants, which were indicated that popular weight-loss diets are ef-
fective and useful, were 28.3%. It was found that 4% of individuals applied 
popular diet and 80% of individuals applying popular diet have preferred 
high protein diets. 
Conclusions and Recommendations: Popular weight-loss diets are be-
coming increasingly widespread use under influence of media often in-
cludes incorrect and inappropriate to principles of healthy eating practic-
es. Educational and informative programs prepared by experts should be 
given more space in the media for people’s consciousness.
T3:PO.112
Weight loss with a modified Mediterranean type diet using fat 
modification through neutral and butter flavored canola oil, 
walnuts and walnut oil
Austel A.1, Ranke C.1, Wagner N.1, Görge J.1, Ellrott T.1
1Institute for Nutrition and Psychology at Göttingen University Medical School, 
Göttingen, Germany
Objective: Mediterranean diets with a high proportion of olive oil and 
nuts can be effective for weight management and the prevention of car-
diovascular disease. For populations with different eating habits and pref-
erences it might be difficult to follow such diets. Therefore, a modified 
Mediterranean type diet using fat modification through neutral and butter 
flavored canola oil, walnuts and walnut oil, and with two portion-con-
trolled sweet daily snacks, was tested in Germany. 
Methods: Randomized waiting-list control study with overweight/grade 1 
obese subjects: 12-week self-help modified Mediterranean type diet with 
6 weeks of modified Mediterranean type diet plans (approx. 1300 kcal/d) 
and 6 weeks of weight loss maintenance training. 40-week follow-up. Trial 
duration 12 months. Oils and nuts were provided free of charge. Subjects: 
See Fig. 1. 
Results: Per protocol weight loss after 12 weeks was 5.2kg in IG vs. 0.4kg 
in CG (p≤0.0001), BMI change –1.8 kg/m˛ vs. –0.1 kg/m˛ (p≤0.0001), 
waist circumference change –4.7cm vs. –0.9cm (p≤0.0001). Weight loss 
after 12 months: 4.2kg (pooled data). Triglycerides, total cholesterol and 
LDL-cholesterol were significantly improved in IG but not in CG after 12 
weeks, for 1-year-data see Fig. 2. 1-year-dropouts: 44% in IG, 53% in CG. 
Conclusion: A five meal modified Mediterranean type diet with two daily 
portion-controlled sweet snacks was effective for weight management in 
a self-help setting for overweight and grade 1 obese subjects. Fat modifi-
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even at 12 months. Such adaptions to local eating habits do not seem to 
compromise important outcomes of Mediterranean diets for weight loss.
Fig. 1. Baseline characteristics of the participants in groups IG and CG 
(mean ± s.e.m.)
Fig. 2. Changes in blood lipids over 1 year (completers; pooled data); Legend. +: 
Week 0 vs Week 12 (p ≤ 0.05); ++ p ≤ 0.01; +++ p ≤ 0.001, #: Week 0 vs Week 52 (p ≤ 
0.05); ## p ≤ 0.01; ### p ≤ 0.001, *: Week 12 vs Week 52 (p ≤ 0.05); ** p ≤ 0.01; *** p ≤ 
0.001
T3:PO.113
Effect of intermittent versus continuous energy restriction on 
compensatory mechanisms activated during weight reduction
Coutinho S.R.1, Gĺsbakk S.1, Halset E.H.1, Kulseng B.1,2, Truby H.3, 
Martins C.1,2
1Obesity Research Group, Department of Cancer Research and Molecular 
Medicine, Faculty of Medicine, Norwegian University of Science and 
Technology, Trondheim, Norway,  
2Centre for Obesity, Department of Surgery, St. Olav Hospital—Trondheim 
University Hospital, Trondheim, Norway,  
3Nutrition & Dietetics Department, Monash University, Melbourne, Australia
Introduction: Intermittent energy restriction (IER) is a popular weight 
loss (WL) strategy. The effects of IER vs continuous energy restriction 
(CER) on body composition and compensatory mechanisms (reduction 
in resting metabolic rate (RMR), increase in exercise efficiency (Ef) and 
increase in hunger/reduction in fullness) activated during WL remain un-
known. The aims of this study were to compare the impact of IER vs CER, 
inducing a similar WL, on the above mentioned mechanisms. 
Methods: 34 obese (BMI: 36 ± 4kg/m2) individuals (26 females, age: 
38.9 ± 9.4y) were randomized to IER or CER for 12 weeks. Each dietary 
pattern was designed to have an overall 33% energy deficit and a similar 
macronutrient composition. The IER group underwent 3 nonconsecu-
tive days of very-low calorie diet/week. The CER group had daily energy 
restriction. Body weight, composition, RMR, Ef and subjective appetite 
were measured pre and post intervention. 
Results: WL (~13%) and body composition changes were similar in both 
groups. A significant reduction in RMR was observed in IER, but not CER 
group. Ef increased significantly in IER, but not CER group at 25 and 
50watts. Fasting prospective food consumption decreased significantly 
with CER but not IER. Differences between groups were not significant 
for any of the above. No significant changes occurred in other appetite 
feelings, either fasting or postprandially, within or between groups. 
Conclusion: A similar WL, achieved either by IER or CER, induces the 
same changes in body composition, RMR, Ef and appetite sensations, but 
CER prevents the reduction in RMR and the increase in Ef observed with 
IER. However, the continuous or intermittent nature of energy restriction 
does not appear, on it own, to modulate the compensatory mechanisms 
activated with WL.
Acknowledgement: Allevo (Cederroth Norge A/S); Fundaçăo para a Cięncia e a 
Tecnologia (Portugal); Regional Center for Morbid Obesity, Department of Surgery, 
St. Olav Hospital (Trondheim, Norway).
T3:PO.114
Comparison of a low calorie-high protein diet and moderate 
calorie-high protein diet with a standard diet in the treatment 
of obesity
Baş M.1, Cengiz E.Ş.1, Sağlam D.1, Büyükkaragöz A.H.1
1Acibadem University, Health Sciences Faculty, Department of Nutrition and 
Dietetics
Introduction: Obesity has been defined as a global epidemic, and its 
prevalence is now maintained or even accelerated in most industrialized 
countries. The leading non-pharmacological approach is the use of diets, 
particularly low-calorie and very low-calorie diets. In the last few years, 
the low-carbohydrate diet has gained progressive recognition over other 
dietary treatments, and the low-carbohydrate ketogenic diet in particular 
has been closely examined. 
Methods: In brief, 45 overweight or obese non-diabetic men and wom-
en (age 34.4 ± 4.5 years) undertook a low calorie-high protein diet (LC), 
moderate calorie-high protein diet (MC) and standard diet (SD) for 4 
weeks, during which some meals were replaced with a SDM formulation 
(S.D.M. - Societŕ Dietetica Medica, Italy). Bioelectrical impedance was 
used to measure body weight and composition using the standard adult 
mode of measurement. A baseline and final blood sample was collected. 
All groups received counseling by dietitian, no perform physical activity 
and adhered to the diet. 
Results: At 4 weeks, the weight reductions in the LC diet, MC diet and 
SD diet groups were 7.5 ± 32.1,5.9 ± 1.3 and 4.5 ± 1.8 kg, respectively 
(p < 0.05). At the end of the study, at 4 weeks, the body fat reductions 
were 6.9 ±1.8, 5.4 ± 1.4 and 3,5± 1.8 kg, respectively (p < 0.05). Also, the 
fasting insulin level reductions were 8.9 ± 6.7, 5.9 ± 3.5 and 3.5 ± 0.7 μIU/
mL, respectively (p < 0.05). Lean mass was unaffected, especially LC diet 
and MC diet groups. 
Conclusions: In summary, the present work demonstrated that a LC diet 
and MC diet were significantly superior in the induction of weight loss 
and body composition in otherwise healthy obese patients compared with 
a SD diet. The prescription of a standard diet in the post weight loss phase 
was important for achieving weight loss success. Further research is need-
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T3:PO.115
Sedentary behavior is related to fat distribution among 
children in South China
Xue H.1, Duan R.1, Yang M.1, Liu Y.1, Cheng G.2
1Department of nutrition, food safety and toxicology, West China School of 
Public Health, Sichuan University, Chengdu, P.R. China,  
2Department of nutrition, food safety and toxicology, West China School of 
Public Health, Sichuan University, Chengdu, P.R. China; State Key Laboratory 
of Biotherapy and Cancer Center, West China Clinical Medical School, Sichuan 
University, Chengdu, P.R. China.
Introduction: Little is known whether sedentary behaviors (SBs) are re-
lated to body fatness independent of physical activity (PA) among Chi-
nese children. The purpose of this study was to explore the independent 
associations of SBs (including TV/DVD viewing, computer use and doing 
homework) with body fatness among Chinese children. 
Methods: A cross-sectional study was conducted in 1586 Chinese chil-
dren (50.3% girls) aged 7–15 years. Height, weight, skin-fold thickness 
were measured and indicators of body fat distribution including percent-
age body fat (%BF), fat mass index (FMI) and fat-free mass index (FFMI) 
were calculated. Information of parental anthropometric measurements 
etc., as well as socio-demographic data were collected. Data on SBs, PA 
and dietary intake were assessed by self-reported questionnaires. Energy 
intake (EI) and energy expended in PA (PAEE) were calculated. The rela-
tions of SBs to body fatness were examined by multivariate linear models 
adjusted for the family average annual income, maternal overweight, EI 
and PAEE. 
Results: Boys spent more time than girls on using computer or doing 
homework (all p < 0.0002). In girls, TV/DVD viewing, computer use 
and doing homework were positively related to %BF, FMI and FFMI (all 
p < 0.04). Moreover, girls who spent more time on SBs had 12.9%-23.3% 
higher FMI and 2.9% higher FFMI. Among boys, time of using computer 
was positively related to FFMI. However, no relation of TV/DVD viewing 
and doing homework to body fatness was observed in boys. Furthermore, 
the above observed associations were more pronounced in girls aged 7–10 
years. 
Conclusion: SBs are positively related to fat distribution among Chinese 
girls, independently of PA. These associations were stronger and consis-
tently significant in the younger groups. Corrending author: Cheng G.
T3:PO.116
Variability in appetite and energy intake responses to 
exercise: A pooled analysis of acute laboratory-based studies
King J.A.1, Wasse L.K.2, Deighton K.3, Broom D.R.4, Douglass J.A.1, 
Stensel D.J.1
1 School of Sport, Exercise & Health Sciences, Loughborough University, UK,  
2Faculty of Medical and Human Sciences, University of Manchester, Manchester, 
United Kingdom,  
3School of Sport, Leeds Metropolitan University, Leeds, United Kingdom,  
4Centre for Sport and Exercise Science, Sheffield Hallam University, UK
Introduction: Exercise is promoted as an effective weight control strat-
egy for all; however emerging data indicates that large variability exists 
regarding energy intake responses to exercise. This investigation pooled 
data from several laboratory studies to more fully explore the individual 
variability within appetite and energy intake responses to acute exercise. 
Methods: Data from 16 of our group’s laboratory studies were pooled to 
determine the between-subject variability in 1) hunger response during 
(n = 182) and after (n = 96) exercise; 2) ad libitum energy intake respons-
es to acute exercise (n = 86). Data was derived from young, healthy, active 
males (age 22.3 ± 2.6 y; BMI 23.6 ± 2.2 kg/m2). Exercise responses were 
determined by comparing exercise and control trial outcomes. Aerobic 
exercise bouts lasted 30–90 min (45–75% VO2 peak) with trials days en-
during for 4–10 h. Hunger (AUC) responses were assessed during trials 
using Visual Analogue Scales and post-exercise energy intake was exam-
ined at ad libitum meals. 
Results: Hunger was suppressed during exercise (-32%, P < 0.001) with 
no differences apparent afterwards. Large variability in response to exer-
cise was evident however, during (-99 to +391%) and after exercise (-87% 
to +360%). No difference was observed in energy intake at the first meal 
(Control 1377 ± 474; Exercise 1411 ± 453 kcal); or for the summation of 
meals after exercise (Control 2951 ± 1085; Exercise 2999 ± 1083 kcal). 
Large variation in response was apparent at the first (-1196 to +1043 kcal) 
and subsequent meals (-1568 to +908 kcal) post-exercise. 
Conclusion: Large variability exists in the individual appetite and energy 
intake response to acute exercise. Recognition of this variation is critical 
for personalised weight management strategies.
Acknowledgement: This study was in-part funded by the National Institute for 
Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research 
Unit based at University Hospitals of Leicester and Loughborough University. The 
views expressed are those of the authors and not necessarily those of the NHS, the 
NIHR or the Department of Health.
T3:PO.117
Associations between nutritional knowledge, physical 
activity, cardiorespiratory fitness and obesity indicators in 
adolescents
Ribeiro J.C.1, Ramos H.1,4, Ferro-Lebres V.1,3, Aires L.1, Mota J.1, 
Guimarăes N.1, Esteves R.1,2, Moreira P.1,2, Silva G.1
1Research Centre in Physical Activity, Health and Leisure, Sports Faculty, 
University of Porto, Portugal,  
2Faculty of Nutrition and Food Sciences, University of Porto, Portugal,  
3Diagnostic and Therapeutic Technologies Department, School of Health 
Sciences - Polytechnic Institute of Braganza, Portugal,  
4Agrupamento de Escolas Emídio Garcia, Braganza, Portugal
Introduction:Overweight and obesity have a multifactorial genesis, sug-
gesting that’s the result from the combination of several factors such as ge-
netic, behavioral, environmental disturbances, lifestyles, physical activity 
and eating habits. The purpose of this study was to analyze the relations 
between nutrition knowledge (NK), physical activity (PA), cardiorespi-
ratory fitness (CRF) and obesity indicators in adolescents in the city of 
Bragança. 
Methods:The sample comprised 132 adolescents (57 girls and 75 boys), 
aged 12–18 years old. PA was measured using an accelerometer (GT3x; 
Actigraph), CRF was assessed by maximal multistage 20m shuttle run, NK 
was assessed by General Nutrition Knowledge Questionnaire, for Ado-
lescents (GNKQA), portuguese version. The obesity indicators measured 
were body mass index (kg/m2), waist and hip circumference (cm). Body 
fat percentage (%BF), total, and trunk, were measured by bioimpedance 
analysis with an electronic scale Tanita BC545. 
Results:Through multiple linear regression, using the Enter method, and 
assuming %BF as the dependent variable and sex, age, NK, CRF and PA 
levels as independent variables, explained up to 52.9% (P < 0.001) of the 
variance in the dependent variable, and only the variables gender, CRF 
and sedentary PA showed significant relations with %BF. In the stepwise 
method, we founded that only CRF explains 40.9% (P <0.001) of the vari-
ance in %BF. In the second model (final), with the inclusion of sex, the 
model went to explain 49.1% (P <0.001) of the variance in the dependent 
variable. 
Conclusions:Of the variables analyzed, CRF and sex are the most deter-
minant variables to explain the variance in the %BF, despite the sedentary 
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T3:PO.118
Web-based intervention to promote weight loss maintenance 
using an activity monitor: Study design and 3-month interim 
report of a randomised controlled trial
Nakata Y.1, Sasai H.1, Tsujimoto T.1, Kobayashi H.1, Hashimoto K.1
1Faculty of Medicine, University of Tsukuba, Tsukuba, Japan 
Introduction: Our previous study suggested that increased physical activ-
ity may be crucial for successful weight loss maintenance. The purpose of 
this study is to test the effectiveness of a web-based intervention designed 
to increase physical activity in promoting weight loss maintenance. 
Methods: We are currently conducting a two-phase 27-month ran-
domised controlled trial. Participants were recruited through newspaper 
advertisements. Eligibility criteria included age (40–64 years), body mass 
index (25–40 kg/m2), and metabolic syndrome components (at least one). 
In phase 1, a 3-month group-based weight loss programme was provided 
to participants. We randomly assigned (1:1) participants who lost at least 
5% weight in phase 1 to the control or intervention groups. Participants 
in the intervention group regularly report their body weight and physi-
cal activity through a web-based system compatible with a weight scale 
and activity monitor. Study staff provides personalized feedback based 
on weight and activity for 24 months. The primary outcome is 27-month 
body weight change. 
Results: We recruited participants in 2 cities in Ibaraki Prefecture. In 
Mito, we enrolled 55 eligible participants in September 2014. In phase 
1,49 participants decreased 5% of the baseline weight and were assigned 
to the control (n=25) and intervention (n=24) groups. In Chikusei, we 
enrolled 64 eligible participants in November 2014; their 3-month mea-
surements will be carried out in February 2015. 
Conclusion: We will continue web-based intervention for 24 months and 
test the hypothesis in February 2017.
Reference: 
Nakata Y et al.: Obesity Facts 7;2014:376–87.
T3:PO.119
Physical activity improves functional exercise capacity for 
children and adolescents with obesity
Napituhina I.1, Maslova O.1, Tase I.1, Agadzanjana K.1, Vetra A.1,2, Dzivite-
Krisane I.1,2, Gailite J.1,2
1Children‘s Clinical University Hospital, Riga, latvia,  
2Riga Stradins University, Latvia 
Introduction: Physical activities and education about healthy eating hab-
its are essential for children with obesity. Six Minute Walk Test ( 6MWT) 
is a valuable and practical tool to measure functional exercise capacity in 
children with obesity. 
Methods: Data about anthropometric parameters (weight, height, body-
mass index (BMI), waist circumference), 6MWT, eating habits and phys-
ical activities was collected and analyzed by a multidisciplinary team in 
Children’s Clinical University Hospital (Riga, Latvia) between August and 
November 2014. 
Results: 31 children participated in study, 14 of them girls and 17 
boys. Mean age (years ± SD) for girls was 13.4 ± 2.2, for boys 13.1 ± 2.7 
(p = 0.689). Mean BMI (kg/m˛ ± SD) for girls was 30.0 ± 5.4, for boys 
32.0 ± 5.0 (p = 0.298). No statistically significant difference was found 
between genders in performing the 6MWT, distance for girls was 
582.5 ± 45.4 m, for boys 571.3 ± 75.2 m (p = 0.628). Statistically signifi-
cant difference was found in between walked distance in children with 
physical activity out of school (629.0 ± 57.0m) and children without phys-
ical activity out of school (556.0 ± 57.3 m) ( p = 0.005). 41.2% of children 
without physical activitiy out of school reported regular physical activity 
(running, swimming, bicycle and playing sports games) and 100% of chil-
dren with physical activity out of school reported regular physical activity 
(p = 0.001).
Conclusions: All professionals and parents should ephasise the role of 
physical activity to children and adolescents with obesity.
T3:PO.120
Physical activity patterns in seven european countries 
measured by accelerometer: The food4me study
Marsaux C.1, Celis-Morales C.2, Forster H.3, Fallaize R.4, Kolossa S.5, Navas-
Carretero S.6, Tsirigoti L.7, Surwillo A.8, Hoonhout J.9, Goris A.10, Walsh M.3, 
Manios Y.7, Traczyk I.8, Martinez J. A.6, Lovegrove J. A.4, Daniel H.5, 
Gibney M.3, Mathers J. C.2, Saris W.1
1Department of Human Biology, NUTRIM, Maastricht University, Maastricht, The 
Netherlands, 2Human Nutrition Research Centre, Institute of Cellular Medicine, 
Newcastle University, Newcastle, UK,  
3Institute of Food and Health, University College Dublin, Dublin, Ireland,  
4Hugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and 
Metabolic Research, University of Reading, Reading, UK,  
5ZIEL Research Center of Nutrition and Food Sciences, Biochemistry Unit, 
Technische Universität München, Germany,  
6Department of Nutrition, Food Science and Physiology, University of Navarra, 
Pamplona, Spain,  
7Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, 
Greece,  
8National Food & Nutrition Institute (IZZ), Poland,  
9Experiences Research Department, Philips Research, Eindhoven, The 
Netherlands,  
10Personal Health Solutions, Philips Consumer Lifestyle, Amsterdam, The 
Netherlands
Purpose: To describe physical activity (PA) patterns of the volunteers of 
the Food4Me Proof-of-Principle study; a 6-month pan European web-
based randomized controlled trial on personalized nutrition, using objec-
tive accelerometry data. 
Methods: Out of 1607 volunteers recruited, 1287 (539 men and 748 wom-
en) provided at least 3 weekdays and 2 weekend days of valid accelerome-
ter data at baseline (tri-axial accelerometer: TracmorD, Philips). 
Results: Following adjustment for country and season, men were slightly 
but significantly more active than women (mean physical activity level 
(PAL) ± standard deviation: 1.75 ± 0.19 vs. 1.72 ± 0.17, p < 0.05). High-
er waist circumference was associated with lower PAL, less time spent 
in Moderate to Vigorous PA (MVPA) and more sedentary time (all 
ps<0.001). PAL was not influenced by age, but, in women, MVPA de-
creased whereas light PA increased with age (p < 0.05). Greek women 
had lower PAL and MVPA compared to the other countries (p < 0.05). 
Adherence to the World Health Organization (WHO) recommendations 
to accumulate weekly 150 minutes of moderate PA or 75 minutes of vigor-
ous PA or equivalent MVPA was 58% for men and 40% for women. This 
is higher than in other large cohorts, especially US cohorts. Adherence 
differed by country for women: 54% met the recommendations in Ireland 
but only 22% in Greece (p < 0.05), but not for men. 
Conclusions: Using accelerometers is feasible in a web-based interven-
tion study and we encourage it in large trials. Participants in the Food4Me 
study had relatively high levels of PA but the majority would benefit from 
more PA.
T3:PO.121
Heterogeneity in the energy cost of posture maintenance 
during standing: Does it reside in differential patterns of 
“weight-shifting”?
Miles-Chan J.L.1, Fares E.J.1, Isacco L.2, Charričre N.1, Montani J.P.1, 
Schutz Y.1, Dulloo A.G.1
1Department of Medicine, University of Fribourg, Fribourg, Switzerland,  
2Culture Sport Health Society Laboratory, EA 4660, and Exercise Performance, 
Health, Innovation Platform, Franche-Comte University, Besançon, France
Introduction: Due to the disease risks associated with sedentary be-
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physical activity. In this context, it is a widely-held belief that altering 
posture allocation can modify energy expenditure (EE) to impact upon 
body weight regulation and health. However, we have recently shown 
the existence of two distinct phenotypes pertaining to the energy cost of 
standing – with the majority of individuals having no sustained increase 
in EE during steady-state standing relative to sitting comfortably. Here 
we investigated whether or not these two distinct phenotypes could be 
related to the presence/absence of spontaneous “weight-shifting”, ie., the 
displacement of body weight from one foot to the other in order to mini-
mise discomfort or maintain postural balance. 
Methods: Min-by-min EE was measured during 10 min of standing in 36 
young adults (18 men, 18 women) by facemask indirect calorimetry. Par-
ticipants were asked to stand “naturally” on a dual-balance system, with 
each foot on a separate balance placed a few cm apart. Weight-shifting was 
assessed min-by-min as the delta weight between the two balances. 
Results: The vast majority of participants (83%) showed no sustained in-
crease in EE during the standing period compared to sitting. However, 
there was no discernible relationship between the energetic cost of stand-
ing and the presence/absence of spontaneous weight-shifting. 
Conclusion: Whilst this study reconfirms that the large majority of indi-
viduals maintain sitting and standing postures at the same energetic cost, 
the mechanisms underlying this heterogeneity do not appear to be related 
to the general pattern of weight-shifting.
T3:PO.122
Influence of obesity on decreased deceleration in the 
horizontal direction during ambulation –lifestyle changes in 
obesity and relationship with kinetic characteristics
Kimura A.1
1Department of Health Sciences, Gunma PAZ College, Gunma, Japan 1
Purpose: Increase in body weight during childhood has an important 
influence on the management of obesity in adulthood. Although we pre-
viously reported a lack of deceleration in the horizontal direction during 
a small clockwise turn in obese children, the influence of participant char-
acteristics and life stage remains uncertain. This study aimed to clarify 
the effect of lifestyle changes on the kinetic characteristics of this lack of 
horizontal deceleration.
Method: This study consisted of an experimental design. Participants 
were recruited using notices posted in the university and excluded if they 
had no previous specialized training for the lower leg muscles. Of the 10 
men (median age, 21 years) that participated, 6 men were in the obese 
(O) group, and 4 men were in the non-obese (NO) group. Median (range) 
weight, height, and body mass index were 93.5 (88.5–100.4) kg, 171 (168–
178) cm, and 31.8 (30.9–33.8) kg/m2, respectively, in the O group and 67.5 
kg, 170 (162–179) cm, and 22.7 (21.5–26.5) kg/m2, respectively, in the NO 
group. The participants were asked to walk on an elliptical track with a mi-
nor axis of 50 cm and major axis of 100 cm for 30 seconds in a clockwise 
direction at their own chosen speed. A force plate (PS-2142, Shimadzu, 
Japan) was placed in the 9-o‘clock position to record the force applied in 
the outward direction, and the power in the horizontal and vertical direc-
tions was measured. 
Results: Increased frequency of carbohydrate beverage intake between 9 
and 18 years old and decreased frequency of physical activity at 12 years 
old (B = -63.5, 95% CI = -78.6 to –48.6.) significantly influenced the 
movement in the horizontal direction in the obese participants.
Conclusion: The age at which movement and intake of carbohydrate-con-
taining drinks decreased had a significant influence on the lack of deceler-
ation in the horizontal direction of a circumferential movement in obese 
participants.
Acknowledgement: Thank you, Everyone who participated in this study.Part of this 
study I received a research grant of Gunma PAZ College.
T3:PO.123
A socio-ecologically framed, school-based physical activity 
intervention has beneficial effects on obesity outcomes in 
adolescents from low ses communities: The pa4e1 rct
Hollis J.L.1,2, Sutherland R.1,2,3, Campbell L.1,2,3, Morgan P.4, Lubans D.4, 
Nathan N.1,2,3, Wolfenden L.1,2,3, Okely T.5, Davies L.1, Gilham K.1,3, Cohen K.4, 
Wiggers J.1,2,3
1Hunter New England Population Health, Locked Bag 10, Wallsend, Australia,  
2School of Medicine and Public Health, University of Newcastle, Australia,  
3Hunter Medical Research Institute, Lambton, Australia,  
4Priority Research Centre in Physical Activity and Nutrition, University of 
Newcastle, Australia,  
5Early Start Research Institute and Illawarra Health and Medical Research 
Institute, University of Wollongong, Australia
Objective: One quarter of adolescents are overweight or obese, with the 
prevalence higher among adolescents from low socio-economic status 
(SES). Physical Activity 4 Every1 (PA4E1) is a 24-month physical activity 
intervention implemented in secondary schools from lower SES commu-
nities that aimed to reduce the decline in physical activity experienced 
during adolescence. This study reports the 12-month mid-intervention ef-
fects of PA4E1 on the secondary outcomes of weight, waist circumference 
and body mass index (BMI). 
Methods: A cluster randomized controlled trial was conducted in 10 
secondary schools located in low SES communities in New South Wales, 
Australia (1237 students, mean age 12 years, 48% boys). The school-based 
intervention was guided by socio-ecological theory and included seven 
physical activity strategies and six implementation strategies. The second-
ary outcomes included weight, waist circumference and BMI. Data was 
analysed using linear mixed models adjusting for school clustering. 
Results: A total of 959 (78%) students provided anthropometric data 
at baseline and 640 (52%) at mid-intervention. There was a significant 
group-by-time effect in favour of the intervention group for mean differ-
ence (95% CI) in body weight (-0.65kg [-1.26 to –0.05], p = 0.04), waist 
circumference (-1.15cm [-1.98 to –0.32], p≤0.01) and BMI (-0.28kg/m2 
[-0.49 to –0.07], p = 0.01). The intervention resulted in significant effects 
on male student’s BMI (-0.33kg/m2 [-0.63 to –0.02], p = 0.04) and female 
students’ waist circumference (-1.85cm [-3.00 to –0.70], p≤0.01). 
Conclusion: A socio-ecologically framed, multicomponent school-based 
physical activity intervention that increases adolescents’ physical activity 
may assist in preventing overweight and obesity in low SES adolescents.
T3:PO.124
Inflammation is related to worse self-perceived fatigue in 
obese boys and girls
Tresignie J.1, Vantieghem S.1, Provyn S.1, Bautmans I.2
1Department of Experimental Anatomy, Vrije Universiteit Brussel, Brussels, 
Belgium,  
2Department of Frailty in Ageing, Vrije Universiteit Brussel, Brussels, Belgium 
Introduction: In obesity, adipocyte dysfunction contribute to elevated 
circulating levels of C-reactive protein (CRP), an important marker for 
inflammatory burden. Inflammation is a well-known contributor to fa-
tigue sensations in several diseases; but its role in obesity-related fatigue 
remains unclear. This study examined the relationship between circulat-
ing hs-CRP and self-perceived fatigue in obese adolescents. 
Methods: 237 obese adolescents (140 girls and 97 boys; 15 ± 2 years) 
were examined for heart rate, blood pressure, body composition (DXA) 
and self-perceived fatigue (Multidimensional Fatigue Inventory, MFI-
20). Blood samples were collected and analyzed for hs-CRP, triglycerides 
(TG), cholesterol (CH), high density lipoproteins (HDL) and low density 
lipoproteins (LDL). Correlations were computed corrected for gender and 
age. 
Results: Higher hs-CRP was significantly related to higher body weight, 
BMI, heart rate and sys BP (resp r=0.17; r=0.24, r=0.19 and r=0.16; 
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self-perceived fatigue (subscale total fatigue r=0.15, general fatigue r=0.16 
and physical fatigue r=0.17; all p < 0.03) and fat parameters (segmental 
and total fat; all r>0.22; all p < 0.001). Despite the fact that hs-CRP was 
related to fat parameters no relations were found for hs-CRP and blood 
lipid levels. 
Conclusion: Based on our results we conclude that higher hs-CRP is not 
only related to fat accumulation and cardiovascular risk factors, but also 
related to worse self-perceived fatigue in obese adolescents.
T3:PO.125
The impact of a 6 week exercise programme on cardiovascular 
fitness in obese individuals attending the Rotherham Institute 
for Obesity (RIO)
Walker L.1, Reale S.1, Capehorn M.1
1Rotherham Institute for Obesity (RIO)
Introduction: Obesity coupled with an association of cardiovascular dis-
ease has caused an increased risk of mortality worldwide. For this reason, 
the assessment of cardiovascular fitness may be useful to help assess CVD 
risk, and in order to provide appropriate and tailored advice for physical 
activity. 
Methods: 46 participants (age=36.7 +/- 20.6 yrs; BMI=36.1 +/- 7.2 kg/
m2) who were attending the on-site gym at the Rotherham Institute for 
Obesity (RIO) completed the Ebelling Protocol, a single stage submaxi-
mal walking test used to calculate predicted maximal oxygen uptake (VO2 
max), at baseline and at 6 weeks. The Ebelling Protocol was used as maxi-
mal testing is not recommended for obese populations, as it is not feasible 
for those who may be limited by pain or fatigue, and increases the risk of 
cardiac events. Data was analysed with parametric tests, descriptive statis-
tics and paired t-tests (t) to compare mean values. 
Results: Following 6 weeks attendance at the RIO gym, resting heart rate 
significantly decreased from 85.1bpm to 76.8bpm (t=5.98, P < 0.001) and 
VO2 max significantly increased from 34.2 ml/kg min to 36.7 ml/kg min 
(t=-4.86, P < 0.001) in comparison to baseline. Furthermore, there was a 
significant increase in self-selected speed (t=-7.46, P < 0.001) and overall 
decrease in rate of perceived exertion (RPE), which was significant for 
those who remained at the same speed (n=17, t=2.13, P = 0.4). 
Conclusion: Results support the inclusion of exercise in a weight manage-
ment programme, facilitating significant improvements on cardiovascular 
fitness. The reduced RPE suggests that individuals may be able to work 
harder and that the exercise is more manageable.
T3:PO.126
Effect of submaximal exercise on muscle carnosine: The role of 
carnosine supplementation
Ukropec J.1, Just-Kukurova I.2, Krumpolec P.1, deCourten B.4, Sedliak M.5, 
Valkovic L.2, Vajda M.5, Vlcek M.1, Derave W.6, Aldini G.7, Krssak M.2,3, 
Ukropcova B.1,8
1Institute of Experimental Endocrinology Slovak Academy of Sciences, 
Bratislava, Slovakia,  
2MR Centre of Excellence, Department of Radiology, Medical University of 
Vienna, Austria,  
3Department of Internal Medicine III, Medical University of Vienna, Austria,  
4Monash Centre for Health, Research and Implementation, School of Public 
Health and Preventive Medicine, Melbourne, Australia,  
5Faculty of Physical Education and Sport, Comenius University, Bratislava, 
Slovakia,  
6Department of Movement and Sport Sciences, Ghent University, Belgium,  
7Department of Pharmaceutical Sciences, Universitŕ degli Studi di Milano, Italy,  
8Faculty of Medicine, Comenius University, Slovakia
Introduction: Carnosine (β-alanyl-L-histidine) is a dipeptide abundant 
in skeletal muscle, with the ability to quench reactive carbonyl species, 
reduce metabolic and exercise-related stress and to improve muscle per-
formance. 
Methods: The effect of submaximal 1 hour run on carnosine levels in 
muscle was studied, before and after 2 months of carnosine supplemen-
tation (2g/day), in 7 male recreational runners/cyclists (age 34.0 ± 1.4y, 
BMI 22.2 ± 0.48 kg.m-2, VO2max 46.8 ± 1.9 ml.kg-1.min-1) applying 
1H-MRS on 7T MR system (Magnetom, Siemens). Muscle carnosine 
measurement was performed before one hour lasting run (11.4 ± 0.4km) 
and repeated twice immediately after the run. Measurements of maximal 
aerobic capacity (VO2max, bicycle ergometry), muscle strength (leg-press 
dynamometer) & habitual physical activity (accelerometer) were also per-
formed before and after the supplementation. 
Results: Carnosine supplementation was associated with 17% (p < 0.05) 
increase in muscle strength, while VO2max & muscle carnosine con-
tent did not change. Supplemented individuals favored glycolytic ener-
gy sources during the maximal load as evidenced by higher respiratory 
quotient. Interestingly, muscle carnosine was negatively associated with 
ambulatory activity (steps /h; r=-0.65, p = 0.02) and vigorous physical 
activity (>8MET, min/day; r=-0.65, p = 0.02). The magnitude of muscle 
carnosine change after the run was, however, positively associated with 
volume (steps /h; soleus m. r=0.64, p = 0.03) and dynamics of habitual 
physical activity (r=0.7, p = 0.01). 
Conclusion: Carnosine supplementation increased muscle strength and 
glycolytic energy utilization during the maximal intensity exercise. The 
positive association of running-induced change in muscle carnosine 
with the volume and intensity of habitual ambulatory activity indicate 
increased carnosine turnover in muscle of physically active individuals.
Acknowledgement: VEGA 2/0192/14, SAIA SK-AT 2013-10-15-0004
T3:PO.127
Moderate to vigorous physical activities during physical 
education lessons, according to gender and body mass index
Ribeiro J.1, Ribeiro J.R.1,2, Silva G.1
1Research Centre in Physical Activity, Health and Leisure, Sports Faculty, 
University of Porto, Portugal,  
2EB 2,3 Gil Vicente, Guimarăes, Portugal 
Introduction: Current recommendations for PA, in school-aged children 
and adolescents, advocate 60 minutes of daily Moderate to Vigorous in-
tensity PA (MVPA). The school, through physical education lessons (PE), 
plays a major role in the promotion and practice of PA. This study seeks 
to analyse, comparatively, levels of PA and the relative contribution of 45 
and 90 minutes PE lessons to achieve daily recommendations for MVPA, 
particularly by gender, age, and weight status. 
Methods: Sample consisted of 266 students, aged 10–17 years, belonging 
to an educational establishment of Guimarăes, Portugal. BMI and body 
fat percentage were collected. We used the ActiGraph´s accelerometer‘s 
wGT3X-BT during PE lessons, in a total of 23 classes. Standard cut-off 
points were used for accelerometers. 
Results: The results suggest that the percentage of MVPA are approxi-
mately equal in 45 and 90 minutes classes (26.7 vs. 26.6 45 min classes 
contribute about 13.3% of 60 minutes a day recommended for MVPA and 
90 min lessons with 33.3 ±10.7%; In classes of 45 and 90 minutes, boys 
accumulate more MVPA and less sedentary PA compared to the girls; In 
45 min lessons, only light PA, are statistically higher than in girls, and 
with similar results when overweight students are compared with nor-
mal weight. Boys, in MVPA, with overweight showing statistically higher 
results than those with normal weight; In 90 min class, only in the vig-
orous activities, girls with normal weight have statistically higher results 
than those with overweight/obesity. Age, BMI and percentage of fat mass 
were inversely related to the time in moderate to vigorous physical activity 
during 45 and 90 min classes. 
Conclusions: Only for classes of 90 minutes, positive correlations were 
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T3:PO.128
Increasing physical activity in children for obesity prevention: 
An innovative methodology using accelerometers
Lecerf J.M.1, Duclos M.4, Brissieux E.1, Bournez C.2, Mayer J.3, Borys J.M.3
1Institut Pasteur Lille,  
2Communaute de Communes Flandre Lys,  
3EPODE International Network,  
4CHU Clermond Ferrand
Introduction: To date, the methods used to measure physical activity 
(PA) in children and adolescents often lead to missing or non-precise 
data. This study provides encouraging results on children participation 
rate and measure of PA, using 3D accelerometers. 
Methods: In the EPODE France community-based programme, 7 facil-
itators were recruited to provide bi-weekly PA sessions to children for 7 
weeks, using a kit including 6 different activities. 215 children aged 8 to 
11 were recruited, from which 124 composed the control group and 91 
the action group. Each child received a 3D accelerometer wristband. Mea-
surement of the children PA was made once a week for 14 weeks (during 
the PA sessions and for 7 weeks after the PA sessions) thanks to the accel-
erometers. In parallel, the children completed a questionnaire on their PA 
habits, screen time and sleeping habits. 
Results: The children participation rate in the sessions and motivation 
is high. First measures of PA level indicate that using an accelerometer 
is an interesting and accurate way to collect data on physical activity in 
children. The formal agreement between the community stakeholders en-
abled the researchers to regularly collect data using the accelerometers 
and the questionnaires. 
Conclusion: Expected results are a 10-minutes increase of the children dai-
ly physical activity, 7 weeks after the end of the physical activity sessions.
T3:PO.129
Knowledge and Beliefs Saudi Female School Teachers on 
Physical Activity Participation by Girls.
Alarfaj G.1, Tigbe W.W.1
1Division of Health Sciences, Warwick Medical School, Un Warwickiversity of 
Background: With the recent shift towards urbanization in Saudi Ara-
bia, physical inactivity and sedentary lifestyle have become predominant, 
particularly among children and adolescent1. Concurrently, obesity levels 
have risen seven-fold between 1988 and 20052. Some level of knowledge 
of the anticipated reward is required to motivate the effort required to par-
ticipate in regular physical activity18,33. Aim: This study explored pos-
sible barriers behind physical inactivity in female students by assessing 
female teachers’ knowledge of physical activity. 
Methods: A validated questionnaire was administered and focused group 
discussions were held with female teachers of Al-Abna’a Schools in Ri-
yadh, Saudi Arabia. 
Results: The study found that the majority of teachers believed that phys-
ical activity was important for children and that girls should have physical 
exercise classes in school. However, teachers’ levels of knowledge on phys-
ical activity recommendations for children was low. Barriers for regular 
physical activity in children were reported lack of social and parental sup-
port, children’s low interest in physical exercise, and lack of sports facili-
ties suitable for young girls. 
Conclusion: Saudi female schools have only female teachers. Therefore, a 
programme to improve physical activity particpation by girls will require 
a comprehensive physical activity education for these female teachers as 
a start.
Acknowledgement: The study was funded by the Saudi Government.
References:
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T3:PO.130
Does objectively quantified physical activity level 
independently predict nafld and visceral obesity?
Keating S.E.1, Parker H.M.1, Baker M.K.2, George J.3, Johnson N.A.1,4
1Discipline of Exercise and Sport Science, University of Sydney, Sydney, 
Australia,  
2School of Exercise Science, Australian Catholic University, Sydney, Australia;,  
3Storr Liver Unit, Westmead Millennium Institute, University of Sydney, Sydney, 
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4Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, Charles 
Perkins Centre, University of Sydney, Sydney, Australia
Introduction: Epidemiologic studies have suggested a negative relation-
ship between nonalcoholic fatty liver disease (NAFLD), visceral adipose 
tissue (VAT) and self reported physical activity levels, but this subjective 
measurement can be inaccurate and prone to reporter bias. We aimed to 
investigate whether objectively measured physical activity predicted NA-
FLD and VAT in overweight/obese adults. 
Methods: Habitual physical activity levels were measured via accelerome-
tery (SensewearTM) across four days (three weekdays and one weekend) 
during an 8-week period. Average daily time spent in sedentary behaviour 
(MET<1.6), light (MET 1.6<3), and moderate (MET 3<5.9) activity was 
quantified (BodyMedia software, v8.0). Liver fat was assessed via proton 
magnetic resonance spectroscopy and VAT volume via magnetic reso-
nance imaging. Bivariate correlations and hierarchical multiple regression 
analyses were performed with reference to prediction of liver fat percent-
age and VAT. 
Results: Preliminary data (n=72) showed a significant correlation between 
VAT and sedentary behaviour (p = 0.008) and moderate activity levels 
(p = 0.006) but not between liver fat and any level of activity (p > 0.05). 
Regression analysis revealed that age, gender and the addition of known 
risk factors for obesity related-NAFLD accounted for 49% and 26% of the 
variance in VAT and liver fat respectively (p < 0.01). Adding sedentary 
and moderate physical activity levels to the model only accounted for a 
further 1% of variance for VAT (p = 0.24) and reduced it by 3% for liver 
fat. 
Conclusion: Objectively measured levels of habitual physical activity and 
sedentary behaviour did not improve the overall capacity of known obe-




Associations between sleep patterns and lifestyle behaviors in 
children: An international comparison
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Introduction: The objective was to examine the associations between 
sleep patterns and lifestyle behaviors in children from 12 countries repre-
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Methods: The sample of this multi-national cross-sectional study comprised 
5,777 children aged 9–11 years from sites in Australia, Brazil, Canada, China, 
Columbia, Finland, India, Kenya, Portugal, South Africa, United Kingdom 
and United States. Sleep duration (h/day), sleep efficiency (%) and bedtime 
(h:min) were measured over 7 days using an accelerometer (validated 24-h 
waist-worn protocol). Outcome measures included moderate-to-vigorous 
physical activity (MVPA), total sedentary time (SED), self-reported screen 
time (ST), and healthy/unhealthy eating patterns (HEP/UEP). 
Results: Overall, participants averaged 8.8 (SD 0.9) hours of sleep per day 
with 96.2 (SD 1.4) % sleep efficiency and a mean bedtime of 22:18. After 
adjustment for age, sex, highest parental education and BMI z-score, re-
sults showed that (i) sleep duration was negatively associated with MVPA, 
SED and UEP score, and positively associated with HEP score; (ii) sleep 
efficiency was negatively associated with MVPA and positively associated 
with SED; and (iii) bedtime was positively associated with ST and UEP 
score, and negatively associated with HEP score. Results also showed that 
some of the associations between sleep patterns and lifestyle behaviors 
were different between study sites. 
Conclusion: Sleep characteristics are important correlates of lifestyle be-
haviors in children, especially sleep duration and bedtime. Differences be-
tween countries suggest that interventions aimed at improving sleep and 
lifestyle behaviors should be culturally adapted.
T3:PO.132
Is Obstructive Sleep Apnea Level Related with Anthropometric 
Measurements and Body Composition?
Celebi F.1, Toka O.2, Kokturk O.3, Rakicioglu N.4
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey,  
2Department of Statistics, Faculty of Sciences, Hacettepe University, Ankara, 
Turkey,  
3Department of Chest Diseases, Faculty of Medicine, Gazi University, Ankara,  
4Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe 
University, Ankara, Turkey
Introduction: Obesity is associated with Type 2 diabetes, hypertension, 
cardiovascular diseases, obstructive sleep apnea syndrome (OSAS). In this 
study, it was aimed to examine body composition and some anthropomet-
ric measurements of individuals who have different OSAS classification. 
Methods: This research was carried out on 105 patients (74 males, 31 fe-
males) , who got diagnosed with OSAS, aged 19–64 years, in Sleep Disor-
ders Center of Gazi University Faculty of Medicine. The classification of 
OSAS was done according to Apnea Hypopnea Index (AHI). The mea-
surements of body weight, height, waist and hip circumference, neck cir-
cumference were taken and body composition was analyzed. 
Results: In this study, the ratio of individuals whose BMI ≥30 kg/m2 was 
60.0% of patients. The percentage of obesite was found to be 48.38%, 
56.67% and 70.45% in patients with mild, moderate and severe OSAS, 
respectively. The mean body mass index (BMI) and neck circumference 
(cm) values with severe OSAS were found higher than moderate OSAS 
in male (p < 0.05). In women, the mean waist circumferences, BMI and 
body fat percentages were found higher in severe OSAS than mild OSAS 
(p < 0.05). AHI was correlated with fat mass (kg) in males (r=0.327) and 
BMI in females (r=0.505) more than the other anthropometric measure-
ments. Oxygen saturation (SaO2) was found higher correlated with body 
fat percentage in males (r=0.472) and fat mass in females (r=0.717) than 
the other anthropometric measurements. 
Conclusion: It was concluded that body composition parameters were 
related to OSAS. The percentage of obesity was found to be higher in indi-
viduals with OSAS. The correlation between body composition and some 
anthropometric measurements were seen differences according to gender 
and OSAS levels.
T3:PO.133
Heart rate variability non-linear dynamics in obese patients 
during wakefulness and sleep
Cabiddu R.1, Trimer R.1, Henriques J.2, Paredes S.2, Mendes R.G.1, 
Oliveira Jr A.D.3, Costa F.S.3, Bianchi A.M.4, Borghi-Silva A.1
1Cardiopulmonary Physiotherapy Laboratory, Federal University of Săo Carlos, 
Săo Carlos, Săo Paulo, Brazil,  
2CISUC, Centro de Informática e Sistemas da Universidade de Coimbra, Coimbra, 
Portugal,  
3Sleep Institute of Săo Carlos, Săo Carlos, Săo Paulo, Brazil,  
4DEIB, Politecnico di Milano, Milano, Italy
Introduction: Obesity is accompanied by altered cardiovascular (CV) 
dynamics, associated with increased mortality risk [1]. Given the CV sys-
tem non-linear nature, by analyzing the HRV complexity it is possible to 
assess the functionality of the underlying regulation system, with high-
er complexity suggesting better adaptability [2]. The dynamics of HRV 
complexity were hereby investigated during wakefulness and sleep, a state 
characterized by important CV changes, in healthy and obese subjects. 
Methods: Seven obese patients and seven controls underwent overnight 
polysomnography. For each subject the electrocardiogram (ECG) was ac-
quired and the tachogram was extracted; the Detrended Fluctuation Anal-
ysis (DFA) and Sample Entropy (SE) indices were calculated on ten-min-
ute tachogram portions selected during wakefulness and sleep. 
Results: Results are shown in Fig. 1. Both during wakefulness and sleep, 
the indices are significantly higher (p-value < 0.05) in the controls than in 
the obese patients. Both indices are higher during sleep for both groups, 
significantly for the obese population. 
Conclusions: Significantly reduced complexity was observed in the obese 
group during wakefulness and sleep, possibly attributable to a regulato-
ry mechanism breakdown. The higher complexity observed in the obese 
group during sleep is indicative of a CV regulation change and should 
be further investigated. Our results suggest that obesity can be associated 
with impaired CV control. Further studies should quantify altered HRV 
complexity impact on CV mortality in obesity.
Acknowledgement: The reserach hereby presented was supported by CAPES, Pro-
grama Atraçăo de Jovens Talentos, project nş 88881.062123/2014-01; Project Car-
dioRisk (FCT PTDC/EEI-SII/2002/2012)
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1  J. Jiang et al.: Association of obesity with CV disease mortality in the PLCO 
trial. Prev Med, 2013.
2  M. Costa et al.: Multiscale entropy analysis of complex physiologic time series. 
Phys. Rev. Lett. 89:068102, 2002.
Fig. 1. a) DFA and b) SE mean values (± SD) during wakefulness and sleep, for the 
control and the obese groups. *
denotes significant difference (p < 0,05) when compared with control 
group; # denotes significant difference (p < 0,05)
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T3 – Sugar and artificial sweeteners
T3:PO.134
Rare sugar d-allulose prevents progression and development 
of diabetes in type 2 diabetes mellitus (t2dm) model otsuka 
long-evans tokushima fatty (oletf) rats
Hossain A.2, Sui L.1, Yamaguchi F.1, Kamitori K.1, Dong Y.1, Tsukamoto I.1, 
Iida T.1
1Department of Cell Physiology, Faculty of Medicine, Kagawa University, 
Kagawa, Japan, 
2Matsutani Chemical Industry Co., Ltd., Hyogo, Japan 
Background: Prevalence of obesity has emerged as single most 
life-style-related health problem, mostly due to excess calorie leading to 
one of its complications, insulin resistance followed by concomitant in-
crease in T2DM. To cope with increased demand of insulin pancreatic 
-cells become hypertrophic leading to failure followed by glucose in-
tolerance. The situation demands age-adjusted balanced food intake. 
Objectives: We introduce a zero-calorie sweet-taste monosaccharide, 
D-allulose, rare in nature and produced through enzymatic conversion 
in Kagawa University, Japan. D-allulose has been evaluated as a unique 
metabolic regulator of hyperglycemia and hyperlipidemia. 
Methods: Treated OLETF rats fed 5% D-allulose where control OLETF 
and non-diabetic healthy control, LETO were fed water only. Body weight, 
food and drink intake were measured weekly, blood glucose and insulin 
monthly. Oral glucose tolerance test was performed. Liver, pancreas and 
other organs were preserved and stained. 
Results: D-allulose controlled abdominal fat accumulation and thus pre-
vented excess body weight increase. D-allulose improved insulin resis-
tance through maintenance of fasting, random and OGTT blood sugar 
levels. It also significantly attenuated progressive β-islet fibrosis and pre-
served islets, evaluated by HE and Masson’s staining and immunostaining 
of insulin, glucagon and α-smooth muscle actin. Serum levels of pro-in-
flammatory and anti-inflammatory adipokines were also controlled well 
by D-allulose. Among several mechanisms of the activity of D-allulose 
against both hyperglycemia and hyperlipidemia strong anti-inflammatory 
activities were prominent. 
Conclusion: Rare sugar D-allulose might be a promising strategy for the 
prevention of obesity and, commencement and prevention of T2DM.
T3:PO.135
Acute metabolic and cardiovascular responses of healthy 
young adults to the ingestion of galactose - the forgotten 
sugar
Charriére N.1, Montani J.P.1, Dulloo A.G.1
1Department of Medicine/Physiology, University of Fribourg, Fribourg, 
Switzerland 
Background: Overconsumption of refined sugars has been implicated 
in the development of obesity and cardiovascular diseases, with fructose 
considered as a more damaging monosaccharide than glucose - in part 
attributed to its greater de-novo lipogenic and blood pressure elevating 
effects. Little is known, however, concerning the metabolic and cardio-
vascular effects of galactose – another monosaccharide (derived from 
lactose). We investigated here, at rest, the extent to which blood pressure 
(BP), energy expenditure (EE) and respiratory quotient (RQ) in response 
to galactose differ from those of glucose and fructose. 
Methods: In a randomized cross-over design, 12 healthy young men 
and women of normal BMI attended 3 separate morning sessions during 
which continuous cardiovascular and indirect calorimetry monitoring 
were performed while sitting comfortably for at least 30 min before and 
150 minutes after ingestion of 500 mL of water containing 60g of either 
glucose, fructose or galactose. 
Results: Fructose ingestion elicited significant increases in both systolic 
and diastolic BP (p < 0.001) compared to little or no changes in BP after 
ingestion of glucose or galactose. EE increased to a similar extent after 
each of the three sugar drinks reaching similar peak values in about an 
hour, but its subsequent fall towards baseline values was faster with galac-
tose and glucose than with fructose (p < 0.05). RQ increased with all three 
sugars, but to a much greater extent with galactose and fructose than with 
glucose (p < 0.001). 
Conclusion: The kinetics of postprandial changes in BP and EE in re-
sponse to galactose are similar to those for glucose, while galactose-in-
duced increase in RQ (reflecting greater carbohydrate oxidation and/or 
de-novo lipogenesis) is closer to that for fructose.
T3:PO.136
Effect of sweetness intensity on ad libitum intake of 
milkshake, appetite, and subsequent snack intake
Yin T.W.1, Fisk I.D.1, Taylor M.A.2, Hewson L.1
1Department of Food Sciences, School of Biosciences, Faculty of Science, 
University of Nottingham, Sutton Bonington Campus, LE12 5RD, UK,  
2Faculty of Medicine & Health Sciences, University of Nottingham, Queen’s 
Medical Centre, NG7 2UH, UK
Introduction: Overconsumption of sugar-sweetened beverages is linked 
to obesity. Previous studies on the effect of sweetness intensity on satiation 
have been conflicting. It may be that sweetness intensity and palatability 
were confounded in these studies. Higher sweetness may lead to faster 
satiation due to increased sensory exposure [1]. However, the high palat-
ability of sweet food may trigger overeating [2]. Our primary objective is 
to investigate if sweetness intensity affects ad libitum intake of milkshake, 
while palatability is controlled. The second aim is to investigate if sweet-
ness intensity in milkshake affects subsequent snack intake. 
Methods: 26 females consumed ad libitum low, ideal, and high sweet-
ness milkshakes (LSM, ISM and HSM) varying in the concentration of 
Canderel Granules sweeteners on 3 mornings. Sweetness intensities were 
selected individually by subject. LSM and HSM were similarly pleasant 
while ISM was the most pleasant. Subjects consumed ad libitum salty and 
sweet snacks following the milkshake. Hunger, desire for sweet and desire 
for salty food was rated before and after milkshake and snack intake. 
Results: After consuming milkshakes, the desire for sweet food decreased 
(p < 0.05) whilst the desire for salty food was unchanged. Subjects con-
sumed more salty snacks than sweet snacks (p < 0.05). There was no sig-
nificant effect of sweetness intensity on intake of milkshake or appetite 
ratings. 
Conclusion: Sweetness intensity did not affect ad libitum intake of milk-
shake, appetite or subsequent snack intake, despite of similar or different 
palatability.
References:
1.  Bolhuis, D.P., Lakemond, C.M.M., de Wijk, R.A., Luning, P.A., de Graaf, C., (2010) 
Chem Senses,35:789–799. 
2. Yeomans, M.R., (1998) P Nutr Soc,57:609–615.
T3:PO.137
Sugar-sweetened beverages and obesity among children and 
adolescents: A review of systematic literature reviews
Keller A.2, Bucher Della Torre S.1
1University of Applied Sciences Western Switzerland (HES-SO), School of Health, 
Geneva (HEdS-GE), Nutrition and Dietetics Department, Switzerland,  
2Research Unit for Dietary Studies, Institute of Preventive Medicine, Bispebjerg 
and Frederiksberg Hospitals, Frederiksberg, Nordre Fasanvej 57, 2000 
Frederiksberg, Denmark
Introduction: The prevalence of overweight and obesity among children 
and adolescents has increased worldwide and has reached alarming pro-
portions. Currently, sugar-sweetened beverages (SSB) are the primary 
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dictive findings from studies and reviews have fuelled an endless debate 
on the role of SSBs in the development of childhood obesity. The primary 
aim of the present review of reviews was to assess how review-level and 
study-level methodological factors explain conflicting results across re-
views and meta-analyses by providing an up-to-date synthesis of recent 
evidence regarding the association between SSB consumption and weight 
gain, overweight and obesity in a population of 6-month to 19–year-old 
children and adolescents. The secondary aim was to assess the quality of 
included reviews using the AMSTAR measurement tool. 
Method: Systematic reviews and meta-analyses were included. The liter-
ature search was performed through the platforms Pubmed, Cinahl and 
Web of Knowledge. 
Results: Thirteen reviews and meta-analyses were included. Nine reviews 
concluded that there was a direct association between SSBs and obesity in 
children and adolescents and four others did not. The quality of the in-
cluded reviews was low to moderate and the two reviews with the highest 
quality scores showed discrepant results. 
Conclusion: The majority of reviews concluded that there was a direct 
association between SSB consumption and weight gain, overweight and 
obesity in children and adolescents. However, recent evidence from well 
conducted meta-analyses shows discrepant results.
T6 – Environmental/ecological  drivers
T6:PO.001
Fitness and food environments around junior high schools in 
taiwan and their association with body composition: Gender 
differences for recreational, reading, food and beverage 
exposures 
Chiang P.H.1, Huang L.Y.1, Tsou H.C.1, Yeh H.L.1, Chang Y.C.1, Lee M.S.2, 
Wahlqvist M.L.1,2
1Division of Preventive Medicine and Health Services Research, Institute of 
Population Health Sciences, National Health Research Institutes,  35 Keyan Road, 
Zhunan Town, Miaoli County 350, Taiwan, ROC.,  
2School of Public Health, National Defense Medical Center, No.161, Sec. 6, 
Minchuan East Road, Taipei, Taiwan 114, ROC.
Introduction: In early adolescence personal behaviours, reproductive 
physiology and body composition (BC) change and the school environ-
ment may contribute. We investigated determinants of energy balance and 
nutritional status during child development by mapping. 
Methods: The Nutritional and Health Survey in Taiwan (2010) for 1458 
junior high school students was geo-mapped for 30 school environs. Fa-
cilities for physical activity (fitness centers, gymnasia and sports stadiums, 
activity centers and parks), sedentary activities (reading material rental 
shops (RMRS), internet cafes) and food and beverage outlets were cal-
culated as weighted numbers within 1000 m of schools. Multiple linear 
regressions were used to predict BC variable z-scores. 
Results: For boys, higher fitness center densities and, for girls, gymna-
sia and sports stadiums were associated with less abdominal fatness. For 
girls, body mass index, waist circumference (WC) and triceps skinfold 
thickness (TSF) were greater when RMRS density was higher as was TSF 
with internet café density. Where there were no food and beverage outlets, 
boys’ WC and TSF were less with more parks, but girls were shorter and 
WC more adverse. With greater RMRS density and no FBOs, girls still had 
increased WC/Hip ratio, and less mid-arm muscle circumference. Boys’ 
findings were more evident after considering puberty. 
Conclusion: Physical activity facilities in school environments favour health-
ier adolescent body composition, but differently for boys and girls. Food and 
beverage outlet absence increases the likelihood of healthier BC for boys.
Acknowledgement: The present study was funded internally by the National Health 
Research Institutes in Taiwan. Prof Wen-Harn Pan is the coordinator of the Nutri-
tion and Health Surveys in Taiwan (NAHSIT) on which the project was based.
T6:PO.002
Association between obesity in a social context and autism 
and other neurodevelopmental disorders 
Yamazaki T.1, Tajima K.1, Sokejima S.1
1Epidemiology Centre for Disease Control and Prevention, Mie University 
Hospital, Japan 
Background: Several studies reported risk factors for autism and oth-
er neurodevelopmental disorders (AND) in children, such as mater-
nal smoking, age and metabolic condition. However, other risk factors, 
particularly impacts of social determinants on AND remain unclear. We 
therefore examined the association between obesity at community level 
and AND in children. 
Methods: We conducted a cross-sectional study in 2014, which recruited 
citizens aged 20 years or older of two towns in central Japan. A self-admin-
istered questionnaire was used to assess possible confounding factors such 
as age, body mass index (BMI), smoking habit and household income. A 
composite outcome of AND was used, which consists of their children’s 
history of pervasive developmental and other three neurodevelopmental 
disorders. To adjust for demographic and possible confounding factors 
and to investigate the contextual effect of obesity at the community level, 
a mixed- effects logistic regression model was performed. Mean BMI in 
each dwelling area was entered into the model as a random effect. 
Results: 5,272 female who had at least one child were included. Individ-
uals with missing data or outliers of age and BMI were excluded. Finally, 
5,095 female were analysed. Prevalence of AND was estimated as 1.4%. 
In the final model, maternal age was associated with AND. However, the 
other individual factors and mean BMI at the community level were not 
associated. 
Conclusion: In the cohort, we did not find any association between obe-
sity at the community level and AND in children. However, we would 
need to conduct further investigation into impact of social determinants 
on neurodevelopmental disorders like other diseases.
T6:PO.003
Urinary phthalate metabolites are associated with insulin 
resistance in obese subjects 
Dirinck E.1, Dirtu A.C.2, Geens T.2, Covaci A.2, Van Gaal L.1, Jorens P.3
1Department of Endocrinology, Diabetology and Metabolism, Antwerp 
University Hospital, Edegem, Belgium, University of Antwerp, Antwerp, 
Belgium,  
2Toxicology Centre, University of Antwerp, Antwerp, Belgium,  
3Department of Clinical Pharmacology, Antwerp University Hospital, Edegem, 
Belgium, University of Antwerp, Antwerp, Belgium
Introduction: Commonly used chemicals such as phthalates have come 
under scrutiny for their potential causative role in type 2 diabetes devel-
opment1. 
Methods: 123 obese subjects were recruited. Data were collected on phys-
ical activity level (PAL), medication use and smoking. Body mass index 
(BMI), 24-hour urine collection, a fasting blood sample and an OGTT 
were obtained. Several fasting and OGTT based estimates of insulin resis-
tance and beta-cell function were calculated. Analysis of 10 major phthal-
ate metabolites (PM) was performed2. The relationship between PM and 
estimates of insulin resistance and beta-cell function was assessed using 
regression analysis, the first adjusting for gender, the second adjusting for 
gender, age, PAL, smoking, medication use and BMI. 
Results: Ten participants were diagnosed with type 2 diabetes, 50 indi-
viduals had abnormal glucose tolerance. Mean age was 41 and mean BMI 
was 38.7 kg/m˛. Both gender and multiple adjusted regression analyses 
indicated several PMs as significantly associated with the Belfiore Index. 1 
PM was significantly associated with HOMA-IR in the multiple adjusted 
model. Several PMs were significantly associated with the Matsuda index, 
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Conclusion: Phthalate levels are associated with markers of increased 
insulin resistance and decreased insulin sensitivity in an overweight and 
obese population. 
References:
1.  Huang, T., et al.: 2014. Gender and racial/ethnic differences in the associations 
of urinary phthalate metabolites with markers of diabetes risk Environ Health. 
13:6. 
2.  Dirtu, A. C., et al.: 2013. Phthalate metabolites in obese individuals undergo-
ing weight loss. Environ Int. 59:344–53.
T6:PO.004
Environmental xenoestrogens contribute to inflammation 
and cardiometabolic risk during obesity in pre-menopausal 
women 
Teixeira D.1,2, Pestana D.2,3, Santos C.3,4, Correia-Sá L.5, Marques C.2, 
Norberto S.2, Meireles M.2, Faria A.2, Faria G.3,6, Freitas P.7,  
Taveira-Gomes A.8, Domingues V.5, Calhau C.2,3, Monteiro R.1,2
1Instituto de Investigaçăo e Inovaçăo em Saúde, Universidade do Porto, 
Portugal,  
2Department of Biochemistry, Faculty of Medicine, University of Porto, Porto, 
Portugal,  
3CINTESIS – Center for Research in Health Technologies and Information 
Systems, Porto, Portugal,  
4Health Information and Decision Sciences Department, Faculty of Medicine, 
University of Porto, Porto, Portugal,  
5REQUIMTE – Instituto Superior de Engenharia, Instituto Politécnico do Porto, 
Porto, Portugal,  
6General Surgery Department, Oporto Hospital Center, Porto, Portugal,  
7Department of Endocrinology, Diabetes and Metabolism, S. Joăo Hospital, 
Faculty of Medicine, University of Porto, Porto, Portugal,  
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Introduction: Xenoestrogens (XEs) exposure have recently emerged as 
a risk factors for obesity and cardiovascular disease. In this regard, we 
investigate the levels of XEs in plasma and AT depots in a sample of pre- 
and postmenopausal obese women and their cardiometabolic impact in 
an obese state. 
Methods: We evaluated XE levels in plasma and visceral (v) and sub-
cutaneous (sc) adipose tissue (AT) samples of portuguese obese women 
undergoing bariatric surgery. Association with metabolic parameters and 
10-year cardiovascular disease (CVD) risk was assessed, according to 
menopausal status (73 pre- and 48 postmenopausal). Levels of XEs were 
determined by gas chromatography. Anthropometric and biochemical 
data were collected prior to surgery. 
Results: There was a different distribution of XEs among the three an-
alyzed locations according to menopausal status. Furthermore, in 
pre-menopausal women, there was a positive correlation between XEs 
levels and metabolic and inflammatory parameters, namely HbA1c and 
the count of plasma monocytes with vAT XEs levels, and more important-
ly XE levels in plasma seem to predict CDV risk.
Conclusions: Our findings suggest that XEs exposure/accumulation/
burden and not obesity per se may contribute to increase CVD risk and 
inflammation especially in premenopausal women, and thus these chemi-
cals may have a potential role in the later development of cardiometabolic 
disease in obese women.
Acknowledgement: This work was supported by FCT (Fundo Social Europeu, Pro-
grama Operacional Potencial Humano da EU (POPH); PEst-OE/SAU/UI0038/2011; 
SFRH/BD/64691/2009, SFRH/BPD/75294/2010, SFRH/BD/93073/2013), and Pro-
jetos de Investigaçăo na Pré-graduaçăo 2011, Universidade do Porto (IJUP).
T6 – The role of industry (inc reformulation)
T6:PO.005
Engendering positive partnerships with industry to address 
obesity: A framework for collaboration. 
Binks M.
Texas Tech University, Lubbock, TX. USA
As obesity continues to dominate public health discussions we are mired in 
an era of conflict and blame that does nothing to serve public health. If we 
are to solve the obesity epidemic worldwide, adversarial relationships with 
industry, particularly the food and beverage industry, must be set aside and 
we must identify ways to successfully engender collaboration. By doing so 
we will leverage resources from all possible constituencies who are interest-
ed in contributing to being part of the solution. If we are to address the obe-
sity epidemic effectively we must engage in thoughtful scientific appraisal 
and develop sound evidence-based approaches to positively impact energy 
balance (i.e. improving the nutrition and physical activity environments) 
and for identifying safe and effective interventions to achieve this both at 
the population and individual level. Unfortunately, efforts to build effective 
industry-academic-public health partnerships in nutrition and obesity re-
search are often met with emotional hyperbole and efforts to find common 
ground are met with interference and opposition. Increasingly both in the 
public and professional domains we have seen otherwise well-conducted 
research, involving fully transparent and appropriate funding, rejected 
out-of-hand based solely on the source of that funding, with no evidence 
whatsoever of misconduct. This must stop if we are to move forward. In 
this presentation, we will address how decades of experience and success 
in other sectors can inform our engagement with the food and beverage in-
dustry to allow meaningful scientific discovery to occur and effective public 
health strategies to be implemented and tested within a collaborative and 
transparent framework. Guidelines to promote ethical industry/academic 
partnerships that can expand our scientific knowledge and improve public 
health will be discussed and relevant research and policy papers discussed.
T6 – Stigma, bias and discrimination
T6:PO.006
Weight Stigma “gets under the skin” – evidence for an adapted 
psychological mediation framework – a systematic review 
Sikorski C.1,2,3, Luppa M.2, Luck T.2,4, Riedel-Heller S.G.2
1IFB Adipsosity Diseases, Leipzig University Medical Center, Leipzig, Germany,  
2Institute of Social Medicine, Occupational Health and Public Health, University 
of Leipzig, Leipzig, Germany,  
3Mailman School of Public Health, Department of Epidemiology, Columbia 
University, New York City, USA,  
4LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, 
Leipzig, Germany
Objective: Research consistently shows a negative view of individuals 
with obesity in the general public and in various other settings. Stigma 
and discrimination can be considered a chronic stressor as these factors 
have a profound impact on the psychological well-being of the affected in-
dividuals. This article proposes a framework that entails a mediation of the 
adverse effects of discrimination and stigmatization on mental well-being 
through elevated psychological risk factors that are not unique to weight 
but that could affect overweight and normal weight individuals alike. 
Methods: A systematic research was conducted to assess the prevalence of 
psychological risk factors, such as self-esteem and coping, in individuals 
with obesity. 
Results: 46 articles were assessed and included for detailed analysis. The 
number of studies on these topics is limited to certain dimensions of psy-
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chosocial aspects is seen for self-esteem. Most studies establish a negative 
association of weight and self-esteem in children and adults. All studies 
with mediation analysis find a positive mediation through psychological 
risk factors on mental health outcomes. 
Conclusions: This review shows that elevated psychological risk factors 
are existent in individuals with obesity and that they may be a mediator 
between weight discrimination and pathopsychological outcomes.
Acknowledgement: This work was supported by a fellowship within the Post-
doc-Program of the German Academic Exchange Service (DAAD) and by the Fed-
eral Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. We 
would also like to thank Mark Hatzenbuehler for his valuable comments and advise 
in drafting this manuscript.
T6:PO.007
The influence of weight-related teasing and non-normative 
eating behaviors on weight loss maintenance 
Hübner C.1, Baldofski S.1, de Zwaan M.2, Hilbert A.1
1Leipzig University Medical Center, Integrated Research and Treatment Center 
AdiposityDiseases, Leipzig, Germany,  
2Hannover Medical School, Department of Psychosomatic Medicine and 
Psychotherapy, Hannover, Germany
Introduction: Weight-related teasing (WRT) during childhood and ad-
olescence is associated with non-normative eating behaviors of which a 
negative relationship with weight loss maintenance is well-documented. 
Due to the lack of longitudinal studies investigating the predictive value 
of WRT and non-normative eating behaviors, the present study aimed to 
prospectively examine the influence of WRT on weight loss maintenance 
as well as the role of non-normative eating behaviors as possible mediators 
of this relationship. 
Methods: The sample consisted of N = 381 participants of the German 
Weight Control Registry who had lost at least 10% of their maximum 
weight and had maintained the reduced weight for at least one year. Par-
ticipants’ WRT during childhood and adolescence, their current eating 
behavior, and the change of their body mass index (BMI) across two years 
were assessed. Structural equation modeling was used to analyze the as-
sumed mediational relationship. 
Results: After controlling for age and sex, a greater effect of WRT during 
childhood and adolescence predicted more frequent restrained, external, 
and emotional eating. Emotional eating in turn predicted a smaller de-
crease or a greater increase of BMI and fully mediated the direct relation-
ship between the effect of WRT and change of BMI. Fit-indices indicated 
good model-fit. 
Conclusion: Weight loss maintenance is less favorable in individuals 
who had suffered from WRT during childhood and adolescence, espe-
cially when more frequent emotional eating is reported. Results under-
line the influence of WRT on non-normative eating behaviors, however, 
only emotional eating adds to the prediction of weight loss maintenance. 
Thus, results highlight the importance of interventions for the reduction 
of WRT and emotional eating.
T6:PO.008
Dieticians and stigma in the context of obesity- a systematic 
review 
Jung F.1,2, Sikorski C.1,2, Wiemers N.1, Riedel-Heller S.1
1Institute of Social Medicine, Occupational Health and Public Health, University 
of Leipzig, Leipzig, Germany,  
2Leipzig University Medical Center, IFB Adiposity Diseases, Leipzig, Germany 
Background: Recently, many studies examined negative prejudice of 
health care professionals towards people with obesity. Only a few stud-
ies focus on dieticians and nutritionists. The aim of this article is to pro-
vide a systematic review on the current state of quantitative research on 
weight-related stigma by dieticians and nutritionists. 
Methods: A systematic literature review was conducted using Pubmed, 
Psycinfo, Web of Science and Cochrane Library. Only studies that investi-
gated the attitude of dieticians towards people with obesity were included. 
Studies investigating other health care professionals, reviews or qualitative 
studies were excluded. 
Results: Eight studies were found. Studies differ in terms of study char-
acteristics (e.g. sample size), measuring instruments or scales (implicit vs. 
explicit) and the origin of the sample. Five studies clearly report prejudice 
by nutritionists towards people with obesity or overweight. Causes of obe-
sity according to dieticians’ beliefs were also investigated, indicating, that 
there is a defined preference for internal factors (such as lack of willpower 
or overeating) rather than genetic or biological causes. 
Conclusions: Results of studies in dieticians are not as homogenous com-
pared to other health care professional groups. The degree of negative 
attitudes towards people with obesity has been found to be slightly less 
pronounced. However, the current review outlines that this type of stigma 
is by all means relevant, especially when looking at dieticians’ beliefs of 
what triggers overweight and obesity.
Acknowledgement: This work was supported by the Federal Ministry of Education 
and Research (BMBF), Germany, FKZ: 01EO1001, and by a junior research grant by 
the Medical Faculty, University of Leipzig.
T6:PO.009
Branding and social identity: Coca-cola does not make 
overweight children more popular 
Boyland E.J.1, Fry R.1, Marks S.1, Hill A.J.2
1University of Liverpool,  
2University of Leeds 
Introduction: Children are exposed to substantial food and beverage 
marketing, which seeks to create brand loyalty from a young age. During 
development, children use brands to express individual and collective 
identity. Previous research has shown that even very young children have 
negative perceptions of overweight. The study aimed to test whether asso-
ciation with a popular brand would reduce this negativity. 
Methods: 120 children (57 male) aged 4–9 years (mean 6.6y±1.2) from 
three UK primary schools were read a story book in which Tom, the main 
character, was drawn as either normal weight (NW) or obese (OB) and 
was either shown to be associated with ‘Coca-Cola’ or a non-branded 
‘fizzy drink’. Children rated Tom on several attributes/behaviours and in-
dicated their perception of their own body shape. 
Results: OB Tom was rated as less popular (p = 0.004) and less well be-
haved (p = 0.002) but not as having increased appetite or watching more 
TV. When associated with Coca-Cola, OB (but not NW) Tom was rated 
as less well behaved (p = 0.020). Popularity was not affected by the brand. 
ANCOVA (adjusting for age) found that OB Tom was also perceived as 
less likely to win a race. There was a non-significant trend (p = 0.072) to 
suggest that the presence of Coca-Cola increased NW (but not OB) Tom’s 
likelihood of winning a race. Participant body shape did not affect ratings. 
Conclusion: Young children recognise the physical limitations of obesity 
but not the likely contributory behaviours (energy intake/expenditure). 
Negative perceptions of overweight are prevalent even in this age group, 
and association with a popular brand does not improve this view. Brand 
association does influence peer perception, but weight stigma is too pow-
erful to be overridden by short-term brand exposure.
T6:PO.010
An experimental study examining effects of health messages 
on explicit and implicit weight bias 
Rudolph A.1, Hilbert A.1
1Integrated Research and Treatment Center AdiposityDiseases, University of 
Leipzig Medical Center, University of Leipzig, Leipzig, Germany
Introduction: A pervasive explicit and implicit weight bias (WB) has 
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lic health campaigns targeting obesity-related themes have been discussed 
as a source of WB due to reinforcing stigmatizing notions. The present 
study examined whether health messages influence explicit and implicit 
WB. 
Methods: In a randomized-controlled study, one hundred thirty-nine 
participants from the community were assigned to an experimental group 
(EG) or a control group (CG). Participants in the EG were presented with 
health related messages and participants in the CG were presented with 
neutral information. Measures of explicit and implicit WB were complet-
ed before and after manipulation. 
Results: In the EG but not in the CG, paired samples t tests showed a 
medium effect increase of explicit WB and a medium effect decrease of 
implicit WB. 
Conclusion: We provided first evidence that brief exposure to health re-
lated messages might have the potential to change WB. Dual-model ap-
proaches postulated two independent information processing systems, 
thus, health messages might have differentially affected measures of ex-
plicit and implicit WB. While emphasizing deliberative processes, health 
messages simultaneously activated automatically associative processes. 
Hence, obesity-related health messages might contribute to both health 
behavior and the pervasiveness of WB.
Acknowledgement: Research relating to this abstract was funded by grant 
01EO1001 from the Federal Ministry of Education and Research (BMBF), Germany.
T6:PO.011
Emotional and behavioural responses to perceived weight 
discrimination before and after substantial weight loss 
Stubbs R.J.1,2, Greenwood L.1, Caven J.1, Morris L.1
1Slimming World, Alfreton, UK, DE55 4RF,  
2College of Life and Natural Sciences, University of Derby, UK DE22 1GB
Introduction. This study examined experience of weight stigma and dis-
crimination in 2573 people participating in the Slimming World pro-
gramme who had attended for a mean (SD) of 16.6 (24.7) months, lost 
20.1 (14.0) kg in weight and were trying to maintain their weight loss. 
Methods: Subjects were questioned about (i) duration of attendance and 
weight change (ii) their experience of discrimination and stigma before 
and after losing weight, (iii) their emotional response to this experience, 
(iv) the impact it had on attempts to control their weight and (v) the im-
pact it had on their ability to manage their weight. 
Results: At their heaviest 40% of participants reported experiencing 
judgment, criticism or humiliation at least once per week. Incidents of 
perceived discrimination left recipients feeling ashamed (47%), depressed 
(41%) and useless (30%). In response to weight discrimination 65% 
turned to food for comfort while only 2% made long-term lifestyle chang-
es. When asked, 63% of respondents reported gaining weight over time 
since they were first treated unkindly because of their size. Respondents 
said that since losing weight they were now more likely to be acknowl-
edged by strangers with a smile (61%), eye contact (54%), a compliment 
(49%), a hello (43%) and a conversation (41%). 
Conclusion: In people with significant weight to lose, perceived weight 
discrimination can cause emotional distress, which undermines weight 
control behaviours. Losing weight reduces experience of weight discrim-
ination and we hypothesise that reducing stigma may actually facilitate 
weight management behaviours.
T6:PO.012
A human rights approach to childhood obesity 
O Cathaoir K.E.1
1Faculty of Law, University of Copenhagen, Copenhagen, Denmark 
Lessons from HIV/ AIDS can be applied to obesity Introduction: Child-
hood obesity is primarily considered an issue of public health or individu-
al responsibility. It has been given limited consideration as a human rights 
concern. However, given human rights’ application to the HIV/ AIDS, it is 
suggested that human rights norms should be explored in order to avoid 
stigmatisation and boost access to healthcare. 
Methods: An examination of the United Nations’ recommendations to 
states on a human rights approach to HIV/ AIDS is conducted. General 
principles that may have application to obesity treatment and prevention 
are distilled. 
Results: Although HIV/AIDS and obesity are different, there are a number 
of general principles that could be given consideration in state responses 
to obesity. The recommendations include identifying and addressing dis-
crimination, securing children’s participation in decisions affecting them, 
ensuring access to age appropriate information, and access to healthcare 
that is adequate, accessible, acceptable and quality. Furthermore, states 
should adopt child centred national action plans, allocate appropriate re-
sources and gather data disaggregated by gender, region and socio-eco-
nomic considerations. 
Conclusion: Although HIV/AIDS and obesity are different, the approach 
suggested warrants consideration. In light of the evidence of stigma and 
discrimination of persons with obesity, human rights principles should 
be given consideration in state interventions in childhood obesity. States 
should include these principles in action plans and outreach in order to 
avoid doing harm through their efforts to prevent obesity. Furthermore, 
states should contribute to the knowledge on childhood obesity by gath-
ering disaggregated data in a rights compliant manner.
T6:PO.013
Obesity in childhood is associated with a much lower degree 
of education 
Hagman E.1, Danielsson P.1, Brandt L.2, Ekbom A.2, Marcus C.1
1Department of Clinical Science Intervention and Technology, Karolinska 
Institutet, Sweden,  
2Department of Medicine, Karolinska Institutet, Sweden 
Introduction: Obesity in childhood may predispose to poor psychosocial 
health. Here we have investigated if the completion of secondary school (9 
school years) and upper secondary school (+3y) is lower in children who 
have been treated for obesity than in matched controls. 
Methods: 1061 Individuals from the Swedish childhood obesity treat-
ment registry, BORIS (www.e-boris.se) were selected. Inclusion criteria: 
≥20 years of age at follow-up. Exclusion criteria: Mental retardation. 
BMI SDS, median(IQR), was 3.36(1.11), age at last visit was 17.1(2.7). 
Mean(SD) time from last visit to follow-up was 6.3(3.0) years. 7780 indi-
viduals, matched for gender, age and living area, were randomly selected 
as controls. They were linked to the national education registry. Level of 
education at follow-up was divided into; 1 = not graduated from second-
ary school, 2 = graduated from secondary school, but not started upper 
secondary school, 3 = started but not graduated from upper secondary 
school, 4 = graduated from upper secondary school. 
Results: The proportion of school completers was much lower among 
obese cases compared with matched controls (Table 1). No differences 
in ethnicity between cases and controls were observed (p = 0.09). Being 
non-Swedish, was associated with a lower degree of graduating from up-
per secondary school among the controls (p < 0.001), but not among the 
cases (p = 0.09). Being a women increased the chance of graduating upper 
secondary school among both cases (p = 0.006) and controls (p < 0.0001). 
Conclusion: Obesity in childhood is associated with a severely lower edu-
cational level. The differences between the groups do not seem to depend 
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Tab. 1.
T6 – Inequalities/Cultural variation
T6:PO.014
Regional inequalities in overweight and obesity among first-
time pregnant women in sweden, 1992–2010 
Chaparro M.P.1, Ivarsson A.2, Koupil I.1, Nilsson K.3, Häggström J.4, 
de Luna X.4, Lindgren U.5
1Centre for Health Equity Studies (CHESS), Stockholm University & Karolinska 
Institutet,  
2Department of Epidemiology and Global Health, Umeĺ University,  
3Department of Sociology, Umeĺ University,  
4Department of Statistics, USBE, Umeĺ University,  
5Department of Geography and Economic History, Umeĺ University
Introduction: Overweight and obesity are on the rise in Sweden but 
regional variations and time-trends are underexplored. Pre-pregnancy 
weight status has implications for pregnancy outcomes and can influence 
later health of the mother and offspring. 
Methods: Using weight and height data on pregnant women from the 
Swedish Medical Birth Register (≥18 years, 8–12 weeks of gestation, first 
pregnancy only), age-standardized prevalence of pre-pregnancy over-
weight/obesity (BMI ≥ 25 kg/m2) and obesity (BMI ≥ 30 kg/m2) were 
estimated for each Swedish county for the years 1992, 2000 and 2010 
(N=116,122). Maps were created using ArcMap v10.2.2 to display region-
al variations over time and logistic regression analyses used to assess if the 
observed trends were significant. 
Results: The prevalence of overweight/obesity and obesity among preg-
nant women increased significantly between 1992 and 2010 in all Swed-
ish counties. In 2010, Södermanland and Gotland exhibited the highest 
age-standardized overweight/obesity (40%) and obesity (15%), respec-
tively. Västerbotten had the sharpest increase (75%) in overweight/obesity 
prevalence and obesity prevalence nearly tripled in Gotland between 1992 
and 2010. Stockholm County had the lowest prevalence of overweight/
obesity (26% in 2010) and obesity (7% in 2010) across years. 
Conclusion: Regional inequalities in overweight and obesity prevalence 
are apparent in Sweden with Stockholm, the capital, displaying an advan-
tage with the lowest prevalence. Further research should elucidate the rea-
sons behind such disparities.
T6:PO.015
Extreme obesity and youth unemployment: Evaluation of a 
structured approach of care to facilitate access to bariatric 
surgery 
Mühlig Y.1, Hebebrand J.1
1Department of Child and Adolescence Psychiatry and Psychotherapy, LVR-
Klinikum Essen, University Duisburg-Essen
Introduction: Adolescent obesity entails a high risk of somatic and psy-
chiatric comorbidities. Additionally, especially extreme obesity often im-
pedes with social and vocational integration. For several reasons, socio-
economically disadvantaged individuals have limited access to available 
obesity treatment options, including bariatric surgery. In our pilot study 
we aimed to capture the rate of unemployed adolescents with extreme 
obesity willing to participate in a structured program to potentially enable 
bariatric surgery. 
Methods: Unemployed adolescents (14.0–24.9 years) with obesity (BMI 
≥ 30 kg/m2) were offered to participate at a group intervention on the 
premises of a local job center. We applied standardized questionnaires to 
assess health-related quality of life (DISABKIDS), depression (BDI-II), 
self-esteem (Rosenberg-Scale) and social anxiety (SASKO). 
Results: Over the 18-months recruitment period of our pilot study, 80 
eligible adolescents were identified by their case managers; of these 53 at-
tended the initial appointment. 34 adolescents (mean BMI (SD) = 45.59 
(6.29)) consented to participate. We found clinically relevant depressive 
symptoms in 33% and symptoms of social anxiety in 60% of the sample. 
Six participants were eligible for bariatric surgery and directed to a local 
competence network for an individual assessment of indication. 
Conclusion: The preliminary results are promising with regard to the pro-
portion of unemployed adolescents with extreme obesity who benefited 
from our treatment program. To evaluate the efficacy of such a program, 
longitudinal data concerning health and vocational perspective are re-
quired. Furthermore, the feasibility of this approach needs to be assessed 
in a larger model region encompassing more than one job center.
Acknowledgement: This study was supported by the German Federal Ministry of 
Education and Research and was integrated within the German Competence Net-
work Obesity (Consortium „Youth with Extreme Obesity“).
T6:PO.016
Health inequalities in energy balance-related behaviours 
among schoolchildren across in Europe: Baseline results of the 
“EPODE for the Promotion of Health  Equity” (EPHE) project.
Mantziki K.1, Vassilopoulos A.2, Radulian G.3, Borys J.4, Gregorio M.5, 
Graca P.6, De Henauw S.7, Handjiev S.8, Visscher T.9, Seidell J. C.1
1VU University of Amsterdam, The Netherlands,  
2Agricultural University of Athens, Greece,  
3UUniversity of Medicine and Pharmacy Bucharest, Romania,  
4Protéines, France,  
5University of Porto, Portugal,  
6Directorate General of Health, Portugal,  
7Ghent University, Belgium,  
8BASORD, Bulgaria,  
9Windesheim, Netherlands
Background: Tackling inequalities in overweight and obesity has become 
a top priority for the European research and policy agendas. It is well-
known that such inequalities accumulate from early childhood onward, 
although they have not been studied extensively in children. This study is 
part of the EPHE project, the overall aim of which is to assess the impact 
and sustainability of the EPODE methodology to reduce health inequali-
ties in childhood obesity. The current data are the results of an explorative 
analysis to identify inequalities in behaviours and determinants between 
groups with high and low socio-economic status. 
Methods: 1266 children aged 6–8 years and their parents, from different 
socio-economic backgrounds, were recruited in 7 countries. To measure 
the energy balance-related behaviours of the children and their determi-
nants, a questionnaire was addressed to the parents. The Mann-Whitney 
U test and Pearson’s χ2 test were used to test differences between the so-
cio-economic groups. 
Results: Children of relatively low socio-economic status consumed fruits 
and vegetables less frequently, had higher intake of fruit juices and/or soft 
drinks and higher screen time than their peers of high socio-economic 
status. Parental rules and home availability were consistently different be-
tween the socio-economic groups in all communities. However a com-
mon pattern for all behaviours was not found and the variability across 
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Conclusions: This study shows socio-economic inequalities in children’s 
behaviours and parental determinants. These baseline results have been 
used to tailor community-based intervention of the EPODE programmes. 
The impact is measured in a second evaluation and first results will be 
available by the time of the congress.
T6 – Consumer perspectives
T6:PO.017
Perceptions and participation in physical activity and pe in uk 
primary schools 
Potter J.A.1, Everley S.C.1
1Department of Physical Education, University of Chichester, Chichester. UK.
Introduction: The importance of children in engaging in physical activity 
and understanding its role in healthy weight healthy lives is well-estab-
lished. This paper will compare genders and year groups for perspectives, 
knowledge and activity levels. 
Methods: 81 pupils from 2 primary schools wore accelerometers for 5 
days during the 6 hours of the school day, drew pictures of them being 
active, followed by interview and completed knowledge and perspective 
questions on health and physical activity. 
Results: Findings indicate differences in, activity levels, choices, percep-
tions and understanding around healthy activity, PE and sport. Boys were 
significantly more active than girls and there were difference in activi-
ty between years. The groups described activity and physical education 
differently, for example year 5 boys were more likely to identify physical 
activity as sport and exercise, but were more likely to be correct in the 
recommended levels of activity required to stay healthy. Girls perceived 
themselves as active but not necessarily healthy whereas boys married the 
two. 
Conclusion: There is a great deal more knowledge and insight needed 
with regards to the opportunities within school for health-inducing activ-
ity and education, if we are to have significant impact of the population’s 
health related behaviours. This paper uses objective activity measures and 
pupil voice, and reports on the different outcomes n perception, under-
standing and action for different groups. This information may contribute 
to the on-going development of delivery of health-related messages.
T6 – Media
T6:PO.018
Television food advertising to children in malta: The extent 
and nature of exposure 
Cauchi D.1, Reiff S.1, Spiteri J.2, Gauci C.1
1Health Promotion and Disease Prevention Directorate, Ministry for Energy and 
Health, Malta,  
2Monitoring Department, Broadcasting Authority, Malta 
Introduction: To provide a comprehensive baseline analysis of the extent 
and nature of food and beverages (F&B) advertising to children on Mal-
tese television. 
Methods: Seven national free-to-air channels were recorded for seven 
consecutive days between 07:00–22:00 in March 2014. Recordings were 
screened for advertisements, which were coded according to predefined 
categories. F&B advertisements were coded as core (healthy)/non-core 
(unhealthy)/miscellaneous foods. Preliminary. 
Results: Across all channels, F&B was the most heavily advertised product 
category (26.9%). The overall proportion of advertisements for core foods 
in the sample was 17.6%, compared to non-core (41.2%) and miscella-
neous foods (41.2%). Within the sample, the three most frequently adver-
tised F&B categories were for non fast-food restaurant/catering establish-
ments (23.7%); fast food meals (17.8%); and supermarkets that advertised 
mostly non-core foods (7.3%). A significantly greater proportion of adver-
tisements for F&B were broadcast during peak (as opposed to non-peak) 
children’s viewing times. Commercial/political channels broadcast a high-
er rate of F&B advertising than public national channels. Furthermore, 
a significantly greater proportion of F&B advertisements were broadcast 
around drama programmes aimed at adults (but within peak children 
viewing hours), than around programmes aimed at children.
Conclusions: Children in Malta are exposed to more TV advertising for 
unhealthy than healthy food items throughout the day. There is a need to 
devise and implement regulation of HFSS foods around programmes that 
are popular with children and adults alike, rather than limiting restric-
tions to children’s programmes only. Ongoing, systematic monitoring is 
essential for evaluation of regulations designed to reduce children’s expo-
sure to HFSS F&B advertising on television in Malta.
Acknowledgement: The authors would like to acknowledge the invaluable assis-
tance of the recording team at the Malta Broadcasting Authority.
T7 – Lifecourse perspective
T7:PO.001
Predicting metabolic syndrome in mid-adulthood from body 
mass index and skinfold thickness values in childhood
Raskiliene A.1, Petkeviciene J.1, Klumbiene J.1, Kriaucioniene V.1
1Institute of Health Research, Faculty of Public Health, Medical Academy, 
Lithuanian University of Health Sciences, Kaunas, Lithuania
Introduction: Several studies demonstrated the association between 
childhood weight status and metabolic syndrome (MS) in adults. How-
ever, it is still unclear whether the observed associations reflect the track-
ing of body mass index (BMI) from childhood to adulthood or whether 
childhood adiposity has an independent effect on risk of MS. This study 
aimed to examine the effect of childhood BMI and skinfold thickness in 
prediction of MS in adults controlling for BMI gain from childhood to 
adulthood. 
Methods: The study subjects were participants of the Kaunas Cardiovas-
cular Risk Cohort study that started in 1977. A random sample of Kaunas 
schoolchildren born in 1964 was examined in the first survey. In 2012, 
a total of 507 subjects (63.9% of eligible sample) participated in the 35-
year follow-up survey being 48–49 years old. In childhood, height, weight, 
subscapular and triceps skinfold thickness measurements were taken. The 
follow-up health examination involved measurements of BMI, waist cir-
cumference, blood pressure, glucose and lipids levels. Logistic regression 
models were fitted to assess the associations of childhood BMI and skin-
fold thicknesses as well as BMI gain with MS in middle age. 
Results: BMI in childhood predicted development of central obesity 
(OR=1.2; 95% CI=1.1–1.3) and MS (OR=1.2; 95% CI=1.1–1.2) in adult-
hood. The sum of subscapular and triceps skinfold thicknesses in child-
hood was also associated with odds of MS (OR=1.3; 95% CI=1.1–1.6) in 
adulthood. The adjustment for BMI gain from childhood to adulthood 
did not diminish the effect of childhood anthropometric measurements 
for the prediction of MS. 
Conclusion: Risk of MS may be affected by childhood BMI and skinfold 
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T7:PO.002
BMI and psychological well-being in primary school children
Sahota P.1, Christian M.1, Day R.1, Cocks K.2
1The Institute for Health and Wellbeing, Faculty of Health and Social Sciences 
Leeds Beckett University (formerly Leeds Metropolitan University) Calverley 
Street, Leeds LS1 3HE,  
2KCStats Consultancy. www.kcstats.co.uk
Introduction: Few studies have explored psychological wellbeing and as-
sociation of body mass index (BMI) in children as young as 6–9 years old. 
The purpose of this study was to describe the association of psychological 
well-being (dieting behaviours and body image perception) and BMI in pri-
mary school children from Year 2 (age 6–7 years) and Year 4 (age 8–9 years). 
Methods: Baseline measurements are of 301 pupils (52% boys) from 8 
primary schools in Northern England participating in the Phunky Foods 
feasibility study. Psychological well-being was measured using the Body 
Shape Perception Scale and the Measure of Dieting Behaviours (modified 
version of the Dutch Eating Behaviour Questionnaire). Fixed effects mod-
els were used to explore the association between BMI and psychological 
well-being, adjusting for gender and year group. 
Results: Children categorised as overweight (85th to 95th percentile) 
or obese (>=95th percentile) using WHO BMI Growth Charts had 
higher body shape dissatisfaction scores than normal weight children 
(p < 0.0001) and girls had higher scores than boys (p = 0.03). Higher di-
etary restraint scores were observed in obese compared to normal weight 
children (p < 0.0001) and in Year 2 compared to Year 4 pupils (p = 0.002). 
Conclusion: The results suggested that body shape dissatisfaction may be-
gin in children, as young as 6–7 years old, and there is an association with 
increased BMI. Obesity prevention programmes need to ensure that psy-
chological-wellbeing is not compromised and further research should be 
conducted on how interventions can help improve psychological well-be-
ing in this age group.
Acknowledgement: This project was funded by Purely Nutrition and Nestle 
Healthy Kids Network UK.
T7:PO.003
Correlations of BMI with handgrip strength, body composition, 
anthropometry, physical performance and inflammation 
markers in (pre)frail community-dwelling persons
Luger E.1, Haider S.1, Kapan A.1, Schindler K.E.2, Lackinger C.3, Dorner T.E.1
1Centre for Public Health, Institute of Social Medicine, Medical University of Vienna, 
2Department of Internal Medicine III, Medical University Vienna, Vienna, Austria,  
3Sportunion Österreich, Vienna, Austria
Introduction: In European countries, the prevalence of frailty and pre-
frailty is about 17% and 42%, respectively1. The aim of the study was to 
investigate the association between handgrip strength, body composition, 
anthropometry, physical performance and inflammation markers among 
the BMI of (pre)frail community-dwelling persons. 
Methods: Frailty status (SHARE-FI2), handgrip strength (dynamometer), 
physical performance (SPPB3), anthropometry, body composition (BIA) 
and inflammation markers (leucocytes, CRP, IL-6) were assessed in (pre)
frail community-dwelling (≥65 years) persons in Vienna, Austria. Fat free 
mass index (FFMI), fat mass index (FMI) and relative handgrip strength 
were height-normalised indices (kg/m˛). The statistical correlations were 
assessed using the Spearman‘s correlation coefficient. 
Results: 85 (pre)frail persons [15% men; 83(8) years; BMI of 27.3(4.5) 
kg/m˛] were analysed. According to the WHO criteria 33% were nor-
mal weight, 43% overweight and 24% obese. There were significant cor-
relations between BMI and age (r=-0.41; p = 0.001), relative handgrip 
strength (r=-0.22; p = 0.005), FFMI (r=0.71; p = 0.001), FMI (r=0.86; 
p = 0.001), abdominal girth (r=0.70; p = 0.001), mid arm circumference 
(r=0.75; p = 0.001), calf circumference (r=0.45; p = 0.001), leucocytes 
(r=0.19; p = 0.001), CRP (r=0.39; p = 0.02), and IL-6 (r=0.23; p = 0.001). 
Conclusion: The BMI correlates significantly with age, handgrip strength, 
fat free mass and fat mass index, anthropometry and inflammation mark-
ers but not with physical performance.
References:
1. Santos-Eggimann B, et al.: J Gerontol A Biol Sci Med Sci, 2009. 64(6):675–681.
2. Romero-Ortuno R, et al.: BMC Geriatr, 2010. 10:57.
3. Hinrichs T, et al.: BMC Geriatr, 2009. 9:37.
T7:PO.004
Waist circumference at 13 years and systolic blood pressure 
at 21 years of age: A direct or indirect effect? - A path analysis 
application.
Araújo J.1,2, Severo M.1,2, Barros H.1,2, Ramos E.1,2
1EPIUnit – Institute of Public Health, University of Porto, Porto, Portugal,  
2Department of Clinical Epidemiology, Predictive Medicine and Public Health, 
University of Porto Medical School, Porto, Portugal
Objective: To study if the prospective association between waist circum-
ference (WC) in adolescence and systolic blood pressure (SBP) in adult-
hood is direct or indirect through the tracking of these variables.
Methods: We analysed data from 1109 adolescents evaluated at 13, 17 and 
21 years of age under the EPITeen cohort (Porto, Portugal). Sample z-scores 
were calculated for both WC (sexand age-specific) and SBP (sex-, age-, and 
height-specific). Path analysis was used to evaluate the relationships between 
WC and SBP, using the data collected at 13, 17 and 21 years of age. Models 
were stratified by sex and results are presented as correlations, r (p-value).
Results: The total effect of WC at 13y on SBP at 21y was r=0.148 (<0.001) 
for females and r=0.169 (<0.001) for males. Path analysis showed that this 
association was mainly mediated by the tracking of WC across age; the 
path representing this tracking (WC13 to WC17 to WC21 to SBP21) pre-
sented a correlation of 0.159 in females and 0.184 in males, while the path 
representing the SBP tracking (WC13 to SBP13 to SBP17 to SBP21) was 
much weaker (r=0.085 for females and r=0.067 for males). Non-signifi-
cant correlations were found for the longitudinal associations (WC13 to 
SBP17 and WC17 to SBP21). We also tested the direct association between 
WC at 13y and SBP at 21 years, but it was not statistically significant and 
did not improve the goodness-of-fit of the path model.
Conclusion: Our results from a path analysis shows that the positive as-
sociation found between WC in adolescence and SBP in early adulthood 
is mainly explained by the tracking of WC during this period, suggesting 
that a causal relationship might happen earlier than 13y.
Fig. 1. Temporal relationship between waist circumference z-score (WCz) and 
systolic blood pressure z-score (SBPz), among females. Statistically significant 
(p < 0.05) correlations are printed in bold. RMSEA: root-mean-square error of 
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Fig. 2. Temporal relationship between waist circumference z-score (WCz) and 
systolic blood pressure z-score (SBPz), among males. Statistically significant 
(p < 0.05) correlations are printed in bold.RMSEA: root-mean-square error of 
approximation; NNFI: non-normed fit index; CFI: comparative fit index.
T7 – Population trends (European comparison)
T7:PO.005
Rapid increase of obesity prevalence in young adults among 
Koreans
Kwon K.Y.1, Park H.S.1, Kim S.H.1
1Department of Family Medicine, Asan Medical Center, University of Ulsan 
College of Medicine, Seoul, Republic of Korea
Background: It is well-known that obesity increases socio-economic loss 
of regional communities as well as individual health problem. Globally, 
prevalence of obesity has been increasing and the obesity was expand-
ing more rapidly in developing countries than developed countries. In 
the present study, we investigated the trend and prevalence of obesity in 
Korea, one of the developing countries in Asia, through Korean National 
Health and Nutritional Examination Survey(KNHANES).
Methods: We performed cross-sectional analysis using KNHANES 
data from 1998 to 2012 over five time periods. Total 54,008 per-
sons(men;23,357 and women;30,651) whose demographic data such as 
BMI(Body mass index)or estimated weight and height were participated 
into study. The study population was classified into three groups accord-
ing to age;(20~39,40~59, and 60~79yr).All subjects also divided into five 
groups by BMI and obesity is defined as BMI ≥30.0kg/m2
Results: The prevalence of obesity increased from 2.38% to 4.50% be-
tween the first(1998) and fifth(2010–2012) survey.Compared to survey in 
1998, the odds ratio(OR) of obesity in 2010–2012 was 2.37 in men and 
1.67 in women.At all intervals among surveys, prevalence of obesityre-
vealed increasing and accelerating trend in men. Considering age groups, 
the OR of obesity increased in young(2.59) and middle age(1.53)adults, 
while there was no significant increase of OR in older adults at all inter-
val. Especially, increasing rate of obesity risk was greatest in young adult 
men(OR3.05).
Conclusion: In Korea, the prevalence of obesity is increasing and the 
speed of increase is more rapid and age of onset is earlier in men than in 
women at the same age group.The risk of obesity more rapidly increases in 
young adult group (20~39yr)than that in other age groups.
T7:PO.006
Prevalence of overweight and obesity at children and 
adolescents – data from electronic databases GPCY
Stritecka H.1, Zmrzla H.2, Marinov Z.3
1University of Defence, Faculty of Military Health Sciences, Department 
of Military Internal Medicine and Military Hygiene, Hradec Kralove, Czech 
Republic,   
2Svitavská hospital Inc., The children‘s department, Svitavy, Czech Republic,  
3Outpatient Clinic for the Treatment of Child Obesity, University Hospital Prague 
Motol, Prague, Czech Republic
Introducing: Czech Republic through nationwide anthropological sur-
veys (CAV), which were organized in every ten years from 1951 to 2001, 
had world-unique tradition in the collection and evaluation of anthro-
pometric data paediatric population. However, in 2011 this tradition was 
interrupted.The aim: Evaluate anthropometric data from electronic data-
bases practitioners for children and young (GPCY). To evaluate changes 
in the prevalence of overweight and obesity in the child population in 
2011 Group: Of the 8 randomly registered offices of primary care paedia-
tricians were selected data from children who meet the conditions for reg-
ular preventive medical examination for fixed age (the age ± 2 months). 
Was evaluated data from 9507 children (girls: 4808 boys: 4699) aged 3–17 
(19) years. In each age group (3,5,7,9,11,13,15,17 years) were 632–708 
children, only in the highest (19 years), only 174.
Methods: The obtained values of anthropometric parameters (height, 
weight) were processed by assessing software evaluated physical growth of 
a child under the CAV 1991 “RustCZ 2.3”.
Conclusion: In offices GPCY is currently registered by age group 24% of 
children with overweight, 14% with obesity and 4% with severely obesity. 
Obese and overweight children form the second largest group of chronic 
disease, immediately after group of children with allergic diseases. Max-
imum for girls (23.8%) overweight were at age 11, (13.5%) obesity at age 
13. For boys maximum (25.9%) overweight were at age 13 and (15.9%) 
obesity at age 11. The ration of obesity on overweight prevailed 57%. Se-
riousness of obesity significantly increased. Till third of obese children 
had a morbid degree of obesity with maximum incidence of 4.4% in ad-
olescence.
T7:PO.007
Should children with overweight or obesity be excluded from 
height references?
Juliusson P.B.1,2, Brannsether B.3, Kristiansen H.4, Hoppenbrouwers K.5, 
Bjerknes R.1, Roelants M.5
1Department of Clinical Science, University of Bergen, Bergen, Norway,  
2Department of Pediatrics, Haukeland University Hospital, Bergen, Norway,  
3Department of Pediatrics, Stavanger University Hosptial, Stavanger, Norway,  
4Department of Pediatrics, District General Hospital of Forde, Norway,  
5Environment and Health, Department of Public Health and Primary Care, KU 
Leuven – University of Leuven, Belgium
Background and objectives: Growth reference charts are usually based 
on measurements of children free from conditions affecting growth. How-
ever, samples collected during the past decades often contain a large pro-
portion of overweight or obese children. Because obesity increases linear 
growth, this brings up the question to what extent the percentiles curves 
for length/height and the limits of “normal” growth are affected by the 
presence of these overweight and obese children in the sample.
Methods: Data from two cross-sectional samples of 2–18 years old chil-
dren were analyzed: 12252 Belgian children, measured in 2002–4, and 
6159 Norwegian children, measured in 2003–6. The LMS method was 
used to estimate height-for-age curves with and without children con-
sidered overweight or obese according to the International Obesity Task 
Force (IOTF) thresholds.
Results: The prevalence of overweight (including obesity) and obesity was 
13.0% and 2.8% in the Belgian and 13.8% and 2.3% in the Norwegian sam-
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ations, SD, in the Belgian and Norwegian sample respectively) or obese (+ 
0.73 and 0.72 SD in the Belgian and Norwegian sample). No differences 
in effect size were observed between the youngest and oldest age groups. 
Excluding overweight and obese children had only a minor impact on the 
growth curves with largest difference in mean height SDS –0.09 in the 
Belgian and –0.12 in the Norwegian sample with a corresponding increase 
of up to 0.5% and 1.2% in number of children above +2 SD.
Conclusion: Current Belgian and Norwegian growth references for 
length/height were found largely unaffected by the current proportion of 
overweight and obese children.
T7:PO.008
Weight status and blood pressure (bp) in pre-school children
Cavero-Redondo I.1, Álvarez-Bueno C.1, Bermejo-Cantarero A.1, Martín-
Espinosa N.M.1, Velasco-Abellán M.1, González-López M.J.1, Artalejo-
DeMora V.1, Muńoz-Pinilla J.1, Rivero-Merino I.1
1Social and Health Care Research Center, University of Castilla-La Mancha, Spain 
Introduction: The relationship between BP and excess body weight has 
consistently been recognized in adolescents and adults, but the evidence 
of this association at early ages is scarce and controversial. The aim of 
this study was to examine the association of weight status and BP among 
children aged 4 to 6 years. 
Methods: Cross-sectional study including all the children aged 4–6 years 
from 21 primary schools of Castilla-La Mancha region, Spain (n: 1588). 
Weight and height were measured twice by standard procedures. Body 
Mass Index (BMI) was categorized as thinness, normal weight, overweight 
and obesity according to gender-and-age specific cut-offs defined by Cole 
(Cole et al, 2000). After 5 min resting interval, with the right arm semi-
flexed at heart level position, BP was measured twice using a calibrated 
semiautomatic OmronW M5-I device and appropriate cuff sizes accord-
ing to arm circumference, with a 5 min interval between measurements, 
in a quite and relaxing conditions. ANCOVA models were estimated using 
BP as dependent variables, weight status categories as fixed factor and age 
and sex as covariates. 
Results: Thinness and normal weight children has lower BP levels than 
their peers with excess of weight (figures 1 and 2) 
Conclusions: Excess of weight is associated to higher BP levels even at 
early ages.
Fig. 1. Mean of systolic blood pressure of weight status categories controlling for 
age, by sex. **p≤0.001
Fig. 2. Mean of diastolic blood pressure of weight status categories controlling for 
age, by sex. **p≤0.001
T7:PO.009
Thinness and excess of weigth prevalence by parental 
socioeconomic status (ses) in spanish preschool children
Álvarez-Bueno C.1, Cavero-Redondo I.1, Notario-Pacheco B.1, González-
García A.1, Lucas-DelaCruz L.1, Pozuelo-Carrascosa D.1, Pardo-
Guijarro M.J.1, Martínez-Andres M.1, Martínez-Vizcaíno V.1
1Social and Health Care Research Center, University of Castilla-La Mancha, 
Cuenca, Spain.
Introduction: The latest reported obesity prevalence in Spanish children 
was higher than 35%. The aims of this study were to estimate the preva-
lence of thinness, overweight and obesity in the 2008–2009-birth cohort, 
and to examine the association between parental SES with weight and 
height status in this cohort. 
Methods: Cross-sectional study including all the children aged 4–6 years 
from 21 primary schools of Castilla-La Mancha region, Spain (n:1398). 
Weight and height were measured twice by standard procedures. Chil-
dren weight status was estimated according to the cut-offs proposed by the 
IOTF child growth standards criteria. Highest father-mother SES index 
was obtained by using the self-reported occupation and education levels. 
Results: Showed in Fig. 1. 
Conclusions: i)obesity prevalence in Spanish children born after the fi-
nancial crisis is drastically decreasing; ii)the prevalence of excess of weight 
is not more frequent in lower SES categories; iii)parental SES is positively 
associated to stature.
Fig. 1. Weight status prevalence and differences in body composition variables 
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T7:PO.010
Fitness and fatness in spanish pre-schoolers.
Cavero-Redondo I.1, Álvarez-Bueno C.1, Cańete García-Prieto J.1, Arias-
Palencia N.1, Torrijos-Nińo C.1, Cerrillo-Urbina A.J.1, Moreno-Escobar P.1, 
Teran-Boaben M.1
1Social and Health Care Research Center, University of Castilla-La Mancha, Spain 
Introduction: At early ages the evidence of the relationship between 
physical fitness (PF) and body fatness indicators is limited. Aerobic capac-
ity has been the only PF parameter studied, forgetting others parameters 
such as strength may be also related with cardiometabolic health. The aim 
of this study is to analyse the association between adiposity parameters 
with strength and aerobic capacity estimators in pre-school children.
Methods: Cross-sectional study including all the children aged 4–6 years 
from 21 primary schools of Castilla-La Mancha region, Spain (n: 1555). 
Adiposity parameters included: weight, height, waist circumference (WC) 
and triceps skinfold thickness (SFT) measured twice using standard pro-
cedures; body fat percentage (BF%) was estimated by bioelectrical im-
pedance analysis; body mass index (BMI) was calculated as weight (kg)/
height (m)2. PF parameters included: cardiorespiratory fitness (CRF) 
measured by 20-m shuttle run test, lower limbs muscular strength by 
standing long jump test corrected by allometric parameter of 0.67 (Jaric 
et al., 2005), and velocity by 4×10m shuttle run test. Partial correlation 
coefficient controlling for age between adiposity and PF parameters for 
each sex was estimated.
Results: Showed in Fig. 1. 
Conclusions: Adiposity parameters are associated to PF even at early 
ages. Strength is the PF parameter more closely related to adiposity in 
pre-schoolers.
Fig. 1. Partial correlation coefficients between adiposity and PF parameters 
controlling for age. All coefficients were significant at p≤0.001
T7:PO.011
Surveillance of Overweight including Obesity in Children 
Under 5: Opportunities and Challenges for the European 
Region
Jones R.1,2, Breda J.2
1Department of Public Nutrition, Rollins School of Public Health, Emory 
University, Atlanta, Georgia,  
2Department of Nutrition, Physical Activity and Obesity, Division 
Noncommunicable Diseases and Lifecourse, World Health Organization 
European Regional Office, Copenhagen, Denmark
Introduction: Current estimates report over 40 million children under 5 
were overweight or obese globally (deOnis et al., 2010). Childhood over-
weight has become an increasingly important contributor to adult obesity, 
diabetes, and noncommunicable diseases (O’Malley et al., 2010) and at the 
opening of the 2014 World Health Assembly Dr. Chan announced a new 
initiative on childhood obesity (WHO press release. ‘Director-general an-
nounces new initiative, 2014). The European Region needs to be more 
aware of the current state of the nutritional status of children under 5 in 
order to begin to make headway in this emerging area.
Methods: A review of publicly available data collected from 2000 on 
which reported prevalence of nutritional status in children under 5 in any 
WHO European Region Member States was done. The authors compiled 
estimates to form a cohesive perspective on the state of young childhood 
nutritional status in the Region.
Results: 28 of the 53 Member States had data available on the nutritional 
status of children under 5, particularly over-nutrition. This data differed 
in age ranges evaluated, cutoffs used (IOTF, WHO or country-specific), 
national representation and the method evaluated (self-report versus di-
rect measurement). The prevalence of overweight (including obesity) in 
children under five ranges from 1% to 27.5% in Member States.
Conclusion: While it is generally recognized that nutritional surveillance 
data are crucial for the development of targeted action and the monitor-
ing progress and success in counteracting obesity, regular assessments 
of the magnitude of overweight and obesity, particularly in children are 
not common in the 53 WHO European Member States (Wijnhoven et al., 
2013). Evidence suggests that early intervention before five years of age 
is necessary if the trajectory to overweight in children is to be arrested 
(Black et al., 2013) and action needs to be taken to have consistent surveil-
lance on this specific population.




















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247Abstracts 125
T7 – Health promotion policies
T7:PO.012
Overcoming obesity - wellbeing from healthy nutrition and 
physical activity. National obesity programme in finland
Mäki P.1, Männistö S.1, Laatikainen T.1,2, Vartiainen E.1, 
for behalf the Working Group for the National Obesity Programme1
1National Institute for Health and Welfare,  
2University of Eastern Finland 
In 2012, the National Institute for Health and Welfare (THL) launched na-
tional programme Overcoming obesity–wellbeing from healthy nutrition 
and physical activity. Obesity is a serious problem in Finland. The mean 
body mass index has increased in men since the 1970s and in women 
since the 1980s. Although this trend has leveled off over the past ten years, 
the prevalence of obesity is still at too high level. In 2012, 66% of working 
aged men and 46% of women were overweight or obese (BMI ≥ 25). Every 
fifth adult was obese (BMI ≥ 30). The aim of the programme is to achieve 
a downward trend in obesity prevalence in order to improve health and 
wellbeing and to maintain the population’s functional and work ability. 
The health care sector plays an important role, but there are other stake-
holders (e.g. policy makers, schools, community planning, non-govern-
mental organizations, industry, media) at local, regional and national level 
which have an important role in preventing obesity of citizens. The aim 
of the programme is to challenge different stakeholders to work towards 
common goal. The actions will focus on healthy diet and physically active 
lifestyle. There are five main priorities: take into account health in all poli-
cies, advance fiscal incentives, improve the prevention and care of obesity 
in the health care, publish positive and not misleading health messages in 
the media and invest in obesity research. THL has developed checklists of 
the targets for different stakeholders. The purpose of lists is to assess how 
the targets of the national programme are achieved at local, regional or 
national level. THL promotes the implementation of measures through 
information guidance and collaboration with stakeholders and monitors 
outcomes through health monitoring and research.
T7 – Community based interventions
T7:PO.013
What is the impact of a community pharmacy-led weight 
management service for adults in a deprived urban area in 
UK? A mixed methods service evaluation
Smith S.1, Todd A.1, Summerbell C.D.1
1School of Medicine, Pharmacy and Health, Durham University, UK.
Introduction: WHO acknowledges that community pharmacies may be 
an important component of the public health agenda to tackle obesity. 
The aim of this study was to evaluate a 12-week community pharmacy-led 
weight management service in a deprived urban area of Stockton-on-Tees, 
UK. 
Methods: The service was delivered by pharmacists and pharmacy tech-
nicians over a 12 week period, targeting overweight adults. Quantita-
tive data included participants’ weight, height, waist circumference, and 
wellbeing scores. One-to-one, face-to-face interviews were conducted 
post-intervention with three pharmacists, two technicians and 11 service 
users (7 completers and 4 dropouts). 
Results: 8 pharmacies and 58 participants were recruited, of which 11 
completed the 12-week programme. On average, a reduction in weight, 
waist circumference and BMI, and an improvement in wellbeing scores, 
were found. The pharmacy was deemed to be a convenient and easily ac-
cessible setting by service users who praised the one-to-one personalised 
delivery approach. The service appeared to be equally effective when 
delivered by pharmacy technicians and pharmacists, which could prove 
useful in future delivery and practice in terms of freeing up pharmacists’ 
time and making best use of resources. The service had knock-on effects 
of improved dietary habits for family and friends. Non-completers were 
complimentary of the service and the delivery, and continued to make 
lifestyle changes and lost weight. 
Conclusion: The feasibility and impact of the service appears promising, 
and a useful option to the range of weight management services commis-
sioned by local health authorities and councils. Further evaluation to as-
sess whether the service has the potential to be offered effectively as a brief 
intervention is planned.
T7:PO.014
Community pharmacy interventions for public health 
priorities: A systematic review of community pharmacy-
delivered weight, smoking and alcohol management 
interventions
Brown T.1, Todd A.1, O‘Malley C.1, Moore H.J.1, Smith S.1, Husband A.K.1, 
Bambra C.2, Kasim A.1, Sniehotta F.F.3, Steed L.4, Summerbell C.D.1
1School of Medicine, Pharmacy and Health, Durham University, UK,  
2Department of Geography, Durham University, UK.,  
3Institute of Health and Society, Newcastle University, UK.,  
4Centre for Primary Care and Public Health, Queen Mary, University of London, 
UK.
Background and Aim: Worldwide, community pharmacies may be an 
important component of the public health agenda to tackle obesity. WHO 
acknowledges that community pharmacies and their staff are easily acces-
sible and, as such, could play a key role in public health initiatives. This 
systematic review aims to assess the effectiveness of interventions based 
in community pharmacies with a focus on weight management, smoking 
cessation and alcohol misuse. 
Methods/design: We searched 10 databases for international studies that 
evaluated interventions based in community pharmacies that targeted 
weight management, smoking cessation and/or alcohol misuse. We in-
cluded RCTs, non-RCTs, controlled before-after studies, interrupted time 
series and repeated measures studies. 
Results: At the time of writing (December 2014), 29 studies are includ-
ed in the review, including 13 on weight management. The final report 
will be delivered to the funders in March 2015. We intend to present the 
results of the review as they relate to weight management, alongside the 
dissemination strategy for the review, at ECO 2015. Discussion: The re-
view will summarise the evidence base on the effectiveness of community 
pharmacy interventions in relation to weight management, smoking ces-
sation and alcohol misuse. It will also explore if, and how, socio-economic 
status, gender, ethnicity and age moderate the effect of the interventions 
and will describe how the interventions have been organised, implement-
ed and delivered, since context is an important factor governing the suc-
cess of public health interventions.The protocol for this systematic review 
is registered with PROSPERO (registration no. CRD42013005943) and 
published (Todd et al. Systematic Reviews 2014, 3:93).
T7:PO.015
Questionnaire on life style for 8–10-year-old children: 
Concordance between parents and child responses
Boulic G.1, Roy C.2, Deken V.1, Romon M.1
1EA 2694 Lille 2 University,  
2Association FLVS
Introduction: Vivons en Forme (VIF) is a program aiming at supporting 
municipalities to implement actions in line with French Nutrition Recom-
mandations. To evaluate actions directed towards children, we built a 
questionnaire on child life style for 8–10-year-old- children and their par-
ents. The aim of this study is to compare the concordance between the 
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was conducted in four schools located in 3 diffrent cities, one school was 
located in deprived area. The questionnaire was given to 99 children and 
their parents. Children filled the questionnaire at school, and parents at 
home. Only 87 parents responded. Statistical analyses were made on 87 
parent-child pairs. Concordance was analysed by concordance percentage 
(C) and calculation of Kappa coefficient (Κ). 
Results: Parent/child concordance is excellent for i) TV in child bed room 
C 83%, Κ0,63 (52%of children declare having TV in bed room), ii) com-
puter in bedroom c 85%, Κ0,66 (29% of children having computer), iii)
extracurricular physical activity C 89%, Κ O,73 (72% of children having 
physical activity; responses are discrepant for i) snacking while watching 
TV C 59%, Κ0,10 (yes : 42% children, 22% parents), ii) candy daily con-
sumption C 25%, Κ0,11 (yes: 39% children, 17% parents), iii) chips daily 
consumption C 36%, K 0,15 (yes: 21% children, 3% parents). 
Conclusion: 1 More than half of children have a screen in their bed room, 
and this should be considered in public health promotion campaigns. 
2 Discrepancies between parents and children relate to unhealthy be-
haviours that are underestimated by parents and may be ignored.Related 
actions targeting parents should be reinforced.
T7:PO.016
PREVIEW: Preventionof diabetes through lifestyle 
intervention and population studies in Europe andaround the 
world. Over 2,000 volunteers randomized to the 3-y RCT.
Raben A.1, Fogelholm M.2, Larsen T.M.2, Drummens M.3, 
Poppitt S.4, Formiguera J.A.5, Macdonald I.6, Handijev S.7, 
Stratton G.8, Feskens E.9, Lam T.10, Schlicht W.11, Brand-Miller J.12, 
on behalf of the PREVIEW consortium1
1Dep Nutrition, Exercise & Sports, Uni Copenhagen, DK,  
2Dep Food & Environmental Science, Uni Helsinki, SF.,  
3Dep Human Biology, Maastricht Uni, NL.,  
4Human Nutrition Unit, Uni Auckland, NZ,  
5Dep Nutrition, Uni Navarra, ES,  
6School of Biomedical Science, Uni Nottingham, UK,  
7Dep pharmacology & toxicology, Medical Uni Sofia, BG,  
8College of Engineering, Swansea University, UK,  
9Div Human Nutrition, Wageningen Uni, NL,  
10NetUnion, Lausanne, SW,  
11Dep Sport & Exercise Science, Uni Stuttgart, DE,  
12Boden Institute of ONEED, Uni Sydney, AUS.
Introduction: PREVIEW is a 6-y EU project (2013–2018) under the FP7, 
KBBE programme. It involves 15 partners from Europe, Australia, Can-
ada, and New Zealand. The primary goal is to identify the most efficient 
lifestyle pattern for the prevention of type-2 diabetes in a population of 
pre-diabetic overweight and obese individuals.
Methods: The project comprises 2 main lines of evidence: a 3-y multi-
centre, 2*2 factorial, clinical, randomized intervention trial (RCT) with up 
to 2,500 participants as well as large population studies in about 170,000 
individuals across all age groups. The impact of a high-protein, low-gly-
cemic index diet vs a high-carbohydrate, medium-glycemic index diet in 
combination with moderate or high intensity physical activity on the in-
cidence of type-2 diabetes and related end-points are investigated. Inter-
actions with habitual stress, sleeping pattern, behavioral, environmental, 
cultural, and socioeconomic variables are also studied. The RCT starts 
with an 8-week weight loss phase on a low-calorie diet, LCD (Cambridge 
Weight Plan) followed by randomization to a 146-weeks weight mainte-
nance phase in the 4 intervention arms.
Results: Between Jun 2013 and Dec 2014, about 13,900 adults have been 
pre-screened; 4,740 screened and more than 2,050 adults enrolled by the 
8 intervention centres. About 50 children/adolescents have also been in-
cluded. The average age of the adults is 52 y, ~ 2/3 being female. During 
the 8-week LCD, a total of 1,327 have now achieved more than 8% weight 
loss (average 10.7% of initial body weight of 99.7 kg), allowing them to 
continue into the weight maintenance phase.
Conclusion: The PREVIEW project is running well with > 2,000 volun-
teers included in the RCT. PREVIEW will continue recruiting till end of 
Feb 2015.
Acknowledgement: The PREVIEW project receives funding from: EU 7th Frame-
work Programme (FP7/2007-2013), grant agreement no. 312057. National Health 
and Medical Research Council - EU Collaborative Grant, AUS. The NZ Health Re-
search Council (14/191) and UoA Faculty Research Development Fund. The Cam-
bridge Weight Plan has kindly donated all products for the 8-weeks Low-Calorie 
Diet.
T7:PO.017
Bulgarian experience in the prevention of childhood obesity. 
“School for health” – for children, parents and teachers
Handjiev S.1, Kuzeva A.1, Handjieva-Darlenska T.1
1Bulgarian Association for the Study of Obesity and Related DiseasesThe 
problem of childhood obesity in Bulgaria is of significant medical and social 
importance.
Recent studies show increase in obesity and overweight rates by 5–15% 
(depending on the age group). As part of the EPHE project (EPODE for 
the Promotion of Health Equity) Bulgarian association for the study of 
obesity and related diseases (BASORD) organized “School for Health – for 
children, parents and teachers” under patronage of the Minister of educa-
tion and science. 270 children (age 7–9 year), parents and teachers from 
ten different schools in Sofia participated in the “School for health”. At one 
of the most famous Bulgarian seaside resorts - Albena families and teach-
ers spent one week together. For this period all the participants were edu-
cated in the principles of healthy and balanced lifestyle with an emphasis 
on diet and physical activity. Anthropometric parameters (body weight, 
body mass index, waist and hip circumferences) as well as body composi-
tion (fat mass and fat free mass) were measured in all participants. Chil-
dren, parents and teachers had special meals for breakfast, lunch and din-
ner based on the national recommendations for healthy nutrition. Each 
day the program began with gymnastics on the beach and was followed 
by swimming in the sea and the pool and walks.The experience that all 
participants gained had very positive impact on their lifestyle. Two years 
after their participation in the project “School for health” they continue 
to apply the new methodic of nutrition and have increased their physical 
activity.
Acknowledgement: Funded and supported by EPHE project (EPODE for the Pro-
motion of Health Equity)
T7:PO.018
Community-based pilot to tackle childhood obesity in a 
London Borough: A whole-system approach
Hrobonova E.1, Lewis E.1, Dunsford E.A.1, Vamos E.P.2,1
1Westminster City Council,  
2Imperial College London 
Introduction: Tackling childhood obesity is a pressing public health pri-
ority requiring multilevel and multi-stakeholder action. The aim of this 
intervention is to enable all members of the community to take part in ef-
fective and sustainable actions to promote healthy lifestyles and ultimately 
prevent childhood obesity.
Methods: This presentation describes the methodology of the interven-
tion. The programme will be piloted in a London Borough between 2015 
and 2018 focusing on children aged 4–16 years in the environment where 
they live, learn and play. Activities will be implemented at 3 levels: local 
government, community and children and their family. Activities will be 
built on existing public and private community-based initiatives, pre-
ventative and management services and environmental strategies. The 
programme has a dedicated local programme manager to mobilise local 
stakeholders and networks and implement actions. In every 6 months, a 
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and national recommendations focusing on a specific nutrition or physi-
cal activity issue (6 themes during the 3-year pilot). All activities at all lev-
els will focus on the specific themes. A local steering group will be formed 
with a wide representation of local stakeholders including private and 
public partners. Methodology also includes continuous workforce train-
ing, wide dissemination of information resources, working with other 
local government departments and local agencies to improve the environ-
ment and community development including a grant scheme to support 
local initiatives. Expected results include increased awareness, improved 
skills and social norms, behaviour change regarding the specific lifestyle 
themes, and ultimately reduction in childhood obesity.
Acknowledgement: To the Royal Borough of Kensington and Chelsea for funding 
and supporting the design and implementation of this pilot.
T7:PO.019
NoHoW: Evidence-based ICT tools for weight loss 
maintenance
Stubbs R.J.1, Heitmann B.L.2, Sniehotta F.F.3, Teixeira P.J.4, Matos M.5, 
Horgan G.6, Clissman C.7, Lähteenmäki L.8, Ermes M.9, Ladha C.10, 
Sacher P.M.11, Woodward E.12
1College of Life and Natural Sciences, University of Derby, UK,  
2Institute of Preventive Medicine, Frederiksberg, Denmark,  
3Institute of Health & Society Faculty of Medical Sciences Newcastle University, 
UK,  
4Faculty of Human Kinetics, University of Lisbon, Portugal,  
5Cognitive and Behavioural Centre for Research and Intervention, University of 
Coimbra, Portugal,  
6Biomathematics & Statistics Scotland, UK.,  
7Pintail Ltd, Dublin, Ireland,  
8Department of Business Administration, Aarhus C, Denmark,  
9Teknologian Tutkimuskeskus, Finland,  
10Axivity, York, UK,  
11Slimming World, Derbyshire, UK,  
12European Association for the Study of Obesity
Introduction: Obesity is a key economic and healthcare challenge for 
Europe. Effective interventions for weight loss are widely available, but 
few comprehensive solutions exist to help with weight loss maintenance 
(WLM) and most people re-gain lost weight. Research suggests promising 
evidence-based behaviour change techniques for WLM are self-monitor-
ing, goal setting, action control, building self-efficacy and intrinsic moti-
vation and that stress management and emotion regulation skills are key 
enablers of relapse prevention. Information and communication technol-
ogy (ICT) has potential to provide accessible, scalable channels for people 
to engage with these evidence-based behaviour change techniques.
Methods: The NoHoW project (No. 633309) is a 3-centre randomized 
controlled trial designed to evaluate the most effective ICT tools for WLM 
using up-to-date behavioural science research. ICT delivery will be facil-
itated via a suite of tools including networked-wireless tracking technol-
ogies, weighing scales and activity sensors, apps, multi media resources 
and internet-based support. Participants will be given feedback based on 
personalised prediction models of what is most effective for them.
Expected results and impact: The RCT and linked studies of European 
consumer needs and behaviour will test whether ICT-based delivery 
of evidence-based behaviour change techniques is effective for WLM. 
Project results will feed into new developments for implementation by 
Slimming World (a large European commercial weight-loss provider), 
providing WLM benefits to >700,000 overweight and obese individuals. 
Large-scale implementation of online WLM tools will provide comple-
mentary, enhanced support to services that promote health education and 
weight management.
T7:PO.020
Are Intervention-Design Characteristics More Predictive than 
Baseline Participant Characteristics on Participant Attendance 
to a Paediatric, Community Weight Management Programme?
Nobles J.1, Pringle A.1, Griffiths C.1, Gately P.1,2
1Leeds Beckett University,  
2MoreLife (UK)
Background: Approximately 50% of participants complete a paediatric 
weight management programme, yet the predictors of attendance and 
dropout are inconsistent. This study investigates subject and interven-
tion-design characteristics associated with attendance at a group based, 
family weight management programme. SETTING AND SUBJECTS: 
Secondary data analysis of 2948 subjects (Age 10.4 ± 2.8 years, BMI 
26.0 ± 5.7kg/m2, Standardised BMI (BMI SDS) 2.48 ± 0.87, White 70.3%) 
from 244 MoreLife (UK) programmes. Subjects attend weekly for 10–12 
weeks, sessions last 2–3 hours. Sessions include lifestyle guidance and 
physical activity. 
Method: Subject characteristics (demographics, psychological (body sat-
isfaction & self-esteem) and sedentary behaviour) were gathered at first 
contact and BMI SDS was noted weekly. Intervention-design characteris-
tics were recorded (year, length (weeks), group size, age segregation and 
day of session). Attendance was calculated as total number of sessions 
attended (%). Multivariate linear regression examined predictors of atten-
dance and multiple imputation countered missing data. 
Results: Average attendance was 59.4%±29.3%. Baseline subject charac-
teristics were ‘poor’ predictors of attendance. Intervention year, group size 
and day of session significantly predicted attendance (Tables 1 & 2). Yet, 
the most predictive marker of attendance was a change in BMI SDS during 
the programme (B = -0.38, 95% CI = -0.43 - –0.33). 
Conclusion: A reduction in BMI was seen to predict greater attendance. 
However, baseline subject characteristics were weakly associated with at-
tendance, refuting past findings. Dominant intervention characteristics 
(large groups, weekend sessions and recent delivery) predicted lower at-
tendance. Future programmes may be better informed.
Acknowledgement: The author would like to thank MoreLife (UK) for providing 
the data for the study and the assistance given by the staff in aiding the author to 
understand the measures used. Additional thanks extend to the British Heart Foun-
dation for funding the PhD study.
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Fig. 2. Predictors of Attendance - Complete Case Data - Purpose of Sensitivity 
Analysis
T7:PO.021
Scaling-up community-based programmes (CBPs) for 
childhood obesity prevention: First results following the 
methodology appraisal of 13 CBPs
Mantziki K.1, Mayer J.2, Renders C.1, Borys J.M.3, Seidell J.C.1
1VU University of Amsterdam, Netherlands,  
2Proteins, France,  
3EPODE European Network Coordinating Team, Proteines, Paris, France
Background: Childhood obesity and overweight is major public health 
concern in Europe. Programmes and initiatives across the region use var-
ious approaches to prevent this issue, encountering challenges in the im-
plementation field. The current study aims to appraise the methodology 
of 13 community-based programmes and initiatives (CBPs) for strength-
ening and up-scaling their process, based on the pillars of EPODE meth-
odology.
Methods: This is a descriptive research to identify strengths and weakness 
of the participant programmes. We conducted semi-structured interviews 
with the principal programme coordinators, assessing their approach 
to political commitment, public-private partnerships, social marketing, 
communication and scientific evaluation and dissemination. Two re-
searchers appraised the information in reference to the EPODE pillars, 
using a scoring scale from 0 to 2.
Results: Formal political commitment existed in the majority of the pro-
grammes. 46% of the programmes had structural public-private partner-
ships and no interference with the methods/contents of programmes. The 
social marketing approach was lacking target group analysis and focus on 
environmental change in most of the programmes. The communication 
and dissemination methods were lacking for the majority of the pro-
grammes. 70% of the programmes conducted an evaluation, but usually 
that did not include all the important aspects of the programme. Results 
will be presented in more details during the congress.
Conclusions: The context and methods of implementation varied be-
tween the CBPs. We identified various aspects to be improved; tailored 
feedbacks, trainings and workshops are led. The next step is the progress 
appraisal of each CBP included in the project.
T7:PO.022
Characteristics of a successful program to decrease BMI and 
LNED intake in school children
Rosário R.1,2, Araújo A.3, Padrăo P.3, Lopes O.4, Pereira B.2, Moreira P.3,5
1School of Nursing, University of Minho,  
2Research Centre en Child Studies,  
3Faculty of Nutrition and Food Sciences,  
4ERDAL, Escola de Referęncia Desportiva,  
5CIAFEL, Research Centre in Physical Activity, Health and Leisure
Healthy eating habits are essential to reduce children´s risk of health 
problems. The prevalence of obesity continues to increase and is grow-
ing concern in Portugal and Europe (Wijnhoven et al., 2014). This study 
aims to describe the characteristics of a successful program to decrease 
BMI and LNED intake among school children. 464 children (239 female, 
6 to 12 years) from seven schools participated in this randomized trial. 
In Portugal children from elementary schools have only one teacher who 
teaches a range of subjects. The intervention program was based on health 
promotion model (Pender, 1996) and the social cognitive theory (Bandu-
ra, 1986) and aimed to promote healthier active lifestyles by encouraging 
children to be more active and make better food selection. The training 
sessions were approved by the Minister of Education with 72 hours of 
duration. The program was implemented over two terms: teachers’ train-
ing delivered by researchers and intervention delivered to children by 
trained teachers. Intervened teachers had 12 sessions of 3 hours each with 
the researchers, according to the topics of nutrition and healthy eating 
for children and family (sessions 1–4); importance of water (session5); 
strategies to increase fruit and vegetable intake (session 6–8); strategies 
to improve physical activity and reduce screen time (sessions 9–10) and 
healthy cooking activities. After each session, teachers were encouraged 
to develop activities in the class according to the learned topics. This in-
tervention program decreased the consumption of Low-nutrition, energy 
dense (LNED) foods and the Body Mass Index (BMI) z-score among the 
intervened children and offers promise to yield best practices in the pre-
vention of overweight and obesity.
Acknowledgement: Our grateful Acknowledgement goes to all the children and 
their parents for the participation in this study, school administrators and school 
staff for the opportunity of the implementation of the study.No conflic
Reference: 
Wijnhoven T; van Raaij J; , Sjöberg A; et al.: (2014). WHO European Childhood 
Obesity Surveillance Initiative: School nutrition environment and body mass in-
dex in primary schools. Int J Environ Res Public Health. 30;11(11):11261–11285.
T7 – Success and failure of interventions
T7:PO.023
A systematic review of the effectiveness of interventions 
targeting specific out-of-home food outlets (Foodscape study)
Brown T.1,2, Hillier-Brown F.1,2, Moore H.J.1,2, Routen A.C.1,2, Lake A.A.1,2, 
Adamson A.J.3, White M.4,5, Summerbell C.D.1,2
1School of Medicine, Pharmacy and Health, Durham University, UK.,  
2Fuse – UKCRC Centre for Translational Research in Public Health, UK.,  
3Human Nutrition Research Centre, Newcastle University, UK.,  
4CEDAR - UKCRC Centre for Diet & Activity Research, University of Cambridge, 
UK.,  
5MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, 
UK.
Introduction: Food served by out-of-home food outlets (OHFOs) is typ-
ically energy dense. Therefore, OHFOs are an appropriate target for inter-
ventions to tackle obesity. This review focused only on OHFOs open to 
the general public (e.g. not workplaces). 
Methods: Nine databases were searched (1993 to 2013) for relevant stud-
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relevant outcome (e.g. consumer or retail level data for dietary fat intake 
or sales figures of certain items). 
Results: 23 studies were included; 13 repeat cross-sectional, 5 cohort, 2 
controlled before and after, and 3 controlled clinical trials. 23 studies of 
six types of interventions/policies were included: nutrient labelling (12), 
trans-fat legislation (1), multicomponent multilevel health promotion (6), 
personalised receipts (1), price promotion (1) and telemarketing (2). Nu-
trient labelling only reduces calories purchased in specific fast food chains 
and for those who use labels. Multicomponent multilevel interventions 
increased healthy food purchases in certain restaurants, but not others. 
No data on cost implications were identified. Nutrient labelling does not 
appear to increase inequalities by having differential effects by age, gender, 
ethnicity, or socioeconomic status. 
Conclusion: Calorie labelling legislation does not appear to be associated 
with a significant decrease in the amount of calories purchased across all 
fast-food chain restaurants. Further robust research is required, particu-
larly in young people and in European populations.The protocol for this 
systematic review has been registered with PROSPERO (registration no. 
CRD42013006931) and published (Hillier-Brown et al. Systematic Re-
views 2014, 3:17).
T7:PO.024
Effects of differences in frequency of guidance and 
intervention period on weight loss
Katayama Y.1, Wakaba K.2, Nagao Y.1
1Department of Education, Kogakkan University, Ise, Japan,  
2Graduate School of Education, Kogakkan University, Ise, Japan
Introduction: There is no evidence on the relationship between weight 
loss and frequency of guidance and intervention period. The aim of study 
was to examine the effects of differences in frequency of guidance and 
intervention period on weight loss. 
Methods: Sixty-four obese or overweight Japanese women with increased 
waist circumference, hypertension, dyslipidemia, or hyperglycemia par-
ticipated in the dietary intervention with different frequency of guidance 
and intervention periods: 1.5-month, bi-weekly guidance (1.5m2w, n = 7, 
54.4 ± 6.6 years); 3-month, weekly guidance (3m1w, n = 32, 54.8 ± 6.4 
years); 3-month, bi-weekly guidance (3m2w, n = 25, 56.5 ± 5.0 years); 
6-month, weekly guidance (6m1w, n =7, 47.6 ± 14.3 years). All four 
groups engaged in equal guidance contents (received same information 
in 24 hours guidance in total) and were instructed to reduce their dietary 
energy intakes to 1,200 kcal per day. 
Results: Weight decreased significantly during the intervention in all 
groups (1.5m2w: –5.1 ± 2.9 kg, 3m1w: –4.9 ± 2.6 kg, 3m2w: –5.8 ± 3.0 
kg, 6m1w: –5.8 ± 2.5 kg, P < 0.05), while group × time interaction was 
not significant (P > 0.05). However, weight loss per guidance (efficiency) 
in 3m1w and 6m1w were significantly higher than the other two groups 
(-0.2 ± 0.1 kg/guidance, –0.4 ± 0.2 kg/guidance, –0.2 ± 0.1 kg/guidance, 
–0.5 ± 0.2 kg/guidance, respectively), weight loss per week in 1.5m2w 
was significantly higher than the other three groups (-0.8 ± 0.5 kg/week; 
–0.4 ± 0.2 kg/week; –0.5 ± 0.2 kg/week; –0.2 ± 0.1 kg/week). 
Conclusion: Since there were little to no effect on the amount of weight 
loss and decrease in the efficiency, it is not necessary to increase the fre-
quency of guidance over weekly or to extend intervention periods over 
1.5 months blindly.
T7:PO.025
Effects of smart diet weight-loss program on weight loss and 
adherence based on surveys of common preferences
Wakaba K.1, Katayama Y.2, Tsujimoto T.3, Nagao Y.2, Tanaka K.4
1Graduate of Education, Kogakkan University, Japan,  
2Department of Education, Kogakkan University, Japan,  
3Faculty of Health and Sports Sciences, University of Tsukuba, Japan,  
4Graduated School of Comprehensive Human Sciences, University of Tsukuba, 
Japan
Introduction: To examine the effects of our weight-loss program (SMART 
diet) on weight loss and adherence based on surveys of common prefer-
ences for the program.
Methods: Among 118 women with obesity or having at least 1 risk fac-
tor for metabolic syndrome (i.e., waist circumference, hypertension, dys-
lipidemia, hyperglycemia) who were encouraged to lose weight, group 1 
(49.8 ± 12.4 years, n = 12) participated in our 12-wk weight-loss interven-
tion using the SMART diet program based on surveys of common (in-
dividual) preferences (preference group: diet and exercise regimen with 
one-on-one guidance sessions 1d/wk, 60 min/session for 12wk) while 
group 2 (57.9 ± 5.8 years, n = 15) participated in our weight-loss inter-
vention using non-preferences (non-preference group: diet regimen with 
group-guidance sessions 2d/wk, 60 min/session for 12wk).
Results: Weight decreased significantly during the intervention (prefer-
ence group: 64.6 ± 12.2 to 58.9 ± 10.9 kg; P < 0.05, non-preference group: 
69.1 ± 7.5 to 63.2 ± 7.8 kg; P < 0.05), but the program × time interaction 
was not statistically significant. However, a significant difference existed 
in the dropout rates (0% vs 53.3%; P < 0.05, respectively). Weight-loss per 
guidance session was higher in the preference group than the non-prefer-
ence group (-0.5 ± 0.2 kg vs –0.2 ± 0.1 kg; P < 0.05).
Conclusion: The SMART diet program based on individual preferences 
contributes to low dropout rate, significant weight loss, and good adher-
ence with less time and less guidance session requirement.
T7:PO.026
The effectiveness of long term physical activity without diet 
interventions on weight loss and blood pressure in adults 
with class i obesity
Lubkowska A.1,2, Dudzińska W.2, Bryczkowska I.1
1Department of Functional Diagnostics and Physical Medicine, Faculty of Health 
Sciences, Pomeranian Medical University in Szczecin, 54 Żołnierska St., 71-210 
Szczecin, Poland,  
2Department of Physiology, Faculty of Natural Sciences, Szczecin University,  
3C Felczaka St., 71-412 Szczecin, Poland
The aim of the study was to access the effectiveness of long term physi-
cal activity intervention on weight loss and body composition and blood 
pressure. 37 obese men participated in the experiment (42 ± 5.0 years of 
age, BMI = 32.69 ± 5.61 kg/m2). The six month long exercise program 
consisted of moderate-intensity cardiovascular exercise involving both 
the upper and the lower limbs for at least 60 to 70% of the subject’s max-
imal heart rate. The subjects exercised 3 times a week (45 minutes each), 
two times a week at the gymnasium under close supervision of an exercise 
physiologist and one time a week a Nordic walking session. Before and 
after the intervention we performed basic anthropometric measurements 
(body weight, body height, waist and hip circumference, and waist to hip 
ratio (WHR). An bioimpedance method (using a Jawon Medical X-Scan-
Plus II) was used to estimate body composition parameters: mean body 
fat (MBF), subcutaneous fat mass (SFM), visceral fat mass (VFM), lean 
body mass (LBM), skeletal muscle mass (SMM) and the percentage of 
these components during the study. Resting blood pressure was measured 
3 times in a seated position using a mercury sphygmomanometer. After 
the exercise program the decrease in total body mass and BMI (p = 0.05), 
mean body fat, both in [kg] and [%] (p = 0.02; p = 0.04), visceral and sub-
cutaneous mass fat (p = 0.02) as well as WHR (p = 0.05) was observed. 
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decrease tendency have been observed. Our results reporting that the ad-
dition of systematic physical activity at 60 to 70% of the subject’s maximal 
heart rate, even without diet modification modestly but significantly in-
duces weight loss and body composition positive changes and is import-
ant to maintain weight loss.
Acknowledgement: The research was supported by the National Science Centre 
grant No. N N404 312940
T7:PO.027
Group studio cycling is an effective intervention to improve 
cardio-metabolic health in overweight sedentary individuals
Faulkner S.H.1, Pugh J.K.1, Hood T.M.1, Menon K.1, King J.A.1, Nimmo M.A.1,2
1School of Sport, Exercise and Health Sciences, Loughborough University, 
Loughborough, UK,  
2College of Life and Environmental Sciences, University of Birmingham, 
Birmingham, UK
Introduction: High intensity interval training (HIIT) improves health 
markers in groups at risk of cardiovascular and metabolic disease. The 
majority of evidence comes from laboratory studies with fixed intensity 
intervals and one to one supervision. Studio cycling, incorporating both 
aerobic and high intensity exercise, offers a platform for the implementa-
tion of HIIT within the wider community. The aim of the present investi-
gation was to test the efficacy of group based studio cycling at improving 
markers of cardio-metabolic health in overweight individuals. 
Methods: Eight, overweight, sedentary (86.1 ± 10.6 kg; 27.1 ± 4.7 ml.kg.
min-1; <1.5 hr.wk-1) but otherwise healthy volunteers completed 8 weeks 
of supervised studio cycling lasting 50 minutes 3 times per week. Heart 
rate was monitored as a guide to exercise intensity achieved. Participants 
underwent evaluation for blood pressure, maximal oxygen uptake (V O_
(2 max)), body composition, and blood lipid profile before and after the 
intervention. 
Results: Adherence to training was >95%. V O_(2 max) improved by 
11.8% (p < 0.0001) and MAP reduced by 6.5% (p < 0.05). Fat free mass 
index increased by 4.4% (p < 0.05) and waist:hip by 1.2% (p < 0.05). Cho-
lesterol was reduced by 13% (p < 0.05).
Discussion: These data show that group exercise is effective at improving 
cardio-metabolic health in overweight individuals and improves markers 
of disease risk with comparable benefits as reported in may laboratory 
HIIT studies. Studio cycling improves fat free mass and as such may help 
improve function of daily tasks due to an increase in lean mass. Coupled 
with a high adherence rate, studio cycling offers an effective intervention 
to improve cardiovascular health in physically inactive cohorts that can be 
implemented on a community wide scale.
Acknowledgement: The present work was in part funded by the NIHR Diet, Life-
style & Physical Activity Biomedical Research Unit based at University Hospitals of 
Leicester and Loughborough University. The views expressed are those of the au-
thors and not necessarily those of the NHS, the NIHR or the Department of Health. 
The authors were fully responsible for conducting the trial and analysing the data.
T7:PO.028
Behavioural, affective and contextual factors are important 
mediators in successful and healthy weight loss maintenance
Christensen B.J.1, Iepsen E.W.2, Lundgren J.R.2, Madsbad S.3, Holst J.J.2, 
Torekov S.S.2
1Institute of Food and Resource Economics, University of Copenhagen,  
2Department of Biomedical Sciences, Faculty of Health and Medical Sciences, 
University of Copenhagen and the Novo Nordisk Foundation Center for Basic 
Metabolic Research,  
3Department of Endocrinology, Hvidovre University Hospital, Hvidovre
Introduction: Weight regain poses an unsolved challenge in obesity 
prevention. Thus, identification of factors securing successful long term 
weight maintenance is essential. Aim: To evaluate physiological and psy-
chosocial mediators of successful weight loss maintenance in good and 
poor weight maintainers. Metabolic risk factors were assessed to identify 
health benefits. 
Methods: 43 obese individuals obtained a 12% body weight loss through 
an 8 week long low-calorie diet. After weight loss, participants were fol-
lowed for 52 weeks. Body weight, waist circumference, blood pressure, 
fasting plasma glucose and lipid levels were measured after weight loss 
and after 1 year. Qualitative interviews were conducted at the end of the 
trial and psychosocial factors characterizing good and poor maintainers 
were identified. 
Results: Based on body weight changes during the 52 weeks, 3 groups 
were identified: group A (mean weight loss < 3.0%, n=9), group B (mean 
weight change from 3.0% weight loss to 3.0% weight gain, n=13) and 
group C (mean weight gain >3.0%, n=21). At week 52, group A and B had 
lower waist circumference, fasting plasma glucose and triglycerides com-
pared to group C (p < 0.05). Specific behavioral, affective and contextual 
factors were identified in the three groups. Good maintainers reported 
regular exercise and a high degree of instrumentalization in their eating 
behavior, and described their everyday life as stable, structured and with 
strong social support as opposed to poor maintainers who reported a lack 
of stability and a high degree of psycho-social stress. 
Conclusion: Sustained weight loss is associated with beneficial health 
outcomes, and behavioral, affective and contextual factors are important 
psycho-social mediators in successful weight loss maintenance.
T7:PO.029
Adding Context: Process evaluation of a childhood obesity 
prevention trial (the WAVES study)
Griffin T.L.1, Clarke J.L.1, Lancashire E.R.1, Pallan M.J.1, Adab P.1
1School of Health and Population Sciences, University of Birmingham, 
Birmingham, West Midlands, UK
Introduction: Process evaluation can help contextualise trial outcomes. 
It can also assess an intervention’s acceptability. A comprehensive process 
evaluation was implemented for the WAVES study, an evaluation of a child-
hood obesity prevention intervention for 6–7 year-olds delivered in UK 
primary schools (n=26). The intervention included additional daily school-
time physical activity (PA), three cooking workshops (CW) for children and 
parents, a 6-week healthy lifestyle programme at a football club (Villa Vitali-
ty (VV)) and two information sheets signposting to local activities.
Methods: Data were collected using logbooks, observations, question-
naires, focus groups and interviews. Quantitative data were summarised 
as appropriate. Qualitative data were analysed using the framework ap-
proach. Based on the data collected for each intervention component 
schools were allocated an implementation score (low-high).
Results: Scores showed variation between schools in terms of implemen-
tation. Most schools implemented PA least well, and VV the best. This 
was contextualised by teacher reports of timetable constraints making PA 
delivery challenging. Parent attendance at CWs was another challenge. 
Teachers thought that VV offered a ‘wow-factor’ which was particular-
ly appealing to children. The impact of the signposting sheets was ques-
tioned by teachers, and parents struggled to recall them.
Conclusion: The process evaluation results will provide context to the trial 
outcomes. Additional daily PA was challenging for teachers to implement. 
The importance of PA for health supports its continued inclusion in interven-
tions, but strategies to support implementation are essential for adherence.
Acknowledgement: With thanks to the WAVES study research team, the trial inves-
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T7:PO.030
Venturing down the rabbit hole of translational research: The 
peachtm child weight management program
Perry R.1, Golley R.2, Hartley J.1, Daniels L.1,3, Magarey A.1,3
1Nutrition and Dietetics, School of Health Sciences, Flinders University, 
Adelaide, South Australia, Australia,  
2Sansom Institute for Health Research, School of Pharmacy and Medical 
Sciences, University of South Australia, Adelaide, South Australia, Australia,  
33School of Exercise and Nutrition Sciences, Queensland University of 
Technology, Queensland, Australia
Child obesity is a dire public health issue. Trials show promising results, 
however few are translated to practice. This paper describes the process of 
translating an effective child weight management program (PEACHTM) 
from an RCT intervention to a community health program and public 
health initiative. PEACHTM is an Australian evidence-based, family-fo-
cussed child weight management intervention for 5–9y olds (NHM-
RC-funded RCT from 2004–08, ACTR 00001104). The trial showed a 
10% reduction in relative adiposity at 6m, maintained for 18m with no 
further contact. Findings were disseminated via academic, professional 
and lay channels. Relationships were developed with government depart-
ments, clinicians and managers. Funding for translation was secured from 
state government and a car manufacturer. This iteration,“PEACHTM in 
the Community”, involved development of a facilitator training program, 
revision of program content, relaxation of eligibility criteria and develop-
ment of an evaluation framework based on the REAIM model. From 2009 
to 2011,8 training workshops were delivered to 54 participants, of which 
11 delivered 8 programs to 62 families. Reach, adoption and implementa-
tion were limited and key lessons were: a) build trust between researchers, 
service deliverers and management, b) understand and implement strat-
egies to respond to the political environment in which community health 
programs are funded and delivered, c) need for adaptation of programs to 
enhance adoption, and d) importance of data collection support. These 
insights inform the current iteration of PEACHTM as a public health 
initiative in the state of Queensland (PEACHTM QLD), where it will be 
delivered to 1400 children over 3y.
T7:PO.031
Impact of participation in the peachtm child weight 
management intervention on parenting and family lifestyle 
behaviours: Pilot results of peachtm queensland
Magarey A.1,2, Moores C.1, Hartley J.1, Perry R.1, Vidgen H.2, Daniels L.1,2
1Nutrition and Dietetics, School of Health Sciences, Flinders University, 
Adelaide, South Australia, Australia,  
2School of Exercise and Nutrition Sciences, Queensland University of 
Technology, Queensland, Australia
Australian clinical practice guidelines for management of childhood over-
weight and obesity 2013 recommend family-focussed lifestyle interven-
tions involving frequent contact with a health professional as effective. 
PEACHTM is an evidence-based group program supporting parents to 
improve the lifestyles of their overweight children 5–11 years via parenting 
skills training focussing on family eating and activity behaviours. Funded by 
the Queensland Government the program will be delivered to 1400 families 
in Queensland Australia in four phases over three years. This study pres-
ents pilot data of the impact on parenting and family lifestyle behaviours. 
A total of 53 families (59 children) were enrolled at 6 sites. Baseline and 
follow up data (at 6 month program end) were obtained from 22 families 
(24 children). Child dietary intake was assessed using the Child Dietary 
Questionnaire (CDQ), activity and sedentary behaviour using the CLASS 
questionnaire and impact on other family members via purpose developed 
questions. Descriptive pre-post comparisons are reported. There were im-
provements in all five sub-scales of the CDQ (eg fruit & vegetable score pre 
vs post median 10.9 vs13.1) and a reduction of 40 minutes/day in screen 
based activity. Parents reported increased confidence in setting limits re-
garding their child’s eating and activity behaviours and improvements 
in their ability to manage their child’s behaviour. All parents reported an 
improvement in eating habits (21/21) and 20/21 in activity patterns of the 
whole family. Most parents (20/22) felt the health and wellbeing of their 
whole family improved post-program. These early results suggest the merits 
and wider impact of taking a parent-led family-focussed approach to child 
weight management, as not only the target child benefits.
Acknowledgement: The families who particiapted in the program and provided 
evaluaiton data, and the project team at Queensland Univesrsity of Technology, 
Queensland, Australia
T7:PO.032
Android obesity and inflammatory markers under the action 
of an interdisciplinary therapy program.
Poli V.S.1,3, Fidalgo J.P.1,3, Nascimento M.A.1,3, Sanches R.B.1,3, Moraes A.S.2,3, 
Araújo G.S.3, Cerrone L.A.1,3, Bresciani P.1,3, Andrade-Silva S.G.1,3, 
Clemente J.C.3, Caranti D.A.3,4
1Post Graduate Program of Interdisciplinary Health Sciences, Federal University 
of Săo Paulo – UNIFESP - Santos, Brazil.,  
2Post Graduate Program of Nutrition, Federal University of Săo Paulo – UNIFESP 
– Săo Paulo, Brazil.,  
3Obesity Study Group (GEO), Federal University of Săo Paulo – UNIFESP - Santos, 
Brazil.,  
4Department of Biosciences, Federal University of Săo Paulo – UNIFESP - Santos, 
Brazil
Introduction: Obesity is one of the major public health problem actually. It 
has a multifactorial etiology and it’s characterized by excessive accumulation 
of adipose tissue (AT). It’s known that AT, especially that with android distri-
bution, has an secreting-endocrine function, releasing any adipokines, which 
are responsible for developing metabolic disorders. They are responsable to 
modify vital functions of the body, such as the heart and imune function.
Objective: Check the effect of Long-Term Interdisciplinary Therapy (IT) 
in Android Obesity (AO) and in pro- and anti-inflammatory markers in 
obese adults.
Methods: There were 23 volunteers with a mean age of 41.34 ± 5.82 years 
old and mean body mass index of 33.97 ± 2.81 kg/cm˛. They underwent 
32 weeks of IT, composed of six weekly interventions, three of physical 
exercise, one of physiotherapy, nutrition and psychology. The evaluations 
were performed on two occasions: before and after 32 weeks of IT. The 
distribution of AT was verified by Dual-energy X-ray absorptiometry 
(DEXA). The plasma levels of inflammatory markers were determined 
after collecting blood of volunteers, by ELISA immunoassay for IL-6, ad-
iponectin and TNF-α. In statistical analysis were used the Student-t test 
and Wilkoxon, according to the normality of the samples. The level of 
considered significance was 5%.
Results: After IT the AO showed a significant reduction of 3.93% ±3.26 
(p <0.001). Proinflammatory markers was had a significant reduction in 
IL-6 (-1.79mg/dL, p = 0.001) and TNF-α (-1.43mg/dL, p = 0.006). The ad-
iponectin showed an increasing trend, although it wasn’t significant.
Conclusion: The TI against obesity promoted reduction of AO and de-
creased plasma levels of pro-inflammatory markers IL-6 and TNF-α.
T7:PO.033
Engagement with on-line programmes to prevent weight gain 
in young adults
Liang Q.1, Lean M.E.1, Nikolaou C.K.1, Hankey C.R.1
1Human Nutrition, University of Glasgow, Scotland 
Introduction: Understanding how young adults engage with and use on-
line resources for obesity prevention may provide valuable information to 
modify programme design and maximise impact. 
Methods: Two 19-week online programmes shown to help to prevent 
weight gain were delivered by random allocation to university students; 
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food issues). 2051 participants, mean age 20.0 SD 3.6 years, BMI 22.4 SD 
4.7 kg/m2 who viewed the resources at least once, were included in this 
analysis, relating participant characteristics, residence-type and body-sat-
isfaction to frequency and timing of log-ins and topic popularity. 
Results: P1 attracted 1196 and P2 527 participants, more female (57.8%): 
45% of all participants were satisfied with their weight but 75% would 
welcome advice on weight control. Mean log-in frequency by 19-week 
programme for P1 was 8.9 (SD 12.3) and 4.9 (SD 6.9) P2. Log-in frequen-
cy did not differ by university faculty, residence-type or gender. For P1, 
interest in weight management advice and baseline BMI were related to 
log-in frequency. Obese participants logged in on more occasions per 
programme; 12 vs. <8 for others with BMI <30 kg/m2 (p = 0.012). Most 
frequent viewings for both programmes were in the first 2 weeks and pro-
gramme usage decreased over time. The timings of log-in occasions (day/
night, weekend/weekdays) were not associated with weight change. 
Conclusion: On-line programmes designed to prevent weight gain are at-
tractive to a range of young adults. Declining usage over time is the single 
biggest obstacle, so a series of shorter programmes might be more effec-
tive than a single long one.
T7:PO.034
Adolescents´ experiences with obesity. A qualitative study.
Øen G.1, Tvedt K.E.2, Kvilhaugsvik B.3, Halding A.G.2
1National Centre for Food, Health and Physical Activity, Bergen University 
College, Bergen, Norway,  
2Sogn and Fjordane University College, Fřrde, Norway,  
3Stord and Haugesund University College, Stord, Norway
Introduction: The Norwegian Healthy Future project aims to develop 
knowledge of how evidence-based interventions could be implemented 
by use of a Comprehensive Participatory Planning and Evaluation (CPPE) 
process. Obese adolescents are especially at risk for being obese adults, 
therefore important to reach to tailor interventions built on adolescents´ 
needs. In-depth understanding of adolescents´ perspectives can reveal po-
tential footholds for interventions, and might strengthen the patient-cli-
nician partnership in identifying patients´ strengths and motivating for 
weight loss. The aim of this study is to explore adolescents´ experiences 
of being obese.
Methods: A qualitative approach with action oriented research in a Nor-
wegian context of primary health care was chosen. Individual repeated 
in-depth interviews were carried out and data analyzed by qualitative 
content analysis. Themes occurred from the data by stepwise developed 
codes, subcategories and categories.
Results: Across the 12 interviews of adolescents´ perspectives on every-
day life with overweight five categories were identified: 1. Adolescents’ 
suggested causes for obesity; 2.To speak about overweight; 3. Challeng-
es in changing behavior; 4. Social relationships; 5.To ask for help. Three 
themes emerged: 1. Obesity as a multi-faced and “difficult-to-solve” con-
dition; 2 Overweight as a shameful and vulnerable subject; 3. Obesity as a 
source for bullying and fragile social relationships.
Conclusion: Adolescents experienced everyday life with obesity different-
ly, according to their experiences from being bullied, given social support, 
and their feelings of control and possibilities to reduce obesity.
T7:PO.035
Outcome of public obesity clinics in malaysia: Retrospective 
data of 417 subjects
Mazapuspavina M Y.1,4, Mohamad M.2, Yusoff K.3, Bulgiba A.4
1Primary Care Medicine Discipline, Faculty of Medicine, Universiti Teknologi 
MARA, Selayang Campus, Selangor, Malaysia,  
2Endocrinology, Medical Department, Hospital Putrajaya, Malaysia,  
3Cardiology, Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, 
Selangor, Malaysia,  
4Julius Centre University of Malaya (JCUM), Department of Social & Preventive 
Medicine, University of Malaya, Kuala Lumpur, Malaysia
Introduction: Data are scarce concerning weight loss outcome of obese 
subjects following clinic program (Vasconcelos et al., 2004, Compe et al., 
2003). The objective was to evaluate outcome and predictors of weight loss 
in outpatient obesity clinics.
Methods: Studied clinics provided endocrinologist and dietician consul-
tations, physical activity with physiotherapists, support group meetings, 
meal replacement and anti-obesant therapy. Records of patients were 
scrutinized at first and 6th month entry. Outcome measures: Anthropom-
etry measurements; biochemistry and co-morbidity profiles. Statistical 
tests: paired t tests, correlation, regression analysis, and ANOVA.
Results: Total of 417 patients (63.1% female, 77.2% Malay, 62.8% mar-
ried) with mean age of 42.7 years (SD±12.43); and mean BMI of 47.1 
(SD±9.47) kg/m2. 63.8% had weight loss but only 17.3% had at least 5% 
weight loss. Mean weight loss is 2.15 (P < 0.001) with an average of 1.64%; 
BMI decreased by 0.89 (P < 0.001), pulse rate by 2.06 (P < 0.04), and waist 
circumference by 2.12 (P < 0.001). BMI changed was negatively correlat-
ed with HDL (r = -0.57, p < 0.01). Total cholesterol and LDL decreased 
by 0.16 (P < 0.03) and 0.15 (P < 0.02); Alkaline Phosphate and Alanine 
Transaminase decreased by 3.99 (P < 0.006) and 4.72 (P < 0.018). Weight 
reduction was significantly correlated with frequency of support group 
attended.
Conclusion: The obesity clinic resulted in an effective weight loss, which 
related to the attendance of support group sessions.
Acknowledgement: The authors acknowledged the Hospital Putrajaya and Hospi-
tal Kuala Lumpur staffs for their contributions towards the study. The authors also 
extend their appreciation to all participants, The Centre for Translational Research 
and Epidemiology (CenTRE), Faculty of Medicine, Universiti Teknologi MARA 
UiTM, and The Julius Center University Malaya for their support.
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Fig. 2. Changes of Clinical Profile
T7:PO.036
Preliminary results of a dietary intervention among primary-
school children
Zafiropulos V.1, Chatzi V.1, Dimitropoulakis P.1, Markaki A.1, Fthenakis Z.G.1, 
Thalassinos N.1, Fragkiadakis G. A.1
1Department of Nutrition & Dietetics, Technological Educational Institute of 
Crete (TEI of Crete),  723 00 Sitia, Greece
Introduction: Prevention of obesity in schools has been planned by de-
veloping and then by evaluating the effectiveness of a Web-based Dietary 
Intervention. The research project „Evaluation of a Web-based Dietary 
Intervention among primary school children“ is being carried out in a 
randomly selected sample of Elementary Schools in central/eastern Crete. 
Objective: The aim is to evaluate the effectiveness of the dietary inter-
vention by measuring body composition and dietary behavior of children 
prior to and after the intervention. 
Methods: The nutritional intervention (material presented in another ab-
stract) has been applied in a number of primary schools in ages 8–11. We 
followed two interventional approaches. The first is the ‘traditional’ inter-
vention, which requires the presence of a dietitian for the lectures. The 
second is web-based, where the students attend digital presentations on 
nutrition and play respective interactive games, assisted by their teachers. 
For body composition measurements the methods BIS, NIR, triceps and 
circumferences were employed, while for dietary behavior a long ques-
tionnaire was distributed. For the statistical analysis the SPSS program 
was used. 
Results: A statistically significant decrease was found (independent sam-
ples t-test) in %BF (P < 0.0001), as well as in triceps (P = 0.002) of chil-
dren participated in the intervention courses (N=382) compared to the 
control group (N=86). There was no difference between the two interven-
tion methods or between boys and girls. In parallel, a statistically signifi-
cant improvement of dietary behavior was recorded.
Conclusions: The dietary intervention applied to 8–11 years old children 
was found to be effective in terms of decreasing the %BF levels and in 
improving the dietary behavior.
Acknowledgement: The current project is implemented through the Operational 
Program „Education and Lifelong Learning“ action Archimedes III and is co-fi-
nanced by the European Union (European Social Fund) and Greek national funds 
(National Strategic Reference Framework 2007 - 2013). We thank the teachers of 
participating schools, as well as Dr. Roussakis and Mr. Klinakis for their valuable 
help.
T7 – Obesity and disease in populations
T7:PO.037
Trends in obesity and low birth weight among macedonian 
women in the period 2004–2013trends in obesity and low 
birth weight among macedonian women in the period 
2004–2013
Spasovski M.1, Kasapinov B.1, Gudeva Nikovska D.1
1Department of Social Medicine, Faculty of Medicine, University Ss Cyril and 
Methodius, Skopje, Republic of Macedonia
In our study we have analyzed 23000 births in the 10-years period 2004–
2013, reported and recorded in the national statistics by National Insti-
tute of Public Health. In the analyzed period, the average infant mortality 
rate (IMR) was 10.44/1000 live births [95% CI, 9.25 – 11.63]. Analyzed by 
5-years intervals, IMR for 2004–2008 was 11.5 [95% CI, 10.18 – 12.82], 
while in the period 2009–2014 the rate was 9.38 [95% CI, 7.81 – 10.96], 
with remarkable continuous decrease. However, there are regional differ-
ences, with highest average IMR registered in Skopje and Polog region 
(11.12/1000 live births), while the rate is lowest in North-East region 
(8.18/1000). Another social determinant associated with IMR is mother’s 
education, with IMR of 15.9/1000 in mothers without education, com-
pared to 4.7/1000 in mothers with university education. Smoking, alcohol 
consumption and adolescent pregnancy are identified as main behavior-
al risk factors for infant mortality, while main biological and social fac-
tors are perinatal depression, bacterial infections, domestic violence and 
mother’s body weight. Smoking, substance abuse, maternal infections and 
obesity have been identified as conditions that are compromising fetal de-
velopment and result in pre-term delivery, low birth weight, respiratory 
problems and chronic conditions that can lead to death of the newborn. 
Holistic approach in defining strategies and implementation of public 
health interventions is key to risk mitigation and provision of environ-
ment in favor of minimizing risks. There is also implicit need to stimulate 
quantitative and qualitative research aimed at identification of specific 
characteristics of infant mortality in Republic of Macedonia and devel-
opment of appropriate programs to address them, based on research data.
Acknowledgement: The study has been funded by University “Sts. Cyril and Metho-
dius” – SkopjeThe study has been funded by University “Sts. Cyril and Methodius” 
– Skopje
T7:PO.038
The role of obesity in hypertension - Epidemiological long-
term trends in the Austrian population
Großschädl F.1, Stolz E.1, Mayerl H.1, Freidl W.1, Rásky E.1, Stronegger W.J.1
1Institute of Social Medicine and Epidemiology, Medical University of Graz, Graz, 
Austria,
Introduction: There is a lack of empirical evidence for the development of 
hypertension prevalence and its related factors. Therefore the aim of this 
study is to analyze the prevalence and long-term-trend of hypertension in 
Austria and identify subpopulations that are affected the most (stratifica-
tion by obesity, sex, age, educational level).
Methods: This representative population-based study is based on self-re-
ported data of adults (mean age: 47.7 ± 17.5; n = 178,818) that were taken 
from five national health surveys between 1973 and 2007. An adjustment 
of self-reported BMI was performed based on a preliminary validation 
study. Obesity was defined as a BMI ≥ 30 kg/m˛. Absolute changes (AC) 
and aetiologic fractions (AF) were calculated from logistic regressions to 
measure trends. To quantify the extent of social inequality, a relative index 
of inequality (RII) was computed.
Results: During the study period the age-standardized hypertension 
prevalence increased from 1.0% to 18.8%, with a considerable rise from 
1991 onwards. There was a positive trend in all subpopulations, with the 
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(+54.4%), whereas the highest risk was observed among the youngest 
obese adults (AF: 99.4%). The RII for hypertension was significantly high-
er for women than men.
Conclusion: Obesity and older age are significant factors for increased 
morbidity of hypertension. The most undesirable trends occurred in 
obese women and obese subjects ≥ 75 years. These risk groups should be 
given special attention when planning hypertension prevention programs. 
However, the high increase in the prevalence of hypertension is due to 
different aspects, e.g. a demographic change and a change in the definition 
of hypertension.
T7:PO.039
Obesity-related breast cancer risk is higher in women with 
asian than white ancestry
Maskarinec G.1, Morimoto Y.1, Wilkens L.R.1, Henderson B.E.2, Kolonel L.N.1, 
Le Marchand L.1
1University of Hawaii Cancer Center, Honolulu, HI, USA,  
2University of Southern California, Los Angeles, CA, USA
Introduction: Breast cancer incidence remains lower in Asian than West-
ern countries, while rates in Asian migrants have risen. Although obesity 
increases postmenopausal breast cancer risk and mortality across popu-
lations, the relation appears to differ by ethnicity. This review examines 
the association of obesity with breast cancer in women of Asian and white 
ancestry and proposes potential mechanisms of action. 
Methods: Using data from the Multiethnic Cohort (MEC) as well as pub-
lished reports from women with Asian ancestry, risk estimates were com-
pared by ethnicity. 
Results: A higher risk for Japanese than white women with a body mass 
index (BMI) >30 kg/m2 was found in the MEC (HR=1.59; 95%CI: 1.24–
2.05 vs. HR=1.38; 95%CI: 1.24–1.53) when compared to normal weight 
participants (1). The risk associated with a high waist to hip ratio (WHR) 
was also stronger for breast cancer incidence (2) and mortality (3) among 
Asian American than white women. This disparity may be due to a higher 
proportion of visceral than subcutaneous adipose tissue resulting in vary-
ing levels of adipokines and inflammatory markers (4). 
Conclusion: Anthropometric measures from imaging are needed to 
understand the relation between obesity, biomarkers, and breast cancer 
across ethnic groups.
Acknowledgement: Research relating to this abstract was funded by grants 
R37CA54281 and UM1CA164973 from the US National Cancer Institute.
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T7:PO.040
Association between semicarbazide sensitive amine oxidase/
soluble Vascular adhesion protein-1, insulin resistance and 
central obesity in adolescent males 
Koborová I.1, Gurecká R.1, Szökő É.2, Tábi T.2, Šebeková K.1
1Institute of Molecular BioMedicine, Medical Faculty, Comenius University, 
Bratislava, Slovakia,  
2Department of Pharmacodynamics, Faculty of Pharmacy, Semmelweis 
University, Budapest, Hungary
Introduction: In the adult type 2 diabetics the activity of semicarbazide 
sensitive amine oxidase (SSAO), analogous to vascular adhesion protein-1 
(VAP-1), is increased; resulting in the production of H2O2 and (among 
others) methylglyoxal (MGO). Enhanced oxidative stress as well as MGO 
might induce insulin resistance (IR). In diabetics, elevated SSAO/VAP-1 
levels are linked to cardiovascular complications. We asked whether alter-
ation in SSAO/sVAP-1 system occurs already in early stages of IR, with 
regard to presence/absence of central obesity (CO). 
Methods: In a cross-sectional study SSAO activity (determined radio-
metrically) and sVAP-1 levels (commercial ELISA) were determined in 4 
groups of male Caucasian non-diabetic adolescents aged 17-to-21-years: 
1/ lean insulin sensitive (LIS, n=33), 2/ lean IR (LIR, n=32), 3/ CO insulin 
sensitive (OIS, n=32), and 4/ CO-IR (OIR, n=31). CO was classified as 
waist-to-height ratio >0.5, IR as QUICKI<0.319. 
Results: No significant between-group differences either in the activity 
of plasma SSAO (LIS=61 ± 18, LIR=60 ± 22, OIS=61 ± 16, OIR=60 ± 14 
pmol/mg/h), or the levels of sVAP-1 were revealed. Enzyme activity of 
SSAO correlated significantly with concentrations of circulating sVAP-1 
(R2=0.33; p < 0.001). 
Conclusion: In non-diabetic adolescent males presence of cardiovascular 
risk factors such as CO, IR or their concurrent manifestation is not assso-
ciated with altered activity of SSAO or circulating sVAP-1 levels. Whether 
SSAO/sVAP-1 alterations become manifested in presence of risk facors in 
older subjects prior to manifestation of diabetes remains to be elucidated. 
Satisfactory correlation between determination of plasma SSAO activity 
and sVAP-1 concentration suggest that the methods could substitute for 
each other.
T7:PO.041
Eddy – a project to prevent obesity and to reduce 
cadiovaskular risk factors in 11–13 years old adolescents
Poeppelmeyer C.1, Helk O.1, Barkhordarian N.1, Cvjetkovic N.1, 
Prochazka O.1, Mehany S.1,  Buchinger K.1, Wessner B.2, Klinglmayr H.2, 
Schwarz G.2, Pachinger O.3, Widhalm K.1
1Austrian Academic Institute for Clinical Nutrition, Vienna, Austria,  
2Department of Sport Science, Vienna,  
3Austrian Heart Foundation, Vienna
Introduction: Diseases of the cardiovascular system are responsible for 
about 43% of all deaths in Austria and correlate strongly with obesity and 
its consequences. According to the HELENA data approximately 23% of 
the adolescents in Vienna are obese. So it is necessary to find concepts to 
prevent obesity.
Methods: The EDDY project is an interventional cohort study with dura-
tion of two years. The cohort is scaled in an intervention group and a con-
trol group consisting of 147 students from Viennese secondary and high 
schools. The intervention group will receive a comprehensive, age-appro-
priate nutrition training, physiological training and an exercise interven-
tion each semester. Before and after intervention and at two follow-ups, 
subjects are physically measured and blood samples are taken. In addition, 
knowledge of nutritional issues, eating habits and psychological parame-
ters are measured with adequate questionnaires. 
Results: Preliminary outcomes show an improvement of nutrition knowl-
edge, a significant reduction in the consumption of junk food, sweets and 
salty snacks as well as cardiovascular risk factors and an improvement of 
physical performance compared to control schools. 
Conclusion: Previous data from the running project indicate that the in-
tervention is able to improve nutrition habits and possibly the physical 
performance. It should be pointed out, that the inclusion of parents and 
teachers are so far not satisfying realized, however this will be very essen-
tial for a long-term effect.
Reference:
Diethelm K et al.: Nutrient intake of European adolescents: results of the 
HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) Study. Public 
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T7:PO.042
Is There an Association Between Weight and Dental Caries 
in School Aged Children: Effect of Being Overweight or Low 
Weight
Karacil M.S.1, Tekcicek M.2, Koksal E.1
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey,  
2Department of Pediatric Dentisty, Faculty of Dentistry, Hacettepe University 
Introduction: Body weight status and dental caries has been associated 
in children by several studies in recent years. This study was aimed to 
evaluate the relationship between antropometric measurement and body 
composition with dental caries of children. 
Methods: This study was conducted 12 ages 96 girls and 92 boys totally 
188 children. Anthropometric measurements of children were taken and 
body fat percentage (%) was measured by bioelectric impedance analyzer. 
Body mass index (BMI) was evaluated according to age and gender with 
the reference of WHO 2007 for 5–19 years. Oral health clinical examina-
tions of children were checked by a dentist. Mean DMFT and dmft index 
are used to evaluate dental caries status of children. 
Results: The children were divided into three groups as underweight 
(9.6%), normal weight (44.7%), and overweight (45.7%). It was found 
that 48.3% of children had one tooth decay at least and mean DMFT was 
1.1 ± 1.41. There was a negative correlation between body weight, waist 
circumference, BMI, body fat and dmfs with dmft index and number 
of temporary teeth caries (p < 0.05). Underweight children had higher 
DMFT and dmft index value and number of decay in primary teeth , than 
obese children but the difference was not found significant (p > 0.05). The 
number of temporary decay and filling teeth were lower in obese children. 
Children who have higher body fat percentage had better values of oral 
health indicators but the difference between the groups was not found 
significant (p > 0.05). 
Conclusion: Development of dental caries is associated with underweight 
as obesity in children. Maintaining of ideal body weight and prevention of 
underweight and obesity with providing adequate and balance nutrition 
are important for prevention of dental caries in children.
T7:PO.043
Association of serum 25-hydroxyvitamin d and parathyroid 
hormone with hypertension in middle-aged and older korean 
adults
Kim D.1, Kim J.1,2
1Department of Medical Nutrition, Graduate School of East-West Medical 
Science, Kyung Hee University, Yongin, South Korea,  
2Research Institute of Medical Nutrition, Kyung Hee University, Seoul, South 
Korea
Background: Previous studies have suggested that serum 25-hydroxyvita-
min D [25(OH)D] and parathyroid hormone (PTH) levels are associated 
with hypertension. However, the associations have yet to be studied in Ko-
reans. This study explored the relationship among serum 25(OH)D, PTH 
concentrations and the risk of hypertension in middle-aged and older Ko-
rean adults using the most recent nationally representative survey data. 
Methods: A population-based, cross-sectional study was conducted with 
data collected from 5,260 Korean adults (aged ≥ 50 years) who partici-
pated in the 2010 and 2011 Korean National Health and Nutrition Exam-
ination Surveys. Hypertension was defined as a systolic blood pressure 
≥ 140 mmHg, diastolic blood pressure ≥ 90 mm Hg, or current use of 
antihypertensive medication. 
Results: The prevalence of hypertension significantly increased accord-
ing to the quartiles of serum PTH levels (P < 0.0001), but not of serum 
25(OH)D levels. In multivariable logistic analysis, the adjusted odds ra-
tios (ORs) for hypertension were significantly higher among subjects in 
the highest quartile than among subjects in the lowest quartile of serum 
PTH level, after adjusting for potential confounders [OR = 1.28, 95% con-
fidence interval (CI) = 1.04–1.59, P for trend = 0.0007]. The adjusted ORs 
for hypertension tended to decrease across the quartiles of serum 25(OH)
D level, but the associations were not significant. 
Conclusion: Serum 25(OH)D was not associated with the risk of hyper-
tension, whereas serum PTH was positively associated with the risk of hy-
pertension, suggesting that serum PTH may be an independent risk factor 
for hypertension in middle-aged and older Korean adults.
Acknowledgement: This research was supported by the Basic Science Research 
Program of the National Research Foundation of Korea (NRF) founded by the Min-
istry of Education, Science and Technology (NRF2012R1A1A1012317).
T7:PO.044
Economic and public health burden of obesity in hungary
Rurik I.2
1University of Debrecen,  
2Hungarian Society for the Study of Obesity 
Background: “Obesity pandemic” reached Hungary, resulting visible high 
prevalence in the population. Previous evaluation in Hungary was com-
pleted in 1988, while obesity related health care expenditures were never 
estimated.
Aim (1)to collect updated prevalence data (2): estimating the economic 
burden of overweight/obesity for health budget.
Method (1)Anthropometric, educational and morbidity data of persons 
above 18y were registered in community and primary care settings, repre-
sentatively in all regions of Hungary. (2)National Health Insurance Fund 
expenses related to inpatient (hospital), outpatient services and sick-leave 
finances related to obesity, diabetes and hypertension were analyzed. The 
incidence of obesity was calculated as 80% among diabetics and as 60% 
among patients with hypertension.
Results: (1)Data (BMI, waist circumference, educational level) of 40,331 
individuals (16,544 men, 23,787 women) were analyzed. Overall preva-
lence for overweight was 40.4% among men, 31.3% among women, while 
for obesity 32.0% and 31.5%, respectively. Abdominal obesity was 37.1% 
in males, 60.9% in females. Data are presented by age-decades as well. 
The highest odds ratio for overweight was at middle the lowest for obesity 
at the highest educational level. The highest proportion of obese people 
lived in villages and in Budapest. Registered metabolic morbidities were 
strongly correlated with BMIs and both were inversely related to the level 
of urbanization. (2)According to the estimation 15–18% of total health 
expenditures and at least 1% of the GDP were spent.
Discussion There was a shift in the population toward being overweight 
and moreover obese, mainly in younger generation. Obesity is an import-
ant contributor of the increased health care expenditures.
Acknowledgement: Since 25y, it is the first population based survey in Hungary 
and the first about the national health care expenses. Shortening the abstract needed 
some compromises in the English grammar
T7:PO.045
Beyond BMI: Projecting the future burden of obesity in 
england using different measures of adiposity
Shaw A.1, Retat L.1, Brown M.1, Divajeva D.1, Webber L.1
1UK Health Forum 
Introduction: Body mass index (BMI) is a frequently used measure to 
assess the weight of an individual adjusted for their height. At a popula-
tion level BMI is a useful tool for monitoring and surveillance, but it can 
underestimate the risk of disease. Waist circumference (WC) appears to 
be a better predictor of disease risk, however comparatively fewer data 
exist. In this study, projections in England to 2050 for BMI and WC were 
compared. 
Methods: Cross-sectional datasets from the Health Survey for England 
(HSE) for 2006–2011 were used to analyse both BMI and WC. For BMI, 3 
categories were used, defined by WHO cut-offs: underweight and healthy 
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For WC, 3 categories were used as suggested by the WHO [1]. For men: 
<94 cm, 94–101.99 cm and ≥102 cm and for women: <80 cm, 80–87.99 
cm and ≥88 cm. Pearson correlation coefficients of BMI and WC were 
calculated in R. Projections to 2050 were generated for BMI and WC in 
males and females by fitting multivariate categorical regression models to 
the datasets. 
Results: In 2011, the correlation coefficient was 0.84. BMI and WC were 
predicted to increase over time for males with a greater increase predicted 
for WC. Preliminary results showing that ~44% will be obese but ~66% 
will have a WC ≥102 cm by 2050. 
Conclusion: Our prediction model shows that current predictions of the 
future burden of obesity related diseases [2] are likely to be underesti-
mates and that predictions may be improved with the inclusion of WC. 
Understanding how distributions of obesity will change in the future is 
important for policy resource planning.
References:
1.  World Health Organization, World Health Organization Technical Report 
Series 894, 2000.
2. Webber L, et al.: BMJ Open 2014.
Fig. 1. Projected BMI prevalence to the year 2050 using HSE data from 2006–2011 
for 18–100 year old males.
Fig. 2. Projected WC prevalence to the year 2050 using HSE data from 2006–2011 
for 18–100 year old males.
T7:PO.046
Adenovirus-36 infection and its relation to dietary intake and 
response to in-patient weight management in obese girls
Zamrazilova H.1, Aldhoon Hainerova I.1,2, Dusatkova L.1,3, Atkinson R.L.4, 
Sedlackova B.1,3, Lee Z.P.4, Hill M.1, Kunesova M.1, Hainer V.1
1Obesity Management Center, Institute of Endocrinology, Prague, Czech 
Republic,  
2Department of Pediatrics and Center for Research of Diabetes, Metabolism and 
Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic,  
3Faculty of Science, Charles University, Prague, Czech Republic,  
4Obetech Obesity Research Center, Richmond, VA, USA
Introduction: Human adenovirus 36 (Adv36) enhances an accumulation 
of fat mass. The response to weight management program (WMP) as well 
as an evaluation of dietary intake with respect to the presence of Adv36 
antibodies has not been broadly investigated. 
Methods: Subjects: 184 Czech obese girls, age 13.0–17.9 years, BMI > 97th 
percentile for sex and age. WMP: a 4-week in-patient supervised program 
included decreased dietary intake individually modified according to age 
and BMI with ensured recommended daily consumption of all essential 
nutrients and appropriate macronutrient balance, aerobic physical ex-
ercise and cognitive behavioral therapy. Adv36 antibodies: competitive 
enzyme-linked immunosorbent assay. Dietary intake: pre-treatment eval-
uation of 3-day dietary records by PC program NutriMaster. Anthropo-
metric measurements, clinical examination and fasting laboratory assess-
ment performed before and after WMP. 
Results: In the pre-treatment period no difference in energy and nutrient 
intake between Adv36 infected and uninfected girls was revealed. After 
the intervention Adv36 positive girls presented with significantly greater 
decrease of z-score of waist circumference (p = 0.024), waist-to-hip ratio 
(p = 0.007) and weight-to-height ratio (p = 0.019) compared to Adv36 
negative girls. On contrary the sum of four skinfolds decreased significant-
ly more in Adv36 negative than in Adv36 positive individuals (p = 0.013). 
None of the further studied metabolic and hormonal parameters showed 
any significant relevance to Adv36 status in response to in-patient WMP. 
Conclusion: In infected obese girls WMP led to a greater decrease of ab-
dominal fat but to a preservation of subcutaneous fat.
Acknowledgement: Research related to this abstract was funded by these grants: 
IGA MZCR NT/13792-4, MH CZ-DRO (Institute of Endocrinology - EÚ, 
00023761), CZ0123 from Norway through the Norwegian Financial Mechanisms.
T7:PO.047
Impact of body mass index (BMI) on clinical in-stent restenosis 
(isr), de-novo stenosis (dns) and repeat revascularization 
(rr) rate in patients undergoing percutaneous coronary 
intervention (pci)
Simoni L.1, Shirka E.1, Kallashi N.1, Kabili S.1, Goda A.1
1Cardiology Service, University Hospital Center “Mother Theresa” Tirana 
Background: Previous studies have described an “obesity paradox” with 
prognosis and various treatments of cardiovascular disease, including 
PCI. Until now exist contradictory data for the impact of BMI on clinical 
ISR, DNS and RR rate in patient undergoing PCI. We sought to investigate 
the impact of BMI on clinical ISR, DNS and RR rate in patients following 
first-time elective PCI.
Methods: Were included 735 patients from September 2011 to Novem-
ber 2013 in Department of Cardiology and followed for one year. Patients 
were categorized according to BMI groups. BMI 18.5 - 24.9 kg/m2 as nor-
mal, 25 - 29.9 kg/m2 overweight and > 30 kg/m2 obese group. Primary 
endpoints were defined as the rate of clinical ISR, DNS and RR (PCI/
CABG) in survivors.
Results: During follow-up survived 726 patients. Baseline clinical pa-
rameters were more severe in overweight and obese individuals. Obese 
compared to normal weight individuals had a higher length of stents 
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ter of stents used (3.14 ± 0.4 vs 2.98 ± 0.33 p = 0.0001). Overweight and 
obese had a reduced rate of ISR respectively (6% vs 18.4% p = 0.0001); 
(8.6% vs18.4% p = 0.015). Overweight had a reduced rate of DNS (6.3% 
vs 12% p = 0.022) There is no significant difference between obese and 
normal weight individuals on DNS rate (7.8% vs 12% p = 0.26). The RR 
rate for was lower in overweight and obese respectively (8.1% vs 22.5% 
p = 0.0001); (12.4% vs 22.5% p = 0.012)
Conclusions: The patients with higher BMI undergoing percutaneous 
coronary intervention paradoxally have less ISR and less RR. The larger 
diameter of vessel treated with larger diameter stents in obese individuals 
may explain the lower incidence of ISR and indirectly the lower need for 
RR in these patients.
T7:PO.048
Overweight and obesity among children in Norway by family 
country background
Biehl A.1, Hovengen R.1, Grøholt E.K.1, Strand B.H.1,2, Meyer H.E.1,2
1Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway,  
2Institute of Health and Society, Faculty if Medicine, University of Oslo, Oslo, 
Norway
Introduction: In the last decades the population of Norway, like other 
Western populations, has been characterised by an increased proportion 
of immigrants. Studies have shown that overweight/obesity is more prev-
alent in some immigrant groups than in the host population. We aimed 
at examining whether ethnicity was associated with general overweight/
obesity and abdominal obesity among children and whether there were 
gender differences. 
Methods: Height, weight and waist circumference were measured in na-
tionally representative samples of 6652 8-year-olds in the 2010 and 2012 
Norwegian Child Growth study. Measurements of general overweight 
(incl. obesity), using IOTF cut-offs, and abdominal obesity (waist-to-
height ratio ≥ 0.5) were included. Ethnicity was determined on the basis 
of parents’ country of birth; Norwegian, Western and Non-Western. Ad-
justed prevalence ratios (PR) were calculated by log-binomial regression. 
Socio-economic position was not adjusted for due to obvious educational 
differences in these groups. 
Results: Children with Non-Western background had 27% higher prev-
alence of general overweight (incl. obesity) and 50% higher prevalence 
of abdominal obesity compared to children with Norwegian background 
(p-values for differences <0.01). Interaction term gender and country 
background was non-significant for all anthropometric measurements 
(p > 0.30) and gender stratified analyses were not performed. 
Conclusion: In this nationally representative study, children with 
Non-Western background had significantly higher prevalence of general 
overweight (including obesity) and abdominal obesity compared to chil-
dren with Norwegian background. The gender difference in overweight/
obesity remained unchanged across country background.
T7:PO.049
Higher BMI z-score, frequent meals and a propensity 
to consume sugar are associated with cariogenic 
microorganisms in children
Arvidsson L.1, Birkhed D.2, Hunsberger M.1, Lanfer A.4, Lissner L.1, 
Mehlig K.1, Mårild S.3, Eiben G.1
1Section for Epidemiology and Social Medicine, University of Gothenburg, 
Gothenburg, Sweden,  
2Department of Cariology, Institute of Odontology, Sahlgrenska Academy, 
University of Gothenburg, Sweden,  
3Department of Paediatrics, Queen Silvia Children’s Hospital, University of 
Gothenburg, Sweden,  
4Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, 
Bremen, Germany
Introduction: The microorganisms mutans streptococci (MS) and lacto-
bacilli (LB) ferment carbohydrates from the diet and contribute to caries 
by lowering the pH in dental plaque. In adults, high counts of MS and LB 
in saliva have been associated with overweight, but in children evidence 
is limited. The objective of the present study was to investigate the associ-
ation between salivary counts of MS and LB and children’s weight status, 
while considering associated covariates.
Methods: Cross-sectional analysis of 271 children in Sweden, from the 
IDEFICS study. Saliva and anthropometric measures were obtained. MS 
and LB counts were dichotomized into low and medium-high counts (cut-
off values related to caries-risk). Number of meals, propensity to consume 
sugar and sleep duration were assessed by a parental questionnaire and a 
24-hour dietary recall. Logistic regression with forward selection of vari-
ables was used to predict medium-high versus low counts of MS and LB.
Results: Medium-high counts of MS, but not LB, were positively asso-
ciated with higher BMI z-score (OR 1.6; 95% CI 1.1–2.3). Furthermore, 
associations were found between medium-high counts of MS and larger 
number of meals (OR 1.5; 95% CI 1.1–2.2), higher sugar propensity (OR 
1.1; 95% CI 1.0–1.3), longer sleep duration (OR 0.5; 95% CI 0.3–1.0) and 
female sex (OR 2.4; 95% CI 1.1–5.4).
Conclusion: Higher BMI z-score was independently associated with me-
dium-high counts of MS. Limiting intake frequency of sugar-rich foods 
and beverages, and promoting adequate amount of sleep could provide 
multiple benefits in public health interventions aimed at reducing caries 
and overweight.
Acknowledgement: We gratefully acknowledge Ann-Britt Lundberg at the Depart-
ment of Cariology at the Institute of Odontology in Gothenburg for analyzing the 
saliva samples.
T7:PO.050
The prevalence of obesity in hospitalised patients and 
ethnicity related variance in access to healthcare may 
adversely influence management of obesity.
Shah S.R.1, Coppack S.1, Emmanuel J.1
1Department of Metabolic Medicine, The Royal London Hospital, Barts Health, 
London, United Kingdom
Introduction: In England 67% of men and 57% of women are overweight 
or obese. We set out to identify the prevalence of obesity in patients admit-
ted acutely unwell, and assess for sleep apnoea. At present there is no data 
exploring the lack in access to healthcare by ethnic minorities in the UK. 
Methods: We assayed all medical patients admitted to The Royal Lon-
don Hospital over 4 weeks (n=441).Weight, height and body mass index 
(BMI) calculated. Epworth Sleepiness Scale score calculated, and primary/ 
secondary care consultations in relation to obesity over a year recorded. 
BMI by ethnicity and Epworth score were analysed by one-way analysis of 
variance (ANOVA). 
Results: 50.1% of patients were classified as overweight or obese and 
26.3% of patients had their weight recorded in the bedside clinical notes. 
No significant difference (p > 0.05) in BMI across ethnic groups. The av-



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts138
Worryingly 53.8% of the 40.0–49.9 BMI group; and 66.7% of the ≥50.0 
BMI group were aware of their stage of obesity. 25.6% of overweight and 
obese Caucasians sought out healthcare advice vs 22.8% of ethnic mi-
nority patients. The mean Epworth score was; 5.77 for the 30.0–39.9 BMI 
group and 10.62 for the 40–49.9 BMI group. 
Conclusion: The BMI of women was greater and obesity prevalence in 
hospitalised patients is low, contrary to other (HSE 2012) reports. There 
was no difference in BMI across ethnic groups, but fewer ethnic minority 
patients sought healthcare advice than Caucasian counterparts due to the 
cultural differences Iqbal G et al (2012).A clear correlation between BMI 
and the Epworth Sleepiness Scale. Only a quarter of patients had weight 
recorded on admission, reflects our approach to managing obesity in sec-
ondary care.
Fig. 1. Bar graphs to show Epworth sleepiness score across BMI ranges
Fig. 2. Bar graphs to compare health care access acros ethnicity variance
Fig. 3. Bar graphs to illustrate lack of awareness of obesity stage by severe obese 
patients
T7:PO.051
Mediterranean Diet and telomere length: The predimed-
navarra study
Garcia Calzon S.1, Martínez-González M.A.2,3, Razquin C.2,3, Bes-
Rastrollo M.2,3, Martínez J.A.1,3,4, Zalba G.5, Marti A.1,3
1Department of Nutrition, Food Science and Physiology, University of Navarra, 
Pamplona, Spain,  
2Department of Preventive Medicine and Public Health, University of Navarra, 
Pamplona, Spain,  
3CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud 
Carlos III, Madrid, Spain,  
4Centre for Nutrition Research, University of Navarra, Pamplona, Spain,  
5Department of Biochemistry and Genetics, University of Navarra, Pamplona, 
Spain
Introduction: A healthy lifestyle has been associated with longer telo-
meres, but whether a Mediterranean dietary pattern affect telomere length 
(TL) has not been fully elucidated yet. The aim of this study was to assess 
the cross-sectional relationship between TL and the adherence to a Medi-
terranean diet (MeDiet) in high cardiovascular risk subjects.
Methods: A total of 521 participants (55–80 years, 55% women) were ran-
domly selected from the PREDIMED-NAVARRA trial. Leukocyte TL was 
measured by RT-PCR and age-adjusted z-scores for TL were calculated. A 
validated 14-item questionnaire was used to appraise adherence of partic-
ipants to the MeDiet.
Results: A significant interaction for TL was found between the adher-
ence to MeDiet and sex, since as the adherence to MeDiet increased, TL 
was predicted to increase only in women (P for interaction=0.049). Fe-
male subjects with a high adherence to a MeDiet (≥9.3 points) had longer 
telomeres than those with a lower adherence (<9.3 points) in multiple-ad-
justed models (PANCOVA=0.009). Interestingly, differences in TL be-
tween quintiles groups of adherence to MeDiet among women were test-
ed, where the higher the compliance to a Mediterranean dietary pattern, 
the longer the telomeres in adjusted models (P trend=0.015). Moreover, a 
higher adherence to MeDiet (Q5) was associated with a 34% lower risk of 
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Conclusion: A greater adherence to a Mediterranean dietary pattern was 
associated with longer telomeres in high cardiovascular risk women in the 
frame of the PREDIMED trial.
Acknowledgement: Research relating to this abstract was funded by Línea Espe-
cial University of Navarra (LE/97), Spanish Government (FIS-ISCIII: PI051579, 
PI050976, PI070240, PI081943, PI1002293, RTIC 06/0045, CIBERobn, CNIC/06, 
SAF-2010-20367) and Government of Navarra (PI41/2005, PI79/2006, PI36/2008, 
PI54/2009).The FPU fellowship to García-Calzón is gratefully acknowledged.
T7:PO.052
Non-overweight ‚apples‘ have higher cardiometabolic risk 
factors than overweight ‚pears‘: Waist-to-height ratio is a 
better screening tool than BMI for plasma cholesterol and 
glycated haemoglobin
Gibson S.1, Ashwell M.2,3
1Sig-Nurture Ltd, Surrey GU1 2TF, UK,  
2Ashwell Associates, Ashwell, Herts SG7 5PZ, UK,  
3Oxford Brookes University, Oxford OX3 0BP, UK
Introduction: We have previously shown that using BMI as a sole proxy 
for obesity and ignoring measures of central obesity such as waist to 
height ratio (WHtR) would misclassify around 10% of the whole UK pop-
ulation, and more than 25% of those of normal weight, as “not at risk’’(1).
Objective: To explore the implications of this ‘misclassification’ in screen-
ing for the cardiometabolic risk factors, total cholesterol (TC) and glycat-
ed haemoglobin (HbA1c) using data from the Health Survey for England 
2009 (HSE).
Results: In HSE adults aged 16y and over (n=2917), 41% of men and 
29% of women classified as ‘normal’ by BMI, have WHtR exceeding 0.5. 
Overall, 12% of the total population would be missed by BMI screening 
(non-overweight ‘apples’). When the HSE population was classified into 
four groups (2×2) using standard boundary values of BMI (<>25kg/m2) 
and WHtR (<>0.5), mean TC was, as expected, lowest in the group with 
low/normal BMI and low WHtR (mean 5.1mmol/L) and highest among 
those with high BMI and high WHtR (mean 5.7mmol/L). Of greater inter-
est, the group with ‘low/normal BMI but high WHtR (non-overweight ‘ap-
ples’) had significantly higher mean TC than the group with high BMI but 
low WHtR (overweight ‘pears’) (5.73mmol/L SE 0.08 vs. 4.98mmol/L; SE 
0.11; P < 0.0001). Similarly, HbA1c levels were higher among non-over-
weight ‘apples’ than among overweight ‘pears’ (5.62% SE 0.03 vs. 5.33% 
SE 0.04; P < 0.0001). These differences were also significant in both sexes.
Conclusions: This study not only supports our previous findings on the 
superiority of WHtR over BMI as a primary screening method for mor-
bidity and mortality risk, but also demonstrates the potentially severe im-
plications of misclassification by BMI alone in screening for cardiometa-
bolic risk factors.
Reference:
1.  Ashwell M, Gibson S. A proposal for a primary screening tool: ‚Keep your waist 
circumference to less than half your height‘. BMC Med. 2014;12:207.
T7:PO.053
Overweight and obesity among polish pupils with visual 
impairment aged 7–18 years atteding special schools
Wrzesińska M.1, Urzędowicz B.2, Motylewski S.3, Pawlicki L.2
1Department of Psychosocial Rehabilitation, Medical University of Lodz, Lodz, 
Poland,  
2Department of Internal Medicine and Cardiological Rehabilitation, Medical 
University of Lodz, Lodz, Poland,  
3Department of Metodology of Teaching Motor Skills, Medical University of 
Lodz, Lodz, Poland
Introduction: Obesity among people with vision impairment may sec-
ondarily aggravate their disability. The study shows results the problem of 
excess weight in Polish children with vision impairment, attending special 
schools for the blind and visually impaired.
Methods: 89 subjects (50 boys and 39 girls) with vision impairment with-
out coexisting disabilities took part in the study. The study was conducted 
in three Polish special schools for children with vision impairment. An-
thropometric measurements and sociodemographic questionnaire were 
carried out. Excessive body weight among subjects was evaluated with the 
use of centile nets of the BMI according to the Polish recommendation.
Results: In the study sample, almost 18% of all children were overweight 
and 12% were obese. Even though girls were more overweight than boys 
(girls –33,3% and boys – 28%), gender gap was not the factor most sig-
nificant in relation to overweight (chi2=0,000; p = 0,995) and obesity 
(z=0,587; p = 0,444). Obesity was not observed among rural inhabitants, 
however they were overweight two times more often than urban inhab-
itants. The family situation had no significant impact on the frequency 
of obesity and overweight among boys (chi2=1,435; p > 0,05) as well as 
among girls (chi2=5,405; p > 0,05).
Conclusion: The frequency of excessive body weight is 10% higher among 
children with vision impairment than in the general Polish population of 
children without disability at the same age. Sociodemographic variables 
had no significant impact on the frequency of overweight and obesity.
Acknowledgement: The authors would like to thank the workers of Polish Special-
ised Training and Education Centre for the Blind and Visually Impaired in Krakow, 
Dabrowa Gornicza and Wroclaw for their help and cooperation.
T7:PO.054
Association between body mass index and waist 
circumference in 7 years old schoolchildren in bulgaria
Rangelova L.1, Duleva V.1, Petrova S.1
1National Center of Public Health and Analyses, Sofia, Bulgaria 
Introduction: Obesity of children is an important health problem in 
Bulgaria. The aim is to study and evaluate association of the overweight 
(OW) and obesity with WCs and waist-to-height ratio (WHtR) in chil-
dren 7-year-old.
Methods: In 2013, a cross-sectional survey on 3353 schoolchildren aged 
7 years, was conducted in the frame of the WHO European Childhood 
Obesity Surveillance Initiative (COSI). Weigh, height and WC of the chil-
dren were measured. OW and obesity were assessed by BMI, using WHO 
Growth Reference 2007. Prevalence of OW and obesity among children 
with WC>90P and WHtR were examined. The results from the study in 
2013 were compared with those obtained in the COSI survey carried out 
in 2008 on children in the same age.
Results: The prevalence of OW among children was 15.1%, obesity-12.9%. 
The rate of children >90P for WC was 9.5%. The prevalence of OW and 
obesity among children with WC>90P was 97.8%. as 2.2% with WC>90P 
were with normal BMI. Of the children with obesity 62.4% had WC>90P. 
Of the children with OW 8.3% had WC>90P, as it was determined a sig-
nificant difference in the prevalence of high WC among boys and girls 
(5.2% vs.11.4%). WHtR values for the children with normal BMI was 0.43; 
with OW was 0.47 and those with obesity 0.53. The comparison of the 
obtained results in 2013 with those from the COSI survey in 2008 showed 
close high rates of OW, obesity as well as the same associations with WC/ 
WHtR. The results confirm the possibility to use WHtR as appropriate 
criterion for OW/obesity assessment.
Conclusions: Overweight and obesity among 7-year-old children in Bul-
garia are still of serious public health concern. Screening for abdominal 
obesity is important and has to be done even for children with BMI in the 
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T7:PO.055
Pai-1/adiponectin and conicity index is a moderate correlation 
between central obesity and inflammation in obesity women.
Busch Furlan C.P.1, Testa Carvalho L.O.2, Moraes A.S.2, Badan R.S.2, 
Maróstica Junior M.R.1, Caranti D. A.2
1Department of Food and Nutrition, Faculty of Food Engineering, University of 
Campinas (UNICAMP), Campinas-SP, Brazil.,  
2Obesity Study Group (GEO), Federal University of Săo Paulo (UNIFESP), Santos-
SP, Brazil.
Introduction: Visceral adiposity is the key promoter of chronic subclin-
ical inflammation characterized by obesity condition. Inflammation cy-
tokines that are secreted by adipocyte like the plasminogen activator in-
hibitor-1 (PAI-1) are involved in the cardiovascular pathogenesis events. 
Unlike the unsaturated fatty acids, the saturated fatty acids are associated 
with cardiovascular diseases and increase PAI-1. This study goal is to an-
alyze the hypothesis of convergence between inflammation marker (PAI-
1), food consumption, anthropometric and body composition indicators.
Methods: Forty-two volunteers, 31 women, aged 23–60 years with BMI 
26–48 kg/m2 were selected. For nutritional assessment it was used the 
body mass index (BMI), conicity index and three days of food consump-
tion alternated. Blood samples were collected after 12h overnight fasting 
to analyze PAI-1, adiponectin and leptin concentrations. Individuals were 
grouped using adjusted terciles of the PAI-1 levels.
Results: The first tercil of the PAI-1 level was between 18.05–10,35 ng/
mL, the second tercil between 10.30–8.11ng/mL and the third tercil be-
tween 7.9–3.52 ng/mL. The ingested fat quality was lower than the recom-
mended, saturated and unsaturated fatty acids showed similar consump-
tion: about 10%. The third tertile showed significant (p <0.05) reduction 
in calories intake and circulating PAI-1. There was a moderate positive 
correlation between PAI-1/adiponectin ratio and conicity index (r=0.54).
Conclusion: These results suggest that measures of central obesity, in-
flammation (PAI/Adiponectin), conicity index and lower caloric intake 
can be used for another method to strengthen clinical subjective data.
T7:PO.056
The prevalence of abdominal obesity is as remarkable for 
underweight and normal adolescent girls as overweight and 
obese
Acar Tek N.1, Şanlıer N.1, Macit S.1
1Gazi University, Faculty of Health Science, Department of Nutrition and 
Dietetics, Ankara/TURKEY
Objective: The study was carried out in order to determine the prevalence 
of the overall and abdominal obesity by using together body mass index 
(BMI) for age z-score, measurements of waist circumference and waist-to-
height ratio in healthy Turkish adolescent girls. 
Methods: A cross-sectional study was conducted on a total of 1112 ad-
olescent girls aged 12 to 18 years old. Subjects were classified into four 
categories of BMI for age z-score (WHO, 2007 for 5–19 years old): un-
derweight, normal, overweight and obese in accordance with the cut-off 
points (≤-2SDs to 1SD, –1SD to 1SD, 1SD to 2SD and ≥2SDs z-scores, 
respectively). Abdominal obesity was defined according to WC≥ 90th 
percentile for Turkish adolescent population references and WHtR ≥ 0.5. 
Results: The prevalence of underweight 17.4%, normal weight 68.5%, 
overweight 12.1% and obese 2.0% were found. A total of 16.9% subjects 
were found abdominal obese based on WC≥90th percentile and 10.4% 
based on WHtR ≥0.5. Abdominal obesity was higher based on WC than 
based on WHtR. When evaluated four groups in terms of abdominal obe-
sity status, prevalence was found 6.4% and 2.6% in underweight, 14.6% 
and 5.8% in normal, 60.0% and 37.3% in overweight and 88.8 and 77.3% 
in obese group according to WC and WHtR respectively. There were sta-
tistically significant difference between four groups both WC and WHtR 
(p < 0.05). Both WC and WHtR was positively correlated with age r:0.332, 
r:0.156, p < 0.05 respectively. There were significant positive correlations 
between BMI values and WC measurements, WHtR in all ages. 
Conclusion: The prevalence of abdominal obesity has been found at high 
levels for overweight and obese adolescents. It should be emphasized that 
abdominal obesity is a condition that should be considered for under-
weight and normal adolescents. In accordance with these results, abdomi-
nal obesity should be regularly assessed for non-obese adolescents to pre-
vent cardiovascular risks, metabolic syndrome and other related disease.
T7:PO.057
Distribution of dynamic plantar pressure of obese boys aged 
8–14 years in China
Yang L.1,2, Yan S.1, Li X.2
1National Engineering Laboratory for Clean Technology of Leather Manufacture, 
Chengdu, China,  
2Key Laboratory of Leather Chemistry and Engineering (Sichuan University), 
Chengdu, China
Introduction: Knowledge concerning the gait characteristics and foot 
structure of obese children has been conducted, which has been applied 
into clinical. The aim of this study was to compare dynamic plantar pres-
sure between obese and non-obese boys at each age.
Methods: Totally 182 boys (8–14 years) were recruited from China, ex-
cluding pathology. Participants were tested by Footscan® Plate system. 
Each participant was required to walk with bare foot for three times in 
a custom speed to collect data of plantar pressure. According to the data 
of Working Group on Obesity in China, all subjects were classified into 
two groups at each age, group1 (thin and normal), group 2 (overweight 
and obese). Ten anatomical masks were defined by Footscan 7 Gait 2nd 
Generation (V7. 97). SPSS 17.0 was used to analyze intergroup difference.
Results: The values of peak pressure and maximum force, excluding toes 
2–5, are greater in group 2, significant differences are mainly found in 
meta 2–5, midfoot and heel areas at each age. The values of load rate of 
two groups are greatest in heel, significant differences focus on meta 2-4 
area. Pressure-time integral and impulse are greater in group 2, the signif-
icant differences of former focus on meta 2-4 area, and the later on meta 
2-5, midfoot and heel areas.
Conclusion: Hlavacek[1] found that the higher load contribute to a de-
crease in the generation of toe reflex function, which leads to the smaller 
peak pressure and maximum force in obese children. The significant dif-
ferences of load rate and pressure-time integral in Meta 2-4 area in obese 
group at each age further confirm the overload in forefoot, therefore, ur-
gent attention must be given to the protection of forefoot.
Reference:
1.  Hlavacek P, Kostelnı´kova L. Comparison of plantar pressures distribu-
tion between obese and non-obese children [J]. Clinical Biomechanics, 
2008;23:662–720.
T7:PO.058
Distribution of dynamic plantar pressure of obese girls aged 
7–13 years in China
Yan S.1, Yang L.1,2, Li X.2
1National Engineering Laboratory for Clean Technology of Leather Manufacture, 
Chengdu, China,  
2Key Laboratory of Leather Chemistry and Engineering (Sichuan University), 
Chengdu, China
Introduction: Obesity directly impacts on development of lower limbs, gait 
characteristics and foot structure. The aim of this study was to compare dy-
namic plantar pressure between obese and non-obese girls at each age.
Methods: Totally 197 girls (7–13 years) without pathology were recruited 
from China. Data of plantar pressures of ten anatomical masks was col-
lected by Footscan® Plate System. Each participant was required to walk 
with bare foot for three times in a custom speed. According to the data of 
Working Group on Obesity in China, all subjects were classified into two 
groups at each age, group1 (thin and normal), group 2 (overweight and 
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Results: Results show that values of peak pressure and maximum force 
are greater in group 2, and significant differences are found in meta 2-5, 
midfoot and heel areas at each age. The values of load rate are greater in 
group 2, but no significant difference exists. The impulse of two groups 
are greater in toe1, meta 2-5 and heel areas, and significant differences are 
found in meta 2-5, midfoot and heel areas at almost each age.
Conclusion: Significant differences in peak pressure and maximum force 
are obvious, particularly in midfoot, which reveals that obesity can con-
tribute to a lower arch. The values of load rate are both greatest in heel 
area. Andrew et al.[1] found that the faster the load rate of change, the 
higher risk of leg injury. Therefore, the protection of heel of children is 
imperative. The great impulse on big toe of most children provides a po-
tential capacity to valgus.
References:
1.  Andrew F-M, et al. Foot orthoses in the prevention of injury in initial military 
training: a randomized controlled trail [J]. The American J of Sports Med 
2011,39(1):30–37.
T7:PO.059
Projection of changes in the prevalence of obesity from 2012 
to 2050 in lithuania
Kriaucioniene V.1, Petkeviciene J.1, Divajeva D.2, Knuchel-Takano A.2, 
Webber L.2
1Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania,  
2UK Health Forum, London, UK
Introduction: Lithuania participates in the EConDA project which is 
funded by the EU Commission and aims to develop models to test the dif-
ferential effect of chronic disease interventions in population sub-groups. 
One aim is to project trends in obesity forward to 2050 by different edu-
cation level groups.
Methods: The data were obtained from six biennial cross-sectional na-
tionally representative postal surveys from 2000 to 2012. In total, 5602 
men and 7712 women aged 20–64 participated in these surveys. Self-re-
ported body weight and height were used to calculate body mass index. 
Trends in overweight and obesity were projected using multivariate 
non-linear regression models by age, sex and education level.
Results: Between 2000 and 2012, the prevalence of obesity increased 
among less educated men from 11.8% to 19.7% and among high educated 
men from 10.7 to 15.8%. It remained almost stable among low and high 
educated women being 22.0% and 16.9% in 2012 respectively. The most 
remarkable increase in the prevalence of obesity was found in the oldest 
age group (55–64 years) of men (from 14.9% to 32.3%) and of women 
(from 32.9% to 41.7%). By 2050, preliminary results show the prevalence 
of obesity among men was projected to increase across all age groups, with 
the exception of 20–29 year olds, irrespective of education. In high edu-
cated women, a slightly downward trend in the prevalence of obesity was 
projected. The proportion of obesity in less educated women was project-
ed to increase across all age groups, with the exception of women older 
than 34 years old.
Conclusion: There are educational differences in the distribution of obe-
sity predicted to 2050 in Lithuania.
T7:PO.060
Application of the uk foresight obesity model in malta: Health 
and economic consequences of projected obesity trends
Cauchi D.1, Gauci D.2, Calleja N.2, Marsh T.3, Webber L.3
1Department of Health Services Research and Policy, Faculty of Public Health & 
Policy, London School of Hygiene and Tropical Medicine, UK,  
2Health Information and Research Directorate, Ministry for Energy and Health, 
Malta, 3UK Health Forum, UK
Introduction: There is increasing worldwide concern about the health 
and economic burden of obesity. The aim of this research is to project 
disease burden and direct healthcare costs for a number of obesity-related 
conditions in Malta using the model developed by the UK Health Forum 
for the Foresight: Tackling Obesities project.
Methods: Self-reported Body Mass Index (BMI) data was obtained from 
nationally representative surveys (including four Health Behaviour in 
School-aged Children surveys and two European Health Interview Sur-
veys for children‘s and adults‘ BMI respectively). Routine data sourc-
es were used to derive incidence, prevalence, mortality and survival 
for twelve obesity-related disease conditions as inputs for the model. A 
two-stage modelling process is used to predict future BMI rates, disease 
prevalence and related costs in a variety of scenarios. Stage 1 employs a 
non-linear multivariate regression model to project BMI trends; stage 2 
employs a microsimulation approach to produce longitudinal disease/
cost projections, and test the impact of reductions in BMI or the effect of 
public health interventions upon future incidence of these disease. Relat-
ed direct or indirect healthcare costs of each disease are calculated on a 
cost-per-case basis.
Preliminary results: Initial projections based on child BMI prevalence 
data show a small decrease in the percentage of overweight and obese 
boys aged between 11 and 15 years by 2030, even as the percentage of 
overweight and obese 11–15 year old girls increases significantly within 
the same time period. Obesity-related disease costs and the impact of a 
number of interventions such as the introduction of a sugar sweetened 
beverage tax are being modelled.
Conclusion: These findings may have significant implications for policy, 
effectively highlighting the need for effective strategies to prevent this 
avoidable health and economic burden.
Acknowledgement: The authors would like to acknowledge the invaluable input 
of Dr. Alexandra Distefano (Clinical Performance Unit, Malta) and Dr. Kathleen 
England (Cancer Registry, Malta).
T7:PO.061
Dxa-derived body fat indices of properly controlled 
hypertensive patients are lower than those of non-properly 
controlled patients in korean women
Kim K.K.1, Lim S.H.1, Hwang I.C.1, Lee K.R.2
1Department of Family Medicine, Gachon University Gil Medical Centre, 
Incheon, Republic of Korea,  
2Department of Family Medicine, Gachon University Dongincheon Gil Hospital, 
Incheon, Republic of Korea
Introduction: The proper blood pressure (BP) control is important in 
hypertensive patients for preventing stroke and cardiovascular diseases. 
Obesity, defined by BMI, is not only a risk factor of hypertension but also 
a related factor to BP control. However, it is uncertain whether body fat 
itself is related to BP control. 
Methods: Data of the Fourth and Fifth Korea National Health and Nutri-
tion Examination Survey (KNHANES IV-V) were applied in this study. 
Of these, 2955 hypertensive subjects, who were 19 years and older with 
DXA data and took antihypertensive drugs more than 20 days a month, 
were included. 
Results: The proportion of the proper BP control (systolic BP under 140 
mmHg and diastolic BP under 90 mmHg) was 59.1%. In male, the se-
rum level of total cholesterol (P < 0.001), HDL cholesterol (P = 0.031) 
and triglyceride (P < 0.001) were lower in properly BP controlled group 
than in non-properly controlled group. However, there were no sig-
nificant differences in DXA-derived body fat indices between the two 
groups. In female, the serum level of total cholesterol (P < 0.001) and tri-
glyceride (P = 0.009) were lower in properly BP controlled group than in 
non-properly controlled group. BMI (P = 0.047), total body fat amount 
and percentage (P = 0.023, P = 0.008), limb fat amount and percentage 
(P = 0.008, P = 0.003) were lower, and appendicular skeletal muscle/body 
weight ratio was higher (P = 0.010) in properly controlled group. 
Conclusion: In Korean hypertensive women, DXA-derived body fat indi-
ces were better in properly controlled patients than in non-properly con-
trolled group. However, there were no differences of DXA indices between 
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T7:PO.062
Clinical potential of 8-electrode BIA for sarcopenic obesity 
diagnosis and monitoring
Pietrobelli A.1,2, Zheng J.2, Jia G.2, Heymsfield S.B.2
1Pediatric Unit, Verona University Medical School, Verona, (ITALY),  
2 Pennington Biomedical Research Center, Louisiana State University System, 
Baton Rouge, LA, (USA).
Introduction: Sarcopenic obesity, a pathological state with excess fat and 
depleted skeletal muscle mass (SM), is increasingly being recognized as a 
phenotype associated with adverse clinical outcomes. How does 8-elec-
trode multi-segment bioimpedance analysis (BIA) compare to dual-ener-
gy x-ray absorptiometry (DXA) as the reference for estimating SM?
Methods: Appendicular lean soft tissue (ALST; arm, leg, and total) was 
measured by DXA and predicted by two BIA systems, MC-780 and MC-
980 (Tanita Corp, Tokyo, Japan) in 74 healthy men and women age >18 
yrs varying in BMI. The MC-780 and 980 results were almost identical and 
findings are therefore presented only for the MC-780.
Results: Total body fat mass measured by DXA and was highly correlat-
ed with BIA estimates (R2, 0.94, p < 0.001). Arm, leg, and total ALST for 
DXA and BIA (kg, X± SD) are shown for males (M), females (F), and 
combined M+F (T) in the table. There were no significant differences (D) 
observed in the regional and total ALST measures across any of the groups 
and group Ds were all <1 kg. DXA and BIA total ALST correlations ranged 
from 0.92–0.94 (all, p < 0.001). ARM D LEG D TOTAL D DXA M 8.4 ± 1.7 
20.9 ± 3.8 ± F 4.5 ± 1.0 14.2 ± 2.6 ± T 6.4 ± 2.4 17.5 ± 4.7 23.9 ± 7.0 MC-
780 M 7.8 ± 1.4 –0.6 ± 0.7 22.2 ± 3.4 1.2 ± 1.4 ± ± F 4.4 ± 0.7 –0.1 ± 0.6 
14.5 ± 1.7 0.3 ± 1.2 ± ± T 6.1 ± 2.0 –0.3 ± 0.7 18.2 ± 4.7 0.8 ± 1.3 
24.3 ± 6.7 ± R2 0.93 0.92 0.94
Conclusion: 8-electrode multi-segment BIA has the potential for diag-
nosing and monitoring sarcopenic obesity in the clinical setting.
T7:PO.063
Association of serum mir-155 and mir-146a with male 
subfertility and obesity
Dermitzaki E.1, Bobjer J.2 3, Katrinaki M.1, Lyroni K.1, Margioris A.N.1, 
Lundberg Giwercman Y.4, Giwercman A.2,3, Tsatsanis C.1
1Lab Clinical Chemistry, Medical School, University of Crete, Heraklion, Crete 
Greece,  
2Reproductive Medicine Research Group, Dept. of Clinical Sciences Malmö, 
Lund University, Malmö, Sweden,  
3Reproductive Medicine Centre, Skĺne University Hospital Malmö, Lund 
University, Malmö, Sweden,  
4Molecular Genetic Reproductive Medicine, Dept. of Clinical Sciences Malmö, 
Lund University, Malmö, Sweden
Introduction: Micro RNAs (miRNAs) are small non-coding RNAs that 
regulate mRNA expression and stability. miRNAs are also present in the 
serum and have been identified as potential biomarkers for several dis-
orders including inflammatory diseases. Among the different miRNAs, 
miR-155 and miR-146a are central regulators of inflammation and their 
intracellular levels are elevated in activated macrophages. Male subfertility 
has been associated with obesity-related Low Grade Systemic Inflamma-
tion (LGSI), as well as with androgen deficiency. Aim of this study was 
to determine potential association of miR-155 and miR-146a with LGSI, 
hypogonadism and fertility in human serum. 
Methods: For this purpose, 60 subjects were randomly selected from an 
ongoing study on subfertile men (hypogonadal; n=20, eugonadal; n=20 
and control group n=19). Circulating miRNAs, reproductive hormone 
levels and inflammatory cytokines were measured in the serum. 
Results: Serum levels of miR-155 were associated with levels of miR-146a, 
but only miR-146a was associated with inflammatory markers. MiR-155 
was associated with subfertility (for subfertile group 2.23 U, 95%CI 1.7 
–2.7 U vs. 1.17, 95% CI 0.98–1.4 U in controls; p = 0.001). ROC analysis 
indicated that miR-155 with a cutoff value of 1.77 had 60% sensitivity and 
95% specificity for identifying subfertility and positive and negative pre-
dictive values of 96% and 56% respectively. When used in combination 
with FSH, specificity and sensitivity were 82% and 84% respectively while 
positive and negative predictive values were 91% and 70% respectively. No 
association was observed with any of these miRNAs and BMI, cholesterol, 
HDL or LDL. 
Conclusion: These results suggest that circulating miRNAs may be used 
as biomarkers of subfertility.
T7:PO.064
Association between physical activity and body composition 
among bariatric surgical candidates
Crisp A.H.1, Revelli M.N.1, Verlengia R.2, Rasera-Jr I.3, 
Marques de Oliveira M.R.1,4
1Post-Graduate Program in Food and Nutrition - Nutritional Sciences, Săo Paulo 
State University, Faculty of Pharmaceutical Sciences (UNESP-FcFar), Araraquara-
SP,  
2Methodist University of Piracicaba (UNIMEP), Piracicaba-SP,  
3Center of Gastroenterology and Surgery of Obesity - Bariatric Clinic, Sugarcane 
Suppliers Hospital, Piracicaba-SP.,  
4Biosciences Institute of the Săo Paulo State University (IB-UNESP), Botucatu
Objective: This study investigates the relationship between moder-
ate-to-vigorous physical activity (MVPA) intensity and body composition 
parameters among women undergoing bariatric surgery.
Methods: Cross sectional analysis was conducted in 22 women 
(mean ± SEM: age 29.1 ± 1.0 years; height 159.1 ± 1.0 cm; body mass 
113.2 ± 1.9 kg; IMC 44.6 ± 0.5 kg/m2) candidates to bariatric surgical. 
Physical activities were measured objectively for seven consecutive days 
using a tri-axial accelerometer (ActiGraph, wGT3X-BT monitor). Addi-
tionally, body composition was estimate by multi-frequency bioimped-
ance analysis (Biospace, InBody 230). Pearson correlation analyses was 
used to test associations between total weekly (min) MVPA and body 
composition parameters.
Results: total weekly MVPA values ranged 100–711 min amongst bar-
iatric patients with mean value of 275.5 ± 33.7 min. There was not ob-
served a significant correlation (p > 0.05) between MVPA with body mass 
(r = 0.33), fat mass (r = 0.18) and body fat percentage (r = -0.23). On oth-
er hand, there was a moderate correlation of MVPA with fat-free mass 
(r = 0.46; p = 0.03) and skeletal muscle mass (r = 0.45; p = 0.03).
Conclusion: MVPA was positively related with fat-free mass and skeletal 
muscle mass in women seeking for bariatric surgery. Our findings indicate 
that the level MVPA should be encouraged among bariatric patients.
Acknowledgement: Support Foundation of Săo Paulo (FAPESP) and National 
Council for Scientific and Technological Development (CNPq)
T7:PO.065
The association of CRP with physical fitness, anthropometry 
and metabolic syndrome z-score in youth may differ by 
gender
Kjartansdottir I.1, Bjarnason R.1,2, Arngrimsson S.A.3, Olafsdottir A.S.3
1University of Iceland School of Health Sciences,  
2Department of Pediatrics, Landspitali - University Hospital, Reykjavik, 
3University of Iceland School of Education
Introduction: C-reactive protein (CRP) is a predictor of cardiovascular 
events in adults but in adolescents the effect is lesser known. The aim of 
the study was to evaluate the correlation of CRP with anthropometric 
measurements in adolescents. Secondly, to investigate the association of 
CRP with markers of glucose metabolism and metabolic syndrome score 
(MetS z-score) and weather physical fitness had impact on this associa-
tion.
Methods: A cross sectional study of 16 year old Icelandic adolescents (113 
boys and 110 girls). Parameters measured were; body composition and 
body fat percentage (skinfolds; %BF), blood pressure, CRP, glucose, in-
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ax). The MetS z-score was calculated from; waist circumference (WC), 
mean-arterial pressure (MAP), triglycerides, HDL (inverted) and HO-
MA-IR.
Results: The correlation of CRP with anthropometrical measurements 
was strongest, although moderate, with %BF and then WC. Multiple 
regression revealed the association of CRP with HOMA-IR and MetS 
z-score to be mediated through body fat. Adjusting further for physical 
fitness caused negligible variation on this association. Participants with 
good to superior PF had more favourable HOMA-IR and MetS z-score 
than those with very poor to fair PF but CRP was only lower among the 
fitter boys. When split up in to thirds according to participants’ %BF all 
metabolic variables, except glucose, were more unfavourable among the 
3rd %BF-group compared to the leaner groups. However, none of the met-
abolic biomarkers among the fit girls in the 3rd %BF-group were more 
favourable than among the girls with poorer fitness.
Conclusion: The association of CRP with HOMA-IR and MetS z-score 
appear to the greatest extent to be mediated through body fat in healthy 
adolescents and independent of physical fitness. High percentage of body 
fat among adolescent girls can hinder the beneficial effects of physical fit-
ness on their metabolic status.
T7:PO.066
Prevalence of overweight and obesity among newly 
diagnosed patients with type 2 diabetes mellitus in durres 
albania
Carcani M.1, Toti F.2, Zalla B.4
1department of internal medicine, regional hospital durres, albania,  
2department of endocrinology and diabetes, QSU Mother Teresa Tirana Albania,  
3institute of public health, family doctor
Aim: Obesity and type 2 diabetes mellitus (DM) strongly affect general 
health of population worldwide. Obesity is considered to be a strong risk 
factor for developing type 2 DM. the aim of this study is to evaluate the 
prevalence of overweight and obesity in newly diagnosed patients with 
type 2 DM.
Methods:Begining in january 2013 until december 2014, 8000 patients 
with type 2 DM were consulted in our department. 1000 of them were 
diagnosed for the first time with type 2 DM. All these were enrolled in this 
study. we documented: weight, height, BMI, eating and exercice habits, 
personal and family history.
Results: 100 of them (10%) had normal body weight, of which 70 were 
females and 30 were males. 250 patients (25%) were overweight, of which 
100 were females (40%) and 150 were males (60%). 650 patients (65%) 
were obese, of which 430 were females (66%) and 220 were males (34%). 
Overweight and obese patients didn‘t have any kind of restrain regarding 
food intake. they admitted having less or no physical activity.
Conclusion: 90% of newly diagnosed patients with type 2 DM were obese 
or overweight. this figure makes us realize about the impact that obesity 
and diabetes have on a patient‘s life, on society health budget and on what 
we should do to manage life with obesity and diabetes more easily, to pre-
vent complications and to promote healthier eating and living.
T7:PO.067
The association between periodontal disease and overweight 
and obesity: A systematic review
Keller A.1, Rohde J.F.1,3, Raymond K.1, Heitmann B.L.1,2,3
1Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, 
Copenhagen, Denmark,  
2The Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, The 
University of Sydney, Australia,  
3Institute of Public Health, University of Southern Denmark, Copenhagen, 
Denmark
Introduction: Periodontitis and obesity are among the most common 
chronic disorders affecting the world’s adult populations, and recent re-
views, primarily based on cross-sectional studies have suggested a poten-
tial link between obesity and periodontitis, thus eliminating the possi-
bility to assess temporal relationships and increasing the risk of reverse 
causality. This review assessed the evidence from longitudinal and exper-
imental studies.
Methods: Intervention and longitudinal studies with overweight or obe-
sity as exposure and periodontitis as outcome were searched through 
Pubmed/Medline and Web of Knowledge by two researchers.
Results: Eight longitudinal and five intervention studies were included. 
Two longitudinal studies found a direct association between overweight 
at baseline and risk of developing periodontitis, and further three studies 
found a direct association between obesity and development of periodon-
titis. The 3 remaining studies did not find significant associations. Two 
intervention studies on the influence of obesity on periodontal treatment 
effects found that the response to non-surgical periodontal treatment was 
better among lean than obese patients, while three studies did not report 
treatment differences between obese and lean.
Conclusion: This systematic review suggests that overweight, obesity, 
weight gain and increased waist circumference may be risk factors for de-
velopment or worsening of periodontal disease.
Acknowledgement: 1. Conflict of Interest: The authors declare not having any con-
flict of interest. 2. Funding: Supported by Tryg foundation, Denmark.
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Association between uric acid and albumin/creatinine ratio in 
pre-metabolic syndrome
Krajcoviechova A.1,2, Cifkova R.1, Wohlfahrt P.1,3, Bruthans J.1, Tremblay J.2, 
Hamet P.2
1Center for Cardiovascular Prevention, Charles University in Prague, First Faculty 
of Medicine and Thomayer Hospital, Prague, Czech Republic,  
2Montreal University Hospital Research Center, CHUM, Montréal, Canada,  
3Department of Preventive Cardiology, Institute for Clinical and Experimental 
Medicine, Prague, Czech Republic
Objective: Association between serum uric acid (UA) and urine albumin/
creatinine ratio (ACR) has been observed in individuals with metabolic 
syndrome (MetS). We evaluated the cross-sectional association between 
UA and ACR in pre-metabolic individuals.
Methods: In a study of a representative Czech population (n=2895) aged 
25–64 years, urinary albumin and creatinine excretion were determined 
in an early morning spot urine sample. Components of MetS were defined 
using the joint statement of IDF, NHBLI, AHA, WHF, IAS, and IASO. 
Individuals presenting with 1 or 2 components were supposed pre-meta-
bolic. Hypertension was defined as systolic blood pressure ≥140 mmHg, 
or diastolic blood pressure (DBP) ≥ 90 mmHg, or current use of blood 
pressure lowering drugs. Individuals with diabetes treated with glucose 
lowering medication and/or current use of inhibitors of xanthine oxidase 
were excluded.
Results: There were 665 (25%) individuals without any component of 
MetS, and 1248 (46.8%) individuals with 1 or 2 components of MetS. In 
univariate linear regression, there was a significant correlation between 
UA and ln-ACR in pre-metabolic men (n=639; β 0.091; p = 0.022) and 
women (n=609; β 0.122; p = 0.003). In multivariate analysis of pre-meta-
bolic individuals, UA was independently associated with ln-ACR (β 0.057; 
p = 0.005), age (β –0.265; p < 0.001), gender (β –0.502; p < 0.001), waist-
to-height ratio (β 0.241; p < 0.001), ln-triglycerides (β 0.070; p = 0.001), 
estimated glomerular filtration rate (β –0.434; p < 0.001), amount of 
grams of alcohol per week (β 0.098; p < 0.001), and diuretics (β 0.056; 
p = 0.006). We observed independent interaction of ln-ACR with hy-
pertension (p = 0.002) and DBP (0.025) in relation to UA. In individuals 
without any component of MetS, there was no association between UA 
and ln-ACR.
Conclusion: We report an independent association between UA and ln-
ACR in pre-metabolic individuals. This association appears to be largely 
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T7:PO.069
Measuring physical activity level, and sedentary behaviours 
among studentsat the university of medicine, albania
Carcani M.1, Janko M.2, Xherahu E.2, Resula B.2, Xhavara E.2, Memia A.2, 
Shehi E.2, Alimehmeti I.2, Toti F.1,2
1Endocrinology Service -UHC Mother Theresa, Tirana-Albania,  
2Faculty of Medicine - University of Medicine, Tirana-Albania
Introduction: Lack of physical is a major risk factor for overweight and 
obesity, leading the way to many other health conditions.Medical students 
are supposed to be best informed on this topic.
Objective:Evaluation of actual physical activity using pedometers, and 
sedentary behaviors among students at the University of Medicine in Ti-
rana.
Methods:301 students (74% females ) were interviewed using a structured 
questionnaire regarding their physical activity level and beliefs, and seden-
tary behaviors.Randomly chosen students (130) were afterwards instruct-
ed to use a pedometer to count the number of daily steps, without any 
suggestion as for the number of necessary steps for not being sedentary.
Results:BMI average was 21.2 kg /m2 ( s.d 2.49 ) in females, and 24.5 kg/
m2 /s.d.3.33) in males.Among females 6.8% were overweight and 0.5% 
were obese.Among males 37.2% were overweight, and 6.4% were obese.
Abdominal perimeter was 72.8cm(s.d.6.6 ) and 88.4 cm (s.d.11) in males.
Average number of steps per day in all students were 8712 (s.d. 5107), 
in females was 8.218 (s.d 4902) and 10.206 (s.d 5408 ) in males.73% of 
the students declared that they were not engaged in any kind of physical 
activity.
Conclusions:We didn‘t encountered a high level of obesity in this popula-
tion, however a sedentary lifestyle was noted with only a small proportion 
of students approaching the level of non-sedentary lifestyle ( >10.000 steps/
day), therefore exposing them to weght gain problems in the next future.
T7:PO.070
Evaluation of body adiposity index as a predictor of 
cardiovascular risk in adults from bogotá, colombia
Ramírez-Vélez R.1, González-Ruíz K.1, García A.I.2, Nińo-Silva L.A.2
1Grupo de Ejercicio Físico y Deportes, Facultad de Salud, Programa de 
Fisioterapia, Universidad Manuela Beltrán, Bogotá D.C., Colombia,  
2Grupo de Cuidado Cardiorrespiratorio, Facultad de Salud, Programa de Terapia 
Cardiorrespiratoria, Universidad Manuela Beltrán, Bogotá D.C., Colombia
Objective: We evaluated the predictive ability of the recently developed 
body adiposity index (BAI) on risk factors associated with early-onset car-
diovascular disease
Materials and methods: A cross-sectional study in 527 volunteers from 
the education and automotive sector in Bogotá, Colombia. BAI was cal-
culated using the Bergman et al. equation ([hip circumference in cm)/
[height in m2]1,5−18]). Clinical and laboratory data were collected: body 
mass index, central obesity, visceral fat, cholesterol, HDL-C, LDL-C, tri-
glycerides and glucose. Atherosclerosis-index (AI): Cholesterol/HDL-C, 
LDL-C/HDL-C, triglycerides/HDL-C and lipid-metabolic index (LMI) 
ratios were calculated. Prevalence rates and means, according to tertiles 
(T), and multivariate analysis between the BAI, clinical and AI outcomes 
were estimated.
Results: Obesity prevalence was 33.9% (BAI > 27.5%). Subjects with low-
er BAI (T-1) had lower cholesterol, triglycerides/HDL-C, cholesterol/
HDL-C levels and better LMI; P < .001. The multivariate model showed 
in T-3 subjects an OR 3.33 (95% CI 2.16 to 5.13) for central obesity and 
an OR 3.39 (95% CI 2.34 to 4.90) for increased visceral fat. As regards 
lipid and carbohydrate metabolism, BAI was able to predict the risk OR 
7.95 (95% CI 4.88 to 12.94), OR 1.60 (95% CI 1.03 to 2.41), OR 1.69 (95% 
CI 1.06 to 2.70) and OR 9.27 (95% CI 2.01 to 21.80), shows a significant 
association between cholesterol, triglycerides, LDL-C and glucose, respec-
tively, P < 0.001.
Conclusion: A high prevalence of obesity by BAI was observed, and statis-
tically positive associations with cardiovascular risk factors were shown.
T7:PO.071
Abdominal obesity as a risk factor for occurrence of metabolic 
syndrome in people with sedentary lifestyles
Simonovska V.1, Spasovski M.2
1Department of Social Medicine, Institute of Social Medicine, Medical faculty, 
University of Saint Cyril and Methodius, Skopje, Republic of Macedonia,  
2Department of Social Medicine, Institute of Social Medicine, Medical faculty, 
University of Saint Cyril and Methodius, Skopje, Republic of Macedonia
Introduction: The modern world faces the obesity as a serious crisis that 
has an epidemic character, in the health care system. Pouliot and his as-
sociates identified obesity as a probable cause for occurrence of metabolic 
syndrome. Goals: To determine the percentage of risk factors that define 
the metabolic syndrome and to determine their correlation, with a spe-
cial turn on abdominal obesity as an important risk factor. Materials and 
methods: In this cross-sectional study 156 subjects participated, of which 
101 women and 55 men. To determine the metabolic syndrome, we have 
used the criteria of the National Cholesterol Education Program’s Adult 
Treatment Panel III. Abdominal obesity was determined by a method of 
measurement of the waist size in centimeters. The data was statistically 
processed with SPSS 8.0. 
Results and discussion: There is a difference between the average waist 
sizes of the groups, the first group, without metabolic syndrome with an 
average of 52.05+6.93, and the other groups with metabolic syndrome, the 
second group with 75.76+13.80, the third group with 84.93+12.78, and the 
fourth group with 97.40+8.32. 
Conclusion: In the group without metabolic syndrome, there was in-
creased waist size in 17.7% of the subjects, whereas in the group with 
metabolic syndrome, with five risk factors, increased waist size was found 
in 20% of the subjects.The ANOVA test carried out between the refer-
ent group and the other groups with metabolic syndrome, and also just 
between the groups with metabaolic syndrome, has shown statistically 
significant difference in the waist size. Key words: abdominal obesity, sed-
entary lifestyle, metabolic syndrome.
Acknowledgement: Simonovska Valentina , MD , MSci , Assistant of Professor , 
Institute of Social Medicine , Medical Faculty , University of Ss Cyril and Methodius 
, Skopje ; Spasovski Mome MD, PhD , Professor , Institute of Social Medicine , Med-
ical Faculty , University of Ss Cyril and Methodius , Skopje ;
T7:PO.072
Peculiarity of eating behavior pattern of women living in rural 
families of the republic of tatarstan
Kamalova F.M.1, Valeeva E.R.1
1Kazan Federal University, Russian Federation 
Introduction: The evidence of cause-effect relation of obesity to severe 
metabolic disturbances and cardiovascular diseases defines the impor-
tance of this problem for modern health care and allows speaking of obe-
sity as of serious threat for public health.
Methods: Selective investigation included the study of 536 women living 
in the rural area of the Republic of Tatarstan in 2013. The lifestyle char-
acteristics was based on the questionnaire survey and direct interviewing 
of women living in rural families. 49.0% of women suffering from obesity 
were revealed in studied population. The eating behavior pattern in fe-
male population of the rural area was formed due to overeating high-fat, 
high- calorie foods. The number of meals per day is 6–7 in 61,6%, where 
the major proportion belongs to fats and carbohydrates, regular eating of 
vegetables and fruit was observed only in 21,3%, vegetable oil- in 32,3%, 
meat – in 49,0%, fish- in 6,8%. The obtained data are indicative of the 
fact that despite the excessive intake of high-calorie foods 88,1% of wom-
en in general are satisfied with their nutrition. The number of hot meals 
significantly decreased (р<0,05) in dynamics for the ten-year period, but 
the number of persons following the dietary regime increased. Consider-
able decrease (р<0,001) of regular intake of vegetables and fruit, vegetable 
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is a source of particular concern. Therewith the incidence of circulatory 
diseases increased from 380,6 to 518,5 cases per 1000 of corresponding 
population. 
Conclusion: To prevent circulatory diseases a healthy eating behavior pat-
tern of women living in rural areas is to be formed.The work is performed 
according to the Russian Government Program of Competitive Growth of 
Kazan Federal University
T7 – Primary/secondary prevention
T7:PO.073
Nuts consumption in relation to overweight, and abdominal 
and general obesity
Rashidkhani B.1
1Shahid Beheshti University of Medical Sciences 
Introduction: Nuts are one of the components of a healthy Mediterranean 
diet which are often restricted in weight management programs due to their 
high fat content. In this study, the relationship between nuts consumption 
and overweight, abdominal obesity and general obesity was assessed.
Methods: In this cross-sectional study, 550 female adolescents aged 15–18 
years were selected from Isfahan Province using a multistage cluster ran-
dom sampling. Anthropometric measures were recorded and dietary in-
takes were evaluated using a validated semi-quantitative food frequency 
questionnaire. nuts are considered in the current analysis were pistachio, 
almond, peanut, walnut and seeds. Abdominal obesity was defined as the 
75th percentile of waist circumference for Iranian children and adoles-
cents. Overweight and obesity were defined on the basis of International 
Obesity Tasks Force (TOTF) cut-points. Models are adjusted for age, total 
energy intake, percentage of energy from fat, and physical activity.
Results: The prevalence of abdominal obesity and overweight/obesity was 
48.9 and 25.7%, respectively. After adjusting for potential confounders, sub-
jects in the top quartile of the nut consumption were less likely to have over-
weight and obesity [OR: 0.25; 95% CI: 0.11–0.54] and abdominal obesity 
(OR: 0.43; 95% CI, 0.22–0.84), compared to those in the lowest quartile.
Conclusion: Consumption of nuts was negatively associated with low-
er risk of abdominal obesity, over weight and obesity. The results of this 
study suggested that replacing nuts into diets might help in controlling the 
weight. Research relating to this abstract was funded by National Nutri-
tion and Food Technology Research Institute
T7:PO.074
Family and lifestyle factors mediate the association between 
socio-economic status and fat mass in children and adolescents
Plachta-Danielzik S.1, Kehden B.1, Stärke F.1, Müller M.J.1
1Institute of Human Nutrition and Food Science, Christian-Albrechts-University 
of Kiel, Kiel, Germany
Background: The socio-economic status (SES) is a major determinant 
of childhood overweight. The explanation of this association is unclear. 
Therefore, we examined mediators of the association between SES and fat 
mass (FM) in children to develop selective preventive measures against 
childhood overweight.
Methods: Data of 5,352 children aged 5–16 years of the Kiel Obesity Pre-
vention Study were used to conduct mediation analyses between SES and 
FM. FM was assessed by bioelectrical impedance analyses. SES was de-
rived from the highest educational level attained by either parent (low: 
18.1%; middle: 32.5%, high: 49.4%). Single parenthood, common meals, 
maternal smoking habits and weight status, media consumption and phys-
ical activity of the children were considered as mediators. Mediation anal-
yses were based on sex-adjusted linear regression models. Significance of 
indirect effects was tested by the use of the delta method (Sobel z test).
Results: Prevalence of overweight was 15.6%. The correlation between 
SES and FM increased with age (-0.068, –0.142 and –0.167 for 5–7-, 
9–11- and 13–16-year olds, respectively (p < 0.001 for all)). In 5–7-year 
olds, media consumption (66.9%) and maternal BMI (54.3%) completely 
mediated the association between SES and FM. In 9–11-year olds, me-
dia consumption (28.1%), maternal BMI (23.9), maternal smoking habits 
(13.1%) and physical activity (9.1%) also completely mediated the associ-
ation. In 13–16-year olds, approximately 55% of the association was me-
diated through maternal BMI (27.0%), maternal smoking habits (12.1%), 
common meals (7.5%) and media consumption (6.3%).
Conclusion: The association between SES and FM could be explained by 
55–100%. The mediators varied by age. Thus, age-specific preventive mea-
sures have to be specified.
T7:PO.075
The effect of a school-based active video gameintervention on 
children’s aerobic fitness, physical activity level, andexercise-
related psychological variables: A preliminary RCT trial
Lau W.C.1, Zhang S.1, Maddison R.2
1Department of Physical Education, Faculty of Social Science, Hong Kong 
Baptist University,  
2National Institute for Health Innovation, Medical and Health Sciences, 
University of Auckland. NZ
Objectives: To determine the effectiveness of the prescribed AVG inter-
vention in the physiological, behavioral and psychological perspectives.
Methods: 40 children aged 9–10 were recruited at a local primary school 
in Hong Kong and were assigned randomly into control and intervention 
group. Children in the intervention group participated in two 60 minutes 
XBOX 360 gaming session per week for 12 weeks. The intervention was held 
in a large function room that allowed all children played at the same time and 
XBOX Sport Season One & Two that provided 12 different games of sports 
with light-to-moderate intensity were at children’s free choice. Baseline and 
post-tests were conducted in both groups, measuring BMI, aerobic fitness, 
PA level (using accelerometer), exercise-related self-efficacy, and enjoyment. 
ANCOVA was employed to determine the post-intervention outcomes 
while controlling for the baseline data, with significant level set at 0.05.
Results: Data analysis revealed three major results: 1) children in the in-
tervention group significantly outperformed those in the control group at 
post-test in aerobic fitness and average daily total physical activity (p < 0.01 
and p < 0.05, respectively); 2) children in the intervention group marginally 
outperformed those in the control group in average daily moderate-to-vig-
orous physical activity (p = 0.08); 3) no significant differences were ob-
served between intervention and control group at post-test in BMI, exer-
cise-related self-efficacy, and enjoyment in physical activity (p > 0.05).
Conclusion: The prescribed AVG intervention provided an effective al-
ternative in promoting children’s aerobic fitness and physical activity in 
school setting.
T7:PO.076
A dyadic focus on obesity preventive health behaviors: 
Opportunities for novel research
Nebeling L.1, Hennessy E.2, Oh A.1, Patrick H.4, Yaroch A.3
1National Cancer Institute, Division of Cancer Control and Population Sciences, 
Behavioral Research Program, Bethesda, MD, USA,  
2Leidos Biomedical Research Inc., Clinical Monitoring Research Program, 
Frederick National Laboratory for Cancer Research, Frederick, MD, USA,  
3Gretchen Swanson Center for Nutrition, Omaha, NE, USA,  
4LiveHealthier, Bethesda, MD, USA
Introduction: To provide an overview of the FLASHE study, a forthcom-
ing public-use resource that evaluates multilevel influences on obesity 
preventive health behaviors (diet, physical activity, sedentary behavior, 
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Methods: FLASHE is a U.S.-based sample drawn from a Consumer 
Opinion Panel. Cross-sectional data were collected between April-Oc-
tober, 2014 using a web-based platform. FLASHE focuses on multilevel 
correlates of obesity among parent-teen dyads (12–17 years old) with an 
oversampling of Non-Hispanic Blacks. Objective physical activity was 
measured in a subsample of teens. Constructs include psychosocial fac-
tors (e.g. self-efficacy, motivation, emotional regulation), interpersonal 
factors (e.g. parenting style and parenting practices), and characteristics 
of the home and neighborhood environments among others (e.g. food in-
security, housing, employment). 
Results: The FLASHE study enrolled 1944 dyads, of which 1251 were 
randomized to receive only the FLASHE surveys and 693 to receive the 
FLASHE surveys plus a physical activity monitor to be worn by teens for 
7 days. Of the 1251,86% of dyads completed all surveys. Of the 693, over 
90% returned the physical activity monitor and 80% completed all surveys 
and returned their monitor. 
Conclusion: FLASHE is a unique, public-use resource to evaluate re-
search questions focused on parents, teens, and parent-teen dyads across 
levels of influence on obesity preventive health behaviors. Work is ongo-
ing to expand this useful resource by adding a geospatial component and 
linking it with extant data resources (e.g. policy databases) providing rich 
research opportunities for the EASO audience.
T7:PO.077
Mind-body practice is inversely associated with body weight 
status in a general population from the NutriNet-Santé Study
Camilleri G.M.1, Méjean C.1, Bellisle F.1, Hercberg S.1,2,3, Péneau S.1
1Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle, 
Centre de Recherche en Epidémiologie et Statistiques, Inserm (U1153), Inra 
(U1125), Cnam, COMUE Sorbonne Paris Cité, Bobigny, France,  
2Unité de Surveillance et d’Epidémiologie Nutritionnelle, Institut de Veille 
Sanitaire, Université Paris 13 Sorbonne Paris Cité, Bobigny, France,  
3Département de Santé Publique, Hôpital Avicenne, Bobigny, France
Introduction: In industrialized countries characterized by a high prev-
alence of obesity and chronic stress, mind-body practices such as yoga 
or meditation may facilitate body weight control. However, virtually no 
data are available to ascertain whether practicing mind-body techniques 
is associated with weight status. We aimed to examine the relationship be-
tween the practice of mind-body techniques and weight status in a large 
sample of the adult general population.
Methods: A total of 14,400 men and 49,228 women aged ≥18 y partici-
pating in the NutriNet-Santé study were included in this cross-sectional 
analysis. We collected data on mind-body practices as well as self-report-
ed weight and height. The association between the practice of mind-body 
techniques and weight status was assessed using multiple linear and lo-
gistic regression models adjusted for socio-demographic, lifestyle and 
dietary factors.
Results: Regular users of mind-body techniques were less likely to be 
overweight (OR (95%CI): 0.74 (0.69 to 0.79) adjusted for socio-demo-
graphic and lifestyle factors) or obese (OR (95%CI): 0.56 (0.50 to 0.62)) 
than never-users. In addition, regular users had a lower BMI than never 
users (slope (95% CI): –0.88 (-0.99 to –0.76)).
Conclusion: Our data provide novel information about an inverse rela-
tionship between mind-body practice and weight status. If causal links 
were demonstrated in further studies, such practice could be fostered in 
obesity prevention and treatment.
T7:PO.078
Intuitive eating is inversely associated with body weight 
status in a general population from the NutriNet-Santé Study
Camilleri G.M.1, Méjean C.1, Bellisle F.1, Andreeva V.A.1, Kesse-Guyot E.1, 
Hercberg S.1,2,3, Péneau S.1
1Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle, 
Centre de Recherche en Epidémiologie et Statistiques, Inserm (U1153), Inra 
(U1125), Cnam, COMUE Sorbonne Paris Cité, Bobigny, France,  
2Unité de Surveillance et d’Epidémiologie Nutritionnelle, Institut de 
Veille Sanitaire, Université Paris 13 Sorbonne Paris Cité, Bobigny, France, 
3Département de Santé Publique, Hôpital Avicenne, Bobigny, France
Introduction: Intuitive eating is an adaptive dietary behavior that em-
phasizes eating in response to physiological hunger and satiety cues, to-
gether with low preoccupation toward food. It has been proposed as an 
alternative to weight loss programs that would promote a healthier food-
mind-body connection. We therefore aimed at studying the relationship 
between intuitive eating and weight status in a large sample of adult gen-
eral population.
Methods: A total of 11,774 men and 40,389 women aged ≥18 y partici-
pating in the NutriNet-Santé cohort were included in this cross-sectional 
analysis. Intuitive eating levels were collected using the validated French 
version of the Intuitive Eating Scale-2. The association between intuitive 
eating, its subscales (categorized into quartiles) and overweight/obesity 
was assessed using multivariate logistic regression models.
Results: A higher IES score was strongly associated with lower over-
weight/obesity in both men and women. The strongest associations were 
observed in women [quartile 4 vs. 1 for overweight (excluding obesity) 
(OR (95% CI): 0.19 (0.17, 0.20)) and obesity (OR: 0.09 (0.08, 0.10))]. As-
sociations in men were as follow [quartile 4 vs. 1 for overweight (exclud-
ing obesity) (OR: 0.43 (0.38,0.48)) and obesity (OR: 0.14 (0.11,0.18))]. All 
IES subscales were inversely associated with weight status: in particular 
Eating for Physical Rather than Emotional Reasons, followed by Reliance 
on Hunger and Satiety Cues and Unconditional Permission to Eat.
Conclusion: Greater intuitive eating is associated with a lower prevalence 
of overweight and obesity which supports the importance of eating in re-
sponse to hunger and satiety signals. These data bear out the relevance to 
promote such behavior for obesity prevention and treatment.
T7:PO.079
Sense of coherence, health perceptions and attitudes towards 
obesity treatment of general practitioners in poland
Bąk-Sosnowska M.1, Kołodziej S.2, Gojdź K.3, Skrzypulec-Plinta V.4
1School of Health Sciencesin Katowice, Medical University of Silesia, 
Department of Psychology, Chair of Philosophy and Humanities, Katowice, 
Poland,  
2Polpharma Biuro Handlowe Sp. z oo., Warsaw, Poland,  
3DrKrzysztofGojdźClinic, Warsaw, Poland,  
4School of Health Sciencesin Katowice, Medical University of Silesia, 
Department ofDepartment of Woman‘s Health, Katowice, Poland
Introduction: Physicians’ attitude towards health may influence the use of 
prophylaxis in patients and their motivation to constructive health behav-
iors. The aim of this study was to evaluate the sense of coherence, health 
perception and attitude towards obesity treatment in primary care.
Methods: We examined 250 GPs. The mean age was 53.55 ± 0.57 yrs, 
mean BMI 25.53 ± 4.16 kg/m2. We used: SOC-29, LZK and own question-
naire exploring the relationship to the obesity treatment.
Results: 60% of doctors have an average score of SOC. Subscale state has 
the highest score in LZK (74%).The most important criteria in LZK are: 
accept yourself(38%), feel happy (37%). 55.6% of respondents never or 
sometimes measure body weight of their patients, 88% recommend obese 
patients weight reduction. There is a positive relationship between SOC 
and LZK in category of process (p < 0.01) and purpose (p < 0.05). Doc-
tors with longer professional experience more often explain to obese pa-
tientsthe possible consequences of obesity (p <0.05). Doctors of the larger 
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ask obese patients about the cause of the obesity (p < 0.05), explain them 
the possible causes (p < 0.01), ask them about the difficulties in reducing 
excess body weight (p < 0.05). Doctors with a higher BMI, frequently ask 
obese patients about the difficulties with body weight reduction (p < 0.05). 
Doctors with low and average score of SOC less frequently measure the 
weight in their patients than doctors with high score SOC (p < 0.05).
Conclusion: GPs in Poland have a sense of coherence and perceive health 
the most commonly in category of status. High sense of coherence has 
impact on the diagnosis of overweight patients.
T7:PO.080
A comparison of a high low intensity exercise programme for 
sedentary middle managers
Potter J.A.1, James B.1, Everley S.C.1
1Department of Physical Education, University of Chichester, Chichester. UK.
Introduction: The importance of an active lifestyle and the value of ex-
ercise in achieving and maintaining a healthy body composition are well 
established. Psychological as well as physical gains are very important in 
order to promote programme adherence. The aim of this investigation was 
to study the effects of two exercise types: High Intensity Interval Training 
(HIIT) and Low Intense Steady State (LISS) exercise, upon psychological 
well-being of sedentary individuals working in stressful middle manage-
ment positions. 
Methods: Two periods of exercise were completed utilising a cross-over 
design with the HIIT and LISS training; 10 participants trained over a 
period of 8 days using an upright cycle. HIIT training consisted of 20–30 
minutes intervals of 20 seconds high intensity followed by 60 seconds 
rest. LISS training consisted of 30 minutes steady state cycling at 60–75% 
max heart rate. Psychological well-being and mood state were measured 
through interview and questionnaire. 
Results: A series of repeated measures ANOVA’s indicated that all partic-
ipants recorded lower levels of tension, calmness and happiness when ex-
ercising as opposed to being sedentary however, the improvements were 
greater with LISS. Where LISS resulted in improved mood state scores 
throughout, HITT resulted in increased depression, confusion and fatigue 
as well as a reduction in vigour. Interviews indicated a lack of confidence 
over being able to maintain a HITT exercise programme. 
Conclusion: Although HIIT training may result in physiological im-
provements and has the advantage of fitting into busy lives, it appears that 
it may not result in the same sense of psychological well-being and may in 
fact lead to negative mood states, and consequently unlikely to promote 
exercise adherence.
T7:PO.081
Preventive and educative project „with children against 
obesity“
Marinov Z.1, Marinová C.2, Pastucha D.3, Střítecká H.4, Ptáček R.5
1Children obesitological clinic, Department of Pediatrics, University Hospital 
Motol and 2nd Faculty of Medicine in Prague, Charles University Prague, Czech 
Republic,  
2Medical Access Solutions s.r.o., Prague, Czech Republic,  
3Children obesitological clinic, Department of Sports Medicine and 
Cardiovascular Rehabilitation, University Hospital Olomouc, Palacký University 
Olomouc, Czech Republic,  
4Department of Military Hygiene, Faculty of Military Health Sciences, University 
of Defence Hradec Králové, Czech Republic,  
5Department of Psychiatry, General University Hospital and 1nd Faculty of 
Medicine in Prague, Charles University Prague, Czech Republic
Introduction: Childhood obesity has become an everyday reality. Mass 
media has become a common part of the educational process for children. 
It significantly influences people´s lifestyle particularly children’s. The first 
specific environment interfering with the daily life of individuals, families 
and children is television but the web environment also influences them. 
Through the web environment, they gain information that shapes knowl-
edge, social norms and perceptions of social life. 
Methods: Obesity is a serious chronic disease leading to significant chang-
es in life quality and decreasing a life expectancy. The websites html://sde-
tmprotiobezite.cz offer basic information about child obesity in the Czech 
Republic. Their aim is a promotion of concerted efforts to influence the 
child´s family in key preventive environments in childhood obesity. 
Results: The preventive project is an open space for anyone who is in-
terested or has questions about the issues of child obesity. The website 
with professional advice addresses five basic groups: families with chil-
dren, health professionals, nutritional consultants, schools and the media, 
which should enable an orientation in the prevention of lifestyle diseases 
and obesity on the web environment. 
Conclusion: The project is an original and innovative prevention web-
site, which offers a comprehensive view of the prevention and treatment 
of overweight and obese children. The project offers original products that 
can be used in the everyday clinical practice for specific individuals who 
risk developing obesity, and those who have a family background of obe-
sity.
Acknowledgement: Research relating to this abstract was funded by Ministry of 
Health Czech Republic, Health Promotion Project 2013 and Medical Access Solu-
tions s.r.o.
T7:PO.082
What works in china? A literature review on effectiveness of 
current intervention for combating obesity among chinese 
school-aged children.
Li X.1, Hesketh T.1
1University College London Institute for Global Health, London, United 
Kingdom 
Introduction: Since 1978, when the Deng Xiaoping’s reforms including 
“Opening up to the World” policy initiated, China has witnessed dramatic 
economic growth. Undergoing nutrition transition, the burden of nutri-
tional problems has been changing from under-nutrition to over-nutri-
tion. The prevalence of overweight/obesity among Chinese children aged 
7–18 has increased dramatically, with 19.0% and 10.9% for boys and girls 
respectively in 2010.
Aim: This review is to explore the effectiveness of interventions for pre-
vention and treatment of overweight/obesity among Chinese schoolchil-
dren. 
Methods: I identified primary studies published from 1980s until 2013. 
Details of data sources, key terms, inclusion and exclusion criteria and 
the whole searching process were summarized in figure1. Data on author, 
study location, study design, age group, sample size, interventions, dura-
tion of study, length of follow-up, and findings were extracted for com-
parison. 
Results: 33 studies were finally identified fulfilling the inclusion criteria. 
28 were conducted in school settings with 3 in community surroundings 
and another 2 in the family setting. The studies consisted of one or more 
components as health/nutrition education, diet adjustment, physical 
activity, behavior modification and parental involvement. The measure-
ments of study outcome included anthropometric measures, changes in 
overweight/obesity rate and changes in levels of obesity-related biomed-
ical markers. Although the methodologies used in studies varied, 23 out 
of 33 (69.7%) were defined as effective according to statistically significant 
results in outcomes. 
Conclusion: Heterogeneity in many aspects of study methodologies lim-
ited the meta-analysis of effectiveness of current interventions. Compre-
hensive school-based interventions seem promising for preventing and 
treating overweight among Chinese schoolchildren. Insufficient evidence 
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Fig. 1. Flow chart of literature searching
T7:PO.083
Muscle strength fitness are related to a high lipid–metabolic 
cardiovascular risk
Ramírez-Vélez R.1, Triana-Reina H.R.2, Carrillo H.A.2, Ramos-Sepúlveda J.A.3, 
González-Ruíz K.4, Rubio F.5, Correa-Bautista J.E.5
1Facultad de Cultura Física, Deporte y Recreación, Universidad Santo Tomás, 
Bogotá, D.C, Colombia,  
2Programa de Licenciatura en Educación Física y Deporte, Universidad del Valle, 
Meléndez, Cali, Colombia,  
3Facultad Educación a Distancia y Virtual. Institución Universitaria Antonio José 
Camacho, Santiago de Cali, Colombia,  
4Grupo de Ejercicio Físico y Deportes, Facultad de Salud, Programa de 
Fisioterapia, Universidad Manuela Beltrán, Bogotá D.C., Colombia,  
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Objective: We studied the association of lipid–metabolic cardiovascular 
risk index with muscle strength fitness (MSF). 
Methods: Healthy young (mean age 21.2 ± 4.7 years) men (n=6,095). MSF 
was measured two times with a TKK analogue dynamometer (handgrip). 
To account for differences in body size, peak grip strength was divided 
by body mass and handgrip (kg)/kg was used in further analysis. Sub-
jects were further divided into six subgroups according to BMI (normal 
vs. overweight/obesity) and MF (tertiles: unfit, average, fit). Fasting blood 
was obtained to measure a lipid profile and glucose levels. A lipid–meta-
bolic cardiovascular risk index (LMCRI) was derived from the levels of 
triglycerides, low-density lipoprotein cholesterol (LDL-c), high-density 
lipoprotein cholesterol (HDL-c), and glucose levels. 
Results: The groups with the lowest MSF had 67% higher a lipid–met-
abolic cardiovascular risk index than the groups with the highest MSF 
(P < 0.0001). In overweight/obese participants, the LMCRI (66%/84%) was 
higher compared with subjects with normal weight (P < 0.005, in all). In 
BMI and MSF subgroups, LMCRI was higher in the overweight/unfit sub-
group (0.008 ± 1.104) when compared with the normal-weight/unfit sub-
group (-0.362 ± 0.722; P < 0.0001) and overweight/fit and normal-weight/
fit subjects (-0.422 ± 0.675 vs. 0.064 ± 0.877; P < 0.0001). Figure 1. 
Conclusions: Overweight and obesity are associated with serum conven-
tional lipids and lipid–metabolic cardiovascular risk index. However, low 
muscular fitness levels should be avoided for primary cardiovascular dis-
ease prevention.
Fig. 1. A lipid–metabolic cardiovascular risk according MSF and BMI groups
T7:PO.084
Impact of body size and composition on energy cost of self-
paced “walking for exercise”
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Introduction: Walking is the primary mode of exercise for adults of all 
ages, and a common health promotion strategy. Previous research sug-
gests that external work of walking is not affected by obesity over speeds 
of 1.8 – 6.3 kph (0.5–1.7 m/s). This study examined if body size impacts 
self-selected exercise pace and walking economy. 
Methods: 197 adults (M=80, F=117; 21 – 64 yrs; 48 – 133 kg; 18 – 43 kg/
m2) were recruited via stratification in 2 sex (male, female), 4 age (20–
34.9, 35–44.9, 45–54.9, 55–65 yrs), and 3 BMI (normal weight (NW): 18–
24.9 kg/m2; overweight (OW): 25–29.9 kg/m2; obese (OB): 30–45 kg/m2) 
groups. The self-paced ‘walking for exercise’ (SPWE) speed was measured 
twice over 2 km on a 400m track. Energy cost of walking was determined 
at four speeds (SPWE-1.2 kph (–0.33 m/s), SPWE-0.6 kph (–0.1667 m/s), 
SPWE, SPWE+0.6kph) via indirect calorimetry. Walking economy (en-
ergy cost per unit walking speed) was determined for each participant 
from the energy – walking speed regression analysis, with a smaller slope 
evidence of greater walking economy. Body composition was determined 
via the 4-C model. 
Results: There was no main effect of age (P = 0.73), but there were main 
effects for gender (M>F; P < 0.001) and BMI (NW>OW>OB; P < 0.001) 
on SPWE speed. Energy cost of walking differed with gender (M>F) and 
BMI (OB>OW>NW). Accounting for body weight and walking speed, 
walking economy did not differ between males and females, but remained 
different for BMI; NW (373 W/kph) > OW (422 W/kph) > OB (486 W/
kph). Accounting for body composition rather than weight, walking econ-
omy did not differ between NW and OW, but a ~10% difference remained 
between OB and the other groups (NW<OB and OW<OB; P < 0.01). 
Conclusion: Obesity impacts self-selected exercise walking speed and 
walking economy at speeds spanning below and above this speed. Conse-
quently, despite obese adults choosing slower walking speeds for exercise, 
there is a great relative energy cost of walking for exercise.
Acknowledgement: Research relating to this abstract was funded by the National 
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T7 – Policy
T7:PO.085
Building bridges between kindergartens and schools and 
primary health care services to reduse social inequalities
Øen G.1
1National Centre for Food, Health and Physical Activity, Bergen University 
College,  5020 Bergen, Norway.
Introduction: There are health inequalities between those with high edu-
cation and income and those without. It is considered that these inequal-
ities might be reduced by giving our children the same opportunities. In 
schools and kindergartens all children can be reached, including those 
who need extra follow-up and motivation. The Ministry of Education and 
Research and the Ministry of Health and Care Services in Norway have 
created a National Centre for Food, Health and Physical Activity to be a 
national resource centre for interdisciplinary work promoting the impor-
tance of good health in all children and young people. The Centre’s aim 
is to promote and communicate the relationship between health and chil-
dren‘s learning and education with an emphasis on healthy meals, good 
food experiences, and physical activity, and further pass on knowledge 
about adaptive measures for children and young persons with chronic ill-
nesses and disabilities, within the framework of an inclusive society by 
experiencing belonging and mastering.
Methods: The Centre’s target groups are primary audience in kindergar-
ten, schools, child health centres, school health services; authorities, own-
ers, managers and staff, and universities and colleges of further education 
of relevant educational programmes.
Results: The Centre undertakes targeted communications, counselling 
and guidance based on results from research, R&D work, and is devel-
oping examples of good practice and support materials that are predomi-
nantly presented Net-based.
Conclusion: The Centre is assigned tasks associated with national initia-
tives in health and education related to quality development and skills de-
velopment, linked to the primary objectives within the two sectors from a 
political long-term perspective.
T7:PO.086
Family intervention targeting obese children: Treatment cost 
differences of two standardized programs
Halsteinli V.1,2, Ødegård R.1,3, Lekhal S.4, Hjelmesæth J.4,5, Benestad B.4
1St Olav Hospital, Trondheim University Hospital,  
2Department of Public Health and General Practice, Norwegian University of 
Science and Technology,  
3Department of Laboratory medicine, Children’s’ and Women’s’ Health, 
Norwegian University of Science and Technology,  
4The Morbid Obesity Centre (MOC), Vestfold Hospital Trust, South-Eastern 
Norway Regional Health Authority,  
5Department of Endocrinology, Morbid Obesity and Preventive Medicine, 
Institute of Clinical Medicine, University of Oslo, Norway
Introduction: Incremental lifetime medical costs of an obese child are 
estimated to be 16 100 Euro (Finkelstein et al, 2014). This estimate reflects 
the potential cost saving of an intervention succeeding to prevent an obese 
child from persistent obesity. In Norway a family intervention has been 
performed (Trial Registry: www.clinicaltrials.gov; NCT01110096). We re-
port treatment costs in the light of potential cost savings. 
Methods: In a two-year randomized controlled trial a program (A) 
consisting of a two-week family treatment camp and four subsequent 
weekend camps was compared with (B) a four day out-patient lifestyle 
education program. The target group was children 7–12 years with a BMI 
≥ iso-BMI 30 and at least one parent with BMI ≥ 30. Both alternatives 
include two days of hospital follow-up. Treatment cost per participating 
individual was calculated by multiplying the number of treatment days by 
average daily cost. Treatment cost per child was the sum of family member 
costs. Descriptive statistics and nonparametric methods will be used. 
Results: Results based on a total of 76 children/families will be present-
ed: Treatment costs according to three time periods 0–3 months, 4 to 12 
months and 13 – 24 months. Cost variation within the two groups might 
be due to family size and families partly absent from the standard number 
of treatment days. 
Conclusion: We presume a substantial cost difference between the two 
programs because of different number of treatment days. When compar-
ing treatment cost to the estimated incremental life-time cost we must 
take intervention success rate and long term effects into consideration. 
Preliminary results indicate clinically meaningful effects of family based 
treatment. 
Acknowledgement: Research relating to this abstract was funded by Norwegian 
Ministry of Health and Care Services, Norwegian Foundation for Health and Reha-
bilitation, GjendisigeStiftelsen.
Reference: 
1. Finkelstein EA et al.: (2014) Pediatrics Vol.133; 5:854–862.
T7 – New analytical approaches in epidemiology
T7:PO.087
Waist circumference vs. waist-to-height ratio in estimation of 
central obesity in Slovak adults
Csongová M.1, Gurecká R.1, Koborová I.1, Volkovová K.2, Gajdoš M.2, 
Šebeková K.1
1Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in 
Bratislava, Bratislava, Slovakia,  
2Medical Faculty, Slovak Medical University, Bratislava, Slovakia 
Background: Central obesity (CO) is a major risk factor for cardiovas-
cular and metabolic disorders. Waist circumference (WC) and the waist-
to-height ratio (index of central obesity, ICO) are the most widely used 
methods; however, if compared a certain level of discrepancy in the clas-
sification occurs.
Aim: We studied the degree of discrepancy between the WC and the ICO 
methods in classification of CO in the population of adults in Slovakia. 
Methods: In secondary analysis of data from 3 cross-sectional studies in 
18–63 year-olds, 2137 males and 2531 females, CO was classified as WC 
>93 cm and 80 cm, respectively; and ICO>0.50. Matching or discrepancy 
of the results was analyzed according to SD of height, or decades of age.
Results: According to WC 718 (34%) male and 859 (34%) females pre-
sented CO, employing ICO 987 (46%) males and 711 (28%) females were 
CO. In males height averaged 179 ± 7 cm; in –3 SD and –2 SD subgroups 
CO was underrated by WC in comparison with ICO in 35%, in the sub-
group –1 SD and average height by 10% and 19%, respectively; while in 
tall subjects (height +2 SD and +3 SD) WC overrated CO in 5% and 12% of 
probands, respectively. Females’ height averaged 166 ± 6 cm; WC under-
rated CO in short females (-3 SD and –2 SD) by 16% and 5%, respectively; 
and overrated CO in all other subgroups starting from –1 SD of height by 
4%, 10%, 15% and 26%. WC and ICO correlated significantly with age in 
both genders; however, discrepancy between WC and ICO classification 
did not differ significantly in age group-decades in either gender.
Conclusion: In Slovak adults WC method to classify CO underrates CO 
in shorter subjects, in males shorter than 180 cm and in females <160 cm, 
while it overrates CO in tall subjects (in males from 187 cm and in females 
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T7 – Optimising monitoring and technology 
with technology
T7:PO.088
Reliability and precision of a segmental multi-frequency BIA 
scale for the assessment of body composition in the elderly
Tognon G.1, Mehlig K.1, Freyer E.1, Malmros V.2, Bosaeus I.2, Lissner L.1
1Section for Epidemiology and Social Medicine, Department of Public Health 
and Community Medicine, University of Gothenburg, Gothenburg, Sweden,  
2Department of Clinical Nutrition, University of Gothenburg, Gothenburg, 
Sweden
Introduction: Segmental bioimpedance analysis (sBIA) is a common tool 
to estimate body composition (body fat mass (FM), fat-free mass (FFM) 
and skeletal muscle mass (SMM)). sBIA is less expensive than dual X-ray 
absorptiometry (DXA) and has the advantage of portability. In the elderly 
the superiority of sBIA in estimating FM compared to anthropometry, is 
in a formative stage and reliability is not established. Therefore, our aim 
was to determine if a multi-frequency sBIA is more accurate measure of 
FM than BMI, waist circumference and waist-to-height ratio (WtHR). The 
second aim was to determine the accuracy of sBIA compared to DXA. 
Methods: Weight, height and waist circumference were measured in 92 
healthy subjects (53 women) aged 80–81 years from the H70 Geronto-
logical and Geriatric study in Gothenburg. WtHR was calculated dividing 
waist (cm) by height (cm). Total and segmental FM, FFM and SMM were 
estimated by DXA and MC-180MA TANITA sBIA scale. The estimations 
from these techniques were compared by Bland-Altman plots and by lin-
ear regression of DXA values vs. the predicted values from sBIA, BMI, 
waist circumference and WtHR. 
Results: sBIA- and DXA-based estimates were highly correlated. The as-
sociations between total and trunk FM by sBIA and DXA were not greater 
than those between BMI and DXA. sBIA underestimated FM, particularly 
trunk FM and FFM. SMM was greatly overestimated by sBIA, although 
highly correlated with DXA lean soft tissue. Good levels of agreement be-
tween the two techniques were found in men, whereas very low agreement 
rates were found in women (Figure 1). The presence of metal prosthesis 
did not influence the results. 
Conclusions: sBIA is not an accurate measure of body composition in the 
elderly; moreover it was not superior to BMI in predicting FM. 
Acknowledgement: We thank the Department of Psychiatry and Neurochemistry, 
Unit of Psychiatric Epidemiology, Mölndal, Sweden for their contribution to the 
H70 study.
Fig. 1. Bland-Altman plots depicting means vs differences of DXA and sBIA 
estimates for FM (panel A) and SMM (panel B) in women. Horizontal lines are 
drawn at the position of the mean difference and at mean value 2SD.
T7:PO.089
Resting oxygen consumption and predective equations for 
resting metabolic rate among bariatric surgical candidates
Crisp A.H.1, Revelli M.N.1, Verlengia R.2, Rasera-Jr I.3, 
Marques de Oliveira M.R.1,4
1Post-graduate Program in Food and Nutrition - Nutritional Sciences, Săo Paulo 
State University, Faculty of Pharmaceutical Sciences (UNESP-FcFar), Araraquara-
SP,  
2Methodist Universiade of Piracicaba (UNIMEP), Piracicaba-SP,  
3Center of Gastroenterology and Surgery of Obesity - Bariatric Clinic, Sugarcane 
Suppliers Hospital, Piracicaba-SP,  
4Biosciences Institute of the Săo Paulo State University (IB-UNESP), Botucatu
Metabolic equivalent (MET) is based in a universal value of resting ox-
ygen consumption (VO2) of 3.5 mL/kg/min. Recent studies suggested 
the correction of 1 MET by equation of Harris-Benedict to provide more 
accurate values. On the other hand, controversies also exist between pre-
dictive equations to estimate resting metabolic rate (RMR), especially in 
severely obese individuals. This study measured resting VO2 and RMR by 
indirect calorimetry (IC) and compared the accuracy predictive equations 
to estimate RMR and 1 MET standard value among women undergoing 
bariatric surgery. Cross sectional analysis was conducted in 44 severely 
obese women candidates to bariatric surgical. RMR was measured by 
using indirect calorimeter CCM express (MedGraphics). The predic-
tive equations used for estimate RMR were: Female Brazilian Popula-
tion (FBP), Mifflin-St Jeor (MSJ), Henry & Rees (HR), Harris-Benedict 
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IC was 1759 ± 36 kcal/day. In kcal/day, the MJS (1817 ± 22; mean differ-
ence [MD]: –58.3) and FBP (1826 ± 21; MD: –66.5) equations estimated 
the closest values (p > 0.05). Whereas HR (1886 ± 19; MD: –126.7), HB 
(1887 ± 18; MD: –127.4), FAO/WHO/UNU (1987 ± 35; MD: –227.9) and 
S (1954 ± 36; MD: –194.4) equations overestimates significantly (p < 0.01) 
RMR. Resting VO2 values ranged 1.47–2.92 mL/kg/min among obese 
women with mean value of 2.22 ± 0.00 mL/kg/min. The measured resting 
VO2 values were 36.4 ± 1.2% less than 1 MET standard value (3.5 mL/kg/
min). Conclusion: In Brazilian severely obese women, MJS and FBP were 
the more precise equations to provide estimation of RMR. Additionally, 
the standard 1 MET value overestimate the measured resting VO2 and 
cannot be applicable to bariatric patients.
Acknowledgement: Support Foundation of Săo Paulo State (FAPESP) and National 
Council for Scientific and Technological Development (CNPq)
Friday, 8 May, 2015
T2 – De novo lipogenesis
T2:PO.001
Resveratrol mediated changes in rat adipose tissue 
microRNAs expression related to fatty acid synthase
Gracia A.1, Miranda J.1,2, Fernández-Quintela A.1,2, Aguirre L.1,2, 
Milagro F.I.2,3, Portillo M.P.1,2
1Nutrition and Obesity Group. Dpt. Nutrition and Food Science, Faculty of 
Pharmacy. University of the Basque Country (UPV/EHU). Vitoria (Spain).,  
2CIBERobn Physiopathology of Obesity and Nutrition, Instituto de Salud Carlos 
III (ISCIII) (Spain).,  
3Department of Nutrition, Food Sciences
and Physiology; Centre for Nutrition Research; University of Navarra, 
Pamplona (Spain).
Introduction: The involvement of epigenetics as an anti-obesity molecule 
has not been addressed so far. The aim of the present study was to as-
sess changes produced by resveratrol in microRNA (miRNA) related to 
de novo lipogenesis, specifically to fatty acid synthase (fasn), in adipose 
tissue from rats fed an obesogenic diet supplemented with resveratrol.
Methods: Sixteen male Wistar rats were divided into two groups, a control 
group and a group treated with resveratrol (30 mg/kg bw/d), both fed a 
diet high in sucrose and fat, for 6 weeks. MiRNAs involved in de novo 
lipogenesis were selected by checking the miRWalk Database and by re-
vising the literature. Mir-539-5p, mir-1224 and fasn gene expressions were 
assessed by qRT-PCR. Protein expression of Sp1 transcription factor (SP1) 
and sterol regulatory element-binding protein 1 (SREBP1) were measured 
by western blot. Statistical analysis was carried out by using Student‘s t test.
Results: Resveratrol treatment reduced adipose tissue size. In rats treated 
with this polyphenol, protein expression of SP1 and SREBP1, two tran-
scriptional factors acting synergistically in the regulation of fasn expres-
sion, were significantly decreased (P < 0.05). In good accordance, gene 
expression of fasn was also reduced (P < 0.05). The expression of mir-539-
5p and mir-1224, two miRNAs involved in the regulation of Sp1, were 
up-regulated by resveratrol (P < 0.05).
Conclusion: The inhibition of de novo lipogenesis induced by resveratrol 
in adipose via fatty acid synthase can be mediated, at least in part, by the 
up-regulation of miR-539-5p and miR-1224. This shows the involvement 
of epigenetic mechanisms in the anti-obesity effect of this polyphenol.
T2 – Mitochondrial functions
T2:PO.002
Cd36 does not directly participate in mitochondrial fatty acid 
transport and oxidation.
Hejzlarová K.1, Pravenec M.1, Zídek V.1, Landa V.1, Kazdová L.2, Vrbacký M.1, 
Drahota Z.1, Mráček T.1, Houštěk J.1
1Institute of Physiology Academy of Sciences of the Czech Republic, Prague, 
Czech Republic,  
2Center for Experimental Medicine, Institute for Clinical and Experimental 
Medicine, Prague, Czech Republic
Introduction: CD36/FAT permease of plasma membrane is the key trans-
membrane transport protein for long chain fatty acids (FA). In the last 
years, conflicting results have been published regarding the localization of 
CD36 in mitochondria and its direct role in mitochondrial FA transport 
and oxidation. 
Methods: We used the spontaneously hypertensive rat (SHR) that har-
bors mutant CD36 and transgenic SHR expressing wild type Cd36 (SHR-
Cd36) and compered parameters of lipid metabolism in brown adipose 
tissue (BAT). 
Results: CD36 protein in BAT was high, comparable to heart and present 
mostly in a glycosylated form. Of all tissues the Cd36 transcript was the 
highest in BAT (2.9 x higher than heart). Most of the CD36 signal was in 
microsomal fraction and only traces in mitochondria, most likely due to 
contamination. We also compared palmitate transport and oxidation in 
BAT and in primary cultures of brown adipocytes from SHR and SHR-
Cd36 to test whether palmitate transport and oxidation is affected by mu-
tant CD36. The import of palmitate into BAT was reduced in the SHR 
when compared to SHR-Cd36 rats (24.1 ± 0.8 vs. 29.0 ± 1.6 nmol palm/
mg prot/2h, P < 0.05), confirming that FA transport across plasma mem-
brane mediated by mutant CD36 is less effective. In contrast, there was no 
significant difference in palmitate oxidation in BAT from SHR and SHR-
Cd36 rats (2.1 ± 0.1 vs. 2.1 ± 0.1 nmol palm/mg prot/2h), suggesting that 
CD36 is not important for FA transport into mitochondria. 
Conclusion: Our results demonstrate important role of CD36 in trans-
port of long chain FA across plasma membrane but not into mitochondria. 
We were not able to detect a significant amount of CD36 in isolated mito-
chondria and CD36 does not seem to directly participate in mitochondrial 
FA transport and oxidation.
Acknowledgement: Research relating to this abstract was funded by ERC CZ 
LL1204 and Grant Agency of the Czech Republic (14-36804G).
T2:PO.003
All-trans retinoic acid induces oxidative phosphorylation and 
mitochondria biogenesis in adipocytes
Ribot J.1, Tourniaire F.2,3,4, Musinovic H.1, Gouranton E.2,3,4, Astier J.2,3,4, 
Marcotorchino J.2,3,4, Arreguín A.1, Bernot D.5, Palou A.1, Bonet M.L.1, 
Landrier J.F.2,3,4
1Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat 
de les Illes Balears, and CIBER de Fisiopatología de la Obesidad y Nutrición 
(CIBERobn), ES-07122 Palma de Mallorca, Spain,  
2INRA, UMR 1260, F-13385 Marseille, France,  
3INSERM, UMR 1062, «Nutrition, Obésité et Risque Thrombotique», F-13385 
Marseille, France,  
4Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France,  
5Assistance Publique-Hôpitaux de Marseille, CHU La Timone, F-13385 Marseille, 
France.
A positive effect of all-trans retinoic acid (ATRA) on white adipose tissue 
(WAT) oxidative and thermogenic capacity has been described and linked 
to an in vivo fat loosening effect of ATRA in mice. However, little is known 
about the effects of ATRA on mitochondria in white fat. Our objective has 
been to characterize the effect of ATRA on mitochondria biogenesis and 
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cytes. Transcriptome analysis, oxygraphy, analysis of mitochondrial DNA 
(mtDNA) and flow cytometry-based analysis of mitochondria density was 
performed in mature 3T3-L1 adipocytes after 24 h incubation with ATRA 
(2 μM) or vehicle. Selected genes linked to mitochondria biogenesis and 
function and mitochondria immunostaining were analysed in WAT tis-
sues of ATRA-treated as compared to vehicle-treated mice. ATRA up-reg-
ulated the expression of a large set of genes linked to mtDNA replication 
and transcription, mitochondrial biogenesis and OXPHOS in adipocytes, 
as indicated by transcriptome analysis. Oxygen consumption rate, mtDNA 
content and staining of mitochondria were increased in the ATRA-treated 
adipocytes. Similar results were obtained in WAT depots of ATRA-treated 
mice. We conclude that ATRA impacts mitochondria in adipocytes, lead-
ing to increased OXPHOS capacity and mitochondrial content in these 
cells.
Acknowledgement: This work was supported by the Aix-Marseille Université, 
INRA and EU FP7 project DIABAT (HEALTH-F2-2011-278373). CIBER de Fisi-
opatología de la Obesidad y Nutrición is an initiative of the ISCIII (Spanish Gov-
ernment).
T2 – Remodeling, fibrosis and inflammation
T2:PO.004
Independent Association Between Circulating Galectin-3 
Concentrations and Aortic Stiffness and Wave Reflection in a 
Community Sample.
Libhaber E.N.2, Woodiwiss A.J.1, Gomes M.1, Libhaber C.D.2, Maseko M.J.1, 
Sareli P.1, Norton G. R.1
1Cardiovascular Pathophysiology and Genomics Research Unit, School of 
Physiology, Faculty of Health Sciences, University of the Witwatersrand, 
Johannesburg, South Africa School of Physiology,,  
2School of Clinical Medicne, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, South Africa
The pro-fibrotic inflammatory substance galectin-3 is associated with 
body mass index (BMI) and predicts outcomes in the general population. 
Whether galectin-3 is associated with arterial stiffness and aortic func-
tion is unknown. We aimed to determine whether circulating galectin-3 
concentrations are associated with aortic pulse wave velocity (PWV) or 
wave reflection in a community sample with a high prevalence of obesity. 
Plasma galectin-3 and C-reactive protein (CRP) concentrations, as well 
as carotid-femoral PWV and the aortic reflected wave index (RI) (appla-
nation tonometry and SphygmoCor software) were determined in 966 
randomly selected participants of black African ancestry from the South 
West Township (SOWETO) of Johannesburg, 42% of whom were obese. 
661 participants had 24-hour ambulatory blood pressure (BP) monitor-
ing (SpaceLabs, model 90207). On bivariate analysis, galectin-3 concen-
trations were strongly correlated with BMI (p < 0.0001). Galectin-3 con-
centrations were independently associated with neither office nor 24-hour 
systolic (SBP) (p = 0.88–0.92), or diastolic (p = 0.25–0.65) BP. In contrast, 
with adjustments for confounders including office or BP, galectin-3 was 
independently associated with aortic PWV (partial r=0.15, p < 0.0001) 
and RI (partial r=0.10, p < 0.005). The BP-independent relations between 
galectin-3 concentrations and aortic hemodynamics persisted with fur-
ther adjustments for CRP (PWV: partial r=0.14, p < 0.0001, RI: partial 
r=0.10, p = 0.002). Despite a lack of independent association with brachi-
al BP, the pro-fibrotic inflammatory substance galectin-3 may contribute 
toward adverse outcomes through an impact on aortic stiffness and the 
magnitude of aortic reflected waves, effects that cannot be attributed to 
general inflammatory changes.
T2:PO.005
Impact of aging on immune cell distribution in brown and 
white adiposetissue depots
Bocian C.1, Schulz T.J.1
1German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany 
Introduction: Age-related changes of adipose tissue mass and function 
are associated with an elevated risk to develop metabolic diseases like obe-
sity and insulin resistance. Obesity is accompanied by a chronic low-grade 
inflammation with increased adipose tissue infiltration of immune cells. 
The correlation of inflammation and insulin resistance during obesity is 
well established. However, little is known about the impact of aging on 
immune cell distribution and activation in different depots and types of 
fat. The concept of ‘Inflamm-aging’ proposes that increased cytokine levels 
produced by immune cells could negatively affect metabolic function.
Methods: Assessment of immune cell gene expression patterns and flow 
cytometric analysis of immune cell distribution was conducted in in-
terscapular brown adipose tissue (iBAT), epididymal and subcutaneous 
white adipose tissue of mice aged 8 weeks, 15 months, and 25 months.
Results: The distribution of immune cell subsets differs between individ-
ual fat depots and during aging, and is in some aspects distinct from the 
effects observed during obesity. For instance, no increase in total number 
of macrophages per depot was found during aging, whereas aging, like 
obesity, is accompanied by a shift from alternatively activated M2 towards 
classically activated M1 macrophages. This is also confirmed by increased 
expression of pro-inflammatory cytokines in freshly isolated macro-
phages. In summary, iBAT contains fewer immune cells and is more resis-
tant to age-induced pro-inflammatory processes.
Conclusion: These findings show distinct sensitivities of different adipose 
depots to the age-related pro-inflammatory shift and suggest that func-
tional changes in aged immune cells may contribute to metabolic dysfunc-
tion.
T2:PO.006
Age-related changes of extracellular matrix composition 
affect the metabolic homeostasis of adipose tissue
Steinbring J.1, Gohlke S.1, Bocian C.1, Graja A.1, Lau A.M.1, Schulz T.J.1
1Department of Adipocyte Development (ADE), German Institute of Human 
Nutrition, Potsdam-Rehbrücke, Germany
Introduction: The composition of the extracellular matrix (ECM) is an 
important part of the cellular microenvironment that affects the mecha-
nisms involved in stem cell homeostasis and tissue regeneration. In brown 
and white adipose tissue, similar to many other organs, a population of 
fibroblast-like progenitors is considered to be the major source of ECM 
while also giving rise to adipocytes. It is hypothesized that senescence 
leads to a pathological ECM-reorganization that in turn contributes to 
an impaired regenerative profile of brown and white adipocyte formation 
and maturation.
Methods: ECM components were assessed in brown and white adipose 
tissue depots from young (6–8 weeks) and old (12–15 months) mice using 
mRNA and protein expression analysis. Furthermore, in vitro assays were 
developed to determine the effects of alterations in the surrounding ma-
trix on brown and white adipogenesis.
Results: qPCR analysis of white and brown adipose tissue revealed a 
significant reduction in the expression of highly abundant ECM com-
ponents, such as collagens and integrins. In our in vitro tests, the ability 
to undergo brown adipogenic differentiation strongly depended on the 
maturation status of the ECM-producing cells: while immature progenitor 
cells produced matrix that supported brown adipogenesis, ECM produced 
by differentiating progenitors or mature adipocytes inhibited expression 
of brown adipocyte marker proteins such as UCP1. Of note, the ability 
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Conclusion: These findings taken together suggest that changes in ECM 
composition with age might promote the development of metabolic dys-
function by affecting the adipogenic potential of tissue-resident progen-
itor cells.
T2:PO.007
Differential expression of glucocorticoid target genes in cell 
types of white adipose tissue from corticosteroid binding 
globulin deficient mice (cbg-/-) submitted to a hyperlipidic 
diet
Ledda A.1, Gulfo J.1, Fernández-López J.A.1,2,3, Grasa M.1,2,3, Esteve M.1,2,3
1Department of Nutrition and Food Science, Faculty of Biology, University of 
Barcelona, Barcelona, Spain,  
2Institute of Biomedicine, University of Barcelona, Barcelona, Spain,  
3CIBEROBN, Spain
Introduction: Glucocorticoids are implicated in the body weight regula-
tion. Scientific evidences suggest that CBG may have an active role modu-
lating glucocorticoid action. Ours aims were to investigate whether white 
adipose tissue (WAT) from cbg-/- mice showed an altered proportion of 
cell types compared with cbg+/+ mice and to characterize the expression 
of glucocorticoid target genes in each cellular fraction.
Methods: Male mice (C57BL/6) cbg+/+ and cbg-/-, were submitted during 
twelve weeks to a control (C) or a hyperlipidic diet (HL). The epidydimal 
WAT was digested with collagenase and adipocytes and stromal vascular 
fraction (SVF) obtained. Total, M1 and M2 macrophages were quantified 
by FACS. Gene expression was determined by RT-PCR.
Results: The abundance of cells from SVF and total macrophages tended 
to be lower in cbg-/- mice than in cbg+/+ with a C diet. Both parameters 
increased similarly in both genotypes when HL diet was consumed. The 
ratio M1/M2 was higher in cbg-/- than in cbg+/+ mice fed a C diet. HL 
diet increased the ratio M1/M2 in cbg+/+ but decreased it in cbg-/- mice. 
About half of 11βHSD1 expression in epidydimal WAT occurred in SVF 
in cbg-/- mice, whereas in cbg+/+ more than 80% of this expression was 
found in adipocytes. Total WAT 11βHSD1 expression was decreased by 
HL diet in both genotypes, but in cbg-/- mice were at expense of expres-
sion in SVF. DUSP expression prevailed in SVF but was much lower in 
cbg-/- than cbg+/+ mice fed a C diet. HL diet decreased DUSP expression 
in cbg+/+ but increased it in cbg-/- mice.
Conclusion: The lack of CBG alters the expression of genes regulated by 
glucocorticoids in different cell types from WAT. The cells in stromal vas-
cular fraction seem specially affected.
Acknowledgement: Funding: Grant PI09/00505 & CIBER ObeNutr, Health Insti-
tute Carlos III
T2:PO.008
Gelatinase a (mmp-2) promotes adipogenesis
Bauters D.1, Scroyen I.1, Van Hul M.1, Lijnen H.R.1
1Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium 
Introduction: The gelatinase subgroup of the matrix metalloproteinase 
(MMP) family (gelatinase A and B, or MMP-2 and –9) is known to play a 
pivotal role in adipose tissue biology. They are secreted by adipocytes and 
their activity is modulated during adipose tissue development. In the pres-
ent study, we have evaluated the role of both gelatinases in adipogenesis.
Methods: Gene shRNA-mediated knockdown (Kd), or overexpression 
was performed in murine 3T3-F442A preadipocytes to evaluate the ef-
fect on differentiation into mature adipocytes. For de novo adipogenesis, 
nude athymic BALB/c mice were subcutaneously injected with genetically 
modified 3T3-F442A cells, and kept on a high fat diet for 4 weeks.
Results: Stable Mmp2 Kd was confirmed by i) 90% decreased mRNA ex-
pression ii) 4-fold reduced antigen levels and iii) 60% reduced gelatino-
lytic activity. Loss of MMP-2 significantly decreased preadipocyte differ-
entiation, as demonstrated by Oil Red O staining (reduction by 65%) and 
mRNA expression of the adipogenic markers aP2, PPARγ and adiponec-
tin. In contrast, overexpression of MMP-2 resulted in enhanced differ-
entiation. Upon selective Mmp9 Kd, no differences in adipogenesis were 
observed as compared to control cells. De novo fat pads derived from 3T3-
F442A cells with/without Mmp2 Kd, did not significantly differ in mass or 
adipocyte size and density. Expression of adipogenic markers was, howev-
er, significantly decreased with Mmp2 Kd. Similar experiments were per-
formed in wild-type and MMP-2 knockout mice (C57Bl/6N). Absence of 
de novo fat pads suggests successful clearance by the host immune system. 
Additional experiments to prevent rejection are ongoing.
Conclusion: Our data indicate that MMP-2 is a key player in early pread-
ipocyte differentiation.
Acknowledgement: Skillful technical assistance by A. De Wolf, I. Vorsters and C. 
Vranckx is gratefully acknowledged.
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Immunological targeting of neoepitopes of osteopontin 
exposed after thrombin and matrix metalloproteinase-
cleavage reduces osteopontin-induced cell adhesion
Jürets A.1, Stein G.1, Neuhofer A.1, Leitner L.1, Tardelli M.1, Staffler G.2, 
Zeyda M.1, Stulnig T.M.1
1Christian Doppler Laboratory for Cardio-Metabolic Immunotherapy and 
Clinical Division of Endocrinology and Metabolism, Department of Medicine III, 
Medical University of Vienna, Vienna, Austria,  
2Affiris AG, Vienna, Austria 
Introduction: Osteopontin has been shown to be involved in immune cell 
migration, adhesion, and promoting inflammatory cytokine production. Its 
central region consists of a canonical RGD integrin binding sequence and 
a contiguous, cryptic integrin-binding site that is unmasked by thrombin 
or matrix metalloproteinase cleavage and is bound by α5β1, α4β1 and α9β1 
integrins expressed, e.g., by leukocytes and other inflammatory cells. We 
targeted this region with monoclonal antibodies or sera induced by peptide 
immunization of mice to prevent cellular adhesion in vitro. 
Methods: Recombinant human OPN in full length or truncated forms 
was immobilized on the surface of V-well microtiter plates to induce 
adhesion of fluorescence-labeled HEK 293 cells as a model system for 
OPN-induced immune cell adhesion. 
Results: Induction of HEK 293 adhesion was markedly stronger by the 
truncated OPN forms as compared to full-length OPN. Using post-im-
mune sera or monoclonal antibodies, we could specifically block the adhe-
sion to OPN fragments corresponding to the thrombin and matrix-metal-
loprotease-cleaved form. 
Conclusion: Cell adhesion to OPN strongly depends on protease cleavage 
and can be immunologically targeted. These results are a step forward to 
an immunotherapeutic approach to target obesity-induced adipose tissue 
inflammation and insulin resistance.
Acknowledgement: Research relating to this abstract was funded by the Federal 
Ministry of Economy, Family and Youth and the National Foundation for Research, 
Technology and Development (to T.M.S.)
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Potential mediatory role of macrophages in air pollution-
related adipocyte dysfunction: Differential effect of two diesel 
exhaust particles samples
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Introduction: Exposure to fine particulate matter (PM) air pollution neg-
atively affects human health, but a possible connection with obesity-as-
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compounds may activate resident or circulating immune cells that could 
then engage in an immune-metabolic interaction with adipocytes. Here 
we assessed whether macrophages exposed to water extracts of two stan-
dard diesel exhaust particles (DEP) samples could induce a conditioned 
medium (CM) that would affect adipocyte function
Methods: RAW264.7 macrophages were treated with water extracts 
of 2 standard DEPs with high/low organic compounds content (SRM-
1650/2975). CM was collected, and used to expose cultured adipocytes 
for 6h.
Results: Adipocytes exposed to CM of untreated macrophages exhibit-
ed a decreased insulin-stimulated p-Akt/T-Akt and p-Gsk/T-Gsk, and 
elevated basal lipolysis, compared to control adipocytes. When CM was 
prepared from macrophages pre-treated with SRM-2975, but not SRM-
1650, a further decline in insulin responsiveness was observed. Lipolysis 
was not further altered. In search of potential macrophage-derived medi-
ators, we considered altered secretion of TNFα, IL-10, IL-6 and additional 
cytokines using specific ELISAs and a multiplex assay. So far, differential 
secretion of these factors has not been consistently evident, suggesting al-
ternative cytokines or non-cytokine mediators.
Conclusion: Results indicate: i. a potential mediatory role for macro-
phages in the induction of PM-related adipocyte insulin resistance; ii. 
different samples from one type of environmental source may induce dif-
ferent endocrine outcomes. The specific PM components, as well as the 
macrophage-derived mediators for PM-related adipocyte dysfunction 
have yet to be identified.
Acknowledgement: Funding: United States- Israel Binational Science Foundation; 
The Environment and Health Fund.
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Gene expression levels of wnt5a and sfrp5 in visceral adipose 
tissue of obese subjects are related to inflammation
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Introduction: Wingless-type MMTV integration site family (WNT)-5A 
is a secreted glycoprotein involved in the regulation of the inflammatory 
response and secreted frizzled-related protein (SFRP)-5 has emerged as an 
anti-inflammatory adipokine binding and sequestering WNT5A. Objec-
tive: The aim was to evaluate the involvement of WNT5A and SFRP5 in 
obesity and obesity-associated type 2 diabetes (T2D) as well as to explore 
their role in visceral adipose tissue (VAT) inflammation.
Methods: Ninety subjects were included in the study. Visceral adipose tis-
sue (VAT) gene expression levels as well as circulating concentrations of 
WNT5A and SFRP5 were analysed. The effect of tumour necrosis factor 
(TNF)-a and lipopolysaccharide (LPS) on the expression levels of WN-
T5A and SFRP5 in cultures of human differentiated adipocytes was also 
explored. We also investigated whether WNT5A itself can activate an in-
flammatory response in human differentiated adipocytes.
Results: Circulating concentrations of WNT5A were significantly in-
creased (P < 0.01) in normoglycaemic (NG) and T2D obese patients com-
pared to lean subjects. In this regard, increased (P < 0.01) expression levels 
of WNT5A together with decreased (P < 0.05) mRNA levels of SFRP5 in 
NG and T2D obese patients were found in VAT. WNT5A expression was 
significantly enhanced (P < 0.01) by TNF-a and LPS, while no effects were 
found in SFRP5 gene expression levels. Furthermore, WNT5A treatment 
significantly enhanced (P < 0.05) the mRNA levels of IL6, IL1B, MMP2, 
MMP9 and SPP1 in adipocytes.
Conclusions: Activation of non-canonical Wnt signalling through the 
upregulation of WNT5A and downregulation of SFRP5 may promote a 
proinflammatory state in visceral adipose tissue contributing to the devel-
opment of obesity-associated comorbidities.
Acknowledgement: CIBERobn is an initiative of the ISCIII, Spain.
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Introduction: The ribosomal protein S6 kinase 1 (S6K1), a component 
of the insulin signalling pathway, has been proposed as a key molecular 
factor in insulin resistance development under conditions of nutrient 
overload. The aim was to evaluate the involvement of S6K1 in obesity as 
well as to explore their association with visceral adipose tissue (VAT) in-
flammation.
Methods: Forty females were included in the study (9 lean and 31 obese). 
Real-time PCR analyses were performed to quantify gene expression lev-
els of S6K1 as well as representative players involved in signalling path-
ways related to S6K1 and inflammation in VAT. We also explored the effect 
of the stimulation with insulin in human visceral adipocytes.
Results: Increased expression levels of S6K1 in obese patients in VAT were 
observed (P < 0.05). Moreover, a positive association (P < 0.05) of S6K1 
expression with different markers of insulin resistance was observed. S6K1 
mRNA levels in human visceral adipocytes were significantly increased 
(P < 0.01) after insulin stimulation. Finally, S6K1 gene expression levels 
were positively correlated with VAT gene expression levels of the inflam-
matory markers CCL2, CD68, MMP2, MMP9, VEGFA and CHI3L1 as 
well as with mRNA levels of MTOR and MAPK8 (JNK).
Conclusion: These data show that S6K1 is upregulated in human VAT in 
obesity, suggesting its role in the dysfunctional adipose tissue via a close 
association with insulin resistance and inflammation development
Acknowledgement: CIBERobn is an initiative of the ISCIII, Spain.
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Introduction: Extracellular matrix remodeling is a hallmark of adipose 
tissue (AT) pathologic alterations in obesity. It relates to metabolic abnor-
malities and associates with AT stiffness, for which we have recently de-
veloped a non-invasive method- the Adiposcan (Echosens, Paris)- based 
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identify how the VCTE (VS) relates to metabolic characteristics and com-
ponents of AT ECM structure and functions in morbid obesity. 
Methods: 119 obese subjects (age 39.4 ± 10.8yr, BMI 46.2 ± 6.5kg/m2, 
female 68.1%) candidates for bariatric surgery (BS) were recruited and 
their phenotypes were determined according to several bioclinical char-
acteristics. AT stiffness (VS) was measured by Adiposcan in the perium-
bilical region before BS. We obtained per-operative subcutaneous AT sam-
ples for fibrosis quantification by histochemistry (picrosirius red). Using 
PCR-ARRAY, we examined the expression of genes related to AT ECM 
structure and function in a subset of non-diabetic women. 
Results: We confirmed that AT stiffness (VS) is positively associated with 
pericellular fibrosis (rho=0.28, p = 0.02) and with blood fasting glucose, 
HbA1c, liver transaminases and triglycerides whereas negatively with 
fat mass% (DXA). We here show that VS is positively associated with ex-
pression of genes encoding profibrotic proteins (SPP1, THBS1, TGFB1), 
matrix fibers (COL6A1, COL6A2), basement membranes (COL4A2, 
LAMC1, LAMB3), adhesion molecules (SELE, ICAM, CD44) and metal-
lopeptidase inhibitors (TIMP1). VS is also positively associated with in-
tegrins involved in mechanotransduction (ITGB2, ITGA5, ITGA8) and 
transcription factors controlling fibrosis and inflammatory genes (NFkB1, 
CEBPB). 
Conclusion: Physical measure of AT stiffness is associated with molecular 
actors of ECM structure and function and need to be confirmed at the 
protein levels. This study illustrates the interest of developing non-inva-
sive tools to phenotype the adipose tissue.
T2:PO.014
Mef-derived adipocytes from e2f1-ko mice exhibit decreased 
basal autopahgy and ask1 signaling and improved metabolic 
and endocrine function, with resistance to stress
Haim Y.1, Blüher M.2, Harman-Boehm I.3, Kirshtein B.3, Shai I.1, Bashan N.1, 
Rudich A.1,4
1Ben-Gurion University of the Negev, Israel,  
2University of Leipzig, Germany,  
3Soroka Academic Medical Center, Israel,  
4NIBN, Israel
Introduction: There is growing interest in metabolic roles of cell cycle 
regulators, and in transcription-level regulation of autophagy and ASK1-
MAP kinase, which are activated in human adipose tissue in obesity. E2F1, 
a cell-cycle –related transcription factor, is up-regulated in omental fat in 
human obesity, correlating with expression of ASK1 and autophagy genes. 
We hypothesized that E2F1 regulates these pathways and contributes to 
adipocyte dysfunction.
Methods: We utilized mouse embryonal fibroblasts (MEF) of E2F1-KO 
mice, differentiated into adipocytes (morphology, oil red O staining, and 
expression of markers of adipocyte differentiation) comparably to WT-
MEFs.
Results: E2F1-KO adipocytes had markedly lower expression of ASK1 
and autophagic flux activity. Insulin sensitivity and responsiveness, as-
sessed by insulin-stimulated phosphorylation of Akt, GSK3 and p70S6 
kinase, were higher in E2F1-KO MEF-adipocytes than WT cells, but over-
all similarly affected by pre-exposure to inflammatory cytokines, resulting 
in insulin resistance. Basal lipolysis was nearly 3-fold lower in the KO vs 
WT adipocytes, but like WT exhibited a 3-fold increase in glycerol and 
FFA release in response to cytokines. Leptin secretion in KO adipocytes 
was decreased 25%, and adiponectin increased 2.5-fold compared to WT. 
Importantly, in the absence of E2F1 cytokines failed to decrease secretion 
of both adipokines as in WT.
Conclusion: E2F1 transcriptionally regulates autophagy gene expression 
and activity, and ASK1 signaling. In its absence, adipocytes exhibit improved 
endocrine/metabolic function, and resistance to adipokine alternations in-
duced by inflammation. Results support metabolic regulatory functions of 
cell-cycle proteins which contribute to adipose dysfunction in obesity.
Acknowledgement: We would like to thank Prof. Gustavo Leone, Department of 
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effects ofobesity on mmp-2 and oxidative stress in left 
ventricle of rats
Lino A.D.S.1, Aquino Júnior A.E.7, Castro C.A.1, Leite R.6, Fina Speretta G.F.5, 
Fabrizzi F.4, Moraes G.3, Selistre Araújo H.S.2, Duarte A.C.G.O.1 
1Laboratory of Nutrition of Metabolism Applied of Exercise, Department of 
Physical Education and Human Motricity, Center of Biological and Health 
Sciences, UFSCar, SP/Brazil;  
2Laboratory of Physical Exercise, UFSCar, 
3Laboratory of Biochemistry and Molecular Biology, UFSCar, 
4Laboratory Of Adaptive Biochemistry, Department of Genetics, UFSCar,  
5Department of Physiology and Pathology, School of Dentistry, Universidade 
Estadual Paulista-UNESP, SP/Brazil,  
6Departament of Physical Education, Federal University of Maranhăo, Săo Luis, 
MA, Brazil,  
7Optics Group from Institute of Physics of Săo Carlos (IFSC) University of Săo 
Paulo, SP/Brazil
Objective: to evaluate the effects of eight-week resistance training (RT) 
on body mass (BM), activity of Metaloproteinase-2 (MMP-2), antioxidant 
enzymes, lipid peroxidation, Citrate synthase (CS) and total lipid content 
in the left ventricle (LV) of obese rats. 
Methods: Sixty Wistar rats was distributed into six experimental groups 
(n=10/each): fed with standard diet: Control (CT), Sedentary (SED) and 
trained (RT) groups, and fed with high-fat diet (CT-Ob), Sedentary (SED-
Ob) and trained groups (RT-Ob). RT protocol was conducted with 4–9 
climbs of a vertical ladder with weights attached to their tails. Sessions 
were carried out every 72 hours.
Results: The three weeks obesity-induction period induced higher BM, LV 
mass, activity of MMP-2, lipid peroxidation and lower CS activity compared 
to CT (p < 0.05). After eleven weeks of high-fat diet, the SED-Ob presented 
a higher BM compared to SED. The consumption of high-fat diet (SED-Ob) 
was able to promote lower Total Super Oxide Dismutase (Total-SOD) and 
Mitochondrial Super Oxide Dismutase (Mn-SOD) and higher Glutathione 
(GSH) activity. The BM was lower to the RT-Ob compared to SED-Ob, even 
though higher compared to RT-Ob (p < 0.005). In the RT-Ob of MMP-2 
activity was higher (p < 0.03) compared to RT, but lower (p < 0.04) com-
pared to SED-Ob. The RT protocol promoted greater CS activity (p < 0.03), 
Total-SOD (p < 0.001) and Mn-SOD (p < 0.03) and lower activity of GSH 
(p < 0.01) in RT-Ob. There was no alterations on TBARs level in the LV of 
the RT-Ob. However, we observed increased lipid content (p < 0.04). 
Conclusion: RT, in obese rats, could be a no pharmacological tool able 
to positively modulate the activity of MMP-2 and some antioxidant en-
zymes. These effects are important for the maintenance of heart health, 
relieving the deleterious effects on obesity-related on LV.
Acknowledgement: Financial support was provided by the Consellho Nacional de 
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contribute to local obesity-induced inflammation
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Introduction: An important underlying cause of obesity-induced IR is 
chronic systemic inflammation derived from progressive inflammation in 
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clear immune cells in peripheral blood (PB), visceral and subcutaneous 
adipose tissue (SAT) of humans.
Materials and methods: Human samples were obtained during laparo-
scopic surgery of patients undergoing elective cholecystectomy. Exclusion 
criteria: age>65 yrs, active infection, current treatment with antiinflamma-
tory or immunosupresive drugs, malignant disease, acute or chronic kid-
ney and liver disease, heart failure (NYHA III or IV), thyroid disease, use 
of weight loss drugs, alcohol abuse. All patients signed an informed con-
sent before tissues were isolated. Statistics. Student’s t test, Mann-Whithey 
and ANOVA tests, with Bonferroni’s posttest Correction for multiple 
comparisons, were used. P < 0.05 was considered statistically significant.
Results: We find that T cells are a dominant immune cell subset in both 
VAT and SAT. Compared to PB, adipose tissue (AT) contains relatively 
more CD8T cells. Markedly, we found that AT contains more NK cells 
than PB. In particular CD56Bright cells, which produce high levels of 
IFNγ, were 2–4 fold increased in AT compared to PB. When NK cell num-
bers were correlated to BMI, we observed a clear positive correlation in 
AT, but not in PB, even though our sample size was too small to reach 
statistical significance. In addition, we observed that VAT, but not SAT ex-
presses activating ligands for the NK cell receptor NKp46. NKp46 ligand 
expression was also positively correlated with BMI.
Conclusion: Our study identifies NK cells as an important immune cell 
subset in AT. The positive correlation of NK cells and activating NK cell li-
gands in AT with BMI might indicate that this pro-inflammatory immune 
cell subset may play an important role in the development of VAT-inflam-
mation and contribute to the development of IR.
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Oral administration of trans10? Cis12 conjugated linoleic acid 
(cla) in mice induces a reversible inflammatory and fibrotic 
signature in adipose tissue.
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Oral administration of trans10, cis12 conjugated linoleic acid (CLA) pro-
vokes an accumulation of macrophages in the adipose tissue (Poirier et la, 
Diabetes 2006). Here, we used this model to assess the components of this 
immune response in adipose tissue and to test whether the compound af-
fect gut immunity, permeability and microflora composition. Immune cell 
abundance and phenotype were assessed by gene expression analysis, im-
munohistochemistry and flow cytometry in adipose tissue, jejunum and 
colon of mice receiving daily gavage of CLA for 7 days. Collagen deposi-
tion and fibrosis-related genes were assessed in adipose tissue. Microbiota 
composition was determined by 16S rRNA analysis. Macrophages and to 
a lesser extent T-lymphocytes accumulated in adipose tissue with CLA 
treatment. Phenotypic analysis revealed the prevalence of M2 anti-inflam-
matory macrophages. This was accompanied by marked collagens depo-
sition. Immune cell infiltration and extracellular matrix accumulation 
were fully reversible after 7 days with no gavage. In contrast to adipose 
tissue, both jejunum and colon displayed no alteration in the expression of 
macrophage and T-lymphocyte markers. However, a decreased expression 
of genes encoding tight junction proteins (claudin and occludin) and a 
significant switch in microbial community were observed. In conclusion, 
we show that adipose tissue response to acute oral CLA administration is 
more adaptive that pathological, as suggested by the reversibility of both 
CLA-induced cellular and structural alterations. These observations en-
lighten an unexpected resilience of adipose tissue in response to a nutri-
tional stressor. Part of the effects of CLA could be mediated by CLA-in-
duced increased intestinal permeability and microbiote alteration.
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Introduction: Indoleamine2,3dioxygenase1 (IDO1) catalyzes the degra-
dation of tryptophan to kyn (Kyn) which in turn is metabolized via the 
kynurenine pathway (KP), to yield bioactive metabolites (collectively, ky-
nurenines (KPm)). Tryptophan catabolism is induced by inflammation, 
suggesting that it could likewise be triggered in obesity. The aim of our 
study was to determine whether serum KPm levels and KP enzyme ex-
pression in the human adipose tissue are altered in obesity.
Methods: We assessed serum KPm levels in 836 individuals from a pro-
spective cohort of French Europeans, and in 100 morbidly obese women 
who underwent bariatric surgery. Gene expression of KP enzymes was an-
alyzed in visceral and subcutaneous adipose tissue from obese women, in 
human primary adipocytes and in monocyte-derived pro-inflammatory 
M1 and anti-inflammatory M2 macrophages.
Results: Increased levels of Kyn were associated with BMI (P = 4.7×10–
19) in the prospective cohort. Moreover, Kyn, kynurenic acid and quino-
linic acid levels were positively associated with BMI (P < 0.05) in obese 
women. The gene expression of several KP enzymes (IDO1, KYNU, KMO 
and CCBL2) was increased in visceral adipose tissue of obese women as 
compared to lean controls (P < 0.05). In vitro stimulation by pro-inflam-
matory cytokines of primary adipocytes induced the expression of these 
enzymes in these cells (P < 0.05) except KMO that was never expressed in 
these cells. In addition, IDO1, KYNU, KMO and CCBL2 expressions were 
higher in M1 than in M2 macrophages (P < 0.05).
Conclusion: Obesity is associated with increased serum KPm levels and 
higher expression of KP enzymes in adipose tissue from obese women 
that may result from pro-inflammatory macrophages and from adipocytes 
in response to inflammatory cytokines.
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Chronic resistance training decrease inflammation in intra-
abdominal adipose tissue of ovariectomized rats
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Introduction: Chronic Inflammation is an obesity hallmark and body mass 
reduction decreased it. However, ovariectomized (OVX) mice showed vis-
ceral adipose tissue (VAT) inflammation and reduced insulin sensitivity 
even without increased adiposity. So we aimed to test if resistance training 
(RT) was able to decrease chronic Inflammation in VAT of ovx rats.
Methods: Sprague-Dawley rats were divided into (n=6): sham-sedentary 
(S-SED), ovariectomized (OVX)-SED, S-resistance trained (RT), OVX-RT, 
S-acute-RT (A) and OVX-acute RT groups. Surgery was performed at 10 
weeks of age. After three weeks, TR groups started a 10-week climbing 
program in a ladder with progressive overload. S-A and OVX-A per-
formedγ one bout session. Mesenteric AT was used for RNAm analysis
Results: OVX-SED rats had higher body mass than SHAM SED rats and 
chronic RT partially abrogate it. VAT of OVX-SED rats displayed evidence 
of immune infiltration and inflammation because had increased expres-
sion of macrophage chemoattractants (Osteopontin, Rantes and MCP-1), 
macrophage infiltration (F4/80 and CD11b), inflammatory cytokines (IL-
1β, IL-6 and TNF-α) and Th1 cytokine IFN-γ. M2 macrophage arginase-1 
was increased but IL-10 decreased. Acute RT increased all these genes 
but also increased IL-10 in non-ovx rats and increased only osteopontin, 
CD11b and IL-1β in ovx rats. Chronic-RT reversed these changes caused 
by ovarian hormone loss or by the acute-RT in non-ovx animals.
Conclusion: Inflammation in VAT induced by ovarian hormone loss is 
restored by chronic-RT even reducing body mass only partially. Non reg-
ular exercise may also induce immune infiltration and inflammation in 
non-ovariectomized rats.
T2 – Oxygen tension
T2:PO.020
Chronic adipose tissue hypoxia and dysfunction in subjects 
with obstructive sleep apnoea
Thorn C.E.1,2, Knight B.A.2, McCulloch L.3, Patel B.4, Shore A.C.1,2, Kos K.3,2
1Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK,  
2NIHR Exeter Clinical Research Facility, University of Exeter Medical School, 
Exeter, UK,  
3Diabetes and Obesity Research Group, University of Exeter Medical School, 
Exeter, UK,  
4Department of Respiratory Medicine, Royal Devon and Exeter NHS Foundation 
Trust, Exeter, UK
Background: Many subjects with morbid obesity suffer from obstructive 
sleep apnoea (OSA). Obesity and OSA are independently associated with 
increased cardiovascular disease (CVD) risk. Adipose tissue (AT) dys-
function of obesity contributes to CVD risk, yet it is unclear if AT is af-
fected by the reduction in arterial oxygenation in OSA or hypoventilation. 
Methods: In 16 obese men with OSA and 15 BMI matched men without 
OSA (controls), the delivery of oxygen to AT was measured in:- 1) arteri-
al blood by finger pulse oximetry (SaO2) 2) blood in abdominal AT mi-
crocirculation by reflectance spectroscopy (SATO2) along with AT blood 
flow (ATBF) 3) abdominal AT itself with Clarke-type electrode (pATO2). 
Abdominal AT biopsies were analysed for gene expression. 
Results: SaO2 was lower in awake OSA subjects compared to controls 
(95.3 ± 1.3% (mean±SD) vs 97.5 ± 1.4%, t-test, p < 0.009, n=10) yet with-
in the abdominal AT neither SATO2 (62.5 ± 18.9 vs 72.5 ± 7.3%, ns, n=12) 
nor pATO2 (49.2 ± 7.5 vs 49.4 ± 13.9mmHg, ns, n=8) were significantly 
different. Interestingly ATBF was higher in OSA subjects (109.6 ± 23.25 vs 
78.9 ± 24.9au, p < 0.005, n=12). In controls higher ATBF was associated 
with increased pATO2 (Spearman’s ρ=0.75, p = 0.02, n=9) but not in OSA. 
Biopsy mRNA expression was significantly higher in OSA for HIF-1alpha 
(48%, p = 0.04), MCP-1 (54%, p = 0.02) and TGFbeta (49%, p = 0.01).
Conclusions: Respiratory hypoxia reduces mean SaO2 in awake OSA 
subjects compared to controls but does not further increase AT hypox-
ia associated with obesity. Changes in gene expression in OSA suggest 
chronic hypoxic tissue dysfunction, perhaps as a result of intermittent 
hypoxia. Increased ATBF with OSA may represent an adaptive compen-
satory mechanism to limit the confounding effect of respiratory hypoxia 
on AT hypoxia.
Acknowledgement: Funding: Royal Devon and Exeter NHS Foundation Trust and 
NIHR Exeter Clinical Research Facility
T2 – Ectopic fat
T2:PO.021
Appendicular and central fat storage is negatively related to 
self-perceived fatigue and muscle performance in obese boys 
and girls.
Vantieghem S.1, Provyn S.1, Tresignie J.1, Bautmans I.2
1Experimental Anatomy,  
2Frailty In Ageing 
Introduction: Maximal strength is an important factor to perform daily 
activities, especially in obese persons whose muscles must carry heavier 
loads, which can induce higher levels of fatigue. Excess weight consists 
mainly of fat mass but also lean mass which can influence the muscle per-
formance positively in non-weight bearing activities. Studies correlating 
grip strength with segmental and total body composition (using DXA) 
in obese children are scarce. This study explores the relation between 
self-perceived fatigue, body composition and muscle performance in 
obese adolescents 
Methods: 140 girls and 97 boys (15 ± 2 years) were examined for body 
composition (BC) (DXA), muscle performance (grip strength (GS), fa-
tigue resistance and grip work) and self-perceived fatigue (Multidimen-
sional Fatigue Inventory, MFI-20). 
Results: Girls showed no difference in absolute muscle performance com-
pared to boys, but when corrected for lean arm mass girls performed sig-
nificantly better than boys. No significant difference was found between 
the sexes for absolute fat mass, but girls showed significantly higher fat 
percentage and lower lean mass than boys. GS showed good correlations 
with lean mass (expressed in absolute and relative values) in as well for ap-
pendicular segments as for total BC, and a negative correlation was found 
for fat% in both sexes. Worse self-perceived fatigue was related to higher 
fat mass and lower lean mass. No relations were found between grip per-
formance and self-perceived fatigue. 
Conclusion: Based on our results we conclude that self-perceived fatigue 
and handgrip performance are significantly related to segmental and to-
tal body composition. Further studies are necessary to evaluate whether 
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T2:PO.022
Danish childhood obesity chronic care treatment reduces 
1h-mrs measured ectopic fat content in liver and muscle
Fonvig C.E.1,2, Chabanova E.3, Ohrt J.D.1, Nielsen L.A.1, Pedersen O.2, 
Hansen T.2, Thomsen H. S.3, Holm J. C.1
1The Children’s Obesity Clinic, Department of Pediatrics, Copenhagen University 
Hospital Holbćk, Denmark,  
2The Novo Nordisk Foundation Center for Basic Metabolic Research, Section 
of Metabolic Genetics, Faculty of Medical and Health Sciences, University of 
Copenhagen, Denmark,  
3Department of Diagnostic Radiology, Copenhagen University Hospital Herlev, 
Denmark
Introduction: Ectopic fat deposition in non-adipose tissue (including 
liver and muscle) is an important predictor of cardiovascular disease. He-
patic and muscular steatosis are both common in obese children, which 
underlines the need for an effective treatment of these conditions, espe-
cially in childhood obesity. 
Methods: Forty-one overweight children and youths, enrolled in The 
Children’s Obesity Clinic Treatment protocol, Holbćk, Denmark, were as-
sessed by anthropometry, fasting blood samples (glucose, insulin, HbA1c, 
and lipids), and liver and muscle fat content (MFC) by magnetic reso-
nance spectroscopy, at enrolment and after intervention. 
Results: The baseline median body mass index (BMI) standard deviation 
score (SDS) was 2.80 (range: 1.49–3.85) with a median age of 14 years (10–
20). During 12 months of intervention, the 41 children and youths (22 
girls) decreased their BMI SDS by 0.22 (95% CI: [0.08; 0.43], p = 0.002) 
accompanied by reductions in liver and muscle fat percentages of 1.0% 
(95% CI: [0.1; 3.5], p = 0.02) and 2.3% (95% CI: [0.4; 3.9], p = 0.02), re-
spectively. The prevalence of hepatic steatosis decreased from 29% to 22% 
and the prevalence of muscular steatosis decreased from 76% to 46%. Lin-
ear regression showed that changes in liver fat associated with changes 
in HbA1c (p = 0.04), changes in MFC (p = 0.04), and baseline levels of 
liver fat (p < 0.0001), while changes in MFC associated with baseline lev-
els of MFC (p < 0.0001) and changes in visceral adipose tissue volume 
(p = 0.04), independent of age, sex, duration of treatment, baseline degree 
of obesity and pubertal developmental stage. 
Conclusion: Reductions in magnetic resonance spectroscopy measured 
liver and muscle fat are possible in childhood obesity treatment and sug-
gest a decrease in cardiovascular disease risk.
T2:PO.023
Heart fat infiltration in subjects with and without coronary 
artery disease
Mazzali G.1, Zoico E.1, Faccioli S.1, Pedrotti M.1, Rizzatti V.1, Micciolo R.2, 
Cinti S.3, Zamboni M.1
1Department of Medicine, Geriatric Section, University of Verona,  
2Department of Psychology and Cognitive Sciences, University of Trento,  
3Institute of Human Morphology, University of Ancona
Background and Aims: Fat may accumulate around the heart in epicardi-
al adipose tissue or inside the heart as lipid droplets (LD). The aims were 
to compare the myocardial steatosis between subjects with and without 
coronary artery disease (CAD), and to identify in which cells LD are con-
tained.
Methods and Results: We studied male subjects undergoing cardiac sur-
gery either for coronary bypass grafting (CAD, n= 23) or for valve replace-
ment (non-CAD, n=18). Body mass index, waist circumference, glucose, 
insulin, HOMA index, leptin, adiponectin and Hs-CRP were evaluated. 
Biopsies were collected from right atrial myocardium during appendix 
incannulation. Immunohistochemistry for perilipin (PLIN) 1 and 2 was 
used to characterize LD and their localization respectively in adipocytes or 
myocardial cells. Both PLIN1 and PLIN2 resulted to be significantly high-
er in subjects with CAD than in those without (respectively: 0.35 ± 0.04 
OD vs 0.28 ± 0.05 OD; p < 0.004; 0.27 ± 0.05 OD vs 0.22 ± 0.05 OD; 
p < 0.004). PLIN 1 was significantly associated with leptin and Hs-CRP 
and negatively with adiponectin, whilst PLIN 2 with BMI, waist circum-
ference, leptin and negatively with adiponectin. After taking into account 
absence/presence of hypertension and CAD/nonCAD, adiponectin was 
inversely associated with PLIN 1 (R2 0.523), while both waist circumfer-
ence and adiponectin were positively associated with PLIN 2 (R2 0.399).
Conclusion: Myocardial steatosis is significantly greater in subjects with 
CAD than in those without, depending on both metabolically active ad-
ipocytes interspersed among cardiomyocytes, and higher fat deposition 
inside cardiomyocytes; serum adiponectin and waist are independent pre-
dictors of myocardial steatosis
Fig. 1. Representative images of immunohistochemical staining showing the 
expression of PLIN1 in the atrium of patients without coronary artery disease 
(NON CAD)(200x magnification. Scale bar = 25μm).
Fig. 2. Representative images of immunohistochemical staining showing the 
greater expression of PLIN1 and a greater number of adipocytes between 
cardiomyocytes in the atrium of patients with coronary artery disease patients 
(CAD) (200x magnification. Scale bar = 25μm).
Fig. 3. Representative images of immunohistochemical staining showing the 
expression of PLIN2 in the atrium of patients without coronary artery disease 
(NON CAD) (400x magnification. Scale bar = 10μm).
Fig. 4. Representative images of immunohistochemical staining showing the 
expression of PLIN2 in the atrium of patients with coronary artery disease (CAD) 
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T2 – Lipotoxicity
T2:PO.024
Sex-dependent differences in rat hepatic mitochondrial 
biogenesis and fat metabolism in response to rosiglitazone 
treatment
Galmés-Pascual B.M.1,2, Bauzá-Thorbrügge M.1,2, Sbert-Roig M.1,2, 
Proenza A.M.1,2,3, García-Palmer F.J.1,2,3, Lladó I.1,2,3, Gianotti M.1,2,3
1Grup de Metabolisme Energčtic i Nutrició, Dept. Biologia Fonamental i Cičncies 
de la Salut and IUNICS, Universitat de les Illes Balears,  
2IdISPa, Palma de Mallorca, Spain,  
3Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la 
Nutrición (CIBERobn, CB06/03/0043), Instituto de Salud Carlos III
Introduction: High caloric intake is linked to hepatic steatosis in which 
mitochondrial dysfunction seems to play a key role, impairing fat homeo-
stasis. Rosiglitazone (Rsg), a PPARγ agonist that ameliorates insulin sen-
sitivity and mitochondrial function, may play a role in mitochondrial bio-
genesis, a process that includes both proliferation and differentiation. The 
aim of this study was to define sex-related differences in mitochondrial 
biogenesis and fat homeostasis in response to Rsg treatment. 
Methods: Eight-week-old male and female Wistar rats were fed a high-fat 
diet (HFD, 23% fat) for 16 weeks. Half of the animals were supplemented 
with Rsg (100mg/kg) during the last two weeks of HFD feeding. Markers 
of mitochondrial biogenesis and fat metabolism were analysed. 
Results: Rsg treatment induced an increase in PGC1α expression lead-
ing to an increase in mitochondrial proliferation (mtDNA) in both sex-
es. Male rats maintained mitochondrial differentiation (COX IV, TFAM, 
UCP2) while females decreased it. In parallel, hepatic triglycerides dimin-
ished more strongly in males, in accordance with the stimulation of fatty 
acid oxidation (PPARα) and inhibition of de novo lipogenesis (SREBP-1c) 
in this sex.
Conclusions: In a fatty liver context, Rsg treatment improves mitochon-
drial function through an increase in mitochondrial proliferation and 
maintenance of mitochondrial differentiation in male rats leading to an 
improvement of hepatic fat homeostasis. The lower degree of steatosis 
reached by HFD females may explain the minor hepatic changes observed 
in response to Rsg treatment in both mitochondrial differentiation and 
fat metabolism.
T2:PO.025
Sexual dimorphism in cardiac adiponectin signalling in rats 
on high fat diet induced obesity: Role of sex hormones
Sbert-Roig M.1,2, Bauzá-Thorbrügge M.1,2, Galmés-Pascual B.M.1,2, 
Lladó I.1,2,3, García-Palmer F. J.1,2,3, Gianotti M.1,2,3, Proenza A.M.1,2,3
1Grup de Metabolisme Energčtic i Nutrició, Dept. Biologia Fonamental i Cičncies 
de la Salut and IUNICS, Universitat de les Illes Balears,  
2IdISPa, Palma de Mallorca, Spain,  
3Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y 
la Nutrición (CIBERobn, CB06/03/0043), Instituto de Salud Carlos III, Palma de 
Mallorca, Spain
Introduction: Adiponectin is an adipokine that increases cardiac insulin 
sensitivity thus exerting an important effect on myocardial function which 
is lost during the development of diabetic cardiomyopathy. Rosiglitazone 
(Rsg) is an antidiabetic drug that increases systemic insulin sensitivity 
through the enhancement of adiponectin synthesis. Previous results from 
our research group show that 17beta-estradiol (E2) activates adiponectin 
signalling in both skeletal muscle and L6 myotubes. The aim of this work 
was to study the role of sex hormones on adiponectin and insulin cardiac 
signalling pathways, as well as the effect of Rsg, in a lipotoxic environment. 
Methods: Male and female rats were fed a control or high fat diet (HFD) 
for 16 weeks. Half of the HFD rats were treated with Rsg during the last 
2 weeks. Animals were sacrificed and cardiac muscles were harvested. 
Concurrently, H9c2 cardiomyotubes were treated with palmitate (PA), E2, 
testosterone (T), and adiponectin. Key proteins of adiponectin and insulin 
signalling pathways were determined by Western blot. 
Results: HFD male rats had a lower p-AMPK to t-AMPK ratio value than 
females. Rsg induced an increase of both p-AMPK to t-AMPK and Akt to 
t-Akt ratios that were more pronounced in females. Moreover, T reduced 
the p-AMPK to t-AMPK ratio in adiponectin treated H9c2 cells. 
Conclusion: In male rats, HFD had a higher deleterious effect on cardiac 
adiponectin pathway activation, the response of which to Rsg was lower 
compared to that of females. Consequently, insulin sensitivity was im-
proved in response to Rsg only in female rats. Our in vitro results suggest 
that T could be involved in the sex dimorphism observed in vivo with Rsg 
treatment.
T2:PO.026
Effect of the Exposition of Persistent Organic Pollutants on 
in vitro model of adipocytes in relation to a higher risk of 
diabetes mellitus type II
Mullerova D.1, Pesta M.2, Dvorakova J.1, Dvorak P.2, Cedikova M.3, Kulda V.4, 
Kripnerova M.2, Babuska V.4, Kralickova M.3
1Department of Public Health Medicine, The Faculty of Medicine in Pilsen, 
Charles University in Prague, Czech Republic,  
2Department of Biology, The Faculty of Medicine in Pilsen, Charles University in 
Prague, Czech Republic,  
3Department of Histology and Embryology, The Faculty of Medicine in Pilsen, 
Charles University in Prague, Czech Republic,  
4Department of Biochemistry, The Faculty of Medicine in Pilsen, Charles 
University in Prague, Czech Republic
Introduction: In humans, organochlorine persistent organic pollutants 
(POPs) are associated in epidemiological studies with a higher risk of di-
abetes mellitus type II. However, the specific mechanism of POPs action 
is not yet known. These lipophilic pollutants are stored primarily in adi-
pose tissue. To examine the effect of POPs on adipocyte metabolism, we 
prepared an in vitro model of adipocytes from human mesenchymal stem 
cells derived from adipose tissue (hMSC). To study the effect of POPs, it 
was necessary to characterize the process of differentiation of adipocytes 
at first. The ongoing process of differentiation was described by quanti-
tative assessment of the expression of selected genes using RT real-time 
PCR with LNA probes. These genes are involved in the processes of imple-
menting the undifferentiated phenotype of adipocytes - OCT4, NANOG 
and SOX2, or direction of differentiation in adipocytes - PPARγ, PPARG-
C1B and PLIN2.
Methods: We prepared a model of adipocytes from human mesenchy-
mal stem cells derived from adipose tissue (hMSC). The differentiation 
of adipocytes was performed in the presence and without of dichlorodi-
phenyldichloroethylene (DDE). During 28 days from the point when dif-
ferentiation was initiated, the samples were taken every 3 days. The pattern 
of expression will be presented. Process of differentiation was analysed 
by quantitative assessment of expression of the following genes: OCT4, 
NANOG, SOX2, PPARγ, PPARGC1B and PLIN2. We also analyzed a pan-
el of control genes (GAPDH, beta-actin, GUSB, HPRT, TBP, YWHAZ) and 
found GUSB, HPRT and YWHAZ to be most relevant.
Results: During differentiation of adipocytes in the presence of DDE, we 
observed silencing of the expression of markers of differentiation (PLIN2, 
PPARγ and PPARGC1B).
Conclusion: 
Results: of the assessment of expression of selected genes indicate that 
DDE could inhibit adipocyte differentiation. Impact on metabolic path-
ways is now being investigated.
Acknowledgement: This work was supported by grant of the Ministry of Health of 
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T2 – Lipid Metabolism
T2:PO.027
Characterization of hypodermic adipose tissue in obese mice
Begey A.L.1, Nguyen-Tu M.S.1, Geloen A.2, Sigaudo-Roussel D.1
1UMR 5305 CNRS,  69367 Lyon cedex 07, France; University of Lyon 1,  
69367 Lyon cedex 07, France,   
2University of Lyon 1, CARMEN INSERM U1060, INSA-Lyon, F-69621, 
Villeurbanne, France
Introduction: In obesity, hypodermic adipose tissue grows at the expense 
of surrounding tissues. The aim of the present study was to character-
ize the hypodermic adipose cells compared to other adipose tissues in a 
mouse diet-induced obesity model.
Methods: C57Bl6 male mice were randomly assigned to a control or a 
high-calorie diet for 4 or 12 weeks (HCD4 or HCD12). We studied the 
changes in mice adipose tissue weights and in adipose cell size distri-
bution in hypodermic (hWAT), subcutaneous (scWAT), retroperitoneal 
(rWAT), and epididymal (eWAT) using multisizer IV (Beckman Coulter). 
The lipolytic response was investigated measuring the glycerol produced. 
We also examined in vitro insulin sensitivity of hWAT compared to the 
other adipose tissues.
Results: In HCD4 and HCD12, the body weight of obese mice was in-
creased compared to non-obese (p < 0.001). hWAT lipolytic response was 
lower than the other tissues responses in HCD4 mice, but was higher than 
eWAT and scWAT responses in HCD12 mice. The bimodal distribution of 
adipose cell sizes of hWAT was not observed in HCD4 mice compared to 
the other tissues whereas it was observed in HCD12 mice. In HCD4 mice, 
adipocyte cell size rose only in eWAT and rWAT while in HCD12 mice, 
adipocyte cell size increased in all adipose tissues.
Conclusion: This study suggests that adipose tissue from hypodermis lay-
er behaves the same than other tissues in HCD12 mice but not in HCD4 
mice.
T2:PO.028
Saturated fatty acids in human visceral adipose tissue 
are associated with increased 11- β-hydroxysteroid-
dehydrogenase type 1 expression
Petrus P.1, Rosqvist F.2, Edholm D.3, Mejhert N.1, Arner P.1, Dahlman I.1, 
Rydén M.1, Sundbom M.3, Risérus U.2
1Department of Medicine, Karolinska Institutet, Karolinska University Hospital, 
Huddinge, Stockholm, Sweden,  
2Clinical Nutrition and Metabolism, Department of Public Health and Caring 
Sciences, Uppsala University, Uppsala, Sweden,  
3Department of Surgical Sciences, Uppsala University Hospital, Uppsala 
University
Background: Visceral fat accumulation is associated with metabolic dis-
ease. It is therefore relevant to study factors that regulate adipose tissue 
distribution. Recently overeating saturated fatty acids promoted greater 
visceral fat storage than unsaturated fatty acids (Rosqvist et al. Diabetes 
2014;63:2356–2368). Visceral adiposity is observed in states of hyper-
cortisolism, and the enzyme 11-β-hydroxysteroid-dehydrogenase type 1 
(11β-hsd1) is a major regulator of cortisol activity by converting inactive 
cortisone to cortisol in adipose tissue. We hypothesized that tissue fatty 
acid composition regulates body fat distribution through local effects on 
the expression of 11β-hsd1 and its corresponding gene (HSD11B1) result-
ing in altered cortisol activity.
Findings: Visceral- and subcutaneous adipose tissue biopsies were col-
lected during Roux-en-Y gastric bypass surgery from 50 obese patients 
(45 women, BMI; 40 ± 4 kg/m2). The fatty acid composition of each biopsy 
was measured and correlated to the mRNA levels of HSD11B1. 11β-hsd1 
protein levels were determined in a subgroup (n=12) by western blot anal-
ysis. Our main finding was that tissue saturated fatty acids were associated 
with increased 11β-hsd1 gene- and protein-expression in visceral but not 
subcutaneous adipose tissue.
Conclusions: The present study proposes a link between HSD11B1 and 
saturated fatty acids in visceral, but not subcutaneous adipose tissue. Nu-
tritional regulation of visceral fat mass through HSD11B1 is of interest 
for the modulation of metabolic risk and warrants further investigation.
Acknowledgement: We would like to thank Siv Tengblad for analysing fatty acids at 
the laboratory at Uppsala University, and Elisabeth Dungner and co-workers at the 
Lipid laboratory at Karolinska University Hospital for excellent technical support. 
We would also like to thank Jakob Hedberg and Eduardo Sima and the surgical team 
at Uppsala university hospital for assistance with biopsy collection.
Fig. 1. This schematic picture presents a hypothetical link between SFAs and 
disease-risk-phenotypes through HSD11B1 expression.
T2:PO.029
Acetylation of malate dehydrogenase 1 promotes adipogenic 
differentiation via activating its enzymatic activity
Kim W.K.1, Kim J.S.1, Min J.K.1, Han B.S.1, Lee S.C.1, Bae K.H.1
1Functional Genomics Research Center, KRIBB, Daejeon 305-806, Republic of 
Korea 
Acetylation is one of the most crucial posttranslational modifi cations that 
affect protein function. Protein lysine acetylation is catalyzed by acetyl-
transferases, and acetyl-CoA functions as the source of the acetyl group. 
Additionally, acetyl-CoA plays critical roles in maintaining the balance 
between carbohydrate metabolism and fatty acid synthesis. Here, we 
sought to determine whether lysine acetylation is an important process 
for adipocyte differentiation. Based on an analysis of the acetylome during 
adipogenesis, various proteins displaying signifi cant quantitative changes 
were identifi ed by LC-MS/MS. Of these identified proteins, we focused 
on malate dehydrogenase 1 (MDH1). The acetylation level of MDH1 was 
increased up to 6-fold at the late stage of adipogenesis. Moreover, over-
expression of MDH1 in 3T3-L1 preadipocytes induced a signifi cant in-
crease in the number of cells undergoing adipogenesis. The introduction 
of mutations to putative lysine acetylation sites showed a signifi cant loss 
of the ability of cells to undergo adipogenic differentiation. Furthermore, 
the acetylation of MDH1 dramatically enhanced its enzymatic activity 
and subsequently increased the intracellular levels of NADPH. These re-
sults clearly suggest that adipogenic differentiation may be regulated by 
the acetylation of MDH1 and that the acetylation of MDH1 is one of the 
cross-talk mechanisms between adipogenesis and the intracellular energy 
level.
Acknowledgement: This work was supported by grants from KRIBB, and the Re-
search Program (grant nos. 2011-0027634, 2011-0027796 and 2011-0030028) of the 
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T2:PO.030
Deuterium labeling and 2H-NMR technique to assess 
triglyceride re-esterification rate in epididymal white adipose 
tissue of mice
Zouhar P.1, Jones J.G.2, Flachs P.1, Svobodova M.1, Janovska P.1, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic,  
2Biocant, Centre for Neuroscience and Cell Biology, University of Coimbra, 
Cantanhede, Portugal
Introduction: Futile cycling of triglycerides (TG) and non-esterified fatty 
acids in white adipose tissue (WAT) may represent an important ener-
gy-consuming process and could contribute to metabolic flexibility and 
lipid homeostasis. In current experiment, we tested if different re-ester-
ification rate in WAT may reflect different propensity to obesity between 
obesity-resistant A/J and obesity-prone C57BL/6J (B6) mice. 
Methods: A/J and B6 male mice were held and dissected at thermoneutral 
temperature (control animals), or exposed to cold for 2 or 7 days. 2 or 
4 days prior to dissection, all mice were injected with a bolus of 2H2O; 
also 5% of their drinking water was replaced by 2H2O for the rest of the 
experiment in order to obtain stable 5% 2H2O concentration in body wa-
ter. Glycerol of TG produced after 2H2O injection was enriched by 2H. 
Therefore, 2H content in TG isolated from epididymal WAT, measured by 
2H-NMR, reflected rate of fatty acid re-esterification. 
Results: 2H-enrichment of glycerol moiety of TG was slightly increased 
after first 2 days in cold. However, only prolonged cold exposure resulted 
in a strong (up to 4-fold) rise in TG production, while re-esterification rate 
was significantly higher in A/J mice. However this inter-strain difference 
became apparent only in the mice injected with 2H2O 2 days but not 4 
days before the dissection. 
Conclusion: Here we present a newly established technique for assess-
ment of the re-esterification rate in WAT in vivo. This rate can be in-
creased several-fold in response to prolonged cold exposure. In compari-
son to B6 animals, futile cycling in A/J mice is more flexible, which could 
be possibly linked to the lean phenotype of these mice (see Flachs et al at 
this meeting).
T2:PO.031
Lipidomic and proteomic profiling reveals possible 
biomarkers of brown adipose tissue aging
Gohlke S.1, Japtok L.2, Kleuser B.2, Schulz T.J.1
1German Institute of Human Nutrition,  
2University of Potsdam 
Background: Ageing is a risk factor for the development of metabolic dis-
eases such as insulin resistance and obesity. Recent studies suggest that 
these pathologies could be exacerbated by an age-related decline of brown 
fat mass and activity. Until now, little is known about the molecular reg-
ulation of brown adipocyte formation and metabolism during ageing. It 
has been proposed that age-related changes in circulating and locally pro-
duced endocrine signals could negatively affect regeneration and function 
of brown adipose tissue thus leading to impaired metabolic health.
Methods: A correlative mass spectrometric approach was chosen to ana-
lyze age-related lipidomic and proteomic changes in murine interscapular 
brown adipose tissue to identify potential biomarkers of reduced brown 
adipocyte function. The effects of candidate biomarkers on brown adipo-
cytes were subsequently characterized on the molecular level.
Results: Lipids were classified into different lipid sub-classes. The amounts 
of prenols and sphingoid base lipids were significantly enhanced with age 
and individual metabolites, such shingosine-1-phospate and ceramides, 
displayed distinct regulatory effects on brown adipogenesis. The proteom-
ic study in turn revealed age-related changes of lipid metabolism, specif-
ically PPAR-signaling and fatty acid metabolism, as among the most sig-
nificantly affected pathways in aged brown adipose tissue.
Conclusions: These findings taken together suggest that the decline of 
brown adipose tissue mass and function could at least in part be due to 
changes of lipid composition and metabolism during ageing.
T2:PO.032
Doses of quercetin in the range of serum concentrations exert 
depilidating effects in 3t3-l1 pre-adipocytes
Eseberri I.1,2, Miranda J.1,2, Lasa A.1,2, Churruca I.1,2, Portillo M.P.1,2
1Nutrition and Obesity Group, Department of Nutrition and Food Science, 
Faculty of Pharmacy and Lucio Lascaray Research Institut, University of País 
Vasco (UPV/EHU), Vitoria (Spain), 
2CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos 
III, Spain 
Introduction: Quercetin (Q) intake in the diet is higher than that of other 
polyphenols and a wide range of biological effects, such as prevention of 
oxidation, inflammation and cancer, have been attributed to this mole-
cule. Nevertheless, data concerning its delipidating effect, are scarce. The 
purpose of the present study was to determine whether doses of Q in the 
range of serum concentrations (around 2 μM) exert any effect on tria-
cylglycerol (TG) accumulation in maturing pre-adipocytes and mature 
adipocytes. The influence on the expression of adipogenic markers and on 
the activity of enzyme involved in TG metabolism were assessed.
Methods: 3T3-L1 pre-adipocytes were treated with low doses (0.1–10 
μM) of Q at different phases (early and late stages of adipogenesis and the 
whole adipogenic process). TG content was measured by spectrophotom-
etry. Peroxisome proliferator-activated receptor γ2 (PPARγ2) and sterol 
regulatory element-binding factor 1 (SREBP1) protein expression were 
assessed by Western-Blot at whole adipogenenic process for 1 and 10 μM 
doses.
Results: During whole adipogenesis, Q reduced TG content at all tested 
doses. At the early state of adipogenesis, doses of 1, 2 and 5 μM reduced 
TG content, but during the late state only doses of 5 and 10 μM were ef-
fective in decreasing TG content. 1 μM of Q reduced SREBP1c mature 
protein levels. 10 μM of Q reduced PPARγ2 and SREBP1c expression.
Conclusion: Quercetin, in the range of serum concentrations, is able to 
inhibit adipogenesis, but depending on the dose the mechanisms of action 
seems to be different.
T2:PO.033
Obesity correlates to an increased transforming growth factor 
β (TGF-β) signaling in human visceral and subcutaneous 
adipose tissue
Rodrigues A.R.1, Salazar J.M.1, Moreira A.3, Guimarăes M.4, Nora M.4, 
Almeida H.1, Monteiro M. P.3, Gouveia A.M.1,2
1Departamento de Biologia Experimental, Faculdade de Medicina; Instituto de 
Investigaçăo e Inovaçăo em Saúde, Instituto de Biologia Molecular e Celular 
(IBMC), Universidade do Porto, Portugal;  
2Faculdade de Cięncias da Nutriçăo e Alimentaçăo, Universidade do Porto, 
Portugal;  
3Department of Anatomy, Multidisciplinary Unit for Biomedical Research 
(UMIB), Institute for Biomedical Sciences Abel Salazar (ICBAS), University of 
Porto, Portugal;  
4Department of General Surgery, Centro Hospitalar de Entre o Douro e Vouga, 
Santa Maria da Feira, Portugal.
Introduction: TGF-β is a pleiotropic cytokine with major roles in adipose 
tissue regulating adipogenesis and inflammation. It signals through phos-
phorylation of receptor-activated Smads, but also crosstalk with many 
others signaling pathways, including ERK1/2 and AKT. Increased plasma 
levels of TGF-β associates to human adiposity but data regarding TGF-β 
signaling in human adipose tissue is lacking. In this context, we aim to 
characterize the TGF-β expression and signaling in adipose tissue from 
normoponderal and overweight/obese patients.
Methods: Adipose tissue samples from subcutaneous and visceral depots 
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dergoing gastric bypass surgery or laparoscopic cholecystectomy, aging 
from 18 to 80 years-old. TGF-β mRNA expression was analyzed by re-
al-time PCR and activation of Smads, AKT and ERK1/2 was evaluated by 
Western blotting.
Results: In normoponderal and overweigh individuals, lower levels of 
TGF-β mRNA were found in subcutaneous adipose tissue when compared 
to visceral pads, a feature that is blunted in the obese state. Nevertheless, 
in both subcutaneous and visceral adipose tissue, TGF-β mRNA levels 
were positively correlated with body mass index (BMI). Concordantly, ac-
tivation of Smad2, Smad3 and Akt was also associated to an increased fat 
mass. In addition, an increased in ERK1/2 phosphorylation was observed 
in overweight but not in obese patients.
Conclusion: In human adipose tissue, TGF-β signaling increases with 
adiposity, most probably through phosphorylation of Smad2, Smad3 and 
also AKT pathway. ERK1/2 signaling should be important during weight 
gain, but in obesity, ERK1/2 activation decreases to basal levels suggesting 
signaling desensitization, a common feature among resistant phenotypes.
T2:PO.034
Expression of Free Fatty Acid Receptors (FFAR) in 
subcutaneous and abdominal adipocytes in an obesity rat 
model with hypercaloric diet
Meza-Cuenca F.1,2, Bautista de Lucio Victor M.2, Bautista-
Hernandez Luis A.2, Buentello-Volante B.2, Colado-Velazquez J.1, Medina-
Contreras J.1, mailloux-Salinas P.1, Bravo G.1
1Pharmacobiology Department, Cinvestav-IPN, Mexico city.,  
2Microbiology department, Instituto de Oftalmología “FAP Conde de Valenciana
Introduction: Free fatty acids receptors (FFAR), whose function in the 
cell surface plays a significant role in the regulation of cell function, are in-
volved in many physiopathological processes, such as metabolic disorders 
like obesity1,2. The aim of this protocol was to analyze the expression of 
FFARs (41, 43 and GPR120) in abdominal and subcutaneous dysfunction-
al adipose tissues.
Methods: Obesity was induced in male Wistar rats, with hypercaloric diet 
(30% sucrose in drinking water) and standard chow ad libitum during 
20 weeks. Dissection of visceral fat (abdominal and subcutaneous) was 
performed for analyze the relative expression by RT-PCR.
Results: The expression of FFAR 43 and 41 was lower in fat tissues in 
obese rats, in contrast to normocaloric diet group. The expression of 
GPR120 in the high sucrose diet, shown no statistical difference versus 
the control group.
Conclusion: The current expression of FFAR 43 and 41 yields significa-
tive statistical difference among the groups, showing a reduction in the 
total presence of RNAm in abdominal and subcutaneous in dysfunctional 
adipose tissues. The GPR120 did not show diferences in the relative ex-
pression when the obesity is present. Further comparative methods are in 
process to clarify if the obesity changes the functional receptors in these 
two tissues for new pharmacological approaches.
References:
1.  Hirasawa A et al.: Free fatty acid receptors and drug Discovery. Biol Pharm Bull 
2008;31(10):1847–1851. 
2.  Yonezawa T et al.: Free fatty acids-sensing G protein-coupled receptors in 
drug targeting and therapeutics. Curr Med Chem 2013;20(31):3855–3871.
T2:PO.035
Garcinia mangostana extract attenuates the mebabolic 
disorders of high-fat-fed mice through activation of ampk 
pathway
Kim Y.M.1, Chin Y.W.1
1College of Pharmacy and BK21PLUS R-FIND Team, Dongguk University-Seoul,  
32 Dongguk-lo, Ilsandong-gu, Goyang, Gyeonggi-do 410-820, Republic of Korea
Obesity is associated with increasing risks of life-threatening pathologies 
such as diabetes, hypertension, and heart disease, while weight loss has 
been reported to ameliorate these associated conditions. Due to the previ-
ous reports regarding anti-adipogenic activity of mangosteen extracts in 
in vitro experiments, we investigated the effects of long-term supplemen-
tation with mangosteen extract (50 and 200 mg/kg/day p.o. for 80 days) 
in mice with established obesity (3-month high-fat diet). Untreated obese 
mice showed a weight gain of 30.1% compared with mice fed a normal 
diet. Therefore, the objective of this study was to investigate the effects 
of mangosteen extract on the metabolic disorder states in high-fat-diet 
(HF)-fed mice and the underlying mechanisms related to adipogenesis. 
Mangosteen extract supplementation produced a marked and sustained 
decrease in body weight compared to the HF group. The levels of serum 
GOT, GPT, glucose, triglyceride, total cholesterol, low-density lipoprotein 
cholesterol, and free fatty acid were markedly elevated in HF mice, where-
as in the 200 mg/kg of mangosteen extract-treated group, these levels were 
significantly reduced (GOT –28.2%, GPT –21.2% , glucose –25.7%, total 
cholesterol –24.8%, free fatty acid –23.0% vs. HF group). Although man-
gosteen extract did not modify high-density lipoprotein cholesterol, it sig-
nificantly reduced low-density lipoprotein cholesterol (LDL, –63.8%) and, 
notably, increased the HDL/LDL ratio (9.4 vs. 3.7 in HF group). Also 200 
mg/kg of mangosteen extract treatment activated the hepatic AMP-acti-
vated protein kinase (AMPK) and Sirtuin 1 and supressed PPARγ expres-
sion in in vivo system. Thus, our results suggest that mangosteen extract 
exerts anti-obesity effects by regulating energy metabolism and hepatic 
lipid homeostasis in HF-induced obese mice.
Acknowledgement: This study was supported by a grant from the GRRC program 
of Gyeonggi province [GRRC DONGGUK2014–B03, Development of functional 
food to alleviating metabolic syndromes and circulatory disorders]
T2:PO.036
Association of plasma lipids fatty acid composition with 
metabolic profile of czech adolescents
Hlavaty P.1, Tvrzicka E.2, Stankova B.2, Zamrazilova H.1, Sedlackova B.1, 
Dusatkova L.1, Kunesova M.1
1Institute of Endocrinology, Prague, Czech Republic,  
24th Department of Internal Medicine, 1st Faculty of Medicine of Charles 
University in Prague and General University Hospital, Prague, Czech Republic
Background: Obesity in childhood increases the risk of obesity in adult-
hood, and is predictive for the development of metabolic disorders. The 
fatty acid composition is associated with obesity and obesity-associated 
disorders. We investigated relationship between serum fatty acids com-
position, adiposity, lipids profile, parameters of glucose metabolism and 
leptin. Design: The study subjects were 380 adolescents aged 15.0 – 17.9 
years. The study‘s variables included anthropometric measurements, se-
rum lipids and hormonal parameters. Individual FA were determined in 
plasma by gas-liquid chromatography and desaturase activities were esti-
mated from product/precursor ratios. 
Results: Percentage of body fat was significantly positively correlated with 
palmitoleic acid (16:1n-7, PA) content, SCD activity and omega-3 fatty 
acids content. PA content positively correlated with serum total, HDL and 
LDL cholesterol and triglycerides levels, C peptide and HOMA-R. SCD 
activity and PA level had a positive significant correlation with leptin. 
Conclusion: Plasma PA content has a significant positive relation with 
adiposity in obese adolescents. Higher levels of PA may be due activation 
of SCD. PA content and SCD activity are associated with insulin resistance 
and dyslipidemia.
Acknowledgement: Research relating to this abstract was funded by grants IGA 
NT12342-5/2011, grant 7F08077 from MSM/7F and grant CZ0123 from Norway 
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T2 – Adipokines
T2:PO.037
Monocyte chemotactic protein-1 is associated with 
intermuscular adipose tissue area independently of the 
visceral fat area
Haam J.1, Kim M.1, Kim Y.1, Koo H.1, Seo N.1, Kim H.1
1CHA Bundang Medical Center, CHA university, Seongnam, Republic of Korea
Introduction: Ectopic fat is lipid accumulated in tissues that typically do 
not store large amount of fat, such as liver, vessel and skeletal muscle and is 
a major risk factor for metabolic disorders. Adipokines such as leptin and 
monocyte chemotactic protein 1 (MCP-1) are secreted from adipose tis-
sue and have roles in lipid and glucose metabolism. It has been shown that 
visceral fat significantly contributes to the development of cardiovascular 
diseases and insulin resistance. Emerging evidence suggests that inter-
muscular fat is also a risk factor for insulin resistance, but the underlying 
mechanism still remains unclear. In this study, we investigated whether 
the levels of leptin, adponectin and MCP-1 are related to intermuscular fat 
area in obese Korean women. 
Methods: A cross-sectional study was performed on 77 obese subjects. 
Visceral fat area and intermuscular fat area were measured by multi-slice 
computed tomography scan. Correlation between the levels of adipokines 
and the fat areas was assessed using Pearson correlation and covariate-ad-
justed multivariable regression. 
Results: Leptin levels were positively correlated with the body fat percent-
age (r = 0.480, P < 0.001) and abdominal subcutaneous fat area (r = 0.452, 
P < 0.001). MCP-1 levels were positively correlated with the intermuscular 
fat area (r = 0.483, P < 0.01). After adjustment for age, height, and other 
body composition metrics, serum levels of leptin were still related to sub-
cutaneous fat area (β = 0.376, P = 0.001). The serum levels of MCP-1 were 
associated with intermuscular fat area (β = 0.447, P = 0.001) after adjust-
ment for visceral fat area. 
Conclusion: Intermuscular adipose tissue area was associated with the 
levels of MCP-1, suggesting its role in the development of insulin resis-
tance.
Acknowledgement: We are grateful to the participants in this study.
T2:PO.038
Adipokines and the risk of metabolic disorders at the different 
types of obesity in women
Karapetyan A.R.1, Selyatitskaya V.G.1, Pinkhasov B.B.1, Dobrovolskaya N.P.1, 
Dvurechenskaya O. V.1
1Siberian Branch of Russian Academy Medical Sciences, Scientific Centre of 
Clinical and Experimental Medicine, Novosibirsk, Russia
Introduction: The purpose of this study was to research the adiponec-
tin and leptin contribution to the development of metabolic disorders in 
women with android and gynoid types of fat distribution.
Methods: The study included 101 women aged 40 to 65 years. The anthro-
pometric examination was conducted, value of the waist-to-hip circum-
ference ratio (WHR) less than 0.85 in women with pre-obese and obese 
referred to the group with gynoid type of fat distribution (GTFD), while 
values of WHR 0.85 and above - to the group with android type (ATFD). 
Serum concentrations of triglycerides, HDL cholesterol, glucose, insulin, 
leptin and adiponectin were determined. Insulin resistance HOMA-IR 
and visceral obesity VAI indexes were calculated.
Results: At the similar degree of accumulation of excess adipose tissue in 
women with GTFD severity of hormonal-metabolic disorders was lower 
than that in women with ATFD whose index of HOMA-IR also indicated 
the presence of insulin resistance. VAI index value was not significantly 
higher in women with GTFD compared to normal body weight (NBW) 
women, but it was 2.4 times higher in women with ATFD. The concentra-
tion of leptin was higher in women with GTFD and ATFD compared with 
women with NBW, which is characterized for obesity, but the concentra-
tion of adiponectin was significantly lower in ATFD and has not differed 
at GTFD compared with women with NBW.
Conclusion: For women with ATFD characterized by high VAI, hypoad-
iponectinaemia, insulin resistance and metabolic disorders, defining high 
risk of cardiovascular diseases and type 2 diabetes. In women with GTFD 
obesity is associated with normal adiponectin levels and low VAI, and 
its hormonal and metabolic features can be characterized as «metabolic 
healthy» obesity.
T2:PO.039
General and central obesity measurement associations 
with markers of chronic low-grade inflammation and type 2 
diabetes
Millar S.R.1, Perry I.J.1, Phillips C.M.1
1Department of Epidemiology & Public Health, University College Cork, Ireland.
Introduction: Inflammation has been suggested a possible mechanism 
linking adiposity with type 2 diabetes. Central obesity indicated by waist 
circumference (WC) measurement is thought to be a greater risk factor 
for chronic low-grade inflammation compared to general obesity charac-
terised by body mass index (BMI). However, evidence for this association 
is still equivocal. In this study we compare biomarker relationships with 
BMI and WC measures and type 2 diabetes. We examine a range of pro-in-
flammatory cytokines, acute-phase response proteins, coagulation factors, 
white blood cell counts and a combination of these markers to determine 
which measurement is more strongly associated with diabetes-related in-
flammation.
Methods: This was a cross-sectional study involving a random sample of 
2,002 men and women aged 50–69 years. Correlation and logistic regres-
sion analyses were used to explore general and central obesity measure-
ment relationships with non-optimal biomarker levels, biomarker combi-
nations and type 2 diabetes.
Results: When compared with BMI, WC was more strongly related to a 
majority of inflammatory markers, adverse biomarker clustering and type 
2 diabetes. In multivariable analysis, only WC remained significantly as-
sociated with type 2 diabetes (OR: 2.96, 95% CI: 1.93–4.55) after adjusting 
for BMI (OR: 0.73, 95% CI: 0.49–1.10) four or more markers (OR: 4.67, 
95% CI: 2.64–8.27) and other potential confounders.
Conclusion: These data suggest that central obesity is a greater risk factor 
for type 2 diabetes and associated chronic inflammation than BMI. How-
ever, our results also demonstrate that the relationship between obesity 
and diabetes-related inflammation cannot be completely accounted for by 
surrogate adiposity measures.
Acknowledgement: This work was supported by a research grant from the Irish 
Health Research Board (reference HRC/2007/13).
T2:PO.040
Autocrine effects of transgenic resistin reduce palmitate and 
glucose oxidation in brown adipose tissue
Šilhavý J.1, Pravenec M.1, Zídek V.1, Landa V.1, Mlejnek P.1, Šimáková M.1, 
Eigner S.3,4, Eigner Henke K.1, Kazdová L.2, Škop V.2, Malínská H.2, 
Drahota Z.1, Mráček T.1, Houštěk J.1
1Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, 
Czech Republic,  
2Institute for Clinical and Experimental Medicine, Prague, Czech Republic,  
3Nuclear Physics Institute, Academy of Sciences of the Czech Republic, Husinec-
Řež, Czech Republic,  
4Faculty of Pharmacy, Charles University in Prague, Hradec Kralove, Czech 
Republic
Introduction: Resistin has been identified as an adipokine that links obe-
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hypertensive rats (SHR) expressing a nonsecreted form of mouse resistin 
(Retn) transgene specifically in adipose tissue (SHR-Retn), we observed 
an increased lipolysis and serum free fatty acids, ectopic fat accumulation 
in muscles and insulin resistance. Recently, brown adipose tissue (BAT) 
has been suggested to play an important role in the pathogenesis of meta-
bolic disturbances by its ability to dissipate energy excess. 
Methods: In the current study, we analyzed autocrine effects of transgenic 
resistin on BAT glucose and lipid metabolism and mitochondrial function 
in the SHR-Retn versus SHR controls. 
Results: We observed that BAT isolated from SHR-Retn transgen-
ic rats when compared to SHR controls showed a lower relative weight 
(0.71 ± 0.05 vs. 0.91 ± 0.08 g/100 g body weight, P < 0.05), significantly 
reduced both basal and insulin stimulated incorporation of palmitate into 
BAT lipids (658 ± 50 vs. 856 ± 45 and 864 ± 47 vs. 1086 ± 35 nmol/g/2h, 
PL0.01, respectively), and decreased palmitate oxidation (37.6 ± 4.5 
vs. 57 ± 4.1 nmol/g/2h, P = 0.007) and glucose oxidation (277 ± 34 vs. 
458 ± 38 nmol/g/2h, P = 0.001). In addition, in vivo microPET imaging 
revealed reduced 18F-FDG uptake in BAT induced by exposure to cold in 
SHR-Retn transgenic versus control SHR controls (232 ± 19 vs. 334 ± 22 
kBq/cc*ccm, P < 0.05). In addition, we observed reduced expression of 
Ucp1 and Cidea genes in SHR-Retn versus SHR rats which suggests lower 
differentiation status of BAT in transgenic rats. 
Conclusion: These results provide compelling evidence that autocrine ef-
fects of resisitin in BAT might play an important role in the pathogenesis 
of insulin resistance in the rat.
T2:PO.041
Comparing effects of exercise- and diet-induced weight 
loss on chemerin, adiponectin, insulin resistance and 
inflammation in obese men
Khoo J.1, Tian R.H.2, Ling P.S.3, Dhamodaran S.4
1Department of Endocrinology, Changi General Hospital,  
2Department of Sports Medicine, Changi General Hospital,  
3Department of Dietetics and Nutrition, Changi General Hospital,  
4Department of Gastroenterolgy
Background: The adipokines chemerin and adiponectin are recipro-
cally related in the pathogenesis of insulin resistance and inflammation 
in obesity. Weight loss increases adiponectin and reduces chemerin, but 
effects of caloric restriction and physical activity are difficult to separate 
in combined lifestyle modification. We compared effects of diet- or exer-
cise-induced weight loss on chemerin, adiponectin, insulin resistance and 
inflammation in obese men.
Methods: Eighty abdominally obese Asian men (BMI ≥ 30 kg/m2, waist 
circumference WC ≥ 90 cm, mean age 42.6 years) were randomized to 
reduce daily intake by ~500 kilocalories (n = 40), or perform moderate-in-
tensity aerobic and resistance exercise (200–300 minutes/week) (n = 40) 
to increase energy expenditure by a similar amount for 24 weeks.
Results: The diet and exercise groups had similar decreases in energy 
deficit (-456 ± 338 vs. –455 ± 315 kilocalories/day), weight (-3.6 ± 3.4 vs. 
–3.3 ± 4.6 kg) and WC (-3.4 ± 4.4 vs. –3.6 ± 3.2 cm). The exercise group 
demonstrated significantly greater reductions in fat mass (-3.9 ± 3.5 vs. 
–2.7 ± 5.3 kg), serum chemerin (-9.7 ± 11.1 vs. –4.3 ± 12.4 ng/ml) and 
high-sensitivity C-reactive protein (-2.11 ± 3.13 vs. –1.49 ± 3.08 mg/L), 
and insulin resistance as measured by homeostasis model assessment 
(-2.45 ± 1.88 vs. –1.38 ± 3.77). Adiponectin increased only in the exercise 
group.
Conclusions: Exercise-induced weight loss was more effective in reducing 
serum chemerin, insulin resistance and systemic inflammation, whereas 
increased adiponectin concentration could be related to exercise itself or 
greater fat loss.
Acknowledgement: We thank all the men who participated in the study.
T2:PO.042
Spirulina maxima reduces blood pressure, oxidative stress 
and improves parameters associated with insulin resistance in 
obese hypertensive patients.
Szulinska M.1, Pupek-Musialik D.2, Musialik K.1, Lis I.1, Stepien M.1, 
Suliburska J.3, Bogdanski P.1
1Department of Education and Obesity Treatment and Metabolic Disorders, 
University of Medical Sciences, Poznan, Poland,  
2Department of Internal Medicine, Metabolic Disorders and Hypertension 
University of Medical Sciences, Poznan, Poland,  
3Department of Human Nutrition and Hygiene, Poznan University of Life 
Sciences, Poznan, Poland
Spirulina maxima (SM) consumption is known to be associated with en-
hanced cardiovascular and metabolic health. The purpose of this study is 
to examine the hypothesis that supplementation with SM alters insulin re-
sistance and associated cardiovascular risk factors in obese, hypertensive 
patients. In a double-blind, placebo-controlled trial, 50 obese, hyperten-
sive subjects were randomized to receive a daily supplement of 4 capsules 
that contained each either 0.5 g of SM extract or a matching placebo, for 
3 months. At baseline and after 3 month of treatment, the anthropometric 
parameters, blood pressure, plasma lipid levels, glucose levels, total anti-
oxidant status (TAS) levels, interleukin 6 (Il 6) levels, and insulin levels are 
assessed. Insulin sensitivity was evaluated by the euglycemic hyperinsulin-
emic clamp technique. After 3 months of supplementation, both systolic 
and diastolic blood pressure had significantly decreased in the SM group 
as compared with the placebo group (p < 0.044). Considerable (p < 0.002) 
reduction in low-density lipoprotein cholesterol level was observed in the 
SM group when compared with the placebo group. Supplementation also 
contributed to significant (p < 0.031) increases in the TAS level and (p < 
0.043) insulin sensitivity ratio. In conclusion, daily supplementation with 
2 g of SM favorably influences blood pressure, insulin sensitivity, oxidative 
stress, and lipid level in patients with obesity-related hypertension.
T2:PO.043
Sleep duration affects theserum adiponectin level of obese 
women undergoing weight loss intervention
Sawamoto R.1, Nozaki T.1, Furukawa T.1, Hata T.1, Morita C.1, Komaki G.2, 
Sudo N.1
1Department of Psychosomatic Medicine, Graduate School of Medical Sciences, 
Kyushu University,  
2School of Health Sciences Fukuoka, International University of Health and 
Welfare
Background: Adiponectin, secreted from adipose tissue, is an adipokine 
that is involved in various cellular processes such as energy metabolism 
and inflammation. Although the serum adiponectin level is inversely cor-
related to BMI and closely associated with obesity and related diseases, 
neither the impact of weight loss on the adiponectin level nor the factors 
that influence the levels of adiponectin during weight loss intervention 
are known.
Objective: We assessed the changes in the serum adiponectin level of 
obese women during seven months of weight loss intervention. In addi-
tion, in order to determine factors that affect the serum adiponectin level, 
various clinical variables were evaluated, including objective sleep param-
eters.
Methods: Ninety overweight and obese women aged 25 to 65 years com-
pleted a seven-month weight loss intervention. Serum levels of adiponec-
tin, body fat rate, depression, anxiety, and objective sleep parameters 
assessed by actigraphy were measured at baseline and at the end of the 
intervention.
Results: The mean values of weight loss and reduction of body fat rate 
were 10.3 ± 4.8 kg and 4.8 ± 3.2%, respectively. The serum adiponectin 
level was significantly increased after weight loss intervention (P < 0.001). 
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positively associated with the magnitude of body fat loss (β = -0.306, 
P = 0.0015) and increase of sleep minutes (β = 0.205, P = 0.0319).
Conclusion: An increase in objective sleep duration was related to a sig-
nificantly increased serum adiponectin level, independent of the change 
of body fat rate during the weight loss intervention. Improvement of sleep 
duration may be important as a component of weight loss interventions 
for obese people.
Acknowledgement: This study was supported by a Research Grant (23–3) for Ner-
vous and Mental Disorders from the Ministry of Health, Labour and Welfare of 
Japan and a Grant-in-Aid for Scientific Research (25460902) from the Japan Soci-
ety for the Promotion of Science. The authors thank Junko Sakaguchi and Akemi 
Kugimaru, national registered nutritionists, for nutritional guidance.
T2:PO.044
Relationship between serum osteoprotegrin concentration 
(sopg) and inflammatory process in group of patients with 
metabolic syndrome (ms).
Musialik K.1, Pupek-Musialik D.2, Bogdanski P.1, Hen K.2
1Department of Education and Obesity Treatment and Metabolic Disorders, 
University of Medical Sciences, Poznan, Poland,  
2Department of Internal Medicine, Metabolic Disorders and Hypertension 
University of Medical Sciences, Poznan, Poland
MS increase risk of atherosclerosis (A)and frequency of cardiovascular 
diseases. Taking into account the fact that, underlying cause of a A is an 
inflammatory process, the correlation between high sensitivity CRP and 
serum osteoprotegrin (sOPG) concentration seems to be very interesting. 
Aim of the study was to evaluate sOPG concentration. The relationship 
between sOPG, anthropometric parameters, insulin resistance and chron-
ic inflammatory process were analyzed. 
Material: 70 patients with MS vs control group – 20 healthy volunteers. 
Methods: Anthropometric parameters such as BMI, WHR were deter-
mined. At the same time the percentage of body fat (% FAT)was assessed 
using electrical bioimpedancy method. Insulin resistance was estimated 
applying HOMA index. Serum insulin concentration was determined by 
ELISA method. 
Results: Patients with MS were characterized by high values of anthropo-
metric parameters (BMI, WHR), higher concentration of insulin, hsCRP, 
HOMA index and sOPG. We have observed the significant correlation 
between sOPG and body weight, WHR, hsCRP, insulin and HOMA index. 
Conclusions: 1) Concentration of sOPG and insulin resistance were sig-
nificantly higher in group of patients with MS. 2) The insulin resistance 
plays significant role in development of an A. Close correlation between 
sOPG and HOMA index may suggest that sOPG could be involved in pro-
cess of development of A. 3) Inflammatory process plays a role in develop-
ment of A. The significant correlation between hsCRP and sOPG can also 
confirm the role of OPG in this process.
T2:PO.045
Macrophage migration inhibitory factor (mif) and adipokines 
in severe obese women with normal and impaired glucose 
tolerance
Sumarac-Dumanovic M.S.1,2, Micic D.D.1,2, Stamenkovic-Pejkovic D.H.2, 
Polovina S.2, Cvijovic G.1,2, Gligic A.B.2, Jeremic D.2
1School of Medicine, Univeristy of Belgrade, Belgrade, Serbia,  
2Clinic for Endocrinology, Diabetes and Diseases of Metabolism, Center of 
Obesity, Clinical Center of Serbia, Belgrade, Serbia
Macrophage migration inhibitory factor (MIF) is implicated in the patho-
genesis of several inflammation related diseases, including obesity and 
type 2 diabetes (T2D). MIF is elevated in obesity. Hyperglycemia could 
increase plasma visfatin in patients with T2DM. This increase gets more 
prominent as the glucose intolerance worsens. The aim of the study was to 
determine level of MIF and adipokines (plasma visfatin, adiponectin and 
leptin) in obese women with normal and impaired glucose tolerance. Ten 
obese women (age: 35.46 ± 2.21yrs; BMI 34.11 ± 0.75 kg/m2) with nor-
mal glucose tolerance (NGT) and 10 age and BMI matched obese women 
(age: 35.80 ± 2.54 yrs; BMI 36.98 ± 1.66 kg/m2) with normal fasting and 
impaired glucose tolerance (OGTT-75 gr of glucose) (IGT) were includ-
ed in the study. Fasting MIF (ELISA, ng/l), plasma visfatin (EIA Phoe-
nix, ng/ml), adiponectin (Linco RIA, ng/ml), leptin (Linco RIA, ng/ml) 
and insulin (RIA Inep, mU/l), were measured. Insulin sensitivity (M in-
dex: mg/kgBW/min) was determined using euglycemic 2hr clamp. There 
was no difference in fasting visfatin between NGT and IGT (72.66 ± 4.11 
vs. 69.80 ± 5.55, p > 0.05), fasting leptin (33.53 ± 2.98vs.30.70 ± 3.88, 
p > 0.05) fasting adiponectin (8.84 ± 1.61vs.9.65 ± 4.59, p > 0.05) and 
plasma MIF (2456.75 ± 428.91 vs. 2344.80 ± 481.80, p >0.05). Insulin sen-
stitivity was reduced in obese women with IGT (6.55 ± 0.51vs.2.74 ± 0.38, 
p < 0.05). There were no significant correlations among investigated pa-
rameters neither with insulin sensitivity index. No significant differences 
among investigated adipocytokines were found in women with IGT in 
comparison with women with NGT. In conclusion, our data suggest that 
impairment in insulin sensitivity precede change in adipocytokines and 
MIF during development of type 2 diabetes in obesity.
Acknowledgement: The is supported by Project 175067, Ministry of Science and 
Techology, Republic of Serbia
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Circulating betatrophin concentrations and adipose tissue 
expression in type 2 diabetes and obesity
Flehmig G.1, Klöting N.2, Kern M.1, Schön M.R.3, Dietrich A.4, Lohmann T.5, 
Dreßler M.5, Fasshauer M.1, Stumvoll M.1, Blüher M.1
1Department of Medicine, University of Leipzig, Leipzig, Germany,  
2IFB ObesityDiseases, Junior Research Group Animal Models, University of 
Leipzig, Leipzig, Germany,  
3Städtisches Klinikum Karlsruhe, Clinic of Visceral Surgery, Karlsruhe, Germany, 
4Department of Surgery, University of Leipzig, Leipzig, Germany,  
5Municipal Clinic Dresden-Neustadt, Dresden, Germany
Context: Recently, the hormone betatrophin has been proposed to pro-
mote pancreatic β-cell proliferation in mice. Even though the results of 
studies in humans are controversy and the mode of action is still unclear, 
an association of betatrophin to obesity, lipid metabolism, and glucose tol-
erance is beyond dispute. 
Objective: Thus, we tested the hypothesis that betatrophin serum concen-
trations and Betatrophin adipose tissue expression are related to parame-
ters of obesity and metabolic abnormalities. 
Design and Methods: Betatrophin serum concentrations and mRNA ex-
pression in paired omental and subcutaneous adipose tissue samples were 
studied in 2 cross-sectional studies of 882 individuals. Additionally we in-
vestigated a subgroup of 115 volunteers who underwent bariatric surgery. 
Results: Higher betatrophin serum and mRNA expression levels were 
measured in individuals with T2D. We found relationships between be-
tatrophin serum concentrations and age, gender, body fat, FPG, HbA1c, 
TG, ALAT, ASAT, and gGT. Despite the relationships to FPG and HbA1c 
remained all correlations significant after adjusting for BMI, gender and 
age. The Betatrophin mRNA expression was correlated to BMI, body fat, 
FPG, HbA1c, FFA, ALAT, ASAT, leptin, adiponectin, but not to FPI and 
lipid metabolism in sc AT, and to BMI, HbA1c, ALAT, ASAT in omental 
AT. After adjustment for age, gender and BMI only the correlation to FPG 
kept significant. Weight loss caused no significant reduction in circulating 
serum betatrophin but in Betatrophin mRNA expression. 
Conclusions: Our data support the hypothesis that betatrophin may play 
a role in linking obesity to type 2 diabetes. The associations between cir-
culating betatrophin and metabolic disorders are partly related to Betatro-
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T2:PO.047
Plasma retinol binding protein type 4 (RBP4) and TNF system 
activity in relation to nutritional status women with and 
without polycystic ovary syndrome (PCOS)
Madej P.1, Bińkowski M.1, Owczarek A.2, Chudek J.3,  
Olszanecka-Glinianowicz M.4
1Department of Gynecologycal Endocrinology, Medical Faculty in Katowice, 
Medical University of Silesia,  
2Division of Statistics, Department of Instrumental Analysis, Faculty of Pharmacy 
and Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice,  
3Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in 
Katowice, Medical University of Silesia,  
4Health Promotion and Obesity Management Unit, Department of 
Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia
Introduction: The aim of the study was to assess the associations between 
TNF system activity and plasma RBP4 levels depending on nutritional sta-
tus and PCOS occurrence.
Methods: A cross-sectional study involving 86 PCOS (47 obese) and 69 
Non-PCOS women (38 obese). Anthropometric parameters and body 
composition were measured. In the fasting state of serum concentrations 
of glucose, insulin, androgens, FSH, LH, SHBG and plasma TNF-α, sTNFs 
and RBP4 levels were assessed.
Results: There were no differences in plasma TNF-α, sTNFR1 and RBP-4 
between PCOS and Non-PCOS group. Plasma sTNFR2 levels were sig-
nificantly higher in PCOS than Non-PCOS group. Regardless of higher 
TNF-α levels in both obese than in normal weight groups, no differenc-
es between corresponding PCOS and Non-PCOS subgroups were found. 
Plasma sTNFR1 levels were higher in obese than normal weight PCOS 
subgroups and no differences were shown between obese and normal 
weight Non-PCOS subgroups. In addition sTNFR1 levels were higher 
in obese PCOS than Non-PCOS subgroups, with no difference between 
normal weight subgroups. In turn, plasma sTNFR2 levels were similar in 
normal weight and obese PCOS and higher in normal than obese Non-
PCOS, as well as in normal weight and obese PCOS than obese Non-
PCOS subgroups. Plasma RBP4 levels were higher in normal weight than 
obese PCOS, and lower in normal weight Non-PCOS than in both obese 
subgroups. In addition RBP4 levels were higher in normal weight PCOS 
than Non-PCOS and lower in obese PCOS than Non-PCOS. The negative 
correlation between plasma RBP4 and TNFR2 levels in all study group 
and Non-PCOS group was shown.
Conclusions: It seems that changes in plasma sTNFR2 and RBP4, but not 
TNF-α and sTNF1 are associated per se with the occurrence of PCOS. 
Although nutritional status is a factor modifying the direction of these 
changes. Circulating RBP4 levels seems to be modified by the concentra-
tion of circulating sTNFR2 regardless of the PCOS occurrence.
Acknowledgement: Research relating to this abstract was funded by Medical Uni-
versity of Silesia
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Plasma insulin like factors and its binding protein levels and 
nutritional status women with polycystic ovary syndrome 
(PCOS)
Lemm M.1, Madej P.1, Owczarek A.2, Chudek J.3,  
Olszanecka-Glinianowicz M.4
1Department of Gynecological Endocrinology, Medical Faculty in Katowice, 
Medical University of Silesia,  
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and Laboratory Medicine in Sosnowiec, Medical University of Silesia,  
3Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in 
Katowice, Medical University of Silesia,  
4Health Promotion and Obesity Management Unit, Department of 
Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia
Introduction: Nutritional status modulates secretion of plasma insulin 
like factors 1 and 2 and its binding proteins. However, the impact of nu-
tritional status on levels on INSL3 in PCOS women is hardly known. The 
aim of the study was to analyze relationships between plasma IGF1, IGF2, 
INSL3, IGFBP1 and IGFBP3 and nutritional status as well as insulin resis-
tance in PCOS women.
Methods: A cross-sectional study involving 85 PCOS (48 obese) and 72 
Non-PCOS women (41 obese). Anthropometric parameters and body 
composition were measured. In the fasting state of serum concentrations 
of glucose, androgens, FSH, LH, SHBG, insulin and IGF1, IGF2, INSL3,
IGFBP1 and IGFBP3 were assessed.
Results: Plasma IGF1 levels were significantly lower in obese than normal 
weight in both PCOS and Non-PCOS subgroup, but without intergroup 
(PCOS vs. Non-PCOS) difference. While, plasma IGF2 levels were signifi-
cantly higher in PCOS than Non-PCOS group, and corresponding sub-
groups, and in obese than in normal weight Non-PCOS women. Higher 
plasma INSL3 levels were also shown in PCOS than Non-PCOS group. 
However, plasma INSL3 levels were higher in obese than in normal weight 
PCOS women and lower in obese than normal weight Non-PCOS wom-
en. Plasma IGFBP1 and IGFBP3 levels were comparable in study groups. 
However, plasma IGFBP1 levels in both PCOS subgroups were signifi-
cantly lower than in normal weight Non-PCOS subgroup, and similar 
as in obese Non-PCOS subgroup. Additionally, in obese PCOS subgroup 
plasma IGFBP3 levels were higher than in normal weight PCOS subgroup, 
but lower than in obese Non-PCOS subgroup.
Conclusions: The activity of IGFs and IGFBPs system is affected by nu-
tritional status. It seems that its impact in PCOS is modify by exacerbated 
insulin resistance.
Acknowledgement: Research relating to this abstract was funded by Medical Uni-
versity of Silesia
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The relationship between circulating visfatin/nicotinamide 
phosphoribosyltransferase, obesity, inflammation and 
lipids profile in elderly population, determined by structural 
equation modeling
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of Silesia,  
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4International Institute of Molecular and Cell Biology, Warsaw,  
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Introduction: The available literature data suggest that circulating visfa-
tin/Nicotinamide Phosphoribosyltransferase (NAMPT) levels variability 
in humans is related to obesity, insulin resistance, inflammation and lipids’ 
profile. The aim of the study was to assess the relationship between circu-
lating visfatin/NAMPT, obesity, insulin resistance, inflammation and lip-
ids’ profile in a large population-based elderly cohort, applying structural 
equation modeling.
Methods: The analysis included 2983 elderly participants of the PolSenior 
study with assessed total blood count, and fasting concentrations of lipids, 
glucose, insulin, CRP, interleukin-6, and visfatin/NAMPT (by ELISA), and 
calculated HOMA-IR.
Results: The circulating visfatin/NAMPT levels were higher in obese than 
normal weight subjects, in those with hs-CRP above 3 mg/L, and with low 
serum HDL cholesterol and in insulin resistant subjects. Based on results 
of the exploratory factor analysis a baseline model of mutual relationship 
between four latent and measured variables was created and a final model, 
was developed by maintaining only two significant paths. The important 
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IL-6 serum levels. In case of the ‘Nutritional status’ construct important 
variables were BMI, waist circumference, and to a less extent insulin resis-
tance.. Additionally, the residual correlation between those two constructs 
was also statistically significant.
Conclusion: The structural equation modeling provided support for the 
existence of a link between visfatin/NAMPT level, nutritional status and 
inflammation. This indicates that, fat depot, especially the visceral one, is 
the important source of circulating visfatin/NAMPT in elderly popula-
tion.
Acknowledgement: Publicly-funded project No. PBZ-MEIN-9/2/2006, Ministry of 
Science and Higher Education and grant from National Centre of Science (No DEC 
2012/07/B/NZ5/02339)
T2:PO.050
Omentin levels are significantly decreased in patients with 
morbid obesity (mo) and increase after gastric bypass surgery
Hoellerl F.1, Brix J.M.1, Kopp H.P.1, Schernthaner G.H.2, Schernthaner G.1, 
Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria,  
2Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Introduction: Patients with MO have a high risk for cardiovascular (CV) 
morbidity, mortality and diabetes. The only effective method to reduce 
weight and the associated risks is bariatric surgery. Omentin, a novel adi-
pokine, – preferentially produced by visceral adipose tissue - was found to 
be associated with insulin resistance and obesity. Thus it was of interest to 
evaluate Omentin levels in patients with MO before and after weight loss 
induced by gastric bypass. 
Methods: We included 81 patients with MO (69 women, BMI 47 ± 7 kg/
m˛) and 39 healthy controls (BMI 26 ± 3 kg/m˛). All patients were in-
vestigated before and one year after gastric bypass surgery. Apart from 
weight and CV risk-markers, an oral glucose tolerance test (oGTT) was 
performed and insulin resistance (IR) was calculated by using HOMA. 
Omentin levels were determined in serum samples by an ELISA. 
Results: Omentin levels were significantly decreased in MO vs healthy con-
trols: 461 ± 153 vs 619 ± 196 ng/ml; p < 0.001. After weight loss induced 
by bariatric surgery Omentin levels significantly increased (461 ± 153 vs 
515 ± 177 ng/ml; p = 0.003). Delta Omentin levels (pre minus post) were 
significantly associated with fasting plasma glucose (p = 0.032), one hour 
(p = 0.002) and two hours (p = 0.007) plasma glucose levels in the OGTT.
Conclusion: This is the first study demonstrating (a) decreased Omentin 
levels in patients with MO compared to healthy controls and (b) a signif-
icant increase of Omentin levels after dramatic weight loss induced by 
gastric bypass. Since Omentin was shown to be associated with insulin 
sensitivity and glucose metabolism, the observed significant increase in 
Omentin after dramatic weight loss might help to understand the benefi-
cial effects of gastric bypass surgery.
T2:PO.051
Angiogenin increases after bariatric surgery (bs) in patients 
with morbid obesity (mo)
Feder A.1, Brix J.M.1, Hoellerl F.1, Kopp H.P.1, Schernthaner G.H.2, 
Schernthaner G.1, Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria,  
2Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Introduction: Angiogenesis is a complex process regulated by stimulato-
ry and inhibitory factors. Angiogenin – a 14,124-Da soluble protein - is 
an important angiogenic growth factor, that has a great influence on the 
process of creation of new vessels. Angiogenin induces nitric oxide syn-
thesis in endothelial cells. Since patients with MO have an increased risk 
for cardiovascular (CV) disease, we were interested in angiogenin levels 
in patients with MO compared to healthy lean controls (CO), as well as 
before and after BS.
Methods: We included 80 patients (mean age: 39 ±11 years; mean BMI: 
45.8 ± 6.9 kg/m˛) with MO in comparison with 40 CO (mean age: 47 ±8 
years; mean BMI: 25.3 ± 5.7 kg/m˛). All patients were investigated before 
and 2 years after BS. Apart from weight and CV risk-markers, a glucose 
tolerance test (75g), renal and inflammation parameters were assessed. 
Angiogenin levels were assessed by an ELISA.
Results: Two years after bariatric surgery Angiogenin levels increased 
significantly: 548 ± 163ng/ml vs 612 ± 164 ng/ml; p < 0.001. Patients with 
MO had significant lower Angiogenin levels than CO: 548 ± 163ng/ml vs 
624 ± 123 ng/ml; p = 0.042. In the correlation analysis ΔAngiogenin lev-
els were associated with ΔTriglycerides (R= 0.361; p = 0.009) and Δ2hour 
postprandial Insulin (R= 0.404; p = 0.024) In a multivariate model Δ2hour 
postprandial Insulin (Beta= 0.4070; p = 0.021) remained as a single pre-
dictor for ΔAngiogenin.
Conclusion: Patients with MO have significant lower Angiogenin lev-
els compared with CO, but Angiogenin levels increase significantly after 
BS. Since Angiogenin can induce angiogenesis and helps formatting new 
blood vessels, our results might help to understand the beneficial effects 
of bariatric surgery regarding CV morbidity and mortality. diabetes and 
lipid profile than women. In limited surgery capacity, one might consider 
to prefer men to women for bariatric procedures.
T2:PO.052
Children’s psychosocial stress and emotional eating: A role for 
leptin?
Michels N.1, Sioen I.1, De Henauw S.1
1Department of Public Health, Ghent University, Belgium 
Introduction: An important public health threat is that stress has been 
associated with a higher energy intake due to emotional or reward-based 
eating. One hypothesis is the effect of stress-induced cortisol changes on 
leptin, an anorexigenic adipokine that decreases reward-related behaviors.
Methods: In 254 Belgian children (5–12y), serum leptin levels were exam-
ined on their association with stress and emotional eating. Stress was mea-
sured by the Strengths and Difficulties Questionnaire (emotional, conduct 
and peer problems) in 2010 and 2012 and by salivary cortisol (4/day) in 
2010. Emotional eating was measured with the DEBQ. Longitudinal linear 
mixed models were adjusted for age, sex, body fat and pubertal stage and 
leptin was tested as mediator or moderator in the stress - emotional eating 
relation.
Results: Stress data, more specific emotional problems, were longitudi-
nally related to higher leptin levels but only in girls (beta=0.11). Also a 
higher daily cortisol output was associated with higher leptin levels in girls 
(beta=0.14). Leptin levels were cross-sectionally but not longitudinally as-
sociated with more emotional eating (beta=0.24). Leptin was no mediator 
but a moderator in the relation between stress and emotional eating.
Discussion: Both self-reported and objectively measured stress increased 
girl’s leptin levels. Moreover, we have confirmed the moderating effect of 
leptin: only in the presence of high leptin, stress increased emotional eat-
ing. These results are in agreement with the hypothesis that stress leads to 
increased leptin levels but that the body might become resistant to leptin 
and as a consequence the reward-lowering effect of leptin might be lost 




















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts168
Fig. 1. Leptin as moderator in the relation between stress and emotional eating.
T2 – Recruitment of adipocytes
T2:PO.053
Adipose tissue inflammation and function in non-obese type 
2 diabetics
Acosta J.R.1, Douagi I.1, Andersson D.1, Bäckdahl J.1, Ryden M.1, Arner P.1, 
Laurencikiene J.1
1Dept. of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden 
Introduction: White adipose tissue (WAT) resident cell populations and 
adipocyte morphology are affected by obesity. Proinflammatory macro-
phages have been associated with increased WAT inflammation observed 
in obesity. Altered adipogenesis has been suggested to affect adipose mor-
phology. We aimed to characterize WAT-resident cell populations in non-
obese type 2 diabetics and matched healthy controls.  
Methods: The stromal vascular fraction of WAT biopsies was isolated 
from a metabolically well-characterized cohort consisting of non-obese 
healthy (n=13) and type 2 diabetic patients (n=14). Fluorescence-activat-
ed cell sorting (FACS) with a 13-color antibody panel was used to deter-
mine frequencies of adipose progenitor cells, endothelial cells, CD4+ and 
CD8+ T cells, Tregs, B cells, tissue resident M1 and M2 macrophages in 
SAT. Fractions of CD45-/CD31-/CD34+ progenitor cells, CD45+/CD14+/
CD206+/CD11c+ M1-WAT macrophages, CD45+/CD14+/CD206+/
CD11c M2 WAT macrophages, and CD45+/CD14+/CD3+/CD4+ T-cell 
fraction was sorted for RNA extraction. Gene expression analysis of ad-
ipogenesis markers was performed by qPCR in progenitor cell fraction.  
Results: Lean type 2 diabetic patients exhibit enlarged adipocyte size, 
587 pl ± 117 pl p < 0.01** compared to healthy controls 451 pl ± 109 pl 
p < 0.01** . No difference in cell fraction frequencies between healthy con-
trols and type 2 diabetic patients were observed. The M1-M2 macrophage 
ratio in SAT correlates positively to adipocyte size (ρ=0.445, p = 0.026*) 
and to TNFα secretion (ρ = 0.495, p = 0.009**). Gene expression analysis 
on the impairment of adipogenesis is currently under evaluation.  
Conclusion: Adipocyte size is the primary culprit potentially underlying 
diabetes and complications caused by WAT inflammation. The M1-M2 
macrophage ratio correlated with adipocyte size and TNFα secretion, sug-
gesting that M1-macrophages might be involved in generating a proin-
flammatory phenotype in non-obese human WAT.
T2 – White, beige and brown Adipocytes
T2:PO.054
Selection of aptamers for mature white adipocytes by cell 
selex using flow cytometry
Han B.S.1, Kim J.S.1, Min J.K.1, Kim W.K.1
1Functional Genomics Research Center, KRIBB, Daejeon 305-806, Republic of 
Korea 
Adipose tissue, mainly composed of adipocytes, plays an important role in 
metabolism by regulating energy homeostasis. Obesity is primarily caused 
by an abundance of adipose tissue. Therefore, specific targeting of adipose 
tissue is critical during the treatment of obesity, and plays a major role in 
overcoming it. However, the knowledge of cell-surface markers specific to 
adipocytes is limited. We applied the CELL SELEX (Systematic Evolution 
of Ligands by EXponential enrichment) method using flow cytometry to 
isolate molecular probes for specific recognition of adipocytes. The ap-
tamer library, a mixture of FITC-tagged single-stranded random DNAs, is 
used as a source for acquiring molecular probes. With the increasing num-
ber of selection cycles, there was a steady increase in the fluorescence in-
tensity toward mature adipocytes. Through 12 rounds of SELEX, enriched 
aptamers showing specific recognition toward mature 3T3-L1 adipocyte 
cells were isolated. Among these, two aptamers (MA-33 and 91) were able 
to selectively bind to mature adipocytes with an equilibrium dissociation 
constant (Kd) in the nanomolar range. These aptamers did not bind to 
preadipocytes or other cell lines (such as HeLa, HEK-293, or C2C12 cells). 
Additionally, it was confirmed that MA-33 and 91 can distinguish between 
mature primary white and primary brown adipocytes. These selected ap-
tamers have the potential to be applied as markers for detecting mature 
white adipocytes and monitoring adipogenesis, and could emerge as an 
important tool in the treatment of obesity.
Acknowledgement: This work was supported by grants from the Korea Research 
Institute of Bioscience and Biotechnology (KRIBB) and from the Research Program 
(grants 2012M3A9C7050101, 2013M3A9A7046301, 2011-0020507, and Global 
Frontier R&D Program) through the National Research Foundation of Korea.
T2:PO.055
Secoisolariciresinol diglucoside inhibits adipogenesis in 3T3-
L1 adipocytes
Kang J.1, Jeong M.1, Kim H.1, Park J.1, Jung Y.1, Yooun D.1, Um J.1, Kim D.2, 
Hong S.2
1College of Korean Medicine, Institute of Korean Medicine, Kyung Hee 
University, 1 Hoegi-Dong, Dongdaemun-Gu, Seoul, Republic of Korea,  
2Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental 
Medicines Research Institute, Wonkwang University, Jeonbuk 570-749, Republic 
of Korea
Introduction: Obesity is a metabolic disorder characterized by chronic 
inflammation and dyslipidemia and is a strong predictor for the devel-
opment of hypertension, diabetes mellitus, and cardiovascular disease. 
Secoisolariciresinol diglucoside (SDG) is a Lignan which belongs to the 
phytoestrogen family. This component exists abundantly in flaxseeds, 
therefore can be isolated from flaxseeds commonly. Flaxseeds are used for 
treating type 2 diabetes, fatty liver, hyperlipidemia, and obesity in Tradi-
tional Korean Medicine. However, anti-obesity effect of SDG has not been 
reported to date. Thus, the aim of this study was to examine anti-obesity 
functions of SDG by assessing differentiation of adipocyte, adipogene-
sis-related gene expressions and protein expressions.
Methods: The cellular lipid content in 3T3L-1 adipocytes was assessed by 
Oil Red O staining. Expressions of peroxisome proliferators activated re-
ceptor-γ (PPAR-γ) and CCAAT/enhancer-binding protein (C/EBP) were 
determined by real-time RT-PCR. Protein expressions of AMP-activated 
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Results: SDG suppressed the differentiation of 3T3-L1 adipocytes by 
down-regulating cellular induction of PPAR-γ, and up-regulating the 
AMPKα. Furthermore, SDG successfully activated phosphorylations 
of AMPKα/LKB1. These results demonstrate that SDG has a potent an-
ti-obesity effect in 3T3-L1 cells due to the inhibition of adipogenesis.
Conclusion: Our results demonstrate that SDG inhibits adipogenesis in 
3T3-L1 adipocytes. SDG may be beneficial in the treatment of obesity and 
can be used as a safe natural promoter of health.
T2:PO.056
Saikosaponin A, an active component of Bupleuri Radix, 
regulates brown adipocyte differentiation via activation of 
SIRT1-AMPKα axis
Youn D.1, Um J.1
1Department of Pharmacology College of Korean Medicine, Institute of Korean 
Medicine, Kyung Hee University
Introduction: Saikosaponin A (SSA) is a major triterpenoid saponin iso-
lated from Bupleuri Radix, a widely used Chinese traditional medicine to 
treat various inflammation-related diseases. Brown adipocytes play an im-
portant role in regulating energy balance, and there is a good correlation 
between obesity and the amount of brown adipose tissue. In spite of sever-
al studies confirming the various effects of SSA including anti-inflamma-
tory and anti-cancer, its effect on brown adipocytes has not been reported 
to date. Therefore, this study examined the regulatory action of SSA in 
brown adipogenic differentiation using primary brown preadipocytes.
Methods: Expressions of uncoupling protein 1 (UCP-1) and peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) 
were determined by real-time RT-PCR. Western blot was used to assess 
the protein levels of silent mating type information regulation 2 homolog 
1 (SIRT1), AMPKα and p-AMPKα.
Results: Our results clearly showed that expressions of brown adipo-
cyte-related genes, such as UCP-1 and PGC-1α were dramatically up-reg-
ulated by treatment with SSA. In addition, SSA increased the expression of 
SIRT1, suggesting its effect on the SIRT1 - AMPKa axis, which plays a key 
role in metabolism. As expected SSA successfully activated the phosphor-
ylation of AMPKα. Our study shows that SSA is capable of increasing dif-
ferentiation of brown adipocytes via activation of p-AMPK, suggesting its 
potential therapeutic application in the treatment or prevention of obesity.
Conclusion: Our results show that SSA induces brown adipocyte differ-
entiation via activation of SIRT1-AMPKα axis. Therefore, SSA may be 
beneficial in the treatment of obesity and can be used as a safe natural 
promoter of health.
T2:PO.057
Effects of all-trans retinoic acid (ATRA) on white adipose tissue 
(WAT) in a model of obesity-related type 2 diabetes (T2D)
Hasan S.1, White R.1, Hamel F.G.2, Desouza C.V.1,2, Bennett R.G.2
1University of Nebraska Medical Center,  
2VA Nebraska Western Iowa 
Obesity-related T2D is characterized by WAT dysfunction including adi-
pocyte hypertrophy, low grade inflammation and few beige adipocytes in 
WAT. We investigated the effect of ATRA on inflammation and remodel-
ing of WAT in 3 month old db/db mice (10/group) treated with vehicle 
(corn oil) or ATRA 0.6 mg/day, 5 days/wk for 12 wks by voluntary oral 
feeding. We monitored a subset of mice for further 8 wks after tx cessa-
tion. ATRA caused a significant reduction in white adipocyte size which 
was maintained in the post tx phase (washout) (8229 ± 165 μm2 CTRL vs 
5775 ± 285 μm2 ATRA vs 5405 ± 571 μm2 post tx, p < .0001). ATRA in-
creased UCP1 gene and protein expression in visceral WAT (1.4 ± 0.47 
CTRL vs 13.42 ± 5.0 ATRA), which was not retained post tx. Obesity 
is characterized by adipose tissue macrophage infiltration, which is the 
source of inflammatory cytokines associated with insulin resistance (IR). 
WAT was examined for the presence of macrophages using the protein 
marker F4/80. ATRA resulted in a significant decrease in the frequen-
cy of F4/80+ crown-like structures (CLS), which was sustained post tx 
(1.02 ± 0.24 CLS/um2 CTRL vs 0.15 ± 0.55 ATRA vs 0.32 ± 0.23 post tx, 
p < .05). The expression of inflammation-related genes (MCP-1, PAI-1, 
and TNF α) were not reduced immediately after tx, however, they were 
significantly suppressed in the post tx phase. We have shown that long-
term ATRA tx promotes the remodeling of WAT and induces UCP1-pos-
itive beige adipose in WAT. Further, ATRA attenuates inflammation by 
reducing macrophage infiltration and suppressing the expression of the 
inflammation-related genes. This suggests that ATRA may be useful for 
obesity-related T2D by inducing the beige phenotype to promote weight 
loss, while simultaneously reducing inflammation to improve WAT func-
tion and IR.
Fig. 1. Mean adipocyte area.
Fig. 2. Immunohistochemistry of F4/80 (brown staining) in WAT.
Fig. 3. Frequency of crown-like structures (CLS) positive for the macrophage 
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Fig. 4. Immunohistochemistry of the beige adipose marker UCP1 (brown staining) 
in WAT (top) Fluorescent immunohistochemistry for the mitochondrial marker 
HSP60 (green), lipid droplet membrane marker perilipin-A (red), or nuclear stain 
DAPI (blue) in WAT (bottom).
T2:PO.058
Tamoxifen: How it influences adipocyte biology in vivo
Hesselbarth N.1, Pettinelli C.1, Kunath A.1, Boege E.2, Kern D.1, Kern M.1, 
Kloeting N.2
1Department of Endocrinology, University Hospital Leipzig, Leipzig, Germany,  
2Integrated Research and Treatment Center (IFB) AdiposityDiseases, University 
Hospital Leipzig, Leipzig, Germany
Tamoxifen is a selective oestrogen receptor modulator (SERM): it can ac-
tivate the oestrogen receptor (ER) in some tissues acting as an oestrogen 
agonist, while inhibits it in others, behaving as an antagonist. This drug is 
commonly used in two important fields: in chemotherapy as endocrine 
treatment of choice for metastatic ER-positive tumours in women and in ge-
netic engineering as a widespread activation system of inducible Cre-medi-
ated recombination technology. However, effects of Tamoxifen treatment on 
adipose tissue are not well characterized in literature. Therefore, this study 
had the aim to investigate how Tamoxifen influences adipocyte biology in 
vivo. To analyse the role of the drug on adipose tissue biology in vivo, in-
bred male mice (C57Bl/6NTac) were treated with Tamoxifen and analysed 
in terms of adipocyte biology, energy homeostasis, insulin sensitivity and 
lipid profile. In this study we obtained that Tamoxifen treatment leads to: 
(I) different body composition (II) increased insulin sensitivity (III) higher 
Triglyceride level in serum (IV) browning effects in subcutaneous adipose 
tissue and (V) an increased Ki67 mRNA expression. In conclusion, Tamox-
ifen has significant effects on adipose tissue biology, body composition and 
glucose metabolism, which need to be considered when using Tamoxifen as 
a tool to generate inducible knockout mouse models. Our data further sug-
gest that Tamoxifen treated control mice should always be characterized in 
addition to the transgenic models to avoid misinterpretation of data related 
to Tamoxifen effects.
T2:PO.059
Adipose tissue site-related differences in lactate procduction 
from glucose by isolated rat adipocytes
Rotondo F.1, Romero M.M.1,2,3, Fernández-López J.A.1,2,3, Remesar X.1,2,3, 
Alemany M.1,2,3
1Department of Nutrition and Food Science, Faculty of Biology, University of 
Barcelona, Barcelona, Spain,  
2Institute of Biomedicine of the University of Barcelona, Barcelona, Spain, 
3CIBEROBN, Spain
Male Wistar rats kept under standard conditions were killed under anaesthe-
sia and samples of subcutaneous inguinal (SC), mesenteric (ME), epididy-
mal (EP) and retroperitoneal (RP) adipose tissue were dissected. Adipocytes 
were isolated with collagenase; adipocyte number, integrity and cell size were 
calculated using direct microscopic observation and Image J. The cells were 
incubated at 37şC and 5% CO2 in DMEN media, supplemented with 3% 
serum albumin, 3% FBS and varying concentrations of glucose (0,5.5,11,22 
and 30 mM). EP and RP cells were larger than in ME. SC cell size was more 
variable. After 48 h incubation, cell viability was well maintained in nornox-
ia. Data for glucose consumption, and release to the medium of lactate, were 
expressed as pmol/cell and day. Maximal glucose uptake was observed at val-
ues >11 mM, and was highest in EP, followed by ME, RP and SC (a 7x differ-
ence between sites). Lactate production was maximal in EP, RP and MS and 
minimal in SC. The proportion of glucose converted to lactate was highest in 
RP, followed by ME and PG, and low in SC. The results show a considerable 
difference in the use of glucose, with RP, EP and ME taking up more glucose 
than SC, but delivering a large proportion of it as lactate as has been found 
in vivo and in cultured cells. The possible importance of this active glucose 
wasting is thus, specifically related to adipose tissue site.
Acknowledgement: Grants: PN Biomedicina SAF2012-34895, and PN Ciencia y 
Tecnología de los Alimentos AGL-2011-23635 from the Government of Spain
T2:PO.060
Potential involvement of mirnas in adipogenesis 
modifications induced by resveratrol metabolites
Eseberri I.1,2, Miranda J.1,2, Lasa A.1,2, Churruca I.1,2, Portillo M.P.1,2
1Nutrition and Obesity Group, Department of Nutrition and Food Science, 
Faculty of Pharmacy and Lucio Lascaray Research Institut, University of País 
Vasco (UPV/EHU), Vitoria (Spain), 
2CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos 
III, Spain 
Introduction: trans-resveratrol (3,4,5-trihydroxystilbene, RSV), a prom-
ising polyphenol in obesity, present in plant origin foods, undergoes rap-
id metabolism resulting in several metabolites. In a previous study we 
described how certain resveratrol metabolites modify the expression of 
genes related to the adipogenesis. The aim of the present work was to de-
termine whether miRNAs are implicated in the observed anti-adipogenic 
effect of resveratrol metabolites in 3T3-L1 murine pre-adipocytes
Methods: 3T3-L1 maturing pre-adipocytes were treated from day 0 to day 
8 of differentiation with 25 μM of resveratrol metabolites: trans-resvera-
trol-3’-O-glucuronide (3G), trans-resveratrol-4’-O-glucuronide (4G) and 
trans-resveratrol-3-O-sulfate (3S). Expression of miRNAs involved in adi-
pogenesis as well as their target genes and other key regulator genes of this 
process were measured by Real Time RT-PCR.
Results: 3G only increased the expression of miR-155. CEBPβ mRNA 
levels were reduced and, surprinsingly, those of SREBF1c were increased. 
No changes were observed in the expression of CEBPα, PPARγ and LPL 
genes. 4G also increased miR-155 expression, as well as that of miR-27b. 
Even though 4G did not change the expression of miR-145, its target genes 
were reduced (IGF1 and KLF5). This metabolite also reduced CEBPβ and 
CREB mRNA levels. 3S increased miR-145 expression, without changing 
those of miR-155 and miR-27b. IGF1, CREB, CEBPβ, KLF5, SREBF1c, 
PPARγ, CEBPα, and LPL gene expression was also reduced after treatment 
with this metabolite.
Conclusion: Whereas 3S inhibits the whole metabolic process by acting 
on miR-145 and miR-27b, 3G and 4G inhibit partially the adipogenesis, at 
least in part, by increasing miR-155.
T2:PO.061
Epa triggers the „brite“ phenotypic shift even at a late stage 
of adipocyte differentiation
Dinnies D.1, Elsen M.1, Romacho T.1, Eckel J.1
1Paul-Langerhans-Group for Integrative Physiology, German Diabetes Center, 
Duesseldorf, Germany
Introduction: We have recently shown that BMP4 promotes browning of 
primary human adipocytes. Besides pharmacological and hormonal reg-
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trigger this process. Alongside this question, it is still under discussion if 
the browning effect is rather caused by transdifferentiation or direct con-
version of differentiated adipocytes.
Methods: Human preadipocytes were isolated from subcutaneous adi-
pose tissue, differentiated for 8 days, and treated from day 8 to 12 with 20 
μM of the n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA), the n-6 PUFA arachidonic acid (ARA) or BMP4. Adipogenic 
state and gene expression markers were analysed via RT-PCR, Western 
Blot and Oil Red O Staining.
Results: Assessing general adipogenesis, PPARγ mRNA expression and 
HSL protein abundance did not show any notable change in response to 
PUFAs or BMP4. Oil Red O Staining was significantly elevated through 
overall PUFA treatment, but not after BMP4 treatment. As expected, adi-
ponectin was upregulated via the n-3 PUFAs EPA and DHA. BMP4, which 
is known to promote browning in the early stage of adipogenesis, was not 
able to enhance expression of the brite/brown marker UCP1 and the mi-
tochondrial marker CPT1B, when applied in the late stage of adipogenesis. 
Most importantly, exclusively EPA lead to an increase in mRNA levels of 
UCP1 and CPT1B. In contrast to EPA, the n-6 PUFA ARA elevated mRNA 
expression of the white adipocyte marker TCF21.
Conclusion: EPA treatment of differentiated adipocytes leads to a “brite” 
phenotypic shift, indicated by enhanced UCP1 and CPT1B mRNA levels. 
This browning effect at a late stage of adipogenesis cannot be triggered by 
BMP4, suggesting a major relevance for dietary n-3 PUFAs.
Acknowledgement: Dr. Romacho is the recipient of FP7-EU-Marie Curie-IEF (AD-
DIO-PIEF-2012-328793)
T2:PO.062
Evaluation of reference genes for gene expression studies in 
human brown adipose tissue
Taube M.1, Andersson-Assarsson J.C.1, Pereira M.J.2, Eriksson J.W.2, 
Svensson P.A.1
1Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, 
Gothenburg, Sweden,  
2Department of Medical Sciences, Uppsala University, Uppsala.
Introduction: Human brown adipose tissue (BAT) has during the last five 
year been subjected to an increasing research interest, due to its putative 
function as a target for future obesity treatments. The most commonly 
used method for molecular studies of human BAT is the quantitative 
polymerase chain reaction (qPCR). This method requires normalization 
to a reference gene (genes with uniform expression under different ex-
perimental conditions, e.g. similar expression levels between human BAT 
and WAT), but so far no evaluation of reference genes for human BAT has 
been performed.
Methods: Two different microarray datasets with samples containing hu-
man BAT were used to search for genes with low variability in expression 
levels. Seven genes (FAM96B, GNB1, GNB2, HUWE1, PSMB2, RING1 
and TPT1) identified by microarray analysis, and eight commonly used 
reference genes (18S, B2M, GAPDH, LRP10, PPIA, RPLP0, UBC, and 
YWHAZ) were selected and further analyzed by quantitative PCR in both 
BAT containing perirenal adipose tissue and subcutaneous adipose tissue. 
Results were analyzed using two different algorithms (Normfinder and 
geNorm).
Results: Most of the commonly used reference genes displayed acceptably 
low variability (geNorm M-values <0.5) in the samples analyzed, but the 
novel reference genes identified by microarray displayed an even lower 
variability (M-values <0.25).
Conclusion: Our data suggests that PSMB2, GNB2 and GNB1 are suitable 
novel reference genes for qPCR analysis of human BAT and we recom-
mend that they are included in future gene expression studies of human 
BAT. The use of reference genes with low variability will increase the fidel-
ity in qPCR results from human BAT.
T2:PO.063
In the rat, adipose tissue lactate levels correlate with lactate 
dehydrogenase gene expression and activity
Arriarán S.1, Agnelli S.1, Sabater D.1,3, Remesar X.1,2,3,  
Fernández-López J.A.1,2,3, Alemany M.1,2,3
1Department of Nutrition and Food Science, Faculty of Biology, University of 
Barcelona, Barcelona, Spain,  
2Institute of Biomedicine of the University of Barcelona, Barcelona, Spain,  
3CIBEROBN, Spain
Female and male adult Wistar rats were fed standard chow or a simplified 
cafeteria diet for one month. Then, the rats were killed and the white ad-
ipose tissue (WAT) in four sites: perigonadal, retroperitoneal, mesenteric 
and subcutaneous (inguinal) were sampled and frozen, measuring also the 
full size of each WAT site. Gene expression analysis of lactate dehydroge-
nase, and key lipogenic and glucose metabolism enzymes were analysed. 
The levels of lactate in tissue and plasma lactate as well as the WAT activity 
of lactate dehydrogenase were measured. Lactate gradients (differences in 
molal concentration) between WAT and plasma were estimated. The influ-
ence of sex and diet (and indirectly WAT mass) on lactate levels and their 
relationships with lactate dehydrogenase activity and gene expressions 
were measured. There was a high production of lactate by WAT, practi-
cally irrespective of site, diet or sex. Tissue lactate levels (and molal gradi-
ents) were a direct correlate of lactate dehydrogenase activity in the tissue. 
Lactate dehydrogenase activity was directly correlated with the expression 
of the genes Ldha and Ldhb for this enzyme when all sites, and sex/diet 
groups were taken in consideration. The ability of WAT to produce lactate 
was not directly dependent of WAT metabolic state. The data suggest that 
there were no post-translational modifications of lactate dehydrogenas-
es (both heart and muscle types, which distribution is similar in this rat 
tissue) elicited by sex or diet, with no site differences either. These data 
agree with a role for WAT lactate dehydrogenase as an 3C outlet for excess 
glucose
Acknowledgement: Grants: PN Biomedicina SAF2012-34895, and PN Ciencia y 
Tecnología de los Alimentos AGL-2011-23635 from the Government of Spain
T2:PO.064
Effects of Hyperthyroidism on Amount and Activity of Brown 
Adipose Tissue in Humans.
Breining P.1,2, Gormsen L. C.4, Pedersen S. B.1,2, Richelsen B.1,2
1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark,  
2Aarhus University Hospital, Aarhus, Denmark,  
3Department of Nuclear Medicine & PET-Center, Aarhus University Hospitalk, 
Denmark
Background: The large majority of knowledge on BAT is derived from 
studies in rodents and very little is known about the amount and effect 
on the metabolism in humans. In rodents thyroid hormones are known to 
increase amount and activity in BAT but two recently published studies in 
humans reach contradictory conclusions. AIM: To investigate the effects 
of thyroid hormones on the amount and activity of BAT in humans 
Methods: 10 patients with thyreotoxicosis (T3 > 3 nmol/L and suppressed 
TSH) will be investigated at diagnosis and after 3–6 months of euthyroid-
ism induced by antithyroid treatment. The patients will all be over the age 
of 50 due to the radiation given by the scans (requested by the local Ethical 
Committee). All will be scanned for active BAT by the integrated FDG 
PET-CT before and after treatment.BAT is activated by means of crushed 
ice placed under the feet in individualized intervals during the scan pro-
cedure. Indirect calorimetry is done to determine the basal metabolic rate 
and subcutaneous fat biopsy to examine the effect on subcutaneous white 
fat and the possible “browning” effect. 
Preliminary results: Five patients have been recruited and the initial 
scans performed. The mean age of the five patients was 58.9 ± 8.7 years 
and the meanT3 level was 3.6 ± 0.8 nmol/l. Only one of the five had active 
BAT initially. Three of these five patients have been investigated after they 



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts172
Conclusions: Results from rodent studies cannot be directly transferred 
to humans. BAT is scarce and the amount varies greatly between human 
individuals. In the present study the presence of BAT seems minor even 
though these patients initially had elevated levels of thyroid hormones. 
These findings may be due to the age of these patients since it is shown 
that there is an inverse association between age and the presence of BAT 
in humans. We plan to have the complete study including adipose tissue 
examination ready within the next months.
Acknowledgement: I would like to thank the Novo Nordisk Foundation for finan-
cial support.
T2:PO.065
Adipose tissue natriuretic peptide receptor dysregulation in 
obesity and type 2 diabetes
Kovacova Z.1, Collins S.2, Pratley R.1,2
1Translational Research Institute for Metabolism and Diabetes, Florida Hospital, 
Orlando, Florida, USA,  
2Diabetes and Obesity Research Center, Sanford-Burnham Medical Research 
Institute, Orlando, Florida, USA
Introduction: Natriuretic peptides (NP), atrial and B-type NP stimulate 
lipolysis and energy expenditure in adipocytes via NP receptor-A (NPRA). 
Both peptides bind also to NP receptor-C (NPRC) promoting NP clear-
ance. Thus, NP receptor ratios determine the strength of NP signaling.
Methods: We measured expression of the NP receptors in human adipose 
tissue in: i) a cross-sectional study of 50 subjects with wide range of BMI 
and glucose tolerance; and ii) a randomized study of 19 subjects with type 
2 diabetes (T2DM) treated for 12 weeks with pioglitazone or placebo.
Results: The NPRA/NPRC mRNA ratio in adipose tissue of obese was 
lower compared to lean subjects (p≤0.001). Independently of BMI, NPRA/
NPRC was reversed in T2DM comparing to subjects with normal and im-
paired glucose metabolism (p≤0.01) and strongly correlated with insulin 
sensitivity (r=0.5824, p≤0.001). Similarly, at the protein level we observed 
a significant reduction of NPRA and increase of NPRC in the obese and 
T2DM subjects relative to the lean. Expression of PGC1-α, a target of 
NP signaling, was also lower in obese vs. lean (p ≤ 0.0001) and strong-
ly correlated with insulin sensitivity. In a 12-week trial with pioglitazone, 
improvements in insulin sensitivity correlated with increases in adipose 
tissue NPRA/NPRC ratio, PGC-1α and UCP1 expression (p≤0.01).
Conclusions: These data indicate that dysregulated expression of NP 
receptors in adipose tissue is associated with obesity and T2DM, while 
improving insulin sensitivity resulted in a net higher NPRA/NPRC ratio, 
the mechanisms underpinning their reciprocal regulation remains to be 
understood.
T2:PO.066
All-trans retinoic acid promotes browning of white adipose 
tissue in adult mice
Arreguín A.1, Bonet M.L.1, Landrier J.F.2,3,4, Palou A.1, Ribot J.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology, Universitat 
de les Illes Balears, and CIBER de Fisiopatología de la Obesidad y Nutrición 
(CIBERobn), ES-07122 Palma de Mallorca, Spain,  
2INRA, UMR 1260, F-13385 Marseille, France,  
3INSERM, UMR 1062, «Nutrition, Obésité et Risque Thrombotique», F-13385 
Marseille, France,  
4Aix-Marseille Université, Faculté de Médecine, F-13385 Marseille, France. 
The role of brown adipose tissue in the regulation of energy balance and 
maintenance of body weight is well known in rodents. Recently, interest in 
this tissue has re-emerged due to the realization of active brown-like adi-
pose tissue in adult humans and inducible brown-like adipocytes in white 
adipose tissue depots in response to appropriate stimuli („browning pro-
cess“). A positive effect of all-trans retinoic acid (ATRA) on white adipose 
tissue (WAT) oxidative and thermogenic capacity has been described and 
linked to an in vivo fat loosening effect of ATRA in mice. However, little is 
known about the effects of ATRA on induction of brown-like adipocytes 
(beige/BRITE) in white adipose tissues. In this study, changes in the ex-
pression of Slc27a1, CD137, TMEM26, HOXC9 and TBX1 genes recently 
described as beige/BRITE-related genes (Wu el al. Cell 2012 and Waldén 
et al., AJP 2012) were analyzed in WAT depots of adult NMRI male mice 
acutely injected with ATRA or vehicle, together with biometric and blood 
parameters. The treatment triggered an up-regulation of the mRNA levels 
of CD137 in all adipose depots of ATRA-treated mice and an up-regula-
tion of Slc27a1, HOXC9 and TBX1 in some adipose depots (mainly vis-
ceral) of ATRA-treated mice in accordance with the previously published 
results showing that ATRA favors the acquisition of brown adipose tis-
sue-like properties in WAT (Ribot et al. Obesity Res. 2001 and Mercader et 
al. Endocrinology 2006). The results indicate that ATRA favors the acqui-
sition of beige/BRITE markers in WAT. Understanding the mechanisms 
and effectors involved in the remodeling of WAT can contribute to new 
avenues of prevention and treatment of obesity and type 2 diabetes.
Acknowledgement: This work was supported by the EU FP7 project DIABAT 
(HEALTH-F2-2011-278373). CIBER de Fisiopatología de la Obesidad y Nutrición 
is an initiative of the ISCIII (Spanish Government).
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Effects of fgf21 gene invalidation on brown and white adipose 
tissue pathophysiology
Quesada T.1, Planavila A.1, Ribas F.1, Cairó M.1, Iglesias R.1, Giralt M.1, 
Villarroya F.1
1Department of Biochemistry and Molecular Biology, and Institute of 
Biomedicine (IBUB). University of Barcelona, and CIBERobn. Barcelona. 
Catalonia. Spain.
Introduction: Experimental increases in the endocrine factor FGF21 pro-
tect against diabetes and obesity in rodents. However, obese patients and 
rodent models of obesity show a paradoxical increase in blood FGF21. 
We undertook a “loss-of-function” approach to get insight in the role of 
FGF21 on adiposity. 
Methods: Male FGF21-KO and wild-type mice were sacrificed. Interscap-
ular BAT, inguinal and epididymal WAT were collected. Metabolites, hor-
mones and cytokines were determined by spectrophotometry, ELISA or 
Multiplex. Gene expression was determined by qRT-PCR. Cell morphol-
ogy was assessed by optical microscopy. Cell precursors from fat depots 
were differentiated to adipocytes in culture, and 14C-glucose oxidation 
was determined. 
Results: FGF21-KO mice did not show major changes in adipose depots 
size; glycemia and insulinemia were increased, and adiponectin levels 
were reduced. The expression of marker genes of carbohydrate and lipid 
metabolism, adipogenesis and “browning” was essentially unaltered in ad-
ipose depots. Increased expression of inflammation and macrophage infil-
tration markers (e.g. Nos2, TNFa, Arg1) was found in BAT from FGF21-
KO mice; opposite changes were found in inguinal WAT. Morphological 
differentiation “in vitro” of brown and white adipocytes lacking FGF21 
was unaltered, whereas the expression of marker genes of “browning” (e.g. 
UCP1, Sirt3, Bmp8b, UCP3) was reduced. Glucose oxidation in FGF21-
KO brown and white adipocytes was significantly reduced. 
Conclusions: In vivo, the lack of FGF21 causes minor effects in adipose 
tissues, with the exception of altered local inflammation status. However, 
the impaired glucose oxidation due to the lack of FGF21 found in adipo-
cytes support the notion of an autocrine role of adipose tissue FGF21 on 
glucose homeostasis.
Acknowledgement: Supported by MINECO-ISCIII (Grant PI14/00063) and FP7-
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T2 – Angiogenesis
T2:PO.068
Effect of 17β-estradiol on 3T3-L1 adipocytes differentiation 
and on VEGFA expression
Fatima L.A.1, Campello R.S.1, Machado U.F.1
1Department of Physiology and Biophysics, Institute of Biomedical Sciences, 
University of Săo Paulo, Săo Paulo, Brazil.
Introduction: Adipogenesis and angiogenesis are two closely related pro-
cesses. In this context, the VEGFA plays an important role, since changes 
on its expression and on the expression of its signaling machinery compo-
nents regulate the angiogenesis and may affect the development of obesi-
ty and insulin resistance. Estradiol (E2) is considered a protector against 
obesity and a regulator of the VEGFA gene. Thus, our hypothesis is that 
VEGFA may be involved in E2-mediated adipogenesis/insulin sensitivity. 
Methods: 3T3-L1 mouse preadipocytes were treated with 17β-estradiol 
during the differentiation. We analyzed the mRNA expression of some 
adipogenesis markers including Pparg, Cebpa and Slc2a4 and GLUT4 
protein. In addition, the expression of VEGFA mRNA and protein was 
analyzed during the differentiation process, and in full differentiated cells 
treated with 17β-estradiol. 
Results: Levels of Pparg, Cebpa and Slc2a4/GLUT4 are progressively in-
creased during the conversion from 3T3-L1 preadipocytes to adipocytes. 
In addition, on day 8 of differentiation, cells exposed to E2 presented a sig-
nificantly increase in GLUT4 protein, Slc2a4 mRNA, and Cebpa mRNA as 
compared to control cells, while Pparg and Vegfa did not change. However, 
when differentiated cells were treated for 24 hours with E2, Vegfa mRNA 
and VEGFA protein expression were increased as compared to control. 
Conclusion: Results suggeste that estradiol promotes adipogenesis en-
hancing expression of adipogenesis markers, such as Cebpa and Slc2a4/
GLUT4. Moreover, the increasing VEGFA production induced by E2 in 
mature adipocytes can improve angiogenesis, protecting the adipose tis-
sue from obesity-induced hypoxia, and consequently, from inflammation, 
which leads to insulin resistance in this tissue.
Acknowledgement: Research relating to this abstract was funded by FAPESP 
#2012/04831-1 #2013/03343-6
T2 – Systemic consequences of adipose tissue 
metabolism
T2:PO.069
Diagnosis of visceral obesity by using imaging methods
Kharlamova E.Y.1, Samoylova Y.G.1, Suslyaeva N.M.1, Oleynik O.A.1, 
Zavadovskaya V.D.1, Koshmeleva M.V.1, Rotkank M.A.1, Soboleva I.N.1, 
Budnikova O.B.1
1Siberian State Medical University, Tomsk, Russia 
Introduction: evaluate the significance of radiological methods of diag-
nosis of visceral obesity in patients with obesity and metabolic syndrome 
(MS).
Methods:examined 78 obese patients with MS, mean age 45,9 ± 15,5 
years, including 38 men and 40 women. Comparison group: 20 obese pa-
tients with varying degrees (8 males, 12 females, mean age of 48,2 ± 9,3 
years) without having criterion MS. The control group included 25 people 
(10 males and 15 females, mean age 46,3 ± 4,1 years) with no obesity. Di-
agnosis of MS accounted indicators anthropometric data, lipid and carbo-
hydrate metabolism, blood pressure and insulin resistance . Methods used 
computer (СT) and magnetic resonance imaging (MRI), ultrasonography 
(USG) visceral obesity (VO).
Results: Radiation exposure during CT, significant time spent in the per-
formance of MRI in conjunction with the economic burden justify the ap-
propriateness of including in the scheme of studies of patients with obesity 
ultrasound to determine VO as an indicator of MS. Standard ultrasound 
technique identified during a highly informative, comparable (r = 0,66 at 
p = 0,0005) with tomographic methods (CT, MRI). Her performance (vis-
ceral adipose tissue - VAT, visceral adipose tissue /subcutaneous adipose 
tissue- VAT / SAT) highly correlated with indicators of disorders of carbo-
hydrate (glucose, insulin, insulin resistance index) and lipid metabolism 
(LDL, VLDL). Threshold VAT above which diagnosed in, according to the 
standard ultrasound in patients with MS was 109.11 mm.
Conclusions: Ultrasonography can be used for screening of patients with 
obesity, including -in children, adolescents and pregnant women in order 
to diagnose visceral obesity as a risk factor for MS.
T2:PO.070
Klk7 plays a role in body weight regulation, insulin sensitivity 
and glucose metabolism
Kunath A.1,2, Kern M.1, Stumvoll M.1, Blüher M.1,3, Klöting N.1,3
1Department of Internal Medicine, Neurology and Dermatology, Clinic for 
Endocrinology and Nephrology, University of Leipzig, Leipzig,  
2Molecular Diabetology & DZD-Paul Langerhans Institute Dresden, TU Dresden, 
Dresden,  
3Integrated Research and Treatment Center (IFB) AdiposityDiseases, University 
of Leipzig, Leipzig
Background: Previous studies showed that beneficial effects on glucose 
metabolism of vaspin are at least in part mediated through inhibition of 
the protease Kallikrein 7 (Klk7). Based on these findings, we investigated 
the physiological relevance of the Klk7-vaspin system in mice with a tar-
geted whole-body disruption of Klk7 in vivo.
Methods: We generated a whole-body Klk7 knockout mouse (Klk7-/-) 
and systematically characterized the consequences of Klk7 deficiency on 
body weight, fat mass, serum concentrations of leptin, basal metabolism, 
food intake and parameters of glucose and lipid metabolism.
Results: Klk7 deficiency causes significant changes in body fat content, 
basal metabolism, spontaneous activity, food intake as well as leptin serum 
concentrations. At an age of 30 weeks, Klk7-/- mice have significantly low-
er body fat (7.2 ± 2.9%) than the controls (9.9 ± 2.7%) (p < 0.05). More-
over, Klk7-/- mice have significantly lower serum leptin concentration 
(25.9 ± 6.2ng/ml) in relation to the controls (42.3 ± 2.5ng/ml) (p < 0.05). 
In female Klk7-/- mice, food intake (4.3 ± 0.5g/day) was significantly low-
er compared to the controls (4.7 ± 0.3g/day, p < 0.05). Although glucose 
tolerance was indistinguishable between Klk7-/- and control mice of both 
genders, male Klk7-/- mice display a significant improved insulin sensi-
tivity compared with littermate controls at an age of 24 weeks (p < 0.05). 
Both genders of Klk7-/- mice showed a different basal energy expenditure 
at day and night phase compared with controls.
Conclusion: Our data indicate that Klk7 plays a previously unrecognized 
role in body weight regulation, food intake, insulin sensitivity as well as 
basal- and glucose metabolism. The mechanisms, how Klk7 disruption af-
fects these traits need to be explored in further studies.
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T2:PO.071
Gip as a new biomarker of metabolic complications in obese 
patients
Malczewska-Malec M.1, Goralska J.1, Kiec-Wilk B.2, Razny U.1, 
Zdzienicka A.1, Solnica B.1, Dembinska-Kiec A.1
1Department of Clinical Biochemistry, Jagiellonian University, Medical College, 
Krakow, Poland,  
2Department of Metabolic Diseases, Jagiellonian University, Medical College, 
Krakow, Poland 
Introduction: The altered GIP secretion and action was recently linked 
to obesity-related metabolic disorders but the underlying mechanisms are 
not well understood. The objective of this study was to compare the pat-
tern of GIP secretion and correlation with metabolic risk markers in obese 
subjects during fasting and postprandial state. 
Methods: In obese and not obese patients fasting and postprandial plas-
ma GIP, glucose, insulin, lipids, glutathione peroxidase, IL-6, sE-selectin, 
MCP-1, leptin, adiponectin, visfatin were measured in five different time 
points during oral lipid tolerance test and glucose tolerance test. 
Results: A total of 114 obese patients and 37 control non-obese subjects, 
were randomized into the study. Fasting GIP levels differed between obese 
(32,22 pg/ml) and control (24,27 pg/ml) subjects (p < 0,05) and correlated 
with glucose, triglycerides, total- and LDL-cholesterol, as well as sE-selec-
tin, MCP-1, visfatin and leptin/adiponectin ratio (p < 0,05). The levels of 
GIP at 120 min after high fat meal were significantly higher than those 
measured at 120 min after glucose ingestion both in obese (365,93 pg/
ml vs 156,4 pg/ml, p < 0,05) as well as control subjects (381,09 pg/ml vs 
154,94 pg/ml, p < 0,05). Enhanced postprandial GIP response to fat or 
glucose challenge (AUC) was positively correlated with glucose AUC, 
TG AUC, FFA AUC and negatively with glutathione peroxidase activity 
(p < 0,05). In patients with the highest fasting GIP concentrations (3rd 
tertile), increased sE-selectin (p < 0,05) and MCP-1 blood levels (p,0,05) 
were observed. 
Conclusions: We suggest, that GIP is a putative early biomarker of meta-
bolic consequences of obesity and associated proinflammatory state.
T2:PO.072
The risk for weight regain after weight loss is related to 
weight loss-induced cellular stress in the adipose tissue
Roumans N.1, Camps S.1, Renes J.1, Bouwman F.1, Westerterp K.1, 
Mariman E.1
1Department of Human Biology, Faculty of Nutrition and Translational Research 
in Metabolism, Maastricht University, Maastricht, The Netherlands
Introduction: Weight loss results in increased lipolysis in adipocytes, 
which lose their fat and shrink (You et al. 2006). However, after returning 
to a stable energy balance, adipocytes rapidly prepare for re-storing fat. 
This metabolic adaptation appears related to an increased stress response 
(Bouwman et al. 2009; Wang et al. 2009). This suggests that cellular stress 
accumulated in adipocytes during a negative energy balance is a driving 
force for weight regain. Our aim was to determine expression levels of 
stress proteins during weight regulation after a dietary intervention and 
a follow-up period.
Methods: Twenty-five healthy subjects started with a very low energy diet 
for 8 weeks with a 10-month follow-up period. Participants were catego-
rized in groups depending on weight loss during the diet period and on 
weight maintenance or regain during follow-up. Before, after the diet and 
after 10 month follow up, abdominal subcutaneous adipose tissue biopsies 
were obtained. Levels of stress proteins in biopsies were determined by 
Western blotting.
Results: Weight regainers showed increased level of β-actin, calnexin, 
HSP60 and HSP70 expression during the weight loss period. BiP, HSP27, 
SOD1 and SOD2 did not change significantly during this period. Correla-
tion analysis showed that changes of β-actin, HSP70 and HSP27 are linked 
via changes in HSP60. Significantly increased levels of β-actin and HSP60 
were also seen after 4 days glucose restriction of mature adipocytes.
Conclusion: Subjects regaining weight after dieting have increased levels 
of cellular stress and structural support proteins in their adipose tissue, 
most likely residing in the adipocytes. We conclude that accumulating cel-
lular stress in adipose tissue during weight loss is a risk factor for weight 
regain.
Acknowledgement: We thank Dr. Ping Wang for helpful discussions and advice.
T2:PO.073
Effect of secretome from obese and lean rat adipose tissue 
on the proliferative capacity and the cancer-related gene 
expression of a normal mammary epithelial cell line
Cabia B.1,2, Amil M.1,2, Andrade S.1,2, Couselo M.C.1,2, Casanueva F.F.1,2, 
Crujeiras A.B.1,2
1Department of Molecular and Cellular Endocrinology, Instituto de 
Investigacion Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago 
(CHUS/SERGAS) and Santiago de Compostela University (USC), Santiago de 
Compostela, Spain.,  
2CIBER de Fisiopatología, Obesidad y Nutrición (CIBERobn), Madrid, Spain.
Introduction: Obesity is associated with higher risk for breast cancer. This 
work evaluates the effect of secretome obtained from obese or lean rat 
adipose tissue on the proliferative capacity of a normal human mamma-
ry cell line, MCF10A, as well as the expression of some genes related to 
pro-carcinogenic events.
Methods: Three week-old female Sprague-Dawley rats were fed a high fat 
diet (DIO: 60% Kcal/g fat, n=12) or standard diet (LEAN: 5.5% Kcal/g 
fat, n=11) for 10 weeks. Retroperitoneal (RPAT) and subcutaneous (SAT) 
adipose tissues were extracted and cultured for secretome collection. MC-
F10A cell line was exposed for 24 hours to a 1% of secretomes from each 
group and proliferation was measured. Furthermore, genes associated 
with cell proliferation (ALDH3A1), antioxidant protection (SIRT1) and 
tumor suppresion (PTEN, TGFB) were quantified by qRT-PCR.
Results: RPAT secretome from obese rats induced a significant increase in 
cell proliferation (2.12 ± 0.13 a.u) with respect to lean animals (1.17 ± 0.05 
a.u; p-value<0.001). No statistically significant differences were observed 
after treatment with SAT secretome from lean (0.89 ± 0.03 a.u) or obese 
rats (0.85 ± 0.02 a.u). Interestingly, gene expression fold change of PTEN 
(0.91 ± 0.07), TGFB (0.81 ± 0.07) and SIRT1 (0.66 ± 0.04) was signifi-
cantly downregulated while ALDH3A1 (1.95 ± 0.18) was upregulated 
(p < 0.05) after MCF10A treatment with obese compared to lean RPAT 
secretome. No statistical differences were found between lean or obese 
SAT secretome treatment.
Conclusions: These results point out to a possible involvement of factors 
produced by obese visceral adipose tissue in changes related to early steps 
of tumor promotion. Further studies are needed to identify those obesi-
ty-related carcinogenic factors.
Acknowledgement: The present research was funded by CIBERobn, Xunta de Gali-
cia, and Instituto de Salud Carlos III.
T2:PO.074
Characterization of the role of alms1 in the adipose tissue in 
mice and humans
Faggian A.1, Favaretto F.1, Milan G.1, Collin G.B.2, Marshall J.D.2, Maffei P.1, 
Naggert J.K.2, Vettor R.1
1Endocrine-Metabolic Laboratory, Internal Medicine 3, Department of Medicine, 
University of Padua, via Ospedale 105, 35128 Padua, Italy,  
2The Jackson Laboratory, Bar Harbor, Maine, United States of America
Introduction: Alström Syndrome (AS) belongs to the class of ciliopathies 
and is a rare recessive disease characterized by obesity and Type 2 diabe-
tes (T2DM), and fibrosis with multiple organ involvement. The disease 
causing gene is ALMS1, which is ubiquitously expressed with multiple 
splice variants. The protein ALMS1 localizes to the centrosomes, basal 
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lular transport, but its link with the metabolic complications is still poorly 
understood.
Methods: We characterized the adipose tissue (AT) of a mouse model 
of AS (Alms1GT/GT) at 6 weeks of age, using gene and protein expres-
sion analysis. We also examined the expression of ALMS1 in the AT oth-
er mouse models of obesity as well as in obese patients with or without 
T2DM and comparing their levels with those obtained in normal weight 
subjects.
Results and Conclusions: Young Alms1GT/GT displayed a systemic glu-
cose intolerance and altered localization of GLUT4 both in the basal state 
and after insulin stimulation, which causes an aberrant insulin signaling, 
downstream or independently of AKT. These events appear before the in-
crease of body weight and circulating insulin levels. AT expansion appears 
to be secondary to the increase in de novo lipogenesis stimulated by the 
high insulin levels. These findings propose a direct role of ALMS1 in the 
glucose homeostasis through the GLUT4 trafficking pathway. ALMS1 ex-
pression in human and mouse models of obesity showed quantitative dif-
ferences between obese and control subjects. Furthermore, the reduction 
of ALMS1 in obese patients suggests its implication in the pathophysiolo-
gy of the AT, independent from AS.
Reference: 
PLoS One. 2014 Oct 9;9(10):e109540.
T2:PO.075
Betulinic acid, a TGR5 agonist, prevents adipogenesis in 3T3-
L1 adipocytes through suppression of STAT3 phosphorylation
Kim G.W.1, Jo H.K.1, Chung S.H.1
1Department of Life and Nanopharmaceutical Science, College of Pharmacy, 
Kyung Hee Univeresity, Seoul, Republic of Korea
Aim of this study was to evaluate the anti-adipogenic effect of betulin-
ic acid (BA), a plant-derived triterpenoid, and its action mechanism in 
relation to STAT3. BA treatment during 3T3-L1 differentiation signifi-
cantly suppressed adipogenesis as demonstrated by Oil Red O staining. 
STAT3 is a key transcription factor, recently known to be involved in the 
adipogenic process. At the initial stage of 3T3-L1 differentiation, phos-
phorylation of STAT3 was significantly increased. Pre-incubation with 
BA inhibited differentiation-induced activation of STAT3 and reduced 
adipogenic (PPARγ, C/EBPα and GLUT4), and lipogenic (SREBP1, FAS, 
SCD1 and adiponectin) mRNA levels, showing that anti-adipogenic effect 
of BA is mediated by inhibition of STAT3 activation. BA is known agonist 
for a Gs-protein coupled bile acid receptor, commonly known as TGR5. 
Involvement of TGR5 in energy homeostasis and metabolic diseases is 
becoming evident, and TGR5 activation is known to negatively regulate 
STAT3 signaling in the liver of TGR5-deficient mice [1]. Interestingly, the 
intracellular level of cyclic-AMP was elevated after 1 h treatment of BA 
and the inhibitory effect of BA on adipocyte differentiation was reversed 
by pre-treatment of SQ22536, an adenylyl cyclase inhibitor, inferring that 
BA might exert anti-adipogenic effect most likely through TGR5 activa-
tion. This study suggests that BA suppresses adipocyte differentiation via 
inhibition of STAT3 phosphorylation and induction of cyclic-AMP level. 
These results direct future studies into identification of specific signaling 
role of TGR5 in adipogenesis.
Reference:
1.  Chen, W.D., et al.: Deficiency of G-protein-coupled bile acid receptor Gpbar1 
(TGR5) enhances chemically-induced liver carcinogenesis. Hepatology. 
2013.57:656–666.
T2:PO.076
Obesity-induced chronic inflammation in C57Bl6J mice, a 
novel risk factor in the progression of renal AA amyloidosis?
van der Heijden R.A.1, Sheedfar F.2, Bijzet J.3, Hazenberg B.P.3, Koonen D.P.2, 
Heeringa P.1
1Department of Pathology and Medical Biology, University Medical Centre 
Groningen, Groningen, The Netherlands,  
2Department of Pediatrics, Section Molecular Genetics, University Medical 
Centre Groningen, Groningen, The Netherlands,  
3Department of Clinical Immunology and Rheumatology, University Medical 
Centre Groningen, Groningen, The Netherlands
Background: Compelling evidence links obesity induced systemic in-
flammation to the development of
chronic kidney disease (CKD). This systemic inflammation may result 
from exacerbated adipose inflammation. Besides the known detrimental 
effects of typical pro-inflammatory factors secreted by the adipose tissue 
(TNF-α, MCP-1 and IL-6) on the kidney, we hypothesize the enhanced 
obesity-induced secretion of serum amyloid A (SAA), an acute inflam-
matory protein, to play a key role in aggravating obesity-induced CKD. 
Methods: Groups of male C57Bl/6J mice (n = 99 in total) were fed a low 
(10% lard) or high (45% lard) fat diet for a maximum of 52 weeks. Mice 
were sacrificed after 24, 40 and 52 weeks. Whole blood samples, kidneys 
and adipose tissues were collected. The development of adipose and renal 
tissue inflammation was assessed on gene expression and protein level. 
Adipocytokine levels were measured in plasma samples. 
Results: A distinct inflammatory phenotype was observed in the adipose 
tissue of HFD mice prior to renal inflammation, which was associated with 
an early systemic elevation of TNF-α, leptin and SAA (1A-C). With aging, 
sclerotic lesions appeared in the kidney, the extent of which was severely ag-
gravated by HFD feeding. Lesions exhibited typical amyloid characteristics 
(2A) and pathological severity positively correlated with bodyweight (2B). 
Interestingly, more SAA protein was detected in lesions of HFD mice.
Conclusion: Our data suggest a causal link between obesity induced 
chronic inflammation and AA amyloidosis in C57Bl/6J mice. Though fu-
ture studies are necessary to prove this causal link and to determine its 
relevance for the human situation, obesity may hence be considered a risk 
factor for the development and progression of renal AA amyloidosis in 
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Fig. 1. Systemic plasma levels of 
(A) Leptin, (B) TNF-a and (C) 
Serum Amyloid A (SAA) in low 
fat (LFD) and high fat (HFD) mice 
after 24, 40 and 52 weeks.
Fig. 2. Representative pictures of kidney 
glomerular pathology after 52w of low-
fat (LFD52) is aggravated by high-fat 
(HFD52) feeding. (A) From top to bottom 
stained for Masson‘s Trichrome, Periodic 
Acid Schiff ‘s, Congo Red (brightfield), 
Congo Red (polarized) and Serum Amy-
loid A protein. (B) Congo Red positive 
area positively correlates with body weight.
T2:PO.077
Insulin resistance is exaggerated in early-onset obesity and 
accompanied by down-regulation of miRNAs that mediate 
inflammation and fibrosis.
Al-Jaber M.J.1, Bakhamis A.1, Orie N.N.1, Lei S.2, Casale C.2, Elrayess M.A.1, 
Al-Sowaidi S.1, Al-Emadi M.3, Bashah M.4, Sufi P.5, Gray R.5, Al-Sayrafi M.1, 
Mohamed-Ali V.1
1Life Sciences Research Division, Anti-Doping Lab Qatar,  
2Adipokines and Metabolism Research Group, Division of Medicine, University 
College London, UK,  
3Al Emadi Hospital, Doha, Qatar,  
4Hamad Medical Corporation, Doha, Qatar,  
5North London Obesity Surgery Service, Whittington Hospital, London, UK
Background: Early and rapid onset of obesity, consequent to abdominal 
adipose tissue expansion is associated with inflammation and insulin re-
sistance (IR). microRNA (miRNA) may be biomarkers and mediators of 
both.
Aims: Cardiometabolic risk factors, before and after weight loss, was in-
vestigated in early- and adult-onset obesity. Expression of miRNA media-
tors was also determined.
Method: Non-diabetic subjects before and after surgical weight loss were 
recruited. Anthropometric measures recorded and fasting blood samples 
used for determination of lipids, glucose, insulin and adipokines. Expres-
sion of miRNA was assessed using an inflammatory array.
Results: Despite both cohorts being morbidly obese, the early-onset 
group was younger, more IR, hyperleptinaemic, had higher levels of IL-6 
and MCP-1 and lower adiponectin. On dichotomization into metaboli-
cally healthy (MHO) and pathological (PO), the prevalence of MHO in 
the early-onset was 20% as opposed 27% in adult-onset. However, in the 
adult-onset the PO had high leptin, while analogous group of the ear-
ly-onset had low leptin levels, compared to the MHO. Surgical weight loss 
improved metabolic profiles of PO of both cohorts, while MHO remained 
unchanged. miRNA expression in the PO compared to the MHO before 
weight loss showed significant down regulation of those associated with 
inflammation (mir-19b, mir-9), IR (mir-142, mir-144, mir-122), fibrosis 
(mir-29) and adipogenesis (mir-15, mir-130a, mir-374a). Weight loss lead 
to upregulation of miRNA expression (mir-302a, b, c, mir-9).
Conclusion: In early onset-obesity IR and inflammation are exaggerated. 
Also lower levels of leptin in this group may suggest greater SNS activa-
tion directly inhibiting adipose leptin. Some, but not all, of the metabolic 
and inflammatory lesions that accompany obesity and IR are ameliorated 
by weight loss, along with up-regulation of miRNAs mediating IR and 
inflammation, but not fibrosis.
T2:PO.078
Α-mangostin regultes the hepatic steatosis and body fat mass 
in obese mice with high-fat diets
You B.H., Choi Y.H.
1Pharmacokinetics lab, College of Pharmacy, Dongguk university, Korea 
Republic,
Obesity is a major risk factor to develop the metabolic disorders 
related to hyperglycemia, insulin resistance, hyperlipidemia, hepatic 
steatosis and cardiovascular diseases, while weight loss has been 
reported to ameliorate these associated conditions. Due to the previous 
reports regarding anti-adipogenic activity of α-mangostin, a major 
active xanthone from mangosteen, Garcinia manostana L., in vitro 
experiments, we investigated the effects of long-term supplementation 
with α-mangostin (10 and 50mg/kg/day p.o. for 7 weeks) in mice with 
established obesity (3month high-fat diet). Therefore, the objective of 
this study was to investigate the effects of α-mangostin on the metabolic 
disorder states in high-fat-diet (HF)-fed mice and the underlying 
mechanisms related to adipogenesis. α-Mangostin supplementation 
produced a marked decrease in body weight and the levels of serum 
GOT, GPT, glucose, triglyceride, total cholesterol, low-density 
lipoprotein cholesterol, and free fatty acid were significantly reduced 
compared to those in mice with HF diets. Also α-mangostin decrease the 
fat volume and size and ameliorated the hepatic steatosis in mice with 
α-mangostin supplementation plus HF. Moreover, α-mangostin activated 
the AMPK, sirT 1 and suppressed PPARγ levels in liver. Thus, our results 
suggest that α-mangostin exerts anti-obesity effects in HF-induced obese 
mice.
Acknowledgement: This work was supported by 2014 Brain Korea 21-plus proj-
ect, the grant of National Research Foundation of Korea (NRF) funded by the gov-
ernment of Korea (S-2014-010400, Y. H. Choi) and GRRC program of Gyeonggi 
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T2:PO.079
Association of serum 25-hydroxy vitamin-d levels with 
cardiometabolic variables in pre-pubertal children with 
obesity
Galcheva S.1, Galunska B.2, Gerova D.3, Lateva M.1, Iotova V.1
1Department of Pediatrics and Medical Genetics, Varna Medical University, 
Varna, Bulgaria , 
2Department of Pharmaceutical Technology, Varna Medical University, Varna, 
Bulgaria,  
3Department of Clinical Laboratory, Varna Medical University, Varna, Bulgaria
Introduction: The relationship between obesity and vitamin-D status has 
already been proven and it seems that obese population is at risk of vita-
min-D deficiency. The aim of this preliminary study was to estimate the 
vitamin-D concentration and its association with cardiometabolic indices 
in pre-pubertal children with different degree of total/abdominal obesity.
Methods: Thirty three children (mean age 8.0 ± 1.3 years, 57.6% males) 
were recruited. Anthropometric and blood pressure (BP) measures, fast-
ing serum 25-hydroxyvitamin-D (25OHD), glucose, insulin, homeostatic 
model of assessment (HOMA-IR) and lipids were investigated. Vitamin-D 
levels < 50 nmol/L were considered as a severe insufficiency and those 
between 50–75 nmol\L - as a mild insufficiency. 25OHD levels were mea-
sured by a validated HPLC/UV method. Obesity status was estimated us-
ing the IOTF reference for BMI and the Bulgarian childhood reference for 
waist circumference.
Results: Severe 25OHD insufficiency was observed in 48.5% of all partic-
ipants, while 30.3% of them had suboptimal Vitamin-D concentrations. 
The median 25OHD level was 48.3 (41.6–60.9) nmol/L, without gender 
differences. Obese children had lower 25OHD concentrations compared 
to their non-obese counterparts [48.2 (32.9–59.9) vs. 62.6 (50.2–76.0)], 
p > 0.05). Serum 25OHD levels correlated negatively with insulin levels 
(r=-0.592, p = 0.012), HOMA-IR (r=-0.521, p = 0.032) and body weight 
(r=-0.526, p = 0.03). No significant association was found with lipids and 
BP measurements. Applying the backward regression model, the age of 
our participants was found as the main predictor of their Vitamin-D sta-
tus.
Conclusion: Abnormal Vitamin-D status is highly prevalent among obese 
pre-pubertal children, associated with increased insulin resistance.
T2:PO.080
Sarcopenic obesity, metabolic syndrome and inflammation in 
adult Caucasian Italian subjects
Poggiogalle E.1,2
1Department Experimental Medicine-Medical Physiopathology, Food Science 
and Endocrinology Section, Sapienza University of Rome, Italy,  
2Department of Medicine, Geriatrics Division, University of Padova, Italy
Introduction: Recently metabolic aspects linked to sarcopenic obesity 
(SO) were investigated. Extant studies involved especially older people 
from Asian or White-mixed American cohorts. The aims of our study 
were to explore the prevalence of SO in Italian pregeriatric subjects and 
to investigate the relationship among SO, metabolic syndrome (MS) and 
inflammation.
Methods: Subjects were recruited from 2011 to 2014. Inclusion criteria 
were age>18 and <65 years, BMI>30 kg/m2. Body weight, height, waist cir-
cumference (WC) were measured. Fat mass (FM) and fat-free mass (FFM) 
were assessed by DXA. Appendicular skeletal muscle mass (ASMM) 
was calculated. Sarcopenia was defined as ASMM/h2 or ASMM/weight 
<2SD than the sex-specific mean of a young population. The cutoffs were 
ASMM/h2<6.54 kg/m2 for men and 4.82 kg/m2 for women, and ASMM/
weight<0.2827 for men and 0.2347 for women. ISI-Matsuda was calculat-
ed. MS was diagnosed (NCEP-ATP III).
Results: 727 subjects (age:44.9 ± 13.54, BMI:37.22 ± 5.08 kg/m2)were en-
rolled. The prevalence of SO was 1.0% or 34.8% in men and 0.6% or 50.1% 
in women, basing on ASMM/h2 ratio or ASMM/weight. SO subjects based 
on ASMM/h2 were scarce, only data relying on ASMM/weight were con-
sidered. SO subjects were older, with higher BMI, WC, FM, and lower 
FFM and ASMM than non- SO individuals. Hs-CRP levels were higher 
and ISI-Matsuda was lower in SO subjects. The presence of MS was higher 
in SO subjects than non-SO subjects (47.6% vs 34.3%). ASM/weight de-
creased when increasing the components of MS (p < 0.05 for all values).
Conclusion: SO is associated with MS and inflammation in adult Cauca-
sian subjects. Metabolic profile evaluation should be recommended in SO.
T2:PO.081
Ageing of human adipose tissue and related systemic 
alterations
Gallego-Escuredo J.M.1,2, Cereijo R.1,2, Villarroya J.1,3, Moure R.1,2, 
Domingo J.C.1, Domingo P.3, Villarroya F.1,2, Giralt M.1,2
1Departament de Bioquímica i Biologia Molecular, Institut de Biomedicina, 
Universitat de Barcelona,  
2CIBER Fisiopatología de la Obesidad y Nutrición,  
3Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain
Introduction: Obesity has a complex and poorly understood relationship 
with the ageing process. Adipose tissue is a main pathogenic actor in obe-
sity and associated metabolic dysregulation. Our aim was to characterize 
adipose tissue alterations associated intrinsically with ageing by compar-
ing healthy elderly with healthy young individuals, and their association 
with systemic parameters related to adipose tissue metabolic and endo-
crine functions.
Methods: 28 healthy elderly individuals (>70 year-old; BMI 27.4+0.6) and 
10 young (<40; BMI 24.3+0.3) healthy adults were studied. Biopsies from 
abdominal subcutaneous adipose tissue (SAT) were obtained. Transcript 
gene expression and telomere length were determined using qRT-PCR 
and qPCR, respectively. Circulating metabolites, adipokines and cytokines 
were measured by spectrofotometry, ELISA or Multiplex.
Results: Lipid profile was unaltered in aged individuals whereas glucose 
homeostasis (HOMA) was moderately worsened. Telomere length was 
reduced in SAT from elderly individuals. Leptin and pro-inflammatory 
gene expression (TNFα, IL-8) was increased in fat from elderly individu-
als whereas no changes were found for adiponectin, PPARγ and C/EBPα. 
Circulating levels of leptin, pro-inflammatory cytokines and FGF21 were 
increased in elderly individuals. Leptin serum levels correlate with leptin 
gene expression in fat, BMI, IL-6 and MCP-1 levels. FGF21 levels correlat-
ed with glucose homeostasis markers and TNFα.
Conclusions: Healthy ageing is associated with altered gene expression in 
adipose tissue. Accordingly, circulating leptin and proinflammatory cyto-
kine levels are increased due to ageing, as well as serum FGF21. Human 
adipose tissue appears as a relevant target of the physiological decay asso-
ciated with the ageing process.
Acknowledgement: Acknowledgments: Supported by ISCIII (PI11/00376, 
PI11/02512, PI14/00063, PI14/00700), MINECO (SAF2011-23636), Spain, and EU 
FP7 BETABAT (HEALTH-F2-277713).
T2:PO.082
Associations of 7-oxygenated derivatives of dhea with 
anthropometric measures and their changes in response 
to a short-term weight management in overweight/obese 
adolescents.
Sedlackova B.1,3, Macova L.2, Zamrazilova H.1, Bicikova M.2, Hill M.2, 
Kazihnitkova H.2, Hampl R.2, Hainer V.1, Starka L.2
1Obesity Management Centre, Institute of Endocrinology, Prague, Czech 
Republic,  
2Department of Steroid Hormones and Proteohormones, Institute of 
Endocrinology, Prague, Czech Republic,  
3Department of Biochemistry, Faculty of Science, Charles University, Prague, 
Czech Republic
Introduction: Anti-obesity potential has been described for dehydroepi-
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reveal whether plasma concentrations of 7α-OH-DHEA, 7β-OH-DHEA 
and 7-oxo-DHEA are associated with adiposity measures and their chang-
es in response to a short-term weight management in adolescents. 
Methods: 248 adolescents: 108 boys - age (x ± SD): 15.0 ± 1.5 years, body 
mass index (BMI): boys 32.9 ± 4.6 kg/m2; 140 girls - age: 15.4 ± 1.5 years, 
BMI: 31.5 ± 4.1 kg/m2. Body composition: bioimpedance Tanita BC-418 
MA. Steroids: liquid chromatography-tandem mass spectrometry. Weight 
management (WM): 4-week supervised in-patient WM programme (en-
ergy restricted diet, daily aerobic exercise and cognitive behavioural ther-
apy). 
Results: Both 7α-OH-DHEA and 7β-OH-DHEA were positively associat-
ed with BMI, BMI SDS, WC and WC SDS (p < 0.01). In addition 7α-OH-
DHEA was also significantly positively related to % fat and % trunk fat 
(p < 0.001). Only in girls baseline 7β-OH-DHEA levels were positively 
related to all anthropometric indexes (p < 0.038). Baseline concentration 
of 7α-OH-DHEA was inversely related to decreases of BMI, % fat and 
% trunk fat (p < 0.003) in response to WM. On the other hand, baseline 
concentrations 7β-OH-DHEA and 7-oxo-DHEA were not associated with 
decline in adiposity measures. 
Conclusions: Plasma concentrations of 7α-OH-DHEA were positive-
ly related to baseline adiposity measures and inversely to their changes 
in response to WM in adolescents. In contrast, baseline concentrations 
of 7β-OH-DHEA and 7-oxo-DHEA were not associated with decline in 
adiposity measures. Our results do not support favourable effects of the 
pre-treatment levels of 7-oxygenated derivatives of DHEA on adiposity 
reduction in response to a short-term WM.
Acknowledgement: Funding: Research relating to this abstract was funded by IGA 
MZCR NT/13792-4, NT/13542-3 and MH CZ - DRO (Institute of Endocrinology 
- EU, 00023761).
T4 – Addiction/Addiction after Bariatric Surgery
T4:PO.001
Continuous Glucose Monitoring for Evaluation of Glycemic 
Excursions and Hypoglycemia after Roux-en-Y Gastric Bypass
Nielsen J.B.1, Abild C.B.1, Richelsen B.1
1Department of Endocrinology and Internal Medicine, Aarhus University 
Hospital, Aarhus, Denmark
Introduction: Hypoglycemia is well-known after Roux-en-Y gastric by-
pass (RYGB) and may be difficult to diagnose since symptoms are non-
specific and difficult to distinguish from dumping syndrome. Continuous 
glucose monitoring (CGM) has been proposed as a diagnostic tool in this 
evaluation. Thus, we aim to assess the CGM technology in evaluating the 
glycemic excursions among RYGB-patients. 
Methods: Twelve subjects with symptomatic hypoglycemia and 12 sub-
jects asymptomatic after RYGB were recruited. Subjects were subjected to 
CGM (measuring interstitial fluid glucose (IFG) every 5 min) for 6 days. 
Moreover a 5-hours mixed meal tolerance test (MMTT) was performed 
measuring plasma glucose (PG).Another day the patients followed a 
low-carbohydrate diet (LCD). The other days the patients followed their 
ordinary diet (OD). 
Results: Fig 1 shows the relationship between mean IFG and mean PG 
during the MMTT. Bland-Altman plot (fig 2) of the relationship between 
minimum IFG and minimum PG indicates that CGM overestimates min-
imum IFG by a fixed bias of 1.0 mM; CI (0.7; 1.4). Mean IFG (from 06 
AM to midnight) was comparable during the day of LCD and an OD-day 
((5.4 ± 0.1 vs. 5.6 ± 0.1) mM; p = 0.06) whereas the standard deviation 
(SD) of mean IFG was significantly lower during LCD compared to OD 
((0.6 ± 0.1 vs 1.1 ± 0.1) mM; p < 0.001). The mean amplitude of glycemic 
excursions (MAGE) was significantly reduced during LCD compared to 
OD (p < 0.001). 
Conclusion: Although CGM overestimates minimum IFG this study 
indicates that CGM may be a useful tool especially in the evaluation of 
treatment effect on glycemic variation in RYGB-operated subjects, as illus-
trated for LCD. LCD reduces the glucose variability compared to OD ex-
pressed both as a reduction in SD and MAGE, even at the same mean IFG.
Fig. 1. Mean interstitial fluid glucose ± standard error of mean interstitial glucose 
(–●–) and mean plasma glucose ± standard error of mean plasma glucose (–□–) 
measurements during a 5-hours mixed meal tolerance test.
Fig. 2. Comparison between minimum plasma glucose (PG) and interstitial fluid 
glucose (IFG) during 5-hours mixed meal tolerance test. Bland Altman plot 
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T4:PO.002
Pre-diabetes and its influence on bariatric surgery outcomes: 
A prospective study in a hospital population
Lau E.1,3,5, Oliveira J.1,3,5, Cunha F.1,3,5, Saavedra A.1,3,5, Costa M.M.1,3,5, 
Bettencourt-Silva R.1,5, Magalhăes D.1,5, Freitas P.1,2,3,5, Varela A.1,2,3,5, 
Queirós J.1,2,5, Correia F.1,2,4, AMTCO A.2, Carvalho D.2
1Department of Endocrinology, Diabetes and Metabolism, Hospital de Săo Joăo 
EPE, Porto, Portugal,  
2Multidisciplinary Assessment of Surgical Treatment of Morbid Obesity, High 
Differentiation Centre for Surgical Treatment of Obesity, Hospital de Săo Joăo 
EPE, Porto, Portugal,  
3Faculty of Medicine, University of Porto, Porto, Portugal,  
4Faculty of Nutrition and Food Sciences, University of Porto, Porto Portugal,  
5Institute for Research and Innovation in Health Sciences, Porto, Portugal
Introduction:Several studies have established the influence of type 2 di-
abetes on bariatric surgery outcomes.As pre-diabetes is the early stage of 
glucose abnormalities, it seems relevant to understand if pre-diabetes has 
already impact on bariatric surgery outcomes. 
Objectives: To evaluate the implications of pre-diabetes on bariatric sur-
gery outcomes.
Methods: Observational, prospective study of obese patients evaluated 
between January/2010-December/2013.Anthropometric and metabolic 
parameters were analyzed.Glucose metabolism abnormalities defined ac-
cording to ADA.
Results: Of 983 patients, 252 were excluded for prior diagnosis of dia-
betes, 68 for insufficient data and 1 for age <18 years.Of the 662 patients 
included, 581(87.8%) were female, with a median age of 42Y(IQR, 34-
51) and body mass index of 43.5 kg/m2(IQR, 40.6-47.1);55 were diabetic 
and 328 pre-diabetic, with no differences in basal BMI.Pre-diabetics had 
higher levels of total cholesterol, LDL cholesterol, triglycerides, systol-
ic blood pressure and HOMA-IR, compared to euglycaemic(p < 0.05).
Comparing to euglycemic at 12 months post-surgery:pre-diabetics had 
a more significant reduction in fasting glucose, HbA1c and HOMA-β; 
had less significant reduction in total cholesterol, LDL and diastolic 
blood pressure(p < 0.05); and had lower % of excess BMI lost(%EBMIL)
(66.0%vs.75.2; p < 0.001).No differences were found regarding %EBMIL, 
comparing diabetics and pre-diabetics.
Conclusion:In our population pre-diabetes is a determinant of bariatric 
surgery outcomes.Regarding %EBMIL, these results demonstrate that the 
statistically significant difference was related to the transition of the eug-
lycemic state to pre-diabetes and not from pre-diabetes to diabetes.These 
data support the need of an early intervention in obese patients, before 
settling down glucose metabolism abnormalities.
T4:PO.003
The role of Helicobacter pylori infection on insulin resistance, 
beta-cell function and metabolic syndrome in an obese 
population
Lau E.1,3,5, Oliveira J.1,3,5, Cunha F.1,3,5, Costa M.M.1,3,5, Saavedra A.1,3,5, 
Bettencourt-Silva R.1,5, Maglhăes D.1,5, Freitas P.1,2,3,5, Queirós J.1,2,5, 
Varela A.1,2,3,5, Correia F.1,2,4, AMTCO A.2, Carvalho D.1,3,5
1Department of Endocrinology, Diabetes and Metabolism, Hospital de Săo Joăo 
EPE, Porto, Portugal,  
2Multidisciplinary Assessment of Surgical Treatment of Morbid Obesity, High 
Differentiation Centre for Surgical Treatment of Obesity, Hospital de Săo Joăo 
EPE, Porto, Portugal,  
3Faculty of Medicine, University of Porto, Porto, Portugal,  
4Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal,  
5nstitute for Research and Innovation in Health Sciences, Porto, Portugal
Introduction: Recent studies have demonstrated an association between 
Helicobacter pylori (Hp) infection, insulin resistance (IR), beta cell dys-
function, and metabolic syndrome (MS), due to activation of pro-inflam-
matory cytokines and deregulation of immune response. However, this 
association is inconsistent and controversial. 
Objective: To evaluate the association between Hp infection and IR, beta 
cell function and MS. 
Methods:Cross-sectional study of 983 obese patients evaluated between 
January/2010-December/2013. Anthropometric and metabolic param-
eters were analyzed.IR was defined by HOMA-IR; beta-cell function by 
HOMA-β; MS by IDF criteria.Test for Hp was carried out by endoscopic 
biopsy.
Results: Of 983 patients, 252 were excluded for prior diagnosis of diabetes, 
13 for insufficient data and 1 for age<18 years.Of the 717 patients includ-
ed, 629(87.7%) were female, had a median age of 41 years (interquartile 
range [IQR], 35–51) and BMI of 43.5kg/m2 (IQR, 40.6–47.1). Body fat 
index of 47.0% (IQR, 46.4–47.5), insulin 16.9U/mL (IQR, 11.1–25.0), HO-
MA-IR 3.7 (IQR, 2.3–5.6) and HOMA-β 242.3 (IQR 144.4–402.3). Median 
C-reactive protein was 6.3 mg/L (IQR, 2.6–12.0). The SM was present in 
57% (95% CI, 53.1 to 60.9) and 15.3% (95% CI, 12.7–17.9) were smokers. 
The Hp was positive in 60.1% (95% CI, 55.8–64.4).Comparing positive vs 
negative Hp infected patients there was no statistically significant differ-
ences in respect to gender, age, BMI, body fat index, smoking, HOMA-IR, 
HOMA-β or MS.
Conclusion: In our population, Hp infection was not associated with in-
creased risk of IR, beta cell dysfunction or MS. Thus, it seems premature 
to advocate other specific intervention attitudes regarding Helicobacter 
pilory in obese patients that could have impact or decrease their cardio-
vascular risk.
T4:PO.004
Increased bioavailability of alcohol following sleeve 
gastrectomy – preliminary results 3 months after surgery 
Strømmen M.1,2, Kulseng B.1, Dale O.3
1Centre of Obesity, Dept. of Surgery, St. Olavs University Hospital, Trondheim, 
Norway,  
2Dept. of Neuroscience, Norwegian University of Science and Technology, 
Trondheim, Norway,  
3Dept. of Circulation and Medical Imaging, Norwegian University of Science and 
Technology, Trondheim, Norway
Introduction: There is growing concern that bariatric surgery increases 
risk of alcoholism postoperatively. As several surgical procedures exist, 
insight into how different operative techniques influence bioavailabili-
ty relatively can be valuable information when deciding for appropriate 
treatment. We set up a trial to compare the effect of sleeve gastrectomy 
versus gastric bypass on 1 year bioavailability of ethanol. This is 3 months 
preliminary data from the 5 first sleeve gastrectomy patients. 
Methods: Participants, all with BMI>40 kg/m2, met fasting and had a 
standardized breakfast one hour prior to alcohol administration. Ethanol 
dosage was calculated on basis of preoperative total body water (TBW) 
estimated by bioelectrical impedance (InBody 720). Dosage was 0.4 g/kg 
TBW for women and 0.5 g/kg TBW for men. Test sequence (intravenous 
or peroral) was randomized with a washout period of minimum 48 hours. 
For peroral testing, participants consumed in 5 minutes vodka 40% dilut-
ed with orange juice to a concentration of 20%. For the intravenous test, 
ethanol 40% was diluted with glucose 5% to a concentration of 5 g/100 ml, 
and administered as infusion over 30 minutes in vena brachialis. Blood 
alcohol content (BAC) was analysed with Roche Modular P with lower 
detection limit of 2.2 mmol/L, and area under curve (AUC) was calculated 
with WinNonlin software. 
Results: 3 months postoperatively uptake of alcohol was more rapid, 
reached higher concentrations and were detectable longer. Relative bio-
availability (AUClast) was considerably higher than prior to surgery. 
Conclusion: Sleeve gastrectomy seems to increase bioavailability of etha-
nol which in turn may enhance its toxicological effects.
Acknowledgement: We are grateful to the Clinical Research Facility at St. Olavs 
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T4:PO.005
Relationship between body mass index and food addiction: 
How do these measures relate? 
Ouellette A.1, Bégin C.1, Lapointe M.2, Côté M.1, Lemieux S.3, Tchernof A.2, 
Biertho L.2
1School of Psychology, Faculty of Social Sciences, Laval University in Quebec 
city, Quebec city, Canada,  
2Quebec Heart and Lung Institute, affiliated with Laval University in Quebec 
city, Quebec city, Canada,  
3Institue of Nutrition and Functional Foods, Faculty of Food and Agriculture, 
Laval University in Quebec city, Quebec city, Canada
Introduction: Few studies have investigated the nature of the relation-
ship between body mass index (BMI) and food addiction (FA), measured 
by the Yale Food Addiction Scale (YFAS; Gearhardt et al., 2009). While 
most of them reported a positive linear relationship between these vari-
ables, one study using aggregated data suggested a non-linear relationship 
(Meule, 2012). The aim of the present study was to pursue the exploration 
of the relationship between BMI and FA in an attempt to shed more light 
on the nature of this relationship among a clinical sample. 
Methods: Individuals seeking help for eating or weight difficulties in clin-
ics affiliated with Laval University were recruited. They were weighted and 
measured, and completed the YFAS (N=70, mean BMI=41.84kg/m2). Lin-
ear and logistic regression analyses were conducted to determine whether 
being in a certain weight category significantly predicted the number of 
FA criteria endorsed and the probability to obtain a FA diagnosis. 
Results: As shown in figure 1, analyses revealed that when compared to 
the obesity class III category (reference group; BMI > 40 kg/m2), the over-
weight (p = 0.044) and the obesity class I (p = 0.019) categories could sig-
nificantly better predict the number of FA criteria endorsed. This model 
explained 13% of the variance. The same pattern was found for the rela-
tionship between BMI and FA diagnosis (odds ratio 11.67 (overweight) 
and 15.56 (obesity class I)) and this model explained 28% of the variance. 
Conclusion: Findings from this study help clarify the way BMI and FA 
relate and highlight the complexity of this relationship, as FA symptom-
atology appears to behave differently across weight categories. Further 
studies are needed to better understand this relationship and its clinical 
implications.
Fig. 1. Prevalence of food addiction diagnoses, in percentage (%), as well as mean 
number of food addiction criteria endorsed in relation to established weight 
categories. *p < 0.05
T4:PO.006
Brain Activity in Obese Individuals with an Addictive 
Tendency to Food 
Manning P.J.1, Ross S.1, Vanneste S.2, Horwath C.1, Sutherland W.1, 
De Ridder D.1
1Departments of Medicine and Neurosurgery, Dunedin School of Medicine, 
University of Otago, Dunedin, New Zealand,  
2School of Behavioral and Brain Sciences, University of Texas at Dallas, USA
Introduction: Obesity is a major healthcare problem facing today’s so-
ciety. Why certain individuals within an obesogenic society are more 
susceptible to becoming obese remains unclear, however differences in 
genetics, physiology and psychology may partly explain variation in risk. 
In addition some individuals may be susceptible to highly palatable food, 
showing addictive-like eating behaviours. However, controversy exists as 
to whether a proportion of people with obesity have an addictive disorder 
relating to food intake. Recently the Yale Food Addiction Scale (YFAS) 
was developed as a validated method for identifying individuals who have 
addictive tendencies towards food. The aim of this study was to compare 
brain activity in food addicted (high YFAS score) and non-addicted obese 
individuals (low YFAS score) and compare this activity to lean individuals 
and individuals with alcohol addiction. 
Methods: Resting state brain EEG activity was compared in 38 obese 
(BMI >30kg/m2), 20 normal weight (BMI 18–25kg/m2) and 13 alcoholic 
individuals were recruited. The obese individuals were divided into low 
(n = 18) and high (n = 20) YFAS groups based on median split of YFAS 
scores. 
Results: Obese individuals increased activity was identified in the precu-
neus and posterior cingulate cortex (PCC), major hubs in the default mode 
complex which is involved in self-referential and bodily information pro-
cessing. A conjunction analysis between food addicted and non-addicted 
individuals revealed anti-correlated activity in the rostral anterior cingu-
late (rACC) and dorso-medial prefrontal (dmPFC) corticies. Increased 
hunger in the food addicted group correlated to increasing activity in the 
rACC in a similar area correlated to craving for alcohol in individuals with 
alcoholism. 
Conclusion: Obese individuals with a tendency to food addiction have 
neurobiological differences when compared to those without food addic-
tion and show similar changes to people with alcoholism.
T4 – Brain imaging and phenotyping
T4:PO.007
High-fat feeding affects cognitive performance and brain 
glucose metabolism in adult mice 
Sanguinetti E.1,2, Tripodi M.1, Panetta D.1, Salvadori P.A.1, Burchielli S.3, 
Iozzo P.1
1Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy,  
2Scuola Superiore Sant’Anna, Pisa, Italy,  
3Fondazione Toscana Gabriele Monasterio, Pisa, Italy
Introduction: Epidemiological evidence and experimental studies sup-
port the association between obesity and cognitive decline. Alterations of 
brain glucose metabolism and insulin sensitivity have been advocated as 
potential causal factors. Our aim was to assess the effect of a 6-month 
high-fat diet (HFD) on cognitive performance and brain metabolic activ-
ity in adult mice. 
Methods: Explorative and cognitive behaviour of lean (n=19), HFD-in-
duced obese (n=20) and Alzheimer’s Disease (AD) mice supplied (n=20) 
or not (n=20) with HFD was monitored up to 8 months of age. Then, brain 
glucose uptake in fasting conditions and during acute intranasal insulin 
stimulation was determined by 18F-Fluoro-2-deoxy-D-glucose positron 
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Results: A progressive decline in exploratory and cognitive performance 
was detected at 8 months of age from ND to HFD, to AD and to HFD-fed 
AD mice (r=-0,4, p < 0,05), with a pronounced worsening in explorative 
behaviour in the latter group (p < 0,05 vs baseline). The encephalization 
quotient was reduced in proportion to the diet-induced weight gain (r=-
0,8, p < 0,001). In fasting conditions, 18F-FDG PET revealed a consider-
ably higher brain glucose uptake in cognitive and homeostatic regions in 
HFD-fed mice regardless of AD (p≤0,05 vs respective controls). A positive 
effect of intranasal insulin administration on brain glucose metabolism 
was observed, especially in the AD group. 
Conclusion: A 6-month HFD exposure significantly alters cognitive 
performance and brain glucose metabolism in adult mice. The acute in-
tranasal administration of insulin has a positive effect on brain glucose 
metabolism in AD.
T4 – Eating Disorders
T4:PO.008
Association between adult attention deficit/hyper activity 
disorder, binge eating and obesity in the population of 
Belarus. 
Ramanouskaya T.
Department of Psychiatry and Medical Psychology, Belarusian State Medical 
University 
Introduction: Attention deficit/hyperactivity disorder (ADHD) is a neu-
robehavioral disorder that affects near 3,2–4.0% of the adult population of 
Belarus. Studies have revealed high rates of ADHD (26–61%) in patients 
seeking weight loss treatment suggesting an association between ADHD 
and obesity. The objective of the present study was to test the association 
between ADHD and overweight and obesity in the population of Belarus 
Methods: Participants were 2560 residents (58.6% female) aged 18–45 
years. A retrospective assessment of childhood ADHD and a self-report 
assessment of adult ADHD were administered. Diagnosis was defined by 
three categories: never met diagnostic criteria, met full childhood criteria 
with no current symptoms, and met full childhood criteria with current 
symptoms. 
Results: The prevalence of overweight and obesity was 34,8 and 28.4%, 
respectively, among adults with ADHD, and 29.6 and 20.6%, respectively, 
among persons with no history of ADHD. Adult ADHD was associated 
with greater likelihood of overweight, (odds ratio (OR) = 1.64; 95% con-
fidence interval (CI) = 1.05, 2.37) and obesity (OR = 1.82; 95% CI = 1.14, 
2.65). 
Conclusion: Results were similar when adjusting for demographic char-
acteristics and depression. Mediation analyses suggest that binge eating 
disorder (BED), but not depression, partially mediates the associations 
between ADHD and both overweight and obesity. 
Results: suggest that adult ADHD is associated with overweight and obe-
sity and BED.
T4:PO.009
Increasing risk of eating disorders in patients with childhood 
obesity 
Ochner L.1, Biino G.2, Bazzano R.1, Giacoletti C.1, Cossali G.1, Passerini A.1, 
De Giuseppe R.1, Grandi F.1, Maffoni S.1, Della Guardia L.1, Cavallaro M.1, 
Guarene M.1, Roggi C.1, Cena H.1, Fonte M. L.1
1Unit of Human Nutrition and Dietetics, Department of Public Health, 
Experimental and Forensic Medicine, University of Pavia, Italy,  
2Institute of Molecular Genetics, National Research Council of Italy, Pavia, Italy
Introduction: Obesity from early age is considered a strong predictor of 
the premature development of cardiovascular diseases and other comor-
bid conditions [1–3]. This retrospective case-control study aims at explor-
ing if childhood obesity may be involved in the development of eating 
disorders (EDs). 
Methods: A group of patients with diagnosis of EDs (n=99) were com-
pared with a control group (n=423). Personal data, socioeconomic status, 
lifestyle, weight history, dieting, body mass index at pubertal development, 
family history of obesity as well as for eating disorder have been consid-
ered. Logistic regression has been used to assess the influence of child-
hood obesity in the development of EDs. 
Results: Obese children had almost two times (p = 0,018) the risk to de-
velop EDs, compared with normal and underweight ones. In particular, 
obese children had a three times (p = 0,018) and 2,6 times (p = 0,031) 
higher risk to develop respectively binge eating disorder (BED) and buli-
mia nervosa (BN). Moreover, the female component of our sample as well 
as the subjects with motherly positive anamnesis for EDs (MPAEDs), had 
respectively a five times (p < 0,001) and four times (p = 0,037) higher risk 
to develop EDs than males and subjects with motherly negative anamnesis 
for EDs (MNAEDs). 
Conclusion: Our results indicate a high and increasing prevalence of EDs 
patients with early history of childhood obesity and suggest the necessity 
to develop more sensibility and awareness by clinicians who treat over-
weight and obese children.
References:
1.  Cena H, Fonte ML, Casali PM et al.: Pediatr Obes 2014; doi: 10.1111/ijpo.227. 
2.  Escudero-Lourdes GV, Morales-Romero LV, Valverde-Ocańa C, et al.: Rev Med 
Inst Mex Seguro Soc 2014; 52 Suppl 1:58–63. 
3.  Dietz WH. Pediatrics 1998; 101(3 Pt 2):518–525.
T4:PO.010
Psychopathology of nes obese patients 
Micanti F.1, Cucciniello C.1, Loiarro G.1, De Blasio A.1, Formisani N.1, 
Pecoraro G.1, Galletta D.1
1Department of Neuroscience.University “Federico II”. Naples.
Introduction: Night Eating Syndrome (NES) is an Eating Disorder char-
acterized by evening hyperphagia (consuming ≥25% of total daily food 
intake after dinner), morning anorexia, and depressed mood that worsens 
in the evening. It is still unclear which are the psychopathological features 
of NES and the importance of the sleep disorder in its etiopathogenesis. 
This study evaluates mental dimension features in NES obese patients and 
psychiatric comorbidities. 
Materials and methods: 980 obese patients (M age: 35; M BMI: 44.4; 
f/m:653/327) were enrolled in this study, 96/980 had NES diagnosis (M 
age: 38; M BMI: 43; f/m:55/41). The diagnostic evaluation includes: psy-
chiatric interview, semi-structured interview for eating behavior and psy-
chodiagnosis to evaluate the mental dimensions: impulsiveness: Binge 
Eating Scale(BES), Barratt Impulsiveness Scale(BIS-11), depression: Beck 
Depression Inventory(BDI-II), body image: Body Uneasiness Test(BUT), 
anxiety: State Trait Anxiety Inventory(STAI-Y 2). 
Results: In this sample, morning anorexia is not present. It turns out to 
have an associated daytime eating behavior: binge24%; nibbling 40%; 
gorging and snacker 36%. BIS = 67.8 and BES = 19.5; STAI-Y = 47.7; BDI-
II = 19.4; BUT: GSI = 2.55; PST = 16.1; PSDI = 0.6; Tot = 84. Prevalent 
comorbities are: depression (21%), an anxiety disorder (12.5%), psychosis 
(2%). 
Conclusions: The psychopathological analysis of obese patients with NES 
requires a psychiatric treatment: psychopharmacological and/or psycho-
therapeutic before any care in fulfilling obesity healing. 
Acknowledgement: Rossetti GL.MD Digestive Surgery Unit. II School of Medicine 
SUN Naples Italy. Belfiore AM MD Department of Nutrition; Colao AM MD and 
Savastano S MD Department of Medicine and Surgery. Division of Endocrinology. 
School of Medicine Federico II Naples Italy
References: 
Jillon et al.: Night eating syndrome: A critical review of the literature. Clin.Psyc.
Rev.32(2012):49–59.
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T4:PO.011
Attitudes and Behaviors Related to Eating and Body Shape in 
Young Adults Born Preterm 
Matinolli H.M.1,2, Sipola-Leppänen M.1,2,3, Tikanmäki M.1,2, Heinonen K.4, 
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6Children‘s Hospital, Helsinki University Central Hospital and University of 
Helsinki, Helsinki, Finland,  
7Imperial College, London, UK,  
8Department of Psychology, University of Warwick, UK,  
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Medicine, University of Helsinki, Helsinki, Finland,  
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Background: Preterm birth has been listed as a potential risk factor for 
later attitudinal and behavioral problems related to eating disorders (ED). 
We examined the association between preterm birth and symptoms relat-
ed to EDs in young adult women and men. 
Methods: We studied young adults from two birth cohorts: ESTER 
(Northern Finland 1985–1989) and Arvo Ylppö Longitudinal Study (Uu-
simaa, Finland, 1985–1986). Of them, 175 were born early preterm (EPT, 
<34 wk GA), 349 late preterm (LPT, between 34–37 wk GA) and 635 were 
term-born controls (N=1159). Mean age was 24.1 (SD 1.4) years. The 
subjects completed 3 subscales of the Eating Disorder Inventory (EDI)-2 
(total of 22 items), including Drive for Thinness (DT), Body Dissatisfac-
tion (BD) and Bulimia (B). Group differences were examined by linear 
regression. 
Results: Mean total EDI score was higher in women than in men (74.2, 
SD 18.9 vs 55.0, SD 14.5, p < .001). Women born EPT scored 5.9 points 
(95% CI –10.6 to –1.3, p < .05) lower in EDI total scores than controls. 
This difference was observed in all three EDI subscales, DT, BD and B. 
The differences persisted after adjustments for cohort, age, parental ed-
ucation, maternal smoking and pre-pregnancy BMI and height, body fat 
percentage, smoking, depression and timing of puberty of the subject. We 
did not observe differences between women born LPT and controls or any 
differences among men. 
Conclusions: Women born EPT have significantly healthier attitudes and 
behaviors related to eating and body shape than controls born at term.
T4 – Psychological support and Patient Support
T4:PO.012
Psychosocial characteristics of bariatric candidates with 
respect to approval, delay and denial at psychological 
assessment prior to surgery 
Herlesová J.1,2, Pichlerová D.1, Coufalová P.3
1OB klinika, Prague, Czech republic,  
2Faculty of Arts, Charles University, Prague, Czech republic,  
3TNS Aisa, University of Economics, Prague, Czech republic
Introduction: Pre-operative psychological assessment of bariatric candi-
dates plays important role in treatment success. It may result in approval, 
delay or denial of bariatric procedure. 
Methods: The study compares outcomes of psychological evaluation 
according to their profiles. Data from 395 bariatric candidates who un-
derwent semi-structured interview and questionnaires of BDI-II, TFEQ, 
OWLQOL & WRSM, were statistically analyzed. Patients were allocated 
into groups according to results of psychological evaluation. 
Results: There were 80.51% of women (318) in the cohort. Average age 
44,11 (±11,28) years, BMI 42,57 (±6,83) kg/m2, weight 122,5 (±24,94) kg. 
Group A: 276 (69,99%) pts in whom no psychological objections to the 
planned bariatric intervention were present. Group B: 119 (30,13%) pts 
were delayed and repeatedly psychologically evaluated. Group B was sub-
divided into Group B1 (70) pts who later met the requirements and un-
derwent bariatric procedure and Group B2 (49) pts, who did not comply 
and were contraindicated. Significantly more women, older subjects > 50 
years, and BMI < 39 kg/m2 were present in Group A. Higher score of re-
striction TFEQ (10,4) was found in Group A vs. Group B1 (8,7) and Group 
B2 (8,3). In comparison with Group A, Group B2 presented more unmar-
ried men with higher average BMI (44,9 vs. 41,8 kg/m2) and more patients 
with BMI > 50kg/m2. Scores of restriction in TFEQ were lower for Group 
B2 than for Group A (average 8,3 vs.10,4), higher in disinhibition (average 
9,5 vs.7,9), showed worse QoL (# of symptoms in WRSM 11,6 vs.9,5). 
Conclusion: Statistically significant difference in questionnaires scorings 
as well as in gender and BMI was found between the Group A and sub-
Group B2.
T4:PO.013
The impact of shame, self-criticism and social rank on eating 
psychopathology in overweight and obese members of a 
commercial weight management programme. 
Duarte C.1, Matos M.1, Gail C.2, Morris L.4, Stubbs R.J.3,4, Gilbert P.2
1Cognitive and Behavioural Centre for Research and Intervention, University of 
Coimbra, Rua do Colégio Novo, Apartado 6153,  3001-802 Coimbra, Portugal,  
2Mental Health Research Unit, Kingsway Hospital, Derby, DE22 3LZ,  
3College of Life and Natural Sciences, University of Derby, Kedleston Road, 
Derby, DE22 1GB, UK,  
4Nutrition and Research Department, Slimming World, Clover Nook Road, 
Somercotes, Alfreton, Derbyshire, DE55 4RF, UK
Background: Research has highlighted the important role social rank, 
shame and self-criticism play in vulnerability to and maintenance of eat-
ing disorders. However, it is not clear if these factors are also important for 
weight control capability in populations who are overweight or obese.This 
study examined associations between self-criticism, social comparison, 
external shame, negative affect (emotions) and eating psychopathology 
in overweight/obese participants attending a weight management pro-
gramme focused on behaviour change. 
Methods: 2236 participants completed an online survey with measures 
of self-criticism, social comparison, external shame and negative affect, 
adapted to address these aspects in relation to eating behaviour, body 
weight and shape. 
Results: Correlational analyses showed that external shame, self-criticism 
and social comparison were associated with negative affect and eating 
psychopathology. Path analysis showed that when the effect of depressive 
symptoms was controlled for the impact of external shame, hated self 
and reassured self on disinhibition and susceptibility to hunger was fully 
mediated by their effect on weight-related negative affect. In turn, inade-
quate self and negative social comparison predicted higher disinhibition 
and susceptibility to hunger directly and partially through weight-related 
negative affect. 
Conclusions: Shame, self-criticism, and perceptions of low social rank 
significantly predict eating-related difficulties in members of the general 
population participating in popular weight-loss programmes. Targeting 
shame, self-criticism, and perceptions of low social rank are important 
areas of focus for interventions in members of the general population ex-
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T4:PO.014
The impact of self-criticism and self-reasurance on weight 
related positive and negative affect and well-being 
in participants of a commercial weight management 
programme. 
Duarte C.1, Matos M.1, Gale C.2, Morris L.4, Stubbs R.J.3,4, Gilbert P.2
1Cognitive and Behavioural Centre for Research and Intervention, University of 
Coimbra, Rua do Colégio Novo, Apartado 6153,  3001-802 Coimbra, Portugal,  
2Mental Health Research Unit, Kingsway Hospital, Derby, DE22 3LZ,  
3College of Life and Natural Sciences, University of Derby, Kedleston Road, 
Derby, DE22 1GB, UK,  
4Nutrition and Research Department, Slimming World, Clover Nook Road, 
Somercotes, Alfreton, Derbyshire, DE55 4RF, UK
Introduction: Weight stigma can potentially undermine weight man-
agement by increasing self-criticism. We recently examined the links be-
tween external shame, self-criticism, social comparison, negative affect 
and eating behaviours in 2,236 participants attending a community based 
weight management program focused on behaviour change. Shame and 
self-criticism influenced measures of eating behaviour (disinhibition and 
perceived hunger)- an effect fully mediated through weight-related neg-
ative affect. In the present study we examined the impact of self-criticism 
on wellbeing. 
Method: 2,175 participants completed an online survey using measures of 
self-criticism, self-reassurance negative and positive affect and well-being 
(which were adapted to specifically address eating behaviour, weight and 
body shape perceptions). 
Results: Correlation analyses showed that self-criticism was associated 
with negative affect and wellbeing. Path analysis suggested that self-crit-
icism significantly decreased well-being, both directly and indirectly, 
mediated by increased levels of negative affect about one’s weight, and by 
decreased levels of positive affect about one’s weight. The ability to self-re-
assure had a higher predictive effect on increased well-being by predicting 
less negative affect and by predicting increased levels of positive affect re-
garding one’s weight. All effects were significant at p <0.001. 
Conclusions: Factors that increase self-criticism impact on well-being in 
participants engaged in attempts to manage their weight, both directly and 
through their impact on weight related affect. Developing self-reassuring 
competencies in weight management programmes enhances weight relat-
ed affect and well-being.
T4:PO.015
No difference in weight loss achieved following a vlcd in 
conjunction with telephone-based group support compared 
with a vlcd in conjunction with face-to-face support 
Johnston K.L.1, Clarizio C.A.1, Dyson L.1, Cox J.1, Hewlett B.1
1LighterLife UK Ltd, Cavendish House, Parkway, Harlow Business Park, Harlow, 
Essex, CM19 5QF
The number of effective weight loss programmes which are readily acces-
sible for our increasingly obese population is a growing problem. Light-
erLife, a commercial weight-loss provider, offers weight loss and mainte-
nance programmes which utilise a tripartite approach consisting of formula 
based foods for weight loss in conjunction with behavioural-change ther-
apy underpinned by group support to aid clients with longer-term weight 
maintenance. LL2U is a pilot weight loss programme in which the group 
support is accessed via telephone rather than face-to-face (F2F). We evalu-
ated the efficacy of LL2U by comparing data for obese clients (n=17) who 
had completed 8 weeks of VLCD whilst receiving group support on LL2U 
with data from an equal sized group of age and BMI matched individu-
als who had completed 8 weeks of VLCD on LighterLife Total (F2F sup-
port). Within-group comparisons were performed using paired t-tests and 
differences in mean weight over time between the groups assessed using a 
repeated measures analysis of variance (RM-ANOVA) (OpenStat, version 
2013 http://www.statpages.org/miller/openstat) After 8 weeks there was a 
significant weight reduction for both groups when compared with baseline 
(mean ± SEM) (LL2U: 98.3 ± 4.0 kg vs. 86.5 ± 3.45 kg, p <0.001 and Total: 
95.3 ± 3.5 kg vs. 83.6 ±3.1 kg, p < 0.001). RM-ANOVA showed that the total 
weight change observed for the LL2U group did not differ significantly from 
that observed in the Total group (-11.8 ± 3.6 kg versus –11.7 ± 3.2 kg, p > 
0.05) throughout the period of observation. These data provide evidence 
that a VLCD alongside LL2U based group support is effective in supporting 
initial weight loss in obese clients. Whilst successful weight maintenance is 
complex and multi-factorial, behavioural change therapy via telephone may 
provide the support required. However, the impact of this on longer term 
weight maintenance still needs to be established.
T4:PO.016
Prevalence of depression and associated factors in greek 
obese patients 
Kouniakis F.1, Gounitsioti I.1, Fotiadou E.1, Dimitroula C.1, Axiotidou E.1, 
Kourtoglou N.1, Bellivani M.1, Savopoulos C.1, Hatzitolios A.I.1
1Obesity & Metabolism Outpatient Clinic, EASO accredited Collaborating COM, 
1st Propedeutic Department of Internal Medicine, AHEPA University Hospital of 
Thessaloniki, Greece
Introduction: Prevalence of depression in obese population is significant-
ly high, resulting in deterioration of overall quality of life. Most of the 
time depression and obesity co-exist, affecting many aspects of life, such 
as sexual life and quality of sleep. 
Methods: In the first COM in Greece a total sample of 48 obese outpa-
tients (mean age 47.8 ± 14.1 years and mean BMI 41.6± 8.1 kg/m2) un-
dergone a psychiatric evaluation of depression status (HDRS), sexual dys-
function (ASEX) and quality of sleep and daytime sleepiness as part of the 
standard baseline assessment. 
Results: All the outpatients have suffered from some degree of depression 
(mild 16.7%, moderate 43.8%, severe 14.6%, very severe 25%). Majority 
of study population were women (79.2%) and morbidly obese (43.8%). 
According to Epworth Sleepiness Scale 87.5% of the outpatients had de-
veloped either moderate or serious sleep disorder, while 33.3% had sexual 
dysfunction. The severity of depression demonstrates a significant positive 
correlation to sexual dysfunction (p < 0.05) as well as to quality of sleep 
(p < 0.01). There was a significant relation between depression and finan-
cial status of individuals (p < 0.05). BMI and weight, on the other hand, 
was not statistically associated to depression degree. 
Conclusion: Although overweight and obesity are positively associated 
with depression and depressive symptoms there is data that report either 
no relationship or an inverse relationship between the two. Nevertheless, 
this study indicates that prevalence of depression and related disorders are 
very common among obese people who seek treatment, a fact that high-
lights the essential role of a psychiatrist as a member of the specialized 
team for the treatment of obesity.
T4:PO.017
Self-esteem and its relation to self-recognition of one’s own 
body in relation to nutritional status of women diagnosed 
with polycystic ovary syndrome 
Wyskida K.1, Dybczak D.1, Izydorkiewicz E.1, Gorki K.1, Gawełek E.1, 
Dworzyńska B.1, Miraś K.1, Bąk-Sosnowska M.2, Chudek J.3, Madej P.4, 
Olszanecka-Glinianowicz M.1
1Health Promotion and Obesity Management Unit, Department of 
Pathophysiology, Medical Faculty in Katowice, Medical University of Silesia,  
2Department of Psychology, School of Health Care, Medical University of Silesia,, 
3Pathophysiology Unit, Department of Pathophysiology, Medical Faculty in 
Katowice, Medical University of Silesia,  
4Department of Gynecological Endocrinology, Medical Faculty in Katowice, 
Medical University of Silesia
Introduction: Symptoms of depression and the lack of self-acceptance is 
more common among women with polycystic ovary syndrome (PCOS) 
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disturbances is nutritional status. Therefore, the aim of the study was to 
assess self-esteem and its relation to self-recognition of one‘s own body of 
women with PCOS in relation to nutritional status. 
Methods: Two-hundred-thirty-four women diagnosed with PCOS were 
enrolled. Body mass and height were measured and BMI was calculated. 
Nutritional status was assessed on the basis WHO criteria. Self-esteem was 
assessed on the basis of polish adaptation M. Rosenberg scale and self-rec-
ognition of own’s body by Franzoi and Shields scale. 
Results: Normal body mass was diagnosed in 66.2% study women, over-
weight in 19.7% and obesity in 14.1%. There were no differences in age of 
the study group (24.7 ± 5.5, 24.9 ± 4.6 and 25.5 ± 4.6 yrs) and satisfaction 
with their sexual attractiveness (47.3 ± 7.7; 47.1 ± 7.6 i 46.1 ± 10.6 points). 
While, the degree of satisfaction with weight control and with physical 
condition (29.3 ± 9.1 vs. 25.4 ± 7.2 vs. 23.8 ± 9.8 points and 32.1 ± 5.9 vs. 
28.9 ± 6.5 vs. 28.0 ± 8.0 points, respectively). Low level of self-esteem was 
more frequent in obese women 18.1%. In addition, any obese women had 
high level of self-esteem. 
Conclusions: Overweight and obesity are the factors decreased satisfac-
tion with weight control and physical condition but not with sexual at-
tractiveness. While, low self-esteem in women diagnosed with PCOS is 
increased by obesity, only.
T4:PO.018
The role of emotional regulation in childhood obesity: 
Implications for prevention and treatment 
Aparicio-Llopis E.1, Michels N.2
1Faculty of Medicine and Health Sciences, Nutrition and Mental Health Research 
Group (NUTRISAM), Institut de Investigació Sanitaria Pere Virgili (IISPV), 
Universitat Rovira i Virgili (URV), Reus, Spain,  
2Department of Public Health, Ghent University, Belgium 
Background: Stress and negative emotions represent an important public 
health threat e.g. by increasing the risk to develop obesity. Since the pro-
cess to cope with negative emotions (= emotion regulation (ER)) already 
develops during childhood, we present a novel conceptual framework 
model on the role of ER in prevention and treatment of childhood obesity. 
Methods: An electronic database search (MEDLINE, Web of Knowledge 
and Scopus) was conducted on observational and interventional/experi-
mental literature concerning the ER-obesity link and its underlying con-
cepts. We also present an overview of ER intervention techniques. 
Results: Our model states that childhood ER is a fundamental link be-
tween stress and obesity. Stress along with ineffective ER causes abnormal 
cortisol patterns, emotional eating, a sedentary lifestyle and sleep prob-
lems. In the development of obesity and ER, also parents play a role. In 
contrast, effective ER skills decrease obesity-related unhealthy behaviour 
and enhance protective factors, which boost mental and physical health. 
In children, some observational studies were found but very few interven-
tion studies, mainly pilot or still on-going studies. 
Conclusions: Encouraging effective ER could be a new approach in the 
fight against and the treatment of childhood obesity. Future ER interven-
tions are needed to confirm this model in children.
Fig. 1. Conceptual framework model on the role of ER in the prevention and 
treatment of childhood obesity
T4:PO.019
Retrospective analysis of subjective wellbeing and weight 
loss in patients receiving talking therapies at the Rotherham 
Institute for Obesity (RIO) 
Boyden C.1, Wilson C.1, Capehorn M.1
Rotherham Institute for Obesity (RIO)
Introduction: RIO is a specialist weight management service with a 
comprehensive multidisciplinary team approach that includes talking 
therapies. The therapies involved are solution focussed and include Moti-
vational Interviewing (MI), Cognitive Behavioural Therapy (CBT), Neu-
rolinguistic Programming (NLP), Emotional Freedom Techniques, life 
coaching and hypnotherapy. Patients are referred by other members of the 
RIO MDT if patients are suspected of emotional eating, are identified as 
having binge eating or comfort eating, or are suspected of having underly-
ing psychological barriers to weight loss. 
Methods: Retrospective analysis of qualitative and quantitative data for 
all partcipants aged 19–80 years, between April 2010 to March 2013, who 
attended the RIO weight management programme (n=4587). Subjective 
wellbeing (SWB) scores were measured by means of the WHO-5 wellbe-
ing index at the initial assessment and at 6 months. 
Results: From the 2091 patients that completed the 6 month RIO pro-
gramme, 627 patients (30%) were seen by a talking therapist (TT). patients 
who saw a TT demonstrated improved SWB scores by 25% (p < 0.001, 
r=0.3) compared to 21% (p < 0.001, r=0.2) who had not seen a TT. Patients 
who were referred had a higher BMI (average 44.4 kg/m2) compared to 
those who had not (41.02 kg/m2). Weight loss was similar for both groups; 
5.8kg in those who received TT compared to 5.7kg in those who did not. 
Conclusion: SWB improvements were enhanced for patients who saw a 
talking therapist, however overall weight loss results were similar for both 
groups. Patients referred for talking therapy were usually those having sig-
inificant difficulty in losing weight, yet relatively a considerable amount of 
weight was seen in this cohort.
T4:PO.020
Does A Health Information Technology developed by Children 
and their Parents improve Obesity Therapie? 
Büchter D.1, Kowatsch T.2, Brogle B.1, Dinther-ter Velde A.1, Pelikosa I.3, 
Durrer D.4, Schutz Y.5, Maas W.6, Wiegand D.1, Laimbacher J.1, L`Ŕllmand D.1
1Department of Adolescent medicine, Children`s Hospital of Eastern 
Switzerland, St. Gallen, Switzerland
Existing interventions prove limited effectiveness and sustainability. IT- 
enhanced interventions have the potential for higher accessibility and 
cost-effectiveness.They aim not only modifying the patient‘s behavior but 
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Methods: In cooperation with therapists, extremely obese children, their 
parents, and differnt researcher, a mobile health information system (HIS) 
with special data security was developed, consisting of a tablet PC with 
cooking and shopping support, relaxation tools, the ability to measure 
speed of eating and emotional parameters and physical activity acceler-
ometer. Three groups of each six extremely obese children (BMI > 99.5, 
median BMI z-score 3.0, age 13.2 ± 2.3 years) were assigned. Therapy in 
either an (1) individual or (2) group setting with HIS, or (3) individual 
care without HIS. All groups were evaluated for above metioned items in 
a specialized centre before and after 12 months of therapy. Questions of 
interest: 1. Does a HIS developed by children and their parents improve 
adherence to therapy and thus improve health outcomes in families with 
low time resources? 2. Can HIS help the family to change its activity, nu-
trition, mood and communication habits. 
Results: 25% of extremely obese children with HIS and 60% without HIS 
decreased their BMI-SDS. HIS children did not reduce their obesity bet-
ter than the control group without HIS, if parents did not support their 
children at home. Those children with parental support did use HIS for 
activity, mood and nutrition monitoring regularly. 
Conclusion: In extremely obese children, home support with HIS is only 
effective, when children are guided by their parents while using the HIS. 
To select appropriate families for HIS home support, a careful examina-
tion of the family system in context with their motivation and their psy-
chosocial problems is unalterable by questionnaires and interviews.
Acknowledgement: ą Children‘s Hospital of Eastern Switzerland, St. Gallen, * SNF 
Grant #CR 10/1 135552 ˛ University of St. Gallen, Switzerland ł ETH Zurich, Swit-
zerland ⁴ Eurobesitas Centre ( COMS) Vevey, Switzerland ⁵University of Fribourg, 
Switzerland ⁶ Saarland University, Germany
T4 – Quality of life
T4:PO.021
Not weight status but parental education and perception of 
weight and health are related to health related quality of life 
in children and adolescents. 
Ligthart K.A.1, Paulis W.D.1, Koes B.W.1, Middelkoop M.1
1Department of General Practice, Erasmus MC, University Medical Center, 
Rotterdam, The Netherlands
Introduction: Previous research suggests that weight status is negatively 
associated with health related quality of life (HRQoL) in children and ad-
olescents. However, little is known on other factors influencing HRQoL. 
Therefore, the aim of this study is to describe the association between 
weight status, children’s characteristics and HRQoL. 
Methods: Baseline data from a prospective cohort studying 715 children 
(2–18 years) in 73 general practices in the Netherlands were used. Height 
and weight were measured during regular consultation and children and 
parents filled-out questionnaires about HRQoL (Pediatric Quality of Life 
Inventory), demographics, parents’ perception of the child’s weight, par-
ents’ perception of the child’s health status and number of GP consulta-
tions over the last twelve months. Data were analysed using a multiple 
linear regression model with HRQoL as dependent variable. 
Results: Global HRQoL scores were significantly lower in overweight and 
obese children (78.2(14.1), n=116) compared to underweight (84.9(10.1), 
n=109) or normal weight (83.6(10.7), n=372) children (p < 0.001). Mul-
tiple linear regression analysis showed that not weight status but lower 
parental education, perceived overweight and perception of lower health 
were significantly associated with decreased global and physical HRQoL 
(p < 0.01). Higher weight status, child considered as overweight and poor 
perceived health were associated with impaired psychosocial HRQoL 
(p < 0.05). 
Conclusion: Physical HRQoL is associated with parental education and 
perception of weight and health while psychosocial HRQoL is associated 
with weight status but also with health and weight perception.
T4.PO.022
Liraglutide 3.0 Mg reduces body weight and improves 
hrqol in overweight or obese adults without diabetes: Scale 
obesity and prediabetes randomized, double-blind, placebo-
controlled, 56-week trial 
Lau D.C.1, Fujioka K.2, Astrup A.3, Greenway F.4, Halpern A.5, Krempf M.6, 
Le Roux C.7, Violante Ortiz R.8, Wilding J. P.9, Wolden M.10, Jensen C. B.10, 
Pi-Sunyer X.11
1University of Calgary, Calgary, AB, Canada,  
2Scripps Clinic, La Jolla, CA, USA,  
3University of Copenhagen, Frederiksberg, Denmark,  
4Pennington Biomedical Research Center, Louisiana State University System, 
Baton Rouge, LA, USA,  
5Hospital das Clínicas, University of Săo Paulo Medical School, Săo Paulo, Brazil,  
6Université de Nantes, Nantes, France,  
7University College Dublin, Dublin, Ireland,  
8Instituto Mexicano del Seguro Social, Cd.Madero, Tam. México,  
9University of Liverpool, Liverpool, UK,  
10Novo Nordisk A/S, Sřborg, Denmark,  
11Columbia University, New York, NY, USA
Obesity is a chronic disease associated with physical and mental health 
problems and reduced health-related quality of life (HRQoL), which can 
be improved by weight loss (WL). The effects of liraglutide 3.0 mg, as ad-
junct to diet & exercise, on body weight (primary endpoint) and HRQoL 
in overweight/obese adults were investigated. Individuals (BMI ≥27 kg/
m˛ with ≥1 comorbidity or ≥30 kg/m˛) were advised on a 500 kcal/day 
deficit diet & exercise program, and randomized 2:1 to once-daily sc li-
raglutide 3.0 mg (n=2487) or placebo (n=1244). Baseline characteristics: 
age 45.1 years, 78.5% female, weight 106.2 kg, BMI 38.3 kg/m˛, 61.2% 
with prediabetes. The Impact of Weight on Quality of Life-Lite (IWQoL), 
Short-Form (36) Health Survey (SF-36) and Treatment Related Impact 
measure-Weight (TRIM-W) questionnaires were used to assess health-re-
lated outcomes (score ranges 0-100). Data were observed means±SD and 
estimated treatment differences (ED), with LOCF. Clinicaltrials.gov ID: 
NCT01272219. At week 56, individuals on liraglutide 3.0 mg had more 
WL (8.0 ± 6.7%) vs placebo (2.6 ± 5.7%; ED –5.4% [95%CI –5.8;-5.0]; 
p < 0.0001). WL was accompanied by improvements in the total IWQoL 
score with liraglutide (10.6 ± 13.3) vs placebo (7.6 ± 12.8; ED 3.1 [2.2;4.0], 
p < 0.0001), mostly driven by improved physical function. The TRIM-W 
total score (ED 2.1 [1.3;3.0], p < 0.0001), SF-36 summary physical/mental 
health scores (ED 1.7 [1.2;2.2], p < 0.0001; 0.9 [0.3;1.5], p = 0.003), and all 
domain scores of IWQoL and SF-36 improved with liraglutide vs placebo. 
In conclusion, weight loss with liraglutide 3.0 mg, as adjunct to diet & 
exercise, was accompanied by weight-related improvements in HRQoL, 
including physical function and mental health. Greater weight loss led to 
greater improvements in HRQoL scores.
Acknowledgement: Supported by Novo Nordisk
T4:PO.023
Quality of life and negative emotionality in overweight and 
obese non-clinical sample 
Pokrajac-Bulian A.1, Kukic M.1, Basic-Markovic N.2
1Department of Psychology, Faculty of Humanities and Social Sciences, 
University of Rijeka, Rijeka, Croatia,  
2Familiy medicine practice, Srdoči 65d, Rijeka, Croatia 
Introduction: The present study investigates the correlates of health-re-
lated quality of life (HRQoL) in the adult overweight and obese popula-
tion and the association between body mass index, depression, anxiety, 
and potential mediating effects of physical health functioning. 
Methods: The research was conducted on a sample of overweight and 
obese adults who visited their primary care physician. A total of 143 wom-
en and 130 men were enrolled in the study, 43% of the subjects were over-
weight, and 57% of the subjects were obese. The subjects ranged in age 
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Hospital Anxiety and Depression Scale (HADS), physical health function-
ing was evaluated using the Medical Outcome Study Short-Form 36 (SF-
36), and BMI was calculated as weight divided by height squared.
Results: The regression analysis results indicated that the components of 
physical HRQoL (physical functioning and role limitation due to physical 
problems) mediate the relationship between body mass index and depres-
sion only in women. The higher level of body mass decreased the quality 
of life, and different aspect of impaired physical health became a potential 
risk factor for the development of depressive symptoms. Men do not relate 
their weight to poorer quality of life (e.g., general health or life roles). 
Conclusion: The results from the present study show that a different pat-
tern of functioning exists between men and women. It is important to 
identify the factors that can effectively motivate and stimulate obese peo-
ple to change their lifestyle and to consider the differences in psychologi-
cal functioning between women and men.
T4:PO.024
Weight loss with liraglutide 3.0 Mg is associated with 
improved health-related quality of life (hrqol) and treatment 
satisfaction in overweight or obese adults with type 2 
diabetes (t2d) 
Le Roux C.1, Davies M.2, Bode B.3, DeFronzo R.4, Lewin A.5, Wolden M.L.6, 
Noctor M.6, Kushner R.7
1University College Dublin, Dublin, Ireland,  
2Diabetes Research Centre, University of Leicester, Leicester, UK,  
3Atlanta Diabetes Associates, Atlanta, GA, USA,  
4Texas Diabetes Institute, San Antonio, TX, USA,  
5National Research Institute, Los Angeles, CA, USA (retired),  
6Novo Nordisk, Sřborg, Denmark,  
7Northwestern University, Chicago, IL, USA
Background: Obesity is a chronic disease associated with T2D and low 
HRQoL, which can be improved by a 5–10% weight loss. We studied the 
impact of weight loss with liraglutide 3.0 mg, as an adjunct to diet and ex-
ercise, compared with placebo and liraglutide 1.8 mg on HRQoL in over-
weight/obese adults with T2D. 
Methods: 846 participants (means: age 55 years; males 50%; BMI 37 
(27–68) kg/m˛; HbA1c 7.9%; diabetes duration 7.3 (0.2−36) years; 11% 
on diet + exercise, 57% on metformin monotherapy, 31% on combination 
OADs) were randomized (2:1:1) to 56 weeks of once-daily s.c. liraglutide 
3.0 mg (n=423), 1.8 mg (n=211) or placebo (n=212) treatment + guided 
diet (500 kcal/day deficit) and exercise. The Impact of Weight on Quality 
of Life (IWQoL) Lite and Diabetes Treatment Satisfaction Questionnaire 
(DTSQ) were used to assess health-related outcomes. Clinicaltrials.gov 
ID: NCT01272232. 
Results: At week 56, weight loss (mean±SD) was 5.9 ± 5.5%, 4.6 ± 5.5% 
and 2.0 ± 4.3% with liraglutide 3.0 mg, 1.8 mg, and placebo, respec-
tively. The mean total score of the IWQoL-Lite improved with 3.0 mg 
(11.7 ± 14.7), but not 1.8 mg (9.1 ± 14.1), vs. placebo (7.6 ± 12.6; estimated 
difference (ED) and 95%CI: 2.7 [0.6 4.9]; p = 0.014); this was driven by an 
improved physical function score (15.4 ± 17.1 with 3.0 mg vs. 9.5 ± 16.6 
with placebo; ED: 4.9 [2.1 7.7]; p = 0.0006). Liraglutide 3.0 mg, but not 
1.8 mg, also improved the DTSQ vs. placebo (ED: 1.4 [0.4 2.5]; p < 0.01). 
Conclusion: In overweight/obese individuals with T2D, liraglutide 3.0 
mg, as adjunct to diet and exercise, was superior to placebo and 1.8 mg on 
weight loss (p < 0.0001 and p = 0.0024, respectively), and also significantly 
improved HRQoL and diabetes treatment satisfaction.
Acknowledgement: Supported by Novo Nordisk
T4:PO.025
 ‘Blodomloppet ‘ - a way to increase self-confidence connected 
to physical aktivity 
Törner S., Simmons C.
1Department of physiotherapy, Queen Silvia Childrens Hospital, Sahlgrenska 
University Hospital, Gothenburg, Sweden
Introduction: Physical activity has an important role to play regards to 
affecting different risk factors, among others insulin sensitivity and im-
proved physical wellbeing (1–2). It is also well known that children and 
young people who are physically active as children tend to retain these 
good habits into adulthood (2). Many young people who suffer from obe-
sity have negative experiences of physical activity and are often excluded 
early from physical activities. This in turn leads to exclusion and increases 
the stigma both physically and socially (3). We decided to start training for 
a non-competitive race and chose ‚Blodomloppet‘, a 5km circuit non-pro-
fessional running competition. 
Method: Reduced starting fees enabled the group to take part free of 
charge. Four young people entered in 2012 and five in 2013. One phys-
iotherapist ran the race with the group and one was placed alongside the 
track to offer support and as a rallying point. This also gave us an opportu-
nity to discuss nutrition and training in connection with the experiences 
from ‚Blodomloppet‘. 
Result: All participants completed the race. They expressed the impor-
tance and strength of the group (community) which gave all the partici-
pants the confidence to run the race. After the race the participants felt an 
increased confidence in their own bodies through physical activity. The 
memory of their achievement was later seen in the group training and as 
a consequence we could raise our expectations of them. Estimations of the 
group BMI before and after the race resulted in a reduction of 0.9 units 
of BMI. Research suggests that a reduction of 0.5 units of BMI means a 
significant health gains with respect to risk factors (1). 
Conclusion: To put the foundation for a healthier lifestyle where physical 
activity remains a certainty, can perhaps become the result when a homog-
enous group is put together to give the conditions they did not have with 
them from the outset.
Fig. 1. Adolecents that participated in „Blodomloppet“
T4:PO.026
Deterioration of quality of life perception depending on 
different obesity levels 
Gounitsioti I.1, Fotiadou E.1, Kouniakis F.1, Dimitroula C.1, Axiotidou E.1, 
Kourtoglou N.1, Bellivani M.1, Grammatikopoulou M.G.2, Savopoulos C.1, 
Hassapidou M.N.2, Hatzitolios A.I.1
1Obesity & Metabolism Outpatient Clinic, EASO accredited Collaborating COM, 
1st Propedeutic Department of Internal Medicine, AHEPA University Hospital of 
Thessaloniki, Greece,  
2Department of Human Nutrition & Dietetics, Alexander Technological 
Educational Institute of Thessaloniki, Greece
Introduction: In recent years, the assessment of quality of life of obese 
people has been extensively studied. Although anthropometric character-
istics are strong indicators of health status, obese population demonstrates 
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relationship between the quality of life self-perception and the obesity de-
gree, using the Moorehead – Ardelt QOL II (MAII) questionnaire, among 
subcategories of obesity in the first COM in Greece. 
Methods: A total of 23 outpatients (mean age 44.6 ± 12.2 years and mean 
BMI 39 ± 5.2 kg/m2) were recruited in order to assess the MA II. Basic 
anthropometric and sociodemographic characteristics were recorded. 
Results: The majority of the outpatients were women (82.6%) and de-
clared a moderate financial status (73.9%). Half of the outpatients (47.8%) 
were university educated. The 34.8% had a regular weekly physical activ-
ity, while 39% were smokers and had metabolic syndrome, according to 
IDF classification criteria. Obesity was sub-grouped into three categories 
according to WHO criteria, class I (17.4%), class II (47.8%) and class III 
(34.8%). MA II total score had a negative correlation with body weight 
(-0.456, p < 0.05) and BMI (-0.548, p < 0.01) and it was significantly dif-
ferent among obesity subgroups (p < 0.05), demonstrating a gradual de-
crease by each higher obesity category. 
Conclusion: This study demonstrates that perceived quality of life dete-
riorates as the obesity degree rises, insinuating that even a small weight 
reduction may play a crucial role not only in health status improvement 
but also into quality of life, underlying the need of holistic treatment of 
obesity.
T4:PO.027
Family-based behavioural treatment for childhood obesity 
decreases BMI and improves health relatetd quality of life 
Brynjolfsdottir B.1, Kristjánsdóttir B.2, Bjornsdottir O.E.1,2,4, Zoega H.2,4, 
Helgason T.1, Olafsdottir A. S.1,3, Bjarnason R.1,4
1Children’s Medical Centre, Landspitali University Hospital, Reykjavík, Iceland.,  
2University of Iceland, Centre of Public Health Sciences Reykjavík, Iceland.,  
3University of Iceland, School of Education, Reykjavík, Iceland.,  
4University of Iceland, Faculty of Medicine, Reykjavík, Iceland
Introduction: Over the past decades childhood obesity rates have tripled. 
Effective treatment for obese children is extremely important because of 
the negative impact it can have on both the physical and psychological 
well-being of the child, as well as health-related quality of life (HRQL). 
The objective of this study was to examine potential benefits of fami-
ly-based behavioral treatment for obese children on BMI standard devia-
tion scores (BMI-SDS), psychological well-being and health related qual-
ity of life HRQL. 
Method: Treatment was provided to 43 obese children, aged 7–12 years 
and a participating parent. The treatment consisted of 18 group and indi-
vidual sessions delivered three times a week over six weeks. Measurements 
included height and weight, BMI-SDS was calculated, and psychological 
well-being and quality of life were assessed with questionnaires (The 
Strength and Difficulties Questionnaire and Pediatric Quality of Life). As-
sessments were conducted at baseline, after the 6 weeks of treatment and 
during booster sessions at 3, 6 and 12 months post-treatment. 
Results: Among the 31 children that finished the 6 weeks program, the 
BMI-SDS decreased significantly during treatment (mean BMI-SDS = 3.49 
(SD = 0.7) at baseline and 3.08 (SD = 0.6) after the 6 weeks of treatment (p 
< .0001). Among the 16 children that met up at the 1-year booster session 
the BMI-SDS decreased significantly (mean BMI-SDS = 3.36 (SD = 0.6) 
at baseline and 2.80 (SD = 0.4) after 1-year (p < .0001). There were no 
significant differences in psychological well-being during treatment (p > 
.05), nor at 1-year follow-up (p > .05). HRQL improved during treatment 
(p < .01) but was not maintained at 1-year follow-up (p > .05). 
Conclusion: The family-based behavioural treatment provided to obese 
children in Iceland produced promising results regarding long term de-
crease in BMI-SDS and in short term health-related quality of life.
T4:PO.028
Skeletal Muscle Quality: Concordant Findings from Two 
Practical Non-Invasive Approaches 
Pietrobelli A.1,2, Johnson C.3, Heymsfield S.B.2, Zheng J.2
1Pediatric Unit Verona University Medical School, Verona (ITALY);,  
2Pennington Biomedical Research Center, Louisiana State University System, 
Baton Rouge, LA, (USA);,  
3University of Virginia, Charlottesville, VA, (USA)
Background: Phase angle (θ), derived from bioelectrical impedance anal-
ysis (BIA) resistance and reactance, decreases with adult age and is associ-
ated with changes in nutritional status, skeletal muscle (SM) function, and 
insulin resistance. Another measure of SM quality is the light fraction (LF) 
measured with ultrasound (US) followed by image processing; echogenic 
light SM is produced with fat and fibrous tissue infiltration of normally 
dark SM. While BIA systems automatically measure θ, technical training 
is needed for operation of the US system and subsequent image analysis. 
Methods: The aim of this study was to examine the associations between 
these two age-related measures of SM quality: θ at 50 KHz using an 8-elec-
trode multifrequency BIA system (MC980, Tanita Corp., Tokyo, Japan); 
US (GE LOGIC). Subjects were 165 males and females, ages 5–80 yrs, with 
US measures of biceps, triceps, calf, and thigh muscles; and θ measures of 
each arm and leg. 
Results: Significant correlations (p < 0.05) were present for key associa-
tions, including: bicep LF and arm θ; triceps LF and arm θ; thigh LF and 
leg θ; age and biceps and thigh LF, and leg θ. Our findings thus show con-
cordant relations between the two different measures of SM quality, θ and 
LF. 
Conclusions: Measurement of θ may be a simple, practical, and clinical-
ly-useful measure of age-related changes in SM quality that can be studied 
in the context of sarcopenia and related metabolic disorders.
T4:PO.029
Psychosocial quality-of-life, lifestyle and adiposity: A 
longitudinal study in preschoolers 
Michels N.1, Kriemler S.2, Marques-Vidal P.M.3, Nydegger A.4, Puder J.J.5
1Department of Public Health, Ghent University, Belgium,  
2Institute for Social and Preventive Medicine, University of Zürich, Switzerland,  
3Department of Internal Medicine, Internal Medicine, Lausanne University 
Hospital (CHUV), Switzerland,  
4Pediatric Gastroenterology Unit, Department of Pediatrics, Centre Hospitalier 
Universitaire Vaudois, University of Lausanne, Switzerland,  
5Service of Endocrinology, Diabetes and Metabolism & Division of Pediatric 
Endocrinology, Diabetes and Obesity, Centre Hospitalier Universitaire Vaudois, 
University of Lausanne, Switzerland
Objective: In obesity prevention, insight about the role of psychosocial as-
pects early in life is pivotal. Several reviews reported contradictory results 
regarding the associations between children’s psychosocial and adiposity 
and they noted the lack of longitudinal studies focusing on explaining or 
moderating lifestyle factors. Therefore, our aim was to test whether low 
psychosocial Quality-Of-Life (QOL) in preschoolers is associated with 
lifestyle and adiposity changes over one schoolyear and whether lifestyle 
moderates the latter. 
Methods: Longitudinal data from 291 preschoolers (initially 3.9–6.3y) 
was collected in the Swiss Ballabeina study: psychosocial QOL (emotion-
al, social and school QOL by PEDsQL), adiposity (BMI, waist, fat%), diet 
(food frequency), screen time and activity-level (accelerometers). 
Results: Low psychosocial QOL was related to unfavorable changes in diet 
(less fruit β=0.21 and more fat intake β=-0.28) and lower physical activity 
(β=0.21). Some longitudinal QOL-adiposity relations appeared only after 
moderation by lifestyle (beta-range: 0.13–0.67). Low psychosocial QOL 
was associated with adiposity increases in children with an unhealthy diet 
intake (i.e. low fruit, high fat intake or high soft drink intake frequency) or 
a high sedentary time. By contrast, low psychosocial QOL was associated 
with longitudinal decreases in adiposity in preschoolers with a high fruit 
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Conclusions: The current study results emphasize the need for test-
ing moderation in the QOL-adiposity relation. An unhealthy diet can 
be a vulnerability factor and high physical activity a protective factor in 
QOL-induced adiposity. Consequently, QOL and lifestyle should be tar-
geted concurrently in multi-factorial obesity prevention.
Fig. 1. Fatty food intake as moderator in the longitudinal effect of QOL on 
adipozity
T4:PO.030
Retrospective analysis of subjective wellbeing index scores, 
with effect of weight change and demographics in patients 
attending the Rotherham Institute for Obesity 
Boyden C.1, Fellows S.2, Capehorn M.1
1Rotherham Institute for Obesity,  
2University of Chester 
Introduction: There is a bi-directional association between obesity and 
mental wellbeing (Gatineau and Dent, 2011). Demographics such as age, 
Body mass Index (BMI), gender, deprivation and employment are also in-
volved in the relationship. This study aimed to identify if the subjective 
wellbeing (SWB) of participants is affected by attending the Rotherham 
Institute for Obesity (RIO), and to investigate whether weight loss or gain 
affects the result, and identify other variables or demographics that may 
affect the initial SWB. 
Methods: Retrospective analysis of qualitative and quantitative data for all 
participants aged 19–80 years who completed the full 6 month RIO weight 
loss programme between Jan 2010 to Dec 2012 was made (n=1895). The 
data included age, gender, weight, BMI, postcode, employment status and 
WHO-5 index scores. 
Results: All participants achieved the WHO-5 criteria of 10% increase in 
scores at 6 months (p < 0.017 Bonferroni adjusted score). Demographics 
did affect initial SWB scores, but overall SWB improved in most catego-
ries apart from participants who were classed as carers (p = 0.01) or per-
manently sick (p = 0.04) or students (p = 0.93). The participants that lost 
or maintained weight achieved the WHO-5 criteria of 10% increase in 
scores achieving significant change (p = 0.001) whereas the patients who 
gained > 4.9kg of weight achieved less than 10% (p = 0.19) 
Conclusion: SWB does improve after completing a 6 month weight man-
agement programme and is affected by demographics initially, and weight 
changes on completion
Reference:
1.  Gatineau M & Dent M (2011). Obesity and Mental Health, National 
Obesity Observatory, Oxford.
T4 – Anxiety and depression
T4:PO.031
Depressive symptoms and associations with low vitamin d 
levels and adherence to mediterranean diet in morbidly obese 
patients 
Luger M.1,2, Kruschitz R.1, Marculescu R.3, Klammer C.1, Adelfang M.1, 
Kral M.1, Hoppichler F.2, Langer F.4, Prager G.4, Schindler K.1, Ludvik B.1
1Department of Internal Medicine III, Medical University of Vienna, Vienna, 
Austria,  
2Special Institute for Preventive Cardiology And Nutrition, Salzburg, Austria,  
3Department of Laboratory Medicine, Medical University of Vienna, Vienna, 
Austria,  
4Department of Surgery, Medical University of Vienna, Vienna, Austria
Introduction: In obese persons vitamin D deficiency (VDD) is present 
and obesity is associated with depression1. We evaluated parameters of 
vitamin D, severity of depression and adherence to Mediterranean diet in 
morbidly obese patients. 
Methods: In this randomized controlled trial (NCT02092376) patients 
with VDD were included. The Beck Depression Inventory (BDI-V)2 was 
used to estimate depression in morbidly obese patients with 35 points 
as threshold. Additionally, 25-hydroxy-vitamin D (25-OHD), 1,25-dihy-
droxy-vitamin D (1,25-DiOHD) and Mediterranean Adherence Score 
(MEDAS)3 were assessed. The threshold of 25-OHD and 1,25-DiOHD is 
75 nmol/l and 86.5 pg/ml. 
Results: In patients [n=39; age 43 (14) years, mean (SD); 72% women; BMI 
of 43.7 (4.6) kg/m2] with following means of 25-OHD: 41.3 (12.2) nmo-
l/l, 1,25-DiOHD: 47.5 (16.7) pg/ml, BDI-V: 31 (16) points, and MEDAS: 
5 (2) points. 35% suffered from clinically relevant depression by BDI-V. 
Patients with lower 1,25-DiOHD levels showed higher BDI-V points (r=-
0.43; p = 0.02). Depressive patients had lower adherence to Mediterranean 
diet [4 (1) vs. 6 (2) points; p = 0.001] compared to non-depressive ones. 
Conclusion: About one third suffered from depression with association to 
low levels of active form of vitamin D. Furthermore, non-depressive pa-
tients showed a higher adherence to Mediterranean diet compared those 
with depression. However, further research regarding causality of the as-
sociation between VDD and depression is required. 
References:
1. Anglin RE, et al.: Br J Psychiatry 2013. 202:100-107. 
2. Schmitt M, et al.: Diagnostica 2006. 52(2):51–59. 
3. Martínez-González M, et al.: PLoS One 2012. 7(8):e43134.
T4:PO.032
Depression and suicidal ideation among adults with 
metabolic syndrome: Data from the 2008–2010 Korea 
National Health and Nutrition Examination Survey 
Kang J.1, Yu S.1, Kim C.1, Ryu O.1, Lee S.1, Hong E.1, Kim D.1, Yoo J.1, Ihm S.1, 
Choi M.1, Yoo H.1
1Endocrinology and Metabolism, Hallym University College of Medicine, 
Anyang, Republic of Korea
AIM: Suicide and depression are one of the highest public health prob-
lems worldwide. Suicidal ideation represents an important phase in the 
suicidal process and often precedes suicidal attempts or completed sui-
cide. Patients with chronic medical disease are more likely to report sui-
cidal thoughts and depression. However the studies on relationship be-
tween these conditions and metabolic syndrome are rare. We aimed at 
investigating the prevalence of depression and suicidal ideation among 
adults with metabolic syndrome in Korea. 
Methods: We analyzed data for 17924 persons (Men; 7516 persons & 
Women; 10408 persons) from 2008–2010 KNHANES who did not have 
cancer or hepatitis or liver cirrhosis. Each individual was assessed for the 
presence of metabolic syndrome according to the NECP-ATP Ⅲ criteria 
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by Korean Society for Study of the Obesity was used. The presence of de-
pression or suicidal ideation and were defined by a self-reported question-
naire asking if the participants had ever been diagnosed with depression 
by medical doctor or had any suicidal thoughts. 
Results: The prevalence of depression (17% vs. 14%, p < 0.001) and sui-
cidal ideation (20% vs. 17%, p < 0.001) was significantly higher in partic-
ipants with metabolic syndrome. Mean scores for the EQ-5D decreased 
significantly with participants with depression (0.80 ± 0.22 vs. 0.91 ± 0.13, 
p < 0.001) and suicidal ideation (0.79 ± 0.22 vs. 0.92 ± 0.13, p < 0.001) in 
the group with metabolic syndrome. 
Conclusions: This study shows that metabolic syndrome is associated 
with depression and suicidal ideation and this relationship was negatively 
associated with health related quality of life.
T4:PO.033
Poor mental health in severely obese patients unexplained by 
the presence of comorbidities 
Somerville R.1, McKenzie K.1, Eslami S.1, Breen C.2, O‘Shea D.2, Wall P.1
1School of Public Health Physiotherapy and Population Science, University 
College Dublin, Dublin, Ireland;,  
2Obesity Research Group, St Columcille’s Hospital, Dublin, Ireland
The prevalence of obesity, especially severe obesity where body mass in-
dex (BMI) exceeds 40 kg/m2 and where the physical risks are greatest, is 
increasing. However, little is known about the impact of severe obesity on 
psychological well-being and self-rated health (SRH). We aimed to inves-
tigate this relationship in patients attending an Irish weight management 
clinic. SRH was measured with a single-item inventory (excellent = 1, 
poor = 5). Well-being was measured with the validated World Health 
Organization-Five Well-being Index (WHO-5), in which scores <13 in-
dicate poor well-being. Previous studies of the Irish population have re-
ported mean SRH = 2.56 (males) and 2.53 (females) and mean well-be-
ing = 16.96. Number of medications was used as a proxy for comorbidity 
and multiple imputation was applied to minimise bias due to missing data 
in self-reported questionnaires. One hundred eighty-two (46.8%) com-
pleted questionnaires were returned. The sample was representative of the 
clinic population with a mean age of 47.1, mean baseline BMI of 51.9 kg/
m2 and 64.3% females. Mean SRH was 3.73 in males and 3.30 in females; 
mean well-being was 10.27 in males and 10.52 in females. In the final 
multivariable models, number of medications, depression and obstruc-
tive sleep apnoea, WHO-5 and current BMI were significant predictors 
of SRH, and secondary level education, social support and mindfulness 
scores were significant predictors of psychological well-being. The results 
show that mean self-rated health and psychological well-being scores in 
this population of severely obese patients are substantially worse than in 
the Irish population at large. The poor psychological well-being seen is 
not explained by the presence of comorbidities, but social support and 
mindfulness may be important targets for improving well-being. Improv-
ing psychological well-being in addition to weight loss and effective man-
agement of comorbidities may be important for improving SRH.
Acknowledgement: The authors gratefully acknowledge statistical support received 
from the Centre for Support and Training in Analysis and Research, University Col-
lege Dublin. This study was funded by the Health Research Board of Ireland.
T4 – Disability/intellectual deficiency
T4:PO.034
Piloting a manualised weight management programme for 
overweight and obese persons with mild-moderate learning 
disabilities: Results of the shape up-ld study 
Beeken R.J.1, Lally P.1, Wahlich C.1, Omar R.2, Marston L.3, Wilson R.1, 
Spanos D.1, Fovargue S.4, Anderson D.4, Hassiotis A.5, King M.5, Wardle J.1, 
Croker H.1
1Department of Epidemiology & Public Health, University College London,  
2Department of Statistical Science, University College London,  
3Department of Primary Care & Population Health, University College London,  
4Anglian Community Enterprise, Essex,  
5Division of Psychiatry, University College London
Introduction: Obesity prevalence is higher among adults with mild-mod-
erate learning disabilities (LD) than in the general population. There is a 
need for services designed to meet the needs of this group. We piloted 
a manualised weight management programme for overweight and obese 
adults with LD (Shape Up-LD). 
Method: A two-arm, individually randomised, controlled pilot trial in 
adults with LD (n=50) comparing Shape Up LD to Usual Care. Shape 
Up LD involves 12 weekly group sessions led by trained facilitators, in-
cluding advice on healthy eating, physical activity and behaviour change 
techniques. Communication is aided through the use of pictorial hand-
outs. Where applicable, carers of the participants attended sessions and 
received training on how to support participants. Anthropometric mea-
sures were taken at baseline, 3 and 6 months. Participants in the groups 
and group facilitators were also interviewed. 
Results: At 3 months, Shape Up-LD participants were 0.34kg lighter than 
those who had received Usual Care (95% CI –2.38kg, 1.69kg). At 6 months 
this difference had increased to –0.55kg (95% CI –4.34kg, 3.24kg). Partic-
ipants and carers were positive about the programme and gave examples 
of behaviour change, though some wanted more practical elements to be 
included. Facilitators liked the programme but were frustrated with carers 
who did not support participation in the group or behaviour change de-
spite the training given. 
Conclusion: Shape Up-LD may be beneficial for weight loss. Although 
the observed difference in this pilot was small, weight loss appeared to 
continue even after the groups had finished. There was enthusiasm for the 
groups among those involved, but more work may be needed to develop 
stronger interventions that better manage the role of carers.
Acknowledgement: This study was funded by the National Institute for Health Re-
search (NIHR) under its Research for Patient Benefit (RfPB) Programme.
T4:PO.035
The effect of weight on cognitive function 
Mullen M.1, Abbott J.1, Skelton F.2, Cleator J.3
1School of Psychology, University of Central Lancashire, Preston, United 
Kingdom,  
2School of Life, Sport and Social Sciences, Edinburgh Napier University, 
Edinburgh, United Kingdom,  
3School of Nursing, Midwifery and Social Work, University of Manchester, 
Manchester, United Kingdom
Introduction: There is some evidence that poor neurocognitive ability 
and conditions such as Alzheimer’s disease may be associated with obe-
sity. A few studies, predominantly in clinical settings, demonstrate poor-
er executive function in obese adults. Executive functions are high level 
cognitive mechanisms that manage everyday thinking and behaviour; 
however, measurement has been problematic and has lacked a theoretical 
foundation. Using Miyake et al’s (2000) model of executive function this 
work (a) assessed the feasibility of employing a range of cognitive tests in 
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Methods: A mixed method sampling strategy was employed to collect 
cross-sectional data from a community sample (e.g. workplaces, commu-
nity centres). Cognitive tests that reflected the main executive functions 
were designed and piloted. Four cognitive tests were used in the study. 
Height and weight were measured and self-reported depression (CES-D), 
demographic and clinical variables were obtained. Individuals were classi-
fied using the 5 traditional BMI groups. 
Results: Three-hundred and fifteen individuals, aged 18 –65 years, were 
recruited to the study (mean age 38 years; 55% female; 61% employed). 
Underweight and obese/morbidly obese individuals demonstrated deficits 
on tests of memory and cognitive processing when compared with normal 
weight individuals, when controlling for age and depression. 
Conclusion: Having a healthy BMI appears to provide a cognitive ad-
vantage. Further data collection and statistical modelling is required to 
control for other potentially key demographic and clinical confounding 
variables. Whether deficits on these cognitive tests translate into deficits in 
everyday tasks also warrants attention.
T4:PO.036
Do patients with mental health conditions or learning 
difficulties that attend the Rotherham Institute for Obesity 
lose weight? 
Steele C.1, Capehorn M.1
1Rotherham Institute for Obesity 
Introduction: The Rotherham Institute for Obesity (RIO) is a specialist 
centre for weight management with a multidisciplinary team approach, 
based in a primary care setting. The commissioned contract did not re-
quire that RIO saw any patient with severe mental health conditions, 
learning difficulties, or anyone else that might be deemed to struggle with 
engagement with the service or understanding of the information/support 
provided. However, the MDT agreed to see these patients and this study 
is the first analysis of whether these cohorts of patients respond to the 
specialist weight management services offered at RIO. 
Methods: A retrospective analysis of adult data during the 12 months 
during 2013 was performed and patients identified with the specified con-
ditions that might be classified as severe mental illness or learning difficul-
ties. A further breakdown of these patients was also performed in order to 
see if there was any variation in success with specific conditions. Further 
analysis of weight loss was performed and other markers of success in-
cluding bio-impedence and blood tests. 
Results: 54 patients with severe mental health illnesses or learning dif-
ficulties attended RIO during the period analysed. Of these, 36 (66.7%) 
did not complete the full 6 month RIO weight management programme, 
which was higher than the normal average drop out rate for completion at 
RIO (approximately 50%). 18 patients did complete the full 6 month RIO 
programme and of these 15 (83%) were successful at losing weight. 
Conclusion: Patients attending RIO who are classified as having severe 
mental health problems, and/or learning difficulties, can lose weight with 
the support of a specialised weight management service.
T5 – Pregnancy
T5:PO.001
Stability and change in BMI, self-esteem, eating and body 
satisfaction during and after pregnancy: A cross cultural 
comparison of israeli and uk women. 
Shloim N.1, Rudolf M.2, Feltbower R.3, Hetherington M.1
1Institute of Psychological Sciences, University of Leeds, Leeds LS2 9JT, UK,  
2Faculty of Medicine in the Galil, Bar Ilan University, Safed, Israel,  
3Centre for Epidemiology and Biostatistics, Leeds Institute for Genetics Health
Introduction: Maternal body mass index (BMI) is associated with nega-
tive body image and restrained eating which are experienced differently 
across cultures. The present study explored if levels of self-esteem, eat-
ing behaviours and body satisfaction change from early pregnancy to 24 
months following birth. An additional aim was to identify if such mea-
surements vary according to country and BMI. 
Methods: 73 women from Israel and the UK participated in the study. 
Data were collected every six months and women completed question-
naires assessing self-esteem (RSEQ), body image (BIS/BIDQ) and eating 
behaviours (DEBQ). Women reported their weight and height and BMI 
were calculated. Regression modelling was used to account for changes 
and to assess the independent impact of BMI on outcomes. 
Results: Self-esteem remained stable across follow-ups and did not differ 
according to country. As mothers’ BMI increased they ate more according 
to emotional cues and were less satisfied with their body. Findings from 
this study note that BMI was the strongest predictor for self-esteem, eating 
behaviours and body satisfaction. 
Conclusion: The period after pregnancy is a key time to investigate how 
well women adjust to motherhood. Future research should aim to contin-
ue and explore mothers’ well- being, eating behaviours and body satisfac-
tion in the immediate time postpartum, but also how well women adjust 
to such changes over time.
T5:PO.002
Patterns of prenatal growth and skinfold thickness at birth 
Norris T.1, Johnson W.2, West J.3, Wright J.3, Cameron N.1
1School of Sport, Exercise & Health Sciences, Loughborough University, UK.,  
2MRC Human Nutrition Research Unit, Cambridge, UK.,  
3Bradford Institute for Health Research, Bradford, UK.
Introduction: Identify whether patterns of restricted or rapid fetal growth 
are related to skinfold thickness at birth. 
Methods: Multilevel models were used for the modelling of fetal and postna-
tal growth from the Born in Bradford (BiB) cohort. Fitted values and Z-scores 
were produced at 20, 30, 40 prenatal weeks. Restricted and rapid growth 
were defined as a change in conditional Z-score in the fetal period of <-0.67 
and >0.67, respectively. ANOVAs and linear regression (adjusted for weight 
at birth) were used to test for differences in subscapular and tricep skinfold 
thickness and the centripetal fat ratio at birth, by type of prenatal growth. 
Results: Neonates who had experienced restricted fetal growth had sig-
nificantly smaller subscapular and tricep skinfold thickness compared to 
those with normal or rapid fetal growth. Rapid fetal growth was also as-
sociated with significantly thicker skinfold thickness compared to normal 
fetal growth. After adjusting for weight at birth, these associations were 
attenuated and became non-significant. There were no significant differ-
ences in the centripetal fat ratio between any of the types of fetal growth, 
before or after adjustment for size at birth. 
Conclusion: Periods of restricted or rapid fetal growth were associated 
with differences in skinfold thickness at birth. However, adjusting for size 
at birth resulted in differences being attenuated to the null, suggesting that 
independent effects of reduced or rapid fetal growth in a particular period 
of time were not apparent. Furthermore, a tendency to deposit fat central-



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247Abstracts 191
T5:PO.003
Extreme obesity in pregnancy and the association with 
preterm and postdate birth: A national study of births in 
england, uk 
Slack E.1, Best K.1, Rankin J.1, Heslehurst N.1
1Institute of Health & Society, Newcastle University, Newcastle upon Tyne, UK
Introduction: Extreme obesity (BMI≥50kg/m2) represents the smallest 
subgroup of maternal obesity (BMI≥30kg/m2) with an incidence of 0.1%. 
However, it is increasing at a rapid rate and significantly associated with 
adverse perinatal outcomes(12). Preterm (<37 weeks) and postdate (≥42 
weeks) births incur increased perinatal risk for mother and baby. There 
is an evidence-base for the association between maternal obesity and 
preterm or postdate birth, but a lack of research on the association with 
extreme obesity. 
Methods: Secondary analysis of existing data on 531,219 singleton live 
births in 16 UK maternity units from 1990–2007 was undertaken. Logistic 
regression controlled for gestation at booking, ethnic group, parity, depri-
vation, maternal age and employment. Adjusted odds ratios (AORs) were 
produced for preterm and postdate births. Analysis of preterm subgroups 
included moderate (32–36 weeks) and very/extreme preterm birth (20–31 
weeks; including births below the limit of viability <24 weeks). 
Results: Following exclusions for missing data, 392,530 births remained. 
Compared to recommended BMI (18.5–24.9kg/m2), extreme obesity was 
significantly associated with preterm (AOR 1.9 95%CI 1.5–2.6) and post-
date birth (AOR 1.8 95%CI 1.3–2.5). Subgroup analyses identified the 
greatest association with very/extreme preterm birth (AOR 2.1 95%CI 
1.1–3.7). 
Conclusion: Maternal extreme obesity was significantly associated with 
an increased risk of preterm and postdate birth. The association was 
greatest between extreme obesity and very/extreme preterm birth. This 
preterm birth subgroup has the greatest risk for the baby, including gesta-
tional age at delivery below the limit of viability.
Acknowledgement: Research relating to this abstract was funded by a UK Medical 
Research Council 1+3 PhD studentship
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Relations between weight change before and during 
pregnancy: Data from the national elfe cohort 
Jacota M.1,2, Forhan A.1, Charles M.A.1, Heude B.1
1INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center 
(CRESS), Team,  
2University Paris-Sud, France.
Introduction: Several studies suggested a beneficial effect of weight loss 
before pregnancy in obese women in regard to pregnancy complications. 
Methods: We studied the associations of weight change and dietary re-
striction in the year before conception with gestational weight gain, glob-
ally and by BMI category at conception, in 14077 mothers of the Elfe na-
tional French birth cohort. We excluded cases of pregestational diabetes 
or hypertension. 
Results: Women who were obese at the beginning of pregnancy (9.1%) 
gained less weight during pregnancy than non-obese women (8.4 ± 7.3 
vs 13.6 ± 4.9 kg, p < 0.0001). They also declared dieting in the year be-
fore pregnancy (29.4%) more often than non-obese women (12.2%, 
p < 0.0001). In multivariable analyses, women who lost more than 5 kg in 
the year before pregnancy were younger, had a higher BMI, were more of-
ten smokers and multiparous (p < 0.0001). Women who declared dieting 
in the year before pregnancy had higher BMI and economic and educa-
tional status, were more often born in France and employed (p < 0.0001). 
Regardless of maternal BMI right before pregnancy, women who lost 
more than 5 kg the year before pregnancy experienced higher gestational 
weight gain than the others (13.4 vs 11.9 kg for women with stable weight 
over the period, for example, global p < 0.0001), as did women who dieted 
before pregnancy (13.7 vs 11.8 kg, p < 0.0001). A similar pre-pregnancy 
weight loss had higher impact on gestational weight gain when associated 
with dietary restriction (interaction p: 0.003). 
Conclusion: Almost 30% of obese women tried to lose weight in the year 
before pregnancy. Regardless of maternal nutritional status, pre-pregnan-
cy weight loss, especially if voluntary, seems to induce a compensatory 
response resulting in higher gestational weight gain.
Acknowledgement: The Elfe cohort was funded by the French National Re-
search Agency (ANR), program “Investments for the Future”: reference ANR-11-
EQPX-0038.
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Implications of pregestational overweigth and obesity on the 
lipid and glucometabolic profile during pregnancy 
Bozkurt L.1, Göbl C.S.2, Hörmayer A.T.1, Luger A.1, Baumgartner-Parzer S.1, 
Kautzky-Willer A.1
1Department of Internal Medicine III, Division of Endocrinology and 
Metabolism, Unit of Gender Medicine, Medical University of Vienna, Vienna, 
Austria,  
2Department of Obstetrics and Gynecology, Division of Feto-Maternal Medicine, 
Medical University of Vienna, Vienna, Austria
Lipid alterations during gestation are suggested to impact obesity and 
GDM associated adverse pregnancy outcomes. The objective is to assess 
longitudinal changes in serum lipids during pregnancy in women with dif-
ferent degrees of obesity under special consideration of the glucometabol-
ic status. 208 pregnant women stratified by preconceptional BMI (normal 
weight with BMI<25: n=89 (42,8%), overweight with BMI 25–29.9: n=59 
(28.4%), obese with BMI>30: n=60 (28.8%)) underwent an 75g-2h-OGTT 
≤21st gestational week (visit 1). Final diagnosis was performed in GW 
24–28 (IADPSG criteria: 129 NGT, 79 GDM). An additional blood drawn 
for the assessment of glucometabolic and lipid profile was performed in 
visit 1 and at further three visits until delivery. OGTT data were used to 
estimate insulin sensitivity. GDM prevalence was related to degree of obe-
sity (normal weight: 25.8%, overweight: 40.7%, obese: 53.3%, p = 0.003). 
At baseline obese and overweight women showed already elevated lev-
els of triglycerides (TG, p < 0.001) and usCRP (p < 0.001) and decreased 
HDL-C values (p = 0.01), whereas total cholesterol (TC) and LDL-C were 
comparable between the groups. In relation to visit 1 all lipid parameters 
showed a significant increase in the whole group. However, the increase in 
serum lipid concentrations was less pronounced in overweight and obese 
compared to normal weight subjects (LDL-C: p = 0.006, TC: p = 0.002, 
TG: p = 0.002). These differences were independent of baseline insulin 
resistance and GDM status. Regarding fetal outcome maternal obesity 
was associated with higher birth weight (percentiles of gestational age). 
Although lipids were not correlated to birth weight there was a significant 
association with preconceptional BMI and insulin resistance during preg-
nancy. Decrease of pregnancy induced hyperlipidemia in obese and over-
weight women is independently prevalent of glucose disorders. Further 
studies on the effect of maternal metabolism on fetal outcome is needed.
Fig. 1. Trajectories of total cholesterol during pregnancy in women categorized by 
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Determination of relationship between prepregnancy 
maternal body mass index and gestational diabetes mellitus 
Ede G.1, Samur G.1, Demirkol K.F.2, Keskin U.2
1Department of Nutrition and Dietetics, Hacettepe University, Ankara, Turkey,  
2Gulhane Military Medical Academy Hospital, Ankara, Turkey
Introduction: Increasing of obesity among women of reproductive age 
may contribute to the occurrence of gestational diabetes mellitus (GDM). 
Aim of this study was to examine the relationship between maternal pre-
pregnancy body mass index (BMI), weight gain during pregnancy and 
improving GDM in pregnant women. 
Methods: Forty women with GDM and 40 healthy women as a control 
group were recruited from the Department of Obstetrics and Gynecolo-
gy. Exclusion criteria were pre-GDM, polycystic ovary syndrome, kidney 
disease, thyroid disease, history of GDM, multiple pregnancy. GDM was 
diagnosed with two-step oral glucose tolerance test. BMI was calculated 
from weight and height and categorized according to the WHO classifi-
cation. 
Results: The average maternal age was 32.1 ± 4.9 years among cases and 
28.7 ± 4.9 years among controls. Maternal weight gain was higher in the 
GDM group than in the control group (16.9 ± 4.33 kg versus 14.4 ± 4.61 
kg, p < 0.05). Women with GDM had a high BMI (mean 26.4 ± 5.73 kg/
m2) than healthy women (22.6 ± 3.56 kg/m2) and the difference between 
the two groups was statistically significant (p < 0.05). In the case group 
22.5% of women were obese while in the control group 2.5% of women 
were obese (p < 0.05). Women’s prepregnancy BMI was significantly posi-
tive correlated with the risk of GDM (r=0.381, p = 0.000).
Conclusion: Higher prepregnancy BMI is correlated positively with im-
proving GDM. Gestational weight gain is a significant risk factor for GDM 
in the overweight or obese patients but not in patients who were under-
weight or had a normal BMI before pregnancy.
T5:PO.007
Maternal overweight and obesity are not associated with 
birth weight discordance in twin pregnancies 
Ferraro Z.M.1,2,4,5, Page R.1, Zhang T.3, Al-Mugbel M.1, Fung-Kee-Fung K.1,4
1Department of Obstetrics, Gynecology and Newborn Care, Division of 
Maternal-Fetal Medicine, The Ottawa Hospital, Ontario, Canada,  
2Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, 
Canada,  
3Methods Centre, Ottawa Hospital Research Institute, Ottawa, ON, Canada,  
4Faculty of Medicine, University of Ottawa Ottawa ON, Canada,  
5Healthy Active Living and Obesity (HALO) research group, Children’s Hospital 
of Eastern Ontario Research Institute, Ottawa, ON, Canada
Introduction: Maternal overweight/obesity (OW/OB) increases risk of 
complications to women and their unborn children. The incidence of twin 
pregnancy has increased due to delayed childbearing and greater use of 
reproductive technologies. Fetal outcomes are worse when differences be-
tween twins birthweight exceed 20%. Fetal nuchal translucency measure-
ment (NT) via ultrasound at 11–14 weeks‘ is a robust screening method 
used to predict many pregnancy outcomes. It is unknown whether ma-
ternal OW/OB and discrepant NT values are associated with discordant 
birthweights in twins. 
Methods: We retrospectively examined 652 twin pregnancies at the Ot-
tawa Hospital between 2008–2012 who opted for first trimester prenatal 
screening. Multivariate logistic regression were performed and odds ratios 
(ORs) calculated. 
Results: When categorized according to birthweight discordance < 20%, 
maternal age (32.8 ± 5 years), pregravid BMI (25.4 ± 6 kg/m2), weight at 
ultrasound (71.8 ± 18 kg), and twin NT difference (0.3 ± 0.5 mm) were 
similar to those with birthweight discordance ≥ 20% (maternal age 
33.0 ± 5 years, BMI 25.6 ± 6 kg/m2, weight at ultrasound 72.5 ± 19 kg, twin 
NT difference 0.4 ± 0.7 mm). Adjusting for maternal age, pregravid BMI, 
gestational age at delivery, and maternal alpha-feto protein level, twin NT 
difference ≥20% vs. <20% (OR 1.22; 95% CI 0.67-2.20, p = 0.52) and pre-
gravid BMI ≥ 25 kg/m2 vs. 18.5-24.9 kg/m2 (OR 0.82; 95% CI 0.46-1.45, 
p = 0.65) were not associated with twin birthweight discordance. 
Conclusion: Prepregnancy OW/OB and NT discordance ≥20% do not 
increase a woman’s chance of giving birth to twins with a ≥20% difference 
in birthweight.
Acknowledgement: ZM Ferraro was supported by a Canadian Institute of Health 
Research (CIHR) allied care provider postdoctoral fellowship from the Institute of 
Human Development, Child and Youth Health. R Page was supported by a summer 
studentship provided by the Division of Maternal-Fetal Medicine at The Ottawa 
Hospital General Campus.
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Patterns of pre-pregnancy BMI and gestational weight gain 
in West Sumatra, Indonesia and their effects on pregnancy 
outcomes 
Soltani H.1, Fair F.1, Liputo I.2, Kilner K.1
1Sheffield Hallam University, UK,  
2Andalas University, Indonesia 
Introduction: Indonesia is currently experiencing a nutrition transition, 
where obesity is increasing while malnutrition has not yet been defeated. 
Energy deficiency, obesity and gestational weight gain (GWG) all impact 
on pregnancy outcomes, which are known to influence the future develop-
ment of obesity and metabolic disorders. 
Objective: The objectives were to determine the pattern of body mass in-
dex (BMI) and GWG in a sample of Indonesian pregnant women and to 
identify the associated pregnancy outcomes. 
Methods: Between August and December 2010, 1013 women in Indone-
sia were enrolled into the study. Birth weight data was available for 579 
women. 
Results: Under-nutrition (BMI<18.5kg/m˛) in pregnancy in Indonesia 
was high at 19.6% and the proportion of women who were overweight 
(BMI≥25.0kg/m˛) or obese (BMI≥30.0kg/m˛) was 13.0% and 1.6% re-
spectively. In pregnancy 50.6% of women gained too little weight accord-
ing to the IOM guidelines. Weight gain in accordance with IOM guidance 
reduced the outcomes of small for gestational age (SGA) and large for ges-
tational age (LGA). Macrosomia increased significantly with increasing 
pre-pregnancy BMI and weight gain above the IOM recommendations. 
Multivariate analysis showed GWG increased with increasing maternal 
education and in those living in urban rather than rural areas and GWG 
decreased with increasing pre-pregnancy weight. Birth weight was found 
in multivariate analysis to increase with increasing maternal age, height, 
pre-pregnancy weight and GWG and to be greater in women living in 
rural than urban areas. 
Conclusions: To improve maternal and infant outcome there is a need to 
ensure adequate weight prior to pregnancy and for maternal education, 
especially in relation to appropriate weight gain in pregnancy.
Acknowledgement: Research relating to this abstract was partly funded by the Di-
rectorate General of Higher Education, Ministry of Education and Culture in Indo-
nesia and the British Council.
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Blood cell transcriptomic-based early biomarkers of adverse 
programming effects of gestational calorie restriction and 
their reversibility by leptin supplementation 
Konieczna J.1, Sánchez J.1, Palou M.1, Picó C.1, Palou A.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), 
University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y 
Nutrición (CIBEROBN), Palma de Mallorca, Spain
Introduction: Moderate maternal undernutrition during gestation in rats 
may program the offspring to develop later pathologies. Oral adminis-
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some of these alterations. Using these animal models, we aimed to identify 
early transcriptome-based biomarkers, indicators of both programmed 
susceptibility to later disorders and response to neonatal leptin treatment 
in peripheral blood mononuclear cells (PBMCs), an easily accessible sur-
rogate tissue. 
Methods: Male and female rats belonging to 3 groups were studied: the 
offspring of ad libitum fed dams (controls), the offspring of 20% calorie 
restricted dams during the first part of pregnancy (CR), and CR rats sup-
plemented with physiological doses of leptin throughout lactation (CR-
Leptin). Animals were sacrificed on postnatal day 25 and PBMCs were 
isolated. Whole genome microarray analysis was performed in PBMCs 
from male rats. 
Results: 224 known genes were differentially expressed between control 
and CR animals (p≤0.01). Leptin treatment in CR males normalised the 
expression of 218 of these genes to control levels; 22 of them were fully re-
versed (p≤0.01). Of these 22 genes, q-PCR analyses in PBMCs from males 
and females revealed Crmp1, Gla, Gls, Lrp11, Paox, Tmsb4x and Ubash3b 
as particularly interesting, because increased expression levels found in 
CR pups were totally reverted by leptin treatment in both genders. 
Conclusion: Leptin supplementation throughout lactation is able to re-
vert most of the transcript-based potential early biomarkers identified in 
PBMCs associated to undernutrition during pregnancy. These markers 
may be useful for early identification and subsequent monitoring of indi-
viduals who are at risk of later diseases and would specifically benefit with 
the intake of appropriate amounts of leptin during lactation.
Acknowledgement: The research leading to these results was supported by the 
Spanish Government (grant AGL2012-33692), the European Union’s Seventh 
Framework Programme FP72007-2013 under grant agreement n. 244995 (BIO-
CLAIMS Project), and the Instituto de Salud Carlos III, Centro de Investigación 
Biomédica en Red Fisiopatología de la Obesidad y Nutrición, CIBERobn.
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Association of excessive gestational weight gain, using the 
iom criteria, with adiposity of their offspring: Systematic 
review 
Perez-Morales M.E.1, Bacardi-Gascon M.2, Jimenez-Cruz A.2
1Facultad de Ciencias Químicas e Ingeniería, Universidad Autónoma de Baja 
California, Tijuana B.C., México.,  
2Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, 
Tijuana, B.C., México.
Introduction: Excessive gestational weight gain (GWG) during pregnan-
cy is associated with an increase in adiposity indicators and metabolic 
disorders of the offspring. The objective of this review was to analyze the 
association of excessive GWG in prospective studies, using the Institute 
of Medicine (IOM) criteria, with the adiposity indicators and metabolic 
diseases of their offspring. 
Methods: An electronic search was conducted in the MEDLINE/PubMed, 
EMBASE, and CINAHL databases from January 2004 to September 2014. 
Selection was restricted to prospective studies, using IOM criteria as defi-
nition of GWG. In total 1312 potential related studies were identified. 
After screening, 126 full papers were reviewed, and five papers met the 
inclusion criteria. 
Results: The offspring age at assessing time ranged from 5 to 21 years. 
Only one study conducted in 21yo showed an association between ex-
cessive GWG with obesity and metabolic diseases of their offspring; one 
including 2 to 20yo, showed an association with child overweight; one at 
nine years of age show that greater GWG was associated with greater ad-
iposity and adverse cardiovascular risk factors; one study of 5yo children 
showed an association of excessive GWG with an increase in child BMI 
Z-score among normal and overweight mothers, and one study of 5yo 
children showed an association between excessive GWG with overweight 
in non-overweight mothers. 
Conclusions: All studies among normal weight mothers consistently 
showed an association of excessive GWG with adiposity indicators or 
other components of the metabolic syndrome early in life, during ado-
lescence or adulthood. However, due to the age range of those studies it 
is warranted more long term studies that confirm this association among 
adult offspring.
T5:PO.011
Maternal intake of a cafeteria diet during lactation in rats leads 
to a thin-outside-fat-inside (tofi) phenotype in the offsping 
Pomar C.A.1, Van Nes R.1,2, Sánchez J.1, Picó C.1, Keijer J.2, Palou A.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), 
University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y 
Nutrición (CIBEROBN), Palma de Mallorca, Spain,  
2Human and Animal Physiology, Wageningen University, Wageningen, The 
Netherlands
Introduction: We aimed to assess, in rats, the influence of maternal intake 
of a cafeteria diet during lactation on the lasting metabolic effects in their 
offspring. 
Methods: Dams were fed with a standard chow (control) diet or a cafeteria 
diet throughout lactation. After weaning, the offspring were fed with con-
trol diet until the age of 15 weeks and body weight was followed. Circulating 
triglycerides (TG) and free fatty acids (NEFA) were measured under ad libi-
tum feeding and 14h fasting conditions at weaning and at 13 weeks of age. 
At this latter age, an oral glucose tolerance test (OGTT) was also performed. 
Results: Maternal cafeteria diet feeding during lactation resulted in a low-
er body weight of their offspring (both in males and females), which was 
already significant at the age of 6 days and was persistent when animals 
were growing (until the age of 8 weeks in males and 15 weeks in females). 
Notably, despite the lower body weight, the offspring of cafeteria diet fed 
dams showed greater fat accumulation than controls at both ages studied. 
They also displayed, at weaning, higher circulating TG levels, both un-
der feeding and fasting conditions, and higher circulating levels of NEFA 
under feeding conditions. At 13 weeks, the hypertriglyceridemia was still 
present in males, and circulating NEFA levels remained higher in females. 
Moreover, offspring of cafeteria diet fed dams presented an altered glyce-
mic response to an OGTT. 
Conclusion: The intake of a cafeteria diet during lactation in rats pro-
duces permanent consequences in the metabolic health of their offspring, 
which are associated with greater fat accumulation, without higher body 
weight: the so-called thin-outside-fat-inside (TOFI) phenotype.
Acknowledgement: This work was supported by the Spanish Government 
(AGL2012-33692), and the Instituto de Salud Carlos III, Centro de Investigación 
Biomédica en Red Fisiopatología de la Obesidad y Nutrición, CIBERobn
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Leptin intake in suckling rats restores altered t3 levels and 
markers of adipose tissue sympathetic drive and function 
caused by gestational calorie restriction 
Konieczna J.1, Palou M.1, Sánchez J.1, Picó C.1, Palou A.1
1Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), 
University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y 
Nutrición (CIBEROBN), Palma de Mallorca, Spain
Introduction: Maternal calorie restriction during gestation in rats has 
been associated with altered white adipose tissue (WAT) sympathetic in-
nervation and function in offspring. Here, we aimed to investigate wheth-
er supplementation with oral leptin (a breastmilk component) throughout 
lactation may revert the aforementioned adverse programming effects. 
Methods: Three groups of male and female rats were studied at postna-
tal day 25: the offspring of control dams, the offspring of 20% calorie-re-
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physiological doses of leptin throughout lactation (CR-Leptin). Tyrosine 
hydroxylase (TH) levels and its immunoreactive area, and mRNA expres-
sion levels of lipid metabolism-related genes and of deiodinase iodothy-
ronine type II (Dio2) were determined in WAT. Triiodothyronine (T3) 
levels were determined in blood. 
Results: In CR males, leptin treatment restored the decreased TH levels 
and its immunoreactive area in WAT, and partially normalized expression 
levels of genes related to lipolysis and fatty acid oxidation (adipose tri-
glyceride lipase, hormone-sensitive lipase, carnitine palmitoyltransferase 
1b, and peroxisome proliferator-activated receptor gamma coactivator 
1-alpha). Leptin treatment also reverted the decreased T3 plasma levels 
and WAT lipoprotein lipase mRNA levels occurring in CR males and fe-
males, and the decreased Dio2 mRNA levels in CR females. 
Conclusions: Leptin supplementation throughout lactation reverts the 
malprogrammed effects on WAT structure and function induced by un-
dernutrition during pregnancy. These findings support the relevance of 
the intake of leptin during lactation, bearing clear characteristics of es-
sential nutrient, and provide a strategy to treat and/or prevent the pro-
grammed trend to obesity acquired by inadequate fetal nutrition.
Acknowledgement: This work was supported by the Spanish Government (grant 
AGL2012-33692), a grant from Fundación Ramón Areces (XVI Concurso Nacio-
nal), the European Union’s Seventh Framework Programme FP72007-2013 under 
grant agreement n. 244995 (BIOCLAIMS Project), and the Instituto de Salud Carlos 
III, Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nu-
trición, CIBERobn
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Maternal obesity during pregnancy affects offspring telomere 
lenght at birth and in later life 
Guzzardi M.A.1, Salonen M.2, Eriksson J.G.3, Iozzo P.1
1Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy,  
2National Institute for Health and Welfare, Helsinki, Finland,  
3University of Helsinki, Helsinki, Finland
Introduction: We have shown that maternal obesity is associated with 
cardio-metabolic diseases in the adult offspring [1]. Overflow of nutrients 
and inflammatory molecules through the placenta during foetal develop-
ment has been suggested as a causal mechanism. We aimed to investigate 
the association between maternal pregnancy body mass index and off-
spring early ageing by the assessment of their telomere length (TL) at birth 
and in adult life. 
Methods: Leukocyte TL was measured in 80 newborn offspring (maternal 
BMI range 18.5–41.0 kg/m2), and in a cohort of 1082 subjects aged 67–79 
years (maternal BMI range 18.6–38.7 kg/m2). All subjects underwent an-
thropometric, metabolic and inflammatory characterization. Information 
on general health and diseases were collected. 
Results: Overweight/obese mothers with high pregnancy weight gain 
gave birth to offspring with shorter TL at birth compared with offspring 
born to mothers in whom only BMI (p = 0.02) or weight gain (p = 0.03) 
was high. Increased maternal inflammatory TNF-alpha (p = 0.07) and 
MCP-1 (p = 0.03) levels were detected in the group with shorter off-
spring TL. In the adult cohort, a negative correlation was observed be-
tween maternal pregnancy BMI and TL in the female offspring (p = 0.04). 
Moreover, in the adult population short TL was a marker of worse health 
conditions (p < 0.05), type 2 diabetes (p = 0.04), history of myocardial in-
farction (p = 0.02), angina pectoris (p = 0.03), and high waist circumfer-
ence (p = 0.004) and weight (p = 0.001). 
Conclusion: We conclude that high BMI and excessive weight gain during 
pregnancy are associated with an increased inflammatory state and short-
er offspring TL at birth extending into late adulthood, when short TL re-
lates to metabolic and cardiovascular disease. 
Acknowledgement: Research relating to this abstract was funded by the EU-FP7-
HEALTH DORIAN project (Grant Agreement #278603)
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Obesity predisposition in rats caused by maternal dietary 
obesity is avoidable by normalizing the diet before mating 
Castro H.1, Sánchez J.1, Picó C.1, Palou A.1
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University of the Balearic Islands and CIBER Fisiopatología de la Obesidad y 
Nutrición (CIBEROBN), Palma de Mallorca, Spain.
Introduction: Maternal obesity during pregnancy and lactation predis-
poses offspring to obesity and other metabolic disorders in adulthood. 
Here we studied in rats whether the expected detrimental effects in the 
offspring associated to maternal dietary obesity may be reverted by the 
removal of the obesogenic diet before mating. 
Methods: Female rats were fed a cafeteria diet (CD) from days 10 to 100 of 
life and then a standard diet (SD) (postcafeteria dams). A parallel control 
group of female rats fed with SD were included. One month after remov-
al of CD, female from control and postcafeteria groups were mated with 
males. At weaning, offspring of control and postcafeteria dams were fed 
with SD until 4-months of age, and then with SD or western diet (WD) 
until 6-months of age. 
Results: Rats fed on a CD had higher body weight and body fat content 
than controls. The removal of the CD produced a reduction in body 
weight and body fat content, although both parameters remained 8% and 
13% higher, respectively, in postcafeteria dams than in controls at mating. 
During lactation, no differences were observed between both groups con-
cerning body weight; however, postcafeteria dams showed higher body fat 
content and higher leptin levels in serum and milk than controls. Notably, 
from the 9th week of life onwards, offspring of postcafeteria dams dis-
played lower body weight than controls; they also showed a lesser increase 
in body weight and body fat content than offspring of control dams after 
2-months exposure to a WD. 
Conclusion: Removal of CD in obese rats before gestation, although with-
out complete reversion of body weight excess, may prevent the detrimen-
tal effects in the offspring associated to maternal obesity. Moreover, it is 
suggested that the greater protection of the offspring of postcafeteria dams 
against fat accumulation in adulthood, particularly when exposed to an 
obesogenic diet, might be related to the intake of greater amounts of leptin 
during the suckling period.
Acknowledgement: This work was supported by the Spanish Government 
(AGL2012-33692), and the Instituto de Salud Carlos III, Centro de Investigación 
Biomédica en Red Fisiopatología de la Obesidad y Nutrición, CIBEROBN.
T5:PO.015
Maternal consumption of High Esterified Pectins during 
pregnancy and lactation and protection from obesity and 
related disorders in the offspring 
Rodríguez A.M.1,2, García-Carrizo F.1,2, Palou A.1,2
1CIBER Fisiopatología de la Obesidad y Nutrición,  
2Laboratory of Molecular Biology, Nutrition and Biotechnology (University of 
the Balearic Islands), Palma de Mallorca, Spain
Prebiotics can modulate the composition of gut microbiota of progeny. 
We aimed to study the offspring effects of supplementation of rat dams 
with high esterified pectins (HEP), during the second half of pregnan-
cy and throughout lactation, studying protection effects against obesity. 
Dams were fed with normal or 5% HEP supplemented diet from day 12 
of pregnancy until the end of lactation. At day 25, weight and adiposity 
(by Echo MRI) of male and female progeny of control or pectin supple-
mented dams (offspring: C and P respectively) were measured; after sacri-
fice, tissue samples were collected. Blood levels of insulin, leptin, glucose, 
irisin and FGF21 were measured. Immunohistochemistry analysis of the 
brown adipocyte marker UCP1 was performed in inguinal white adipose 
tissue (iWAT). At 4 months, half of animals of each group were fed an 
obesogenic Western Diet (WD). Biometrical parameters were followed. At 
6 months, general blood parameters were measured under fed and fasted 
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irisin blood levels; FGF21 levels tended to decrease in P males and to in-
crease in P females. We observed multilocular adipocytes and UCP1 pos-
itive cells in iWAT in P males and females. At 6 months, both P males and 
females showed lower body weight under chow diet, but only P females 
showed decreased fat mass under WD and tended to show lower cumu-
lative calorie intake, and significantly lower fasting plasma triglycerides. 
Our results suggest a protective role of mother HEP supplementation 
during pregnancy and lactation against obesity related disorders, especial-
ly in female offspring, and a possible WAT browning effect in both sexes. 
Also, this model may be suitable for the validation of early biomarkers of 
metabolic robustness.
Acknowledgement: This work was supported by the Spanish Government (proj-
ect BIOBESMARKERS, AGL2009-11277) and the European Commission (project 
BIOCLAIMS, FP7-244995). The CIBER Fisiopatología de la obesidad y nutrición is 
an initiative of the ISCIII.
T5:PO.016
Structural changes on bone a in male rat offspring depending 
on maternal diet
Perić Kačarević Ž.1, Šnajder D.2, Marić A.1,3, Bijelić N.4, Radić R.1, Selthofer R.1
1Department of Anatomy and Neuroscience, Faculty of Medicine, University of 
Osijek, Osijek, Croatia,  
2Clinical Institute of Nuclear Medicine and Radiation Protection, University 
Hospital Osijek, Osijek, Croatia,  
3Department of Physical Medicine and Rehabilitation, University Hospital 
Osijek, Osijek, Croatia,  
4Department of Histology and Embryology, Faculty of Medicine, University of 
Osijek, Osijek, Croatia
Introduction: Obesity as an epidemic problem induces many diseases 
including the metabolic syndrome. It causes low-grade systemic inflam-
mation, which can also affect bone architecture. Proinflammatory cyto-
kines are key mediators in osteoclast differentiation and bone resorption 
through the RANKL/RANK/OPG pathway. In our study we compared 
bone microstructure and TNF-α bone expression in animal subjects in 
dependence to diet exposed to in utero, during and after lactation. 
Methods: Ten female Sprague Dawley rats, nine weeks old, were ran-
domly divided in two groups and fed either a control diet or food rich in 
saturated fatty acids during five weeks, and then mated with genetically 
similar male subjects. After birth and lactation male offspring rats from 
both groups were randomly divided in four groups depending on the diet 
they were fed until twenty-two weeks of age. Body weight throughout the 
experiment was measured and body mass index was calculated, total cho-
lesterol, triglyceride level, IL-6 and TNF-α in serum were measured. Bone 
microstructure was analyzed in fifth lumbar vertebra (n=24) using digital 
photographic images. TNF-α expression was measured in bone samples 
using immunohistochemistry. 
Results: The offspring of healthy female rats fed with high content of sat-
urated fatty acid food had the highest serum concentrations of the IL-6 
(157.39 ± 48.38 pg/ml) and TNF-α (63.49 ± 3.43 pg/ml) and also the 
highest intensity of the TNF-α immunohistochemical staining in the bone 
marrow. The same group had the lowest values of trabecular bone volume 
and trabecular number, but the highest values of trabecular separation. 
Conclusion: Such result suggests that saturated fatty acid food stimulates 
TNF-α expression in the bone marrow, which contributes to deterioration 
of the bone mass and bone structure in rat’s offspring.
T5:PO.017
Changes in nutrition type between generations influence on 
bone structural changes in female offspring
Marić A.1,2, Perić Kačarević Ž.1, Vrselja Z.1,3, Radić R.1
1Department of Anatomy and Neuroscience, Faculty of Medicine, University of 
Osijek, Osijek, Croatia,  
2Department of Physical Medicine and Rehabilitation, University Hospital 
Osijek, Osijek, Croatia,  
3Department of Radiology, University Hospital Osijek, Osijek, Croatia
Introduction: It is believed that changes in feeding protocol between gen-
erations have influence on the balance of the whole organism. Epidemio-
logical studies suggest that skeletal growth is programmed during intra-
uterine and early postnatal life. The aim of the study was to determinate 
impact of maternal dietary fat excess and nutrition of female offspring on 
the bone structural changes. 
Methods: Ten female Sprague Dawley rats were randomly divided in two 
groups. One group was fed with high content of saturated fatty acid food 
(HFD) and the other one with standard laboratory chow (CD). Offspring 
from both groups were randomly divided in two subgroups after cou-
pling and lactation period, subsequently there were four groups of off-
spring (n=6 each) with different feeding protocol: a) CD-CD – control 
diet mothers and offspring, b) CD-HFD – control diet mothers and high 
fat diet offspring, c) HFD-CD – high fat diet mothers and control diet 
offspring and d) HFD-HFD – high fat diet mothers and offspring. At the 
age of 18 weeks in female offspring bone microstructure was analyzed in 
fifth lumbar vertebra using digital photographic images. 
Results: The control diet female offspring of high fat fed mothers showed 
the highest values of trabecular thickness and trabecular number, while 
the CD-HFD offspring group had the highest values of trabecular separa-
tion and cortical thickness. 
Conclusion: Maternal nutritional status affects the future bone develop-
ment of female offspring.
T5 – Early feeding practices and nutrition
T5:PO.018
Infant eating behaviours- impact of age, maternal BMI and 
country 
Shloim N.1, Rudolf M.2, Feltbower R.3, Mohebati L.4, Hetherington M.1
1Institute of Psychological Sciences, University of Leeds, Leeds LS2 9JT, UK,  
2Faculty of Medicine in the Galil, Bar Ilan University, Safed, Israel,  
3Division of Epidemiology and Biostatistics,, School of Medicine, University of 
Leeds, Leeds LS2 9JT, UK,  
4Brigton and Sussex Medical School, Brighton, East Sussex, BN1 9PX.
Introduction: Rapid weight gain in infancy is positively associated with 
the development of later obesity. The present study aimed to address ma-
ternal perception of babies eating behaviours. Specific objectives were if 
mothers’ perceptions of their babies eating vary according to babies’ age, 
country and BMI. As mother’s well-being and satisfaction with body affect 
their own eating behaviours, this study explored if such associations affect 
mothers’ perceptions of babies’ eating. 
Methods: 73 women and babies from Israel and the UK participated in a 
two years follow-up study. Data were collected every six months. Women 
filled out questionnaires assessing eating/ feeding behaviours, maternal 
wellbeing and satisfaction with body. Regression modelling was used to 
account for change and to assess the independent impact of BMI on out-
comes. 
Results: Healthy-weight mothers were more aware of their infant’s satiety 
cues whereas overweight and obese mothers were more likely to feed ac-
cording to a schedule. UK mothers were more concerned for their babies 
hunger than Israeli counterparts. Mothers with high levels of self-esteem 
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fied with their body were more concerned for their baby being overweight 
or overeating. 
Conclusion: Strong associations were identified between maternal psy-
chological characteristics (including eating behaviours) and babies’ eating 
behaviours.
T5:PO.019
Prevalence of overweight and obesity and growth patterns in 
czech breastfed children 
Paulová M.1, Vignerová J.1, Shriver L.2, Riedlová J.3
1Department of Children and Adolescents, National Institute of Public Health, 
100 42 Prague 10, Czech Republic,  
2Department of Nutrition, University of North Carolina Greensboro, NC, 27412, 
USA,  
3Department of Anatomy, 3rd Faculty of Medicine, Charles University, 100 00 
Prague 10, Czech Republic
Introduction: Breastfeeding is considered to be one of the fundamental 
factors in children‘s obesity prevention. Because growth references are 
important for children’s weight and nutritional status assessment, under-
standing potential practical consequences when using available tools is 
critical. Material and methods: In the Czech Republic, longitudinal data 
from a total sample of more than 1700 breastfed children aged 0 - 18 
months were collected to assess prevalence of overweight and obesity. 
To compare a growth pattern of Czech breastfed children with the cur-
rent WHO growth standards (2006) as well as with the Czech references 
(1991,2001) the sample of 960 Czech breastfed children was subsequently 
selected using the same criteria as in the WHO MGRS study. 
Results: The prevalence of overweight and obesity in the sample of Czech 
breastfed children was significantly lower compared to the reference pop-
ulation. This difference was statistically significant at the age of 6 months 
and the number of obese and overweight breastfed children further de-
creased with age. Thus only 0,7% children fed according to the WHO rec-
ommendation (i.e. exclusively breastfed for 6 months) were diagnosed as 
obese at 18 months. Czech breastfed infants were longer with a greater 
head circumference at all percentiles compared to WHO standards and 
were similar to national references. The percentile weight-for-age and 
weight-for-length values of Czech breastfed infants differed from both the 
WHO standards as well as the national references. The differences com-
pared to the current Czech references were smaller than differences com-
pared to the WHO standards.
T5:PO.020
Determinants of weight gain during the first two years of life - 
the gecko drenthe birth cohort 
Küpers L.K.1, L‘Abée C.1,2, Bocca G.2, Stolk R.P.1, Sauer P.J.2, Corpeleijn E.1
1Department of Epidemiology, University Medical Center Groningen, University 
of Groningen, the Netherlands,  
2Department of Pediatrics, Beatrix Children’s Hospital, University Medical Center 
Groningen, University of Groningen, the Netherlands
Background: Rapid weight gain in infancy is known to be related to 
childhood obesity. It is not clear exactly which period in infancy is most 
important for the development of overweight. To explain weight gain in 
the first two years of life, the predictive values of individual factors were 
compared within four different domains: prenatal, nutrition, lifestyle and 
socioeconomic factors. 
Methods: In a Dutch population-based birth cohort, length and weight 
were measured in 2475 infants at 1,6, 12 and 24 months. Determinants 
were retrieved from medical files and parental questionnaires. Factors 
were compared with linear regression to best explain differences in weight 
gain, defined as changes in Z-score of weight-for-age and weight-for-
length over 1–6, 6–12 and 12–24 months. 
Results: Birth weight (prenatal domain) and type of feeding (nutrition-
al domain) were most importantly related to weight gain in the first six 
months, see Figures 1–4. From six months onwards, the ability to explain 
differences in weight gain decreased substantially (from R2total=38.7% to 
R2total<7%). Breastfeeding vs. formula feeding showed distinct growth 
patterns in the first six months, but not thereafter. We found two categories 
of predictors. First, those related to Z-score deviations, e.g. paternal BMI. 
Second, those that predict baseline risk for future overweight and have a 
permanent effect on Z-scores, e.g. maternal BMI. 
Conclusion: The prenatal and nutrition domain were most important to 
predict weight gain, mainly in the first six months of life. After these first 
six months other yet undetermined factors start to play a role.
Fig. 1. Mean weight-for-age Z-scores for birth weight over time.
Fig. 2. Mean weight-for-length Z-scores for birth weight over time.
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Fig. 4. Mean weight-for-length Z-scores for type of feeding over time.
T5:PO.021
Associations between pickiness, conflicts around mealtime 
and weight development among children age 2–6 years; 
results from the „healthy start“ study 
Rohde J.F.1,5, Stougaard M.1, Händel M.N.1,2, Olsen N.J.1, Mortensen E.L.3, 
Heitmann B.L.1,4,5
1Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The 
Capital Region, Copenhagen, Denmark,  
2Institute of Clinical Research, Odense Patient Explorative Network, University of 
Southern Denmark,  
3Department of Public Health and Center for Healthy Aging, University of 
Copenhagen, Copenhagen, Denmark,  
4The Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders, 
University of Sydney, Australia,  
5National Institute of Public health, University of Southern Denmark, 
Copenhagen, Denmark
Introduction: Problematic eating behaviours, such as rejecting certain 
food items, are sources of concerns for parents. Especially pickiness which 
may lead to malnutrition and if prolonged influence the child’s growth. 
The objective of the present study was to examine if conflicts around 
mealtime were associated with pickiness, and furthermore, if pickiness or 
conflicts around mealtime were associated with weight development over 
1˝ year. 
Methods: Information was obtained from the randomized intervention 
study “Healthy Start” and included 509 children from 2–6 years. Logis-
tic regression was used to examine the association between pickiness and 
conflicts adjusted for potential confounders. Among the control children 
(n=198), linear regression was used to examine if pickiness or family con-
flicts at baseline were associated with BMI at baseline and after 1˝ year 
follow-up. 
Results: Analyses showed a strong association between pickiness and con-
flicts (OR:3.15, p < 0.001) also after adjustment for possible confounders 
(OR:3.55, p < 0.01). There were no significant differences in mean BMI be-
tween picky and not picky children, at baseline (p = 0.64) or after 1˝ year 
follow-up (p = 0.48). A direct association was seen between conflicts at 
mealtime and BMI at baseline, after adjusting for parental BMI (p < 0.01). 
No association were seen after follow-up (p = 0.18). 
Conclusion: Our results suggest that conflicts around mealtime and pick-
iness are highly related. Moreover, conflicted meals seemed to be related to 
lower BMI, whereas neither pickiness nor conflicted meals seemed related 
to development in BMI over 1˝ year follow-up period.
Acknowledgement: Conflict of Interest: The authors declare not having any conflict 
of interest. Funding: The Danish Heart Foundation, TrygFonden, Danish Medical 
Council and The Health Foundation.
T5 – Healthy development
T5:PO.022
BMI in 1˝ year old children in relation to parental BMI: A cross-
sectional study 
Lindkvist M.1,2, Ivarsson A.1, Silfverdal S.A.3, Eurenius E.1
1Department of Public Health and Clinical Medicine, Epidemiology and Global 
Health, Umeĺ University, SE 901 87 Umeĺ, Sweden,  
2Department of Statistics, Umeĺ School of Business and Economics, Umeĺ 
University, SE 901 87 Umeĺ, Sweden,  
3Department of Clinical Science, Paediatrics, Umeĺ University, SE 901 87, Umeĺ, 
Sweden
Background: Overweight and obesity is accelerating throughout the 
world; a threat to population health and longevity. Healthy BMI and life-
style need to be established early in life. In this study we aimed to deter-
mine BMI of 1˝-year-olds in relation to parental BMI. 
Methods: Parents’ of 697 1˝-year-olds completed a questionnaire on pa-
rental and child health. For this study data on parental weight and height 
and socio-demographics were used, as well as child weight and height 
measured at an ordinary visit in child health care. We used thresholds 
for children’s BMI recommended for surveillance by the Royal College of 
Paediatrics and Child Health (RCPCH) in 2012, based on the WHO Child 
Growth standards derived from an international sample. 
Results: Among 1˝-year-olds BMI was above the 85th percentile for 33%, 
and above the 95th percentile for 14%. Thus, these Swedish children of 
today had a considerably higher BMI than children in the reference pop-
ulation already at this early age. The probability of a child having a BMI 
above the 95th percentile was significantly increased if either the mother 
or father was overweight. Furthermore, we found a positive synergy effect 
between the mother and father being overweight and the child having a 
BMI above the 85th percentile. Overall, our findings seem largely valid for 
the whole country, except for country of origin, and can therefore proba-
bly be generalised outside the study area with less immigrants. 
Conclusion: Overweight is common already at 1˝ year of age in this pop-
ulation. The risk increases if one parent is overweight, and even more if 
both parents are overweight. Health promotion activities early in life need 
to be strengthened.
Acknowledgement: Thanks to all personnel involved in the data collection, parents 
and children participating and the Salut team. Financial support for participation 
in this conference was gratefully acknowledged from the Research Unit of the De-
partment of Medicine-Geriatrics at Skellefteĺ Hospital. The study was undertaken 
within the FAS Centre for Global Health Research at the Medical Faculty of Umeĺ 
University.
T5:PO.023
Strain-specific difference in maturation of amp-activated 
protein kinase in murine skeletal muscle during early 
postnatal development 
Hansikova J.1, Janovska P.1, Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic
Introduction: AMP-activated protein kinase (AMPK) is engaged in con-
trol of energy metabolism. Little is known about changes in AMPK sub-
units expression and AMPK activity in skeletal muscle during the early 
postnatal development, between birth and weaning. The aims of the study 
were to characterize the activity of AMPKα1 and AMPKα2 isoforms and 
gene expression of these subunits in skeletal muscle while comparing obe-
sity-prone C57BL/6 (B/6) and obesity-resistant A/J mice. 
Methods: Male (M) and female (F) pups of the B/6 and A/J mice were 
born and maintained at 30°C. Gastrocnemius muscle was collected by 
freeze-clamping and AMPK activity was determined using AMARA pep-




















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts198
Results: The activity of AMPKα1 at 10 days (D) was significantly higher 
in comparison with the AMPKα2 activity in all tested groups. Between 
10D and 28D, the AMPKα1 activity decreased in mice of both strains ex-
cept for A/J F. In A/J mice at 28D, activity of AMPKα2 was higher than 
that of AMPKα1. Total activity of AMPK (α1+α2) in B/6 mice decreased 
significantly between 10D and 28D but it stayed constant in A/J mice. Ex-
pression of AMPKα1 gene was constant in both A/J and B/6 mice between 
10D and 28D. Expression of AMPKα2 gene increased between 5D and 
28D in both strains. 
Conclusion: During early postnatal development strain-specific chang-
es in AMPK activity in murine skeletal muscle were observed. While in 
the obesity-resistant A/J mice the activity stayed constant, it declined in 
the obesity-prone B/6 mice. Changes in AMPK activity in skeletal muscle 
during early postnatal development may affect propensity to obesity in 
adulthood, depending on the genetic background of the mice.
T5:PO.024
Plasma acylcarnitines levels as an early complex biomarker of 
propensity to high fat diet-induced obesity 
Horakova O.1, Hansikova J.1, Bardova K.1, Kuda O.1, Rossmeisl M.1, 
Kopecky J.1
1Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic
Introduction: Induction of obesity by high-fat diet (HFD) in mice is 
associated with development of impaired glucose tolerance and dyslip-
idemia, i.e. characteristic features of metabolic syndrome in humans. 
Various inbred strains of mice vary in their propensity to HFD-induced 
obesity. Moreover, individual mice differ substantially in their responses 
to the obesogenic environment, resulting in large variations in their body 
weight gain, glycemic control, and plasma lipid profiles in spite of identi-
cal genetic background. Well characterized C57BL/6J (B6) mice represent 
a suitable model for studying the mechanisms underlying propensity to 
obesity and insulin resistance. 
Methods: We have explored a possibility to use complex changes in plas-
ma metabolome, namely in the acylcarnitine levels, as a biomarker of 
propensity to dietary obesity and associated disorders. B6 mice (n=200) 
were fed since 3 months of age either HFD or standard Chow, and plas-
ma samples and physiological data were collected at 2, 4, 12, 22, 24 weeks 
of age. Spearman pairwise correlations between plasma metabolite levels 
and various physiologic parameters were performed with respect to age, 
gender and feeding status. 
Results: It was found that C6 and C18:1 plasma acylcarnitine levels at 4 
weeks of age positively correlated with body weight at 24 weeks of age 
independently of gender. The links between circulating acylcarnitines at 
young age and glucose homeostasis in the adult animals are being further 
analyzed. 
Conclusion: Our results document that plasma acylcarnitines levels could 
serve as biomarkers of propensity to obesity and possibly as a complex 
biomarker of obesity-associated metabolic disorders.
T5:PO.025
Longitudinal study of intracellular water and growth in 
children aged 8–11 years 
Zafiropulos V.1, Chatzi V.1, Giagkidis G.1, Moudanos K.1, 
Dimitropoulakis P.1, Markaki A.1, Fthenakis Z.G.1, Fragkiadakis G.A.1
1Department of Nutrition & Dietetics, Technological Educational Institute of 
Crete (TEI of Crete), 723 00 Sitia, Greece
Introduction: Accurate determination of body hydration is of great im-
portance considering its contribution in health issues1.Likewise, high ad-
iposity associated with childhood obesity, may increase the risk of adult 
diseases2.These constitute reasons why evaluation of body measurements 
are necessary during all stages of growth. 
Objective: The aim was to assess the variations in growth and body com-
position in 8–11 year-old children. 
Methods: In the context of an interventional project (presented in anoth-
er abstract) body composition assessment (percent body fat %BF, percent 
intracellular water %ICW using BIS) and anthropometric measurements 
(weight, height, SKF) were performed in a sample of 589 school children 
before and after the intervention, lasted from February to June 2014. 
Results: The increase of height over time differed with gender and age and 
was higher in female than male (0.060 versus 0.052 m/y with statistically 
significant difference P = 0.001), especially within 9–11 years. Also, girls 
had significantly higher %BF and %ICW than boys both at baseline and at 
the end of the intervention. %ICW was negatively correlated with %BF as 
expected. Initial %ICW was also negatively correlated with the change of 
%ICW (between the two measurements). The difference of %BF between 
the two measurements was negatively linked to the respective difference 
of %ICF. 
Conclusions: This study indicated the close relationship between %ICW 
and %BF, both of which are markers of growth. Based on these markers, 
School-aged girls were found closer in the adolescent age phase, compared 
to boys. References 1. Ellis KJ, Shypailo RJ, Wong WW. Am J Clin Nutr, 
1999;70:847–53. 2. Day RS, Fulton JE, Dai S, Mihalopoulos NL, Barradas 
DT. Am J Prev Med 2009;37(1S):S25-S33.
Acknowledgement: The current project is implemented through the Operational 
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nanced by the European Union (European Social Fund) and Greek national funds 
(National Strategic Reference Framework 2007 - 2013). We thank the teachers of 
participating schools, as well as Dr. Rousakis and Mr. Klinakis for their valuable help.
T5 – Education/Schools
T5:PO.026
Web-based interactive material for dietary intervention 
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Thalassinos N.1, Chatzi V.1, Kalamari A.1, Markaki A.1, Dimitropoulakis P.1, 
Mavrikakis I.1, Manios Y.2, Kafatos A.3, Fragkiadakis G.A.1, Zafiropulos V.1
1Department of Nutrition & Dietetics, Technological Educational Institute of 
Crete (TEI of Crete),  
723 00 Sitia, Greece,  
2Department of Dietetics & Nutritional Science, Harokopio University, Kallithea, 
Greece,  
3Preventive Medicine and Nutrition Clinic, Department of Social Medicine, 
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Introduction: Primary prevention of obesity in elementary schools can 
be applied by developing and introducing modern computer/information 
applications. The Project „Evaluation of a Web-based Dietary Intervention 
among primary school children“, also aims to develop digital-interactive 
material for dietary interventions. Objective: The aim was to establish and 
validate a public digital-interactive site for dietary intervention in elemen-
tary schools, focusing in fruit and vegetable consumption. 
Methods: An HTML and CSS based website, providing presentations and 
games concerning nutrition, through PowerPoint, VISUAL BASIC pro-
gramming and Flash, was designed and utilized for nutritional interven-
tion in a number of primary schools. 
Results: In the web-based approach developed, the students attend mul-
timedia presentations on nutrition and play respective interactive games, 
assisted by their teachers. The designed website is divided in two main 
sections; the first provides guidance for parents and teachers, while the 
second includes the digital presentations and interactive games, combin-
ing thus information and practice. To become children-friendly, the mul-
timedia design utilizes vitamin super-heroes, animations, voices, funny 
sounds, and short tales with options for the children to choose correctly 
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Conclusions: The developed educational material concerning dietary in-
tervention in children is of public domain and may be used freely in Greek 
schools to prevent obesity.
Acknowledgement: We would like to thank the teachers and the directors of 
schools whose children participated to the survey. The current project is implement-
ed through the Operational Program „Education and Lifelong Learning“ action Ar-
chimedes III and is co-financed by the European Union (European Social Fund) and 
Greek national funds (National Strategic Reference Framework 2007–2013).
T5 – Childhood and adolescence
T5:PO.027
Development of the Child Three Factor Eating Questionnaire 
Bryant E.J.1, Marshall V.1, Shafiq I.1, Ayaz-Shah A.1, Jozwiak P.1, Gately P.2
1Division of Psychology, University of Bradford, UK,  
2MoreLife, Leeds Beckett University, UK
Introduction: The revised TFEQ 21 item questionnaire (TFEQr21: 
Cappelleri et al, 2009) is a more psychometrically robust version of the 
original TFEQ. The TFEQr21 measures Cognitive Restraint (CR), Uncon-
trolled Eating (UE) and Emotional Eating (EE). 
Method: 182 children (89 males, 93 females, aged 8–14 years, BMI 15.82 
– 32.36kg/m2) were recruited from schools and the MoreLife weight loss 
camp in West Yorkshire, to assess the feasibility of using the TFEQr21 in 
children. Questionnaires assessing the TFEQr21 and self-esteem were 
completed and height and weight were measured. A subsample took part 
in structured interviews to determine understanding of the TFEQr21. The 
results from the feasibility study informed the development of the child 
version of the TFEQr21 (CTFEQ). Recruitment is still underway for val-
idation of the CTFEQ. 
Results: Preliminary data suggest children below 11years do not have ad-
equate understanding of the TFRQr21. For children 11years and above, 
body weight was significantly and positively related to UE, females scored 
sig. higher on EE and a lower self-esteem was associated with higher CR 
and EE scores, particularly in females. A number of items were identi-
fied as problematic, through both item analysis and the interviews. These 
items were subsequently simplified in the development of the CTFEQ to 
aid comprehension whilst maintaining original meaning. 
Conclusion: The TFEQr21 is not accurately comprehended in children. 
A child version of the questionnaire has thus been developed and is un-
dergoing validation. The results from the feasibility study suggest that the 
factors of the TFEQ functions similarly in children compared to adults. 
This will be particularly important for assessing eating behaviour traits 
across childhood to adulthood.
T5:PO.028
Epicardial fat thickness: Threshold values and lifestyle 
correlation in male adolescents 
Cena H.1, Fonte M.L.1, Casali P.M.2, Maffoni S.1, Roggi C.1, Biino G.3
1Department of Public Health, Experimental and Forensic Medicine - Unit of 
Human Nutrition, University of Pavia, Italy,  
2Medical Sport Centre “Medica Sport Minerva”,  
3Institute of Molecular Genetics, National Research Council of Italy, Pavia, Italy
Background: Obese adolescents with high proportion of visceral fat are at 
higher risk of developing the metabolic syndrome. 
Objectives: The study aims to investigate if echocardiographic epicardial 
fat thickness (EF) could be predictive of visceral obesity (VO) early in life 
and to provide EF threshold values specific for male adolescents. Further 
aim was to investigate the association between EF, lifestyle and metabolic 
disease familiarity. 
Methods: Anthropometric data were collected from 102 normal weight 
and overweight, healthy male adolescents (mean age: 14.91 ± 1.98 years); 
bioelectrical impedance analysis and transthoracic echocardiogram were 
performed in the same sample. Each participant fulfilled a validated 
self-administered lifestyle questionnaire. 
Results: We found higher EF values in sedentary adolescents (P < 0.05), 
in those who never eat fruit and vegetables (P < 0.05), and in those with 
overweight mothers (P < 0.05). The strongest independent predictor of EF 
was waist circumference (P < 0.0001). Using the waist to height ratio as a 
marker of VO, logistic regression analysis revealed that 1 mm EF gain is 
responsible for seven times higher VO risk (P < 0.0001). Receiver Operat-
ing Characteristic (ROC) analysis showed that the optimal cut-off for EF 
thickness associated to youth VO is 3.2 mm. 
Conclusion: Ultrasonography EF measurement might be a second-level 
assessment tool, useful to detect early cardiometabolic damage stage.
T5:PO.029
Weight-loss treatment in children and adolescents: Systematic 
review and evaluation of the effect of conservative treatment 
on weight status 
Mühlig Y.1, Hebebrand J.1
1Department of Child and Adolescent Psychiatry and Psychotherapy, LVR-
Klinikum Essen, University Duisburg-Essen
Introduction: In Europe, prevalence rates for childhood obesity have pla-
teaued at a high level. Due to the elevated risk of long-lasting somatic and 
psychiatric comorbidities, effective interventions are in frequent demand. 
Weight loss treatment has been shown to be effective, yet the overall out-
come concerning weight status has not been sufficiently highlighted. The 
objectives of this review were a literature update and the deduction of 
clinical implications. 
Methods: A systematic literature research was performed for studies pub-
lished between May 2008 (terminating date of a 2009 Cochrane review) 
and December 2013 in Medline via PubMed. Studies were assessed on the 
basis of defined inclusion criteria and relevant criteria for methodological 
quality. 
Results: 48 randomized controlled trials with a total of 5025 partici-
pants were identified. With regard to eligible studies fulfilling predefined 
methodological quality criteria, weight losses between 0.05 and 0.42 BMI 
z-score within 24 months after starting treatment were reported. 41 stud-
ies included data on dropout rates before the end of the intervention. 
These were 10% or higher in 27 studies (66%) and 25% or higher in 9 
studies (22%). 
Conclusion: Based on consistent evidence, treatment seeking families 
should be informed about the limited effect of conservative obesity treat-
ment on weight status. The investigation of predictors for treatment suc-
cess and the evaluation of additional treatments focusing on coping with 
obesity warrant future research. References: Mühlig Y, Wabitsch M, Moss 
A, Hebebrand J. Weight loss in children and adolescents – a systematic 
review and evaluation of conservative, non-pharmacological obesity treat-
ment programs. Dtsch Artzebl Int 2014; 111:818–24.
Acknowledgement: This study was supported by the German Federal Ministry of 
Education and Research and was integrated within the German Competence Net-
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T5:PO.030
Experience of major life events during childhood and 
development of obesity in adulthood: A co-twin control study. 
Jindong D.1, Heitmann B.L.3, Kyle R.3, Vámosi M.2
1University of Southern Denmark, Institute of Public Health, Department of 
Nursing Science,  
2University of Aarhus, Research Unit for Dietary Studies, Bispebjerg and 
Frederiksberg Hospitals, Copenhagen  
3University and National Institute of Public Health, University of Southern 
Denmark, Denmark., 
4Institute of preventive medicine, Research Unit for Dietary Studies, Bispebjerg 
and Frederiksberg Hospitals Denmark.
Background: The etiology of adult obesity is still poorly understood, even 
if often simply attributed to too much food and too little exercise. A few 
studies have suggested that adverse psychological factors may predispose 
the development of adult obesity among normal weight children Aims 
The aim of this study was to examine if separation from parents, parental 
loss and living in a “children‘s home” during childhood could be associated 
with development of adult obesity Key 
Methods: A total of 146 complete adult twin pairs discordant for BMI 
(one had a normal BMI and the co-twin a BMI > 30 kg/m˛) were iden-
tified from the Danish Twin Registry. The twins gave an interview and a 
physical examination in 2006. The Childhood Family Relationship Ques-
tionnaire (CFRQ) was used to assess life events 
Results: Before age 17, 20.8% of the participants had been separated from 
mother, 26.1% had been separated from father for a period on average 
4.5 years during childhood. Furthermore 9.3% of the children had expe-
rienced living in children’s home and 6.8% had lost their father. There was 
a tendency that staying in a children´s home and separation from father 
was related to discordance for BMI in adulthood, whereas separation from 
mother and paternal death was related to less discordance. However, none 
of these differences were significant.
Conclusion: The present study did not demonstrate independent effects 
of major life events during childhood and development of obesity in 
adulthood
T5:PO.031
Assessment of vitamin d status in obese and nonobese turkish 
adolescents: Its relation to insulin resistance and nutritional 
status 
Sağlam D.1, Samur G.2, Turan S.3
1Health Science Faculty, Department of Nutrition and Dietetics, Acıbadem 
University, İstanbul, Turkey,  
2Health Science Faculty, Department of Nutrition and Dietetics, Hacettepe 
University, Ankara,  
3Department of Pediatric Endocrinology, Marmara University, Istanbul
Introduction: There is increasing epidemiological evidence linking sub-op-
timal vitamin D status with overweight and obesity. Although increasing 
BMI and adiposity have also been negatively associated with the change in 
vitamin D status following supplementation, results have been equivocal. 
Methods: The research was carried out with 39 obese (BKI>95.th percen-
tile) and 30 nonobese adolescents (n=69), aged between 12 and 17 years. 
The questionnaire was developed including the demographic status, nu-
tritional status and dietary habits, physical activities of adolescents, an-
thropometric measurements were taken and body composition was mea-
sured by bioelectric impedance analysis. In the third stage, biochemical 
analysis were measured. 
Results: There was no statistical differences between obese serum 25(OH)
D (16.2 ± 6.2 ng/ml) and nonobese (18.1 ± 5.9 ng/ml) serum 25(OH)D 
(p > 0.05). We sought to evaluate the prevalence of low levels of 25(OH) 
D by examining hypovitaminosis D (<30 ng/L), vitamin D sufficiency 
(>or =30 ng/L) in obesity. Serum 25(OH) D level was inversely correlat-
ed with antropometric mesurements in obese and nonobese adolescents 
(p > 0.05). While there was no significant difference between serum 
25(OH)D levels and HOMA-IR; there was a positive correlation between 
serum calcium and HOMA-IR (r=0.276 p < 0.05) independent of body 
adiposity. There was a positive correlation between serum 25(OH)D lev-
els and amount of daily dietary calcium (r=0.371) and phosphorus intake 
(r=0.438) (p < 0.05). 
Conclusion: Low vitamin D status is prevalent among adolescents. The re-
sults suggest that the importance of vitamin D fortification and increased 
dietary calcium in the Turkish diet to meet RDA requirements and avoid 
onset of vitamin D deficiency-related diseases in Turkish adolescents.
T5:PO.032
Evaluation of childhood obesity assessments in secondary 
care paediatric clinic reference: Obesity services for children 
and adolescents (osca) network group uk guidelines 
Moodambail A.R.1, Begum M.R.2
1Consultant & Honorary Senior Lecturer, Department of Paediatrics, Barts Health 
NHS Trust in London & Queen Mary University of London, UK,  
2Barts and the London Medical School, Queen Mary University of London, UK
Aim of Study: to evaluate clinical assessment of obesity in a secondary 
care paediatric set up against current OSCA Guidelines for childhood 
obesity assessments in UK. 
Method: 72 children (1–16 yrs) were primarily assessed for obesity; data 
entered on to a pro forma based upon OSCA guidelines, for analysis. 
Results: 33 patients (46%) were classified as morbidly obese, 24(33%) 
severely obese, 15(21%) obese. Evaluation showed 46% of children and 
young persons with obesity had not been assessed well and adequately. 
Clinical examination (in 85%) and investigations (in 76%) were adequate 
in majority of patients, but adequate history assessment was lacking in 
90% of patients. This would lead to non-identification of causation and 
co-morbidities, and further leading to possible lack of adequate timely 
interventions. The most common co-morbidity newly identified was Vi-
tamin D deficiency (40%). Significant co-morbidities like PCOS (36% of 
adolescent girls), Type 2 Diabetes, Impaired glucose tolerance, hyperten-
sion, dyslipidaemia and psychological distress/bullying were also newly 
identified through the assessments. Children with neurodevelopmental/
behavioural/learning difficulties were at higher risk to develop obesity. 
The clinical assessment for obesity related sleep disorders was grossly in-
adequate, and did not use recommended Paediatric Sleep Questionnaires. 
Conclusion: We suggest use of a Obesity Assessment Pro-forma in clinics 
to improve assessments in secondary care. The Study suggests pragmatic 
approach to check Vitamin D level in all, and sex hormone profile in pu-
bertal girls (to exclude PCOS) with obesity. The evaluation highlights lack 
of customised physical activity programmes; some children will benefit 
from psychology support while dealing with their weight management.
Acknowledgement: Ms J Leung, Paediatric Dietician, Department of Paediatrics, 
Barts Health NHS Trust in London, UK Mrs W Hawkins, Patient Pathway Coordi-
nator in Paediatrics, Barts Health NHS Trust
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Fig. 2. Childhood obesity Co-morbidities
T5:PO.033
Children’s BMI is strongly effected by family income at birth – 
but parental education is of major importance for the growing 
social gap up to 8 years of age 
Bramsved R.1, Regber S.2, Mehlig K.3, Novak D.1, Lissner L.3, Mĺrild S.1
1Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, 
Gothenburg University, Gothenburg, Sweden,  
2School of Health and Education, University of Skovde, Skovde, Sweden,  
3Public Health Epidemiology Unit, Department of Public Health and Community 
Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, 
Sweden
Background: The development of BMI in early childhood is dependent 
on socioeconomic factors. Our aim was to explore the impact of parental 
education level and family income for development of BMI from birth to 
8 years age. 
Methods: 3018 children born in 1998–2006 from the IDEFICS study and 
register controls were included. Weight and height measurements from 
birth up to 8 years of age were obtained from the Child Health Services. 
Parental education and family disposable income, obtained from Statistics 
Sweden and the Medical Birth Register, were defined as high/low. Obesity 
was defined by WHO references. Confounders were sex and age of the 
child, parental origin, maternal smoking and maternal BMI. 
Results: At birth, the children’s mean BMI (SD) was lower in families of 
low vs. high income (13,74 (1,35) vs. 13,94 (1,36), p < 0.0001). Results re-
mained significant after adjusting for confounders. No differences in birth 
BMI were detected between children of low and high-educated parents 
(13,87 (1,37) vs. 13,83 (1,35), p = 0.48). From 6 months onwards, chil-
dren of low-educated parents showed higher mean BMI than children 
of high-educated. At 8 years, mean BMI in the low/high educated groups 
were 17.12 (2.44) and 16.38 (1.94), p < 0.0001. Results remained signifi-
cant after adjusting for confounders. Prevalence of obesity in the low and 
high-educated groups were 11% and 4,1%, p < 0,0001. The difference in 
BMI at 8 years seen in the low/high income group disappeared after ad-
justing for confounders (17.5 vs. 17.6, p = 0,63). 
Conclusion: Impact of family socioeconomic factors on children’s BMI 
differs by income and education. The effect of parental education becomes 
more evident by age up to 8 years of age. Interventions for healthy weight 
development must start very early in life.
T5:PO.034
Preschool children, dxa fat parameters and obesity risk 
factors. 
Lateva M.1, Popova R.2, Galcheva S.1, Georgieva V.1, Iotova V.1
1Department of pediatrics and medical genetics, Medical University Varna, 
Varna, Bulgaria,  
2Department of imaging diagnostics and radiotherapy, Medical University 
Varna, Varna, Bulgaria
Introduction: Preschool age is perceived as a strategic preventive target 
regarding long-standing obesity. This study aims to evaluate the associ-
ation between preschool obesity, fat distribution and future risk factors. 
Methods: A total of 25 healthy children, aged 5.52 ± 0.61 (4.2–7 years, 36% 
boys) were investigated in 2014. Standard anthropometry (body weight, 
height and waist circumference (WC)) was performed, blood pressure 
(BP) was measured. A history and child’s behavior patterns questionnaire 
was filled by caregivers. Fat mass was estimated by DXA. Overweight and 
obesity were defined according to the IOTF references (Cole et al., 2000). 
The presence of hypertension was defined according to NHBPEP (2004) 
as a measure above 95th percentile for age, sex and height. 
Results: One third of the participants (32%) were overweight or obese, 
and 76% of all had family history of obesity. Two of the children (8.3%) 
had elevated systolic BP (SBP). The total fat tissue (%) measured by DXA 
scan correlated with BMI, WC (p < 0.001) and with SBP (p = 0.004, with 
elevated SBP - p = 0.009). Both android and ginoid fat distribution cor-
related positively with elevated SBP, although the stronger correlation was 
with android fat distribution (p = 0.006). The only child (a boy) with ele-
vated both systolic and diastolic BP was born small for gestational age and 
had android fat distribution. There was a significant negative correlation 
between systolic and diastolic BP and reported sports training (p = 0.019, 
p = 0.003 resp.). 
Conclusion: The current findings suggest early development of obesity 
related risk factors in preschool healthy children who have android fat 
distribution and positive family history of obesity. Sports training has fa-
vorable effect on BP even at this young age.
T5:PO.035
Prevalence of obesity in students of elementary schools. 
Impact of socioeconomic factors . Data from the hellenic 
national action plan for the assessment, prevention and 
treatment of childhood obesity 
Vlachopapadopoulou E.1, Psaltopoulou T.2, Karachaliou F.1, 
Koutsouki D.3, Manios Y.4, Bogdanis G.3, Karagianni V.5, Sergentanis T.2, 
Panagiotopoulos I.1, Papadopoulou A.6, Hatzakis A.2, Michalakos S.1
1Dept. of Endocrinology, Children‘s Hosp. P. A. Kyriakou, Athens, Greece,  
2Department of Hygiene, Epidemiology and Medical Statistics, Univ. of Athens, 
Athens, Greece,  
3School of Physical Education and Sports Science, Univ. of Athens, Athens, Greece, 
4Dept. of Nutrition and Dietetics, Harocopion Univ. of Athens, Athens, Greece,  
5Dept. of Biometrics, Technological Educational Institute of Athens, Athens, Greece, 
6Dept. of Social Pediatrics, Children‘s Hosp. P. A. Kyriakou, Athens, Greece
Introduction: The aim of the study is to assess the prevalence of over-
weight/obesity of elementary school students and evaluate correlations 
with socioeconomic parameters. 
Materials and methods: This is a cross-sectional study conducted 
from10/2012- 12/2013. A pre-selected, representative elementary school 
cohort (N=18.648, age range 5.9–12.3 years)was derived, using stratifica-
tion and PPS methodology. Parents responded to questionnaire and stu-
dents were measured with high sensitivity methods (Ht 0.1cm, Wt 0.1kg, 
BMI calculated). IOTF cut offs were used to classify the children. So-
cio-economic status index was calculated (SES index range 0–13) on years 
of parental education, rented vs owned residence, m2/person, number of 
vehicles. Logistic regression was applied using STATA 11.0. 
Results:A 9.4% of students were overweight and 25.0% were obese, for 
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nificantly more obese (11.3± 6.6 vs 8.4 ± 3.6 city areas, p < .005). Mother’s 
higher education has protective effect (OR= 0.97, 95% CI: 0.96–0.99), as 
well as father’s education (OR=0,98). There was statistical significant dif-
ference in SES index between obese and normal weight students. Children 
of mothers working longer hours are at higher risk of being overweight/
obese (OR=1,03,95%CI: 1.01–1.06), and the same applies for fathers. Fur-
thermore there was a positive correlation with overweight/obese status 
and grandmother’s responsibility of children’s nutrition.There was no sig-
nificant difference by sex (p = 0.63) or age (p = 0.52). 
Conclusions: The prevalence of overweight/obesity in Greek students 
of elementary schools is high. Parental education has a protective effect, 
however longer parental working time is correlated with obesity and over-
weight.
T5:PO.036
Subclinical hypothyroidism in danish overweight and lean 
children and youths 
Jensen M.D.1, Ohrt J.D.1, Fonvig C.E.1,2, Kloppenborg J.T.1,3, Pedersen O.2, 
Hansen T.2,4, Holm J. C.1,5
1The Children’s Obesity Clinic, Department of Pediatrics, Holbaek Hospital, 
Holbaek, Denmark,  
2The Novo Nordisk Center for Basic Metabolic Research, Section of Metabolic 
Genetics, University of Copenhagen, Copenhagen, Denmark,  
3Department of Pediatrics, Herlev Hospital, Herlev, Denmark,  
4University of Southern Denmark, Faculty of Health Sciences, Odense, Denmark, 
5University of Copenhagen, Faculty of Medical and Health Sciences, 
Copenhagen, Denmark
Introduction: The aim of the study was to investigate the prevalence of 
subclinical hypothyroidism (SH) and examine possible associations be-
tween thyroid hormones and anthropometric measures in Danish over-
weight and lean children and youths. 
Methods: In this cross-sectional study, 1948 overweight children and youths 
(873 boys), aged 2–24 years, and 1339 lean controls (517 boys), aged 6–22 
years, were included from the Registry of the Danish Childhood Obesity 
Biobank. All participants were characterized by anthropometrics and serum 
thyroid-stimulating hormone (TSH), triiodothyronine (T3), free T3, and 
free thyroxine (T4). SH was defined as TSH in the range 4.5–10.0 mIU/L, 
which is above the normal range, and free T4 and free T3 within the normal 
range (free T4: 13.0–21.0 pmol/L, free T3: 3.9–7.7 pmol/L).
Results: The prevalence of SH among overweight participants was 10.9% 
(213 of 1948) vs. 6.9% (93 of 1339) in the lean group (OR: 1.6, 95% CI: 
[1.3;2.1], p = 0.0001). The overweight group had higher BMI SDS (me-
dian 2.77 (range 1.28–6.65) vs. 0.07 (-3.16–1.28)), higher concentrations 
of serum TSH (median 2.60 (range 0.02–62.36) vs. 2.30 (0.50–30.0), 
p < 0.0001), and free T3 (median 5.8 (range 3.6–8.9) vs. 5.6 (2.6–9.8), 
p < 0.0001). Linear regression analysis demonstrated a positive associa-
tion between serum TSH concentrations and BMI SDS (p < 0.0001) and 
waist/height-ratio (p < 0.0001) across both groups, independent of age, 
sex, and pubertal development stage. 
Conclusion: The prevalence of subclinical hypothyroidism is more fre-
quent in Danish overweight children and youths compared to lean. 
Furthermore, serum concentrations of TSH and free T3 are positively 
associated with BMI SDS indicating a relationship between obesity and 
dysregulated thyroid homeostasis.
T5:PO.037
Predictive validity of the core index in predicting obesity. 
Data from the hellenic national action plan for the assessment 
– prevention and treatment of childhood obesity 
Manios Y.1, Vlachopapadopoulou E.2, Karachaliou F.2, Psaltopoulou T.3, 
Koutsouki D.4, Moschonis G.1, Bogdanis G.4, Karagianni V.5, Hatzakis A.3, 
Michalakos S.2
1Dept. of Nutrition and Dietetics, Harokopio Univ. of Athens, Athens, Greece,  
2Dept. of Endocrinology, Children‘s Hosp. P. & A. Kyriakou, Athens, Greece,  
3Dept. of Hygiene, Epidemiology and Medical Statistics, Univ. of Athens, Athens, 
Greece,  
4School of Physical Education and Sports Science, Univ. of Athens, Athens, 
Greece,  
5Dept. of Biometrics, Technological Educational Institute of Athens, Athens, 
Greece
Introduction:As the prevalence of childhood obesity increases, a tool for 
risk prediction of childhood overweight/obesity is of utmost importance. 
The aim of this study, is to validate the CORE (Childhood Obesity Risk 
Evaluation)index, introduced by the Healthy Growth Study, as a predictor 
of obesity development in late childhood. 
Materials and methods: This is a cross-sectional study conducted 
from10/2012- 12/2013. A pre-selected, representative elementary school 
cohort (N=18.648, age range 5.9–12.3 yrs) was evaluated. It was derived by 
using stratification and PPS methodology. Students with fully completed 
questionnaires were eligible for this analysis (N=5.946, 2822 boys, mean 
age 11.1 ±2.2 yrs). Information requested included: Mother’s pre-preg-
nancy weight status, maternal smoking during pregnancy, maternal ed-
ucational level and infant weight gain in the first 6 months of life and the 
children’s gender for the development of theCORE Index. 
Results: A 27.4% of them (28.6% boys and 26.2% girls) were overweight 
and 9.1% (9.6% boys and 8.8% girls) were obese, for a total of 36.5% 
(38.1% boys and 35% girls) of the students being overweight or obese.
The CORE index was 3.06 ±1.9 (boys 3.49 ±1.84, girls 2.65 ±1.91), range: 
0.0–11.0. The likelihood of developing obesity by unit increase of the 
CORE index is 1.3 (O.R 1.3, 95%, CI 1.18–1.33). The optimal cut off point 
of CORE index for obesity risk reduction is 3.5, with 58.6% sensitivity and 
63.6%specificity. 
Conclusions: CORE index is a simple and inexpensive tool that can be 
used by paediatricians and practitioners enabling valid parent counsel-
ling regarding their child’s risk of developing obesity. Ref. Manios et al. 
Childhood Obesity Risk evaluation based on perinatal factors and family 
sociodemographic characteristics: CORE Index , Eur.J of Peds, 2013
T5 – Screening and early interventions
T5:PO.038
Prevalence Obesity among Saudi College Students 
Alrowaily M.A.
Department of Family medicine and Primary health care 
Abstract: Aim. (i) To estimate the prevalence of the metabolic abnormal-
ities among Saudi college students in Riyadh, Saudi Arabia, and (ii) to in-
vestigate the association between different indicators of body composition 
and these abnormalities. 
Methods: A total of 501 college students participated in a cross-sectional 
study. Anthropometric assessments, BP measurements, and biochemical 
assessment were done. Metabolic abnormalities were identified. 
Results: Applying BMI, 21.9% and 20.6% of students were classified as 
overweight and obese, respectively. Central obesity was prevalent in 26.9% 
and 42.2% of students based on WC and WHtR, respectively. Other met-
abolic abnormalities were hypertension (23.6%) and abnormal FPG level 
(22.6%). Three or more abnormalities were prevalent in 7.8% of students 
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on BMI, WC, and WHtR, respectively. With the exception of abnormal 
FPG, prevalence of individual metabolic abnormalities as well as the num-
ber of these abnormalities significantly increased with increasing BMI, 
WC, and WHtR (P < 0.001 each). 
Conclusion: Our findings provide evidence for the presence of MS in Sau-
di college students. Central adiposity contributes to the high incidence of 
individual MS components. College health programs that promote health-
ful lifestyle and avoidance of adult weight gain are recommended.
Acknowledgement: To King Abdullah International Medical Reseach Center
T5:PO.039
Preventive project „with infants against obesity“ – 
skojenciprotiobezite.cz
Marinov Z.1, Marinová C.2, Vyhnalová P.2, Fikrová L.2
1Children obesitological clinic, Department of Pediatrics, University Hospital 
Motol and 2nd Faculty of Medicine, Charles University in Prague, Czech 
Republic,  
2Medical Access Solutions s.r.o., Prague, Czech Republic
Introduction: Serious consequences are to be awaited since the pan-
demic of childhood obesity in 21st century. Prevention and treatment of 
childhood obesity by physician for children have significant potential if 
it is started early. The prevalence of overweight is in 6.9% of infants in 
6 months in Czech Republic, which represents the absolute number of 
about 7000 infants per year. 
Methods: The preventive program „With Infants Against Obesity“is 
designed for physicians for children in the context of preventive exam-
inations. The website html://skojenciprotiobezite.cz presents the tool for 
effective communication and collaboration between pediatricians, nurses 
and parents. The main objective of the project is to enable parents and 
physicians understand the problems of overweight and obesity prevention 
in key preventable period, in infancy. 
Results: The website html://skojenciprotiobezite.cz is a free accessible 
website to the general information. For health care professionals there is 
an established registered access to expert information of Guideline for 
Prevention of Overweight and Obesity in Infancy. For parents of infants 
this is a practical approach to preventive and curative measures of child-
hood overweight. 
Conclusion: The preventive project “With Infants Obesity” is an original 
and innovative prevention website, which offers a comprehensive view of 
the prevention of overweight and obese children. The project offers useful 
guidance that can be used in the everyday clinical practice for infants with 
risks of developing obesity, including their family background.
Acknowledgement: Research relating to this abstract was funded by Všeobecná 
zdravotní pojištovna České republiky, The Health Preventive Project 2014 and Med-
ical Access Solutions s.r.o.
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The prevalence and the risk factors of obesity among 
elementary school children in adiyaman, turkey 
Geçkil E.1, Aslan S.2, İster Derya E.2, Küçükkelepçe Şimşek D.2, Şahin T.2, 
Erdemir F.2
1Nursing Department, Faculty of Health Sciences, Necmettin Erbakan University 
in Konya, Konya, Turkey,  
2Nursing Department, Health School, Adıyaman Univesity in Adıyaman, 
Adıyaman, Turkey
Background: Childhood obesity is an important problem in the twen-
ty-first century. Pediatric nurses have a key role in the prevention, diag-
nosis and management of childhood obesity. Objectives: The aim of this 
study is to determine the prevalence and the risk factors of obesity among 
elementary school children. 
Methods: This is a descriptive and cross-sectional study. The research 
population includes 36,082 elementary school children in Adiyaman, 
Turkey. The research sample includes 3,028 children from seven schools 
selected according to stratified random sampling. Research participation 
was voluntary. The data was obtained from a demographic form and a 
25 question-survey which was sent to the families. Children’s height and 
weight were measured by the researchers. To analyze the data, SPSS and 
Excel were used. The values for frequency, mean, standard deviation, chi–
square, one way anova, and logistic regression were calculated. 
Results: The children were all between 5 and 15 years old. Of them, 51.2% 
were male, 13.4% were overweight (between 85 and 95 percentile) ac-
cording to the Body Mass Index (BMI), and 8.7% were obese (above 95 
percentile). Risk factors for childhood overweight and obesity include be-
ing male, having average or high socioeconomic status (SES), traveling to 
school by car or bus, parents with higher levels of education and parents 
who are overweight. 
Conclusion: Childhood obesity is an important problem which needs to 
be resolved. To create a plan of care for obese children, nurses need to 
consider the risk factors defined in this study.
Keywords: Childhood obesity, overweight, risk factors, nurse.
T8 – Comorbidities (inc diabetes, hypertension, 
lipids, sleep apnea, sexual dysfunction)
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Assessment of nutritional status in patients with non-
alcoholic fatty liver disease
Rusu E.1, Dragut R.2, Rusu F.3, Jinga M.3, Enache G.4, Nan R.2, 
Popescu Valceanu H.2, Teodoru I.1, Homentcovschi C.2, Costache A.2, 
Radulian G.1,2
1National Institute of Diabetes, Nutrition and Metabolic Diseases „Prof. N. 
Paulescu”, Bucharest,  
2University of Medicine“Carol Davila”, Bucharest,  
3Emergency Clinical Hospital “Carol Davila”, Bucharest,  
4Emergency Hospital Calarasi
Aims: Obesity is associated with nonalcoholic fatty liver disease (NAFLD) 
and adversely affects the progression of liver diseases. Currently, there is 
no consensus on the parameters that have the highest value in assess-
ing the nutritional status in patients with non-alcoholic steatohepatitis 
(NASH). The aim of this study was to assess the nutritional status of pa-
tients with NAFLD through five methods. Material and methods: A total 
of 124 patients with NAFLD – 60 men (48.3%) and 64 women (51.6%), 
with an average age 58.3 ± 9.1 years, were included into the study. The 
data were collected with a structured questionnaire that was divided into 
two parts: the first part included Mini-Nutritional Assessment (MNA), 
subjective global assessment questions (SGA) and instant nutritional as-
sessment (INA), and the second part included information about diet and 
eating problems (we used a modified food-frequency questionnaire). We 
also calculated Nutritional Risk Index (INR). 
Results: Malnutrition was found in 4 (3.22%) patients by MNA and 
SGA, in 6 (6.45%) by INA, and in 20 (20.1%) by INR. The INR detected 
malnutrition at a significantly higher rate compared with the other four 
methods. All patients had body mass index (BMI) over 19 kg/mp. Risk 
factors for malnutrition (assessed by the combined score) were the follow-
ing: low HDL-cholesterol (HDL-cholesterol below 40 mg/dl in men, and 
less than 50 mg/dl in women) (OR=5.82, CI95% 1.6 to 10.04, p = 0,001), 
hypertriglyceridemia (TG over 150 mg/dl) (OR=2.1, CI95% 1.01 to 4.91, 
p = 0.045), the AST/ALT ratio >1 (OR=3.17,95%CI 1.05 to 9.6, p = 0.011 
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Conclusions: The prevalence of combined obesity and malnutrition in 
patients with NAFLD is higher than estimated.
Acknowledgement: This paper is supported by The Sectoral Operational Pro-
gramme Human Resources Development (SOP HRD), financed from the European 
Social Fund and by the Romanian Government under the contract number POS-
DRU/159/1.5/S/137390.
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Diabetes Remission Clinical Trial (DiRECT): Protocol for cluster 
randomised controlled trial
Leslie W.1, Brosnahan N.1, Barnes A.2, Thom G.1, McCombie L.3, Ross H.3, 
Taylor R.2, Lean M.1
1University of Glasgow, Scotland,  
2Newcastle University, Newcastle-Upon-Tyne, England,  
3Counterweight Ltd
Introduction: Type 2 diabetes mellitus (T2DM) can be reversed by an 
energy restricted diet and around 15kg weight loss. This non-surgical ap-
proach can be provided at relative low cost in Primary Care, where obesity 
and T2DM can be routinely managed, using a structured weight man-
agement programme. This 5 year study will establish the frequency with 
which it is possible to produce remission of T2DM at 12 months and sus-
tain this over 2 years. 
Methods: Cluster-randomised design with GP practices the unit of ran-
domisation: 280 patients from c.30 practices in Scotland and Tyneside will 
be allocated either to continue usual guideline-based care or to add Coun-
terweight Plus, which includes 12–20 weeks total diet replacement (TDR), 
food reintroduction and long-term weight loss maintenance. Main inclu-
sion criteria: men and women aged 20–65 years, all ethnicities, T2DM 
0–6 years duration, body mass index >27kg/m2, <45kg/m2. Tyneside sub-
jects will undergo MR studies of pancreatic and hepatic fat, and metabolic 
studies of insulin secretion to determine mechanisms underlying T2DM 
reversal. All participants will be followed up at 1 and 2 years. 
Results: Co-primary endpoints: weight reduction 15kg or more and re-
versal of diabetes (HbA1c <48mmol/mol) at one year. 
Conclusion: This study will establish if a structured weight manage-
ment programme, delivered in Primary Care by practice nurses or dieti-
tians, is a viable treatment to achieve T2DM remission and guide future 
management. Results will be available from 2018. Trial Registration IS-
RCTN03267836
T8:PO.003
Treatment with continuous positive airway pressure (CPAP) 
decreases plasma Heme Oxygenase 1 (HO1) levels in morbidly 
obese patients (MO) with severe obstructive sleep apnea 
(OSA)
Tirado R.1, Vigil L.2, Masdeu M J.2, Villaplana M.1, Couto Y.1, Hurtado M.1, 
Pareja R.1, Pons B.1, Rigla M.1, Caixŕs A.1
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Introduction: HO1 is a new adipokine with a protective role against 
the cellular stress and hypoxia (1). MO presents with high circulating 
levels and high adipose tissue expression of HO1 (2). Its role with the 
coexistance of OSA and the treatment with CPAP have not yet been 
studied. 1.Abraham N et al. Heme Oxygenase: a target gene for antidi-
abetic and obesity. Current Pharmaceutical Design,2008;14:412–21. 2. 
Lehr S et al. Identification and Validation of novel adipokines released 
from primary human adipocytes. Molecular & Cellular Proteomics 2012; 
Jan;11(1):M111.010504. 
Methods: we studied 57 MO with sever OSA, 40 women and 17 men (age 
46.2 ± 10.0 years, BMI 46.8 ± 7.06 kg/m2, AHI (Apnea hipoapnea index) 
64.1 ± 27.6 events/hour). Thirty were treated with CPAP, 24% were smok-
ers, 67% had hypertension and 38% type 2 diabetes. Levels of HO1 were 
measured by ELISA (Elisa Kit bioNova científica, s.l.Madrid). Epworth 
sleepiness scale (ESS) score, AHI and percentatge of total sleep time with 
oxygen saturation < 90% were determined by overnight conventional 
polisomnography (CE-Series Compumedics, Victoria, Australia). Waist 
circumference, % body fat by bioelectrical impedance (TANITA) and 
HOMA insulinresistance index were also measured. For statistical analisis 
SPSS-PC-plus version 19 was used. 
Results: patients treated with CPAP had lower plasmatic levels of HO1 
compared with patients without treatment (5.89 ± 1.29 vs 8.84 ± 6.70pg/
mL, p = 0.029). The only variables that were different between both groups 
were the presence of DM2 (52% vs 26%, p = 0.038) and the ESS score 
(13.5 ± 5.74 vs 9.70 ± 3.64, p = 0.007) in the treated vs untreated groups. 
Conclusion: CPAP treatment reduces HO1 plasmatic levels in MO with 
sever OSA.
Acknowledgement: Funding: Supported by CIRI Grants 2014 Fundació Parc Taulí
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Sleep architecture, body composition and metabolic profile 
after one month of weight loss intervention in obese people 
with Obstructive sleep apnea
de Melo C.M.1, del Re M.P.1, dos Santos M.V.1,2, Antunes H.K.2, Tufik S.1, 
de Mello M.T.1
1Federal University of Sao Paulo – Department of psychobiology,  
2Federal University of Sao Paulo – Department of Biosciences
Introduction: Weight loss has been extensively recommended for obese 
people with obstructive sleep apnea. This work aims to compare sleep ar-
chitecture, body composition and metabolic profile of obese individuals 
with obstructive sleep apnea (OSA) after one month of weight loss inter-
vention. 
Methods: 23 obese men, 41.6 ± 7.9 years old were submitted to one 
month of caloric restriction. Energy deficit was 30% of total energy ex-
penditure. Before and after intervention the following evaluations were 
made: laboratory polysomnography, body composition by plethysmogra-
phy and blood collection for lipd profile, glycemia and hormones insulin 
and IGF-1 determination. 
Results: One month intervention resulted in improvements in all anthro-
pometric and body composition parameters as body mass (103.8 ± 12.5 to 
99.8 ± 12.7kg, p = 0.000), BMI (35.4 ± 4.2 to 33.8 ± 4.2 kg/m2, p = 0.000), 
% of fat mass (38.1 ± 5.6 to 36.8 ± 6.4%, p = 0.012), % of fat free mass 
(61.5 ± 5.9 to 63.3 ± 5.8%, p = 0.000) and waist circumference (112.3 ± 9.4 
to 107.3 ± 8,7 cm, p = 0.000). Glycaemia (108.4 ± 7.7 to 101.1 ± 5.1 
mg/dL, p = 0.000), Total Cholesterol (187.2 ± 29.0 to 166.6 ± 22.3 mg/
dL, p = 0.001), LDL Cholesterol (112.5 ± 25.9 to 102.4 ± 18.4 mg/dL, 
p = 0.022), Insulin (36.0 ± 16.1 to 27.4 ± 10.8 uIU/mL, p = 0.000) and 
HOMA-IR (5.32 ± 2.58 to 3.17 ± 1.27, p = 0.002) were improved. No 
differences were found in HDL-cholesterol. In relation to sleep archi-
tecture were improved: Apnea-Hypopnea Index (AHI, 46.4 ± 25.6 to 
40.2 ± 27.2 events/h, p = 0.028), hypopneas events per night (111.7 ± 57.1 
to 76.2 ± 65.4 events, p = 0.027), oxyhemoglobin saturation (93.6 ± 1.5 
to 94.8 ± 1.6%, p = 0.009) and desaturation index during NREM sleep 
(45.8 ± 24.9 to 34.2 ± 25.6, p = 0.001). 
Conclusion: One month of weight loss intervention is sufficient to cause 
a significant reduction on body weight, improvements in body compo-




















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247Abstracts 205
T8:PO.005
The prevalence of co-morbidities in obese individuals 
embarking on a very low calorie diet (vlcd) weight loss 
programme at lighterlife
Johnston K.L.1, Dyson L.1, Cox J.1, Hewlett B.1, Capehorn M.1
1LighterLife, Cavendish House, Parkway, Harlow Business Park, Harlow, Essex, 
CM19 5QF
LighterLife is a commercial weight loss provider offering a range of pro-
grammes for overweight and obese individuals. Those with conditions 
which are contra-indicated for a VLCD are refused entry onto this pro-
gramme and those with certain co-morbidities must see their general 
practitioner for monitoring. There are strict rules within the UK on the 
marketing of products which facilitate weight control. Administered by 
the Advertising Standards Authority (ASA), the Committee for Advertis-
ing Practice (CAP) states that ‘Obesity is frequently associated with a med-
ical condition and a treatment for it must not be advertised to the public 
unless it is to be used under suitably qualified supervision’. The prevalence 
of co-morbidities which require medical monitoring in obese individuals 
embarking on the LighterLife Total VLCD weight loss programme has not 
previously been investigated. Cross-sectional analysis of client baseline 
medical data was performed to assess the prevalence of co-morbidities 
in all obese individuals who applied to embark on the LighterLife VLCD 
programme in 2014. Data from 14,855 individuals with a mean age of 44.6 
(±11.7) years and mean BMI of 36.9 (±6.0) were analysed. 970 individuals 
(7%) presented with contra-indications for a VLCD and were declined 
onto the programme. 1084 individuals (7.3%) without contra-indications 
presented with co-morbidities and were required to undergo medical su-
pervision. 86% of all obese individuals who sought to join the LighterLife 
VLCD programme in 2014 presented with no obesity related co-morbid-
ities and did not require medical supervision. These data provide insight 
into the prevalence of co-morbidities in obese individuals prior to joining 
a weight loss programme which is significantly lower than that suggested 
by CAP. To ensure that the rules regarding the advertising of weight loss 
products and programmes to obese individuals are evidence-based, these 
data should be taken into consideration.
T8:PO.006
Effect of a dietary weight loss intervention on the lipid profile 
of obese individuals with signs of non-alcoholic fatty liver 
disease: Beyond standard lipids.
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Introduction: Cardiovascular disease (CVD) is an important cause of 
morbidity and mortality in non-alcoholic fatty liver disease (NAFLD). 
Dyslipidaemia is one of the suggested mechanisms linking CVD and NA-
FLD. We assessed an extensive lipid profile in obese patients with NAFLD 
signs and looked at dietary impact. 
Methods: Obese patients had a metabolic and liver assessment. If NAFLD 
was suspected, liver biopsy was proposed. After 6 months of diet, patients 
were re-evaluated, including an extensive lipid profile with apolipopro-
teins, LDL and HDL subspecies. 
Results: We selected 73 patients that completed a 6-month weight loss 
program, with baseline BMI 35.1kg/m˛ (Q1-Q3:32.4–39.8) and age 
48 ± 12y. In 69 patients at least one standard lipid parameter was dis-
turbed at baseline. Biopsy proven liver steatosis was associated with small-
er LDL (p = 0.056) and HDL particle size (p = 0.040). This was also re-
flected by the inverse associations between liver scores for NAFLD/NASH 
and LDL and HDL particle size. Serum GGT (p < 0.001), Fatty Liver In-
dex (p < 0.001), calculated liver percentage (p < 0.001) and NAFLD liver 
fat score (p = 0.001) were higher in patients with a hypertriglyceridemic 
waist. Patients achieved a weight loss of 9.1 ± 5.6% and most parameters 
of lipid metabolism improved. Changes in some lipids (TG, HDL, HDL2b, 
HDL3a, HDL3b, HDL mean particle size, ApoB, ApoE, RLP) were related 
to change in visceral adipose tissue. 
Conclusion: We confirm the proatherogenic lipid profile in NAFLD, with 
high total cholesterol, high LDL and smaller LDL peak particle size. This 
lipid profile is associated with markers of steatosis and fibrotic NASH, 
suggesting that dyslipidaemia may play a role in the link between NAFLD 
and CVD. We observed that weight loss improves most parameters of lipid 
metabolism.
Acknowledgement: Research was supported by the European Union: FP6 (HE-
PADIP Contract LSHM-CT-2005–018734) and FP7-HEALTH (RESOLVE nr. 
305707).
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Diagnosis of diabetes mellitus in a population of obese 
patients: Ogtt or a1c/fasting plasma glucose
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Introduction: Obesity is associated with an increased risk of type 2 Dia-
betes Mellitus (DM). Oral glucose tolerance test (OGTT), fasting plasma 
glucose (FPG) and A1c test can be use to diagnose the condition. As the 
OGTT is more expensive and time consuming than alternative tests is 
questionable to perform the test in all obese patients.  Objective: To com-
pare OGTT with A1c and FPG in the diagnosis of DM in obese patients.  
Methods: Cross-sectional study of a population of 717 morbidly obese 
adults evaluated in a Multidisciplinary Assessment of Surgical Treatment 
of Morbid Obesity between January/2010-December/2013. Demographic, 
anthropometric and metabolic parameters were evaluated. Diabetes was 
defined according to ADA criteria. 
Results: In a cohort of 717 patients, 629 (87.7%) were female, with a me-
dian age of 41 years (IQR 35–51) and a median BMI of 43.5kg/m2 (IQR 
40.6–47.1). Of 707 patients who performed FPG, 18 (2.5%) met DM crite-
ria; of 657 patients who underwent OGTT, 37 (5.6%) fulfilled DM criteria; 
of 673 who performed A1c, 25 patients (3.7%) had DM by this criterion. 
629 patients performed the three diagnostic tests. Of those, 18 patients 
(2.9%) did not meet criteria for DM by A1c or FPG, but they were diag-
nosed by OGTT. The FPG and A1c diagnosed DM in 12 patients (1.9%) 
with a normal OGTT. The FPG and A1c test showed a specificity of 98% 
and a sensitivity of 48.6% for the identification of patients with DM com-
pared with OGTT. 
Conclusion: OGTT diagnosed diabetes in patients with normal FPG and 
A1C. FPG or A1c showed a low diagnostic sensitivity, which highlights 
the importance of performing OGTT in obese patients, in order to reduce 
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Improved cartilage quality indicated by dgemric after more 
than 12% weight loss with a 16 week formula diet programme 
in elderly obese with knee osteoarthritis: A cohort study
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Purpose: To assess if weight loss can improve the quality of hyaline car-
tilage in patients with Knee osteoarthritis (KOA). Cartilage quality was 
assessed by delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC) 
in 1.5 tesla (T) MRI scanner. 
Method and materials: 19 patients (BMI>30) with symptomatic KOA 
from a 16-week formula diet (Cambridge Weight Plan ®, Northants., 
UK) weight loss intervention study were included from the CAROT 
trial (NCT00655941). Included patients had K/L (Kellgren/Lawrence) 
grade 1–2 in the lateral tibiofemoral compartment. Inversion recovery 
dGEMRIC with four inversion times was performed using intra articular 
contrast at baseline and after 16 weeks. Weight-bearing posterior femo-
ral cartilage was region of interest (ROl). Differences in weight loss and 
dGEMRIC T1-values were compared between the groups. 
Results: 9 patients with K/L 1 and 10 patients with K/L 2 were included. 
No group differences at baseline: dGEMRIC T1-values: 467 ms for K/L 1, 
and 518 ms for K/L 2 (p = 0.11); at 16 weeks: weight loss: 12.3% of BMI for 
K/L 1 and 14.3% of BMI for K/L 2 (p = 0.37). Average dGEMRIC T1-value 
increased with approximately 28 ms (CI: –29; 86) in K/L-group 1, and 
decreased 61 ms (CI: –116;-7) in K/L-group 2 (p = 0.03). Taking baseline 
dGEMRIC into account, the changes showed the same trend, although 
less pronounced (p = 0.10). Reproducibility was similar to previous publi-
cations: ICCs of 0.96 for intra-reader and 0.92 for inter-reader variability. 
Conclusion: Our results indicate that improvement of cartilage quality 
after more than 12% weight loss may be possible in early stage but not in 
later stage KOA. The results may indicate a point of no return for improve-
ment of cartilage quality. 
Acknowledgement: Supported by the Oak Foundation, the Velux Foundation, 
Cambridge Weight Plan ®, Northants., UK, the Danish Rheumatism Association, 
the Augustinus Foundation, the A.P. Mřller Foundation for the Advancement of 
Medical Science, Erik Hřrslev og hustru Birgit Hřrslevs Fond, Aase og Ejnar Daniel-
sens fond and Bjarne Jensens Fond.
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Decrease of microalbuminuria (mi) by weight loss induced by 
bariatric surgery (bs) in patients with morbid obesity (mo)
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Introduction: Since MI is an important risk factor for both kidney and 
cardiovascular disease, we investigated albumin excretion rate (AER) and 
kidney function (eGFR) in a large cohort of patients with MO before and 
after BS. 
Methods: 1280 patients with MO (BMI: 45.4 ± 6.3km/m2, mean±SEM, 
age 40 ± 12y) were included in a cross-sectional study and 288 were an-
alysed 2 years after BS. Apart from anthropometric data, a 75g oGTT, 
renal parameters and lipids were assessed. HOMA-IR and eGFR (CKD-
Epi formula) were calculated, AER was quantified by collecting 24h urine 
on 3 consecutive days. Hyperfiltration was defined as eGFR> 90ml/
min/1.73m². 
Results: 246 of 1280 (19.2%) patients had MI (16.1%) or macroalbumin-
uria (MA;3.1%) and 623 (48.7%; mean eGFR 105.4 ± 15.0ml/min/1.73m²) 
had hyperfiltration. Patients with diabetes (n=274), had more often 
(χ=34.712; p < 0.001) an increased AER (30.9% vs 14.6%) compared to 
patients without (n=733). Patients with MI were more obese (p < 0.001), 
older (p = 0.002), had a higher systolic (p < 0.001) and diastolic blood 
pressure (p = 0.001), fasting blood glucose (p = 0.001) and 1h postpran-
dial (pp) blood glucose levels (p = 0.001), HbA1c (p < 0.001), fasting 
(p < 0.001), 1h pp (p = 0.001), 2h pp insulin levels (p = 0.010) and HO-
MA-IR (p < 0.001), triglycerides (p < 0.001) and HDL cholesterol levels 
(p < 0.001) compared to normoalbuminuria. After BS (mean weight loss 
41 ± 12kg), AER decreased from 12.2 (6.8–23.1) to 8.9 (5.3–14.8)mg/24h 
(p < 0.001) in the whole and from 59.9 (39.6–104.1) to 12.1 (8.2–28.4)
mg/24h (p < 0.001) in the MI group and only 9.7% (n=28) had still MI 
or MA. 
Conclusion: Increased AER and hyperfiltration are present in a substan-
tial portion of patients with MO. Weight loss induces a dramatic decrease 
of AER by about 50%, which parallels reduction of risk factors.
T8:PO.010
Associations between non-alcoholic fatty liver disease, 
anthropometry and diabetes in morbidly obese patients
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Introduction: Non-alcoholic fatty liver disease (NAFLD) is very prev-
alent and obesity is a significant risk factor. Diagnosis of non-alcoholic 
steatohepatitis (NASH) requires liver biopsy. We estimated the prevalence 
of NASH and fibrosis in morbidly obese patients. 
Methods: In this randomized controlled trial (NCT02092376) liver bi-
opsy was performed at the time of bariatric surgery and Bedossa’s SAF 
(Steatosis, Activity, Fibrosis) score was used for categorizing liver lesions1. 
Additionally, total body fat content by dual-energy-absorptiometry and 
serum liver enzymes were examined. 
Results: 35 patients [71% women, age 43(13) years, mean(SD)] with a 
BMI of 44.1(4.7) kg/m2, waist circumference (WC) of 128.2(11.0) cm, 
and total body fat of 42.8(7.0)%, were analyzed. The following risk factors 
were present: diabetes 26%, hyperlipidemia 23%, and hypertension 43%. 
Moreover, 80% had some degree of steatosis (S≥1), 77% had NASH (A≥2), 
31% demonstrated significant liver fibrosis (F2-F3), and 6% had cirrhosis 
(F4). Total body fat and diabetes were significantly associated with fibrosis 
(r=-0.543, p = 0.001 and r=0.584, p = 0.001). WC was related to degrees of 
steatosis (r=0.363, p = 0.01). Furthermore, patients with NASH compared 
to those without had significantly higher alanine transaminase (ALAT) 
levels [40.6(21.4) vs. 21.3(6.8) U/l, p = 0.001]. 
Conclusion: In this study, NASH and significant liver fibrosis are pres-
ent in a high percentage of morbidly obese patients. Fibrosis and steatosis 
seem to be associated with total body fat, diabetes and WC. Furthermore, 
patients suffering from NASH demonstrated higher levels of ALAT. 
Reference:



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247Abstracts 207
T8:PO.011
Bariatric surgery as hypouricemiant therapy in a population 
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Introduction: Hyperuricemia is considered by some authors as a risk 
factor for cardiovascular disease and several studies demonstrated asso-
ciation between hyperuricemia and increased cardiovascular mortality. 
Bariatric surgery (BS) in addition to the reduction in weight can lead to 
improvement in obesity comorbidities including hyperuricemia. 
Objective: Evaluation of the prevalence of hyperuricemia in a population 
of obese patients underwent BS before and 12 months after the procedure. 
Methods: Retrospective study of patients who underwent BS between 
January 2010 and June 2013. We included only patients with uric acid as-
say at 0 and 12 months after surgery. We compared the uric acid (UA) and 
the prevalence of hyperuricemia before and after the procedure. Hyper-
uricemia is defined by uric acid value greater than 6,8mg/dL. 
Results: 791 patients were included, with mean age of 42.7 ± 10.8 years 
and BMI 44.4 ± 5.6 kg/m2. We observed decreased of uricemia in the total 
sample (before 5.9 vs 12m 4.6mg/dL, p <0.001), in females (before 5.8 
mg/dL vs 12m 4.3 mg/dL, p <0.001) and in males (before 6,6mg/dL vs. 
12m 6.5/mg/dL, p <0.001). For hyperuricemia there was a reduction in 
the prevalence (total sample – before 12,9% vs 12m 4.2%; Female gender 
- before 8.2% vs 12m 1.8%; Male - before 44.7% vs 12m 20,4%, p <0.001 
for all). 
Discussion: The UA values and the prevalence of hyperuricemia were 
higher in males, which is in agreement with other studies. The BS was 
shown to be useful in reducing the UA values and decreased prevalence 
of hyperuricemia. These results demonstrate the effectiveness of BS as hy-
pouricemiant therapy. In obese patients with gout treated with hipourice-
miant drugs, the BS can be an opportunity for suspension of these drugs.
T8:PO.012
The diagnostic dilemma for type 2 diabetes in patients with 
morbid obesity
Feder A.1, Kopp H.P.1, Brix J.M.1, Schernthaner G.H.2, Schernthaner G.1, 
Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria,  
2Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Background: The incidence of type 2 diabetes (T2DM) amongst patients 
undergoing bariatric surgery ranges from 15–23%. In 2010 HbA1c was 
recommended for use as a diagnostic test for diabetes by the ADA. This is 
the first study comparing the different diagnostic criteria (DC) for diabe-
tes in a large cohort of patients with MO 
Methods: In total 926 patients with MO (mean age 40 ± 12 years) were 
included, of whom 14.2% (n=145) had a known T2DM and were there-
fore excluded. All patients with unknown T2DM (n=781) underwent an 
oral glucose tolerance test (OGTT; 75g glucose) and were included. The 
thresholds of DC for diabetes were HbA1≥6.5%, fasting plasma glucose 
(FPG) ≥126mg/dl and 2 hour post-challenge glucose ≥200mg/dl. Insulin 
levels were assessed in the fasting state as well as post OGTT and HO-
MA-Insulin resistance (IR) was calculated. In addition, cardiovascular 
risk factors were evaluated in all patients. 
Results: The prevalence of undiagnosed T2DM was 6.9% (n=54) using the 
HbA1c criteria, 7.1% (n=55) using the 2-hour OGGT criteria ≥200mg/dl, 
but only 3.6% (n=28) using the FPG criteria. Remarkably, only 2.4% (n=19) 
of the patients fulfilled all 3 criteria. Prevalence of the metabolic syndrome 
using the ATP III criteria was similar in patients diagnosed for diabetes by 
HbA1c (83%), FPG (79%) or 2 hour post-challenge glucose (87%). HO-
MA-IR was 8 (5;13) in the group defined by HbA1c, 9 (8;14) in the 2 hour 
post-challenge glucose and 10 (7;18) in the group defined by FPG. 
Conclusion: The present study indicates a significantly higher prevalence 
of diabetes when HbA1c or 2 hour glucose are used as DC in comparison 
with FPG indicating that the previously used FPG criteria underestimate 
the existence of diabetes in patients with morbid obesity.
T8:PO.013
Anthropometric Approach to Insulin Resistance: Neck 
Circumference Measurement
Kaner G.1, Soylu M.2, Pamuk G.3, İnanc N.4
1Department of Nutrition and Dietetics, Faculty of Health Sciences, University of 
Nuh Naci Yazgan, Kayseri, Turkey,  
2Department of Nutrition and Dietetics, Faculty of Health Sciences, University of 
Nuh Naci Yazgan, Kayseri, Turkey,  
3Department of Family Medicine, Bozyaka Research and Training Hospital, İzmir, 
Turkey,  
4Department of Nutrition and Dietetics, Faculty of Health Sciences, University of 
Nuh Naci Yazgan, Kayseri, Turkey
Insulin resistance is associated with visceral fat content. Neck circumfer-
ence is an index for upper body subcutaneous adipose tissue distribution. 
In addition, neck circumference has been evaluated in relation to insulin 
resistance. The aim of the present study was to determine the relationship 
between neck circumference and insulin resistance. A total of 104 wom-
en in normal weight (BMI: 18.5–24.9 kg/m2, n:51), and obese (BMI: ≥30 
kg/m2, n:53) aged 20–49 years, were included in the study. In this study, 
biochemical parameters (glucose, insulin, HbA1C) were performed after 
8–10 hours fasting. Homeostasis model assessment of insulin resistance 
(HOMA-IR) was calculated as fasting glucose level (μU/mL)×fasting in-
sulin level (mg/dL) /405. Neck circumference (at the level of the thyroid 
cartilage) were measured and cut off value was accepted 35 cm for wom-
en. Mean BMI of normal weight and obese women were 23.18 ± 3.4 kg/
m2, 35.2 ± 4.2 kg/m2, respectively. It was determined that all of the obese 
women’s neck circumference were above the 35 cm. Mean neck circumfer-
ence of obese and normal weight women were 37.2 ± 1.9 cm and 31.0 ± 1.6 
cm, respectively. Mean HOMA value of obese and normal weight wom-
en were 2.7 ± 1.3, 1.2 ± 0.57. Obese women’s HOMA value was above 
the normal range (<2.5). A significant relationship was found between 
HOMA, HbA1C, BMI, glucose and insulin levels and neck circumference 
(p < 0.05). It was determined that neck circumference strongly correlated 
with BMI, glucose, insulin, HOMA (p = 0.000). At the end of this study, it 
was concluded that neck circumference is associated with BMI and insu-
lin resistance. Neck circumference measurement could be used in clinical 
screening of obese patients. Moreover, determination of beneficial effects 
of neck circumference may be valuable for studies in future.
T8:PO.014
Incidence and remission of type 2 diabetes in relation to 
weight loss, weight stability and degree of obesity: The 
swedish obese subjects (sos) study.
Sjöholm K.1, Pajunen P.2, Jacobson P.1, Karason K.1, Sjöström D.3, 
Torgerson J.4, Carlsson L.1, Sjöström L.1, Peltonen M.2
1Institute of Medicine, The Sahlgrenska Academy at the University of 
Gothenburg, Gothenburg, Sweden,  
2Department of Chronic Disease Prevention, National Institute for Health and 
Welfare, Helsinki, Finland,  
3Global Medicines Development, Cardiovascular and Metabolic Disease, 
AstraZeneca, Mölndal, Sweden,  
4Department of Health Care, Västra Götaland Region, Gothenburg, Sweden
Aim: To analyse the incidence and remission rates for type 2 diabetes 
(T2D) among obese individuals in relation to initial BMI and magnitude 
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Methods: 3485 obese individuals receiving bariatric surgery or conven-
tional treatment were included in this report. Individuals were grouped 
into four BMI categories according to baseline BMI (<35; 35–40; 40–45; or 
≥45 kg/m2) and five weight change categories depending on the resulting 
BMI at 2 years (weight increase (≥1 BMI unit increase), weight stable (less 
than 1 BMI unit change), minor weight reduction (–1 to –9 BMI units), 
medium weight reduction (–0 to –14 BMI units), and major weight reduc-
tion (more than –15 BMI units). The incidence and remission of T2D at 
2 years was assessed. 
Results: Among weight stable individuals, T2D incidence rates were 5.5, 
7.4, 8.3 and 5.2%, in the four baseline BMI categories, respectively. Among 
those with an initial BMI of 35–40, 40–45 and ≥45 attaining a minor re-
duction of weight, the corresponding rates were 1.3, 1.2 and 3.4%, respec-
tively. In the medium/major weight reduction groups, T2D incidence was 
≤0.5%. Among weight stable individuals with T2D at baseline, the T2D 
remission rates were 15.3–26.9%, and for individuals attaining a minor 
weight reduction, remission rates were 48.1–70%. In the medium/major 
weight reduction groups, the remission rates were 77–97%. There were no 
differences in the 2-year incidence and remission rates between the differ-
ent baseline BMI groups obtaining the same degree of weight reduction. 
Conclusion: Our results suggest that, in obese subjects, the favourable 
effect of weight reduction on T2D incidence and remission is independent 
of the initial degree of obesity.
Acknowledgement: We thank the staff members at 480 primary health care centers 
and 25 surgical departments in Sweden that participated in the study.
T8:PO.015
Weight loss success in obese knee osteoarthritic patients is 
independent of pressure-pain sensitivity at enrolment: A 
prospective cohort study
Jørgensen T.S.1, Henriksen M.1, Christensen R.1, Bliddal H.1, Jespersen A.1
1The Parker Institute, Department of Rheumatology, Copenhagen University 
Hospital, Bispebjerg and Frederiksberg, Denmark 
Purpose: Weight loss is a recommended treatment for adipose patients 
with knee osteoarthritis (KOA). It is unknown if sensitization of the noci-
ceptive system prevents improvement in pain induced by weight loss. The 
aim of the study was to investigate if baseline pressure-pain sensitivity of 
the lower leg influences weight loss success of a diet intervention in obese 
KOA patients. 
Methods: 168 out of 192 participants from a prospective cohort were 
included (ClinicalTrials.gov identifier: NCT00655941). A computerized 
tourniquet cuff pressure algometer was used to determinate pressure 
pain sensitivity. Pressure-pain threshold (PPT), pressure-pain tolerance 
threshold (PTT) and tolerance threshold pain score (TTPvas) was mea-
sured before a 16-week diet intervention. We dichotomised the changes in 
pain and body weight into treatment response (y/n) knee pain improve-
ment >30%, and weight loss success (y/n) defined as a weight loss >10%. 
We assessed the associations between baseline pain sensitivity variables 
and the binary variables predicting response/success. 
Results: 30% achieved an improvement in knee pain above 30% (mean 
change: 9.6 [SD 14.5]/mm). Baseline pressure pain sensitivity could not 
predict improvements in knee pain above 30% (PPT: OR=1.03 [95% 
CI 0.99to1.08]/kPa; PTT: OR=1.01 [95% CI 0.98to1.04]/kPa; TTPvas: 
OR=1.06 [95% CI 0.85to1.32]/mm). 74% achieved a weight loss above 
10% (mean change: –12.6 [SD 6.1]/kg). Baseline pressure pain sensitiv-
ity could not predict weight loss success either (PPT: OR=1.01 [95% CI 
0.97to1.06]; PTT: OR=1.01 [95% CI 0.98to1.04]; TTPvas: OR=1.03 [95% 
CI 0.84to1.27]). 
Conclusions: Pressure pain sensitivity at baseline does neither have a 
prognostic value for predicting the clinical outcome nor the weight loss 
success of a diet intervention in obese KOA patients. These results suggest 
that all obese patients with KOA will benefit from weight loss intervention 
treatment independently of any sensitization of their nociceptive system.
Acknowledgement: This study was supported by grants from The Oak Foundation, 
The Cambridge Health and Weight plan UK, The Danish Rheumatism Association, 
The Augustinus Foundation, The A.P. Møller Foundation for the Advancement of 
Medical Science, Hørslev Foundation, Bjarne Jensens Foundation and Aase and 
Ejnar Danielsens Foundation
T8:PO.016
Determinants of evolution of glomerular filtration rate one 
year after bariatric surgery
Coupaye M.1, Flamant M.2, Sami O.1, Calabrese D.3, Ledoux S.1
1Service des Explorations Fonctionnelles-Centre de l‘obésité (CINFO), Hôpital 
Louis Mourier, Faculté Paris Diderot, 92700 Colombes, France,  
2Service des Explorations Fonctionnelles-Hôpital Bichat, Faculté Paris Diderot, 
75018 Paris, France,  
3Service de Chirurgie-Centre de l‘obésité (CINFO), Hôpital Louis Mourier, Faculté 
Paris Diderot, 92700 Colombes, France
Introduction: Many studies have shown that hyperfiltration induced by 
obesity decreases after bariatric surgery, but some studies also shown an 
increase of glomerular filtration rate (GFR). Furthermore, the factors that 
influence GFR after bariatric surgery have been poorly studied. 
Methods: We studied the evolution of GFR in 323 candidates for bariatric 
surgery (age 43 ± 11 yr, M/F 49/274, BMI 46 ± 7 kg/m˛), by measuring 
creatinine clearance (assessment of plasma and 24h-urinary creatinine) 
before and one year after surgery. The links between creatinine clearance 
and clinical and biological parameters were also studied. 
Results: Excess weight loss was 61 ± 24%. Body surface decreased from 
2.26 ± 0.23 to 1.98 ± 0.21 m˛ (p < 0.001). Plasma creatinine decreased 
from 72 ± 16 to 69 ± 36 μmol/l (p < 0.001) and 24h-urinary creatinine 
from 13.4 ± 4.8 to 11.5 ± 4.5 mmol/24h (p < 0.001). Mean GFR de-
creased from 133 ± 37 to 122 ± 49 ml/min (P < 0.001) in parallel to body 
surface. GFR decreased in subjects with preoperative GFR>120 ml/min 
(P < 0.001), but was stable in those with 90<GFR<120 ml/min and in-
creased in those with GFR<90 ml/min (p < 0.01). In multivariate analy-
sis, GFR did not correlate with blood pressure or metabolic parameters, 
but correlated positively with body surface (P < 0.001) and protein intake 
(P < 0.01) and negatively with age (P < 0.001) and persistence of antihy-
pertensive drugs (P < 0.001) after surgery. 
Conclusion: GFR decreased after bariatric surgery in subjects with hyper-
filtration, but increased in subjects with renal failure. The main determi-
nants of creatinine clearance after surgery were body surface, age, protein 
intake and antihypertensive treatment.
T8 – Metabolic outcomes (diabetes, lipids, 
hypertension)
T8:PO.017
Effect of metformin on cardiometabolic risk factors in patients 
with abdominal obesity and non-alcoholic fatty liver disease 
(NAFLD)
Komshilova K.A.1, Troshina E.A.1, Ershova E.V.1, Mazurina N.V.1
1Endocrinology Research Center, Moscow, Russian Federation 
Introduction: NAFLD is the chronic disease associated with obesity, in-
sulin resistance and cardiometabolic diseases. Aim: to study the efficacy of 
metformin and its impact on cardiometabolic risk factors in patients with 
abdominal obesity with NAFLD according to liver biopsy. 
Methods: 77 patients aged 30–50 were divided into a control group of 
non-pharmacological treatment (n=37) and primary (n=40) with met-
formin 2 g per day for 1 year. 
Results: The group with metformin: the median weight loss in the study 
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(p = 0,002), and waist circumference - 6.0 and 4.0 cm (p = 0,003), re-
spectively (p < 0,005). In the main group clinically significant weight loss 
(≥5%) reached 72.5%, in the control group - 37.8%. In the study group 
there was a significant reduction in fasting plasma glucose of 9.7% and up 
to 120 minutes OGTT by 16.2%, 20.8% insulin, HOMA-IR by 32.1%, total 
cholesterol by 9.7% LDL-cholesterol by 13.2%, triglycerides by 25% and a 
significant increase in HDL-cholesterol by 18.2% (p < 0.0001). The con-
trol group indicated a less pronounced decrease in these indicators, except 
for a statistically significant reduction of insulin (p > 0,05) and the chang-
es in HDL-cholesterol (p = 0,07). The study group showed a significant 
increase in adiponectin by 46.9% (p < 0.001) reduction in CRP by 48.6% 
(p < 0.001) and PAI-1 activity by 12.1% (p = 0,0005), markers of endo-
thelial dysfunction: endothelin-1 by 20%, E-selectin on 3,6%, ICAM-1 by 
6.5%, VCAM-1 by 8.1% (p < 0.0001); there were no significant changes of 
these indicators in the control group. 
Conclusion: A therapy with metformin in patients with abdominal obe-
sity contributes to a significant reduction in body weight and correction 
associated with NAFLD cardiometabolic disorders.
T8:PO.018
Particularities of the association of obesity with chronic 
kidney disease in the patients with type 1 diabetes mellitus
Bicu M.L.1, Bicu D.2, Vladu I.M.1,3, Clenciu D.1, Sandu M.4, Mota M.3,4
1Department of Diabetes, Hospital Municipal Clinical Filantropia Craiova, 
Romania,  
2Department of Neurology, Hospital Municipal Clinical Filantropia Craiova, 
Romania,  
3Department of Diabetes, University of Medicine and Pharmacy, Craiova, 
Romania,  
4Department of Diabetes, Hospital Clinical Emergency County Craiova, Romania
Introduction: The objective of study was the assessment of obesity and 
insulinresistance (IR) in patients with type 1 Diabetes Mellitus (DM) with 
and without chronic kidney disease (CKD). 
Methods: We analised a random sample of 140 patients with type 1 DM, 
40% women and 60% men, to whom were recorded: age, gender, dura-
tion of DM, IR parameters ((waist circumference (WC), body mass index 
(BMI), waist-hip ratio (WHR), glicated hemoglobin (HbA1c), estimated 
glucose disposal rate (eGDR), the daily insulin requirement, C peptide, 
hypertensive status, dyslipidaemia)), smoking status, creatinine, estimat-
ed Glomerular Filtration Rate (eGFR)(MDRD-4). CKD was defined as 
eGFR < 60 ml/min/1.73 m2 or urinary albumin to creatinine ratio ≥ 30 
mg/g. 
Results: The prevalence of CKD was 58.57% (42.85% of women and 
69.04% of men); of patients with CKD, 29.26% were women and 70.73% 
men. Average age, duration of DM, WHR, abdominal obesity, the pres-
ence of neuropathy was comparable at the two groups. Patients with 
CKD have presented overweight or obesity 40.24% vs. 32.75%, lower 
eGDR (5.86 ± 2.24 vs. 7.16 ± 2.24 mg x kgⅢą x minⅢą), higher HbA1c 
(8.90 ± 1.72% vs 8.33 ± 1.65%), lower daily insulin necessary, lower C 
peptide than patients without CKD. Between patients with CKD, 67% 
have presented HTA, dyslipidaemia 70.73%, 63.41% smoking status, dia-
betic retinopathy 83% comparatively with 39.65%, 53.44%, 36.20%, 63.8% 
of those without CKD. 
Conclusions: Overweight or obesity, eGDR, HTA, dyslipidaemia, poor 
glycemic control, C peptide, the daily insulin requirement, smoking sta-
tus, retinopathy were significantly associated with BCR (P < 0.005). IR 
parameters are associated with CKD.
T8:PO.019
The Potential Role of Iron and Copper in Pediatric Obesity and 
Nonalcoholic Fatty Liver Disease
Zsoldos F.1,3, Feldman A.2,3, Aigner E.2,3, Weghuber D.1,3, Paulmichl K.1,3
1Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria,  
2First Department of Medicine, Paracelsus Medical University, Salzburg, Austria,  
3Obesity Research Unit, Paracelsus Medical University, Salzburg, Austria
Introduction and summary: Obesity is a rapidly growing health problem 
and is paralleled by a multitude of comorbidities, including nonalcohol-
ic fatty liver disease (NAFLD). NAFLD has become the most common 
chronic liver disease both in adults and children. The current understand-
ing of NAFLD is still fragmentary. While simple steatosis is character-
ized by the interplay between excessive free fatty acid accumulation and 
hepatic insulin resistance, the progression to NASH has been related to 
oxidative stress and a proinflammatory state with dysbalanced adipokine, 
cytokine levels and endotoxin-mediated immune response. In addition, 
oxidative stress has been suggested to play a central role for the sequelae 
leading to NASH. Trace elements are critical in regulatory, immunologic 
and in antioxidant functions resulting in protection against inflammation 
and peroxidation and consequently against the known comorbidities of 
obesity. Disruptions of the metal detoxification processes located in the 
liver are plausibly related to NAFLD development via oxidative stress. Per-
turbations of iron and copper homeostasis have been shown to contribute 
to the pathogenesis of NAFLD. 
Methods and results: This review presents current data from pediatric 
studies. In addition, data from adult studies are summarized where clini-
cal relevance may be extrapolated to pediatric obesity and NAFLD.
Acknowledgement: Elmar Aigner is supported by PMU-Forschungsförderungs-
fonds (E-13/17/086-AIG). Daniel Weghuber and Katharina Paulmichl would like 
to acknowledge support by a grant from the European Commission (FP7 contract 
279153, Beta-JUDO).
T8:PO.020
Exploring the feasibility of investigating the impact of diet-
induced weight loss on biomarkers for colorectal cancer (crc): 
Preliminary results from the intercept study
Beeken R.J.1, Croker H.1, Heinrich M.1, Wilson R.1, Obichere A.2, Finer N.2, 
Gunter M.3, Wardle J.1
1University College London, London, UK,  
2University College London Hospital, London, UK,  
3Imperial College London, London, UK
Introduction: Epidemiological data demonstrate that obesity is associated 
with raised risk of some cancers, but there is less evidence that weight loss 
reduces risk. Bariatric surgery is associated with reduced risk of cancer in 
some studies, but there are no comparable data for dietary/behavioural 
programmes. The notorious difficulty of weight-loss maintenance makes 
it difficult to examine effects on long-term cancer outcomes. Cancer-relat-
ed biomarkers could provide a valuable intermediate end-point 
Methods: This single-arm study examined the feasibility of investigating 
the effects of diet-induced weight loss on molecular biomarkers of CRC 
risk in serum and colon tissue. Twenty obese, but otherwise healthy, 
adults (21–57yrs) followed an 8-week complete meal replacement weight 
loss programme. Before and after treatment, blood was drawn for serum 
biomarkers and endoscopic examinations were used to obtain colon biop-
sies. Anthropometric measures were taken by a nurse. 
Results: Participants achieved successful weight loss (9–18%), adhered to 
study procedures and reported high satisfaction with the study. Mean lev-
els of IGF-1 were similar pre- and post-intervention (IGF-1 mean Δ=0.87 
nmol/L), whereas insulin and CRP levels were reduced (insulin mean Δ=-
3.97 mIU/L, CRP mean Δ=4.37 mg/L). Linear change score models sup-
ported associations between changes in weight and change in both insulin 
(β=0.37, p < .001) and CRP (β=0.10, p = 0.003). 
Conclusion: This approach to studying the effects of weight loss on CRC 
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improvements in two serum biomarkers for CRC risk. Analysis of tissue 
biopsies is underway and will provide insight into the effect of weight loss 
on molecular markers in target tissues for CRC.
Acknowledgement: Research relating to this abstract was funded by Cancer Re-
search UK. Meal replacement products were supplied by the Cambridge Weight 
Plan®, Northants, UK.
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Association between obstructive sleep apnea screening and 
adverse pregnancy outcomes among obese gravidas
Weatherford R.D.1, Henderson J.L.1, Goldshore M.A.2,3, Weatherford J.S.4
1Department of Gynecology and Obstetrics, Johns Hopkins University School of 
Medicine, Baltimore, Maryland, USA,  
2Bloomberg School of Public Health, Johns Hopkins University, Baltimore, 
Maryland, USA,  
3The School of Medicine and Health Sciences, George Washington University, 
Washington, DC, USA,  
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Background: Obstructive sleep apnea (OSA) in pregnancy may be asso-
ciated with preeclampsia (PEC), cesarean delivery (CD) and gestational 
diabetes mellitus (GDM). We implemented the STOPBANG Question-
naire (SB), a common screening tool for OSA, in a subspecialty obstetrics 
clinic established to mitigate gestational weight gain in low-income, ur-
ban obese gravidas. Subjects met biweekly with a maternal-fetal medicine 
specialist, a nutritionist and a social worker to enact lifestyle changes for 
enhanced health. 
Objective: To evaluate the association between the SB findings and ad-
verse maternal outcomes among an obese, pregnant cohort. 
Methods: Of the 297 women prospectively enrolled in the cohort, 157 had 
both delivery and SB data and thus were included in the current analysis. 
BMI was measured at the time of SB screening. The associations between 
SB findings and adverse maternal outcomes were analyzed using multi-
ple logistic regression to control for potential confounders, including age, 
parity, hypertension, and BMI. 
Results: BMI ranged from 30 to 71 kg/m^2 (M=41, SD=7.5), age from 15 
to 42 years (M=26.7, SD=5.6) and 93% were African American. 46% of 
women screened positive for OSA using SB. A + SB screen was associated 
with an increased risk of GDM (OR=2.71, CI=1.02–7.21) but was not as-
sociated with CD or PEC in this cohort. 
Conclusions: Among obese gravidas, a + SB screen was a significant pre-
dictor of GDM, suggesting an independent association between sleep-dis-
ordered breathing and glucose metabolism. This association suggests that 
early glucose screening is indicated in the obese gravida with a + OSA 
screen. Further study is needed to determine if preconception OSA evalu-
ation and treatment, in addition to standard weight loss management, can 
mitigate GDM and its consequences.
Fig. 1. OSA Screening and Maternal Health Outcomes
T8:PO.022
Additional analyses of the weight-lowering efficacy of 
liraglutide 3.0 Mg in overweight and obese adults: The scale 
obesity and prediabetes randomised trial
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Le Roux C.7, Violante Ortiz R.8, Wilding J.P.9, Jensen C. B.10, Svendsen C. B.10, 
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This trial investigated the safety and efficacy of liraglutide 3.0 mg for weight 
management as adjunct to a 500 kcal/day deficit diet and exercise pro-
gram (NCT01272219). Adults with BMI ≥27 kg/m˛ and ≥1 comorbidity 
or with BMI ≥30 kg/m˛ were randomised 2:1 to once-daily liraglutide 3.0 
mg (n=2487) or placebo (PBO) (n=1244). Data are observed means for the 
full analysis set with LOCF at week 56, unless stated otherwise. Statistical 
analyses are estimated treatment differences (ETD; ANCOVA, continuous 
variables) or odds ratios (OR; logistic regression, categorical). Baseline BMI 
subgroups were ≤29.9, 30–34.9, 35–39.9 and ≥40 kg/m˛. Baseline charac-
teristics were age 45y, 79% female, body weight (BW) 106 kg, BMI 38 kg/
m˛ and 61% with prediabetes. A total of 92% of patients on liraglutide lost 
BW vs 65% on PBO (figure). Completers on liraglutide (n=1789,72%) lost 
9.2% (9.7 kg) of BW vs 3.5% (3.8 kg) on PBO (n=801,64%; ETD –5.7%, 
p < 0.0001). In total, 73% of completers on liraglutide lost ≥5% BW vs 35% 
on PBO (OR 5.0, p < 0.0001). BW loss of >10% occurred in 41% vs 14% (OR 
4.0, p < 0.0001) of liraglutide-treated vs PBO-treated patients. Overall, BW 
loss with liraglutide was similar in those with and without prediabetes at 
screening (–8.0% vs –7.9%, respectively, p = 0.59) and across baseline BMI 
subgroups (%, p = 0.054; kg, p = 0.54). Non-completion was mainly due to 
GI AEs and lack of efficacy for liraglutide and PBO groups respectively. In 
conclusion, liraglutide 3.0 mg, as adjunct to diet and exercise, induced sig-
nificant BW loss compared to placebo; 92% of subjects treated with liraglu-
tide lost weight. For liraglutide-treated patients completing the study, mean 
BW loss was 9.2% vs 3.5% on PBO. BW loss with liraglutide was indepen-
dent of baseline prediabetes status and BMI.
Acknowledgement: Supported by Novo Nordisk
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T8:PO.023
The influence of obesity and diabetes on the effectiveness of 
statin therapy in patients with increased cardiovascular risk.
Holecki M.1, Duława J.1, Almgren-Rachtan A.2, Chudek J.3
1Department of Internal Medicine and Metabolic Diseases, School of Health 
Science, Medical University of Silesia, Katowice, Poland,  
2Department of Pharmacovigilance, Europharma Rachtan Co.Ltd. Katowice, 
Poland,  
3Pathophysiology Unit, Department of Pathophysiology, Medical University of 
Silesia, Katowice, Poland
Background: Statins are used to reduce cardiovascular risk in patients 
with cardiovascular diseases. However, the effectiveness of therapy in 
many cases remains unsatisfactory. The aim of this study was to evaluate 
the efficacy of statin therapy in patients with elevated cardiovascular risk 
and the factors affecting the efficacy of treatment. Patients and methods: 
This study was conducted on the basis of questionnaires obtained from 
8998 adult patients diagnosed with cardiovascular diseases, by cardiolo-
gists based on the patient history and physical examination of the patient 
and the available documentation during routine cardiological outpatient 
consultations. 
Results: 39.4% of respondents were obese according to WHO criteria and 
62.3% according to the IDF criteria of visceral obesity. 24.3% of patients 
had been diagnosed with type 2 diabetes. The most commonly utilized 
statin was atorvastatin (44.6%), followed by simvastatin (30.6%) and ro-
suvastatin (25.4%). Treatment was not considered fully effective in 2999 
(91.8%) of patients (treated with a statin for at least 3 months) with report-
ed recent complete lipid profile on statin therapy. LDL-cholesterol target, 
adjusted for cardiovascular risk, was obtained by 8.2% of study patients, 
most frequently on rosuvastatin therapy (18.4% of treated). Patients with 
very high risk of cardiovascular disease were least likely to attain target 
LDL cholesterol - 3.4%. The effectiveness of treatment decreased along 
with nutritional status (13.8% with normal weight, 9.8% of overweight 
and 5.2% obese) and was lower in patients with type 2 diabetes (5.4% vs. 
9.4% without diabetes, p <0.001). 
Conclusions: The effectiveness of treatment of hypercholesterolemia with 
statins is low, not adjusting for cardiovascular risk. Obesity, and type 2 
diabetes are among factors limiting the efficacy of statins treatment.
T8:PO.024
Can weight loss outcomes be improved by teaching weight 
maintenance skills before a weight loss intervention?
Fuller N.R.1, Sainsbury A.1, Caterson I.D.1, Denyer G.1, Fong M.1, Gerofi J.1, 
Williams K.H.1, Lau N.S.1, Markovic T.P.1
1The Boden Institute, The University of Sydney, Australia 
Introduction: Previous research has shown that teaching weight mainte-
nance skills prior to a weight loss intervention leads to better long-term 
weight maintenance outcomes. Within the context of a randomised, con-
trolled trial looking at the effects of a high versus low egg diet on circu-
lating lipid profiles, we sought to determine whether implementation of a 
weight maintenance program before a weight loss program would lead to 
better weight outcomes. 
Methods: 140 overweight or obese participants with pre-diabetes or type 
2 diabetes were randomised. Participants attended the clinic monthly for 
the first six months. For the first three months, participants were instruct-
ed to maintain their weight whilst making healthier food choices. For the 
ensuing three months (3–6 months), they were prescribed a daily energy 
restriction of 500 kcal per day and instructed on the specific types and 
quantities of foods to consume. No intervention took place during the 
follow-up (6–12 months). 
Results: Baseline BMI of participants (mean±standard deviation (SD)) 
was 34.6 ± 6.2 kg/m2 and body weight was 95.7 ± 19.1 kg. Only a small 
1.8 ± 2.5 kg weight loss was evident during the weight loss intervention 
(3–6 months). However, weight loss continued after the end of the inter-
vention, from 6–12 months, to 3.1 ± 5.8 kg. When assessing the change 
in weight from the initial contact with participants (month 0), the total 
weight loss over the 12 month study was 3.8 ± 5.8 kilograms (~4% of ini-
tial body weight). There were no significant differences in weight change 
between the two groups. 
Conclusion: Weight loss continued from end of intervention to end of fol-
low-up. These findings provide indirect support for the concept of teach-
ing participants how to maintain a consistent body weight prior to weight 
loss interventions as typically weight regains after the end of an interven-
tion. A longer-term follow-up > 12 months is needed in future studies. 
Reference: 
Kiernan M et al.: J Consult Clin Psych 2013;81:336–346.
T8:PO.025
Preterm delivery is related to pre-pregnancy obesity in 
mothers with gestational diabetes
Barquiel B.1, Cos A.I.1, Hillman N.1, Burgos M.A.1, Pallardo L.F.1, Herranz L.1
1Diabetes and Pregnancy Unit. Obesity Unit. Department of Endocrinology. 
University Hospital La Paz. Madrid. Spain
Aim: To assess the association between preterm delivery, pre-pregnan-
cy body mass index (pre-BMI), overweight and obesity in mothers with 
gestacional diabetes (GDM). 
Method: Observational retrospective study including all women with 
GDM and singleton pregnancies followed in our Unit (N=3,151). Women 
with pregestational diabetes were excluded. Associations between preterm 
delivery and pre-BMI, overweight, obesity, age, GDM severity defined 
by fasting glucose and area under the 100g-oral glucose tolerance test 
(OGTT) at GDM diagnosis; fasting insulinemia previous to GDM treat-
ment, gestational age at GDM diagnosis, insulin treatment, excess gesta-
tional weight gain, urogenital infection, hydramnios and pregnancy-in-
duced hypertensive disorder were studied. Student’s t, Mann-Whitney U 
and two-sided Χ2 tests were used in univariate analyses. Preterm delivery 
associated factors (P < 0.005) were introduced in a multiple logistic re-
gression model. 
Results: Preterm delivery was reported in 126 (4.0%) of GDM mothers. 
It was associated with pre-BMI (24.7 ± 4.6 vs. 26,0 ± 5,4 kg/m2 in preterm 
deliveries, P = 0,014), pre-pregnancy obesity (3.1 vs. 5.4%, P = 0.036), 
maternal age (mean±SD: 33 ± 4 vs. 34 ± 5, P < 0.001), fasting glu-
cose (90 ± 14 vs. 94 ± 17 mg/dl, P = 0.032) area under the 100g-OGTT 
(513 ± 52 vs. 522 ± 63 mg/dl·min-1, P = 0.048), fasting insulinemia 
(median (IQ range): 10 (7–13) vs. 13 (9–17) μUI/ml, P = 0.009), lower 
gestational age at GDM diagnosis (27 ± 5 vs. 25 ± 6, P = 0.006) and preg-
nancy-induced hypertensive disorder (6.2% vs. 11.2%, P = 0.027). Preg-
nancy-induced hypertensive disorder was the main risk factor of preterm 
delivery in multivariate analysis (AOR 95%CI) (1.90 1.07–1.37). This risk 
magnitude was increased in mothers (N=336) being obese pre-pregnancy 
(4.38 1.24–15.49). 
Conclusion: In GDM mothers, preterm delivery is related to being obese 
pre-pregnancy. GDM mothers with pregnancy-induce hypertensive 
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T8:PO.026
Efficacy and safety of liraglutide 3.0 Mg and 1.8 Mg in weight 
loss responders vs non-responders in overweight/obese 
adults with type 2 diabetes (t2d): A subgroup analysis of the 
scale diabetes trial
Mosenzon O.1, Bergenstal R.2, Davies M.3, DeFronzo R.4, Skjřth T.V.5, 
Noctor M.5, Kushner R.6
1Hadassah Hebrew University Hospital, Jerusalem, Israel,  
2International Diabetes Center, Minneapolis, MN, USA,  
3Diabetes Research Centre, University of Leicester, Leicester, UK,  
4Texas Diabetes Institute, San Antonio, TX, USA,  
5Novo Nordisk, Sřborg, Denmark,  
6Northwestern University, Chicago, IL, USA
SCALE Diabetes (NCT01272232) evaluates the efficacy and safety of lira-
glutide for weight management in overweight/obese adults with T2D. This 
subgroup analysis compares outcomes in responders (weight loss [WL] 
≥5%) vs non-responders (WL<5%) at 56 wk. Adults (50% male, mean age 
55 yr, BMI 37 kg/m2, HbA1c 7.9% and T2D duration 7.3 yr) were ran-
domised 2:1:1 to liraglutide 3.0 mg (n=423), 1.8 mg (n=211) or placebo 
(PBO) (n=212) as adjuncts to diet and exercise. Change from baseline are 
LS means (efficacy) or observed means (safety) with LOCF. More individ-
uals on liraglutide 3.0 mg (49.9%) and 1.8 mg (35.6%) were responders 
compared with PBO (13.8%), p < 0.0001. Mean WL for liraglutide 3.0 mg, 
1.8 mg and placebo responders and non-responders is shown in Table. 
Consistent with greater WL, responders on liraglutide 3.0 mg and 1.8 mg 
had improved efficacy outcomes vs non-responders (Table). In responders 
and non-responders AEs were reported by 96 vs 92% and 96 vs 90% for li-
raglutide 3.0 mg and 1.8 mg respectively, and 94 vs 85% for PBO. SAE fre-
quency was similar in responders and non-responders. Most AEs were GI 
and were more common in responders vs non-responders with liraglutide 
3.0 mg (76 vs 55%) but not different for liraglutide 1.8 mg (58 vs 57%) and 
PBO (41 vs 39%). Rates (events/pt/yr) of documented symptomatic hypo-
glycemia (PG≤56 mg/dL) were similar in responders vs non-responders 
across all groups: liraglutide 3.0 mg (0.9 vs 0.8), liraglutide 1.8 mg (0.8 vs 
1.1); placebo (0.1 vs 0.3). Mean change in pulse across groups is shown in 
Table. In conclusion, more individuals achieved ≥5% WL with liraglutide 
3.0 mg and 1.8 mg. Non-responders on liraglutide still had significant im-
provements in HbA1c, indicating a WL-independent effect. AE incidence 
was similar across subgroups.
Acknowledgement: Supported by Novo Nordisk
Fig. 1. Efficacy and safety endpoints for responders and responders on liraglutide 
3.0 mg, liraglutide 1.8 mg and placebo in the SCALE Diabetes trial.
T8:PO.027
Significant increase of low magnesium (mg) serum levels 
in diabetic patients after weight loss induced by bariatric 
surgery (bs)
Brix J.M.1, Kopp H.P.1, Sperker C.1, Schernthaner G.H.2, Schernthaner G.1, 
Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria,  
2Department of Surgery, Rudolfstiftung Hospital, Vienna, Austria,  
3Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Background: Low Mg levels are associated with insulin resistance, type 2 
diabetes (DM), but also vascular calcification and subsequently cardiovas-
cular events. The aim of this study was to assess Mg levels in patients with 
morbid obesity (MO) before and after BS. 
Methods: 302 patients with MO (82.1% women, mean BMI 46.2 ± 6.7kg/
m˛) were investigated in a longitudinal study before and 2 years after 
BS and compared to 92 non-obese healthy controls (CO; mean BMI 
25.6 ± 4.5kg/m˛). Serum Mg levels and cardiovascular risk factors were 
assessed. All patients underwent a 2-hour 75g OGTTwhich revealed: 60 
patients with DM, 53 with impaired fasting glucose (IGT) and 189 with 
normal glucose tolerance (NGT). 
Results: Patients with MO had significantly lower levels of Mg than CO 
(0.84 ± 0.07mmol/lvs 0.92 ± 0.06mmol/l; p < 0.001). After BS an increase 
of Mg was noted (0.85 ± 0.08mmol/l, p = 0.014), but did not reach the 
levels of CO (0.92 ± 0.06mmol/l; p < 0.001). Before BS we found a step-
wise decrease of Mg levels from NGT over IGT to DM (0.80 ± 0.09 
vs0.84 ± 0.07vs0.85 ± 0.07, p < 0.001). The difference in Mg between DM/
IGT (p = 0.009) and DM/NGT (p < 0.001) were significant. Post surgery 
Mg values were not different between the subgroups. Concordantly we ob-
tained a difference between changes of Mg levels pre- to post-op between 
the three subgroups; overall: p < 0.001; DM (increase 7%):p < 0.001; IGT 
(increase 1%):p = 0.858, NGT (increase 1%):p = 0.657. Multivariate re-
gression demonstrated fasting blood glucose as the strongest predictor of 
Mg levels (Beta=-0.222, p < 0.001). 
Conclusion: Patients with morbid obesity have significantly lower serum 
Mg levels before as well as after weight loss due to BS compared to CO. 
The increase in the whole group is mainly due to the 7% increase of Mg 
levels in the group of patients with DM.
T8:PO.028
Diabetes remission is higher in men compared to women after 
bariatric surgery
Brix J.M.1, Kopp H.P.1, Krzizek E.C.1, Sperker C.2, Schernthaner G.H.3, 
Schernthaner G.1, Ludvik B.1
1Department of Medicine I, Rudolfstiftung Hospital Vienna, Vienna, Austria,  
2Department of Surgery, Rudolfstiftung Hospital Vienna, Vienna, Austria,  
3Department of Medicine II, Division of Angiology, Medical University of Vienna, 
Vienna, Austria
Introduction: The majority of patients undergoing bariatric surgery (BS) 
are women. Women and men have a different risk for gaining cardiovas-
cular (CV) disease. It is still not clear if morbidly obese men have the 
same risk profile as women. Therefore we investigated gender differences 
regarding diabetes and weight loss in patients before and after BS. 
Methods: We included 438 patients with MO (mean age 40 ± 12years, 347 
(84%) females, 66 males) before and 2 years after BS. In patients without 
diabetes a 75g oGTT was performed. Diabetes Mellitus was defined by 
ADA criteria. Apart from demographic and CV risk factors renal, inflam-
mation parameters and Insulin levels were assessed. HOMA-Insulin resis-
tance (IR) was calculated. 
Results: Women and men did neither differ in age (40 ± 12vs41 ± 12, 
p = 0.679), nor in BMI (46.5 ± 7.1vs46.0 ± 6.7kg/m2; p = 0.603). But men 
had a slightly higher but not significant excess BMI loss compared to 
women (73.7 ± 23.2 vs 66.4 ± 29.8%; p = 0.064). Before BS men had sig-
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of patients with prediabetes (19.7vs19.5%); Chi-Square 16.941; p < 0.001. 
After surgery, only 1.6% of the male and 2.6% of the female patients 
were still suffering diabetes and 6.3% vs 6.7% were suffering prediabetes; 
Chi Square 0.079; p = 0.961. Men had a greater decrease in HOMA-IR 
(p = 0.013), LDL-cholesterol (p = 0.030), triglycerides (p < 0.001) and 
HbA1c (p = 0.002) and an increase in HDL-cholesterol (p = 0.002) than 
women. 
Conclusion: Our data indicate that, even though there are no differences 
in excess BMI loss men benefit more from BS regarding
T8:PO.029
The relationship between type ii diabetes risks and 
sociodemographic characteristics
Karaca K.E.1, Toprak D.2, Bas M.1, Tevfikoglu Alceylan L.3
1Health Science Faculty, Department of Nutrition and Dietetic, Acıbadem 
University, Istanbul, Turkey 1  
2Sisli Hamidiye Etfal, Training and Research Hospital, Department of Family 
Medicine, Istanbul, Turkey 2,  
3Health Science Faculty, Department of Nutrition and Dietetic, Trakya University, 
Edirne, Turkey 3
Aim: The aim of this study was to determine the relationship between 
socio demeographic characters and Type II diabetes(DM) risk in adults. 
Methods: This study was performed in 4400 individuals between 18–65 
years of age.The subjects were chosen by using basic random sampling 
method.All subjects were administered a questionnaire including ques-
tions about sociodemographic characteristics.Type II Diabetes Risk As-
sessment Questionnare was used to evaluate type diabetes risk and scores 
were grouped as “very high (over 20 points), high (15–12 points), middle 
(12–14 points), slight (7–11 points), low (lower than 7 points)”.Frequen-
cies, mean values, chi-square were used; p < 0.05 was considered signifi-
cant. 
Results: Of 4400 participants 50.3% (n=2212) were female and 49.7% 
(n=2188) were male with the mean ages of 41,18 ± 14.73 and 37.38 ± 14.24 
respectively. There were 2353 (53.5%) subjects in 18–39 years age group 
and 2047 (46.5%) subjects in 40 and over age group. A total of 67.7% were 
married,29.6% were house wives,%17.7were students.%26.0 of the par-
ticipants were active smokers and 13.0% had hypertension.Women had 
more 10 years diabetes risk than men (p = 0.042) and their risk scores 
were significantly higher than men (p = 0.037). Similarly being married 
was significantly high risk for DM (p = 0.000). BMI was a significant 
risk factor (p = 0.000); as a person had higher body weight the was near-
ly 15 fold more for type II DM.We found 10 years DM risk scores more 
in active smokers group (p = 0.000).The risk scores were higher (10.3% 
in very high risk group) in retired people as we expect, because of the 
age(p = 0.000).Education level was an important risk factor for 10 years 
DM risk (p = 0.000).As a person had a higher education level the risk 
score was lower. 
Conclusion: In this study it was determined that type II DM risk was 
incresed realeted with gender, marrital status, age, BMI, smoking, occu-
pation and having a chronical disease.
T8:PO.030
Combined intervention with pioglitazone and n-3 fatty acids 
in metformin-treated diabetic patients
Veleba J.1, Kopecky J.1, Janovska P.2, Kuda O.2, Horakova O.2, Malinska H.1, 
Kazdova L.1, Oliyarnyk O.1, Skop V.1, Trnovska J.1, Hajek M.3, Skoch A.3, 
Flachs P.2, Bardova K.2, Rossmeisl M.2, Olza J.4, de Castro G.S.4, Calder P.4, 
Gardlo A.2, Fiserova E.5, Jensen J.6, Bryhn M.7, Kopecky J.2, Pelikanova T.1
1Centre, Institute for Clinical and Experimental Medicine, Prague, Czech 
Republic,  
2Department of Adipose Tissue Biology, Institute of Physiology Academy of 
Sciences of the Czech Republic v.v.i., Prague, Czech Republic,  
3Department of Diagnostic and Interventional Radiology, Institute for Clinical 
and Experimental Medicine, Prague, Czech Republic,  
4Human Development & Health Academic Unit Faculty of Medicine University 
of Southampton, Southampton, United Kingdom,  
5Department of Mathematical Analysis and Applications of Mathematics, 
Faculty of Science, Palacky University in Olomouc, Czech Republic,  
6University of Oslo,  
7Silentia A.S., Svelvik, Norway
Aims/Hypothesis: Marine n-3 fatty acids eicosapentaenoic (EPA) and 
docosahexaenoic (DHA) acids help in primary prevention of cardiovas-
cular disease, but their impact on glucose homeostasis in type 2 diabet-
ic (T2D) patients remains unclear. We aimed to evaluate the effect of a 
combination intervention using EPA+DHA and a suboptimal doses of 
insulin-sensitizing drug pioglitazone in obese patients with T2D already 
treated with metformin. 
Methods: In a double-blind, placebo-controlled trial, 69 patients, 38–70 
years of age (66% men) were randomly assigned to 24-week-interven-
tion using: (i) corn oil (5 g/day; Placebo), (ii) pioglitazone (15 mg/day; 
Pio), (iii) EPA+DHA (2.75 g/day; Omega3), or (iv) pioglitazone and EP-
A+DHA (Pio+Omega3). The primary endpoints were the changes from 
baseline in insulin sensitivity and in triacylglycerol clearance assessed 
using hyperinsulinemic-isoglycemic clamp and a meal test. Secondary 
endpoints included changes in fasting glycemia and HbA1c, glucose and 
NEFA clearance and inflammatory markers. 
Results: Omega3 and Pio+Omega3 increased EPA+DHA content in 
plasma phospholipids. Pio and Pio+Omega3 increased body weight and 
adiponectin levels. Both fasting glycemia and HbA1c were increased by 
Omega3, but unchanged by Pio+Omega3. Insulin sensitivity was im-
proved by Pio + Omega-3 
Conclusions: Besides preventing a modest negative effects of Omega-3 
on glycemic control, the combination of pioglitazone and EPA+DHA can 
be used to increase insulin sensitivity and postprandial lipid clearance in 
T2D patients on stable metformin therapy.
Acknowledgement: Trial registry number: 2009-011106-42. Supported by the Min-
istry of Health of the Czech Republic ( NT13763-4).
T8:PO.031
The evalutaion of metabolic syndrome status at menopause
Akbulut G.1, Celebi F.2
1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi 
University, Ankara, Turkey
Metabolic syndrome (MetS) is characterized by hypertension, dyslipid-
emia [low levels of high-density lipoprotein cholesterol (HDL-C)and el-
evated triglycerides (TG) levels], obesity, insulin resistance and elevated 
blood glucose levels. It is a risk factor for cardiovascular diseases (CVD) 
and type 2 diabetes mellitus . Studies have shown that about 50% of post-
menopausal women are obese .The increase in body fat (BF) in postmeno-
pausal women, especially the increase in abdominal adipose tissue, will 
result in the increasing risk of dyslipidemia, insulin resistance and CVD. 
Among women, the development of CVD shows an increase after 45–54 
years of age (menopause age), appearing 10 years later than men. Besides, 
menopause is an important risk factor for metabolic syndrome. A number 
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factor for CVD: the age- adjusted risk of CVD in women with premature 
menopause is higher than it is in pre-menopausal women. Oestrogens 
also increase plasma lipids and triglycerides profile in postmenopausal 
females. It is interesting to note that the first four risk modifiable factors 
are components of the MetS. To conclude, the hypoestrogenaemia of 
menopause would play a direct and indirect role inthe biochemical and 
mechanic changes that contribute to the development of hypertension. 
The effects of menopause on serum lipids may modulate CVD risk. In 
conclusion, postmenopausal status seems to play an important role in the 
prevalence of the metabolic syndrome.
T8:PO.032
The impact of subclinical hypothyroidism in microvascular 
damage in patients with metabolic syndrome
Bychina E.S.1, Panchenkova L.A.1, Troshina E.A.2, Mazurina N.V.2, 
Platonova N.M.2, Komshilova K. A.2
1Moscow State University of Medicine amd Dentistry, Moscow, Russia,  
2Endocrinology Research Center, Moscow, Russia
Background: High risk of coronary heart disease, heart failure and car-
diovascular mortality is observed in metabolic syndrome (MS). Subclin-
ical hypothyroidism (SH) is also associated with an increased risk of car-
diovascular diseases. The aim of the study was to assess the impact of SH 
in microvascular damage in patients with MS and arterial hypertension 
(AH). 
Methods: 87 patients were divided into 3 groups: 25 (28.7%) patients with 
AH, 37 (42.6%) patients with AH and MS, 25 (28.7%) patients with AH, 
MS and SH. 22 practically healthy people were included in the control 
group (CG). Microvascular function was determined in all the patients by 
laser Doppler flowmetry. 
Results: Statistically significant reduction of the standard deviation of 
microcirculation (SD M) was observed in all groups in comparison with 
healthy controls. In the AH+MS+SH group a significantly increased heart 
rate induced fluctuations (AmaxCF/3SD M) (values more 30%), respira-
tory rate fluctuations (AmaxHF/3SD M) (values more 30%) and intravas-
cular resistance (AmaxCF/M) (values more 10 perfusion units (PU)) were 
found as compared to healthy individuals, patients with AH and patients 
with AH and MS. In the AH+MS+SH group the index of the effectiveness 
of the microcirculation (IEM) was decreased in comparison with healthy
controls and AH+MS patients (1,23 [0,99; 1,65] vs 1,75 [1,23; 2,24] и 1,67 
[1,31; 2,00] PU respectively (p < 0,05)). 
Conclusions:Results of microvascular function examination were sim-
ilar in MS+AH and MS+AH+SH groups. Microvascular dysfunction in 
MS+AH+SH patients was stronger and was particularly characterized by 
suppression of active regulation mechanisms and severe venous and cap-
illary congestion.
T8 – Long term outcomes
T8:PO.033
Effectiveness of a multidisciplinary weight loss programme 
to maintain a weight loss greater than 10% from the initial 
weight, after two years follow up. PROKAL Study: Results at 24 
months
Moreno B.1, Bellido B.2, Sajoux I.3, Goday A.4, Saavedra D.1, Crujeiras A.B.5, 
Casanueva F.F.6
1Div. of Endocrinology and Nutrition, HGU Gregorio Marańon, Madrid, Spain,  
2Div. of Endocrinology, CHU de Ferrol and Coruńa University, El Ferrol, Spain,  
3Med Dept Pronokal, Protein Supplies SL, Barcelona, Spain,  
4Div of Endocrinology, Hospital del Mar, Dep of Medicine, Universitat Autonoma 
de Barcelona, Barcelona, Spain,  
5Molecular and Cellular Laboratory, Inst Inv Sanitarias, CHU de Santiago, 
Epigenetics and Cancer Biology Program, IDIBELL, Barcelona, Spai,  
6Div of Endocrinology, Dep of Medicine, CHU de Santiago, Santiago de 
Compostela University
Introduction: The PronoKal Method® is a multidisciplinary weight loss 
method combining diet, physical activity and coaching, which not only 
achieves quick and safe weight loss, but also re-educates the patient in 
healthy lifestyle habits that help to maintain long term results. 
Objective: To assess the effectiveness of the PronoKal Method® with pro-
gressive dietary guidelines vs a standard low calorie diet, in weight re-
duction and long-term maintenance. METHODS: A randomised, open, 
controlled clinical trial on weight loss with a multidisciplinary weight loss 
programme with progressive dietary guidelines that include a ketogenic 
VLCD diet based on protein preparations followed by a low calorie diet 
with the progressive reintroduction of natural foods and a low calorie 
maintenance diet (VLKD group) compared with a standard low-calorie 
diet. The percentage of patients achieving a weight loss greater than 5% 
and 10% at one year and at two years was subject to study. 
Results: The percentage of patients with a weight loss greater than 5% 
and 10% was statistically higher throughout the study in the VLKD group 
compared to low-calorie group. At 12 months, almost 90% of the VLKD 
patients group maintained a weight loss greater than 10%, while at two 
years 43% of patients still maintained a loss of between 5% and 10%, and 
58% of patients with a loss greater than 10% of the initial weight, com-
pared to only 21.7% of patients in the low-calorie group (p <0.05). 
Conclusions: The results of this study demonstrate that the multidisci-
plinary weight loss programme is effective not only for weight loss but for 
long-term maintenance. This achievement meant that at two years almost 
60% of patients maintained a loss of more than 10% compared to their 
initial weight.
T8:PO.034
The long-term effectiveness of a multidisciplinary approach to 
weight loss compared with a low calorie diet. PROKAL Study: 
Results at 24 months.
Moreno B.1, Bellido D.2, Sajoux I.3, Goday A.4, Saavedra D.1, Crujeiras A.B.5, 
Casanueva F.F.6
1Div of Endocrinol and Nut, HGU Gregorio Marańon, Madrid, Spain,  
2Div of Endocrinol, CHU de Ferrol and Coruńa University, El Ferrol, Spain,  
3Med Dep Pronokal, Protein Supplies SL, Barcelona, Spain,  
4Div of Endocrinol, Hospital del Mar, Dep of Med, UAB, Barcelona, Spain,  
5Mol and Cel Lab, Inst de Inv Sanitarias, CHU de Santiago, Epigenetics and 
Cancer Biology Program, IDIBELL, Barcelona, Spain,  
6Div of Endocrinol, Dep of Med, CHU de Santiago, Santiago de Compostela
Introduction: The PronoKal Method® is a multidisciplinary slimming 
which start with a ketogenic VLCD diet based on protein preparations 
followed by a low calorie diet with the progressive reintroduction of foods, 
food re-education and a low calorie maintenance diet; physical activity 
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Objective: To evaluate the effectiveness of the multidisciplinary slimming 
method in the short, medium and long term (2 years) for weight loss com-
pared with a standard low calorie diet in obese patients. METHODS: A 
randomized (1:1), open, controlled clinical trial to assess the effectiveness 
of the Método PronoKal® (VLCK diet group) vs a standard low calorie 
diet (LC diet group) accompanied by physical activity and emotional 
support, in the weight reduction of obese patients. The follow-up lasted 2 
years. The results between the groups was compared at 2 to 6 months,12 
months and 24 months. 
Results: Differences were found between both groups in weight reduction, 
which was significantly higher in the VLCK diet throughout the study (2 
months: –13.6 vs 4.8 kg; 6 months: –22.0 kg vs –6. 8 kg; 12 months:-19.9 
vs –7.0 kg and 24 months –12.53 kg vs –5.2 kg; all p < 0.001). This weight 
loss translated into a statistically higher decrease in BMI and waist cir-
cumference (WC) in the VLCK group at one year (BMI: –7.0 vs –2.6 kg/
m2 and WC: –18.4 vs –7.0 cm; both p < 0.001), and also at two years (BMI: 
–4.3 kg/m2 vs –1.9 kg/m2; and WC: –11.5 cm vs –4.1 cm; both p < 0.01). 
The decrease in BMI allowed the VLCK group of patients to remain out-
side the obese range (<30 kg/m2) for 18 months, whereas the low-calorie 
patients remained > 30 kg/m2 despite the weight loss. 
Conclusions: The PronoKal Method® has not only proved to be more ef-
fective than a standard low calorie diet in the short, medium and long 
term, but, unlike the low-calorie diet, it has been able to maintain the pa-
tients free from obesity during a period of 18 months.
T8:PO.035
Obese hypogonadal men with cardiovascular diseases (CVD) 
lose weight and benefit from long-term treatment with 
testosterone undecanoate injections (TU): Observational data 
from a registry study
Saad F.1,2, Haider K.S.3, Haider A.3, Doros G.4, Traish A.5
1Bayer Pharma AG, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Private Urology Practice, Bremerhaven, Germany,  
4Boston University School of Public Health, Boston, USA,  
5Boston University School of Medicine, Boston, USA
Introduction: Hypogonadism is associated with cardiometabolic. There 
is little information on long-term effects of testosterone therapy (TRT) in 
men with CVD. Material and 
Methods: Prospective, cumulative, observational registry study from a 
single urologist’s office. 347 hypogonadal men received TU for up to 87 
months. A subgroup of 68 men with a previous diagnosis of coronary ar-
tery disease (CAD; n=40) and/or a history of myocardial infarction (MI; 
n=40) and/or stroke (n=6) were analyzed. These patients are considered 
high-risk patients. 
Results: Mean age: 60.76 ± 4.94 years, mean observation time 72 
months. 64/68 men were obese. 68 men were followed for 3 years, 59 4 
years, 54 5 years, 44 6, and 28 7 years. Declining numbers reflect the na-
ture of the registry but not drop-out rates. Weight (kg) decreased from 
115.07 ± 13.71 to 90.79 ± 8.92. Waist circumference (cm) decreased 
from 112.07 ± 7.97 to 99.14 ± 6.53. BMI decreased from 37.27 ± 4.45 to 
29.58 ± 3 (p < 0.0001 for all). Mean weight loss was 18.75 ± 0.71%. Fast-
ing glucose decreased from 108.74 ± 17.08 to 96.14 ± 2.01 mg/dl, HbA1c 
from 7.81 ± 1.16 to 5.86 ± 0.49% (p < 0.0001 for both). Total cholesterol 
decreased from 304.66 ± 34.09 to 187.75 ± 7.6, LDL from 184.28 ± 37.51 
to 120.64 ± 29.29, triglycerides from 308.38 ± 56.3 to 187.04 ± 7.65 mg/
dl. HDL increased from 63.79 ± 17.79 to 67.14 ± 16.71 (p < 0.0001 for 
all). Systolic (from 167.82 ± 11.01 to 142.39 ± 9.54) and diastolic (from 
102.28 ± 8.23 to 80.07 ± 7.13 mmHg) BP decreased (p < 0.0001 for both). 
C-reactive protein (CRP) decreased from 3.97 ± 4.73 to 0.32 ± 0.44 mg/dl. 
No major cardiovascular events occurred. 
Conclusion: TRT in hypogonadal men with CVD was well tolerated and 
resulted in significant and sustained improvements of cardiometabolic 
risk factors.
T8:PO.036
Effects of long-term treatment with testosterone undecanoate 
injections (TU) on excessive obesity in hypogonadal men – 
experience from observational registry studies
Saad F.1,2, Haider A.3, Yassin A.2,4
1Bayer Pharma AG, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Private Urology Practice, Bremerhaven, Germany,  
4Institute for Urology and Andrology, Norderstedt, Germany
Introduction: Obesity can cause hypogonadism, and hypogonadism pro-
motes further accumulation of fat mass in a vicious cycle. In excessive-
ly obese men (BMI ≥40 kg/m2), a 75% prevalence of hypogonadism was 
found. Material and 
Methods: Cumulative, prospective, observational registry studies of 
609 men from two cohorts with total testosterone levels ≤12.1 nmol/L 
receiving TU for up to 11 years. A subgroup of 39 men with excessive 
obesity (BMI minimum: 40.1; maximum: 46.5 kg/m2) received uninter-
rupted treatment for up to 114 months. Minimum treatment duration: 42 
months, maximum: 114 months. 
Results: Average weight decreased from 128.7 kg to 101.5 kg, average 
weight loss 27.2 kg. The magnitude of weight loss depended on treatment 
duration: the longer the treatment, the greater the weight loss. Minimum 
weight loss was 18 kg in a subject who had received 42 months of treat-
ment, maximum weight loss of 39 kg was observed in a man who had 
been treated for 87 months. No subject gained weight, and weight loss was 
progressive over time. Average waist circumference decreased from 118.0 
cm to 104.9 cm by 13.1 cm. The smallest reduction of 6 cm was seen in a 
man who had been treated for 57 months, the greatest reduction of 25 cm 
was observed in a man who had been treated for 114 months. 
Conclusions: Treating hypogonadism by TU in hypogonadal men with 
excessive obesity resulted in sustained improvements in weight and waist 
circumference in all subjects. The magnitude depended on treatment du-
ration.
T8:PO.037
Effects of continuous treatment up to 11 years with 
testosterone undecanoate injections (TU) in 115 hypogonadal 
men on anthropometric parameters: Real-life data from an 
observational registry study
Saad F.1,2, Yassin A.2,3, Doros G.4, Traish A.5
1Bayer Pharma AG, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Institute for Urology and Andrology, Norderstedt, Germany,  
4Boston University School of Public Health, Boston, USA,  
5Boston University School of Medicine, Boston, USA
Introduction: The longest-term follow-up on testosterone replacement 
therapy (TRT) in the literature is 6 years. In this registry study, we assessed 
effects of TRT beyond this period. Material and 
Methods: Single-center, cumulative, prospective, registry study of 262 
hypogonadal men receiving TU for up to 11 years. In 147 men, TRT had 
been temporarily discontinued. In 115 men reported here, TRT was con-
tinued for up to 11 years. 4 patients dropped out, 2 due to relocation, 2 
were lost to follow-up. Measures were taken at every other visit. Results at 
the end of 10 years follow-up are reported. 
Results: Mean age was 59.05 ± 9.36 years (min.: 19; max.: 80). Total T 
increased from 7.84 ± 2.34 nmol/L to trough levels (measured prior to the 
following injection) between 17 and 20 nmol/L, free T from 150.31 ± 65.24 
to 400–500 pmol/L, and SHBG decreased from 40.12 ± 20.73 to 
33.11 ± 22.14 nmol/L (p < 0.0001). Mean waist circumference decreased 
from 106.47 ± 8.72 to 92.33 ± 5.32 cm. The decrease was statistically sig-
nificant vs baseline (p < 0.0001) and significant vs previous year for the 
first 7 years. The reduction of waist circumference was 11.98 ± 5.03%. 
Mean weight decreased from 97.3 ± 12.88 to 84.65 ± 7.04 kg. Mean BMI 
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tically significant vs baseline (p < 0.0001) and significant vs previous year 
for the first 8 years. Weight reduction was progressive and accumulated 
to 18.51 ± 6.46% after 10 years. No major adverse cardiovascular event 
(MACE) occurred during the entire observation time. 
Conclusions: Long-term TRT improved anthropometric parameters in 
hypogonadal men in a meaningful and sustained fashion.
T8:PO.038
Temporary withdrawal of testosterone treatment (TRT) with 
testosterone undecanoate injections (TU) in morbidly obese 
hypogonadal men – a series of case reports
Saad F.1,2, Yassin A.2,3
1Bayer Pharma AG, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Institute for Urology and Andrology, Norderstedt, Germany
Introduction: Little is known about the optimal duration of TRT in el-
derly hypogonadal men. We assessed anthropometric parameters and 
glycaemic control in 9 morbidly obese, hypogonadal men with or without 
withdrawal of long-term treatment with TU. Material and 
Methods: From a registry study of 262 hypogonadal men, 9 men with 
obesity grade III were analysed. All men received TU for approximately 
6 years. In 6 men, TU was withdrawn for approximately 2 years before 
treatment was resumed. 3 men received continuous treatment for up to 
10 years. 
Results: Patient age at baseline: 54–69 years. 2 men had type 1 diabetes 
mellitus (T1DM), 5 men type 2 diabetes mellitus (T2DM). Patients with 
T1DM or T2DM received treatment by their individual general practi-
tioners / internists. Weight decreased in all patients while on TU by 13 to 
37 kg, waist circumference 6 to 25 cm. During interruption of T therapy, 
all patients gained weight and waist circumference which started drop-
ping again after resuming T treatment. In diabetics, HbA1c decreased by 
at least 1.1% to a maximum of 3%. After discontinuation of TU, HbA1c 
increased by a minimum of 1.1% and improved again after resuming TRT. 
At end of observation, all diabetic patients had HbA1c <7%, 5 out of 7 had 
an HbA1c ≤6.5%. 
Conclusions: In morbidly obese hypogonadal men, benefits of TRT on 
anthropometric parameters are partly reversed after discontinuation but 
recovered after resuming therapy. In diabetic men, TRT improves glycae-
mic control but effects seem to be largely lost when treatment is inter-
rupted.
T8:PO.039
Effects of interrupting and resuming long-term testosterone 
replacement therapy (TRT) on anthropometric parameters 
in hypogonadal elderly men. How long should hypogonadal 
subjects be treated?
Saad F.1,2, Yassin A.2,3, Al Mehmadi Y.3, Doros G.4, Traish A.5
1Bayer Pharma AG, Berlin, Germany,  
2Gulf Medical University, Ajman, UAE,  
3Institute for Urology and Andrology, Norderstedt, Germany,  
4Boston University School of Public Health, Boston, USA,  
5Boston University School of Medicine, Boston, USA
Introduction: This study investigated effects of long-term TRT, its with-
drawal and resumption on anthropometric parameters in hypogonadal 
men. Material and 
Methods: Prospective, cumulative, registry study in 262 hypogonadal pa-
tients (mean age 59 years) receiving testosterone undecanoate injections 
(TU) 1000 mg in 12-week intervals for up to 11 years. After TRT for a 
median duration of 5 years, 147 men interrupted TRT for 2 years, mainly 
due to cost reimbursement issues, and resumed TRT thereafter (Group 
I; I). 115 men were treated continuously (Group C; C). Three periods of 
equal duration were defined: pre-interruption (on TRT), during interrup-
tion (off TRT) and post-interruption (on TRT after resumption of TRT). 
For comparison, the same periods were analysed for those patients who 
continued TRT throughout. Anthropometric parameters were measured 
at every other visit. 
Results: I: T was 16.54 pre, dropped to 7.48 and increased to 18.5 nmo-
l/L post-interruption. C: T was stable at 19.61,19.76 and 19.65 nmol/L. 
I: Waist circumference (WC) was 100.16 pre, increased to 105.44 during 
and decreased to 102.29 cm post-interruption. C: WC declined from 98.4 
to 97.2 and 95.7 cm. I: Weight was 92.1 pre, increased to 97.1 during and 
decreased to 94.4 kg post-interruption. C: Weight declined from 87.7 to 
86.2 and 84.4 kg. In Group I, 6 patients had major adverse cardiovascular 
events (MACE) while off TRT. There were no MACEs in Group C or in 
Group I while patients were on TRT. 
Conclusions: Interruption of TRT resulted in worsening of symptoms. 
Hypogonadism may require lifelong TRT.
T8:PO.040
Allostatic load in patients with type ii diabetes
Macit S.1, Acar Tek N.1
1Gazi University, Faculty of Health Science, Department of Nutrition and 
Dietetics, Ankara/TURKEY
Objective: Optimal glycemic control is necessary to prevent and extend 
the complications of diabetes. If the regulation couldn’t be maintained, 
homeostasis is interrupted in consequence of altered metabolic processes. 
Chronic dysregulation of physiological systems may lead allostatic load 
(AL). The aim of the present study was to investigate the association of AL 
biomarkers in patients with diabetes that who gained control with blood 
glucose regulation or not.
Methods: Total 103 patients with diabetes enrolled from the outpatient 
clinic of Endocrinology and Metabolism of Ondokuz Mayıs University. 
Patients divided into two groups which are unregulated and regulated di-
abetes, according to HbA1c levels higher and lower than 6.5%. Twelve 
biomarkers were used; fasting blood glucose, blood pressure, body mass 
index (BMI), waist/hip circumference, total cholesterol, HDL cholesterol, 
HbA1c (%), body fat percentage, serum C-reactive protein (CRP), albu-
min, cortisol , DHEA-S levels to asses AL. Values within higher than the 
referances were scored as 1 while those falling below the referances scored 
as 0. AL indices ranged from 0 to 12. 
Results: The study was carried out on 30 male (29.1%) and 73 female 
(70.9). The mean ages of the patients were found 46.46 ± 5.973 years. 
Mean AL score among the sample having unregulated and regulated 
blood glucose was 5.1 ± 1.18 and 4.32 ± 1.64, respectively. The difference 
between groups was statistically significant (p < 0.05). Biomarkers that 
contribute to allostatic load score were evaluated, mean CRP levels were 
4.6 ± 2.06 mg/dL, fasting blood glucose were 113.5 ± 23.45 mg/dL in the 
sample that having regulated blood glucose and mean CRP levels were 
7.39 ± 8.71 mg/dL, fasting blood glucose were 165.04 ± 52.99 mg/dL in 
the sample that having unregulated blood glucose. Dietary carbohydrate 
percentage of energy was higher (42.1 ± 6.48%) in the unregulated group 
than the regulated group (42.1 ± 6.48%) but not statistically significant. 
The difference between total energy, fat and sodium amount of dietary 
intakes were different between groups (p < 0.05). Diabetes duration rep-
resents statistically significant correlation with AL (r: 0.201) and HbA1c 
(r: 0.489). 
Conclusion: Poor glycemic control have negative effects on AL biomark-
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T8:PO.041
A systematic review and meta-analysis on the effects of 
exercise training versus hypocaloric diet: Distinct effects on 
body weight and visceral adipose tissue
Verheggen R.J.1, Maessen M.F.1, Green D.J.2,3, Hermus A.R.4, Hopman M.T.1, 
Thijssen D.H.1,2
1Department of Physiology, Radboud university medical center, Radboud 
Institute for Health Sciences, Nijmegen, the Netherlands,  
2Research Institute for Sport and Exercise Sciences, Liverpool John Moores 
University, Liverpool, United Kingdom,  
3School of Sport Science, Exercise and Health, University of Western Australia, 
Crawley, Western Australia, Australia,  
4Department of Internal Medicine, Division of Endocrinology, Radboud 
university medical centre, Radboud Institute for Health Sciences, Nijmegen, the 
Netherlands
Introduction: Exercise training (“training”) and hypocaloric diet (“diet”) 
are frequently prescribed for weight loss in obesity. Whilst changes in 
body weight are commonly used to evaluate lifestyle interventions, vis-
ceral adiposity (VAT) is a stronger predictor for morbidity and mortality 
than body weight. Currently, it is not known whether training or diet has 
superior effects on VAT. The aim of this study is to compare the impact of 
training versus diet on VAT in overweight/obese humans. 
Methods: Pubmed, Cochrane, Web of Science and Embase were system-
atically searched for eligible studies that evaluated the effects of training or 
diet (duration >4 weeks) on radiographic quantified VAT in overweight/
obese humans. 
Results: 117 Studies (n=4,815) were included. Training and diet caused 
VAT loss (standard mean difference (SMD): –0.47; 95%CI –0.56/-0.39 
and SMD –0.63; 95%CI-0.71/-0.55, respectively, (both P < 0.0001). When 
comparing diet versus training, diet caused a larger weight loss (SMD 
0.308; 95%CI 0.02/0.596; P = 0.04). In contrast, a trend was observed to-
wards a larger VAT decrease in training (SMD –0.59; 95%CI –1.248/0.071; 
P = 0.08). Changes in weight and VAT showed a strong correlation af-
ter diet (R˛=0.737, P < 0.001), and a modest correlation after training 
(R˛=0.451, P < 0.001). In the absence of weight loss (Y-axis intercept), 
training is related to 6.1% decrease in VAT, whilst diet showed virtually 
no change (1.1%). 
Conclusion: Both training and diet reduce VAT. Despite a larger effect 
of diet on weight loss, training tends to have superior effects in reducing 
VAT. Finally, weight loss does not necessarily reflect changes in VAT and, 
therefore, examining weight loss may lead to spurious conclusions when 
evaluating benefits of lifestyle-interventions.
Fig. 1. Forest plot of the effect size (SMD) of (A) exercise training versus 
hypocaloric diet on weight loss and (B) exercise training versus hypocaloric on 
VAT loss in 8 RCT‘s (n=400) that directly compared interventions. The SMD and 
95%CI for individual studies and the pooled estimate (assessed with the use of 
Random Effects Model) are depicted.
Fig. 2. Correlation between %VAT change and %weight change for exercise studies 
(R˛=0.4531, P < 0.001; trendline: y = –3.03x – 6.1), and caloric restriction studies 
(R˛=0.737, P < 0.001; trendline: y = -2.46x - 1.1).
T8:PO.042
Bariatric surgery – does age matter?
Schindler K.1, Schmetterer P.1, Kefurt R.2, Kral M.1, Kruschitz R.2, Langer F.2, 
Luger M.1, Prager G.2, Krebs M.1, Ludvik B.3
1Medical University Vienna, Dpt. Internal Medicine III,  
2Medical University Vienna, Dpt. Surgery,  
3Hospital Rudolfstiftung
Introduction: Bariatric surgery is considered as more effective treatment 
of morbid obesity than conservative medical treatment. However, there is 
contradictory evidence regarding the influence of age on bariatric surgery 
outcome [length of hospital stay (LOS), long-term weight loss] and long-
term adherence to postoperative care. 
Methods: Pre- and postoperative [2 (Y2) and 5 years (Y5)] evaluation 
of 96 adult female morbidly obese patients [mean age 43.9(15.3) years] 
who underwent Y-Roux gastric bypass. Patients were split into two groups 
[Young 20–36y, Old 50–72y] and matched for Body Mass Index [mean 
BMI kg/m˛ Y 46.2(4.8) vs. O 46.6(5.3)]. 
Results: LOS of O was significantly longer compared to Y [mean (stan-
dard deviation), Y 7.1(3.2), O 10.3(10.0), p = 0.023]. After 2 years 60% of 
Y, 81% of O (p = 0.019) and after 5 years 42% of Y and 63% of O (p = 0.03) 
were available for postoperative follow-up. Mean BMI loss (kg/m˛) was 
16.7(4.8) in Y vs. 15.0(5.4) in O after Y2. After Y5 Y had reduced BMI 
by –15.9(5.0)kg/m˛ vs. O –14.6(5.9)kg/m˛. In Y5 67% had a higher BMI 
[mean +2.6(1.9)kg/m˛] than three years before, with no difference be-
tween groups. Linear regression revealed a significant association between 
age and LOS (p = 0.007), as well between Y5 BMI loss, age (p = 0.04) and 
baseline BMI (p = 0.001). 
Conclusion: Patients at higher age, compared to younger ones, might ex-
perience a longer LOS and less pronounced BMI reduction. This and less 
extensive adherence of younger patients to postoperative care should be 
considered when information about the surgical intervention and postop-
erative care is given and bariatric surgery is planned. Reasons for limited 
adherence to follow-up need further evaluation.
T8:PO.043
Behavioral predictors of weight regain after bariatric surgery
Calvo I.1, Exposito M.1, Cos A.I.1
1Obesity Unit. Department of Endocrinology. University Hospital La Paz. Madrid. 
Spain 
Introduction: A significant percentage of patients undergoing bariatric 
surgery procedures (CB), the weight regain occurs after the first years, it 
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lem. AIM: We propose to identify the factors regarding lifestyle, which 
can reduce the effectiveness of the CB past three or four years after Gastric 
Bypass (BYG) or Tubular gastrectomy (GT). 
Methods: The study was performed in 68 patients (71% female and 29% 
male) operated in 2008–2009 of CB (48% GT and 52% BYG) in the Obesi-
ty Unit of the La Paz University Hospital, Madrid, Spain. By questionnaire 
“ad hoc” were recorded attendance monitoring visits and physical activity 
and self-perception about the results. Has been results established tele-
phone contact with each patient to confirm data history. 
Results: Mean age of 41.4 ± 9.3 years. We observed that patients with BYG 
lost more weight 74% versus 46.2% with GT, using as an indicator the % 
excess BMI lost. When evaluating the % weight loss (PP): 66% of BYG 
loses a ≥30% and ≤30% % PP 64% GT. 56%, patients with BMI between 
40 and 50 lost> 30% body weight while in cases of extreme obesity (BMI> 
50), only 44% lost> 30%. With a trend to significance (0.067). Regard-
ing physical activity, 53% stated „active“ and of them, 70% lost > 30% PP. 
26.5% did not do any physical activity. Regarding self-perception on the 
results, 86% reported feeling well and great correlated with weight loss. 
Conclusion: The importance of nutritional monitoring is a mechanism to 
ensure the success of bariatric surgery. Adherence to a program of physi-
cal activity is a predictive factor in maintenance weight loss.
T8 – Bariatric and metabolic surgery
T8:PO.044
Bpd as a re-do bariatric and metabolic operation
Dolezalova K.1,2, Fried M.1,2, Sramkova P.1,3, Pichlerova D.1
1OB klinika – Center for treatment of Obesity and Metabolic Disorders, Prague, 
Czech Republic,  
21st Faculty of Medicine, Charles University, Prague, Czech Republic,  
3Endocrinology Institute, Prague, Czech Republic
Introduction: Biliopancreatic diversion (BPD) is considered as one of 
the most powerful primary operation in WL and metabolic outcomes. 
Multifactorial background of obesity and multi-level obesity „defend-
ing“ mechanisms may potentially contribute to unsatisfactory treatment 
results, neccessitating re-do surgery. Malabsorptive re-do operations fol-
lowing failed restrictive procedures may lead to the best outcomes. 
Methods: Between January 2003 and December 2012, 2781 different bar-
iatric and metabolic procedures were performed by our team. In total, 
251 (9.02%) patients required reoperation due to procedure (weight loss/
metabolic outcome) failure. In 81 (32.3%) BPD was chosen for re-do. In 
this re-do group, 38 (46.9%) patients were T2DM. Prospectively, basic de-
mographic data were collected, as well as pre re-operation, 1,3, 6, 12 and 
24 mths post-op %EWL, %EBMIL and T2DM changes (glycaemia, IRI, 
Hb1A, HOMA IR, fasting insulin secretion) were monitored. 
Results: As a re-do procedure, BPD resulted in statistically significant 
(p < 0.001) changes: mean %EWL (55.5± 8,4), %EBMIL (76,0 ± 6.8). 
In diabetics glycemia decreased (7.9 ± 2.4mmol/l to 5.4 ±1.1mmol/l 
p < 0.001), Hb1A decreased (7.3 ± 1.7% to 4.3 ± 0.9% ), HOMA-IR de-
creased (9.9 ± 2.7 to 3.1 ± 1.5) p < 0.001). Six months after re-do BPD 20 
patients (52.6%) were without any anti-DM medication, in one year re-
mission and/or improvement was observed in 34 (89.5%) T2DM patients. 
Conclusions: As a re-do procedure, BPD is safe and effective procedure in 
terms of %EWL and T2DM improvement/resolution.
T8:PO.045
Novel transoral endoscopic technique to reduce stomach 
volume induces changes in gastrointestinal transcriptome
van der Wielen N.1,2, Paulus G.F.3, van Avesaat M.1,4, Masclee A.A.4, 
Witkamp R.F.2, Meijerink J.2, Bouvy N. D.3
1TI Food and Nutrition, Wageningen, The Netherlands,  
2Division of Human Nutrition, Wageningen University, Wageningen, The 
Netherlands,  
3Department of Surgery, Maastricht University Medical Center, Maastricht, The 
Netherlands,  
4Division of Gastroenterology and Hepatology, Maastricht University Medical 
Center, Maastricht, The Netherlands
Introduction: Bariatric surgery is a very effective intervention strategy in 
obesity. Recently, a novel minimally invasive technique, the Articulating 
Circular Endoscopic stapler has been developed, which reduces gastric 
volume. This procedure results in a 34.9%(IQR 17.8–46.6) median per-
centage of excess weight loss in the first year [1]. Here, we present the first 
study investigating changes in gene expression and underlying molecular 
pathways in stomach and duodenum tissue from humans subjected to Ar-
ticulating Circular Endoscopic stapler. 
Methods: Ten obese patients underwent a transoral endoscopic proce-
dure in which several gastric plications were created to reduce the volume 
of the stomach. Prior to the procedure and after one year, mucosal biop-
sies were taken from the fundus, antrum and duodenum. Gene expression 
was measured using microarray analysis. Transcriptome data were cor-
related to changes in gut hormone levels and weight loss. 
Results: Transcriptome analysis revealed that expression of somatostatin 
was reduced in both the fundus and duodenum after the stomach reduc-
tion procedure, which was in line with the obtained results on plasma 
hormone levels (ghrelin, GLP-1 and PYY). Gene sets related to inflamma-
tion were downregulated in the fundus. In the duodenum the procedure 
resulted in an upregulation of gene sets related to lipid metabolism. 
Conclusion: This transcriptome analysis is one of the first studies using 
biopsies from humans subjected to a gastric volume reduction and pro-
vides key insights into underlying mechanisms of this novel minimally 
invasive bariatric surgical technique.
Reference:
1. Paulus, et al.: Obes Surg, 2014.
T8:PO.046
The quality of follow-up is essential for success after 
laparoscopic adjustable gastric banding in adolescent
Khen-Dunlop N.1,5, de Filippo G P.3, Jais P.4,5, Bougneres P.3, Goulet O.2,5, 
Revillon Y.1,5, Dabbas M.2
1Pediatric Surgery, AP-HP, Necker-Enfants malades Hospital,  
2Pediatric Gastro-enterology and Nutrition, AP-HP, Necker-Enfants malades 
Hospital,  
3Pediatric Endocrinology, AP-HP, Bicetre Hospital,  
4Department of biostatistics, AP-HP, Necker-Enfants malades Hospital, 
5Universite Paris Descartes
This study is based on a prospective follow-up of 49 severely obese ad-
olescent (75% girls) operated in a single French institution since 2008. 
Surgery was proposed only after at least one-year lifestyle intervention 
in a multidisciplinary program managed by a pediatric team. Post-op-
erative management included several multidisciplinary visits. The mean 
age at surgery was 16.2 ± 0.9 years. Mean body mass index was 42.5 ± 5.9 
kg/m˛, corresponding to a mean weight of 118.8 ± 22.3 kg. At 12 and 
24 months after surgery, mean weight was 98.7 ± 21 kg and 93.6 ± 19.3 
kg respectively (p < 0.001); corresponding to mean BMI 34.7 ± 6.2 and 
32.3 ± 6.7 (p < 0.001) and a percentage of excess weight loss ( EWL) of 
41.8 ± 21.4% and 59.1 ± 24.9% (p < 0.001). The mean number of visits 
per patient was 9 in the first year (range 4–24) and 7 in the second year 
(range 3–16). During the follow up, 6 (12%) gastric bands were removed: 
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realized but none device infection was observed. There was one death, 
46 months after surgery from uncontrolled aorta hemorrhage during the 
procedure for gastric band removing. In multivariate analysis, including 
the sex, age at surgery and the mean number of consultations/year, only 
this last criterion was found significant on weight loss. Two years after 
surgery, significant differences were found between patients who had 6 
or less consultations/year and those with 12 consultations/year for final 
weight (p = 0.004) or EWL (p = 0.005). These results show that more than 
50% EWL can be obtained two years after gastric banding in adolescents. 
But they plead for the primordial role of compliance and thus for the im-
portance of multidisciplinary medical support.
T8:PO.047
Bariatric surgery reduces the long-term incidence of diabetes-
associated vascular disease in initially non-diabetic obese 
patients
Peltonen M.1, Sjöholm K.2, Svensson P.A.2, Jacobson P.2, Sjöström L.2, 
Carlsson L.2
1National Institute for Health and Welfare, Finland,  
2Sahlgrenska Academy at the University of Gothenburg
Background: Bariatric surgery reduces the risk for diabetes in obese pa-
tients, and prevents micro- and macrovascular complications in obese pa-
tients with diabetes. We analysed the effects of bariatric surgery on micro- 
and macrovascular events in obese patients without diabetes at baseline. 
Methods: The Swedish Obese Subjects (SOS) study is a prospective 
matched intervention study conducted at 25 surgical departments and 480 
primary healthcare centers in Sweden. The current analyses included 3429 
obese patients who did not have diabetes at baseline. Of them, 1658 pa-
tients underwent bariatric surgery and 1771 obese matched controls given 
usual care. Microvascular (eyes, kidneys and peripheral nerves) and mac-
rovascular (legs, heart and brain) events requiring hospital or specialist 
outpatient treatment or that were associated with death during follow-up 
were traced by searching the Swedish Cause of Death Register and the 
Swedish National Patient Register. Median follow up time was 18 years. 
Results: Bariatric surgery reduced the incidence of the combined endpoint 
of micro- and macrovascular events, whichever came first, in patients 
without diabetes at baseline (566 and 411 events in the control and sur-
gery groups, respectively; HR=0.73; 95%CI: 0.64–0.82; P < 0.001). When 
analyzed separately, both microvascular (HR=0.48; 95%CI:0.38–0.60; 
P < 0.001) and macrovascular (HR=0.80; 95%CI:0.70–0.92; P < 0.002) 
were reduced in the surgery group. The reduction of the incidence of 
micro- and macrovascular events was more pronounced in patients with 
prediabetes at baseline compared to those with normal glucose status (in-
teraction P-value=0.005). 
Conclusion: Bariatric surgery reduced the long-term risk of diabetes-as-
sociated vascular disease in obese patients without diabetes at study start.
T8:PO.048
Insulin sensitivity and secretion after different bariatric 
operations
Vrbikova J.1, Tura A.3, Pacini G.3, Kunesova M.1, Hill M.1, Sramkova P.4, 
Dolezalova K.4, Fried M.4, Bradnova O.1, Grimmichova T.1, Dvorakova K.1, 
Hainer V.1, Kyrou I.2, Kumar S.2
1Institute of Endocrinlogy, Prague, CZ,  
2Division of Metabolic and Vascular Health Warwick, UK,  
3ISIB CNR, Padua, IT,  
4OB Klinika Prague, CZ
Laparoscopic gastric plication (P) is an emerging bariatric procedure.We 
aimed to compare the effects of laparoscopic gastric banding (LAGB ) 
and biliopancreatic diversion (BPD) on insulin resistance and secretion 
with the effects of P. A total of 52 T2DM women (age: 30–66 years) were 
recruited into three study groups: (i) 20 in P; (ii) 16 BPD; and (iii) 16 
LAGB. Euglycaemic clamps (glucose disposal per kg of fat free mass, Mk 
per FFM) and mixed meal tolerance tests were performed before (exam 
1), at 1 month post-op (exam 2) and at 6-months post-op (exam 3). Beta 
cell function was evaluated using the mathematical model. Mk per FFM 
was higher in P than in LAGB or BPD (p < 0.05) in exam 1 and was sig-
nificantly higher in all groups in exam 2 than in exam 1 and in exam 3 vs. 
exam 1 (p < 0.001). Basal insulin secretion was higher in both BPD and 
LAGB than in P in exam 1. It decreased significantly in LAGB in exam 2 
vs 1 (p < 0.01) and exam 3 vs 1 (p < 0.001), whereas in BPD the decrease 
was significant in exam 2 vs 1 (p < 0.01) and in exam 3 vs 2 (p < 0.05) and 
vs 1 (p < 0.001); and in P, it decreased only between exam 1 and 3 (p < 
0.05). Total insulin secretion decreased significantly only in BPD, in exam 
2 vs exam 1 and in exam 3 vs exam 1 (p < 0.001). Glucose sensitivity was 
similar in all groups before operations. It increased in LAGB in exam 2 vs 
1 (p < 0.05) and in exam 3 vs 1 (p < 0.05) and in P, it increased in exam 2 
vs 1 (p < 0.05). In conclusion, we have found similar improvement in in-
sulin sensitivity after all types of operations. Only BPD led to the decrease 
in demand on beta cells (decreased integrated insulin secretion during 
meal test), on the contrary it didn´t improve glucose sensitivity, which was 
however improved after both P and LAGB.
Acknowledgement: Supported by EFSD New Horizons 111309 grant and by grant 
Ministry of Health, Czech Republic NT/13735-4
T8:PO.049
Pre-operative liquid low-calorie diet reduces liver fat and liver 
volume in morbidly obese patients undergoing roux-en-y 
gastric bypass
Bottin J.H.1, Thomas E.L.1, Fitzpatrick J.A.1, Durighel G.1, Balogun B.1, 
Moorthy K.1, Leeds A.R.2, Bell J.D.1, Frost G.S.1
1Imperial College London, UK,  
2University of Copenhagen, Denmark 
Introduction: Roux-en-Y gastric bypass (RYGB) is considered the 
gold-standard treatment to provide sustained weight loss in morbidly 
obese individuals. A pre-operative diet is advised to reduce liver size and 
decrease risks of complications. There is no consensus on the optimal type 
and duration of this diet. Previous studies have shown that low-calorie 
diets (LCD) may be of benefit to reduce liver fat and volume (1,2,3,4)
Aim: To compare the effect of 3 pre-operative diets on liver fat and volume 
in morbid obese patients awaiting RYGB 
Methods: Morbidly obese volunteers (n=30, BMI:40–55kg/m2) on the 
waiting list for RYGB were randomly assigned to a liquid formula 810kcal/
day LCD (Cambridge Weight Plan®, Northants, UK) for 2 weeks (2W 
LCD), for 6 weeks (6W LCD), or to a 800–1000kcal/day conventional 
food diet (CONTROL) for 2 weeks. Liver fat and volume were measured 
by 1H MRS and MRI respectively using a 1.5T Phillips MR scanner 
Results: 23 participants completed the diet (table 1). Liver fat reduced 
from 8.59% (4.81–15.4%) to 4.42% (2.11–9.28%) and liver volume from 
2.23L (1.99–2.50L) to 1.89L (1.66–2.15L). Liver fat and volume (log) sig-
nificantly correlated at baseline (r= 0.58, p = 0.003) and overall (r=0.64, 
p < 0.0001). Reductions in liver fat (-38.3 ± 6.9%) and liver volume 
(-15.0 ± 1.9%) were significantly correlated (r=0.66, p = 0.0007). Liver 
fat and liver volume significantly reduced in both LCD groups compared 
with the control with no significant difference between the 2W and 6W 
groups (table 2, figure A and B) 
Conclusion: The LCD induced significant liver fat and volume reduction 
by 2 weeks compared with the conventional food diet with no significant 
further reduction by 6 weeks
Acknowledgement: The Section is funded by grants from the MRC, BBSRC, NIHR, 
an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7- 
HEALTH- 2009- 241592 EuroCHIP grant and is supported by the NIHR Imperial 
Biomedical Research Centre Funding Scheme and Cambridge Weight Plan, Ltd.
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Fig. 1. Baseline characteristics of participants
Fig. 2. Reduction in liver fat and liver volume following the diet
Fig. 3. Changes in liver fat (A) and liver volume (B) following the diet
T8:PO.050
Improvement of plasma Heme Oxygenase 1 (HO1) levels in 
morbidly obese patients (MO) with severe osbstructive sleep 
apnea (OSA) after bariatric surgery
Caixás A.1, Tirado R.1, MadeuM J.2, Vigil L.2, Rebasa P.3, Luna A.3, 
Villaplana M.1, Couto Y.1, Pons B.1, Rigla M.1
1Endocrinology and Nutrition Department, Hospital de Sabadell, Corporació 
Sanitária Parc Taulí, UAB, Campus Excel.léncia Internacional, Bellaterra, Spain,  
2Pneumology Department, Hospital de Sabadell, Corporació Sanitária Parc Taulí, 
UAB, Campus Excel.léncia Internacional, Bellaterra, Spain,  
3Surgery Department, Hospital de Sabadell, Corporació Sanitária Parc Taulí, 
UAB, Campus Excel.léncia Internacional, Bellaterra, Spain
Introduction: HO1 is a new adipokine with a protective role against the 
cellular stress and hypoxia (1). MO presents with high circulating levels 
and high adipose tissue expression of HO1 (2). The effect of bariatric sur-
gery on HO1 has not yet been studied. 1.Abraham N et al. Heme Oxy-
genase: a target gene for antidiabetic and obesity. Current Pharmaceutical 
Design,2008;14:412–421. 2. Lehr S et al. Identification and Validation of 
novel adipokines released from primary human adipocytes. Molecular & 
Cellular Proteomics 2012; Jan;11(1):M111.010504. 
Methods: we studied 57 MO with sever OSA, 40 women and 17 men (age 
46.2 ± 10.0 years, BMI 46.8 ± 7.06 kg/m2, AHI (Apnea hipoapnea index) 
64.1 ± 27.6 events/hour) before and after bariatric surgery. Thirty were 
treated with CPAP, 24% were smokers, 67% had hypertension and 38% 
type 2 diabetes. Levels of HO1 were measured by ELISA (Elisa Kit bioN-
ova científica, s.l.Madrid). All patients underwent overnight conventional 
polisomnography (CE-Series Compumedics, Victoria, Australia). Waist 
circumference, % body fat by bioelectrical impedance (TANITA) and 
HOMA insulinresistance index were also measured. Sleeve gastrectomy 
or Roux-en-Y gastric bypass was performed according to the local proto-
col. For statistical analisis SPSS-PC-plus version 19 was used. 
Results: taking all the patients as a group, plasma HO1 levels decreased 
after bariatric surgery (7.43 ± 5.13 vs 6.95 ± 4.27 pg/mL, p = 0,022), how-
ever, this effect was only observed in those patients who had not been 
treated with CPAP (8.84 ± 6.72 vs 8.00 ± 5.69pg/mL, p = 0,021). 
Conclusion: Bariatric surgery improves HO1 levels in MO with severe 
OSA without treatment with CPAP.
Acknowledgement: Funding: Supported by CIRI Grants 2014 Fundació Parc Taulí
T8:PO.051
Long-term albuminuria remission after bariatric surgery in 
swedish obese subjects (sos)
Svensson P.A.1, Peltonen M.2, le Roux C.W.3, Sjöholm K.1, Sjöström L.1, 
Carlsson L.M.1
1Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, 
Gothenburg, Sweden,  
2National Institute of Health and Welfare, Helsinki, Finland,  
3University College Dublin, Ireland
Introduction: Obesity is associated with increased risk of chronic kidney 
disease (CKD). Albuminuria is a predictor of progressive CKD. Bariatric 
surgery reduces body weight in obese subjects, but the effects on CKD 
is unclear. We have previously shown that bariatric surgery is associated 
with reduced incidence of albuminuria compared with conventional obe-
sity treatment. 
Methods: The SOS (Swedish Obese Subjects) study is a prospective, con-
trolled intervention study including 2010 participants who underwent 
bariatric surgery and 2037 controls receiving conventional obesity treat-
ment. 24-h urine collections were performed at baseline, and after 2, 10 
and 15-years. Urinary albumin excretion (UAE) was calculated based on 
24-h urine collection (urine albumin concentration (mg/l) × urine vol-
ume (l))/urine collection time (min)) and expressed as mg per 24 h. For 
the current analysis, 699 SOS study participants with microalbuminuria 
(defined as UAE between 30–300 mg/24 h) at baseline were included. Re-
mission of albuminuria (defined as UAE < 30 mg/24 h) over 15 years was 
the main outcome measure. 
Results: Microalbuminuria remission during follow-up (2, 10 and 
15-years) was observed for more than 65% of the study participants un-
dergoing bariatric surgery. The odds-ratios for remission after surgery 
were 5.8, 1.9 and 3.8 after 2, 10 and 15-years follow-up, respectively when 
compared to conventionally treated patients (all P≤0.001). 
Conclusion: Participants with microalbuminuria who underwent bariat-
ric surgery had increased likelihood of remission compared with partici-
pants receiving conventional obesity treatment.
T8:PO.052
Obese subjects with Type 2 Diabetes undergoing Sleeve 
Gastrectomy: Impact on Cardiac Function
Leung M.1,2, Xie M.1,2,3, Durmush E.4, Leung D.Y.1,2, Wong V.W.2,3
1Department of Cardiology, Liverpool Hospital, Sydney, Australia,  
2South Western Clinical School, University of New South Wales, Sydney, 
Australia,  
3Liverpool Diabetes Collaborative Research Unit, Ingham Institute of Applied 
Science, Liverpool, Sydney, Australia,  
4The Life Weight Loss Centre, Liverpool, Australia
Introduction: Diabetic cardiomyopathy is an increasingly prevalent 
health issue, with no specific management options. Patients with type 2 
diabetes are often obese, and management of obese subjects with diabetes 
is always challenging. In this study, we examined the impact of bariatric 
surgery (sleeve gastrectomy) on diabetic cardiomyopathy for obese pa-
tients with type 2 diabetes. 
Methods: Eight obese patients with poorly controlled type 2 diabetes un-
dergoing sleeve gastrectomy had left ventricular (LV) systolic and diastolic 
function assessed by advanced echocardiographic techniques: global lon-
gitudinal strain (GLS), LV ejection fraction (both for LV systolic func-
tion) and septal e’ (for LV diastolic function), before and 9-months after 
surgery. 
Results: Following sleeve gastrectomy, the subjects had a mean weight 
loss of 28.0 ± 16kg with the body mass index decreasing from 44 ± 9kg/m2 
to 35 ± 6kg/m2 (p < 0.001). Glycaemic control improved, with HbA1c de-
creasing from 9.2 ± 2.0% at baseline to 6.7 ± 1.3% at follow-up (p = 0.002)
(figure 1). There was a significant improvement in LV systolic function: 
GLS improved from –13.2 ± 3.7% to –19.7 ± 2.2% (p < 0.001), and LV 
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provement in GLS was associated with the amount of weight lost (ρ=0.81, 
p = 0.015). LV septal e’ velocities increased from 6 ± 1 to 8 ± 2 cm/s 
(p = 0.015), indicating better LV diastolic function. 
Conclusion: Sleeve gastrectomy in obese patients with type 2 diabetes is 
effective not only in reducing weight and improving glycaemic control, 
but also results in significant improvement in both systolic and diastolic 
LV function. This may have implications for obese subjects with diabetic 
cardiomyopathy.
Fig. 1. Graphs showing improvements with regards to glycated haemoglobin 
(HbA1c) (Panel A), weight (Panel B) and global longitudinal strain (Panel C) 
before and after surgery for our cohort of patients
T8:PO.053
Bone mineral density after gastric bypass surgery
Abeysekera A.1, Head A.J.1, Labib M.H.1
1Department of Clinical Biochemistry, Russells Hall Hospital, Dudley Group NHS 
Foundation Trust, Dudley, United Kingdom
Introduction: Reduced bone mineral density (BMD) is a recognised 
complication of Roux-en-Y gastric bypass (RYGB) surgery. Calcium mal-
absorption, secondary to vitamin D deficiency, is partially responsible and 
calcium/vitamin D supplementation is recommended to reduce risk of os-
teoporosis. However, some studies documented declines in BMD in the 
absence of significant changes in circulating vitamin D or PTH. 
Methods: We audited BMD at 1–5 years in 66 patients (40 women and 26 
men; mean age 46.5 ± 9.3 years), who underwent RYGB and who were on 
calcium/vitamin D supplementation. We compared serum calcium, PTH, 
vitamin D and % Excess Body Weight (EBW) loss between those with low 
and normal BMD. 
Results: 25 of the 66 patients (37.9%) showed low BMD (19 osteopenia 
and 6 osteoporosis) either at lumbar spine or hips. Mean serum calcium 
and PTH concentrations were not significantly different between those 
with low BMD and those with normal BMD (p = 0.43 and p = 0.15, re-
spectively). Mean %EBW loss was significantly higher in patients with low 
BMD (75.1 ± 14.0%) compared to those with normal BMD (61.8 ± 17.5%) 
[p = 0.0006]. 
Conclusion: Our audit showed that over a third of patients who under-
went RYGB developed osteopenia or osteoporosis despite being on cal-
cium/vitamin D supplementation, suggesting that other mechanisms, 
such as rate of weight loss or protein intake may be important factors in 
contributing to low BMD following RYGB. The greater weight loss in our 
patients with low BMD is in keeping with studies which found an associ-
ation between weight loss and bone loss. Also, diets containing 1.0–1.5 g/
kg protein are recommended for optimum bone health indicating that the 
common practice of prescribing 60–80 g of protein after bariatric surgery 
is inadequate and may contribute to bone loss.
T8:PO.054
The adjustable gastric banding does not reduce monocytes 
count 1 year after bariatric surgery
Cunha F.M.1,2, Oliveira J.1,2, Saavedra A.1,2, Costa M.M.1,2, Lau E.1,2, 
Magalhăes D.1, Bettencourt-Silva R.1, Freitas P.1,2, Varela A.1,2, Carvalho D.1,2
1Department of Endocrinology, Diabetes and Metabolism, Hospital Săo Joăo, 
Porto, Portugal,  
2Faculty of Medicine, University of Porto, Porto, Portugal
Introduction: Monocytes (Mn) associate with atherosclerosis. Monocy-
tosis is common in obesity. We studied the Mn count 1 year after bar-
iatric surgery (BS) and the predictors of Mn variation. METHODS: We 
retrospectively studied morbidly obese patients submitted to BS: AGB 
(adjustable gastric banding), RYGB (Roux-en-Y gastric bypass) and SG 
(sleeve gastrectomy) between 2010 and 2012. Follow-up: 1 year. We ex-
cluded patients without complete white blood cells (WBC) count before 
or 1 year after BS. We compared WBC counts before and 1 year after BS. 
We evaluated the correlation between Mn and BMI, insulin resistance 
(HOMA2-IR), and HDL. A multivariable linear regression analysis was 
built to study predictors of Mn variation. RESULTS: We studied 796 
patients (AGB 248, RYGB 466, SG 82). RYGB patients were younger; 
AGB patients had lower initial BMI and HOMA2-IR values and lost less 
weight. AGB patients had lower initial Mn count compared to RYGB and 
SG [0.46 (0.38–0.58); 0.53 (0.43–0.64) and 0.52 (0.43–0.68), respectively; 
p < 0.001]. In AGB patients, there was a significant increase in Mn count 
1 year after BS [0.50 (0.40–0.66); p < 0.001], and a reduction in RYGB and 
SG [0.47 (0.38–0.58); p < 0.001 and 0.48 (0.40–0.62); p = 0.005, respec-
tively]. At baseline, there was no correlation between Mn count and BMI 
(rho= –0.07; p = 0.20); a weak positive correlation between Mn count 
and HOMA2-IR (rho=0.16; p = 0.02); and a weak negative correlation 
between Mn count and HDL (rho=-0.13; p < 0.001). In a multivariable 
linear regression analysis, AGB surgery was an independent predictor of 
Mn count increase.
Conclusions: Except for AGB, BS can lead to a reduction in the Mn count 
1 year after surgery. AGB associates with an increase in Mn count inde-
pendent of age, sex, insulin resistance and HDL.
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T8:PO.055
Effect of three types of bariatric surgery on anthropometry 
and glucose metabolism: Two years follow-up – pilot study
Bradnova O.1,4, Sedlackova B.1, Vrbikova J.1, Dolezalova K.2,3, Sramkova P.2, 
Vcelak J.1, Hainer V.1, Bendlova B.1, Fried M.2,3, Kunesova M.1
1Institute of Endocrinology, Prague, CZ,  
2OB clinic, Prague, CZ,  
3First Faculty of Medicine, Charles University, Prague, CZ,  
4Anthropology and Human Genetics, Charles University, Prague, CZ
Introduction: Bariatric surgery is the most effective tool in the treatment 
of obesity and related comorbidities, such as Type 2 Diabetes Mellitus, 
dyslipidemia, hypertension, etc. We compared effect of laparoscopic gas-
tric banding (LAGB), laparoscopic greater curvature plication (LGCP) 
and biliopancreatic diversion (BPD) in morbidly obese women with Type 
2 Diabetes. 
Methods: 41 obese diabetic women underwent bariatric surgery: 11 
LAGB (age: 58.3 ± 6.19 yrs; BMI: 44.8 ± 7.16 kg/m2), 16 LGCP (age: 
51.8 ± 9.79 yrs; BMI: 41.6 ± 8.93 kg/m2), 14 BPD (age: 50.4 ± 6.19 yrs; 
BMI: 47.8 ± 8.02 kg/m2). All women underwent 3-hour mixed meal toler-
ance test before the treatment and after 2 years. Index of insulin resistance 
(HOMAR) and area under curves (AUC) were calculated. For statistical 
analyses, Mann-Whitney and ANOVA with repeated measurements were 
used (NCSS, 2004). 
Results: LAGB (n=11): weight declined by 15 ± 9 (min: 2.6; max: 31.4) 
kg; body mass index (BMI) by 4.9 ± 2.89 kg/m˛; fat mass (FM; Tani-
ta TBF-300) by 10.8 ± 7.2 kg LGCP (n=16): weight declined by 14 ± 20 
(1.9; 65.2) kg; BMI by 5.1 ± 7.46 kg/m˛; FM by 5.7 ± 4.5 kg BPD (n=14): 
weight declined by 33 ± 16 (10.4; 65.8) kg; BMI by 11.4 ± 4.78 kg/m˛; FM 
by 26.2 ± 14.4 kg Significant decrease of fasting and stimulated param-
eters of glucose metabolism was found in the group of BPD (HOMAR: 
p < 0.0001; AUC Glucose:p < 0.001; AUC Insulin:p < 0.0001; AUC C-pep-
tide:p < 0.001). After LAGB, only fasting parameters decreased (Glucose: 
p < 0.02; Insulin: p < 0.03; C-peptide: p < 0.01; HOMAR: p < 0.04). 
Conclusion: Although the study is limited by the small number of pa-
tients, we found that BPD resulted in the best long-term glucose metab-
olism improvement. Determination of incretin levels will be subject of 
further analyses.
Acknowledgement: Supported by EFSD New Horizons 111309 grant and by grant 
Ministry of Health, Czech Republic NT/13735-4
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Polyneuropathy after bariatric surgery - case report
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2Multidisciplinary Assessment of Surgical Treatment of Morbid Obesity of 
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Introduction: The knowledge about bariatric surgery complications is in-
creasing with the rising numbers of procedures performed. Neurological 
complications of nutritional deficiencies following bariatric surgery are 
rare with an incidence of 4.6% and may result in serious consequences. 
Case report: A 30-year-old woman (BMI 50.6kg/m2) underwent gastric 
bypass in August/2011. Two months later she began persistent vomiting 
and required hospitalization. After discharge she complained about pro-
gressive muscle weakness in lower and upper limbs, with significant func-
tional impairment. She noted sensory loss in all four limbs. Neurological 
examination revealed: distal tetraparesis predominantly in lower limbs, 
glove and sock hypoesthesia and abolished osteotendinous reflexes, with 
gait disability. She was admitted to the Neurology Department. Nerve 
conduction studies revealed severe axonal sensorimotor polyneuropathy 
and sural nerve biopsy showed absent myelinated fibers. Analytical study 
revealed: folic acid 1.9mg/dL (2.2–17.5) and vitamin D 9ng/mL (>30). 
CBC, iron kinetics, vitamin B12, vitamin E and copper were normal. A 
vitamin complex was started (thiamine, folic acid and vitamin D), with 
progressive recovery of deficits. Currently she has autonomous gait with 
mild motor deficit in dorsiflexion of the left foot. It was assumed a diagno-
sis of carencial sensorimotor polyneuropathy due to thiamine deficiency. 
Conclusion: Vitamin deficits following bariatric surgery can present with 
severe polyneuropathy, not always fully reversible. Because body reserves 
of thiamine are low, its deficiency may develop in the first few months 
after surgery. The present case highlights the need for early recognition of 
signs and symptoms and the importance of immediate supplementation.
T8:PO.057
Effectiveness of prolonged low calorie liquid diet in pre-
operative optimisation of super super obese patients 
undergoing bariatric surgery
Stevens L.1, Khan O.A.1, Leeds A.R.1,2, Russell K.1, Walshaw L.1, Jennings K.3, 
Sufi P.1
1North London Obesity Surgery Service, Whittington Hospital, London, UK,  
2University of Copenhagen, Denmark,  
3Independent Cambridge Consultant, London, UK
Introduction: Patients with super super obesity (SSO; BMI >60) under-
going bariatric surgery present major technical and physiological chal-
lenges. Techniques suggested to manage peri-operative risk include pre-
op restricted-calorie diet and intra-gastric balloon. In our institution we 
prospectively instituted a policy of introducing a long duration, low calo-
rie liquid diet prior to surgery. We compared this strategy with our results 
prior to its introduction. 
Methods: A prospectively maintained database was interrogated to iden-
tify all SSO patients undergoing bariatric surgery between February 2007 
and September 2013. Those having procedures prior to May 2011 did not 
have prolonged, specific pre-operative diet. From May 2011 however all 
patients were enrolled on a Cambridge Weight Plan® liquid diet – >six 
weeks 700–920kcal/day following an initial 1500kcal/d diet for > two 
weeks. We compared pre-operative weight loss, peri-operative compli-
cations and long term outcome in those receiving the liquid diet versus 
those not. 
Results: 18 SSO patients used Cambridge diet and 22 did not. Mean 
pre-operative BMI and co-morbid status were similar. Mean excess body 
weight loss from pre-diet clinic assessment to operation was slightly high-
er in the Cambridge diet group (15.3% vs. 10.4%, p = 0.18). Operations 
performed were similar with all patients having their planned procedure. 
Peri-operative complications were significantly more common in the 
non-Cambridge diet group( 6 patients versus 1, p = 0.04). 
Conclusion: The Cambridge diet gives good pre-bariatric procedure 
weight loss in the super super obese population. This appears to contrib-
ute to better outcomes with regard to surgical complication rates as com-
pared to patients having a non-standardised pre-operative diet. This may 
reflect more effective loss of intra-abdominal and hepatic adiposity, or an 
effect of improved metabolic and nutritional status, in patients undergo-
ing prolonged, liquid low calorie diet.
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T8:PO.058
Bariatric Surgery: Prior History in Parents does not mean 
future intentions for children
Kalic R.J.1,2, Curran J.A.2, Davis E.A.1,2
1Diabetes and Obesity Research, Telethon Institute for Child Health Research, 
Centre for Child Health Research, The University of Western Australia, Perth, 
Western Australia,  
2Department of Endocrinology and Diabetes, Princess Margaret Hospital for 
Children, Perth, Western Australia, Australia
Background: Custodial attitudes towards bariatric surgery in their chil-
dren are under-researched; though as rates of bariatric surgery in obese 
adults in Western Australia increases alongside incidence of childhood 
obesity, we expect surgery to increasingly be considered a viable weight 
loss treatment. 
Methods: We explored parental history and attitudes towards bariatric 
surgery through a questionnaire administered during a weight manage-
ment clinic. Quantitative information was collected on surgery history, 
type, and professionals consulted regarding surgery, diet changes, phys-
ical activity, and satisfaction with surgery and outcomes; and if custodi-
ans would consider bariatric surgery for their child. Qualitative data was 
collected through an open-format comments section, and analysed for 
common themes. 
Results: Families of 49 adolescents responded: 44 mothers, 4 fathers and 
1 grandmother. Surgery had been performed upon 3 of the reporting 
custodians, 3 other immediate family members, and a further 11 family 
members and associates. 5 custodians were on the waiting list. Lap-band-
ing was the most common of surgery performed, and satisfaction with 
the outcome and experience was high. Surgeons were the most common 
professional consulted prior to, and following, surgery. Lifestyle chang-
es post-surgery focussed primarily on diet. Half of custodians surveyed 
would consider bariatric surgery for their child. This did not appear to be 
affected by history of surgery in the family. When comments were anal-
ysed, the main theme was that surgery would be a last resort, after diet and 
exercise attempts had been exhausted. Custodians reported being aware 
of risks and side-effects however their belief was that the risks of obesity 
were greater. 
Conclusion: Custodial attitudes towards bariatric surgery in their child 
are complex and must be explored further. Preliminary findings show that 
custodians are making balanced decisions, with primary consideration for 
the welfare of their child.
Acknowledgement: The participants and the CLASP team.
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A RCT of Intragastric balloons in obese adolescents: 
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Curran J.A.1,2, Kalic R.J.1,4, Sherrington C.S.3, Ravikumara M.3, Messina D.1, 
Mews C.3, Tremayne A.1, Forbes D.2,3, Davis E.A.1,2
1Department of Endocrinology, Princess Margaret Hospital for Children, Perth, 
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2School of Paediatrics and Child Health, University of Western Australia, 
Australia,  
3Department of Gastroenterology, Princess Margaret Hospital for Children, 
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Background: Intragastric balloons (balloon) are an effective, less invasive 
weight loss method used in adults. Their use in adolescents has not been 
studied. The purpose of this RCT was to determine if the balloon has a 
role in obesity management in adolescents receiving lifestyle modifica-
tion. 
Methods: A total of 30 obese adolescents with co-morbidities were ran-
domly allocated to 2 groups: A Control group undertook a 1 year lifestyle 
program; a 3 month intensive phase followed by a 9 month maintenance 
phase. The intervention group in addition to the lifestyle program was ad-
mitted for insertion and removal of the balloon under general anaesthetic; 
the balloon remained in situ for 6 months. Outcomes were measured at 6 
and 18 months. 
Results: Baseline demographics were similar in both groups. Con-
trol group: 16 pts, 5M:11F, age 14.0 ±1.2 years, weight 106.5 ±13.8kg, 
BMI zscore 2.49 ±0.18, waist circumference 116.9 ± 10.2 cm, body fat 
% 46.3 ± 6.3 (mean±SD). Intervention group: 14 pts, M7:7F, age13.58 
±1.26 years, weight 111.4 ± 22.5 kg, BMI zscore 2.58 ± 0.20, body fat % 
43.5 ± 4.9 (mean±SD). At 6 months both the control and intervention 
groups had significant reductions in BMI zscore (-0.15 ±0.1 p = 0.0002 
vs –0.10 ± 0.15 p = 0.018) and body fat % (-2.6 ± 3.7% p = 0.017 vs 
–3.1 ± 3.8% p = 0.021) respectively (mean±SD). The intervention group 
also showed a significant reduction in weight, waist circumference and 
fat mass. Changes observed at 6 months were not seen at 18 months. The 
groups did not differ in weight loss, BMI z-score or body fat % change. No 
adverse events occurred during insertion or removal of the balloon, one 
patient required early removal of the balloon 1 month post insertion for 
psychological intolerance. 
Conclusion: Both lifestyle and balloon and lifestyle improve BMI z-score 
and reduce body fat % in obese adolescents in the short term, however 
these changes are not maintained in the long term. The balloon appears to 
be safe and well tolerated in obese adolescents.
Acknowledgement: The families who have given their time freely, and the CLASP 
clinical service at Princess Margaret Hospital.
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Inflammatory status and iron homeostasis in women 
supplemented before and after obesity surgery
Marin F.A.1, Sousa Novais P.F.1, Crisp A.H.1, Verlengia R.2, Rasera-Jr I.3, 
Marques de Oliveira M.R.1,4
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State University, Faculty of Pharmaceutical Sciences (UNESP-FcFar), Araraquara-SP,  
2Methodist University of Piracicaba (UNIMEP), Piracicaba-SP,  
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Bariatric surgery may lead to specific nutritional deficiencies, such as iron 
deficiency, especially in women of childbearing age because of their high-
er iron requirement for appropriate erythropoiesis. On the other hand, 
surgery improves inflammation and iron homeostasis, which raises the 
question of whether supplementation is still required. The objective was to 
analyze the effect of Roux-en-Y gastric bypass (RYGB) and preoperative 
and postoperative vitamin and mineral supplementation on the inflam-
mation status and iron homeostasis of premenopausal women. This inter-
ventional prospective study included 45 nonmenopausal women aged 20 
to 45 years, with a body mass index (BMI) of 35 to 60 kg/m2, who either 
took one recommended daily allowance (RDA) of vitamin and mineral 
supplements for 30 days before surgery and two RDAs for six months after 
surgery (Group 1; n=34); or who took 1 RDA for six months after sur-
gery (Group 2; n=11). Assessment relied on the sample’s anthropometric 
measurements and laboratory tests (iron metabolism and inflammation 
markers). The baseline transferrin saturation index (TSI) of 10 women in-
dicated iron deficiency. Six months after surgery, the BMI, high-sensitiv-
ity C-reactive protein (hs-CRP), and insulin resistance of the two groups 
had decreased. The TSI of Group 1 increased and transferrin decreased, 
indicating better iron status due to preoperative and postoperative sup-
plementation. Serum iron increased in Group 2. Six months after surgery, 
both groups had lower ferritin, and the prevalence of anemia was 9%. 
Hepcidin correlated with ferritin before and after surgery. 
Conclusion: Inflammation had improved six months after RYGB. Vita-
min and mineral supplementation before and after surgery improved the 
markers of iron status.
Acknowledgement: Support Foundation of Săo Paulo (FAPESP) and National 
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Interest of using continuous glucose monitoring system 
(cgms) among pregnant women undergone a bariatric 
surgery at 24–28 gestation weeks
Derveaux A.1, Deruelle P.3, Vambergue A.2, Caiazzo R.4, Romon M.1, 
Pattou F.4, Pigeyre M.1
1Department of Nutrition, University Hospital in Lille, France,  
2Department of Diabetology, University Hospital in Lille, France,  
3Department of Obstetrics, University Hospital in Lille, France,  
4Department of Endocrine Surgery, University Hospital in Lille, France
Introduction: Among pregnant women, who had undergone bariatric 
surgery, it is difficult to evaluate glycemic status with usual care. Our ob-
jective was to describe glycemic profile at 24–28 gestation weeks by using 
a Continuous Glucose Monitoring System (CGMS), in this population. 
Methods: 12 pregnant women (8 malabsorptive procedures, 4 restric-
tive procedures) were evaluated during 72 hours with a CGMS. Pre- and 
post-prandial glycemic profile was analyzed. As the same time, a 75g Oral 
Glucose Tolerance Test (OGTT) was performed for diagnosis of gesta-
tional diabetes (GDM) and its tolerance was evaluated by visual analogic 
scale. 
Results: Maternal age was 30.3 ± 6 years and pre-pregnancy body mass 
index was 35.3 ± 8.8 kg/m˛. Mean period between surgery and pregnan-
cy was 2.9 ± 2.5 years. Mean blood glucose level was 87.7 ± 15.8 mg/dl. 
1 and 2 hours post-prandial blood glucose levels (PPG1h and PPG2h) 
were 114.3 ± 13.6 mg/dl and 91.3 ± 17.1 mg/dl respectively. Time to reach 
post-prandial peak of glucose level was 55.1 ± 17.1 min. Moreover, in our 
population, we observed higher glycemic variability with higher level of 
GPP1h and lower level of GPP2h, especially following gastric bypass, than 
in pregnant women without bariatric surgery (1). Four women had GDM 
(2 diagnosis according to abnormal glucose values in OGTT, 2 to abnor-
mal values in CGMS). Moreover, one third of the OGTT was invalid fol-
lowing bypass gastric because of vomiting. 
Conclusion: CGMS is useful to examine the particular glycemic profile 
among pregnant women who had undergone bariatric surgery, when it is 
difficult to diagnose a GDM with usual care, especially following gastric 
bypass. Also, the variability of glycemic profile can be explained by the 
consequences of surgery. 
Reference:
1. Yogev et al.: Am J Obstet Gynecol. 2004.
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Long-term prevalence of anaemia and related micronutrients 
deficiency after bariatric surgery
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Introduction: Iron, vitamin B12 (VitB12) and folic acid (FAc) deficien-
cy can occur after bariatric surgery (BS) and may cause anaemia. Aim: 
To determine the prevalence of anaemia and micronutrients deficit (iron, 
VitB12 and FAc) before,12, 24 and 36 months (M) after gastric band-
ing(GB), gastric bypass(RYGB) and sleeve gastrectomy(SG). 
Methods: Retrospective longitudinal study of patients submitted to BS 
between 01/2010–06/2013. Patients without medical records of blood cell 
count (BCC), iron, VitB12, FAc, supplements or blood transfusion were 
excluded. Anaemia was defined according WHO criteria. Deficit of mi-
cronutrients: serum iron <60μg/dL, transferrin saturation <20% or ferri-
tin <15ng/mL; VitB12 <200pg/mL; AcF <2.2ng/mL. 
Results: Sample composed by 953 patients, mean age 42.6(10.8)years, 
86% women. RYGB performed in 59.8% patients, BG in 28.5% and SG in 
11.6%. Prevalence of anaemia before surgery 7.7% (N=953); 12M 13.1% 
(N=847); 24M 17.3% (N=439); 36M 18.7% (N=251). The majority of pa-
tients with anaemia had undergone RYGB (12M: RYGB 71.2% / BG 15.3% 
/ SG 13.5% p = 0.002; 24M: RYGB 77.6% / GB 13.2% / SG 9.2% p = <0.001; 
36M: RYGB 80.9% / GB 17.0% / SG 2.1% p = <0.001). Deficiency of any 
micronutrient was found more frequently in RYGB group (statistical sig-
nificance regarding 24 and 36M iron deficiency and VitB12).There was no 
association between micronutrients deficiency and weight loss. We found 
more supplements prescription in RYGB group. Only 1 patient required 
blood transfusion at 12M and 36M, respectively. 
Discussion: Our results are in agreement with previously published and 
highlight the importance of checking BCC/micronutrients levels after BS 
to avoid important complications such as anaemia.
T8:PO.063
Routine closure of mesenteric defects in laparoscopic roux-
en-y gastric bypass results in no internal hernia developed in 
180 consecutive cases
Yang W.1, Wang C.1, Yang J.1, Cao G.1, Lin M.1, Huang Y.1, Sun P.1, Zhou X.1
1Department of Gastrointestinal Surgery, First Affiliated Hospital of Jinan 
University, Guangzhou, China
Background: Internal hernia after LRYGB is a serious complication lead-
ing to rise in patient’s morbidity and mortality. But the closure of the mes-
enteric defects remains a subject of controversy. The aim of this study is to 
evaluate the results of routine closure of mesenteric defects in retrocolic 
antegastric LRYGB. 
Methods: Clinical data of patients underwent LRYGB in the First Affili-
ated Hospital of Jinan University between January 2012 and January 2014 
were reviewed. All the patients had retrocolic and antegastric anastomo-
sis as a standard procedure with linear stapling. The jejunojejunal anas-
tomotic mesenteric defect and Peterson’s defect were routinely closed by 
interrupted permanent suture. The patients were follow-up at 1, 3, 6, 12 
months and annually thereafter. 
Results: 180 LRYGB were performed. There were 121 males and 59 fe-
males with mean age of 33.6 years (range, 18–58), mean preoperative BMI 
42.3 (range, 28.6–78.3), mean operating time 122 minutes (range, 104–
139). All the patients had at least 12 months follow-up. Percentage of ex-
cess weight loss in 1, 3, 6, and 12 month after operation were 27.3 ± 8.3%, 
54.2 ± 7.4%, 76.8 ± 8.7%, 79.6 ± 8.6%, respectively. No any patient (0%) 
developed internal hernia postoperatively. No any severe complications 
and death cases were observed. 
Conclusions: Routine closure of mesenteric defects in LRYGB does not 
increase much operating time. No internal hernia was developed if the 
mesenteric defects are properly closed. Randomized control trial is need-
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Fig. 1. Close the mesenteric defects and the Peterson’s defect
Fig. 2. Close the mesenteric defects and the Peterson’s defect
Fig. 3. Close the mesenteric defects and the Peterson’s defect
T8:PO.064
Long lasting effect of gastric bypass on risk factors for 
atherosclerosis
Polovina S.P.1, Sumarac-Dumanovic M.1, Gligorijevic J.3, Bajec D.D.2, 
Kendereski A.1, Zoric S.1, Cvijovic G.1, Stamenkovic-Pejkovic D.1, Micic D.D.4, 
Jeremic D.1, Gligic A.1, Micic D.D.1
1Clinic for endocrinology, diabetes and diseases of metabolism, Clinical Center 
of Serbia, Belgrade,  
2Clinic for digestive surgery, Clinical Center of Serbia, Belgrade,  
3Dietary unit, Outpatient Clinic, Clinical Center of Serbia, Belgrade,  
4Emergency Center, Clinical Center of Serbia, Belgrade
Obesity is associated with insulin resistance, affected glucose toleration, 
change in serum lipids, and mild systemic inflammation. Metabolic sur-
gery improves proatherogenic metabolic parameters as well as weight re-
duction. 
Methods: In Center for obesity, Clinical Center of Serbia, were oper-
ated 146 obese patients (90 females and 56 males). Average body mass 
index (BMI) was 43.4 ± 7.3kg/m2, 34.2 ± 6.8 years of age. Serum glu-
cose level was 5.56 ± 1.3mmol/l, total cholesterol 5.21 ± 1.3mmol/, HDL 
1.15 ± 0.7mmol/l, LDL 3.03 ± 0.4mmol/l, triglycerids 2.11 ± 1.2mmol/l, 
C-reactive protein 13.3 ± 9.8mg/l. In all patients were performed gastric 
bypass. Before surgery patients were on dietary regiment with 500kcal cal-
orie restriction per day during 4–6 months. Three weeks before surgery 
daily energy intake was 1000kcal. 
Results: Two years after surgery BMI was lower 29,9% (13.2 ± 0.9kg/
m2,, p = 0.01) than before. Serum glucose was lower 9.7% 
(0.5mmol/l±0.3mmol/l, p < 0.05). Total cholesterol decreased 9.7% 
(0.74 ± 0.2mmol/l, p < 0.05), as well as LDL cholesterol which de-
creased 34.5 ± 0.6%(p < 0.05). The level of triglycerids was less 54.6% 
(1.1 ± 5mmol/l, p < 0.001) than before operation. HDL cholesterol in-
creased 21% (0.3 ± 0.2mmol/l, p < 0.05) after two years. Creactive protein 
was markedly decreased two years after surgery, 89% (11.3 ± 3.2mg/l, 
p < 0.001). 
Conclusion: Metabolic surgery, especially gastric bypass in morbidly 
obese patients have long-lasting beneficially effect on lipid profile, blood 
glucose, and systemic inflammation and due to this action, lowering risk 
for atherosclerosis, diabetes type 2 and obesity related metabolic diseases.
T8:PO.065
Weight loss after 3 types of bariatric surgery - 3 years of 
follow-up
Saavedra A.1,2,3, Costa M.M.1,2,3, Oliveira J.1,2,3, Cunha F.1,2,3, Lau E.1,2,3, 
Bettencourt-Silva R.1, Magalhăes D.1, Moreira A.C.4, Santos A.C.2,5, 
Freitas P.1,2,3,6, Varela A.1,2,3,6, Queirós J.1,6, Correia F.1,6,7, Carvalho D.1,2,3, 
AMTCO Group6
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Săo Joăo EPE, Porto, Portugal,  
2Faculty of Medicine, University of Porto, Portugal,  
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Faculty of Medicine, University of Porto, Portugal,  
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Hospitalar de Săo Joăo EPE,  
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Introduction: Different bariatric surgery (BS) techniques are currently 
available (restrictive, malabsorptive, mixed procedures). Aim: To com-
pare the effect on weight, body mass index (BMI) and percentage of alter-
able weight loss (AWL) over 3 years after 3 BS techniques - gastric band 
(GB), gastric bypass (RYGB) and sleeve gastrectomy (SG). 
Methods: Retrospective longitudinal study of patients who had under-
gone BS between 01/2010-06/2011. Variables analyzed at 12, 24 and 36 
months: Weight (W), Weight Change (WC), BMI, BMI variation; %AWL 
(AWL = 100% x [(initial BMI - BMI time x) / (initial BMI - 13)]. 
Results: Sample composed by 215 patients, mean age 43.2(10.1)years, 
91.6% women. 54.9% of patients placed BG (W 109.2 (15.6)kg; BMI 43.2 
(5.7)kg/m2); 42.8% underwent RYGB (W 121.3 (19.5)kg; BMI 46.2 (5.9)
kg/m2); 2.5% were submitted to SG (W126.6 (19.5)kg; BMI 46.9(5.7) 
kg/m2). The greater reduction in weight was achieved with in RYGB 
group, but close to that obtained with the SG (RYGB 41.6/42.5/41.6 vs. 
BG 18.9/18.9/18.4 vs. SG 41.1/42.1/40.6 p = <0.001). RYGB also reduced 
more units of BMI, but all techniques were associated with a slight re-
gain at 36 months (RYGB 30.44/30.06/30.42; BG 35.73/35.69/35.89; SG 
31.90/31.57/32.18). The %AWL was significantly higher in patients who 
had undergone RYGB (RYGB 46.98/47.96/46.91 vs. BG 24.28/24.50/23.86 
vs. SG 44.21/45.23/43.71). 
Discussion: Our results confirm that RYGB is the surgical technique with 
greater effect on weight reduction. However, regardless of the technique 
chosen there was a slight regain in weight/BMI three years after surgery, 
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T8:PO.066
Single stage precise laparoscopic roux-en-y gastric bypass 
in the treatment of asian super obese patients: Comparison 
between BMI ≥50 and <50
Yang W.1, Wang C.1, Yang J.1, Cao G.1, L M.1, Sun P.1, Huang Y.1, Zhou X.1
1Department of Gastrointestinal Surgery, First Affiliated Hospital of Jinan 
University, Guangzhou, China
Background: The aim of this study is to investigate the surgical tech-
niques and clinical outcomes of precise laparoscopic Roux-en-Y gastric 
bypass (PLRYGB) in treatment of Asian super obesity with BMI≥50. 
Methods: Clinical data was collected and analyzed in consecutive patients 
underwent PLRYGB in the First Affiliated Hospital of Jinan University 
between March 2011 and March 2014. 30 patients in super obesity group 
with BMI≥50, and 30 patients in ordinary obesity group with BMI<50 as 
a control. Patients were followed up for 12~36 months. 
Results: No any conversion to open operations or deaths. Preoperative 
BMI were (ordinary obesity group vs super obesity group) 38.1 ± 5.3 kg/
m2 and 58.3 ± 4.7 kg/m2, respectively(P < 0.05). Compare with baseline, 
the BMI decreased gradually and reach the peak one year after the op-
eration in both groups: 27.2 ± 3.3 kg/m2 and 36.7 ± 4.8 kg/m2, respec-
tively (P < 0.01). %EWL and preoperative BMI were in a linear negative 
correlation (P < 0.05). %EWL in 12 and 24 months of the two groups 
were: 75.3 ± 14.0%, 63.6 ± 9.4%; 80.1 ± 12.3%, 71.4 ± 12.5%, respectively 
(P < 0.05). The %EWL in super obesity group was lower than that in the 
ordinary obesity group(P < 0.05). Co-morbidities including fatty liver, hy-
pertension, T2DM, hyperuricemia, sleep apnea and hyperlipidemia were 
cured or relieved after one year of operation. Mild postoperative compli-
cations were observed in the two groups, including 9 cases of hair loss and 
3 cases of dumping syndrome. Occurrence of loose skin after surgery is 
higher in super obesity group(6 cases, 20%) than that in ordinary obesity 
group (2 cases, 6%), P < 0.05. 
Conclusions: PLRYGB is safe and feasible as a single stage operation for 
Asian super obese patients. The %EWL in ordinary obesity group is higher 
than that in super obesity group after one year of operation. Preoperative 
weight loss may be favorable in overall weight loss outcomes. Occurrence 
of loose skin after surgery is higher in super obesity group.
T8:PO.067
Vitamin d deficiency and obesity: Retrospective evaluation 
of vitamin d variation in obese subjects undergoing bariatric 
surgery
Magalhăes D.1, Bettencourt-Silva R.1, Saavedra A.1,2, Costa M.M.1,2, 
Cunha F.1,2, Oliveira J.1,2, Lau E.1,2, Santos A.C.3, Freitas P.1,4,5, Varela A.1,4,5, 
Queirós J.1,4, Correia F.1,2,4, Carvalho D.1,2
1Department of Endocrinology, Diabetes and Metabolism of Centro Hospitalar 
de Săo Joăo, EPE,  
2Faculty of Nutrition Science and Food, Oporto’s University,  
3Department of Clinic Epidemiology, Preventive Medicine and Public Health of 
Centro Hospitalar de Săo Joăo, EPE,  
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5Faculty of Medicine, Oporto’s University
Introduction: There seems to be a causal relationship between vitamin D 
deficiency (vitD) and obesity, but the nature of this association remains 
controversial. 
Objectives: Evaluate: (1)the prevalence of vitD deficiency in obese subject 
undergoing bariatric surgery before and 12 months after surgery; (2)vari-
ation of vitD over 12 months of follow-up; (3)correlation between the vitD 
and excess BMI (EIMCP). 
Methods: We performed a retrospective study of 983 patients undergoing 
bariatric surgery between January/2010 and June/2013 on Centro Hospi-
talar de Săo Joăo. Patients were divided into surgical technique - adjust-
able gastric banding (AGB), gastric bypass (GB), sleeve gastrectomy (SG). 
Baseline and 12 months post-surgery values of vitD were determined. 
Results: Follow-up was completed in 245 patients, of which 13.1% were 
men and 86.9% were women, with a median age of 43.0 years (inter-
quartile range(IQR) from 35.00 to 53.00), median weight 113,05kg (IQR 
103.78–127.00), and median BMI 43,5940kg/m2 (IQR 40.1463–46.6769). 
Median baseline vitD were 12,0ng/mL (IQR 8.0–17.0). A larger percent-
age of patients had prior vitD deficiency (80.8%) than at 12 months after 
surgery (42.9%), having found an average increase of vitD at 12 months 
of 9.19 ± 11,006ng/ml (p < 0.001). The variation of vitD was statistically 
significant in all groups (p = 0.004), with a median of 10,0ng/mL in the 
AGB (IQR 2.0–15.0), 7,0ng/mL in GB (IQR 0,0–15.0), and 13,0ng/mL in 
SG (IQR 6.5–20.0). The weight loss at 12 months was statistically signifi-
cant (p < 0.001), with a median loss of –17,800kg for AGB [IQR –9.975-
(-17,800)]; –38,000kg for GB [IQR –31.800-(-44.900)]; –28,150kg for SG 
[IQR –21.600-(-41.650)]. There was no correlation between the vitD and 
EIMCP. 
Conclusions: VitD deficiency was confirmed in our study population. We 
verified a significant increase in vitD with weight loss and over the 12 
months follow-up. However, there was no correlation between the vitD 
and EIMCP.
T8:PO.068
Acute weight loss following omega-loop-gastric bypass 
surgery impairs liver transaminases and cholestatic 
parameters in diabetic and non-diabetic patients
Kruschitz R.1, Luger M.1,2, Kienbacher C.3, Trauner M.3, Walker M.3, 
Schindler K.1, Langer F.4, Prager G.4, Krebs M.1, Ludvik B.1
1Division of Endocrinology and Metabolism, Department of Internal Medicine 
III, Medical University of Vienna, Austria,  
2Special Institute for Preventive Cardiology and Nutrition – SIPCAN save your 
life, Salzburg, Austria,  
3Division of Gastroenterology and Hepatology, Department of Internal 
Medicine III, Medical University of Vienna, Austria,  
4Division of General Surgery, Department of Surgery, Medical University of 
Vienna, Austria
Introduction: 50–75% of obese and diabetic patients exhibit non-alcohol-
ic fatty liver disease, which is associated with elevated liver enzymes. We 
hypothesized that increased flux of toxic lipids mobilized from adipose 
tissue to the liver during acute weight loss might be a risk factor for liver 
impairment within the first months after bariatric surgery. 
Methods: Within our cohort study we evaluated liver enzymes (AST, 
ALT), De Ritis Ratio (DRR) and cholestatic parameters (CP) (AP, bili-
rubin) pre-, 3, 6 and 12 months postoperative (T0-T12) in non- (N) and 
diabetic (D) patients with omega-loop gastric bypass. 
Results: N [n=28;Ⅲ=82%; 41 ± 15(mean±SD) years] and D [n=22;Ⅲ=68%; 
54 ± 10 years] obese patients showed a significant weight loss (WL) of 
37.4 ± 6.6% in N vs. 33.7 ± 7.9% in D at T12, (N vs. D n.s.). Acute WL 
was greater for N [N 22.7 ± 5.6% vs. D 18.4 ± 3.9%, p = 0.02], and AST 
dropped significant in N [23(16–41)U/l, median(min-max) to 27(19–58)
U/l, p = 0.01] at T3. At T0 D had significant higher DRR than N [1.2 ± 0.9 
vs. 0.8 ± 0.2, p = 0.01]. This difference appears also at T3 [N 0.9 ± 0.2 vs. D 
1.1 ± 0.5, p = 0.01], whereby it dropped in D and rose in N. In the whole 
cohort we found an increase in CP [AP: 87(55–115)U/l to 93(65–136)U/l, 
p = 0.01; N vs. D n.s.; bilirubin: 0.6(0.3–1.0)mg/dl to 0.8(0.5–1.5)mg/dl, 
p = 0.00; N vs. D n.s.]. At T12 all parameters returned to preoperative val-
ues, except for AST in N [T0 to T12, N:5(-11–30)U/l vs. D:1(-43–25)U/l, 
p = 0.01]. 
Conclusion: Acute weight loss results in rise of transaminases, DRR, and 
CP in N, probably due to increased free fatty acid flux, as they exhibited 
greater weight loss with a potential risk for acute liver decompensation for 
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T8:PO.069
The effect of omega-loop versus roux-en-y gastric bypass on 
weight loss liver and cholestatic parameters
Kruschitz R.1, Luger M.1,2, Melanie W.3, Kienbacher C.3, Trauner M.3, 
Schindler K.1, Langer F.4, Prager G.4, Ludvik B.1
1Division of Endocrinology and Metabolism, Department of Internal Medicine 
III, Medical University of Vienna, Austria,  
2Special Institute for Preventive Cardiology and Nutrition – SIPCAN save your 
life, Salzburg, Austria,  
3Division of Gastroenterology and Hepatology, Department of Internal 
Medicine III, Medical University of Vienna, Austria,  
4Division of General Surgery, Department of Surgery, Medical University of 
Vienna, Austria
Introduction: There is evidence that Omega-Loop Gastric Bypass (OLGB) 
demonstrates promising results for weight loss (WL). However, it‘s impact 
on liver enzymes compared to Roux-en-Y Gastric Bypass (RYGB) has not 
yet been determined. 
Methods: We evaluated liver enzymes (AST, ALT), cholestatic parameters 
(CP: GGT, AP, bilirubin) and NAFLD fibrosis score (NFS)1 pre-,3,6 and 
12 months postoperative (T0-T12). 
Results: Non-diabetics who underwent either RYGB [n=25;Ⅲ=92%; 
BMI:45.6 ± 4.1(mean±SD); age:44.3 ± 10.2] or OLGB [n=25;Ⅲ=88%; 
BMI:45.3 ± 5.3; age:43.5 ± 13.2] were analysed. OLGB showed a great-
er WL compared to RYGB [T3: RYGB 15.7 ± 4.3 vs. OLGB 23.3 ± 5.5%; 
p = 0.001; T6: 23.8 ± 6.0 vs. 33.5 ± 6.6%; p < 0.001; T12: 29.7 ± 9.2 vs. 
37.0 ± 6.5%; p < 0.01]. ALT dropped in RYGB (T0-T12:p = 0.04), while 
rising in OLGB (p < 0.05) over the observation period [T0: 33 ± 21 vs. 
32 ± 15U/l, n.s.; T12:25 ± 8 vs. 37 ± 16U/l; p < 0.01]. Compared to T0 
RYGB vs. OLGB showed a significant higher AST at T6, this difference 
disappeared at T12 [T0: 28 ± 12 vs. 26 ± 9U/l; n.s.; T6: 25 ± 7 vs. 34 ± 16; 
p = 0.04]. GGT increased in RYGB from T0-T6 [T0: 43 ± 57U/l vs. T6: 
19 ± 11U/l; p < 0.05], while it remained stable in OLGB [T0: 33 ± 15 vs. 
T6:33 ± 32U/l; n.s.]. NFS initially showed higher proportion of NAFLD 
in RYGB vs. OLGB [20 vs.12%] this proportion changed at T12 [13 vs. 
24%]. In the whole cohort a maximal rise in CP was found at T3 in RYGB 
and OLGB [AP: (T0: 88 ± 24 vs. 84 ± 21U/l; n.s. T3: 107 ± 21 vs. 96 ± 21; 
n.s.); bilirubin: (T0: 0.5 ± 0.1 vs. 0.6 ± 0.2mg/dl; p = 0.02; T3: 0.7 ± 0.3 vs. 
0.9 ± 0.3mg/dl; n.s.)]. Increased AP (T0-T12; p = 0.01) and bilirubin (T0-
T12; p < 0.001) remained high until T12. 
Conclusion: OLGB vs. RYGB results in greater WL but deterioration of 
liver parameters in the first year after surgery.
Reference:
1. Angulo P, Hui JM, Marchesini G et al.: Hepatology.2007;45(4):846–854.
T8:PO.070
Effect of two preoperative low-energy diets on liver fat 
content in bariatric patients: A randomized trial
Schuetz T.1, Peter V.1, Garnov N.1,2, Schaudinn A.1,2, Linder N.1,2, Busse H.2, 
Shang E.3, Petroff D.4, Dietrich A.5
1IFB Adiposity Diseases, Leipzig University Medical Center, Leipzig, Germany,  
2Department of Diagnostic and Interventional Radiology, Leipzig University 
Hospital, Leipzig, Germany,  
3Klinik Dr. Rinecker, Munich, Germany,  
4Coordination Centre for Clinical Trials, Leipzig University, Leipzig, Germany,  
5Clinic of Visceral, Transplantation, Thoracic and Vascular Surgery, Section of 
Baraitric Surgery, Leipzig University Hospital, Leipzig, Germany
Introduction: It is known that a preoperative low-energy diet (LED) can 
effectively reduce liver fat content (LFC). In a prospective, randomized 
intervention study, we compared two LED products (high protein plus 
low carbohydrate vs. high carbohydrate) concerning their effects on LFC. 
Methods: 69 patients scheduled for bariatric surgery were randomized 
to receive LED1 (75 g protein, 28 g fat, 80 g carbohydrates) or LED2 (58 
g protein, 19 g fat, 111 g carbohydrates) and 200 g of vegetables daily for 
two weeks. Pre- and post-interventionally, LFC was measured by a ded-
icated analysis of MRI data (1.5 T, 2-point Dixon method). Patients with 
LFC>10% at baseline were included (n=46). 
Results: Age and BMI were similar between groups (LED1: n=22; 13 
f, mean age 46.6 years, mean BMI 48.4 kg/m˛; LED2: n=24; 15 f, 47.2 
years, 47.9 kg/m˛). LFC decreased significantly from 28.9 ± 10.1% by 
4.9% (LED1) and from 21.0 ± 8.8% by 4.4% (LED2). This decrease was 
1.0 (-2.9; 5.0) percentage point higher in LED2 compared to LED1 (AN-
COVA; p = 0.6). Relative changes were 19% in LED1 and 20% in LED2, 
respectively. Baseline values were strongly correlated to follow-up values 
(r=0.82 [0.70; 0.90]). There were, however, no associations between the 
relative changes in LFC and body weight (r=-0.02 [-0.31; 0.28]; p = 0.9) 
and liver volume (r=-0.04 [-0.3; 0.21]; p = 0.7). 
Conclusion: Both diets resulted in a significant reduction in liver fat con-
tent by 20% previous to bariatric surgery, independent of changes in body 
weight or liver volume.
Acknowledgement: This work was supported by the Federal Ministry of Education 
and Research (BMBF), Germany, FKZ: 01EO1001.
T8:PO.071
Long term outcomes of three types of bariatric surgery on 
obesity and type 2 diabetes
Dicker D.1, Yahalom R.2, Comaneshter D.3, Vinker S.3
1Internal Medicine D &Obesity Clinic, Hasharon Hospital-Rabin Medical Center, 
Petach-Tikva, Israel,  
2Hospital Devision, Clalit Health Services, Tel aviv, Israel,  
3Chief Physician office, Clalit Health Services, Tel Aviv, Israel
Objective: To compare weight loss and glucose control in individuals with 
type 2 diabetes after three types of bariatric surgery: gastric banding (GB), 
sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB), with up 
to 5 years follow-up. 
Methods: A retrospective study of all persons with diabetes who are 
members of the largest health maintenance organization in Israel, who 
underwent bariatric surgery during the years 2002–2011. HbA1c <6% at 
follow-up was defined as remission from diabetes. Types of surgery were 
compared using one-way analysis of variance (ANOVA) and chi-square 
test, as applicable. Multivariate logistic regression models were applied to 
study relationships between risk factors and remission. 
Results: 2190 individuals were included, 64.8% women. The operations 
performed were: 1027 GB, 1023 SG and 140 RYGB. Mean BMI+SD at 
baseline, 1 year postoperative and 5 years postoperative were 43.5+6.18, 
36.6+6.06, 36.2+6.45 for GB, 43.6+6.42, 34.3+6.23, 36.5+7.25 for SG and 
42.8+5.85, 32.7+5.22, 34.1+4.87 for RYGB. Mean HbA1c+SD at baseline, 
1 year postoperative and 5 years postoperative were 7.6+1.58, 6.5+1.22, 
6.8+1.48 for GB, 7.7+1.63, 6.4+1.18, 6.7+1.57 for SG and 8.0+1.78, 
6.3+0.98, 7.04+1.42 for RYGB. Altogether, at one year follow up, the pro-
portion of patients who achieved remission was 37.4%, and at 5 years, 
32.9%. In the multiple regression model, all operation types had the same 
remission rate at five years. Five-year remission was inversely associated 
with baseline HbA1c and with treatment with insulin at baseline, and pos-
itively associated with BMI. 
Conclusions: For all three surgeries, mean BMI and HbA1c decreased 
considerably during the first year postoperative, and remained lower than 
the basal values until the end of follow up. Early improvements were great-
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T8:PO.072
Subclinical hypothyroidism in a population of obese patients
Costa M.M.1,2, Belo S.1,2, Saavedra A.1,2, Oliveira J.1,2, Cunha F.1,2, Lau E.1,2, 
Magalhaes D.1, Silva R.1, Freitas P.1,2, Varela A.1,2, Queirós J.1, Correia F.3, 
Carvalho D.1,2
1Department of Endocrinology, Centro Hospitalar Sao Joao, Porto, Portugal,  
2Faculty of Medicine, Porto University, Portugal,  
3Faculty of Nutrition and Food Sciences, Porto University, Portugal
Introduction: The incidence of subclinical hypothyroidism (SH) varies 
from 4 to 10% depending upon the gender, age and population studied. 
Increased levels of TSH are observed in obese patients and previous stud-
ies have demonstrated that with increasing TSH there is an increase in 
BMI. 
Objective: SH prevalence and comparison of weight loss among patients 
with SH and euthyroid patients (ET) in a population of obese undergoing 
bariatric surgery. 
Methods: Retrospective study of patients who underwent bariatric sur-
gery between January 2010 and June 2013. We included patients with 
preoperative determination of TSH and FT4 and excluded patients with 
thyroid disease, patients on therapy (levothyroxine or antithyroid synthe-
sis) and those without information on these two factors. 
Results: 820 patients were analyzed, 86.7% (n = 711) were female, with 
mean age of 42.6 (10.7) years, baseline BMI 44.3 (5.6) kg/m2. Of these, 
760 were ET and 44 had SH. The prevalence of SH baseline was 5.4%. The 
mean baseline TSH was higher in SH (SH 5.24 (1.58) vs ET 1.88 (0.80) 
μUI/mL; p < 0,001); no difference in the levels of FT4 (SH 1.04 (0.15) vs 
ET 1.07(0.15) ng/dL; p = 0,176). No differences were found with statistical 
significance between the ET and SH in initial BMI (ET 44.3 (5.7) vs SH 
45.2 (5.8)kg/m2; p = 0.292), in weight loss (ET 32.3 (15.4) kg vs SH 32.6 
(15.2) kg, p = 0,927) and BMI at 12 months (ET 31.9 (5.5) vs 32.7 SH (56) 
kg/m2; p = 0,351). 
Conclusion: The HS prevalence in this population was similar to that re-
ported in previous studies. In this sample basal, TSH was not a determi-
nant of the decrease in weight after surgery.
T8:PO.073
Nutritional factors affecting weight loss at three months after 
laparoscopic sleeve gastrectomy
Gherasim A.1, Arhire L.I.1, Padureanu S.S.1, Ungureanu C.1, Gavril R.S.1, 
Mihalache L.1
1“Grigore T. Popa“ University of Medicine and Pharmacy, Iasi, Romania
Background and aim: Laparoscopic sleeve gastrectomy (LSG) is a newer 
bariatric surgical procedure with promising results and fewer long-term 
complications. The factors influencing weight loss after LSG are not en-
tirely understood. The aim of this study was to investigate how the preop-
erative nutritional status of the patients undergoing LSG influence weight 
loss at three months after surgery. 
Material and methods: We included in this study all patients who under-
went LSG during 2013–2014 in our center. We calculated body mass index 
(BMI) before surgery and % excess weight loss (% EWL) at 3 months after 
surgery. We assessed the following seric markers before, and 3 months af-
ter surgery: total proteins, albumin, iron, calcium, magnesium, potasium, 
vitamin D, PTH, folic acid, C reactive protein. 
Results: We evaluated 30 patients (22 women). Average age was 41 ± 11.9 
years, and average BMI before surgery was 44.1 ± 8.3 kg/m2 (min. 34.5 
kg/m2, max. 63.8 kg/m2). Before surgery, the most common nutritional 
deficiency was in vitamin D: average value was 14.9 ± 9.4 ng/dl (95%CI: 
10.5–19.5 ng/dl), but 36.8% of patients had values of ≤10 ng/dl. % EWL 
a 3 months after surgery was 45.6 ± 12%. We saw that % EWL correlat-
ed positively with the following preoperative seric markers: seric albu-
min (R=0.868, p = 0.05), kaliemia (R=0.555, p = 0.049), magnesemia 
(R=0.615, p = 0.048) and vitamin D (R=0.45, p = 0.039) and negatively 
with age (R=-0.544, p = 0.044), preoperative weight (R=-0.657, p = 0.028), 
C reactive protein (R=-0.693, p = 0.042) and PTH (R=-0.841, p = 0.034).
Conclusions: Given that older age, greater weight and a poorer preoperative 
nutritional status hinter weight loss after LSG, we suggest that this proce-
dure should be disscused with patients earlier, to increase its benefits.
T8:PO.074
Genetic polymorphisms and body weight loss in women: One 
year after roux-en-y gastric bypass surgery
Novais P.F.1, Koester Weber T.2, Crisp A.H.1, Verlengia R.3, Rasera Jr I.4, 
Marques de Oliveira M. R.1,2
1Graduate Program in Food and Nutrition – Nutrition Sciences, Paulista State 
University, School of Pharmaceutical Sciences (UNESP-FcFar), Araraquara/SP, Brazil,  
2Institute of Biosciences of the Paulista State University (UNESP) – Botucatu – SP, 
Brazil,  
3College of Health Sciences, Methodist University of Piracicaba, Piracicaba, Brazil,  
4Gastroenterology and Obesity Surgery Center – Bariatric Clinic, Hospital 
Fornecedores de Cana, Piracicaba-SP, Brazil
Introduction: The preva¬lence of obesity is constantly increasing under 
the influence of genetic, environmental, dietetics and metabolic factors. 
To treat morbid obesity and obesity co-morbidities, bariatric surgery has 
configured as the only treatment to achieve loss suitable weight and dura-
ble. The aim of this study was to investigate the association of body weight 
loss with different genetic polymorphisms in women underwent bariatric 
surgery, one year after the procedure. 
Methods: Were included 351 women in the study. Analyzes for the iden-
tification of single nucleotide polymorphism (SNP) were performed be-
fore the bariatric surgery, using the TaqMan Genotyping Assay (Applied 
Biosystems®). The polymorphisms analyzed were: GHRL rs26802; GHSR 
rs572169, rs7799039 LEP, LEPR rs1137101, rs3813929 HTR2C; UCP2 
rs659366; rs660339 UCP2, UCP3 rs1800849, rs7498665 SH2B1; TAS 
rs35874116, TAS rs9701796 and rs9939609. One year after Roux-en-Y 
gastric bypass surgery, the loss weight was associated with SNP. 
Results: After one year of surgery, was observed a body weight loss about 
43 (24–83) kg among women, with a percentage of excess weight lost 
(%EWL) equal 69 (37 – 119) %. Genotypes often less than 10% corre-
sponded to genes GHSR, HTR2C, TAS and TAS. Of the 12 SNPs evaluated 
2 show the effect on body weight loss. Volunteers who had TT genotype 
of GHSR gene had 3.5 times more possibility to be below the median of 
%EWL compared CC+CT genotype. Volunteers who presented T allele 
of the FTO gene had 2.2 times more possibility to be below the median 
of %EWL. 
Conclusion: The polymorphisms related with ghrelin receptor (GHSR) 
and fat mass and obesity (FTO) were associated with body weight loss 
after one year of Roux-en-Y gastric bypass surgery in women.
Acknowledgement: Support Foundation of Săo Paulo (FAPESP) and National 
Council for Scientific and Technological Development (CNPq)
T8:PO.075
SADIS – new method in bariatric/metabolic surgery.
Holeczy P.1,3,4, Bužga M.2, Keher I.4, Bolek M.1, Figurová E.4
1Surgical department, Vitkovice hospital, Ostrava-Vítkovice, Czech republic,  
2Department of fysiology and patofysiology, Medical Faculty, Ostrava University, 
Ostrava, Czech republic,  
3Department of surgical disciplines, Medical Faculty, Ostrava University, Ostrava, 
Czech republic,  
4Surgical dept, University hospital, Trnava University, Trnava, Slovakia SADIS 
– new method in bariatric/metabolic surgery Holéczy, P., Bužga, M., Keher, 
I., Bolek, M., Figurová, E. Surgical department, Vitkovice hospital, Ostrava-
Vítkovice, Czech republic Department of fysiology and patofysiology, Medical 
Faculty, Ostrava University, Ostrava, Czech republic Department of surgical 
disciplines, Medical Faculty, Ostrava University, Ostrava, Czech republic Surgical 
dept, University hospital, Trnava University, Trnava, Slovakia 
Aim: Bariatric surgery has more than 60 years history. There were invent-
ed and introduced to surgical practise more than 50 types of operations. 
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alternative to biliopancreatic diversion – duodenal switch - SADIS (single 
anastomosis duodenoileal with sleeve gastrectomy.
Material and methods: After obtaining agreement from ethical commit-
tee we started to perform this operation in our two centers in the frame 
of prospective study. The indication for surgery was failed sleeve resection 
and weight regain. Four patiens were operated on from may to september 
2014. Two of them were diabetics, two had hypertension, in one dyslip-
daemia was under medical treatment. 
Results: significant weight loss was recorded in all patients, antidiabetic 
treatment and antihypertensive drugs was removed and all patiens express 
satisfaction with the operation. Improvement in glycaemic control was 
observed, as well. No surgical complication was recorded. 
Conclusion: It is impossible to create any firm conclusion from this pilot 
report. More patiens and longer follow up are necessary to confirm very 
optimistic report of Torres and co.
T8:PO.076
No evidence of impaired oral hormone substitution after 
gastric bypass surgery in patients with morbid hypothalamic 
obesity and hypopituitarism secondary to craniopharyngioma
Wolf P.1, Winhofer Y.1, Smajis S.1, Kruschitz R.1, Schindler K.1, Gessl A.1, 
Vila G.1, Raber W.1, Langer F.2, Prager G.2, Ludvik B.3, Luger A.1, Krebs M.1
1Medical University of Vienna, Department of Internal Medicine III, Division of 
Endocrinology and Metabolism,  
2Medical University of Vienna, Department of Surgery,  
3Rudolfstiftung, Department of Internal Medicine I, Division of Endocrinology, 
Diabetology and Nephrology
Background: Craniopharyngiomas (CP) are benign brain tumors pre-
senting in childhood treated by tumor resection together with radiother-
apy. In about half of the cured patients hypothalamic damage leading to 
eating disorders and obesity as well as to hypopituitarism, necessitating 
consequent hormone substitution therapy, is observed. Bariatric surgery 
is an efficient treatment strategy for morbid obesity. However, so far it is 
unknown, whether oral hormone substitution is hampered by impaired 
intestinal absorption, leading to severe hypopituitarism or adrenal insuf-
ficiency. 
Methods: 4 CP-patients with hypopituitarism and morbid obesity treat-
ed by gastric bypass surgery were included in this retrospective analysis. 
Dosage of hormone substitution, hormonal blood concentrations, adverse 
effects of impaired drug absorption and anthropometric characteristics 
were investigated pre and 3 to 12 months post operatively. 
Results: In all CP-patients (3w/1m; BMIbasal 49 ± 7kg/m2) gastric bypass 
resulted in distinct weight loss (-35 ± 27kg). In follow-up examinations 
mean concentration of fT4 increased (fT4basal 0.9 ± 0.31ng/dl vs fT4Fol-
lowUp 1.28 ± 0.29ng/dl). No patient developed any signs of adrenal in-
sufficiency postoperatively. Mean daily dosage of oral thyroid hormone 
substitution (levothyroxinebasal 156 ± 44μg/d vs levothyroxineFollowUp 
150 ± 30μg/d) and hydrocortisone (hydrocortisonebasal 29 ± 12mg/d 
vs hydrocortisoneFollowUp 26 ± 2mg/d) was unchanged. Mean in-
sulin-like-growth-factor-1 concentration decreased after weight loss 
(IGF-1basal 217 ± 93ng/ml vs IGF-1FollowUp 111 ± 36ng/ml), whereas 
daily growth-hormone substitution was slightly increased (somatotropin-
basal 0.9 ± 0.5mg/d vs somatotropinFollowUp 1.0 ± 0.4mg/d). 
Discussion: Our results in n=4 CP patients suffering from hypopituita-
rism indicate that oral hormone substitution is not impaired following 
gastric bypass operation, probably making it a safe and considerable treat-
ment strategy in patients suffering from hypothalamic obesity.
T8:PO.077
The Discrepancy Between Patient Expectations and 
Achievable Body Weight Loss Ratios in Patients Undergoing 
Bariatric Surgery
Murt A.2, Ozkara H.M.1, Yalaza Kahraman A.1, Yumuk V.1
1Istanbul University Cerrahpasa Medical Faculty, Department of Endocrinology 
and Methabolism,  
2Istabul University Cerrahpasa Medical Faculty, Department of Internal Medicine
Background: We had the observation that patients scheduled for bariatric 
surgery had unrealistically high weight loss expectations, probably due 
to lack of delivery of proper information by healthcare providers. In this 
study, we have formally tabulated the expectations of patients from bar-
iatric surgery and compared this information with the reported outcomes 
of the procedure. 
Methods: Patient Expectations from Bariatric Surgery Questionnaire 
was applied to 42 patients followed at Metabolism Clinic of Cerrahpa-
sa Medical Faculty and were referred to the bariatric surgery clinic. The 
questionnaire was applied within a week prior to the surgery. Weight loss 
expectations percentage for each patient was calculated by dividing the 
expectation stated by a patient to his/her absolute excess weight. Addi-
tionally, factors that motivate patients were questioned. 
Results: 42 patients (8 male, 34 female, preoperative mean BMI: 48.82 
±8.99kg/m2) attended to the survey. Laparoscopic sleeve gastrectomy was 
planned for 40 patients and en-Y gastric baypass was planned for 2 pa-
tients. Average weight loss expectation was 97 ±18% (range: 46–141%). 
There was no significant correlation between body weights or BMIs and 
weight loss expectations. We have also asked the main motivating factor 
that lead the patients to seek for bariatric surgery. Most of the patients 
believed that bariatric surgery would cure their related morbidities com-
pletely (diabetes, hypertension etc) by losing their excess weight, as well as 
having a better physical comfort. 
Conclusion: A recent meta-analysis on the follow-up of patients after bar-
iatric surgery has shown that patients lose their 61% of excess body weight 
by a bariatric surgery procedure. Our study indicated that our patients 
have developed unrealistic goals and expectations from bariatric surgery 
procedures. This discrepancy may be a reason for disappointments after 
the procedures and loss of motivation to follow their post-op Methabo-
lism Clinic visits
T8 – Multidisciplinary treatment
T8:PO.078
Common misconceptions about dieting and nutrition by the 
obese patients of our diet program.
Poon P.1
1Dr. Poon‘s Metabolic Diet Clinic, Thornhill, Ontario, Canada 
We counsel patients who are obese and are suffering from Metabolic Syn-
drome. Our diet plan does not require the patient to count calories. It is 
mainly a low-sugar, low-starch, low-saturated fat and low-sodium diet. 
The patients are encouraged to eat until they are full and they are allowed 
to eat at any time of the day. The diet is high in lean protein, omega-3 and 
omega-6 fatty acids, and vegetables with high fiber content. Here is a list of 
statements from patients that are commonly heard in our clinic: I have to 
drink milk and eat cheese everyday because I have osteoporosis I cannot 
eat meat because I have high cholesterol I have to eat sugar because I heard 
that my brain needs sugar to function I have to eat some sugar and starch 
because I am a type 2 diabetic I have to eat my rice and bread everyday 
because it is in my culture I am eating fruits because fruit contain natural 
sugar I do not drink diet soda because I was told that I can gain weight 
even if it contains zero calories I do not eat after 7 PMI was told break-
fast is the most important meal of the day I was told to eat more often 
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my birthday I am on a fat free diet I gain all this weight because I cannot 
exercise All these misconceptions might hinder the patient’s weight loss 
progression. This presentation will provide an opportunity to discuss the 
validity of these statements
T8:PO.079
Pharmacological studies on the effects of topiramate on 
appetite and metabolism
Handjieva-Darlenska T.1, Klisurov R.1, Boyadjieva N.1
1Department of pharmacology and toxicology, Medical Faculty, Medical 
University, Sofia, Bulgaria
Introduction: Topiramate is a well-known antiepileptic drug. Recent data 
show that low doses of Topiramate leads to weight reduction in humans. 
The objectives of our study were to investigate the influence of Topiramate 
on metabolism in obese rats, and to investigate its action on the free rad-
icals in plasma. Materials and methods: Wistar female rats (n= 16) were 
randomly assigned to either control diet (chow food) or an experimental 
high-fat diet to develop an experimental model of obesity. The nutritional 
period lasted for one month. Then, rats were divided into two groups - 
control and experimental (obese treated with Topiramate - 50mg/kg p.o.) 
Topiramate was administered for another two months. Body weight was 
weekly measured. At the end of the study rats were anaestezised and de-
capitated. Blood samples, liver, adipose tissue, brain were taken for further 
measurements. The concentration of free radicals in the plasma was deter-
mined by the method of MTT - formazan. 
Results: Topiramate significantly decreased the body weight of the obese 
group compared to the control group (p < 0.001). Secondly, Topiramate 
reduced the plasma levels of free radicals in the experimental group.
Conclusions: Our data suggest that Topiramate has a potent beneficial ef-
fect on body weight and metabolism in rats. Moreover, the drug decreases 
the plasma free radicals which may influence the mechanisms for devel-
opment of obesity.
T8:PO.080
The national observational study results of effectiveness and 
safety of obesity medical treatment
Galieva M.1, Troshina E.2, Mazurina N.3, Komshilova K.A.3
1Endocrinology Research Center, Moscow, Russian Federation 
Introduction: Despite the newly emerging drugs safety in the treatment 
of obesity is the primary goal. In Russia performed observational study on 
the efficacy and safety of sibutramine for the treatment of obesity. 
Methods: At the time of evaluation of results 12093 patients (10048 wom-
en and 2045 men) were included in the study, a 6-month course of treat-
ment completed the 10503 patients, 920 patients completed 12 months. 
Inclusion criteria were the following: age 18–65 years, BMI ≥ 30 kg/m2 
or a BMI ≥ 27 kg/m2 with type 2 diabetes and/or dyslipidemia. Exclusion 
criteria were: cardiovascular diseases, uncontrolled hypertension, men-
tal illness, severe liver and chronic kidney disease. All patients received 
sibutramine 10 or 15 mg once daily. 
Results: After the first 6 months and the subsequent 6-month of sibutra-
mine treatment period (median/95% CI) weight loss was –14.25 kg (-14.4; 
–14.1) / –19.16 kg (-19.8; –18.5), BMI change –5.14 kg/m2 (-5.2; –5.1) / 
–6.97 kg/m2 (-7.2; –6.7), WC –10.5 cm (-10.7; –10.3) / –14.7 cm (-15.5; 
–13.9); HR 0.26 bpm (0.1; 0.4) / 0.19 bpm (-0.2; 0.6), SBP –1.36 mmHg 
(-1.5; –1.2) / –0.96 mmHg (-1.5; –0.4), DBP –1.15 mmHg (-1.3; –1.0) / 
–0.32 mmHg (-0.8; 0.2) (p <0.001). According to the Well-Being Ques-
tionnaire (WBQ-12) after 12 months of treatment revealed change of 
positive well-being, negative well-being, energy and general well-being 
(mean ± SD): 3.7 (± 4.0), –3.8 (± 3.8), 3.8 (± 3.7), 11.4 (± 10.5) respec-
tively (p <0.001). During the observation period 1.6% of patients were re-
ported adverse events, hypertension and tachycardia amounted for 0.1%. 
Severe side effects have not been identified. 
Conclusion: Long-term therapy of obesity with sibutramine is effective 
and safe subject to the indications and contraindications for its prescrip-
tion.
T8:PO.081
Risk of overweight and obesity in adult patients with the 
genetic disorder sickle cell disease: Are all types created 
equal?
Hill L.K.1, O‘Garo K.N.1, Binks M.2, Wood M.1, Feliu M.1, Barker C.S.3, Keys A.1, 
Kaufman K.2, Kahathuduwa C.2, Dorfman C.1, Putilin D.1, Applegate K.1, 
Robinson E.4, Edwards C.L.1
1Duke University Medical Center, Durham, NC. USA,  
2Texas Tech University, Lubbock, TX. USA,  
3B and D Behavioral Health, Durham, NC. USA,  
4Winston Salem State University, Winston Salem, NC. USA
Introduction: Historically, patients with the genetic disorder Sickle Cell 
Disease (SCD) were considered at risk for underweight, malnutrition, and 
premature death. Thus, little attention was placed on dietary management, 
exercise, sleep hygiene or stress management as these patients were not 
considered at risk for overweight and obesity. Our recently published data 
however, suggests that patients with SCD live longer; with over half of our 
sample at risk for overweight and obesity1. The current study used base-
line data collected via survey methodology, and evaluated the association 
of SCD subtype with obesity risk. 
Methods: Data from N = 242 (46% female) adult (M = 33.37 ± 12.68 
years) SCD clinic attendees taking part in an ongoing IRB-approved lon-
gitudinal study at a Southeastern United States medical center was exam-
ined. A 700-item psychosocial/medical survey was completed, height and 
weight were measured and BMI calculated (kg/m2). Subjects were classi-
fied according to SCD subtype. 
Results: Using ANCOVA with Bonferroni correction for multiple com-
parisons; we considered SCD type/BMI associations with covariates age, 
gender and education. We found that BMI was greater (i.e. in the over-
weight to obese range) among individuals possessing the SB+ and SC sub-
types (ps<.001) compared to individuals with SS type whose BMI’s were 
lower and more consistent with traditional conceptualizations of SCD. 
Conclusion: Our study suggests that patients with SB+ and SC type SCD 
must increasingly be concerned with morbidities of lifestyle, like obesity. 
Interventions should be tailored to disease type. Reference 1. Pells JJ, Pres-
nell, KE, Edwards, CL, Wood M, Harrison, MO, DeCastro, L, Johnson S, 
Feliu M, Canada S, Jonassaint JC, Barker C, Leach-Beale B, Mathis MJ, 
Applegate K, Holmes A, Byrd G, Robinson E. Moderate Chronic Pain, 
Weight and Dietary Intake in African-American Adult Patients with Sick-
le Cell Disease. Journal of the National Medical Association.2005;97(12): 
1622-1629
T8:PO.082
Impact of multidisciplinary preparation to bariatric surgery 
on health behaviors
Ledoux S.1, Breuil M.C.1, Delapierre M.1, Larger I.1, Sami O.1, Coupaye M.1
1Service des Explorations Fonctionnelles-Centre de l‘obésité (CINFO), Hôpital 
Louis Mourier, Faculté Paris Diderot, 92700 Colombes, France.
Introduction: International guidelines emphasize the need for multidis-
ciplinary preparation before bariatric surgery to improve safety and effec-
tiveness, but its impact has been little studied. Our aim was to explore the 
impact of this preparation on dietary habits, physical activity, weight loss 
and quality of life before surgery. 
Methods: We prospectively recorded in 78 candidates for bariatric sur-
gery (age:43 ± 12 yr; M/F:15/63; weight:122 ± 17 kg; IMC:44 ± 5 kg/m˛), 
anthropometric parameters, food intake, physical activity (Beacke ques-
tionnaire) and quality of life (SF36) at the beginning and the end of the 
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Results: Reported caloric intake decreased from 2143 ± 640 to 1906 ± 564 
kcal/24h (p < 0.001) during the preparation and snacking from 68 to 13% 
of the subjects. Physical activity increased (p < 0.05) and quality of life 
improved (p < 0.01), but mean weight change was zero (±5 kg). The mean 
number of preoperative consultations proposed (with nutritionist, dieti-
cian, psychologist and sports coach) was 7 ± 2 and was as greater as pa-
tients gained weight during the preparation (R =0.2992, p < 0.01). Howev-
er, the number of consultations was positively correlated with the decrease 
of reported caloric intake (R=0.2885, p < 0.05). Furthermore, weight loss 
before surgery was positively related to postsurgical weight loss (record-
ed at 6 ± 1 months in 59 subjects), whereas preoperative dietary changes 
were not. 
Conclusion: Despite increase of dietary knowledge (reflected by improved 
diet report) during preoperative preparation, candidates for bariatric sur-
gery have difficulty to actually change their eating behavior (reflected by 
weight change) before surgery. However, only weight change seems to im-
pact the success of bariatric surgery.
T8:PO.083
Overweight and obesity in sickle cell disease: Primary disease 
management, psychosocial considerations, and health 
promotion.
Binks M.1, Keys A.2, Feliu M.2, O‘Garo K.2, Hill L.2, Kaufman K.1, Edwards C.L.2
1Texas Tech University, Lubbock, TX. USA,  
2Duke University Medical Center, Durham, NC. USA
Background: Sickle Cell Disease (SCD) is a genetic disease that influences 
hemodynamics in such a way that red blood cells exhibit diminished capa-
bility to effectively transport oxygen and carbon dioxide to and from the 
lungs and the tissues of the body. The disease affects primarily non-white 
populations. It is the most common genetic blood disorder in the US and 
one of the most common worldwide. Medical and psychosocial conse-
quences of SCD are often devastating. Medical comorbidities include 
small vessel occlusions in major organs, increased incidence of stroke; fre-
quent, unpredictable, intense and debilitating pain and premature death. 
Psychosocial consequences include disturbed mood, body image and 
reduced quality of life. In recent years, advancements in hematological 
treatments have improved prognosis for some patients affected by SCD 
with improved life-expectancy as a result. Consequently, there has been 
an increase in chronic, lifestyle-related diseases that typically, dispropor-
tionately affect African American men and women such as hypertension, 
diabetes, and obesity. We will provide a comprehensive overview of the 
existing (albeit limited) research on the etiology, consequences and treat-
ment of SCD and its comorbid medical and psychosocial correlates within 
a biopsychosocial framework paying particular attention to healthy life-
styles and lifestyle-related disease states. Our overarching theme will be 
centered on a framework for comprehensively and holistically treating the 
patient within a Behavioral Medicine paradigm to improve overall health 
and lifestyle-related factors; particularly as they relate to overweight, obe-
sity and related comorbidities. Areas of research covered will include: 1) 
Sickle Cell Disease: History, prevalence, etiology, treatment; pain man-
agement (behavioral & pharmacological); psychosocial correlates: Psy-
chopathology, social support, and body Image; and the role of nutrition, 
physical activity and weight management.
T8:PO.084
Two years obesity intervention program in children and 
adolescents: The importance of age at enrollment
Linde S.F.1, Aßmus J.2, Danielsen Y.3, Langeland E.4, Norgren S.5, 
Juliusson P.B.6
1Department of Internal Medicine, Haukeland University Hospital, Bergen, 
Norway,  
2Centre for Clinical Research and University, Haukeland University Hospital, 
Bergen, Norway,  
3Department of Clinical Psychology, University of Bergen, Bergen, Norway,  
4Faculty of Health and Social Sciences, Bergen University College, Bergen, 
Norway,  
5Department of Women´s and Children´s Health, Karolinska Institutet, 
Stockholm, Sweden,  
6Department of Pediatrics, Haukeland University Hospital, Bergen, Norway
Aim: To evaluate pre-post changes following a two-year outpatient hos-
pital based intervention program with monthly sessions for childhood 
obesity. 
Methods: Data on body mass index (BMI) during intervention, two years 
prior start and two years after treatment termination, was collected from 
34 children and adolescents with obesity (age range 5.5 – 15.1 years, 17 
girls). Paired t-tests and multivariate linear regression models were used 
for analysis. Blood samples were taken at start an end of treatment. 
Results: In children under 12 years of age (n=18), a significant reduc-
tion of BMI SDS was observed (-0.35, p = 0.003) with a non-significant 
increase in BMI SDS (0.23, p = 0.061) in children over 12 years (n=16). 
Two years after end of intervention, 55% of the children (n=29) showed 
stabilization or further reduction (>-0.25) in BMI SDS while increase of 
0.25 BMI SDS or more occurred in 45%. Significant reduction was found 
in blood lipids. 
Conclusion: The intervention was found beneficial in younger children, 
underlining the importance of early intervention. However, post-treat-
ment increase in BMI SDS of more than 0.25 SDS in almost half of the 
treated children indicates a need for longer follow-up or treatment content 
that better enhance long term maintenance of positive lifestyle changes.
T8:PO.085
The effect of long-term interdisciplinary therapy on bone 
metabolism and adipokines in obese adults
Nascimento M.A.1,2, Yi L.C.1,2, Ferreira C.L.1, Sanches R.B.1,2, Poli V.F.1,2, 
Fidalgo J.P.1,2, Moraes A.S.1,2, Bresciani P.1,2, Andrade-Silva S.G.1,2, 
Clemente J.C.3, Caranti D.A.1,2
1Post Graduate Program of Interdisciplinary Health Sciences, Federal University 
of Săo Paulo – UNIFESP - Santos, Brazil.,  
2Obesity Study Group (GEO), Federal University of Săo Paulo – UNIFESP - Santos, 
Brazil.,  
3Multimagem Clinical.
Introduction: Obesity has been associated with increased bone miner-
al density (BMD). However, it is suggested that pro-inflammatory adi-
pokines from adipose tissue can increase resorption activity and decrease 
bone formation and that anti-inflammatory adipokines can increase bone 
mass. This study aimed to assess the effects of long-term Interdisciplinary 
Therapy (IT) on pro- and anti-inflammatory adipokines and bone me-
tabolism in obese adults and to check the role of bone metabolism in adi-
pokines of this population. 
Methods: Nineteen adult obese women were submitted to a 32 week IT. 
The IT consisted of intervention with physical exercise, physiotherapy and 
nutritional and psychological support. The body composition, total BMD, 
total bone mineral content (BMC), TNF-α and IL-6 (pro-inflammatory 
adipokines) and adiponectin (anti-inflammatory adipokine) blood con-
centration were evaluated before and after the therapy. The paired Student 
t-test and Wilcoxon test were used to assess the data. Also, the correlation 
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Results: The IT promoted a significant reduction in body mass (-4,96kg), 
body mass index (BMI) (-1,87kg/m˛), fat mass (-3,45kg), percentage of fat 
mass (-1,60%), IL-6 (-1,54ng/ml), TNF-α (-1,41ng/ml) and a increase in 
total BMC (78,1g) all with p < 0,05. The total ΔBMC was correlated with 
the other Δ variables and a positive association was found with Free Fat 
Mass (p = 0,003) and a negative correlation was observed with Fat mass 
(p = 0,009) and IL-6 (p = 0,022). 
Conclusion: IT promoted an improvement in body composition, total 
BMC and pro-inflammatory adipokines. Moreover, the increase of BMC 
was associated with a reduction in IL-6 blood concentration.
T8:PO.086
Changes in body mass index (BMI) standard deviation 
score (sds) during one-year outpatient obesity intervention 
program in children and adolescents
Soreide H.1, Danielsen Y.S.2, Linde S.F.3, Haaland O.4, Morken M.H.1, 
Júlíusson P.B.1
1Institute of Clinical Science, University of Bergen, Bergen, Norway,  
2Department of Clinical Psychology, University of Bergen, Bergen, Norway,  
3Department of Internal Medicine, Haukeland University Hospital, Bergen, 
Norway,  
4Department of Global Public Health and Primary Care, University of Bergen, 
Bergen, Norway
Introduction: Efficient treatment-strategies are needed for overweight 
and obese children. The aim of the present study was to evaluate an obesi-
ty intervention program for severe childhood obesity in Bergen, Norway. 
One-year changes in BMI SDS were analyzed. 
Methods: Ninety-three obese children and adolescents (35 boys) with a 
mean age of 11.8 years (range 5.5–17.9) and mean (SD) BMI SDS 3.07 
(0.49) were included, completing one year of the intervention. The treat-
ment was an interdisciplinary family-based lifestyle intervention for chil-
dren with severe obesity, combining both a hospital outpatient clinic and 
the primary health care. The treatment targeted diet, physical activity and 
sedentary behaviour. The participants were scheduled to undergo physical 
examinations every six months by a paediatrician at hospital and monthly 
weighing sessions by a nurse in the primary health care. BMI was stan-
dardized using Norwegian growth charts. 
Results: Mean (SD) BMI SDS was unchanged in the group as a whole, with 
a baseline value of 3.07 (0.49) and 3.07 (0.63) after one year of treatment 
(p = 0.830). A significant reduction in mean BMI SDS was however seen 
in boys (-0.13, p = 0.001) and for children below 12 years of age (-0.12, 
p = 0.003). For children entering the intervention at age 12 years and 
older, the mean BMI SDS was in contrast significantly increased (+0.09, 
p = 0.023). A multiple linear regression analysis showed that changes in 
BMI SDS were significantly dependent on both gender (p < 0.001) and 
age (p < 0.001). 
Conclusion: Better response in the prepubertal age range underlines the 
importance of early interventions. Further studies are needed to find good 
treatment solutions for the adolescents.
T8:PO.087
Changes in food intake, energy expenditure and body 
composition after a long-term interdisciplinary therapy in 
obese adults
Poli V.S.1,2, Moraes A.S.1,2, Sanches R.B.1,2, Fidalgo J.N.1,2, Leite P.B.1,3, 
Andrade-Silva S.G.2, Nascimento M.A.1,2, Cipullo M.T.2, Clemente J.C.4, 
Caranti D.A.2,5
1Post Graduate Program of Interdisciplinary Health Sciences, Federal University 
of Săo Paulo – UNIFESP – Santos (SP), Brazil,  
2Obesity Study Group (GEO), Federal University of Săo Paulo – UNIFESP – Santos 
(SP), Brazil,  
3Post Graduate Program of Nutrition, Federal University of Săo Paulo – UNIFESP 
– Santos (SP), Brazil,  
4Multimagem Clinical – Santos (SP), Brazil,  
5Department of Biosciences, Federal University of Săo Paulo – UNIFESP –Santos 
(SP), Brazil
Introduction: Obesity is a chronic disease, strongly associated with an 
energy imbalance. This imbalance is due to excessive intake of food cou-
pled with physical inactivity. The prevention and treatment of obesity is 
a major challenge worldwide. Interdisciplinary weight loss therapy has 
emerged as an alternative to prevent and treat obesity by promoting a life-
style modification. 
Methods: The population considered on the study was comprised of 25 
obese participants aged 41.5 ± 5.6 years. The participants were submitted 
to an interdisciplinary therapy involving diet, exercise and psychological 
support during the course of one year. The food intake was estimated by 
three-day dietary record. The dual-energy x-ray absorptiometry was per-
formed to determine body fat and fat-free mass. The resting energy ex-
penditure was measure through indirect calorimetry. All measures were 
performed at baseline and after the therapy. 
Results: Changes in food intake were significantly observed after thera-
py. Energy intake was reduced 21.4%, carbohydrate intake was reduced 
25.3%, fat intake was reduced 26.2%, and sodium intake was reduced 34%. 
The therapy was effective in reducing body weight (6.5%, p < 0.001), BMI 
(6.5%, p < 0.001), body fat (6.0%, p < 0.001), waist circumference (5.8%, 
p < 0.001), and hip circumference (4.6%, p < 0.001). 
Conclusion: Long-term interdisciplinary therapy was effective to change 
food intake, body composition and to reduce weight loss. In this way, the 
interdisciplinary approach is a good strategy to prevent and treat obesity 
and its associated comorbidities.
T8:PO.088
Clinical Effectiveness of the Intensive Weight Management 
Programme
Kelsey M.E.1, Golubic R.1,2, Livesy A.3, Connell C.4, Hoensch J.4, Laur C.1, 
Park A.4, Ray S.1,4
1UK Need for Nutrition Education/Innovation Programme (NNEdPro),  
2West Suffolk Hospital, Cambridge University Associate Teaching Hospital, UK,  
3University of Cambridge Medical School, UK,  
4Institute of Metabolic Science, Addenbrooke‘s Hospital, Cambridge, UK
Introduction: Evidence suggests that lifestyle modifications including 
diet and physical activity (PA) play a key role in the management and 
prevention of obesity. We aimed to assess the effectiveness of the Intensive 
Weight Management Programme (IWMP) in middle-aged obese adults. 
Methods: IWMP is a prospective intervention conducted in the obesi-
ty clinic from 2009–2013. It consisted of 3 phases, each lasting 8 weeks: 
1. weight loss, 2. weight stabilisation and 3. weight maintenance. In each 
phase, patients were required to adhere to a prescribed dietary regime and 
record food intake and PA. This „before and after analysis“ is geared to 
assess the clinical effectiveness of the IWMP. Primary outcome was weight 
change between the baseline and the end of the programme. Secondary 
outcomes included changes in blood pressure (BP) and other cardio-met-
abolic variables. Changes in the outcomes were analysed by age, sex, 
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Results: Data were available for 141 patients. Mean (SD) weight change 
was –20.5 (9.8) kg. 86% of the patients lost the expected 5% of their base-
line weight by the end of the intervention. Patients reporting non-seden-
tary occupations experienced significantly greater mean (SD) weight loss 
than their sedentary counterparts, 16.9 (7.9)% vs. 12.7 (6.4)%, p = 0.030. 
Changes in weight did not substantially vary by other socio-demographic 
factors studied. Median (IQR) change in systolic and diastolic BP was –5 
(-16,10) mmHg and 0 (-10,6) mmHg, respectively. However, the differ-
ences in blood pressure changes by socio-demographic factors were not 
statistically appreciable. 
Conclusion: IWMP was associated with substantial body weight reduc-
tion consistently across the strata of age, sex, smoking and employment 
and modest reduction in BP.
T8:PO.089
Interdisciplinary therapy effects on anthropometrics, VO2max 
and quality of life in obese adult women.
Andrade-Silva S.G.1,2, Sanches R.B.1,2, Fidalgo J.P.1,2, Araujo G.S.2, 
Cerrone L.A.1,2, Moraes A. S.2,4, Rebelo R.A.1,2, Poli V.S.1,2, Bresciani P.L.2,4, 
Nascimento M.A.1,2, Yi L.C.2, Caranti D.A.1,2,3,4
1Post Graduate Program of Interdisciplinary Health Sciences, Federal University 
of Săo Paulo/UNIFESP - Brazil.,  
2Obesity Study Group (GEO) - Federal University of Săo Paulo/UNIFESP - Brazil.,  
3Department of Biosciences, Federal University of Săo Paulo/UNIFESP - Brazil.,  
4Post Graduate Program of Nutrition - Federal University of Săo Paulo/UNIFESP 
- Brazil.
Introduction: Obesity is cited as an aggravating factor of physical func-
tioning, such as general health perception and vitality as well as psycho-
logical functioning and social well-being. It was associated with poor 
body image, depression, stigmatisation, discrimination, diminished social 
interactions, and lower socioeconomic status, affecting the quality of life. 
Methods: 22 adult obese women were enrolled at presential therapy con-
sisted of physical exercise sessions three times a week and nutritional, psy-
chological and physiotherapy intervention once a week at the Federal Uni-
versity of Săo Paulo – Brazil.. Maximal oxygen uptake (Fitmate®), body 
composition (Lunar Prodigy DEXA) and quality of life (WHOQOL-brief) 
were recorded before and after 32 weeks of intervention. 
Results: Showed in figure 1 
Conclusion: These findings showed an important increase in all domains 
of Quality of Life promoted by interdisciplinary therapy. An improvement 
in VO2max and decreased in fat mass are a potential triggers that corrob-
orate these improvements.
Fig. 1. Anthropometrics, VO2max and Quality of Life after Interdisciplinary 
Therapy
T8:PO.090
The influence of a 6 month intervention on self-perceived 
fatigue, body composition and handgrip performance in 
obese boys.
Vantieghem S.1, Provyn S.1, Tresignie J.1, Bautmans I.2
1Experimental Anatomy,  
2Frailty In Ageing 
Introduction: The main goals of obesity intervention programs are de-
creasing body weight, fat mass and increasing lean mass. It is general-
ly accepted that fat mass decreases with weight loss, but results on lean 
mass are inconsistent. The relation between weight-loss induced changes 
in body composition and fatigue sensations in obese adolescents remain 
unexplored. This study examined the effect of a 6 months weight loss pro-
gram on self-perceived fatigue, grip performance and body composition. 
Methods: 81 obese boys (15 ± 2 years) were examined for body compo-
sition (DXA), maximal grip strength, fatigue resistance (the time during 
which grip strength decreased to 50% of its maximum value during sus-
tained maximal contraction), grip work (calculated as fatigue resistance 
x 0.75 x maximal grip strength, corresponding to the area under the 
curve) and self-perceived fatigue (Multidimensional Fatigue Inventory, 
MFI-20). The boys were divided into 2 groups; a high weight loss group 
(HWL, >20% body weight) and a low weight loss group (LWL, <20% body 
weight). 
Results: At baseline HWL and LWL showed similar weight, BMI and grip 
parameters. HWL improved significantly for all grip and self-perceived 
fatigue parameters whereas LWL improved only for fatigue resistance and 
grip parameters corrected for body weight. Both LWL and HWL lost sig-
nificant fat mass, but the HWL also lost significant lean mass and signifi-
cantly more fat mass compared to LWL. 
Conclusion: After a 6 month multidimensional weight loss program, 
HWL showed significantly improvements in self-perceived fatigue and 
grip performance despite the fact that they also lost more lean mass.
T8:PO.091
Obesity and outcome in the icu
Theodorakopoulou M.1, Tsagkari B.1, Christodoulopoulou D.1, 
Diamantakis A.1, Kontogiorgi M.1, Armaganidis A.1, Dimopoulou I.1
1ICU Department, University Hospital ATTIKON, Athens Greece 
Introduction: The prevalence of obesity in the critically ill seems to cor-
relate with the rise in obesity in the general population Overweight pa-
tients seem to have a poorer outcome and a higher risk of complications 
such as increased ICU length of stay, and increased ventilation require-
ments during their Intensive Unit Care (ICU) stay. 
Objectives: A prospective observational study was carried out to evalu-
ate the relationship between Body Mass Index (BMI), ICU lenght of stay 
(ICU-LOS), duration of mechanical ventilation and mortality among 
these patients. Patients with Metabolic Syndrome were excluded from the 
study. 
Methods: A prospective observational study in a 24 bed General ICU. 
All medical, surgical and trauma patients that were hospitalized in the 
ICU over a period of two years were included in the study. Based on their 
BMI values, the patients were divided into 3 groups. Group A: BMI be-
tween 18.5 and 24.9 (n=571); Group B: BMI between 25 and 39.9 (n=123); 
Group C: BMI >40 (n=54). Demographic data was obtained for all pa-
tients. APACHE and SOFA scores were calculated upon admission. 
Results: 748 patients were included in the study. These patients had a 
SOFA score between 8 and 15. Significant differences were observed be-
tween groups A and C: in ICU length of stay (p < 0.01), duration of me-
chanical ventilation (p < 0.01) and ICU mortality (p < 0.01). Moreover, we 
found no statistically significant differences in terms of mortality between 
groups A and B (17.35% vs 18.87%). 
Conclusions: In our study a BMI >40 was significantly associated with an 
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T8:PO.092
Positive preliminary evaluation of the results in a newly 
established childhood obesity clinic including children who 
drop out of follow-up
Larusdottir A.E.1, Olafsdottir A.S.2,3, Brynjolfsdottir B.2, Bjornsdottir O.E.2, 
Bjarnason R.1,2, Helgason T.2
1University of Iceland, Faculty of Medicine, Reykjavík, Iceland,  
2Children’s Medical Centre, Landspítali University Hospital, Reykjavík, Iceland,  
3University of Iceland, School of Education, Reykjavík, Iceland
Introduction: In 2011 a small multidiciplinary team was formed at Land-
spitali University hospital to treat obese children by improving their life 
style (the Health School, 6 specialities, less than 2 positions in total). It has 
reached 10% of all obese children in Iceland in 4 years. As in other obesity 
treatments, a high proportion of families do not return to scheduled vis-
its. The aim of this study was to investigate the reasons for drop-out and 
estimate the effect of the treatment on body weight. 
Methods: The children were treated individually or in groups, based on 
cognitive behavioural family treatment. All children seen at the Health 
School from 1.1.2011 to 15.3.2013 were included in this study. Parents 
were contacted by phone and invited to a visit, with the child. Weight, 
height and waist circumference were measured, and the parents asked to 
answer a survey with questions about motivation, achievement and life-
style. 
Results: 173 children were included. Last contact with the Health School 
was over a year ago in 66%,, median follow-up time was 27 months. In to-
tal 88% (n=153) were reached and measurements were obtained from 51% 
(n=89). Reduction in BMI Standard Deviation Score (BMI-SDS) was seen 
in 66% (n=59). The overall decrease in BMI-SDS was –0.24 (responders 
only –0.59). The questionnaire was answered by 76% (n=132). The most 
frequent reasons for drop-out were not knowing of the follow-up (31%) 
and lack of interest (23%).The majority (94%) was satisfied with the ser-
vice offered and would recommend the Health School. 
Conclusion: A small dedicated team can have a lasting effect on obese 
children and even a large portion of children who drop out of treatment 
lose weight in the long term. The main reasons for not continuing treat-
ment are lack of motivation and time. 
References:
Cole, T. et al.: BMJ 2000 (320): 1240–1243.
Karlberg, J et al.: Acta Pćdiatrica 2001 (90): 1427–1434.
Gunnarsdottir, T. (2011). Ph.D. Thesis. Univ. of Iceland.
T8:PO.093
Family-based behavioral treatment of obesity - the fabo-study
Danielsen Y.S.1,2, Skjåkødegård H.F.3, Kolko R.P.4, Wilfey D.E.5, 
Juliusson P.B.6,7
1Department of Clinical Psychology, University of Bergen, Bergen, Norway,  
2Section for Eating Disorders, Haukeland University Hospital, Bergen, Norway,  
3Obesity Outpatient Clinic, Haukeland University Hospital, Bergen, Norway,  
4Western Psychiatric Institute and Clinic, University of Pittsburgh Medical 
Center, Pittsburgh, PA, USA,  
5Department of Psychiatry, Medicine, Pediatrics, and Psychology, Washington 
University School of Medicine, St.Louis, MO, USA,  
6Department of Pediatrics, Haukeland University Hospital, Bergen, Norway,  
7Department of Clinical Science, University of Bergen, Bergen, Norway
Introduction: The purpose of the FABO study is to evaluate the effect of 
family-based behavioral weight loss treatment (FBBT) compared with the 
effect of today’s standard treatment given to children and adolescents suf-
fering from obesity at the Obesity Outpatient Clinic (OOC), Haukeland 
University Hospital. FBBT has been demonstrated to be the most effective 
treatment option for youth with obesity. Such treatment has not previous-
ly been incorporated into an obesity clinic in Norway. 
Methods: The FABO study is a randomized controlled trial, in which fam-
ilies (N=120) will be recruited among children and adolescents between 
ages 8–16 years referred to the OCC by their general practitioner. Criteria 
for admission to the clinic are an (IOTF) isoBMI of ≥ 35, or isoBMI ≥ 
30 with obesity related co-morbidity. Families are randomized to receive 
FABO treatment immediately or following standard treatment (wait-list 
control condition). The FABO treatment consists of 17 weekly manualized 
sessions with subsequent follow-up every three month for two years. Out-
come variables include the following: Anthropometry: BMI, waist-cir-
cumference and body composition (measured with BIO-impedance and 
DXA scan). Physiological measures: blood samples, blood pressure. Ac-
tivity level/inactivity and sleep pattern (measured with accelerometer). 
Psychological measures: Questionnaires (DEBQ, YEDE-Q, CBCL, CDI, 
SPPC) and food records (4-day diet record). 
Results: Details of the FABO treatment and study will be presented along 
with the preliminary analysis. 
Conclusion: This is the first systematic application of FBBT in the treat-
ment of obesity among youth in Norway. The preliminary response to 
treatment is promising and indicates that FBBT is likely to become a part 
of a stepped-care treatment.
T8:PO.094
Influences of gastric bypass surgery on their own, partners’ 
and children’s weight and physical activity
Rasmussen F.1, Berglind D.1, Willmer M.1, Näslund E.2, Ghaderi A.3
1Department of Public Health Sciences, Karolinska Institutet, Stockholm, 
Sweden,  
2Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden,  
3Department of Clinical Neroscience, Karolinska Institutet, Stockholm, Sweden
Roux-en-Y gastric bypass (RYGB) surgery results in great weight loss in 
most women, but less is known about the influences on their own, part-
ners’ and children’s physical activity, and influences on children’s and 
partners BMI. Research questions: (i) Are obese women, treated by RYGB 
gastric bypass, who lose a large amount of weight, more physically active 9 
months after surgery? (ii) Are the children and partners of obese women 
treated by RYGB, with great weight loss after RYGB, more physically ac-
tive 9 months after surgery? Are children and partners of obese women, 
with great weight loss after RYGB, affected in terms of BMI? 
Methods: RYGB was conducted in 5 specialized clinics. Height, weight 
and physical activity (PA) were measured objectively 3 months before and 
9 months after RYGB. PA was measured by tri-axial Actigraph GT3X+ 
accelerometers during 1 week. PA was categorized by time spent in mod-
erate or vigorous PA (MVPA), low PA (LPA), and sedentary behavior (SB). 
Approximately 60 women, 35 spouses, and 75 children (7–14 years of age) 
were included in most analyses. Linear regression models for repeated 
measurements were used to evaluate changes in own, partners’ and chil-
dren’s BMI and PA, between the two time points. 
Results: The women lost on average 11.7 BMI units (33.2 kg) between the 
two data collection time points. Their partners lost on average 0.9 BMI 
units (2.5 kg) over the 9 months period. Among the children the prev-
alence of overweight and obesity went from 57.0% to 48.6%, reflecting a 
relative risk of 0.85 (95% CI 0.73; 1.00, p = 0.048). For obesity only, the 
prevalence went from 18.2% to 15.9%, giving a relative risk of 0.87 (95% 
CI 0.62; 1.24, p = 0.447). We found no significant differences in MVPA, 
MVPA, LPA or SB from 3 months before to nine months after surgery 
in women, despite substantial weight loss. 44% of partners and 39% of 
children decreased time spent on MVPA, and increased time spent in SB, 
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T8 – Drugs (approval, regulation)
T8:PO.095
Phentermine/topiramate/ephedrine with coffee shows to 
weight management in obesity for 4 weeks, especially those 
with high VAT and hyperglycemia
Lee K.R.1, Ko K.D.2, Whang I.C.2, Kim K.K.2, Suh H.2
1bariatric unit, Department of Family Medicine, Dong-incheon Hospital, Gachon 
University, Incheon, Korea,  
2Department of Family Medicine, Gil Medical Center, Gachon University, 
Incheon, Korea
Although caffeine/ephedrine (thermogenic) and Qsymia (anorectic) were 
approved, they are not available in Korea. It is crucial for anti-obesity 
medication that thermogenic as well as appetite suppression would be in-
cluded. Therefore we investigated the effect of weight loss using by phen-
termine/topiramate/ephedrine over a cup of coffee in obesity. In addition 
which fatness markers; metabolic variables further would be assessed to 
relate with its outcome. 50 obese subjects (female: 76%, 29.79 kg/m2) were 
investigated to study the clinical efficacy of phentermine7.5mg/topira-
mate50mg/ephedrine20mg with a sip of coffee for weight management for 
4 weeks. All of them were examined their energy intake, and given behav-
ioral counseling. Weight, height, body fat (bioelectric impedance (BIA)), 
and visceral adipose tissue (VAT) were measured at initial visit. Fasting 
plasma glucose (FPG), insulin, free fatty acid, lipid profiles were obtained. 
The regimens were taken once a day, and body fat was assessed through 
BIA at 4 week visit. Pearson coefficient, paired t-tests and ANOVA anal-
ysis were performed. FPG, visceral adipose tissue showed the significant 
association with medication after adjusted for age. Therefore the weight, 
body fat were compared according to 4 groups based on FPG, VAT. All 
subjects lost 6.83 kg**, 1.82% for 4 weeks respectively. While the weight 
loss showed best in high VAT/FPG group, fat loss did in low VAT/FPG 
group. (*: P < 0.05, **: P < 0.01) In conclusion, phentermine/topiramate/
ephedrine with coffee demonstrates to promote the significant weight loss, 
especially tends to show weight loss in obese subjects with high VAT and 
hyperglycemia for 4 weeks. Well controlled clinical trial would be consid-
ered in the future.
Fig. 1. Comparison of change of weight and body fat for 4 weeks
Fig. 2. The change of weight according to fasting plasma glucose and visceral 
adipose tissue
Fig. 3. The change of body fat according to fasting plasma glucose and visceral 
adipose tissue
T8:PO.096
Clinical efficacy of weight and body fat using by hutermin 
(phentermine)/topiramate/aperin to Korean overweight 
subjects for 4 weeks
Lee K.R.1, Ko K.D.2, Whang I.C.2, Kim K.K.2, Suh H.2
1bariatric clinic, Family Medicine, Dong-Incheon Gil Hospital, Gachon University,  
2Family Medicine, Gil Medical Center, Gachon University
In order to explore the effect of weight loss by combined medication of 
Qsymia and Retigen, we investigated the effect of weight and body fat 
using by hutermin 15mg (phentermine; Huons, Korea), aperin (Huons, 
Korea; ephedrine 25 mg, caffeine 25 mg, acetaminophen 200 mg) and 
topiramate 50mg for 4 weeks. 46 subjects (female 87%, BMI 28.3 kg/m2) 
were enrolled to study the clinical efficacy of weight loss using by huter-
min/topiramate/aperin. Weight, height, and body fat (bioelectric imped-
ance (BIA), DXA, CT) were measured at initial visit. In addition, body fat 
and weight were assessed through BIA at 4 week visit. Pearson coefficient, 
pair t-test were performed for statistics. The probability less than 0.05 was 
considered as significant at two sided. As visceral (VAT) and subcutane-
ous adipose tissues (SAT) were significantly related with medication use, 
weight and body fat were compared for 4 weeks according to 4 groups 
based on adipose tissue. 5.35 kg** (71.67 +/- 1.92 to 66.32 +/- 1.7), 2.69%* 
(33.47 +/- 1.07 to 33.47 +/- 1.07) were decreased in all of participants 
for 4 weeks (*: P < 0.05, **: P < 0.01) Among 4 groups, weight change in 
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low VAT/SAT group was, Noted were minor adverse events such as hot 
flushing, palpitation, and insomnia. In conclusion, hutermin/topiramate/
aperin showed the significant reduction in weight and fat for overweight 
subjects for 4 weeks. Interestingly, body fat decreased most in lower SAT/
VAT group. It implies that hutermin/topiramate/aperin may affect SAT as 
well as VAT. Further controlled cohort trial would be needed to explore 
the relationship between adipose tissue and the regimen in the future.
Fig. 1. Comparison of weight for 4 weeks
Fig. 2. Comparison of body fat for 4 weeks
Fig. 3. Comparison of weight change for 4 weeks between groups based on adipose 
tissues
Fig. 4. Comparison of body fat change for 4 weeks between groups based on 
adipose tissues
T8:PO.097
Should the dosage of phentermine is adjusted for lower BMI 
patients?
Kim J.E.1, Kim N.C.4, Kim H.J.2, So J.Y.1, Son B.D.1, Eo K.N.4, Lee S.H.2, Jo M.Y.3, 
Chae G.H.1
1365MC Obesity Clinic, Seoul, South Korea,  
2Department of Liposuction, Seoul 365MC Hospital, Seoul, South Korea, 
3Department of Bariatric surgery, Seoul 365MC Hospital, Seoul, South Korea, 
4365MC Obesity Clinic, Busan, South Korea
Introduction: Phentermine is recommended for subjects whose BMI are 
30kg/m2 or greater and 27kg/m2 or greater having weight-related comor-
bidity. But in South Korea, the cutoff point of BMI for obesity is lower 
than that in Western countries, so in many cases, phentermine is being 
prescribed for the patients who have lower BMI than the recommenda-
tion. The aim of this study is to know whether to adjust the dosage of 
phentermine considering the lower BMI state. 
Methods: The pateints who participated in the treatment were divided 
into the two groups, BMI 25kg/m2 or greater(high BMI group: n=37) 
and less than 25kg/m2(low BMI group: n=39). They all received phenter-
mine-HCl 37.5mg per day with life style modification for 4weeks. They 
were checked BMI, body weight, body fat weight before and at the end of 
the treatment. And to check the adverse reactions, at every visit, twice a 
week, they were asked about the discomfort with the medication. Result: 
The mean of weight loss was 3.79 ± 1.72kg(5.0 ± 2.0% of initial weight) in 
hight BMI group and 3.36 ± 1.85kg(5.37 ± 2.9% of initial weight) in low 
BMI group. There were no significant differences in the change of body 
weight, BMI, body fat and the incidence of adverse reactions between 
both groups. 
Conclusion: Phentermine was well tolerated and made the favorable re-
sults in weight control for lower BMI patients like for obese patients. It is 
considered that it doesn‘t need to adjust the dosage of the agent even for 
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T8:PO.098
Early phase of metformin action in dietary-obese mice: Lack 
of involvement of amp-activated protein kinase and possible 
interaction with n-3 fatty acids
Kucharikova P.1, Horakova O.1, Rossmeisl M.1, Kopecky J.1
1Department of Adipose Tissue, Institute of Physiology Academy of Sciences of 
the Czech Republic v.v.i., Prague, Czech Republic.
Introduction: We have shown previously that n-3 fatty acids (omega-3) 
prevent both hepatic steatosis and insulin resistance in obese mice de-
pending on AMPK. Metformin lowers glycaemia presumably via sup-
pression of mitochondrial complex I activity leading to AMPK activation; 
however, AMPK-independent effects were also observed. We investigated 
whether pretreatment with omega-3 could enhance acute metformin ac-
tion, and whether AMPK is involved. 
Methods: Adult C57Bl/6 mice were fed a high-fat diet (HFD) for 6 weeks, 
and then either HFD or HFD with 15% lipids replaced by omega-3 
(HFD-F) for 2 weeks. At the end, mice were given metformin (400 mg/
kg) or saline and then underwent oral glucose tolerance test (OGTT) or 
were killed to collect liver samples. Similiar experiment with a lower dose 
of metformin (60 mg/kg) was performed with mice lacking α2 AMPK 
subunit (AMPKα2-KO). 
Results: During OGTT, metformin, but not saline, lowered glycaemia as 
well as an area under the glycaemic curve (AUC). In saline-treated mice, 
AUC was lower in HFD-F fed group (p < 0,05). Omega-3 also tended to 
augment effect of metformin, but the difference was not statistically sig-
nificant. We observed no change in AMPK activity in liver, and no differ-
ence between control and AMPKα2-KO mice in response to omega-3 or 
metformin during OGTT. 
Conclusions: The absence of changes in AMPK activity in liver as well as 
no difference in response of AMPKα2-KO mice collectively suggest that 
AMPK is not essential for the acute hypoglycaemic effect of metformin. 
Moreover, there was a trend for an additive effect of omega-3 and met-
formin on glucose metabolism, which deserves further characterization.
T8:PO.099
Characteristics of anti-obesity medication prescribers prior to 
the approval of new pharmacotherapy in the US
Schmidt S.L.1, Horn D.B.2, Bryman D.5, Westman E.C.4, Hendricks E.J.3
1American Society of Bariatric Physicians,  
2University of Texas Health Science Center Houston, 
3Center for Weight Management Sacramento,  
4Duke Lifestyle Medicine,  
5Midwestern University
Introduction: A survey of obesity medicine specialists was conducted be-
fore the recent approval of several new anti-obesity medications (AOMs) 
in 2012 and 2014. A subset of physicians reported that they “frequently” 
prescribed phentermine (P) for weight loss. The aim of this analysis is to 
characterize the prescribing practices of these physicians, as they may be 
the most comfortable in prescribing new AOMs for their patients as they 
become available. 
Methods: An Internet survey was sent to obesity medicine physicians in-
quiring about their practice and prescribing habits. 
Results: 307 respondents reported frequently prescribing P to treat obe-
sity. They treated 1235 ± 2212 patients per year per physician, compared 
to 339 ± 472 patients for doctors who rarely prescribe P (n=18). 40% 
of these doctors practice only obesity medicine. Less than 5% were in a 
surgical setting and over 75% were in private practice. 13% prescribe P 
for 12 weeks or less, while 53% prescribe P long term for chronic dis-
ease management. . Only 30% require patients to take drug holidays. 47% 
are located in the southern US. Liraglutide was prescribed by 9% of these 
physicians; bupropion: 35%; naltrexone: 5%; topiramate: 36%; orlistat: 
14%; exenatide: 14%; metformin: 38%; diethylpropion: 51%: phendime-
trazine: 50%; zonisamide: 4%. With regard to combination therapy, 32% 
were prescribing phentermine/topiramate; 44% prescribe phentermine + 
metformin and5% prescribed bupropion/naltrexone. The most common 
nutrition strategy was a low carbohydrate diet. 
Conclusion: Physicians who frequently prescribe P treat a large number 
of patients for obesity. In 2012, these physicians had limited options in 
medications and prescribed some medications off-label to help in obesity 
treatment. Recommended next steps will be to assess changes in AOM 
prescribing that may occur with the recent US approval of many of the 
prescription strategies already described in this study.
T8 – Medico-Surgical approaches
T8:PO.100
The impact of roux-en-y gastric bypass on neuroendocrine 
regulation of energy balance and their possible implications 
on appetite/satiety
Netto B.M.1, Bettini S.C.3, Clemente A.P.1, Masquio D.C.1, Farias G.3, 
Boritza K.3, Silva L.G.2, Von der Heyde M. E.2, Earthman C. P.4, Dâmaso A.R.1
1Universidade Federal de Sao Paulo – Escola Paulista de Medicina - UNIFESP - 
EPM - Brazil,  
2Universidade Federal do Paraná - UFPR - Brazil,  
3Hospital das Clínicas - UFPR - Brazil,  
4University of Minessota - USA
Introduction: The body weight varies depending on the prevailing di-
rection of environmental pressures, however; physiological factors could 
intervene in the control of body weight. The aim of the present study was 
assess the impact of Roux-en-Y gastric bypass (RYGB) on hormones and 
peptides involved in the control of energy balance and their possible im-
plications on appetite/satiety. 
Methods: The sample was composed of 41 extremely obese (39 women 
and two men) who underwent Roux-en-Y gastric bypass (RYGB). An-
thropometric and biochemical markers were collected prior to surgery 
and 6 months post-RYGB. 
Results: The BMI decreased from 44.62 ± 6.32 kg/ m2 to 31.66 ± 5.66 
kg/m2 (p < 0.001) at the 6th month. Percentage of excess weight lost was 
63.50 ± 24.99%. Levels of the glucose decreased significantly 6 months af-
ter gastric bypass (p < 0.001). Also, at the 6th month after the surgery, the 
PYY values were significantly higher than the baseline period (p < 0.001).
The multiple linear regression analysis revealed that α-MSH levels and 
BMI were together dependents predictors of changes in PYY concentra-
tions.
Conclusions:The RYGB surgery seems to be relate to neural mechanisms, 
which possibly by an adaptive response are involved in mediating post-
surgery changes in PYY secretion. This finding could explain the good re-
sults of surgery in mediate the control of energy intake, modulates feeding 
behavior and contribute to improvements in glycemic and the appetite/
satiety control.
Acknowledgement: FAPESP (2013/04136-4; 2013/19046-0; 002804928-41), CNPq 
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T8 – Ethics and guidelines
T8:PO.101
Bariatric surgery in adolsecents: Is there a consensus in 
treatment algorithms
Fried M.1,2
1OB klinika – Center for treatment of Obesity and Metabolic Disorders, Prague, 
Czech Republic,  
221st Faculty of Medicine, Charles University, Prague, Czech Republic
Introduction: Childhood obesity shows increasing prevalence becoming 
serious health, social and economic problem. There´s variation in obe-
sity prevalence among different age and sex groups, and geographical 
regions. It is widely accepted that bariatric surgery is the most effective 
treatment for morbidly obese adults, reducing mortality, improving/re-
solving co-morbidities, decreasing health-care utilization and costs, how-
ever there´s a lack of robust data about the role of bariatric surgery and 
standardized approach in surgery for obesity in adolescents. 
Methods: Review of the most frequently adopted algorithms for surgi-
cal treatment of obese adolescents was carried out and generally accepted 
common grounds as well as the most frequent differences are highlighted. 
Results: The commonly accepted criteria for childhood bariatric treat-
ment are: BMI > 40 ( 99.5th percentile for the respective age) and at least 
one co-morbidity; BMI > 50 with less serious comorbidities; Failure of 
nonsurgical treatments with at least 6–12 months of weight-reducing at-
tempts in a specialized center; Patient shows skeletal and developmental 
maturity / attains 95% of adult height based on estimates from bone age. 
Is able to commit a comprehensive medical and psychological evaluation 
before and after surgery. Is willing to participate in a postoperative multi-
disciplinary treatment program; 
Conclusion: More evidence and algorithm for bariatric surgery in ad-
olescents is needed to evaluate outcomes, including influence on physi-
cal growth and QoL, international registry and definition of specialized 
childhood MDT centers is necessary.
T8 – Emerging treatments
T8:PO.102
Low-level laser therapy (lllt) associate with aerobic plus 
resistance training to improve inflammatory biomarkers in 
obese adults.
Campos R.S.1, Dâmaso A.R.1, Masquio D.C.1, Aquino Jr A.E.2, Sene-
Fiorese M.2, Duarte F.O.3, Tock L.4, Parizotto N. A.3, Bagnato V. S.2
1Pos-Graduate Program of Nutrition - Federal University of Săo Paulo - Paulista 
Medicine School- UNIFESP-EPM - Săo Paulo - Brazil,  
2Optics Group from Institute of Physics of Săo Carlos (IFSC - USP) - Săo Carlos - 
SP- Brazil,  
3Department of Physical Therapy - Federal University of Săo Carlos - UFScar - 
Săo Paulo - Brazil,  
4Weight Science - Obesity Management - Săo Paulo - Brazil
Introduction: Recently investigations suggest the benefits of Low-Level 
Laser (light) therapy (LLLT) in noninvasive treatment of cellulite, im-
provement of body countering and control of lipid profile. However, the 
underlying key mechanism for such potential effects associated to aerobic 
plus resistance training to reduce body fat and inflammatory process, re-
lated do obesity in women still unclear. 
Methods: For this study, it was involved 40 obese women with age of 20–
40 years. Inclusion criteria were primary obesity, body mass index greater 
than 30 kg/m˛ and less than 40 kg/m˛. The voluntaries were allocated in 
two different groups: Phototherapy group and SHAM group. The inter-
ventions consisted on physical exercise training and application of pho-
totherapy (830nm), immediately after the physical exercise, with special 
designed device. Pro/anti-inflammatory adipokines were measured. 
Results: It was showed that LLLT associated to physical exercise is more 
effective than physical exercise alone to increase adiponectinemia the 
most potent anti-inflammatory adipokine. Also it was showed reduced 
values of neck circumference (cm), insulin concentration (μU/ml) and 
interleukin-6 (pg/ml) in LLLT group. 
Conclusion: physical exercise training and Low-Level Laser (light) thera-
py promote improvement in inflammatory framework and body compo-
sition, suggest the phototherapy can be an important tool in the treatment 
of obesity, being this results applicable in the clinical practice.
Acknowledgement: FAPESP (2013/04136-4; 2013/19046-0; 002804928-41), CNPq 
(150177/2014-3; 300654/2013-8) and CAPES.
T8:PO.103
Energy cost of lower body vibration across varying 
frequencies in young men and women
Fares E.J.1, Miles-Chan J.L.1, Charričre N.1, Montani J.P.1, Schutz Y.1, 
Dulloo A.G.1
1Department of Medicine, University of Fribourg, Fribourg, Switzerland 
Introduction: There is increasing recognition about the importance of 
enhancing energy expenditure (EE) for weight control through increases 
in low-intensity physical activities compatible with daily life (2–4 METS; 
i.e. 2–4 times the resting EE). Whole-body vibration increases EE mod-
estly and could present both a useful adjuvant for obesity management 
and a tool for metabolic phenotyping. However, it is not clear whether a 
“dose-response” relationship exists between vibration frequency and EE. 
The aim of this study was to investigate the relationship between lower 
body vibration (LBV) frequency and EE. 
Methods: EE was measured by indirect calorimetry in 8 healthy young 
adults (4 men, 4 women), first at rest while sitting in a comfortable seat 
and then standing without vibration, and subsequently during 5 cycles of 
intermittent LBV (30s vibration and 30s rest per cycle) at 3 frequencies 
of 30, 40 and 50 Hz (validated by accelerometry) separated by 5 min rest 
while sitting; LBV was standardized with the subject standing with both 
knees slightly bent to the extent that body vibration occurred only below 
the waistline. 
Results: LBV increased EE relative to resting levels (+55% vs sitting, 
p < 0.001; +37% vs standing, p < 0.001). However, no differences in EE 
were observed across vibration frequencies, including in a subgroup (n=4) 
which repeated the protocol on 3 separate days. Intra-individual coeffi-
cient of variation in EE during sitting, standing without vibration and 
during LBV was 2.2, 7.7, and 10%, respectively. 
Conclusion: No relationship could be demonstrated between EE and LBV 
frequency in the range of 30–50Hz, raising the possibility that within this 
range, the impact of increased vibration on skeletal muscle tension is buff-
ered by tendon elasticity.
T8:PO.104
Combination prolonged-release naltrexone/bupropion 
therapy resulted in clinically meaningful improvements in 
weight and quality of life (qol) - integrated analysis of four 
phase 3 trials
Halseth A.E.1, Burns C.M.1, Walsh B.1, Klassen P.1, Kolotkin R.L.2
1Orexigen Therapeutics, La Jolla, CA USA,  
2Quality of Life Consulting, Durham, NC USA
Introduction: Comprehensive treatment for obesity ideally will improve 
physical, psychological, and social aspects of health in addition to facili-
tating weight loss. 
Methods: This integrated analysis of 4 Phase 3, 56-week trials of naltrex-
one/bupropion 32/360 mg prolonged-release (NB) vs placebo (PBO) in-
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Weight on Quality of Life-Lite (IWQOL-Lite) scale at baseline and at 8, 
16, 28, and 56 weeks of treatment. All patients (NB n=2043, PBO n=1319) 
had BMI ≥27 and ≤45 kg/m2. Treatment group differences (LS mean±SE) 
in the modified ITT-LOCF population (≥1 post-baseline weight while on 
study drug) were evaluated by ANCOVA with treatment, study, and base-
line values as covariates. 
Results: Baseline characteristics were similar between treatment arms: 
81% female, 79% Caucasian, mean age 46 years, mean BMI 36 kg/m2, 
mean IWQOL-Lite total score of 71. Completion rate was 66% (NB) and 
59% (PBO). NB was associated with significantly greater improvements 
in weight (Week 56: –7.0 ± 0.2% NB vs –2.3 ± 0.2% PBO; p < 0.001), 
IWQOL-Lite total score (Week 56: +11.9 ± 0.3 NB vs +8.2 ± 0.3 PBO; 
p < 0.001), and all IWQOL-Lite subscores (Physical function, Self-esteem, 
Sexual life, Public distress, Work; all p < 0.05 vs PBO). At Week 56, sig-
nificantly more patients reduced body weight by ≥5% with NB (53% vs 
21%; p < 0.001); greater improvement in IWQOL-Lite was observed in 
these patients. 36% of NB subjects (vs 12% PBO; p < 0.0001) achieved 
clinically meaningful improvement in both weight (≥5% weight loss) and 
IWQOL-Lite. The most common adverse events with NB, consistent with 
the individual components, were nausea (32%), constipation (19%), head-
ache (18%), and vomiting (11%). 
Conclusion: NB meaningfully improved both weight and psychosocial 
outcomes.
T8:PO.105
Prolonged-release naltrexone/bupropion improves glucose 
control in individuals with prediabetes
Halseth A.E.1, Walsh B.1, Gilder K.1, Hollander P.2
1Orexigen Therapeutics, La Jolla, CA USA,  
2Baylor Medical Center, Dallas, TX USA
Introduction: Combination therapy with prolonged-release naltrexone/
bupropion 32 mg/360 mg (NB) reduces body weight in subjects with and 
without type 2 diabetes mellitus (T2DM), and improves glycemic control 
in subjects with T2DM. Given the well-established relationship between 
weight loss and prevention of T2DM, we examined the effects of NB in 
overweight/obese subjects without T2DM but with impaired fasting glu-
cose (FG) in 3 Phase 3 clinical trials. 
Methods: Subjects with impaired FG (≥5.56 mmol/L at screening and 
baseline) who completed 56 weeks of treatment in conjunction with life-
style modification were assessed (NB n=176, placebo [PBO] n=108; 76% 
female, mean age 51 years, mean BMI 37 kg/m2, mean weight 103 kg). 
Weight and FG were analyzed as LS means, insulin and HOMA-IR as geo-
metric LS means; differences were evaluated by ANCOVA with treatment, 
study, and baseline values as covariates. 
Results: At week 56, weight change was significantly greater with NB (-9%) 
vs PBO (-5%; p < 0.001 vs. NB). At baseline, FG was 6.17 mmol/L for NB 
and 6.08 mmol/L for PBO. At 56 weeks, FG was reduced by 0.59 mmol/L 
with NB vs 0.38 mmol/L with PBO (p = 0.013 vs NB). Fasting insulin was 
similar at baseline (NB: 15.5 μIU/mL; PBO: 15.3 μIU/mL) and was signifi-
cantly reduced with NB (30%) vs PBO (13%) at week 56 (p = 0.002 vs NB). 
HOMA-IR was 4.2 (NB) and 4.1 (PBO) at baseline; greater improvement 
was observed with NB (-37%) vs PBO (-19%; p = 0.001 vs NB). Weight 
loss was correlated with reductions in FG (r=0.38), insulin (r=0.49), and 
HOMA-IR (r=0.50; all p < 0.001, no difference between NB and PBO).
Conclusion: Greater weight loss with NB was associated with significantly 
greater improvement in FG, insulin, and HOMA-IR vs PBO. Such weight 
loss may delay the progression to T2DM.
T8:PO.106
Antiobesity activities of aminoprocalcitonin in high-fat-diet–
induced obese mice
Maldonado R.1, Minano F.J.1,2, Tavares E.1
1Clinical and Experimental Pharmacology Research Unit, Valme University 
Hospital, Seville, Spain.,  
2Department of Pharmacology, Pediatrics and Radiology, Faculty of Medicine 
University of Seville, Seville, Spain.
Background: Obesity is associated with insulin resistance and a state of 
abnormal inflammatory response. Recently aminoprocalcitonin (NPCT), 
a neuroendocrine peptide produced in the brain and peripheral tissues, 
has been shown to play an important neuroimmune role in inflamma-
tion. NPCT act as a catabolic mediator in neuroendocrine and metabolic 
mechanisms that regulate energy homeostasis. NPCT may be a candidate 
for participation in the cross-talk between inflammatory and metabolic 
signals. 
Objective: This study investigated the effects of chronic subcutaneous 
infusion of NPCT on obesity and its associated factors in high-fat-diet-
induced obese (HF) mice. 
Methods: Male C57BL/6 mice were randomly assigned to one of four 
groups: low-fat-diet (LF)-vehicle, LF-NPCT, HF-vehicle and HF-NPCT. 
NPCT was administered via subcutaneous osmopumps. After 4 week of 
treatment, obesity-associated factors, including food/caloric intake, body 
weight, plasma concentrations of insulin, glucose (insulin-resistance), and 
circulating markers of inflammation were measured. 
Results: A 4-week infusion of NPCT significantly decreased the food/ca-
loric intake body weight and plasma levels of proinflammatory cytokines 
(TNF-α, IL-6, and/or IL-1β ) in HF fed mice. The anti-inflammatory ef-
fects of NPCT were associated with improved glycemic status in the treat-
ed animals, evidenced by improved glucose tolerance.
Conclusions: These findings identify a potential novel application for 
NPCT as an anti-obesity and anti-inflammatory agent.
Acknowledgement: This work was supported by grants from Instituto de Salud Car-
los III (FIS2012/01074), Consejeria de Salud, Junta de Andalucia (DP00012/2011 
and PI0293/2010).
T8:PO.107
Can lllt associated with a mixed training change the 
cardiovascular risk in obese women?
Duarte F.O.1, Fiorese M.S.2, de Aquino Junior A.E.1,2, Masquio D.L.4, 
Campos R.M.4, Duarte A. O.5, Tock L.3, Dâmaso A. R.3,4, Bagnato V. S.2, 
Parizotto N. A.1
1Universidade Federal de Săo Carlos, Departamento de Fisioterapia, Programa 
de Pós Graduaçăo de Biotecnologia, Săo Carlos, Brazil,  
2Universidade de Săo Paulo, Instituto de Física de Săo Carlos, Grupo de Óptica, 
Săo Carlos, Brazil,  
3Weight Science, Săo Paulo,  
4Universidade Federal de Săo Paulo, Departamento de Psicobiologia, Săo Paulo, 
Brazil,  
5Universidade Federal de Săo Carlos, Departamento de Educaçăo Física e 
Motricidade Humana, Programa de Pós Graduaçăo em Cięncias Fisiológicas, Săo 
Carlos, Brazil
Introduction: The use of phototherapy as a non-invasive treatment has 
been disseminated in recent years, mainly in controlling diseases, muscle 
performance and also in the aesthetic treatment. Recently, our research 
group demonstrates that the phototherapy when associated with exer-
cise training was efficient to ameliorate the lipid profile in obese woman. 
Objective: Investigate the effect of the LLLT associated with aerobic and 
resistance mixed training on cardiovascular risk in obese women. Meth-
odology: Women aged 20–40 years (BMI ≥ 30 kg/m˛), was divided into 
2 groups: Phototherapy (P) and Sham (S). They trained aerobic plus re-
sistance exercises (in a concurrent mode), 1 hour, 3 time/week during 16 
week. Phototherapy was applied after each exercise session for 16 minutes, 



















   
   
   
   
   
   
   
   
   



















Obesity Facts 2015;8(suppl 1):1–247 Abstracts240
energy delivery 50 Joules. The body composition was measured with bio-
impedance InBody®. 
Results: Described in table above. 
Conclusion: LLLT when associated with concurrent (mixed) exercise 
potentiate the exercise effects decreasing neck and waist circumference, 
visceral fat and platelets, all of these factors included in the cardiovascular 
risk in obese woman. These results suggest the LLLT as new therapeutic 
tool to control the cardiovascular risk in obese people.
Table 1. Body mass, visceral fat and platelets.*initial versus end; ** Sham versus 
Phototherapy
Table 2. Waist and neck circumference.*initial versus end; ** Sham versus 
Phototherapy
T8:PO.108
Early achievement of significant weight loss with prolonged-
release naltrexone/bupropion is associated with additional 
weight loss at one year - an integrated analysis of four phase 
3 trials
Walsh B.1, Plodkowski R.A.2, Shan K.1, Fujioka K.2
1Orexigen Therapeutics, Inc., La Jolla, CA, USA,  
2Scripps Clinic, La Jolla, CA, USA
Introduction: Naltrexone prolonged-release (PR) / bupropion PR (NB 
[32mg/360mg]) significantly reduced body weight vs placebo (PBO) in 
four Phase 3 trials of overweight/obese subjects (BMI ≥27 and ≤45 kg/
m2) at Week 56: NB –7.0% (SE=0.2) body weight vs PBO –2.3% (SE=0.2; 
p < 0.001). As early response to treatment may be indicative of greater 
long-term weight loss, an integrated analysis of four Phase 3 NB trials 
(n=2043 NB, n=1319 PBO) was performed to evaluate the proportion of 
early responders (observed ≥5% weight loss at Week 16) and their long-
term weight loss. 
Methods: Treatment differences (LS mean) in the modified ITT-LOCF 
population (≥1 post-baseline weight on study drug) were evaluated by 
ANCOVA with treatment, study, and baseline values as covariates. 
Results: Baseline characteristics were similar between treatment groups: 
81% female, 79% Caucasian, mean age 46 years, and mean BMI 36 kg/m2. 
The goal of ≥5% weight loss by Week 16 was achieved in 51% of NB sub-
jects (similar across the overweight and 3 obesity classes [range: 44–54%]) 
and 19% of PBO subjects. Of the early NB responders, 87% completed 56 
weeks of treatment. In the early NB responders (-9.2% LS mean weight 
change at Week 16), body weight at Week 56 was further reduced (-11.3% 
from baseline) and weight loss of ≥10% or ≥15% was achieved by 55% and 
30% of subjects, respectively. The safety/tolerability profile of NB was con-
sistent with its individual components. The most frequent AEs with NB in 
both the overall Phase 3 population and the early responder population 
were nausea, constipation, and headache.
Conclusions: The majority of subjects treated with NB achieved ≥5% 
weight loss by Week 16; these subjects exhibited additional weight loss at 
1 year, and 87% continued treatment to study end.
T8:PO.109
An integrated analysis of weight loss with combination 
prolonged-release naltrexone/bupropion therapy by BMI 
classification
Walsh B.1, Apovian C.2, Burns C.M.1, Taylor K.1
1Orexigen Therapeutics, Inc., La Jolla, CA, USA,  
2Boston University School of Medicine, Boston, MA, USA
Introduction: Naltrexone prolonged-release (PR) / bupropion PR (NB 
[32/360 mg]) significantly reduced body weight vs placebo (PBO) in the 
four Phase 3 trials of overweight/obese patients (BMI 27–45 kg/m2). This 
integrated analysis examined weight loss in these trials when stratified by 
baseline BMI (obesity class): Class-I (30.0–34.9 kg/m2), Class-II (35.0–
39.9 kg/m2), Class-III (≥40 kg/m2). 
Methods: Treatment group differences (LS mean±SE) in the modified 
ITT-LOCF population (≥1 post-baseline weight on study drug) were eval-
uated by ANCOVA with treatment, study, and baseline values as covari-
ates. 
Results: Baseline characteristics were similar between treatment arms 
(NB n=2043; PBO n=1319): 81% female; 79% Caucasian; mean age 46 
years; mean BMI 36 kg/m2; obesity Class-I 37%, Class-II 36%, Class-III 
25%. Completion rate was 66% (NB) and 59% (PBO). At Week 56, sig-
nificantly greater weight loss was observed with NB (-7.0 ± 0.2%) vs PBO 
(-2.3 ± 0.2%; p < 0.001), and a more patients attained ≥5% weight loss 
with NB (odds ratio vs PBO: 4.1; p < 0.001). NB patients experienced fa-
vorable shifts in BMI class from baseline (NB vs PBO: improved = 45% 
vs 20%, no change = 53% vs 74%, worsened = 2% vs 6%; p < 0.001), and a 
non-obese BMI was achieved in 17% of Class-I NB subjects (vs 6% PBO) 
and 3% of Class-II NB subjects (vs 1% PBO). Weight loss with NB was 
similar across the 3 obesity classes (-4.0% to –5.0% PBO-corrected, all 
p < 0.001), as was achievement of ≥5% weight loss (odds ratio vs PBO: 3.5 
to 4.3; all p < 0.001). The safety/tolerability profile of NB was consistent 
with its components; the most common AEs were nausea (32%), constipa-
tion (19%), headache (18%), and vomiting (11%). 
Conclusion: The clinically significant weight loss associated with NB was 
consistent across a wide BMI range.
T8:PO.110
Vitamin d supplementation promotes weight loss and waist 
circumference reduction in overweight/obese adults with 
hypovitaminosis d
Vigna L.1, Lonati C.1, Sommaruga D.2, Tirelli A.S.3, Riboldi L.1
1Dept of Preventive Medicine, Fondazione IRCCS Ca’ Granda Ospedale Maggiore 
Policlinico, Milano,  
2Servizio dietetico direzione sanitaria di presidio, Fondazione IRCCS Ca’ Granda 
Ospedale Maggiore Policlinico, Milano,  
3Laboratorio analisi cliniche e microbiologia, Fondazione IRCCS Ca’ Granda 
Ospedale Maggiore Policlinico, Milano
Hypovitaminosis D is associated with adiposity and higher risk of de-
veloping obesity-related complications. Intervention studies with chole-
calciferol provided inconsistent results. The objective was to evaluate 
whether restoration of optimal vitamin D status promotes weight loss 
and improves metabolic serum biomarkers. Four-hundred overweight or 
obese patients with vitamin D insufficiency were recruited from 2011 to 
2013. Participants received a balanced moderately-low-calorie diet and 
were assigned to 3 groups: 1) no treatment; 2) cholecalciferol 25.000 UI 
/ month; 3) cholecalciferol 100.000 UI / month. At baseline (T0) and af-
ter 6 months (T1) we determined: anthropometric measures, BMI, waist 
circumference, body composition, plasma 25-hydroxyvitamin (OH) D, 
fasting glucose, fasting insulin, and glycated hemoglobin. Differences 
were investigated using repeated measures ANOVA regardless of patient 
adherence to treatment (intention-to-treat analysis). Six-month supple-
mentation with 25.000 and 100.000 UI increased serum 25(OH), but only 
100.000 allowed achievement of optimal vitamin D status (p < 0,001) (Fig. 
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100.000 UI groups (–3,8 kg and –5,4 kg) compared to untreated (-1.2 kg) 
(Fig. 2). Waist circumference reduction was more substantial in the vita-
min D group (25.000: –4.00 cm; 100.000: –5.48 cm; untreated: –3.21 cm; 
p < 0,05) (Fig. 2). Adjustment for age, sex, and BMI did not affect statis-
tical significance. Improved HbA1c was noted in patients supplemented 
with 100.000 UI, but this finding lost significance after adjustment for 
weight decrease. The present data indicate that vitamin D supplementa-
tion ameliorates anthropometric profiles and enhances the beneficial ef-
fects of hypocaloric diet.
Fig. 1. Plasma 25(OH) concentration increase after 6-month cholecalciferol 
supplementation. RM Two- way ANOVA, Bonferroni post hoc test. * p < 0.05 vs 
untreated; *** p < 0.001 vs untreated; § p < 0.05 vs 25.000 UI
Fig. 2. Decrease in weight , BMI, waist circumference and fat mass after 6-month 
cholecalciferol supplementation. RM Two- way ANOVA, Bonferroni post hoc test. 
* p < 0.05 vs untreated; § p < 0.05 vs 25.000 UI
T8:PO.111
Randomized, double-blind, placebo–controlled, 4-week proof 
of concept trial of beloranib, a novel treatment for patients 
with prader-willi syndrome
Kim D.D.1, Malloy J.L.1, Chen A.1, Taylor K.1, Hughes T.E.1
1Zafgen, Inc. Boston MA USA
Patients with Prader-Willi syndrome (PWS) fail to regulate metabolism 
and hunger, resulting in preoccupation with food and extreme drive to eat 
that leads to severe obesity. Beloranib is a MetAP2 inhibitor that reduc-
es hunger and restores balance to the production/utilization of fat; prior 
studies have shown ~11% body weight (BW) loss and ~50% reduction in 
hunger over 12 wks in exogenous obesity. This was a randomized, doubleⅢ
blind, placebo-controlled study in 17 adults with PWS. Patients were ran-
domized to receive blinded twice weekly SC doses of 1.2 mg (n=5), 1.8 mg 
(n=6) of beloranib, or placebo (n=6) for 4 weeks. All patients were offered 
50% increase in daily calorie allowance throughout the trial. All 17 pa-
tients (11 females, age 33.5yr, BMI 31.4kg/m2, BW 72.0kg) completed the 
trial. After 4 wks, patients on placebo had an average (±SEM) increase of 
3.6% ± 2.4% total body fat vs. a reduction in total body fat of 0.9% ± 1.1% 
and 4.5% ± 2.0% in the 1.2 mg and 1.8 mg beloranib groups, respectively 
(p < 0.05 for both doses). Biomarkers associated with cardiovascular dis-
ease risk (lipids, hs-CRP) and adipose tissue function (adiponectin) were 
also improved in both beloranib groups. Food-related problem behaviors, 
as measured by Hyperphagia Questionnaire, improved by 1.8% (1.2mg), 
52.4% (1.8mg), vs. worsening by 40.5% with PBO (p = 0.025 vs. 1.8 mg). 
Beloranib was well-tolerated with no severe/serious adverse events and 
no clinically significant changes in laboratory values or ECG/vital signs 
observed.. This study demonstrated proof-of-concept safety and effective-
ness of beloranib on body composition, food related problem behaviors, 
and cardiovascular risk markers in PWS. Phase 3 trial assessing safety and 
efficacy of beloranib in patients with PWS has been initiated.
T8:PO.112
In a phase 2 study, beloranib, a novel methionine 
aminopeptidase 2 (metap2) inhibitor, appeared safe and 
showed significant body weight loss over 12 weeks in obese 
adults
Taylor K.1, Chen A.1, Malloy J.L.1, Hughes T.E.1, Kim D.D.1
1Zafgen, Inc. Boston MA USA
Beloranib is a MetAP2 inhibitor that reduces hunger and restores balance 
to the production and utilization of fat. Previous studies in obese women 
showed ~4% - 6% body weight (BW) loss with 1–4 mg beloranib admin-
istered twice weekly over 4 weeks. In the current Phase 2, randomized, 
double-blind, placebo-controlled study, 147 subjects were randomized to 
one of 3 beloranib dose groups; 0.6 mg (n=37), 1.2 mg (n=37) or 2.4 mg 
(n=35), or to placebo (n=38) given twice-weekly over 12 wks. Changes 
in BW, hunger, and cardiometabolic biomarkers were measured. Subjects 
were mostly white females with mean age 48.4 yr, BW 100.9 kg, and BMI 
37.6 kg/m2. Greater than 80% of the subjects completed the trial in the 0.6 
mg, 1.2 mg and placebo groups, while ~43% of the 2.4 mg group complet-
ed treatment. The primary reason for early withdrawal was due to adverse 
event (AE), with the most common AEs leading to withdrawal being re-
lated to sleep disorders in the 2.4 mg group. There were no serious AEs 
deemed to be related to study drug and no clinically significant abnor-
mal laboratory measures, vital signs, or ECG findings. AEs were generally 
mild, transient, and self-limiting. After 12 wks of treatment, subjects on 
0.6 mg, 1.2 mg, or 2.4 mg lost an average (±SEM) of –5.5 ± 0.5, –6.9 ± 0.6, 
and –10.9 ± 1.1 kg vs. –0.4 ± 0.4 kg for placebo (all p < 0.0001 vs. place-
bo). Hunger, blood pressure, LDL-c, triglycerides, and hs-CRP decreased 
in the beloranib groups. Beloranib treatment for 12wks, representing the 
longest duration of drug exposure in humans, appeared safe and generally 
well-tolerated at doses less than 2.4 mg, and resulted in clinically mean-
ingful BW loss, with improved hunger and cardiometabolic markers. Be-
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T8 – Diagnostics
T8:PO.113
Influence on helicobacter pylori eradication of laparoscopic 
gastric plication
Tokocin M.1, Vartanoglu T.1, Koy Y.2, Tolga D.2, Arici S.1, Solmaz A.1, 
Tokocin O.3, Celebi F.1, Tetikkurt U.S.2, Kutanis R.1
1Department of General Surgery, Bagcilar Training and Research Hospital, 
Istanbul, Turkey,  
2Department of Patology, Bagcilar Training and Research Hospital, Istanbul, 
Turkey,  
3Department of Emergency Medicine, Cerrahpasa Medical Faculty, Istanbul 
University in Istanbul, Istanbul, Turkey
Introduction: Among the surgical procedures for the treatment of mor-
bid obesity, laparoscopic gastric plication has known as a bariatric technic 
with little or no studies regarding operative findings and patient follow-up. 
Aim of this study is to evaluate the incidence of Helicobacter pylori (HP) 
infection on the preoperative and post operative outcomes of patients un-
dergoing laparoscopic gastric plication. 
Methods: A retrospective study was done on the gastric pathology speci-
mens results of randomly selected asymptomatic 100 patients of 407 who 
underwent laparoscopic gastric plication from 2010 to 2013.All the speci-
mens were analysed by the same pathologist and histological grading was 
based on the Sidney classification. 
Results: 76 of the 100 patients are HP positive while 24 were negative. 
There is no significant difference between two groups in terms of age, 
BMI, sex and weight.Altough no differences were found at the preoper-
ative and postoperative gastroscopies of these 100 patients according to 
the activity, atrophy, intestinal metaplasia and the positivity of HP, we ob-
served difference at the aspect of inflammation (p = 0.012). 
Conclusions: While HP were not be treated via laparoscopic gastric pli-
cation, we detected the positive influence on the inflammation of patients 
operated by laparoscopic gastric plication.
Acknowledgement: The authors declare that there is no Acknowledgement regard-
ing the publication of this paper.
T8:PO.114
Spise: Single point insulin sensitivity estimator – a novel 
parameter to evaluate insulin sensitivity in obese adolescents
Paulmichl K.1, Anderwald C.H.2,3, Binder S.1, Eidherr A.1, Labmayr V.1, 
Widhalm K.1,4, Weghuber D.1
1University hospital of pediatrics salzburg, beta-judo consortium, obesity 
research unit, salk / paracelsus medical university, Salzburg, Austria,  
2Department of endocrinology and metabolism, general hostpital Vienna, 
Medical University Vienna, Austria,  
3CNR, Padua, Italy,  
4Department of pediatrics, general Hospital Vienna, Medical University Vienna, 
Austria
Introduction: Insulin resistance is a key feature of obesity-associated 
metabolic comorbidities. Clinical assessment of insulin sensitivity (IS) 
currently uses indices calculated from plasma glucose and insulin val-
ues (fasting as well as during oral glucose tolerance test). These indices 
correlate insufficiently with the IS assessed by the glucose-clamp method. 
The goal of the current study is to contrive and validate a new and sim-
ple index for IS which does not necessitate the prevenient evaluation of 
insulin-levels. 
Methods: This study was carried out by the Beta-JUDO consortium (Be-
ta-Cell Function in Juvenile Diabetes and Obesity) and included 21 mor-
bidly obese patients (age 14.5 ± 1.8 years, 29% female, WHO-ISO-BMI 
41.6 ± 12.7 kg/m2). They underwent both a standardized oral glucose tol-
erance test and an isoglycemic glucose-clamp from which IS indices were 
derived. The SPISE is calculated by mathematical modeling and includes 
BMI (kg/m2), serum triglycerides (mg/dL) and serum-HDL-cholesterol 
(mg/dL). The detailed description of the SPISE is complex and at present 
in preparation for publication. 
Results: Matsuda’s ISI comp, HOMA-IR respectively QUICKI correlate 
with the M-value from glucose-clamps with r = 0.51, 0.52 and 0.51 (each 
with a p-value of <0.05) in this study population. In comparison, the 
SPISE shows an r-value of 0.59 (p-value <0.01) when correlated with the 
M-value. 
Conclusion: As an innovative index the SPISE enables an improved esti-
mation of peripheral insulin sensitivity derived from a single fasting sam-
ple without the need to determine insulin.
T8:PO.115
Comparison of correlation between prostate volume and 
obesity
Huh J.1,3, Park J.2, Kong M.2,3, Kim H.2,3
1Department of Urology, Jeju National University Hospital,  
2Department of Family Medicine, Jeju National University Hospital,  
3School of Medicine, Jeju National University in Jeju, Korea
Introduction: Benign prostatic hyperplasia(BPH) is a common condition 
in males more than 40 years old, and the incidence of BPH has shown a 
tendency to increase with age. Obesity is state of excessive accumulation 
of fat in the body, and leads to changes in the body‘s metabolism and en-
docrine function, so progression of BPH occurs in obesity status accord-
ing to many articles. The purpose of this study is to compare the efficacy 
of obesity indices which correlate with prostate volume. 
Methods: The study was carried out in 285 males, who visited health pro-
motion center in Jeju National University Hospital and underwent tran-
srectal ultrasonography and abdominal fat computed tomography from 
April, 2010 to June, 2013. Anthropometric parameters were measured 
directly and blood samples were obtained in a fasting state more than 8 
hours in the morning. Then, we analyzed the correlation between obesity 
indices and prostate volume. 
Results: After adjusting by age, prostate volume was positively correlat-
ed with BMI(r=0.227, P < 0.001), waist circumference(WC)(r=0.151, 
P = 0.011), waist to height ratio(WHtR)(r=0.149, P = 0.012), visceral fat 
area(VFA)(r=0.157, P = 0.008). However prostate volume was not cor-
related with subcutaneous fat area(SFA) and visceral to subcutaneous ra-
tio(VSR). WHtR had the largest area under the curve(AUC) for the identi-
fication of prostate volume more than 30ml(AUC=0.595, P = 0.017). Then 
the VFA and BMI were in order. 
Conclusion: Prostate volume was positively correlated with BMI, WC, 
WHtR and VFA in the obesity indices and WHtR had the largest AUC 
and then, VFA and BMI were in order.
T8:PO.116
BMI, in itself, is not sufficient parameter for evaluation of 
nutritional state of professional soldiers in the armed forces 
of the czech republic
Fajfrová J.1, Pavlík V.1, Vacková M.1, Blažek O.1
1Department of Military Internal Medicine and Military Hygiene, Faculty of 
Military Health Science University of Defence Hradec Králové, Hradec Králové, 
Czech Republic
Introduction: In the Armed Forces of the Czech Republic there has been 
introduced a system evaluating the health capability of active-duty ser-
vice, regulation No 103/2005 Sb. One of the evaluation criteria is also the 
nutritional state assessed only by BMI values. Aim of our study was to 
determine real nutritional state of soldiers. 
Methods: Nutritional state assessment was focus on body composition 
measured by bioimpedance analysis supplemented with waist circumfer-
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Results: For now we enrolled 404 male soldiers and 50 female soldiers 
with mean age 32.0 ± 7.4 years and 28.6 ± 8.6 years, respectively. BMI was 
25.8 ± 3.5 kg/m2 vs. 23.5 ± 3.5 kg/m2. Overweight was found in 51.2% vs. 
20%, obesity in 10.2% vs. 6%. Percentage of body fat in range of over-
weight was found in 11.4% vs. 32%, and in range of obesity was found 
in 6.2% vs. 20%. Waist circumference ≥ 94 cm for men and ≥ 80 cm for 
women was found in 10.2% and 6% and waist circumference ≥ 102 cm for 
men and ≥ 88 cm for women was found in 5.7% and 6%. 
Conclusion: First results of our work indicate that the BMI criterion, in 
itself, is not sufficient, especially for evaluating overweight and it is nec-
essary to extend the current assessment algorithm with other parameters, 
that means waist circumference and percentage of total body fat. These 
parameters are able to complete the BMI values and better identify indi-
viduals with the risk of development of obesity and associated complica-
tions. Nowadays we prepare amendment of regulation about evaluating 
the health capability of active-duty service.
T8:PO.117
Phenotypic characterization further anthropometric 
measures in morbid obesity
Cos Blanco A.I.1, Calvo I.1, Cardenas J.J.1, Pelegrina B.1, Roldan M.C.1, 
Vazquez C.2, Pallardo L.F.1
1Obesity Unit. Department of Endocrinology. University Hospital La Paz, Madrid, 
Spain,  
2Department of Endocrinology. Jimenez Diaz Foundation. Madrid. Spain
Introduction: Body composition, fat distribution, presence and extension 
of co-morbidities, weight history, functional status and degree of compul-
sivity are among others, phenotypic traits that allow us a more accurate as-
sessment of health risk of obese people. AIM: Characterize and categorize 
obese patients according to their clinical and functional status. 
Method: Data is collected from 81 patients with severe obesity. Weight, 
height, waist circumference, biochemical parameters and blood pressure 
are registered. Also recorded are hepatic, renal and osteoarticular diseases, 
sleep-apnoea syndrome and/or gastro-oesophageal reflux, if present. The 
degree of functional capacity is assessed and patients are categorized ac-
cording criteria of hypertriglyceridemic waist (HW), Garvey‘s Cardiometa-
bolic Disease Staging System (CMDS) and Edmonton Staging System (ESS). 
Results: 67% women. Average age 47+10y, 18% below 30y. Average BMI 
of 47 kg/m2, 26% of patients have a BMI >50 kg/m2. Average waist circum-
ference of 132+14cm, 22% of women and 10% of men have a high HW 
index. 55% of the patients have hypertension, 33% diabetes, 34% show 
sleep-apnoea syndrome and 25% gastro-oesophageal reflux. Most patients 
(62%) live sedentarily. Applying ESS, nine patients (11%) are in the high-
est risk range and 70% are in the high-risk range. Using CMDS 51% show 
high risk and 22% medium risk. No correlation was found between BMI 
and CMDS/ESS. 
Conclusion: A diagnostic approach using clinical staging systems pro-
vides us with information on presence or extension of co-morbidities 
which can guide the decision making process. A proper characterization 
of obese people could help determining and establishing better criteria to 
prioritize therapeutics interventions in this group of patients.
T8:PO.118
COMPARISON OF TWO DIFFERENT BIA INSTRUMENTS
Sekli E.1, Luger M.1, Kruschitz R.1, Kral M.1, Langer F.2, Krebs M.1, Prager G.2, 
Ludvik B.3, Schindler K.1
1Department of Internal Medicine III, Medical University of Vienna, Vienna, 
Austria,  
2Department of Surgery, Medical University of Vienna, Vienna, Austria, 
3Hospital Rudolfstiftung, Vienna, Austria
Introduction: Bioelectrical impedance analysis is a simple and non-inva-
sive method to assess the effectiveness of weight reduction interventions, 
to identify the patient’s health risk and to formulate individual dietary and 
exercise recommendations. A standardized BIA measurement is needed 
to allow accurate monitoring of changes in the body composition. In this 
study two BIA instruments were compared to determine agreement. 
Methods: 88 postoperative bariatric surgical patients, 69 women and 19 
men, (BMI= 31.58 ± 6.6 kg/m2, age = 42.3± 12.1years) underwent BIA 
measurement with the BIA Corpus RX 4000 (BIAC), lying in supine posi-
tion1, and with the Seca mBCA 515®, standing barefoot, as recommended
by the manufacturer. Body composition was calculated with Gray et al.2 
prediction equation. Bland Altman method was used to determine agree-
ment. 
Results: Comparison of Seca® and BIAC resulted in an observed differ-
ence in resistance (+71.8 ± 25.2Ω, p = <0.001), reactance (-1.3 ± 4.0Ω, 
p = 0.002) and phase angle (-0.85 ± 0.3°, p = <0.001). Limits of agreement 
between Seca® and BIAC were 121.17Ω/ 22.3Ω for resistance, 6.6Ω/ –9.3Ω 
for reactance and –0.3°/-1.5° for phase angle. A significant (p < 0.001) dif-
ference remained after calculation of FFM (kg) (-3.1 ± 1.6 kg, p < 0.001), 
FM (kg) (3.1 ± 1.6 kg, p < 0.001) and FM% (3.5 ± 1.7%, p < 0.001), result-
ing in lower FFM and higher FM values determined with Seca®. 
Conclusion: Changing BIA instruments while monitoring body compo-
sition over time needs consideration of potential differences in the mea-
surement.
References:
1.  Lukaski, Henry C., et al.: „Validation of tetrapolar bioelectrical imped-
ance method to assess human body composition.“ J Appl Physiol 60.4 
(1986): 1327–1332. 
2.  Gray, David S., et al.: „Effect of obesity on bioelectrical impedance.“ The 
American journal of clinical nutrition 50.2 (1989): 255–260.
T8:PO.119
Cardiometabolic risk factors and inflammation in adipose 
tissue are increased in obese subjects classified as 
metabolically healthy
Gómez-Ambrosi J.1,6,7, Catalán V.1,6,7, Rodríguez A.1,6,7, Andrada P.2, 
Ramírez B.1,6,7, Ibáńez P.2,7, Vila N.2, Romero S.2, Margall M.A.2, Gil M.J.3,6,7, 
Moncada R.4,6, Valentí V.5,6,7, Silva C.2,6,7, Salvador J.2,7, Frühbeck G.1,2,6,7
1Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, 
Spain,  
2Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, 
Pamplona, Spain,  
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4Department of Anesthesiology, Clínica Universidad de Navarra, Pamplona, 
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Introduction: It has been suggested that individuals with the condition 
known as metabolically healthy obesity (MHO) may not have the same 
increased risk for the development of metabolic abnormalities as their 
non-metabolically healthy counterparts. However, the validity of this 
concept has recently been challenged since it may not translate into lower 
morbidity and mortality. The aim of the present study was to compare 
the cardiometabolic/inflammatory profile and the prevalence of impaired 
glucose tolerance (IGT) and type 2 diabetes (T2D) in patients categorized 
as MHO or metabolically abnormal obesity (MAO). 
Methods: We performed a cross-sectional analysis to compare the car-
diometabolic/inflammatory profile of 222 MHO and 222 MAO patients 
(62% women) matched by age, including 255 lean subjects as reference 
(cohort 1). In a second cohort, we analysed the adipokine profile and the 
expression of genes involved in inflammation and extracellular matrix re-
modelling in visceral adipose tissue (VAT, n=82) and liver (n=55). 
Results: The cardiometabolic and inflammatory profiles (C-reactive pro-
tein, fibrinogen, uric acid, leukocyte count and hepatic enzymes) were 
similarly increased in MHO and MAO in both cohorts. Moreover, above 
30% of patients classified as MHO according to fasting plasma glucose ex-
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well as novel (SAA and MMP9) adipokines was almost identical in MHO 
and MAO groups in cohort 2. Expression of genes involved in inflamma-
tion and tissue remodelling in VAT and liver showed a similar alteration 
pattern in MHO and MAO individuals. 
Conclusion: The present study provides evidence for the existence of a 
comparable adverse cardiometabolic profile in MHO and MAO patients.
Acknowledgement: Supported by grants from the ISCIII (PI09/91029, PI11/02681 
and PI12/00515), the Department of Health (31/2009, 48/2011 and 58/2011) of the 
Gobierno de Navarra and CIBERobn, Spain.
T8:PO.120
Relationship of serum tsh with body mass measures in healthy 
adults
Solanki A.1, Jindal S.2, Bansal S.3
1Resident, Department of Medicine, Peoples College of Medical Sciences, 
Bhopal(M.P), INDIA.,  
2MD DM Endocrinology, Proffesor, Department of Medicine, Peoples College of 
Medical Sciences, Bhopal(M.P), INDIA.,  
3Associate Proffesor, Department of Medicine, Peoples College of Medical 
Sciences, Bhopal(M.P), INDIA.
Introduction: The problem of obesity is multi-faceted and requires the 
understanding of different areas to effectively address and reverse the 
current trends.The present study aims to look at the association between 
thyroid-stimulating hormone and body mass measures. 
Methods: 742subjects, healthy, self reported, euthyroid staff of Peoples 
University aged 18–60 years were screened and those with TSH between 
0.3mU/L-10mU/L were taken for the purpose of analysis.TSH was esti-
mated by 3rd generation chemiluminescence assay.Pearsons correlation 
coefficient was calculated. 
Results: We derived significant positive correlation between TSH 
and BodyMassIndex(P < 0.0001), TSH and Weight(p = 0.0016), 
TSH and WaistCircumference(P = 0.0007), TSH and HipCircumfer-
ence(P = 0.0017). 
Conclusion: In our study we derived a significant positive correlation 
between TSH and BMI in euthyroid adults. The studies so far about the 
relationship of weight and thyroid functions have shown significant and 
positive correlation [1] as well as no correlation [2]. There is a need to look 
at serum TSH levels of an individual in light of his/her weight as obese/
overweight people tend to have higher serum TSH.Further the inverse 
derivation of the available data can open new avenues for treatment of 
obesity presuming thyroid hormones have significant impact on adiposity. 
References
1.  Svare A, Nilsen TIL, Bjřro T, Asvold BO, Langhammer A. Serum TSH related to 
measures of body mass: longitudinal data from the HUNT Study, Norway. Clin 
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Fig. 1. Linear regression analysis for correlation of TSH with BMI.
Fig. 2. Correlation of TSH level with weight, Height and BMI.
Fig. 3. Correlation of TSH level with WC, HC, W /H
T8:PO.121
The influence of glucose homeostasis on body weight loss
Branco T.1, Baiăo D.1, Lopes P.1, Martins S.1
1Instituto Prof. Teresa Branco 
Introduction: The primary objective of the present study was to eval-
uate the influence of the glucose homeostasis, evaluated by HOMA, on 
body weight loss promoted by a 6-month weight loss program, based on a 
multidisciplinary approach, with personalized interventions and lifestyle 
group sessions. 
Methods: The sample comprised 94 adults (40,8 ± 10,1yr; 30.7 ± 5,5kg/
m2). Body weight was assessed at baseline and at the end of the 6-months 
loss program with an electronic scale (SECA, Hamburg, Germany). The 
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sessions and all the participants were follow by a multidisciplinary team 
comprised a physician, a nutritionist, a psychologist and an exercise phys-
iologist. Glucose homeostasis was evaluated by HOMA Test (baseline 
insulin (μU/ml) x baseline glucose (mg/dl) / 405) at baseline. Multiple 
regression analysis was performed to assess the multivariate relationships 
between glucose homeostasis and body weight loss. 
Results: At 6-month, participants lost, on average, 6.4kg ± 6.2kg (p < .001) 
of initial body weight (range: –6.7kg – 26,4 kg loss), with no differences 
between genders (p > 0.05). Glucose homeostasis was not associated with 
body weight loss (p > 0.05). No correlation was found between baseline 
glucose homeostasis and body weight loss at 6-month (p > 0.05).
Conclusions: This analysis suggested that glucose homeostasis does not 
influence body weight loss in adults that follow a 6-month weight loss 
commercial program, that included nutritional and physiologic sessions 
and physical activity recommendations.
T8 – Geriatric obesity, treatment
T8:PO.122
The implications of sarcopenia and sarcopenia obeisty on 
lung function in healthy eldery
Kim H.1,3, Moon J.1, Kong M.1,3, Huh J.2,3
1Department of Family Medicine, Jeju National University Hospital,  
2Department of Urology, Jeju National University Hospital,  
3School of Medicine, Jeju National University in Jeju, Korea
Introduction: Previous studies have demonstrated a positive association 
between obesity and decreased lung function. In this study, we evaluated 
the impact of sarcopenia and sarcopenic obesity on pulmonary impair-
ment in healthy elderly. 
Methods: This study included 2,850 subjects aged over 60 (1,198 men and 1,652 
women) that participated in the Korean National Health and Nutrition 
Examination Survey (KNHANES) from 2008 to 2011. We excluded in-
dividuals who had chronic diseases such as chronic liver disease, chronic 
kidney disease. We also excluded individuals who had FEV1/FVC<0.7 
and chronic obstructive lung disease, bronchial asthma, tuberculosis. 
Appendicular skeletal muscle mass (ASM) divided by weight (ASM/Wt, 
%) was estimated by dual X-ray absorptiometry (DXA). Sarcopenia was 
defined as 2 standard deviations below the gender specific mean for young 
healthy adults. Obesity was defined as waist circumference greater than 
90cm in men and 85cm in women. 
Results: According to the above definition, our cut off value for sarcope-
nia in men and women was 27.85% and 21.35%, respectively. The preva-
lence of sarcopenia in individuals aged over 60 was 10.0%. Significant pos-
itive correlations were found for ASM/Wt with forced vital capacity (FVC) 
(R2 0.428, P < 0.001) and forced expiratory volume in 1 second (FEV1) 
(R2 0.342, P < 0.001). Lung function in the sarcopenic obesity group ap-
peared to be decreased compared to the normal group after adjusting for 
age, smoking status, alcohol consumption and exercise by multiple logistic 
regression.
Conclusions: In conclusion, sarcopenia and sarcopenic obesity were 
closely associated with decreased lung function in healthy Korean elderly.
T8 – Complications
T8:PO.123
Waist Circumference Correlates with Disease Severity in Acute 
Pancreatitis
Štimac D.1, Franjić N.1, Poropat G.1, Mikolašević I.1, Klobučar Majanović S.2
1Division of Gastroenterology, Department of Internal Medicine, University 
Hospital Rijeka, School of Medicine Rijeka,  
2Division of Endocrinology, Diabetology and Metabolic Diseases, University 
Hospital Rijeka, School of Medicine Rijeka
Background/aims: obesity is a well-known factor contributing to the eti-
ology of acute pancreatitis (AP). In order to clarify its role in the patho-
genesis and progression of the disease, several studies were conducted 
with different outcomes. Since the number of performed studies is lim-
ited, we decided to check the conclusions and present our own results. 
Method: In this retrospective study, medical histories of 156 patients diag-
nosed with AP during the years 2008 and 2009 were analyzed. Of the 156 
patients, 81 were men and 75 women, mean age 64,2 ± 14,5 years, average 
APACHE II score 8,58 ± 4,07. Body-mass index (BMI), waist circumfer-
ence (WC), hip circumference and waist-hip ratio were retrieved and their 
correlation with local, systemic complications and death outcomes were 
compared using receiver operating characteristic (ROC) curves. 
Results: among the researched parameters only WC correlated with local, 
systemic complications and death outcomes. According to ROC curves, 
the cut-off value of 96 cm had 94.6% sensitivity and 40,3% specificity val-
ue in predicting systemic complications (p = 0,0018). The cut-off value of 
103 cm had 68% sensitivity and 59,4% specificity value in predicting local 
complications (p = 0,0048), while the cut-off value of 100 cm predicted 
mortality with 80% sensitivity and 42,5% specificity value (p = 0,0031). 
Among other parameters, only waist-hip ratio – local complications ROC 
curve reached statistical significance; for cut-off value of 0,96 sensitivity 
was 80% and specificity 42,5% (p = 0,0101). 
Conclusion: although obesity is a definitive risk factor for AP, the exact 
measure which should be used to quantify the level of risk still eludes us. 
Statistical analysis has shown that in our case BMI was a poor parameter 
and WC had a better correlation in predicting complications, including 
death, in patients with AP. However, low specificity is the problem which 
will impede WC from gaining a more pronounced role in everyday prac-
tice.
T8 – Alternative treatments
T8:PO.124
Effects of Traditional Chinese acupuncture for treatment of 
obesity: A systematic review
Lenon G.B.1, Li K.X.1, Yang Y.W.1, Xue C.C.1
1Traditional & Complementary Medicine Research Program, Health Innovations 
Research Institute; School of Health Sciences, RMIT University, Bundoora 
Campus, Victoria 3083, Australia;
Background: Traditional Chinese acupuncture has become popular for 
obesity throughout the world but there is a lack of evidence of its efficacy 
and safety. The aim of this study is evaluate the safety and therapeutic 
benefits of traditional acupuncture treatment in management of obesity 
in randomized controlled trials (RCT) 
Methods: The review was conducted according to Cochrane Handbook 
for Systematic Reviews 5.1.0 and searched in 22 electronic databases and 
hand search for all RCT quasi-RCT without language restrictions. Key 
words were acupuncture, obesity, overweight, randomized clinical trial 
and their synonyms. The risk of bias of included studies was assessed. The 
differences in effect size between traditional acupuncture and control: 
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Result: A total of 5,805 potential studies were identified following search 
strategy and 5,710 of them were excluded after screening titles and ab-
stracts. Eight studies were included in this study. The total sample size is 
965 with an average of 120 per trial. The participants aged from 13 to 60 
years old. The duration of treatment varied from 30 days to three months. 
Only two trials involved follow-up period, half year and one year respec-
tively. All included RCTs had unclear or high risk of bias in all domains. 
Meta-analyses showed that acupuncture was more effective for reducing 
body weight and BMI than placebo, no treatment and dietary therapy/
exercise for short-term effects.
Conclusions: In conclusion, although acupuncture appeared to be bene-
ficial for reducing body weight and BMI in patients with obesity, hoewver 
due to the high or unclear risk of bias and unexplained substantial hetero-
geneity, the results need to be interpreted with caution.
T8:PO.125
Evaluation of the efficacy and safety of Redusure (IQP-
AK-102), a proprietary combination for weight reduction
Riede L.1, Grube B.2, Bongartz U.1, Lim Y.M.3
1analyze & realize, GmbH, Weißenseer Weg 111, 10369 Berlin, Germany 
2Practice for General Medicine, Kurfürstendamm 157/158, 10709 Berlin, 
Germany,  
3InQpharm Europe Ltd, Invision House,  Wilbury Way Hitchin, Hertfordshire,  
SG4 0TY, United Kingdom
Introduction: IQP-AK-102 is a novel combination of three soluble fibres. 
Due to its unique physicochemical properties, satiety sensation in the up-
per gut is enhanced through gastric distension and delayed gastric empty-
ing, which subsequently reduces food intake1,2.
Methods: 119 overweight and obese subjects participated in this random-
ized, double-blind, placebo-controlled trial. Subjects took either 2 cap-
sules of IQP-AK-102 or placebo twice daily and were counseled to main-
tain a 20% calorie-deficit diet (energy contributions: 50% carbohydrates, 
30% fat, and 20% protein) and moderate physical activity for 12 weeks. 
Results: 111 subjects were included in the final analysis. Body weight and 
body fat mass were similar in both groups at baseline. After 12 weeks, 
subjects on IQP-AK-102 experienced a statistically significant greater re-
duction in mean body weight compared to placebo group (3.53 ± 2.28 kg 
versus 0.14 ± 1.84 kg, p < 0.001). IQP-AK-102 group had higher body fat 
mass decrease (2.51 ± 3.16 kg versus 0.05 ± 1.95 kg, p < 0.001). Statistical-
ly significant reduction in waist and hip circumference was also observed 
after 12 weeks. No serious product-related adverse events were reported. 
Conclusion: The results indicate that IQP-AK-102 is an effective inter-
vention for body weight reduction with a good safety profile. 
References
1.  Halford, J.C.G., & Harrold, J.A. (2012). Satiety-enhancing products for appetite 
control: science and regulation of functional foods for weight management. 
The Proceedings of the Nutrition Society, 71(2), 350–362. 
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T8:PO.126
The effect of pioglitazone in combination with DPP-4 
inhibitors on liver function and glycemic control in type 2 
diabetes patients with nonalcoholic fatty liver disease.
Ueno N.1
1Ueno Internal Medicine and Diabetes Clinic 
Introduction: Liver cancer is now the main cause of death in type 2 di-
abetes patients. Nonalcoholic steatohepatitis, which can develop to liver 
cancer, often coexists with type 2 diabetes sharing the same risk factors 
including insulin resistance. Pioglitazone is effective in treating nonalco-
holic steatohepatitis, and recently, it has been reported that DPP-4 may 
involve in exacerbating nonalcoholic fatty liver disease. We investigated 
effects of pioglitazone in combination with DPP-4 inhibitor in type 2 dia-
betes patients with nonalcoholic fatty liver disease. 
Methods: Pioglitazone was administered to type 2 diabetes patients with 
nonalcoholic fatty liver disease who had been taking DPP-4 inhibitors. 
Liver function, HbA1c, fasting blood glucose and markers for liver fibrosis 
were monitored for 12 months. 
Results: HbA1c and fasting blood glucose significantly decreased 
(7.8 ± 0.4 to 6.4 ± 0.2%, 148 ± 9 to 123 ± 6 mg/dl). ALT decreased re-
markably and reached the normal range (75 ± 9 to 32 ± 8 IU/l). Type Ⅲ 
collagen 7S decreased significantly (5.1 ± 0.3 to 4.4 ± 0.3 ng/ml) in 12 
months following the additional medication of pioglitazone. 
Conclusion: Combination of pioglitazone with DPP-4 inhibitors mark-
edly ameliorated liver damage from fat deposits with improvement of 
glycemic control, leading to improvement in liver fibrosis marker. This 
combination therapy may be useful in treating type 2 diabetes patients 
with nonalcoholic fatty liver disease.
T8:PO.127
Evaluation of the use of The Malory Band in patients 
attending the Rotherham Institute for Obesity (RIO)
Steele C.1, Reale S.1, Boyden C.1, Capehorn M.1
1Rotherham Institute for Obesity (RIO)
Introduction: The Malory Band is a soft, narrow, adjustable cord that is 
worn around the waist. It is intended to help prevent over-consumption 
by tightening around the waistline as food is consumed, therby potentially 
increasing awareness of food intake and reducing overall intake. To date 
there has been no evaluation of its use, in terms of effectiveness as a weight 
loss aid or patient satisfaction, in a clinical setting. 
Methods: 76 patients (age=45 +/- 13.6 yrs; BMI=41.5 +/- 8.4 kg/m2) who 
were currently engaged with a weight management programme at the 
Rotherham Institute for Obesity (RIO) were involved in a 12 week study. 
38 patients gave consent to trial the Malory Band, and to give subjective 
feedback regarding the product. A further 38 were matched for age and 
initial BMI to act as a control group for comparison. Weight, waist cir-
cumference and questionnaires were completed at baseline, 6 weeks and 
at 12 weeks. 
Results: At baseline, participants loved the idea of the Malory Band, were 
confident in the method by which it intended to work, and expected it to 
control food intake. Participants wore the band for 10–15 hours per day, 
for 3–4 days per week. However, by week 12, 29 (76%) of the participants 
in the study group had withdrawn, of which 8 reported „unable to toler-
ate the band“ as the primary reason. A significant decline in perceived 
helpfulness was reported by the end. The group wearing the Malory Band 
appeared to have done better with primary outcomes than the matched 
group, but there was no statistically significant difference between them 
for weight loss or waist circumference loss. 
Conclusion: The Malory Band appears to be a new and novel intervention 
to assist with weight maintenance. However, initial study results suggest 
that patient compliance with using the product may not be high, and we 
were unable to demostrate and statistically significant improvements in 
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T8:PO.128
Obesity clinic for teenagers - a successful spinoff project, 
bicycling around the country
Danielson T.1, Sigurdardottir G.1, Arnason E.1, Bjarnason R.2,3, Helgason T.3
1Hjolakraftur.com, bicycle training for adolescents,  
2University of Iceland, Faculty of Medicine, Reykjavík, Iceland,  
3Children’s Medical Centre, Landspítali University Hospital, Reykjavík, Iceland
Introduction: Many projects and teams treating obesity in older children 
have faced the challenge of keeping their subjects motivated for physical 
activity. In this project we describe a novel approach that reached a num-
ber of children and led to a personal victory for many of them. 
Methods: When children come to the Health School, the obesity team 
of the National childrens hospital, our aim is to find out what activity is 
most likely to motivate them. Teens were referred to a physiotherapist and 
a fanatic cycling enthusiast, forming groups for regular biking exercises. 
Standardized questionnaires were asked before and after the season. 
Results: The adherence was very good, and a large proportion kept on 
cycling that summer, challenging themselves. The questionnaires revealed 
that the self-esteem and belief in own ability was significantly better. Val-
di was crazy enough to drop the idea that if the teens would be willing 
to work hard, he would do everything in his power to take them to the 
biggest bike race in Iceland. In accordance with the power of the children 
the challenge was taken on to compete in the annual WOW-Cyclothon, a 
biking relay-race around Iceland (1332 km). A team of 6 children, 2 par-
ents and 2 trainers completed the race. The goal was set and reached on 
finishing last, but at the same time to have every team-member win him/
herself, to win the media attention and the fundraiser for the National 
Hospital. This won the group a flight ticket and a biking tour in Lyon, 
France, in September 2014. The aim for 2015 is to have at least 3 teams 
from Hjólakraftur. 
Conclusion: This is an example of a successful spin off project which was 
made possible by the newly formed obesity clinic, enthusiastic trainers 
and good will towards obesity treatment in the society.
T8:PO.129
Effects of α-lipoic acid and eicosapentaenoic acid on 
inflammation and cardiovascular risk markers in overweight/
obese women following an energy-restricted diet
Huerta A.E.1,2, Martínez J.A.1,2,3, Moreno-Aliaga M.J.1,2,3
1Department of Nutrition, Food Science and Physiology, University of Navarra, 
Pamplona, Spain.,  
2CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud 
Carlos III, Madrid, Spain.,  
3Centre for Nutrition Research, University of Navarra, Pamplona, Spain.
There is strong evidence that the pro-inflammatory state accompanied 
by the enlargement of the adipose tissue plays an important role in the 
appearance of related obesity metabolic comorbidities. The aim of this 
trial was to evaluate the additional effects to body weight loss on some 
inflammatory markers of dietary supplementation with α-lipoic acid and 
eicosapentaenoic acid (EPA) separately or in combination in healthy over-
weight/obese women following a hypocaloric diet. 
Methods: Seventy-seven Caucasic healthy overweight/obese sedentary 
women (38.7 ± 7.2 years old) were assigned to one of the four experimen-
tal groups: Control, EPA (1.3 g/d), α-lipoic acid (0.3 g/d), and EPA+α-li-
poic acid (1.3 g/d+0.3 g/d). All groups followed a 10 weeks intervention 
with a personalized hypocaloric diet. At beginning and at the end, inflam-
matory markers were measured in plasma using the appropriate ELISA 
kits. 
Results: The treatment with α-lipoic acid, significantly (P < 0.05) reduced 
circulating levels of C-reactive protein (CRP) and Asymmetric dimeth-
ylarginine (ADMA) while prevented (P < 0.01) the fall of apelin levels 
observed during weight loss. Additionally, the α-lipoic acid reduced leu-
kocyte count, even adjusting by weight loss and initial level (P < 0.01). The 
changes in leukocyte count were significantly and positive correlated with 
changes in CRP and waist circumference (P < 0.01).
Conclusions: The dietary supplementation with α-lipoic acid appears to 
improve some inflammatory and cardiovascular risk markers, suggesting 
additional positive effects of this antioxidant in combination to hypoca-
loric diet in obesity-related metabolic disorders.
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rio de Economía y Competitividad, Spain, AGL 2009-10873/ALI; and by Línea Es-
pecial de Investigación “Nutrición, Obesidad y Salud”, University of Navarra-Spain. 
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